PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kerr, D				Kerr, D			As fit as a butcher's dog	LANCET			English	Editorial Material									Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England		Kerr, D (corresponding author), Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England.	david.kerr@rbch.nhs.uk							0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1981	1981		10.1016/S0140-6736(05)66668-8	http://dx.doi.org/10.1016/S0140-6736(05)66668-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936430				2022-12-01	WOS:000229587800036
J	Phillips-Silver, J; Trainor, LJ				Phillips-Silver, J; Trainor, LJ			Feeling the beat: Movement influences infant rhythm perception	SCIENCE			English	Article									McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada	McMaster University	Trainor, LJ (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.	LJT@mcmaster.ca		Trainor, Laurel/0000-0003-3397-2079				Brown S, 2000, ORIGINS OF MUSIC, P3; CLARK DL, 1977, SCIENCE, V196, P1228, DOI 10.1126/science.300899; Lackner J R, 1992, J Vestib Res, V2, P307; Lehrdal F., 1983, GENERATIVE THEORY TO; Trainor Laurel J., 2003, COGNITIVE NEUROSCIEN, P310; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084	6	375	380	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1430	1430		10.1126/science.1110922	http://dx.doi.org/10.1126/science.1110922			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933193				2022-12-01	WOS:000229619300042
J	Yip, CK; Kimbrough, TG; Felise, HB; Vuckovic, M; Thomas, NA; Pfuetzner, RA; Frey, EA; Finlay, BB; Miller, SI; Strynadka, NCJ				Yip, CK; Kimbrough, TG; Felise, HB; Vuckovic, M; Thomas, NA; Pfuetzner, RA; Frey, EA; Finlay, BB; Miller, SI; Strynadka, NCJ			Structural characterization of the molecular platform for type III secretion system assembly	NATURE			English	Article							NEEDLE COMPLEX; ASSOCIATION; MULTIMER; INSIGHTS; PROGRAM	Type III secretion systems ( TTSSs) are multi-protein macromolecular 'machines' that have a central function in the virulence of many Gram-negative pathogens by directly mediating the secretion and translocation of bacterial proteins ( termed effectors) into the cytoplasm of eukaryotic cells(1). Most of the 20 unique structural components constituting this secretion apparatus are highly conserved among animal and plant pathogens and are also evolutionarily related to proteins in the flagellar-specific export system. Recent electron microscopy experiments have revealed the gross 'needle-shaped' morphology of the TTSS2-4, yet a detailed understanding of the structural characteristics and organization of these protein components within the bacterial membranes is lacking. Here we report the 1.8-angstrom crystal structure of EscJ from enteropathogenic Escherichia coli (EPEC), a member of the YscJ/ PrgK family whose oligomerization represents one of the earliest events in TTSS assembly(5). Crystal packing analysis and molecular modelling indicate that EscJ could form a large 24-subunit 'ring' superstructure with extensive grooves, ridges and electrostatic features. Electron microscopy, labelling and mass spectrometry studies on the orthologous Salmonella typhimurium PrgK within the context of the assembled TTSS support the stoichiometry, membrane association and surface accessibility of the modelled ring. We propose that the YscJ/ PrgK protein family functions as an essential molecular platform for TTSS assembly.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; Dept Microbiol & Med, Seattle, WA 98195 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of Washington; University of Washington Seattle; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Thomas, Nikhil/0000-0003-3037-425X; Yip, Calvin/0000-0003-1779-9501				Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x; EVANS PR, 1993, P CCP4 STUD WEEK DAT, P1114; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kimbrough TG, 2002, MICROBES INFECT, V4, P75, DOI 10.1016/S1286-4579(01)01512-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; LESLIE AGW, 1992, CCP4 ESF EAMCB NEWSL; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101	28	158	164	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					702	707		10.1038/nature03554	http://dx.doi.org/10.1038/nature03554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931226				2022-12-01	WOS:000229476200056
J	Petersen, J; Hagan, IM				Petersen, J; Hagan, IM			Polo kinase links the stress pathway to cell cycle control and tip growth in fission yeast	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE; GENETIC-CONTROL; DIVISION CYCLE; MAP KINASE; HISTONE H3; PHOSPHORYLATION; ADAPTATION; EXPRESSION; PROTEIN; LENGTH	Stress-activated mitogen-activated protein kinase cascades instigate a range of changes to enable eukaryotic cells to cope with particular insults. In Schizosaccharomyces pombe these responses include the transcription of specific gene sets and inhibition of entry into mitosis(1,2). The S. pombe stress response pathway (SRP) also promotes commitment to mitosis in unperturbed cell cycles to allow cells to match their rate of division with nutrient availability(1,3). The nature of this SRP function in cell cycle control is unknown. Entry into mitosis is controlled by mitosis-promoting factor (MPF; Cdc2/cyclin B) activity. Inhibitory phosphorylation of Cdc2 by Wee1 kinase inactivates MPF until Cdc25 removes this phosphate to promote mitosis(4). The balance between Wee1 and Cdc25 activities is influenced by the recruitment of polo kinase (Plo1) to the spindle pole body (SPB)(5). The SPB component Cut12 mediates this recruitment(5,6). Hyper-activating mutations in either cut12 or plo1 enable Cdc25-defective cells to enter mitosis(5,7). The hyperactive cut12.s11 mutation suppresses cdc25.22, as it promotes recruitment of active Plo1 to interphase SPBs(6,7). Here we show that the SRP promotes phosphorylation of Plo1 on Ser 402. In unperturbed cell cycles, SRP-mediated phosphorylation of Ser 402 promotes Plo1 recruitment to SPBs and thus commitment to mitosis. Ser 402 phosphorylation also ensures efficient reinitiation of cell tip growth and cell division during recovery from particular stresses. Thus, phosphorylation of Plo1 Ser 402 not only enables SRP signalling to modulate the timing of mitotic commitment in response to nutrient status in unperturbed cycles, but also promotes the return to normal cell cycle control after stress.	Paterson Inst Canc Res, Canc Res UK Cell Div Grp, Manchester M20 4BX, Lancs, England; Rockefeller Univ, New York, NY 10021 USA	Paterson Institute for Cancer Research; Rockefeller University	Hagan, IM (corresponding author), Paterson Inst Canc Res, Canc Res UK Cell Div Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	ihagan@picr.man.ac.uk		Petersen, Janni/0000-0003-0729-9335; Hagan, Iain/0000-0002-5858-9415				Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; HUDSON JD, 1990, GENETICS, V126, P309; MacIver FH, 2003, YEAST, V20, P587, DOI 10.1002/yea.983; MacIver FH, 2003, GENE DEV, V17, P1507, DOI 10.1101/gad.256003; MARKS J, 1985, EUR J CELL BIOL, V39, P27; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAY JW, 1986, NATURE, V322, P752, DOI 10.1038/322752a0; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mulvihill DP, 1999, MOL BIOL CELL, V10, P2771, DOI 10.1091/mbc.10.8.2771; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OGDEN JE, 1986, CURR GENET, V10, P509, DOI 10.1007/BF00447384; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Toone WM, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P57; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9	28	95	98	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					507	512		10.1038/nature03590	http://dx.doi.org/10.1038/nature03590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917811				2022-12-01	WOS:000229337800057
J	Gould, DB; Phalan, FC; Breedveld, GJ; van Mil, SE; Smith, RS; Schimenti, JC; Aguglia, U; van der Knaap, MS; Heutink, P; John, SWM				Gould, DB; Phalan, FC; Breedveld, GJ; van Mil, SE; Smith, RS; Schimenti, JC; Aguglia, U; van der Knaap, MS; Heutink, P; John, SWM			Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly	SCIENCE			English	Article							IV COLLAGEN; CAENORHABDITIS-ELEGANS; MOUSE; HEMIPLEGIA; LETHALITY; MICE	Porencephaly is a rare neurological disease, typically manifest in infants, which is characterized by the existence of degenerative cavities in the brain. To investigate the molecular pathogenesis of porencephaly, we studied a mouse mutant that develops porencephaly secondary to focal disruptions of vascular basement membranes. Half of the mutant mice died with cerebral hemorrhage within a day of birth, and similar to 18% of survivors had porencephaly. We show that vascular defects are caused by a semidominant mutation ill the procollagen type IV alpha 1 gene (CoNa1) in mice, which inhibits the secretion of mutant and normal type IV collagen. We also show that COL4A1 mutations segregate with porencephaly in human families. Because not all mutant mice develop porencephaly, we propose that CoNa1 mutations conspire with environmental trauma in causing the disease.	Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Erasmus Med Ctr, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Human Genet, Sect Med Genom, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Ctr Neurogenom & Cognit Res, NL-1081 BT Amsterdam, Netherlands; Univ Catanzaro, Reg Epilepsy Ctr, I-89100 Reggio Di Calabria, Italy; Free Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 BT Amsterdam, Netherlands; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Howard Hughes Medical Institute; Jackson Laboratory; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Magna Graecia University of Catanzaro; Vrije Universiteit Amsterdam; Tufts University	John, SWM (corresponding author), Howard Hughes Med Inst, Bar Harbor, ME 04609 USA.	swmj@jax.org	Aguglia, Umberto/AAB-9898-2019	Aguglia, Umberto/0000-0002-4574-2951; Heutink, Peter/0000-0001-5218-1737	NCI NIH HHS [CA34196] Funding Source: Medline; NEI NIH HHS [EY11721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY011721, R01EY011721] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguglia U, 2004, NEUROLOGY, V62, P1613, DOI 10.1212/01.WNL.0000123113.46672.68; BERG RA, 1983, ARCH NEUROL-CHICAGO, V40, P567, DOI 10.1001/archneur.1983.04050080067013; BLUMBERG B, 1987, J BIOL CHEM, V262, P5947; CATTANACH BM, 1993, MOUSE GENOME, V91, P853; Debus OM, 2004, ANN NEUROL, V56, P287, DOI 10.1002/ana.20184; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.bb.20.060191.001033; GOULD DB, UNPUB; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; HAAR F, 1977, NEUROLOGY, V27, P849, DOI 10.1212/WNL.27.9.849; KEFALIDES NA, 1971, BIOCHEM BIOPH RES CO, V45, P226, DOI 10.1016/0006-291X(71)90073-8; Mancini GMS, 2004, EUR J PAEDIATR NEURO, V8, P45, DOI 10.1016/j.ejpn.2003.10.002; MAYNE R, 1984, J CELL BIOL, V98, P1637, DOI 10.1083/jcb.98.5.1637; MUTHUKUMARAN G, 1989, J BIOL CHEM, V264, P6310; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; PASTERNAK JF, 1980, AM J DIS CHILD, V134, P673, DOI 10.1001/archpedi.1980.02130190041010; POSCHL E, 2004, DEVELOPMENT; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; RENIERI A, 1994, NEPHRON, V67, P444, DOI 10.1159/000188020; SCHUPPAN D, 1980, FEBS LETT, V115, P297, DOI 10.1016/0014-5793(80)81191-4; SENSI A, 1990, CLIN GENET, V38, P396; SIBLEY MH, 1994, EMBO J, V13, P3278, DOI 10.1002/j.1460-2075.1994.tb06629.x; SMIT LME, 1984, BRAIN DEV-JPN, V6, P54, DOI 10.1016/S0387-7604(84)80010-8; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRUEB B, 1982, J BIOL CHEM, V257, P5239; Urabe N, 2002, ARCH HISTOL CYTOL, V65, P133, DOI 10.1679/aohc.65.133; Vilain C, 2002, AM J MED GENET, V112, P198, DOI 10.1002/ajmg.10452; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; ZONANA J, 1986, J PEDIATR-US, V109, P671, DOI 10.1016/S0022-3476(86)80240-2	29	357	372	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1167	1171		10.1126/science.1109418	http://dx.doi.org/10.1126/science.1109418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905400				2022-12-01	WOS:000229293400043
J	Vermot, J; Pourquie, O				Vermot, J; Pourquie, O			Retinoic acid coordinates somitogenesis and left-right patterning in vertebrate embryos	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; CHICK-EMBRYO; SEGMENTATION CLOCK; NODAL EXPRESSION; SOMITE FORMATION; MOUSE; INFORMATION; PATHWAYS; GENE; BUD	A striking feature of the body plan of a majority of animals is bilateral symmetry. Almost nothing is known about the mechanisms controlling the symmetrical arrangement of the left and right body sides during development. Here we report that blocking the production of retinoic acid ( RA) in chicken embryos leads to a desynchronization of somite formation between the two embryonic sides, demonstrated by a shortened left segmented region. This defect is linked to a loss of coordination of the segmentation clock oscillations(1). The lateralization of this defect led us to investigate the relation between somitogenesis and the left - right asymmetry machinery(2,3) in RA-deficient embryos. Reversal of the situs in chick(4,5) or mouse(6) embryos lacking RA results in a reversal of the somitogenesis laterality defect. Our data indicate that RA is important in buffering the lateralizing influence of the left - right machinery, thus permitting synchronization of the development of the two embryonic sides.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000E 50th St, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Vermot, Julien/I-6568-2016; Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227; , Julien/0000-0002-8924-732X				Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; BRUECKNER M, 1989, P NATL ACAD SCI USA, V86, P5035, DOI 10.1073/pnas.86.13.5035; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 1997, DEV BIOL, V189, P57, DOI 10.1006/dbio.1997.8662; Maden M, 1998, DEVELOPMENT, V125, P4133; Maden M, 2000, INT J DEV BIOL, V44, P151; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363	29	183	192	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					215	220		10.1038/nature03488	http://dx.doi.org/10.1038/nature03488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889094				2022-12-01	WOS:000229021100043
J	Blank, S; Schillinger, JA; Harbatkin, D				Blank, S; Schillinger, JA; Harbatkin, D			Lymphogranuloma venereum in the industrialised world	LANCET			English	Editorial Material									New York City Dept Hlth & Mental Hyg, Bur Sexually Transmitted Dis Control, New York, NY 10013 USA; Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; Callen Lorde Community Hlth Ctr, New York, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA	Blank, S (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Sexually Transmitted Dis Control, New York, NY 10013 USA.	sblank@health.nyc.gov						*CDC, 2004, MMWR-MORBID MORTAL W, V53, P955; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; GOTZ HM, 2004, EURASURVEILLANC 0122; *HLTH PROT AG, 2005, CDR WKLY        0415; Koo D, 1996, J Public Health Manag Pract, V2, P4; Nieuwenhuis RF, 2004, CLIN INFECT DIS, V39, P996, DOI 10.1086/423966; PERINE PL, 1999, SEXUALLY TRANSMITTED, P423	7	33	33	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 7	2005	365	9471					1607	1608		10.1016/S0140-6736(05)66490-2	http://dx.doi.org/10.1016/S0140-6736(05)66490-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885284				2022-12-01	WOS:000228933700009
J	Anderson, B; Cole, WW; Barrett, SCH				Anderson, B; Cole, WW; Barrett, SCH			Specialized bird perch aids cross-pollination	NATURE			English	Editorial Material									Univ KwaZulu Natal, Sch Bot & Zool, ZA-3209 Pietermaritzburg, South Africa; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada	University of Kwazulu Natal; University of Toronto	Anderson, B (corresponding author), Univ KwaZulu Natal, Sch Bot & Zool, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	barrett@botany.utoronto.ca	Barrett, Spencer CH/M-3751-2013; ANDERSON, BRUCE/E-5853-2011; Barrett, Spencer C.H./S-5782-2019	Barrett, Spencer C.H./0000-0002-7762-3455; Anderson, Bruce/0000-0002-7264-4505				Barrett SCH, 1996, TRENDS ECOL EVOL, V11, P73, DOI 10.1016/0169-5347(96)81046-9; BROWN NE, 1932, T ROY SOC S AFR, V20, P261; Goldblatt Peter, 1999, Adansonia (Paris), V21, P25; WESTERKAMP C, 1990, BOT ACTA, V103, P366, DOI 10.1111/j.1438-8677.1990.tb00176.x	4	51	52	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					41	42		10.1038/435041a	http://dx.doi.org/10.1038/435041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875009				2022-12-01	WOS:000228864600031
J	Brown, SA; Ripperger, J; Kadener, S; Fleury-Olela, F; Vilbois, F; Rosbash, M; Schibler, U				Brown, SA; Ripperger, J; Kadener, S; Fleury-Olela, F; Vilbois, F; Rosbash, M; Schibler, U			PERIOD1-associated proteins modulate the negative limb of the mammalian circadian oscillator	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; COURTSHIP SONG; CLOCK; CELLS	The clock proteins PERIOD1 (PER1) and PERIOD2 (PER2) play essential roles in a negative transcriptional feedback loop that generates circadian rhythms in mammalian cells. We identified two PER1-associated factors, NONO and WDR5, that modulate PER activity. The reduction of NONO expression by RNA interference (RNAi) attenuated circadian rhythms in mammalian cells, and fruit flies carrying a hypomorphic allele were nearly arrhythmic. WDR5, a subunit of histone methyltransferase complexes, augmented PER-mediated transcriptional repression, and its reduction by RNAi diminished circadian histone methylations at the promoter of a clock gene.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA; Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland	University of Geneva; University of Geneva; Brandeis University; Howard Hughes Medical Institute	Brown, SA (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	steven.brown@molbio.unige.ch; Ueli.schibler@molbio.unige.ch	Brown, Steven/E-4955-2013					Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; RENDAHL KG, 1992, J NEUROSCI, V12, P390; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; STANEWSKY R, 1993, GENETICS, V135, P419; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	18	212	231	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					693	696		10.1126/science.1107373	http://dx.doi.org/10.1126/science.1107373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860628				2022-12-01	WOS:000228810900050
J	Gollogly, S				Gollogly, S			Do as I say, not as I do	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1499	1499		10.1016/S0140-6736(05)66421-5	http://dx.doi.org/10.1016/S0140-6736(05)66421-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850635				2022-12-01	WOS:000228651600029
J	Wu, T; Malinverni, J; Ruiz, N; Kim, S; Silhavy, TJ; Kahne, D				Wu, T; Malinverni, J; Ruiz, N; Kim, S; Silhavy, TJ; Kahne, D			Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli	CELL			English	Article							CELL-SURFACE; PROTEINS; LIPOPROTEIN; LIPOPOLYSACCHARIDE; EXPORT; GENE; K-12; LOCALIZATION; PATHWAY; SYSTEM	Gram-negative bacteria have an outer membrane (OM) that functions as a barrier to protect the cell from toxic compounds such as antibiotics and detergents. The OM is a highly asymmetric bilayer composed of phospholipids, glycolipids, and proteins. Assembly of this essential organelle occurs outside the cytoplasm in an environment that lacks obvious energy sources such as ATP, and the mechanisms involved are poorly understood. We describe the identification of a multiprotein complex required for the assembly of proteins in the OM of Escherichia coli. We also demonstrate genetic interactions between genes encoding components of this protein assembly complex and imp, which encodes a protein involved in the assembly of lipopolysaccharides (LPS) in the OM. These genetic interactions suggest a role for YfgL, one of the lipoprotein components of the protein assembly complex, in a homeostatic control mechanism that coordinates the overall OM assembly process.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Princeton University; Harvard University; Princeton University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	kahne@chemistry.harvard.edu	Kim, Seokhee/C-2303-2018; Wu, Tao/C-7533-2013	Kim, Seokhee/0000-0003-0806-583X; Silhavy, Thomas/0000-0001-7672-5153; Ruiz, Natividad/0000-0002-6369-2206	NIGMS NIH HHS [GM34821, GM66174] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174, R37GM034821, R01GM034821] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYER ME, 1968, J VIROL, V2, P346, DOI 10.1128/JVI.2.4.346-356.1968; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; BOUVIER J, 1991, J BACTERIOL, V173, P5523, DOI 10.1128/jb.173.17.5523-5531.1991; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FREUDL R, 1985, EMBO J, V4, P3593, DOI 10.1002/j.1460-2075.1985.tb04122.x; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; GENNITY JM, 1991, J BIOL CHEM, V266, P16458; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; HALEGOUA S, 1979, J MOL BIOL, V130, P39, DOI 10.1016/0022-2836(79)90551-5; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KELLENBERGER E, 1990, MOL MICROBIOL, V4, P697, DOI 10.1111/j.1365-2958.1990.tb00640.x; Kloser A, 1998, MOL MICROBIOL, V27, P1003, DOI 10.1046/j.1365-2958.1998.00746.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; METCALFE M, 1980, FEMS MICROBIOL LETT, V7, P111, DOI 10.1111/j.1574-6941.1980.tb01587.x; MISRA R, 1991, J BIOL CHEM, V266, P13592; MUHLRADT PF, 1973, EUR J BIOCHEM, V35, P471, DOI 10.1111/j.1432-1033.1973.tb02861.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; ONUFRYK C, 2005, J BACTERIOL, V25, P765; PAGES JM, 1990, BIOCHIMIE, V72, P169, DOI 10.1016/0300-9084(90)90142-4; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; RIED G, 1990, J BACTERIOL, V172, P6048, DOI 10.1128/jb.172.10.6048-6053.1990; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; SAMPSON BA, 1989, GENETICS, V122, P491; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; SCIDMORE MA, 1993, MOL BIOL CELL, V4, P1145, DOI 10.1091/mbc.4.11.1145; SILHAVY TJ, 1984, EXPT GENE FUSIONS PL; SMIT J, 1978, J BACTERIOL, V135, P687, DOI 10.1128/JB.135.2.687-702.1978; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	43	550	561	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					235	245		10.1016/j.cell.2005.02.015	http://dx.doi.org/10.1016/j.cell.2005.02.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851030	Bronze			2022-12-01	WOS:000228705000011
J	Dejean, A; Solano, PJ; Ayroles, J; Corbara, B; Orivel, J				Dejean, A; Solano, PJ; Ayroles, J; Corbara, B; Orivel, J			Insect behaviour: Arboreal ants build traps to capture prey	NATURE			English	Editorial Material									Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Clermont Ferrand, Lab Psychol Sociale Cognit, CNRS, ESA 6024, F-63037 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Illinois System; University of Illinois Urbana-Champaign; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Dejean, A (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France.	orivel@cict.fr	Orivel, Jerome/C-4034-2011	Orivel, Jerome/0000-0002-5636-3228; CORBARA, Bruno/0000-0003-4232-8234; Dejean, Alain/0000-0002-3561-2248				Benson WW, 1985, AMAZONIA, P239; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Dejean A, 2003, ARTHROPODS OF TROPICAL FORESTS, P341; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holldobler B., 1990, pi; MORAIS HC, 1994, INSECT SOC, V41, P339, DOI 10.1007/BF01242307; Offenberg J, 2001, BEHAV ECOL SOCIOBIOL, V49, P304, DOI 10.1007/s002650000303; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101	8	88	96	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					973	973		10.1038/434973a	http://dx.doi.org/10.1038/434973a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846335				2022-12-01	WOS:000228524600026
J	Coggon, DIW; Martyn, CN				Coggon, DIW; Martyn, CN			Time and chance: the stochastic nature of disease causation	LANCET			English	Article									Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Martyn, CN (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.	cnm@mrc.soton.ac.uk						*BIBLE, KING JAMES, V11; Pepys Samuel, 1664, DIARY S PEPYS; WHEATLEY HB, PROJECT GUTENBERG RE	3	37	37	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2005	365	9468					1434	1437		10.1016/S0140-6736(05)66380-5	http://dx.doi.org/10.1016/S0140-6736(05)66380-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836893				2022-12-01	WOS:000228401900033
J	Mayer, AL; Kauppi, PE; Angelstam, PK; Zhang, Y; Tikka, PM				Mayer, AL; Kauppi, PE; Angelstam, PK; Zhang, Y; Tikka, PM			Importing timber, exporting ecological impact	SCIENCE			English	Article							FOREST POLICY; CONSERVATION; MANAGEMENT		US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; Swedish Univ Agr Sci, Fac Forest Sci, Sch Forest Engineers, S-75007 Uppsala, Sweden	United States Environmental Protection Agency; University of Helsinki; Swedish University of Agricultural Sciences	Mayer, AL (corresponding author), US EPA, Off Res & Dev, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA.	mayer.audrey@epa.gov	Mayer, AL/AAO-3225-2020	Mayer, AL/0000-0003-3278-1182				Angelstam P, 2003, AMBIO, V32, P527, DOI 10.1639/0044-7447(2003)032[0527:TGAATF]2.0.CO;2; ANGELSTAM P, 2004, ECOL B, V51; BARBIER EB, 1999, WORLD FORESTS SOC EN, P106; Bergeron Y, 2004, FOREST CHRON, V80, P458, DOI 10.5558/tfc80458-4; BERLIK MM, 2002, 26 HARV U; Burnett C, 2003, CONSERV ECOL, V7; Burton PJ, 2003, TOWARDS SUSTAINABLE MANAGEMENT OF THE BOREAL FOREST, P1; Carlson A, 2000, FOREST ECOL MANAG, V131, P215, DOI 10.1016/S0378-1127(99)00215-7; Dekker-Robertson DL, 1998, BIOSCIENCE, V48, P471, DOI 10.2307/1313245; DUDAREV G, 2002, ETLA SERIES B, V195; FILIPTCHOUK AN, 2001, 18 UN EC COMM EUR; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Hammett AL, 2001, J FOREST, V99, P4; Hanski I, 2000, ANN ZOOL FENN, V37, P271; Lehtonen E, 2003, ENVIRON SCI POLICY, V6, P195, DOI 10.1016/S1462-9011(03)00035-2; Linden H, 2000, WILDLIFE BIOL, V6, P179, DOI 10.2981/wlb.2000.007; Liski J, 2003, CLIMATIC CHANGE, V61, P89, DOI 10.1023/A:1026365005696; LUND HG, 1998, P INT WORKSH JOENS F; Moiseyev A., 1999, World forests, society and environment, P351; Sedjo RA, 2001, FOREST CHRON, V77, P221, DOI 10.5558/tfc77221-2; SEDJO RA, 1995, J FOREST, V93, P25; Sohngen B, 1999, AM J AGR ECON, V81, P1, DOI 10.2307/1244446; *US EMB BEIJ, 2000, FOR PEOPL PRC NAT FO; VEIJOLA P, COMMUNICATION; Wang S, 2004, FOREST POLICY ECON, V6, P71, DOI 10.1016/S1389-9341(02)00078-3; Wernick IK, 2000, J FOREST, V98, P8; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; 2003, XINHUA NEWS AGE 1201	28	128	135	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					359	360		10.1126/science.1109476	http://dx.doi.org/10.1126/science.1109476			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831743	Green Submitted			2022-12-01	WOS:000228492000034
J	Farmer, H; McCabe, N; Lord, CJ; Tutt, ANJ; Johnson, DA; Richardson, TB; Santarosa, M; Dillon, KJ; Hickson, I; Knights, C; Martin, NMB; Jackson, SP; Smith, GCM; Ashworth, A				Farmer, H; McCabe, N; Lord, CJ; Tutt, ANJ; Johnson, DA; Richardson, TB; Santarosa, M; Dillon, KJ; Hickson, I; Knights, C; Martin, NMB; Jackson, SP; Smith, GCM; Ashworth, A			Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; POLY(ADP-RIBOSE) POLYMERASE; REPLICATION FORKS; PROTEIN; CANCER; BREAKS; RECOMBINATION; PHOSPHORYLATION; INHIBITORS; PARP-1	BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination(1), and mutations in these genes predispose to breast and other cancers(2). Poly(ADP-ribose) polymerase ( PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks(3). We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis. This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination. These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.	Canc Res UK Gene Funct & Regulat Grp, London SW3 6JB, England; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Guys Hosp, London SE1 9RT, England; KuDOS Pharmaceut Ltd, Cambridge CB4 0WG, England; Univ Cambridge, Gurdon Inst Canc & Dev Biol, Wellcome Trust & Canc REs UK, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; AstraZeneca; Cancer Research UK; University of Cambridge; University of Cambridge	Ashworth, A (corresponding author), Canc Res UK Gene Funct & Regulat Grp, Fulham Rd, London SW3 6JB, England.	gcmsmith@kudospharma.co.uk; alan.ashworth@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Dry, Kate/I-2328-2014; Lord, Christopher J/B-3295-2012; Santarosa, Manuela/A-7300-2013; Jackson, Stephen Philip/R-4548-2019	Lord, Christopher J/0000-0002-3226-0515; Santarosa, Manuela/0000-0001-7682-2578; Jackson, Stephen Philip/0000-0001-9317-7937; Tutt, Andrew/0000-0001-8715-2901; Hickson, Ian/0000-0002-9167-0514	NCI NIH HHS [F31 CA260794] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Now		Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Boulton S, 1999, CARCINOGENESIS, V20, P199, DOI 10.1093/carcin/20.2.199; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Dillon KJ, 2003, J BIOMOL SCREEN, V8, P347, DOI 10.1177/1087057103008003013; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; LOH VM, IN PRESS BIOINORG ME; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284	22	4310	4475	29	682	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					917	921		10.1038/nature03445	http://dx.doi.org/10.1038/nature03445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829967				2022-12-01	WOS:000228327600045
J	Mehta, RH; Alexander, JH; Van de Werf, F; Armstrong, PW; Pieper, KS; Garg, J; Califf, RM; Granger, CB				Mehta, RH; Alexander, JH; Van de Werf, F; Armstrong, PW; Pieper, KS; Garg, J; Califf, RM; Granger, CB			Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; MEDICATION ERRORS; THROMBOLYSIS; TRIAL; PREDICTORS; MORTALITY; ALTEPLASE; BENEFITS; STROKE; AGENTS	Context Incorrect dosing of alteplase has been associated with worse clinical outcomes in patients. However, patients at high risk of adverse events are more prone to dosing errors, thus confounding this relationship. Objective To determine if the association between incorrect dosing of alteplase and adverse outcomes is related to cause and effect or to confounding. Design, Setting, and Patients Observational analysis in May 2004 of a double-blind, double-dummy trial of 16949 patients with ST-segment elevation myocardial infarction who were enrolled in the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) trial and were assigned to either a bolus of tenecteplase (with alteplase placebo bolus plus infusion) or a bolus of alteplase (with tenecteplase placebo plus infusion). Main Outcome Measures Thirty-day mortality, in-hospital stroke, and major bleeding associated with incorrect dosing of active alteplase compared with placebo alteplase. Results Incorrect dosing occurred in 4.9% of patients who received active alteplase and in 4.6% of patients who received alteplase placebo. Patients receiving incorrect doses of alteplase or alteplase placebo were more likely to be older, female, black, shorter, have lower body weight and systolic blood pressure, and have a higher Killip class at presentation. Thirty-day mortality was higher in patients who received an overdose (9.8%) or underdose (19.5%) of alteplase compared with those who received a correct dose (5.4%). The same pattern was present in patients who received an alteplase placebo (10.0% for overdose, 23.5% for underclose, and 5.4% for correct dose). Similar patterns were seen for in-hospital intracranial hemorrhage and major bleeding. The higher rates of adverse outcomes with incorrect dosing were largely accounted for by adjusting for baseline characteristics. Conclusions The relationship between incorrect dosing and patient outcome in ASSENT-2 is primarily due to confounding factors rather than incorrect dosing itself. These data highlight the need for caution when ascribing a causal relationship to associations between incorrect dosing and adverse outcomes.	Duke Univ, Med Ctr, Durham, NC 27710 USA; Duke Clin Res Inst, Durham, NC USA; Katholieke Univ Leuven Hosp, Dept Internal Med, Div Cardiol, Louvain, Belgium; Univ Alberta, Dept Internal Med, Div Cardiol, Edmonton, AB, Canada	Duke University; Duke University; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Alberta	Granger, CB (corresponding author), Duke Univ, Med Ctr, Box 3409, Durham, NC 27710 USA.	grang001@mc.duke.edu	Granger, Christopher B/D-3458-2014; Alexander, John/GVS-7271-2022	Granger, Christopher B/0000-0002-0045-3291; Van de Werf, Frans/0000-0001-9479-7767; Armstrong, Paul/0000-0002-0460-3445; Alexander, John/0000-0002-1444-2462				Berkowitz SD, 1997, CIRCULATION, V95, P2508, DOI 10.1161/01.CIR.95.11.2508; Cannon CP, 2000, AM HEART J, V140, pS154, DOI 10.1067/mhj.2000.111605; Cannon CP, 2000, AM J CARDIOL, V85, p17C; COULTER SA, 2000, CIRCULATION S2, V102, P1590; Freedman JE, 2002, CIRCULATION, V106, P2623, DOI 10.1161/01.CIR.0000037748.19282.7D; GORE JM, 1995, CIRCULATION, V92, P2811, DOI 10.1161/01.CIR.92.10.2811; GRANGER CB, 1994, CIRCULATION S1, V90, P1324; Gurwitz JH, 1998, ANN INTERN MED, V129, P597, DOI 10.7326/0003-4819-129-8-199810150-00002; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Phillips DP, 1998, LANCET, V351, P643, DOI 10.1016/S0140-6736(98)24009-8; SMALLING RW, 1995, CIRCULATION, V91, P2725, DOI 10.1161/01.CIR.91.11.2725; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; VORCHHEIMER DA, 1997, CIRCULATION S1, V96, P1535	13	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2005	293	14					1746	1750		10.1001/jama.293.14.1746	http://dx.doi.org/10.1001/jama.293.14.1746			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915JS	15827313	Bronze			2022-12-01	WOS:000228301100028
J	Crombie, C; Fraser, A				Crombie, C; Fraser, A			Treating genetic disease through RNA interference	LANCET			English	Editorial Material							CELLS		Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Fraser, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	agf@sanger.ac.uk		Fraser, Andrew/0000-0001-9939-6014				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Reich S, 2003, MOL VIS, V9, P210; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121	7	4	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2005	365	9467					1288	1290		10.1016/S0140-6736(05)61006-9	http://dx.doi.org/10.1016/S0140-6736(05)61006-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823365				2022-12-01	WOS:000228219600007
J	Huber, D; Veinante, P; Stoop, R				Huber, D; Veinante, P; Stoop, R			Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala	SCIENCE			English	Article							EXTENDED AMYGDALA; BINDING SITES; IN-VITRO; RAT; BEHAVIOR; BRAIN; RELEASE; NUCLEUS; ANTAGONIST; EXPRESSION	Vasopressin and oxytocin strongly modulate autonomic fear responses, through mechanisms that are still unclear. We describe how these neuro-peptides excite distinct neuronal populations in the central amygdala, which provides the major output of the amygdaloid complex to the autonomic nervous system. We identified these two neuronal. populations as part of an inhibitory network, through which vasopressin and oxytocin modulate the integration of excitatory information from the basolateral amygdala and cerebral cortex in opposite manners. Through this network, the expression and endogenous activation of vasopressin and oxytocin receptors may regulate the autonomic expression of fear.	Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Cellular Biol & Morphol, CH-1015 Lausanne, Switzerland; Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland; Univ Strasbourg 1, CNRS, UMR 7519, Strasbourg, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Stoop, R (corresponding author), Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Cellular Biol & Morphol, CH-1015 Lausanne, Switzerland.	rstoop@unil.ch	Huber, Daniel/C-2932-2013	Veinante, Pierre/0000-0002-6608-8960; Huber, Daniel/0000-0002-0744-7679				Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; CONDESLARA M, 1994, BRAIN RES, V637, P277, DOI 10.1016/0006-8993(94)91245-9; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Ebner K, 2005, NEUROPSYCHOPHARMACOL, V30, P223, DOI 10.1038/sj.npp.1300607; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Kang-Park MH, 2004, NEUROPHARMACOLOGY, V46, P1, DOI 10.1016/S0028-3908(03)00340-X; Koob GF, 2003, EUR NEUROPSYCHOPHARM, V13, P442, DOI 10.1016/j.euroneuro.2003.08.005; KOVACS GL, 1994, PHARMACOL REV, V46, P269; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu YF, 1997, BRAIN RES, V768, P266, DOI 10.1016/S0006-8993(97)00655-0; Lubin DA, 2003, BEHAV NEUROSCI, V117, P195, DOI 10.1037/0735-7044.117.2.195; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; Nie ZG, 2004, SCIENCE, V303, P1512, DOI 10.1126/science.1092550; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Savander V, 1996, J COMP NEUROL, V374, P291, DOI 10.1002/(SICI)1096-9861(19961014)374:2<291::AID-CNE10>3.0.CO;2-Y; SOFRONIEW MV, 1983, TRENDS NEUROSCI, V6, P467, DOI 10.1016/0166-2236(83)90221-7; Veinante P, 1997, J COMP NEUROL, V383, P305; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829	27	601	623	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					245	248		10.1126/science.1105636	http://dx.doi.org/10.1126/science.1105636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821089				2022-12-01	WOS:000228273700051
J	Bricelj, VM; Connell, L; Konoki, K; MacQuarrie, SP; Scheuer, T; Catterall, WA; Trainer, VL				Bricelj, VM; Connell, L; Konoki, K; MacQuarrie, SP; Scheuer, T; Catterall, WA; Trainer, VL			Sodium channel mutation leading to saxitoxin resistance in clams increases risk of PSP	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; TETRODOTOXIN; INSENSITIVITY; ADAPTATION; MECHANISMS; BINDING; TOXINS; REGION; GENE	Bivalve molluscs, the primary vectors of paralytic shellfish poisoning (PSP) in humans, show marked inter-species variation in their capacity to accumulate PSP toxins (PSTs)(1) which has a neural basis(2,3). PSTs cause human fatalities by blocking sodium conductance in nerve fibres(4,5). Here we identify a molecular basis for inter-population variation in PSP resistance within a species, consistent with genetic adaptation to PSTs. Softshell clams (Mya arenaria) from areas exposed to 'red tides' are more resistant to PSTs, as demonstrated by whole-nerve assays, and accumulate toxins at greater rates than sensitive clams from unexposed areas. PSTs lead to selective mortality of sensitive clams. Resistance is caused by natural mutation of a single amino acid residue, which causes a 1,000-fold decrease in affinity at the saxitoxin-binding site in the sodium channel pore of resistant, but not sensitive, clams. Thus PSTs might act as potent natural selection agents, leading to greater toxin resistance in clam populations and increased risk of PSP in humans. Furthermore, global expansion of PSP to previously unaffected coastal areas(6) might result in long-term changes to communities and ecosystems.	Natl Res Council Canada, Inst Marine Biosci, Halifax, NS B3H 3Z1, Canada; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA 98112 USA	International Business Machines (IBM); National Research Council Canada; University of Maine System; University of Maine Orono; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Bricelj, VM (corresponding author), Natl Res Council Canada, Inst Marine Biosci, Halifax, NS B3H 3Z1, Canada.	monica.bricelj@nrc-cnrc.gc.ca	KONOKI, Keiichi/U-2249-2019; Trainer, Vera/AAE-9306-2022					AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; Bricelj V, 1996, HARMFUL TOXIC ALGAL, P405; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; BRICELJ VM, 1991, MAR ECOL PROG SER, V74, P33, DOI 10.3354/meps074033; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Fozzard HA, 1996, PHYSIOL REV, V76, P887, DOI 10.1152/physrev.1996.76.3.887; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Hallegraeff G. M., 2003, MANUAL HARMFUL MARIN, P25; He HQ, 1999, BIOCHEM BIOPH RES CO, V261, P558, DOI 10.1006/bbrc.1999.1076; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KONTIS KJ, 1993, MOL PHARMACOL, V43, P635; KVITEK RG, 1991, MAR ECOL PROG SER, V69, P47, DOI 10.3354/meps069047; Linford NJ, 1998, P NATL ACAD SCI USA, V95, P13947, DOI 10.1073/pnas.95.23.13947; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; Liu MY, 1998, ARCH INSECT BIOCHEM, V37, P73, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;73::AID-ARCH9&gt;3.0.CO;2-W; MACQUARRIE S. P., 2002, THESIS DALHOUSIE U; Martin JL., 1996, HARMFUL TOXIC ALGAL, P3; NARAHASHI T, 1968, J GEN PHYSIOL, V51, pS93; Oshima Y., 1995, MANUAL HARMFUL MARIN, P81; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TWAROG BM, 1972, TOXICON, V10, P273, DOI 10.1016/0041-0101(72)90012-8; Twarog BM, 1974, P 2 INT COR REEF S, P505; Yamane M, 2003, INST GLOB ENVIRONM S, V3, P3	27	237	251	5	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					763	767		10.1038/nature03415	http://dx.doi.org/10.1038/nature03415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815630				2022-12-01	WOS:000228160700041
J	Strom, BL				Strom, BL			Statins and over-the counter availibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Strom, BL (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.								0	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1403	1405		10.1056/NEJMp058025	http://dx.doi.org/10.1056/NEJMp058025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814874				2022-12-01	WOS:000228145200001
J	Jenner, L; Romby, P; Rees, B; Schulze-Briese, C; Springer, M; Ehresmann, C; Ehresmann, B; Moras, D; Yusupova, G; Yusupov, M				Jenner, L; Romby, P; Rees, B; Schulze-Briese, C; Springer, M; Ehresmann, C; Ehresmann, B; Moras, D; Yusupova, G; Yusupov, M			Translational operator of mRNA on the ribosome: How repressor proteins exclude ribosome binding	SCIENCE			English	Article							RAY CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; SYNTHETASE GENE; SUBUNIT; SITE; EXPRESSION; S1	The ribosome of Thermus thermophilus was cocrystallized with initiator transfer RNA (tRNA) and a structured messenger RNA (mRNA) carrying a translational operator. The path of the mRNA was defined at 5.5 angstroms resolution by comparing it with either the crystal structure of the same ribosomal complex lacking mRNA or with an unstructured mRNA. A precise ribosomal environment positions the operator stem-loop structure perpendicular to the surface of the ribosome on the platform of the 30S subunit. The binding of the operator and of the initiator tRNA occurs on the ribosome with an unoccupied tRNA exit site, which is expected for an initiation complex. The positioning of the regulatory domain of the operator relative to the ribosome elucidates the molecular mechanism by which the bound repressor switches off translation. Our data suggest a general way in which mRNA control elements must be placed on the ribosome to perform their regulatory task.	Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Paul Scherrer Inst, Swiss Light Source, CH-8048 Zurich, Switzerland; Inst Biol Physicochim, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Yusupov, M (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.	marat@titus.u-strasbg.fr	ROMBY, Pascale/AGP-3328-2022; Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Jenner, Lasse/0000-0003-3917-8853				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Blaha G, 2001, COLD SPRING HARB SYM, V66, P135, DOI 10.1101/sqb.2001.66.135; Caillet J, 2003, MOL MICROBIOL, V47, P961, DOI 10.1046/j.1365-2958.2003.03364.x; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; GRAFFE M, 1992, SCIENCE, V255, P994, DOI 10.1126/science.1372129; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; KEITH GM, UNPUB; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Nogueira T, 2001, J MOL BIOL, V310, P709, DOI 10.1006/jmbi.2001.4796; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Romby P, 2003, TRENDS GENET, V19, P155, DOI 10.1016/S0168-9525(03)00020-9; Sacerdot C, 1998, MOL MICROBIOL, V29, P1077, DOI 10.1046/j.1365-2958.1998.00995.x; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schlax PJ, 2003, MOL MICROBIOL, V48, P1157, DOI 10.1046/j.1365-2958.2003.03517.x; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; SPIRIN A, 1998, METHOD ENZYMOL, V164, P631; Torres-Larios A, 2002, NAT STRUCT BIOL, V9, P343, DOI 10.1038/nsb789; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	25	76	83	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					120	123		10.1126/science.1105639	http://dx.doi.org/10.1126/science.1105639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802605				2022-12-01	WOS:000228221500047
J	Kinjo, Y; Wu, D; Kim, GS; Xing, GW; Poles, MA; Ho, DD; Tsuji, M; Kawahara, K; Wong, CH; Kronenberg, M				Kinjo, Y; Wu, D; Kim, GS; Xing, GW; Poles, MA; Ho, DD; Tsuji, M; Kawahara, K; Wong, CH; Kronenberg, M			Recognition of bacterial glycosphingolipids by natural killer T cells	NATURE			English	Article							NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; CUTTING EDGE; ACTIVATION	Natural killer T (NKT) cells constitute a highly conserved T lymphocyte subpopulation that has the potential to regulate many types of immune responses through the rapid secretion of cytokines(1,2). NKT cells recognize glycolipids presented by CD1d, a class I-like antigen- presenting molecule. They have an invariant T-cell antigen receptor (TCR) alpha-chain, but whether this invariant TCR recognizes microbial antigens is still controversial. Here we show that most mouse and human NKT cells recognize glycosphingolipids from Sphingomonas, Gram-negative bacteria that do not contain lipopolysaccharide(3-5). NKT cells are activated in vivo after exposure to these bacterial antigens or bacteria, and mice that lack NKT cells have a marked defect in the clearance of Sphingomonas from the liver. These data suggest that NKT cells are T lymphocytes that provide an innate-type immune response to certain microorganisms through recognition by their antigen receptor, and that they might be useful in providing protection from bacteria that cannot be detected by pattern recognition receptors such as Toll-like receptor 4.	La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; NYU, Sch Med, Dept Med, Div Gastroenterol, New York, NY 10016 USA; Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA; Kitasato Inst, Minato Ku, Tokyo 1088642, Japan	La Jolla Institute for Immunology; Scripps Research Institute; Scripps Research Institute; New York University; Rockefeller University; New York University	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	mitch@liai.org	Tsuji, Moriya/B-1471-2008	Poles, Michael/0000-0002-7993-6156; Tsuji, Moriya/0000-0001-8587-277X				Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brossay L, 1998, J IMMUNOL, V161, P5124; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; FISCHER B, 1985, FERTILITAT, V1, P101; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Kawahara K, 2002, FEMS MICROBIOL LETT, V214, P289; KAWAHARA K, 1991, FEBS LETT, V292, P107, DOI 10.1016/0014-5793(91)80845-T; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi E, 1995, ONCOL RES, V7, P529; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Mempel M, 2002, J IMMUNOL, V168, P365, DOI 10.4049/jimmunol.168.1.365; Neef A, 1999, J IND MICROBIOL BIOT, V23, P261, DOI 10.1038/sj.jim.2900768; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Shaw PX, 2003, J IMMUNOL, V170, P6151, DOI 10.4049/jimmunol.170.12.6151; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	30	740	771	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					520	525		10.1038/nature03407	http://dx.doi.org/10.1038/nature03407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791257				2022-12-01	WOS:000227836000045
J	Janke, C; Rogowski, K; Wloga, D; Regnard, C; Kajava, AV; Strub, JM; Temurak, N; van Dijk, J; Boucher, D; van Dorsselaer, A; Suryavanshi, S; Gaertig, J; Edde, B				Janke, C; Rogowski, K; Wloga, D; Regnard, C; Kajava, AV; Strub, JM; Temurak, N; van Dijk, J; Boucher, D; van Dorsselaer, A; Suryavanshi, S; Gaertig, J; Edde, B			Tubulin polyglutamylase enzymes are members of the TTL domain protein family	SCIENCE			English	Article							ALPHA-TUBULIN; TYROSINE LIGASE; CELLS; POLYGLYCYLATION; GLUTAMYLATION; TETRAHYMENA; CENTRIOLE; COMPLEX; BRAIN	Polyglutamylation of tubulin has been implicated in several functions of microtubules, but the identification of the responsible enzyme(s) has been challenging, We found that the neuronal tubulin polyglutamylase is a protein complex containing a tubulin tyrosine ligase-like (TTLL) protein, TTLL1. TTLL1 is a member of a large family of proteins with a TTL homology domain, whose members could catalyze ligations of diverse amino acids to tubulins or other substrates. In the model protist Tetrahymena thermophila, two conserved types of polyglutamylases were characterized that differ in substrate preference and subcellular localization.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; Adolf Butenandt Inst, Dept Mol Biol, D-80336 Munich, Germany; Univ Strasbourg 1, F-67087 Strasbourg, France; Univ Paris 06, CNRS, Biochim Cellulaire Lab, F-75252 Paris, France	University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Munich; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Gaertig, J (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jgaertig@cb.uga.edu; bernard.edde@crbm.cnrs	Gaertig, Jacek/F-1553-2010; Kajava, Andrey V/E-1107-2014; Włoga, Dorota/R-4078-2016; Janke, Carsten/A-7279-2011	Kajava, Andrey V/0000-0002-2342-6886; Włoga, Dorota/0000-0003-3314-7773; Janke, Carsten/0000-0001-7053-2000; Regnard, Catherine/0000-0001-9915-7494; Strub, Jean-Marc/0000-0001-6224-3428; Rogowski, Krzysztof/0000-0002-0206-3289				Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.0.CO;2-5; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Campbell PK, 2002, GENETICS, V162, P307; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Gaertig J, 2000, J EUKARYOT MICROBIOL, V47, P185, DOI 10.1111/j.1550-7408.2000.tb00037.x; Gagnon C, 1996, J CELL SCI, V109, P1545; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; *I GEN RES, TETR THERM SEQ BLAST; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Million K, 1999, J CELL SCI, V112, P4357; PRESTON SF, 1979, J MOL EVOL, V13, P233, DOI 10.1007/BF01739482; RAYBIN D, 1977, J CELL BIOL, V73, P492, DOI 10.1083/jcb.73.2.492; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 2003, J CELL SCI, V116, P4181, DOI 10.1242/jcs.00743; Regnard C, 1998, BIOCHEMISTRY-US, V37, P8395, DOI 10.1021/bi9804131; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; ROGOWSKI K, UNPUB; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Trichet V, 2000, GENE, V257, P109, DOI 10.1016/S0378-1119(00)00383-8	25	221	252	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1758	1762		10.1126/science.1113010	http://dx.doi.org/10.1126/science.1113010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15890843				2022-12-01	WOS:000229926800046
J	Choudhry, NK; Avorn, J				Choudhry, NK; Avorn, J			Over-the-counter statins	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; CONSUMER USE; PREVENTION; THERAPY; PERSISTENCE; PRAVASTATIN; LOVASTATIN; AVERAGE; EVENTS	In late 2004, the British government decided to allow a lipid-lowering agent to be sold as an over-the-counter medication. In contrast, the U.S. Food and Drug Administration recently decided not to do so. The United States and other countries will soon face similar decisions for other statins. Although statins have infrequent side effects and have been shown to be effective in moderate-risk primary prevention populations, many questions remain unanswered about their effectiveness at lower doses in over-the-counter use, the ability of patients to self-select themselves for appropriate therapy, and the social and economic implications associated with this method of distribution for preventive medications. A rational policy decision concerning over-the-counter statin use will require an effectiveness trial to provide data on how such drugs would be used in this context, as well as on the clinical outcomes that could be expected from this novel "route of administration".	Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St, Boston, MA 02120 USA.							Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; ALVAREZ L, 2004, NY TIMES        1015, pA10; [Anonymous], 2004, LANCET, V363, P1659; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Avorn J, 2004, POWERFUL MED BENEFIT; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Brass EP, 2004, AM J CARDIOL, V94, p22F, DOI 10.1016/j.amjcard.2004.07.051; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *CTR DRUG EV RES, OV THE COUNT DRUG PR; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dyer Owen, 2005, BMJ, V330, P164, DOI 10.1136/bmj.330.7484.164-d; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; JOHNSON LA, OTC STATUS SOUGHT ST; Kopjar B, 2003, AM J CARDIOL, V92, P1106, DOI 10.1016/j.amjcard.2003.07.008; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; *MED HLTH PROD REG, 2003, RECL SUMM SIMV POM P; Melin JM, 2004, AM J CARDIOL, V94, P1243, DOI 10.1016/j.amjcard.2004.08.007; Mitka M, 2004, JAMA-J AM MED ASSOC, V292, P317, DOI 10.1001/jama.292.3.317; PARKS MH, NONPR MEV 20 MG JOIN; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Schneeweiss S, 2004, BRIT MED J, V328, P560, DOI 10.1136/bmj.38020.698194.F6; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SHETTY D, MEVACOR DAILY 20 MG; United States Preventive Services Task Force, 2014, ANN INTERN MED; *US FDA, CONS BEH SAF DAT NON; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	31	13	13	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					910	913		10.7326/0003-4819-142-11-200506070-00009	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941698				2022-12-01	WOS:000229556300005
J	Eisen, SA; Kang, HK; Murphy, FM; Blanchard, MS; Reda, DJ; Henderson, WG; Toomey, R; Jackson, LW; Alpem, R; Parks, BJ; Klimas, N; Hall, C; Pak, HS; Hunter, J; Karlinsky, J; Battistone, MJ; Lyons, MJ				Eisen, SA; Kang, HK; Murphy, FM; Blanchard, MS; Reda, DJ; Henderson, WG; Toomey, R; Jackson, LW; Alpem, R; Parks, BJ; Klimas, N; Hall, C; Pak, HS; Hunter, J; Karlinsky, J; Battistone, MJ; Lyons, MJ		Gulf War Study Participating Inves	Gulf war veterans' health: Medical evaluation of a US cohort	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC-FATIGUE-SYNDROME; POPULATION-BASED SURVEY; OPERATION-DESERT-STORM; AL ESKAN DISEASE; VISCERAL INFECTION; LEISHMANIA-TROPICA; ILLNESS; FIBROMYALGIA; PREVALENCE; ACTIVATION	Background: United States military personnel reported various symptoms after deployment to the Persian Gulf during the 1991 Gulf War. However, the symptoms' long-term prevalence and association with deployment remain controversial. Objective: To assess and compare the prevalence of selected medical conditions in a national cohort of deployed and nondeployed Gulf War veterans who were evaluated by direct medical and teledermatologic examinations. Design: A cross-sectional prevalence study performed 10 years after the 1991 Gulf War. Setting: Veterans were examined at 1 of 16 Veterans Affairs medical centers. Participants: Deployed (n = 1061) and nondeployed (n = 1128) veterans of the 1991 Gulf War. Measurements: Primary outcome measures included fibromyalgia, the chronic fatigue syndrome, dermatologic conditions, dyspepsia, physical health-related quality of life (Short Form-36 [SF36]), hypertension, obstructive lung disease, arthralgias, and peripheral neuropathy. Results: Of 12 conditions, only 4 conditions were more prevalent among deployed than nondeployed veterans: fibromyalgia (deployed, 2.0%; nondeployed, 1.2%; odds ratio, 2.32 [95% Cl, 1.02 to 5.27]); the chronic fatigue syndrome (deployed, 1.6%; nondeployed 0.1%; odds ratio, 40.6 [Cl, 10.2 to 161]); dermatologic conditions (deployed, 34.6%; nondeployed, 26.8%; odds ratio, 1.38 [Cl, 1.06 to 1.80]), and dyspepsia (deployed, 9.1%; nondeployed, 6.0%; odds ratio, 1.87 [Cl, 1.16 to 2.99]). The mean physical component summary score of the SF-36 for deployed and nondeployed veterans was 49.3 and 50.8, respectively. Limitations: Relatively low participation rates introduce potential participation bias, and deployment-related illnesses that resolved before the research examination could not, by design, be detected. Conclusions: Ten years after the Gulf War, the physical health of deployed and nondeployed veterans is similar. However, Gulf War deployment is associated with an increased risk for fibromyalgia, the chronic fatigue syndrome, skin conditions, dyspepsia, and a clinically insignificant decrease in the SF-36 physical component score.	Washington Univ, Sch Med, Med Affairs Med Ctr 151 JC, St Louis, MO 63103 USA; St Louis Univ, St Louis, MO 63103 USA; US Dept Vet Affairs, Vet Hlth Adm, Environm Epidemiol Serv, Washington, DC USA; Uniformed Serv Univ Hlth Sci, Washington, DC USA; Hines Vet Affairs Hosp, Cooperat Studies Program, Coodinating Ctr, Hines, IL USA; Harvard Univ, Vet Affairs Med Ctr, Brockton, MA 02401 USA; Harvard Univ, Sch Med, Massachusetts Mental Hlth Ctr,Vet Affairs Med Ctr, Harvard Inst Psychiat Epidemiol & Genet, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston, MA 02215 USA; Vet Affairs Med Ctr, Miami, FL 33125 USA; Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA; Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA	Washington University (WUSTL); Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Antonio Military Medical Center; United States Department of Defense; United States Army; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Eisen, SA (corresponding author), Washington Univ, Sch Med, Med Affairs Med Ctr 151 JC, 915 N Grand Ave, St Louis, MO 63103 USA.	seth.eisen@med.va.gov	Lyons, Michael J./B-6119-2011	Eisen, Seth/0000-0001-7746-6624; , Domenic/0000-0003-1831-4270; Lyons, Michael/0000-0001-6516-9219				Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; [Anonymous], 1996, FIN REP; Buchwald D, 2001, PSYCHOSOM MED, V63, P936, DOI 10.1097/00006842-200111000-00012; BUCHWALD D, 1992, ANN INTERN MED, V116, P103, DOI 10.7326/0003-4819-116-2-103; Coker WJ, 1999, BMJ-BRIT MED J, V318, P290, DOI 10.1136/bmj.318.7179.290; Cook DB, 2003, MED SCI SPORT EXER, V35, P569, DOI 10.1249/01.MSS.0000058438.25278.33; Davis LE, 2004, NEUROLOGY, V63, P1070, DOI 10.1212/01.WNL.0000138426.88460.CB; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; Endresen GKM, 2003, RHEUMATOL INT, V23, P211, DOI 10.1007/s00296-003-0355-7; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Hickie I B, 2001, Twin Res, V4, P94, DOI 10.1375/twin.4.2.94; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Karlinsky JB, 2004, ARCH INTERN MED, V164, P2488, DOI 10.1001/archinte.164.22.2488; KELLER RH, 1994, CLIN INFECT DIS, V18, pS154, DOI 10.1093/clinids/18.Supplement_1.S154; Kennedy G, 2004, ANN EPIDEMIOL, V14, P95, DOI 10.1016/j.annepidem.2003.10.004; Khan F, 2004, CLIN SCI, V106, P183, DOI 10.1042/CS20030246; Kipen HM, 1999, ARCH ENVIRON HEALTH, V54, P313, DOI 10.1080/00039899909602493; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; KORENYIBOTH AL, 1992, MIL MED, V157, P452, DOI 10.1093/milmed/157.9.452; KorenyiBoth AL, 1997, MIL MED, V162, P1; LANDAY AL, 1991, LANCET, V338, P707, DOI 10.1016/0140-6736(91)91440-6; MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904; MAGILL AJ, 1994, CLIN INFECT DIS, V19, P805, DOI 10.1093/clinids/19.4.805; Murphy FM, 1999, MIL MED, V164, P327, DOI 10.1093/milmed/164.5.327; MURRAYLEISURE KA, 1994, 34 INT C ANT AG CHEM; Naschitz JE, 2001, SEMIN ARTHRITIS RHEU, V31, P199, DOI 10.1053/sarh.2001.27738; Natelson BH, 2001, JAMA-J AM MED ASSOC, V285, P2557, DOI 10.1001/jama.285.20.2557; NICHOLSON G, 1996, INT J OCCUPAT MED IM, V5, P69; OSTER CN, 1992, HOSP PRACT, V27, P145; Oumeish OY, 2002, CLIN DERMATOL, V20, P401, DOI 10.1016/S0738-081X(02)00241-9; Patarca-Montero R, 2001, Appl Neuropsychol, V8, P51, DOI 10.1207/S15324826AN0801_7; PRICE RK, 1992, PUBLIC HEALTH REP, V107, P514; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; ROBINSON A, 1995, CAN MED ASSOC J, V152, P944; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; STRAUS SE, 1993, CIBA F SYMP, V173, P132; STRAUS SE, 1993, J CLIN IMMUNOL, V13, P30, DOI 10.1007/BF00920633; STRAUS SE, 1993, CIBA FOUND S, V173, P139; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Visser J, 2001, J NEUROIMMUNOL, V119, P343, DOI 10.1016/S0165-5728(01)00400-3; Ware J.E., 1993, SCORING SF 36 SF 36, DOI DOI 10.6-10.7; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; 1995, MMWR MORB MORTAL WKL, V44, P443	48	95	97	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					881	890		10.7326/0003-4819-142-11-200506070-00005	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	932LX	15941694				2022-12-01	WOS:000229556300001
J	Haas, JS; Phillips, KA; Gerstenberger, EP; Seger, AC				Haas, JS; Phillips, KA; Gerstenberger, EP; Seger, AC			Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITORS; PHARMACY BENEFITS; PHYSICIAN; COMPANIES	Background: Generic substitution is one mechanism of curtailing prescription drug expenditures. Limited information is available about the potential savings associated with generic substitution. Objective: To estimate the potential savings associated with broad substitution of generic drugs. Design: Cross-sectional, nationally representative survey of noninstitutionalized adults. Setting: United States. Participants: Adults included in the Medical Expenditure Panel Survey Household Component, 1997-2000. Measurements: Use of a multisource drug (that is, a drug available in a brand-name and >= 1 generic formulation) or a generic drug and the potential cost savings associated with broad generic substitution for all multisource products. Results: Fifty-six percent of all outpatient drugs were multisource products, accounting for 41% of total outpatient drug expenditures. Of these multisource drugs, 61% were dispensed as a generic. If a generic had been substituted for all corresponding brand-name outpatient drugs in 2000, the median annual savings in drug expenditures per person would have been $45.89 (interquartile range, $10.35 to 158.06) for adults younger than 65 years of age and $78.05 (interquartile range, $19.94 to $241.72) for adults at least 65 years of age. in these age groups, the national savings would have been $5.9 billion (95% Cl, $5.5 billion to $6.2 billion) and $2.9 billion (Cl, $2.6 billion to $3.1 billion), respectively, representing approximately 11% of drug expenditures. Limitations: Specific information about an individual's formulary was not available, so the authors could not estimate how much of the potential savings would benefit an individual or his or her health plan. Conclusion: Although broad substitution of generic drugs would affect only a modest percentage of drug expenditures, it could result in substantial absolute savings.	Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Haas, JS (corresponding author), Brigham & Womens Hosp, Div Gen Med & Primary Care, 1620 Tremont St, Boston, MA 02120 USA.	jhaas@partners.org		HAAS, JENNIFER/0000-0001-7227-851X				ANDERSON GF, 2004, HLTH AFF MILLWOOD, V4, P396; Bae JP, 1997, HEALTH SERV RES, V32, P87; Banahan BF, 1997, ARCH INTERN MED, V157, P2080, DOI 10.1001/archinte.157.18.2080; Brennan TA, 2004, ANN INTERN MED, V141, P126, DOI 10.7326/0003-4819-141-2-200407200-00011; Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; COHEN SB, AHCRP PUB; CRUICKSHANK JM, 1988, BRIT MED J, V297, P1597, DOI 10.1136/bmj.297.6663.1597; CUBANSKI J, 2004, HLTH AFF W, V4, P198; DeCara JM, 1998, CHEST, V113, P261, DOI 10.1378/chest.113.2.261; Dong BJ, 1997, JAMA-J AM MED ASSOC, V277, P1205, DOI 10.1001/jama.277.15.1205; Fischer MA, 2003, HEALTH SERV RES, V38, P1051, DOI 10.1111/1475-6773.00162; Gaither CA, 2001, J AM PHARM ASS, V41, P729, DOI [10.1016/S1086-5802(16)31308-0, DOI 10.1016/S1086-5802(16)31308-0]; Ganther J M, 2000, J Am Pharm Assoc (Wash), V40, P378; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; HARRIS G, 2003, NY TIMES        1005, P1; Hellerstein JK, 1998, RAND J ECON, V29, P108, DOI 10.2307/2555818; HENRY J, 2003, FAMILY FDN; *HJ KAIS FAM FDN, 2001, KAIS COMM MED UN; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; *MEDC HLTH SOL INC, ANT 1 TIM GEN 2004 2; MOELLER JF, 1996, AHRQ PUB; MOON N, 2004, BENEFICIARIES FARE N; Mott DA, 2002, MED CARE, V40, P662, DOI 10.1097/00005650-200208000-00006; Murphy JE, 1999, ARCH INTERN MED, V159, P429, DOI 10.1001/archinte.159.5.429; Nightingale SL, 1998, JAMA-J AM MED ASSOC, V279, P645, DOI 10.1001/jama.279.9.645-b; *NIH CAR MAN FDN, 2002, PRIM GEN DRUGS PAT P; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; Robinson AR, 2004, ARCH INTERN MED, V164, P427, DOI 10.1001/archinte.164.4.427; Schneeweiss S, 2004, MED CARE, V42, P653, DOI 10.1097/01.mlr.0000129497.10930.a2; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Suh DC, 1999, PHARM WORLD SCI, V21, P260, DOI 10.1023/A:1008781619011; *US FOOD DRUG ADM, NEW FDA IN IMPR; 2002, FORMULARY, V38, P499; 2001, PRESCRIPTION DRUG TR	34	185	192	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					891	897		10.7326/0003-4819-142-11-200506070-00006	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941695				2022-12-01	WOS:000229556300002
J	Anway, MD; Cupp, AS; Uzumcu, M; Skinner, MK				Anway, MD; Cupp, AS; Uzumcu, M; Skinner, MK			Epigenetic transgenerational actions of endocrine disruptors and mate fertility	SCIENCE			English	Article							POSTNATAL TESTIS DEVELOPMENT; ANDROGEN RECEPTOR; METHOXYCHLOR; CELLS; VINCLOZOLIN; EXPOSURE; RAT; IMMUNOLOCALIZATION; DIFFERENTIATION; INHERITANCE	Transgenerational effects of environmental toxins require either a chromosomal or epigenetic alteration in the germ line. Transient exposure of a gestating female rat during the period of gonadal sex determination to the endocrine disruptors vinclozolin (an antiandrogenic compound) or methoxychlor (an estrogenic compound) induced an adult phenotype in the F-1 generation of decreased spermatogenic capacity (cell number and viability) and increased incidence of mate infertility. These effects were transferred through the mate germ line to nearly all mates of ail subsequent generations examined (that is F-1 to F-4). The effects on reproduction correlate with altered DNA methylation patterns in the germ line. The ability of an environmental factor (for example, endocrine disruptor) to reprogram the germ line and to promote a transgenerational disease state has significant implications for evolutionary biology and disease etiology.	Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@mail.wsu.edu	Reis-Silva, Thiago M./E-6318-2013; Anway, Matthew D/B-1480-2008					Barber R, 2002, P NATL ACAD SCI USA, V99, P6877, DOI 10.1073/pnas.102015399; BUEHR M, 1993, DEVELOPMENT, V117, P273; Chapin RE, 1997, FUND APPL TOXICOL, V40, P138, DOI 10.1006/faat.1997.2381; Cummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899; Cupp AS, 2003, J ANDROL, V24, P736; DeRosa C, 1998, J TOXICOL ENV HEAL B, V1, P3, DOI 10.1080/10937409809524541; Dong H, 2004, BIOCHEMISTRY-US, V43, P15922, DOI 10.1021/bi0482194; Durcova-Hills G, 2001, DIFFERENTIATION, V68, P220, DOI 10.1046/j.1432-0436.2001.680409.x; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Foran CM, 2002, TOXICOL SCI, V68, P389, DOI 10.1093/toxsci/68.2.389; Gaido KW, 1999, ENDOCRINOLOGY, V140, P5746, DOI 10.1210/en.140.12.5746; Goyal HO, 1997, ANAT REC, V249, P54, DOI 10.1002/(SICI)1097-0185(199709)249:1<54::AID-AR7>3.0.CO;2-F; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; JOST A, 1981, HUM GENET, V58, P59, DOI 10.1007/BF00284150; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kelce WR, 1997, TOXICOL APPL PHARM, V142, P192, DOI 10.1006/taap.1996.7966; MAJDIC G, 1995, J ENDOCRINOL, V147, P285, DOI 10.1677/joe.0.1470285; Morris ID, 2002, INT J ANDROL, V25, P255, DOI 10.1046/j.1365-2605.2002.00372.x; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Shi BS, 2004, MUTAT RES-FUND MOL M, V556, P1, DOI 10.1016/j.mrfmmm.2004.05.014; Tokumura A, 2004, J CELL BIOCHEM, V92, P869, DOI 10.1002/jcb.20147; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008	24	1770	1852	3	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1466	1469		10.1126/science.1108190	http://dx.doi.org/10.1126/science.1108190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933200	Green Published			2022-12-01	WOS:000229619300053
J	Foster, KR				Foster, KR			Biomedicine - Hamiltonian medicine: Why the social lives of pathogens matter	SCIENCE			English	Editorial Material							PARASITE VIRULENCE; COMPETITION; BIOFILMS; BACTERIA		Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA	Rice University	Foster, KR (corresponding author), Wissensch Kolleg Berlin, Inst Adv Study, Wallotstr 19, D-14193 Berlin, Germany.	krfoster@rice.edu		Foster, Kevin/0000-0003-4687-6633				Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Ewald P.W., 1994, EVOLUTION INFECT DIS; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Kreft JU, 2005, MICROBIOL-SGM, V151, P637, DOI 10.1099/mic.0.27415-0; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Massey RC, 2004, P ROY SOC B-BIOL SCI, V271, P785, DOI 10.1098/rspb.2004.2676; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; [No title captured]	12	52	52	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2005	308	5726					1269	1270		10.1126/science.1108158	http://dx.doi.org/10.1126/science.1108158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919984				2022-12-01	WOS:000229482300035
J	van Heel, DA; Ghosh, S; Butler, M; Hunt, KA; Lundberg, AMC; Ahmad, T; McGovern, DPB; Onnie, C; Negoro, K; Goldthorpe, S; Foxwell, BMJ; Mathew, CG; Forbes, A; Jewell, DP; Playford, RJ				van Heel, DA; Ghosh, S; Butler, M; Hunt, KA; Lundberg, AMC; Ahmad, T; McGovern, DPB; Onnie, C; Negoro, K; Goldthorpe, S; Foxwell, BMJ; Mathew, CG; Forbes, A; Jewell, DP; Playford, RJ			Murarnyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease	LANCET			English	Article							NOD2; SUSCEPTIBILITY	Both NOD2 (CARD15) alleles are mutated in roughly 15% of patients with Crohn's disease, but functional effects are unclear. We analysed the cytokine response of peripheral blood mononuclear cells to muramyl dipeptide (MDP), the ligand for NOD2. MDP induced little TNF alpha or interleukin 1 beta, but strong interleukin-8 secretion. MDP also substantially upregulated secretion of TNF alpha and interleukin 1 beta induced by toll-like receptor ligands. These effects were abolished by the most common Crohn's NOD2 double mutant genotypes at low nanomolar MDP concentrations, and provide the basis to develop a test of NOD2 functional deficiency. In Crohn's disease, there are defects in neutrophil recruitment driven by NOD2 and interleukin 8 and in cross talk between the NOD2 and toll-like receptor pathways, which suggests that the immune system fails to receive an early priming signal.	Univ London Imperial Coll Sci & Technol, Dept Gastroenterol, Intestinal Inflammat & Repair Grp, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, Kennedy Inst Rheumatol, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, St Marks Hosp, London W12 0NN, England; Univ Oxford, Radcliffe Infirm, Gibson Labs, Gastroenterol Unit, Oxford OX2 6HE, England; Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England; Tohoku Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Sendai, Miyagi 980, Japan	Imperial College London; Imperial College London; University of Oxford; Imperial College London; Radcliffe Infirmary; University of Oxford; University of London; King's College London; Tohoku University	van Heel, DA (corresponding author), Univ London Imperial Coll Sci & Technol, Dept Gastroenterol, Intestinal Inflammat & Repair Grp, Hammersmith Campus, London W12 0NN, England.	d.vanheel@imperial.ac.uk	Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838; Playford, Raymond/0000-0003-1235-8504; van Heel, David/0000-0002-0637-2265; Forbes, Alastair/0000-0001-7416-9843				Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Traub S, 2004, J BIOL CHEM, V279, P8694, DOI 10.1074/jbc.M310556200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092	8	261	266	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 21	2005	365	9473					1794	1796		10.1016/S0140-6736(05)66582-8	http://dx.doi.org/10.1016/S0140-6736(05)66582-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	928SI	15910952				2022-12-01	WOS:000229291600024
J	Mery, F; Kawecki, TJ				Mery, F; Kawecki, TJ			A cost of long-term memory in Drosophila	SCIENCE			English	Article							CONSOLIDATED MEMORY		Univ Fribourg, Dept Biol, Sect Ecol & Evolut, CH-1700 Fribourg, Switzerland	University of Fribourg	Mery, F (corresponding author), Univ Fribourg, Dept Biol, Sect Ecol & Evolut, Chemin Musee 10, CH-1700 Fribourg, Switzerland.	frederic.mery@unifr.ch	Kawecki, Tadeusz/K-5466-2015	Kawecki, Tadeusz/0000-0002-9244-1991				Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Karan D, 1998, EVOLUTION, V52, P825, DOI [10.1111/j.1558-5646.1998.tb03706.x, 10.2307/2411276]; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Nevo E, 1998, HEREDITY, V80, P9, DOI 10.1046/j.1365-2540.1998.00274.x; Niven JE, 2003, P ROY SOC B-BIOL SCI, V270, pS58, DOI 10.1098/rsbl.2003.0010; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0	6	183	186	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1148	1148		10.1126/science.1111331	http://dx.doi.org/10.1126/science.1111331			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905396	Green Submitted			2022-12-01	WOS:000229293400037
J	Gardner, TJ; Naef, F; Naef-, F				Gardner, TJ; Naef, F; Naef-, F			Freedom and rules: The acquisition and reprogramming of a bird's learned song	SCIENCE			English	Article							CANARY SONG; ZEBRA FINCHES; SPEECH	Canary song is hierarchically structured: Short stereotyped syllables are repeated to form phrases, which in turn are arranged to form songs. This structure occurs even in the songs of young isolates, which suggests that innate rules govern canary song development. However, juveniles that had never heard normal song imitated abnormal synthetic songs with great accuracy, even when the tutor songs lacked phrasing. As the birds matured, imitated songs were reprogrammed to form typical canary phrasing. Thus, imitation and innate song constraints are separate processes that can be segregated in time: freedom in youth, rules in adulthood.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA; Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland	Rockefeller University; Rockefeller University; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Gardner, TJ (corresponding author), Rockefeller Univ, Lab Anim Behav, 1230 York Ave, New York, NY 10021 USA.	tgardner@mit.edu	Naef, Felix/C-9527-2011	Naef, Felix/0000-0001-9786-3037	NIMH NIH HHS [MH18343, MH63132] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018343, R01MH018343] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson SE, 1996, J ACOUST SOC AM, V100, P1209, DOI 10.1121/1.415968; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GUTTINGER HR, 1981, Z TIERPSYCHOL, V56, P323; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Lashley K. S., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1982, DEV PSYCHOBIOL, V15, P369, DOI 10.1002/dev.420150409; MARLER P, 1970, AM SCI, V58, P669; MARLER P, 1977, J COMP PHYSIOL PSYCH, V91, P8, DOI 10.1037/h0077303; Marler Peter, 2004, P1, DOI 10.1016/B978-012473070-0/50004-9; Mundinger PC, 1995, ANIM BEHAV, V50, P1491, DOI 10.1016/0003-3472(95)80006-9; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; Rabiner L., 1993, FUNDAMENTALS SPEECH; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; THORPE W. H., 1958, IBIS, V100, P535, DOI 10.1111/j.1474-919X.1958.tb07960.x; Thorpe W. H., 1955, Ibis, V97, P247, DOI 10.1111/j.1474-919X.1955.tb01911.x; Vu ET, 1998, J NEUROSCI, V18, P9088; VU ET, 1994, J NEUROSCI, V14, P6924; WANCHUN L, IN PRESS P NATL ACAD; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	23	86	86	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1046	1049		10.1126/science.1108214	http://dx.doi.org/10.1126/science.1108214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890887				2022-12-01	WOS:000229190700054
J	Waite, JH; Niemann, H; Yelle, RV; Kasprzak, WT; Cravens, TE; Luhmann, JG; McNutt, RL; Ip, WH; Gell, D; De La Haye, V; Muller-Wordag, I; Magee, B; Borggren, N; Ledvina, S; Fletcher, G; Walter, E; Miller, R; Scherer, S; Thorpe, R; Xu, J; Block, B; Arnett, K				Waite, JH; Niemann, H; Yelle, RV; Kasprzak, WT; Cravens, TE; Luhmann, JG; McNutt, RL; Ip, WH; Gell, D; De La Haye, V; Muller-Wordag, I; Magee, B; Borggren, N; Ledvina, S; Fletcher, G; Walter, E; Miller, R; Scherer, S; Thorpe, R; Xu, J; Block, B; Arnett, K			Ion Neutral Mass Spectrometer results from the first flyby of Titan	SCIENCE			English	Article							ISOTOPIC FRACTIONATION; NITROGEN; ATMOSPHERE; ORIGIN; TEMPERATURE; C-12/C-13; CLATHRATE; HCN	The Cassini Ion Neutral Mass Spectrometer (INMS) has obtained the first in situ composition measurements of the neutral densities of molecular nitrogen, methane, molecular hydrogen, argon, and a host of stable carbon-nitrile compounds in Titan's upper atmosphere. INMS in situ mass spectrometry has also provided evidence for atmospheric waves in the upper atmosphere and the first direct measurements of isotopes of nitrogen, carbon, and argon, which reveal interesting clues about the evolution of the atmosphere. The bulk composition and thermal structure of the moon's upper atmosphere do not appear to have changed considerably since the Voyager 1 flyby.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BW, England; SW Res Inst, San Antonio, TX 78228 USA	University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Kansas; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Central University; Imperial College London; Southwest Research Institute	Waite, JH (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.		McNutt, Ralph L/E-8006-2010	McNutt, Ralph L/0000-0002-4722-9166				ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; COUSTENIS A, 1989, ICARUS, V80, P54, DOI 10.1016/0019-1035(89)90161-9; Cravens TE, 1997, PLANET SPACE SCI, V45, P889, DOI 10.1016/S0032-0633(97)00064-0; FEGLEY B, 1995, GLOBAL EARTH PHYS HD, P320, DOI DOI 10.1029/RF001P0320; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Gautier D, 2005, SPACE SCI REV, V116, P25, DOI 10.1007/s11214-005-1946-2; Gurwell MA, 2004, ASTROPHYS J, V616, pL7, DOI 10.1086/423954; Hidayat T, 1997, ICARUS, V126, P170, DOI 10.1006/icar.1996.5640; JOHNS TF, 1957, ATOMIC ENERGY RES ES; Kallenbach R, 1998, ASTROPHYS J, V507, pL185, DOI 10.1086/311702; Kasprzak W, 1996, P SOC PHOTO-OPT INS, V2803, P129, DOI 10.1117/12.253413; LODDERS K, 1999, PLANETARY SCI COMPAN; LUNINE JI, 1987, ICARUS, V70, P61, DOI 10.1016/0019-1035(87)90075-3; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; Lunine JI, 1999, PLANET SPACE SCI, V47, P1291, DOI 10.1016/S0032-0633(99)00052-5; MCKAY CP, 1988, NATURE, V332, P520, DOI 10.1038/332520a0; Mousis O, 2002, ICARUS, V156, P162, DOI 10.1006/icar.2001.6782; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; OWEN T, 1982, PLANET SPACE SCI, V30, P833, DOI 10.1016/0032-0633(82)90115-5; Owen TC, 2000, PLANET SPACE SCI, V48, P747, DOI 10.1016/S0032-0633(00)00040-4; Press WH., 1986, NUMERICAL RECIPES FO; STROBEL DF, 1997, ESA SPECIAL PUBLICAT, P299; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; Waite JH, 2004, SPACE SCI REV, V114, P113, DOI 10.1007/s11214-004-1408-2; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Yung YL, 1997, SCIENCE, V278, P1778, DOI 10.1126/science.278.5344.1778; YUNG YL, COMMUNICATION	28	348	350	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					982	986		10.1126/science.1110652	http://dx.doi.org/10.1126/science.1110652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890873				2022-12-01	WOS:000229190700034
J	Riley, JR; Greggers, U; Smith, AD; Reynolds, DR; Menzel, R				Riley, JR; Greggers, U; Smith, AD; Reynolds, DR; Menzel, R			The flight paths of honeybees recruited by the waggle dance	NATURE			English	Article							HARMONIC RADAR; BEES; TRACKING	In the 'dance language' of honeybees(1,2), the dancer generates a specific, coded message that describes the direction and distance from the hive of a new food source, and this message is displaced in both space and time from the dancer's discovery of that source. Karl von Frisch concluded that bees 'recruited' by this dance used the information encoded in it to guide them directly to the remote food source, and this Nobel Prize-winning discovery revealed the most sophisticated example of non-primate communication that we know of(3,4). In spite of some initial scepticism(5-9), almost all biologists are now convinced that von Frisch was correct(3,4,10-14), but what has hitherto been lacking is a quantitative description of how effectively recruits translate the code in the dance into flight to their destinations. Using harmonic radar(15-17) to record the actual flight paths of recruited bees, we now provide that description.	Rothamsted Res, Plant & Invertebrate Ecol Div, Harpenden AL5 2JQ, Herts, England; Free Univ Berlin, Fachbereich Biol Chem Pharm, Inst Biol Neurobiol, D-14195 Berlin, Germany; Univ Greenwich, Nat Resources Inst, Plant Anim & Human Hlth Grp, Chatham ME4 4TB, Kent, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Free University of Berlin; University of Greenwich	Riley, JR (corresponding author), Rothamsted Res, Plant & Invertebrate Ecol Div, Harpenden AL5 2JQ, Herts, England.	joe@radarent.freeserve.co.uk	Reynolds, Donald R/C-7361-2013	Reynolds, Donald/0000-0001-8749-7491				Baker TC, 1996, PHYSIOL ENTOMOL, V21, P20, DOI 10.1111/j.1365-3032.1996.tb00831.x; Carde RT, 1997, INSECT PHEROMONE RESEARCH, P275; CHITTKA L, 1995, ETHOLOGY, V99, P117, DOI 10.1111/j.1439-0310.1995.tb01093.x; Dyer F.C., 1994, ANIM BEHAV, V47, P1242; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; ESCH H, 1970, Z VERGL PHYSIOL, V68, P175, DOI 10.1007/BF00297693; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; GOULD JL, 1975, SCIENCE, V189, P685, DOI 10.1126/science.1154023; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; MAUTZ D, 1971, Z VERGL PHYSIOL, V72, P197, DOI 10.1007/BF00297822; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Reynolds D. R., 1997, P111; Riley Joseph R., 2001, Symposia of the Royal Entomological Society of London, V20, P129, DOI 10.1079/9780851994567.0129; Riley JR, 1999, NATURE, V400, P126, DOI 10.1038/22029; Riley JR, 2003, P ROY SOC B-BIOL SCI, V270, P2421, DOI 10.1098/rspb.2003.2542; Riley JR, 2002, COMPUT ELECTRON AGR, V35, P151, DOI 10.1016/S0168-1699(02)00016-9; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Riley JR, 1998, J INSECT BEHAV, V11, P287, DOI 10.1023/A:1021004209198; SEELEY T, 1991, NATURE, V349, P114, DOI 10.1038/349114a0; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONFRISCH K, 1967, SCIENCE, V158, P1072; WELLS PH, 1973, NATURE, V241, P171, DOI 10.1038/241171a0; Wenner A.M., 1990, ANATOMY CONTROVERSY, DOI [DOI 10.7312/WENN90330, 10.7312/wenn90330]; Wenner AM, 2002, J INSECT BEHAV, V15, P859, DOI 10.1023/A:1021131725124; WENNER AM, 1991, AM ZOOL, V31, P768	30	242	248	23	298	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					205	207		10.1038/nature03526	http://dx.doi.org/10.1038/nature03526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889092				2022-12-01	WOS:000229021100040
J	Huang, JK; Hu, RF; Rozelle, S; Pray, C				Huang, JK; Hu, RF; Rozelle, S; Pray, C			Insect-resistant GM rice in farmers' fields: Assessing productivity and health effects in China	SCIENCE			English	Article							BIOTECHNOLOGY; PESTICIDES	Although no country to date has released a major genetically modified (GM) food grain crop, China is on the threshold of commercializing GM rice. This paper studies two of the four GM varieties that are now in farm-level pre-production trials, the last step before commercialization. Farm surveys of randomly selected farm households that are cultivating the insect-resistant GM rice varieties, without the aid of experimental station technicians, demonstrate that when compared with households cultivating non-GM rice, small and poor farm households benefit from adopting GM rice by both higher crop yields and reduced use of pesticides, which also contribute to improved health.	Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08901 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University of California System; University of California Davis; Rutgers State University New Brunswick	Huang, JK (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Jia 11,Datun Rd, Beijing 100101, Peoples R China.	jkhuang.ccap@igsnrr.ac.cn						ANTLE JM, 1994, AM J AGR ECON, V76, P418, DOI 10.2307/1243654; Deng CY, 2003, ACTA BOT SIN, V45, P1084; HUANG J, 2001, 2001RR3 EEPSEA IDRC; Huang JK, 2003, AGR ECON, V29, P55, DOI 10.1016/S0169-5150(03)00044-6; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Paarlberg R. L., 2003, ISSUES SCI TECHN SPR; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310	8	250	302	2	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					688	690		10.1126/science.1108972	http://dx.doi.org/10.1126/science.1108972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860626				2022-12-01	WOS:000228810900048
J	Spiegel, PB				Spiegel, PB			Differences in world responses to natural disasters and complex emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; HEALTH; WAR; POPULATIONS; ATTITUDES; KOSOVO; DARFUR; SUDAN		UN High Commissioner Refugees, CH-1211 Geneva, Switzerland		Spiegel, PB (corresponding author), UN High Commissioner Refugees, Case Postale 2500, CH-1211 Geneva, Switzerland.	spiegel@unhcr.ch	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Anderson Mary B., 1999, DO NO HARM AID CAN S; [Anonymous], 2004, SUDAN DARFUR RAPE WE; [Anonymous], 2004, DEMOCRATIC REPUBLIC; BECKER E, 2005, US NEARLY TRIPLES TS; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; CORDER M, 2005, FEARS TSUNAMI DEAD C; de Goyet CD, 2000, LANCET, V356, P762, DOI 10.1016/S0140-6736(00)02642-8; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Deutsche Presse Agentur, 2005, INDONESIA ACEH REBEL; *EUR PROGR INT EP, RETR MORT SURV INT D; Grandesso F, 2005, JAMA-J AM MED ASSOC, V293, P1490, DOI 10.1001/jama.293.12.1490; GURR T, 2003, EARLY WARNING SYSTEM; HOGE W, 2005, UN OFFICIAL SAYS PLE; *IRC, 2004, IRC STUD REV 31 000; King Dennis, 2002, PAYING ULTIMATE PRIC; LECHAT MF, 1990, EPIDEMIOL REV, V12, P192, DOI 10.1093/oxfordjournals.epirev.a036053; LEWIS D, 2005, 9 UN PEACEKEEPERS KI; MISHIYAMA G, 2005, UNICEF CONF TSUN CHI; NAKASHIMA E, 2005, ACEH REBELS DESCRIBE; Noji E.K., 1997, PUBLIC HLTH CONSEQUE; *PAN AM HLTH ORG, 1981, EM HLTH MAN NAT DIS, V407; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; PINE A, 1993, US SOLDIERS KILLED 2; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Sen Amartya, 1999, DEV FREEDOM; Sheik M, 2000, BRIT MED J, V321, P166, DOI 10.1136/bmj.321.7254.166; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; *UN, 2004, PLEDG C UN RAIS 520; *UNICEF, 2005, PROT CHILDR TSUN ZON; World Health Organization, 2003, MENT SOC ASP HLTH PO; 2005, WORLD LEADERS WARNED; 2004, MEASLES MALNUTRITION; SITUATION DARFUR SAV; 2005, SITUATION REPORTS S; 1998, WORLD S ASIA UN WARN	38	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1915	1918		10.1001/jama.293.15.1915	http://dx.doi.org/10.1001/jama.293.15.1915			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840867				2022-12-01	WOS:000228401700031
J	Nakajima, M; Imai, K; Ito, H; Nishiwaki, T; Murayama, Y; Iwasaki, H; Oyarna, T; Kondo, T				Nakajima, M; Imai, K; Ito, H; Nishiwaki, T; Murayama, Y; Iwasaki, H; Oyarna, T; Kondo, T			Reconstitution of circadian oscillation of cyanobacterial KaiC phosphorylation in vitro	SCIENCE			English	Article							CLOCK SYSTEM; EXPRESSION; FEEDBACK; GENETICS; TIME	Kai proteins globally regulate circadian gene expression of cyanobacteria. The KaiC phosphorylation cycle, which persists even without transcription or translation, is assumed to be a basic timing process of the circadian clock. We have reconstituted the self-sustainable oscillation of KaiC phosphorylation in vitro by incubating KaiC with KaiA, KaiB, and adenosine triphosphate. The period of the in vitro oscillation was stable despite temperature change (temperature compensation), and the circadian periods observed in vivo in KaiC mutant strains were consistent with those measured in vitro. The enigma of the circadian clock can now be studied in vitro by examining the interactions between three Kai proteins.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; JST, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	kondo@bio.nagoya-u.ac.jp	Jansen, Heiko T./A-5770-2008; Ito, Hiroshi/A-7782-2010	Jansen, Heiko T./0000-0003-0178-396X; Iwasaki, Hideo/0000-0002-3754-4955				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Nakahira Y, 2004, P NATL ACAD SCI USA, V101, P881, DOI 10.1073/pnas.0307411100; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	15	737	773	5	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					414	415		10.1126/science.1108451	http://dx.doi.org/10.1126/science.1108451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831759				2022-12-01	WOS:000228492000053
J	Miller, LG; Perdreau-Remington, F; Rieg, G; Mehdi, S; Perlroth, J; Bayer, AS; Tang, AW; Phung, TO; Spellberg, B				Miller, LG; Perdreau-Remington, F; Rieg, G; Mehdi, S; Perlroth, J; Bayer, AS; Tang, AW; Phung, TO; Spellberg, B			Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANTON-VALENTINE LEUKOCIDIN; FIELD GEL-ELECTROPHORESIS; SOFT-TISSUE INFECTIONS; STREPTOCOCCAL INFECTIONS; ACQUIRED PNEUMONIA; VIRULENCE FACTORS; UNITED-STATES; RISK-FACTORS; SKIN; IDENTIFICATION	BACKGROUND: Necrotizing fasciitis is a life-threatening infection requiring urgent surgical and medical therapy. Staphylococcus aureus has been a very uncommon cause of necrotizing fasciitis, but we have recently noted an alarming number of these infections caused by community-associated methicillin-resistant S. aureus (MRSA). METHODS: We reviewed the records of 843 patients whose wound cultures grew MRSA at our center from January 15, 2003, to April 15, 2004. Among this cohort, 14 were identified as patients presenting from the community with clinical and intraoperative findings of necrotizing fasciitis, necrotizing myositis, or both. Results: The median age of the patients was 46 years (range, 28 to 68), and 71 percent were men. Coexisting conditions or risk factors included current or past injection-drug use (43 percent); previous MRSA infection, diabetes, and chronic hepatitis C (21 percent each); and cancer and human immunodeficiency virus infection or the acquired immunodeficiency syndrome (7 percent each). Four patients (29 percent) had no serious coexisting conditions or risk factors. All patients received combined medical and surgical therapy, and none died, but they had serious complications, including the need for reconstructive surgery and prolonged stay in the intensive care unit. Wound cultures were monomicrobial for MRSA in 86 percent, and 40 percent of patients (4 of 10) for whom blood cultures were obtained had positive results. All MRSA isolates were susceptible in vitro to clindamycin, trimethoprim-sulfamethoxazole, and rifampin. All recovered isolates belonged to the same genotype (multilocus sequence type ST8, pulsed-field type USA300, and staphylococcal cassette chromosome mec type IV [SCCmecIV]) and carried the Panton-Valentine leukocidin (pvl), lukD, and lukE genes, but no other toxin genes were detected. CONCLUSIONS: Necrotizing fasciitis caused by community-associated MRSA is an emerging clinical entity. In areas in which community-associated MRSA infection is endemic, empirical treatment of suspected necrotizing fasciitis should include antibiotics predictably active against this pathogen.	Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA; Harbor UCLA Med Ctr, Div HIV Med, Torrance, CA 90509 USA; Harbor UCLA Med Ctr, Dept Internal Med, Torrance, CA 90509 USA; Harbor UCLA Med Ctr, Los Angeles Biomed Inst, Torrance, CA 90509 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; St Mary Hosp, Long Beach, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California San Francisco	Miller, LG (corresponding author), Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA.		a, a/M-9467-2013		ODCDC CDC HHS [R01/CCR923417-01] Funding Source: Medline	ODCDC CDC HHS		Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Bancroft E, 2003, 41 ANN M INF DIS SOC; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boussaud V, 2003, INTENS CARE MED, V29, P1840, DOI 10.1007/s00134-003-1918-5; BROOK I, 1995, ARCH SURG-CHICAGO, V130, P786; BROOK I, 1995, J CLIN MICROBIOL, V33, P2382, DOI 10.1128/JCM.33.9.2382-2387.1995; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; Carratala J, 2003, EUR J CLIN MICROBIOL, V22, P151, DOI 10.1007/s10096-003-0902-x; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Diep BA, 2003, J CLIN MICROBIOL, V41, P4559, DOI 10.1128/JCM.41.10.4559-4564.2003; Eady EA, 2003, CURR OPIN INFECT DIS, V16, P103, DOI 10.1097/00001432-200304000-00007; Eguia Jose M., 2003, Curr Infect Dis Rep, V5, P459, DOI 10.1007/s11908-003-0087-6; Elliott D, 2000, AM J SURG, V179, P361, DOI 10.1016/S0002-9610(00)00360-3; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; File Thomas M. Jr., 2000, Comprehensive Therapy, V26, P73, DOI 10.1007/s12019-000-0015-8; Fontes R A Jr, 2000, J Am Acad Orthop Surg, V8, P151; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FRAZEE B, IN PRESS ANN EMERG M; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Headley AJ, 2003, AM FAM PHYSICIAN, V68, P323; Imamura Yuzo, 1995, Journal of Dermatology (Tokyo), V22, P960; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P3677; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Klein JL, 2003, INTENS CARE MED, V29, P1399, DOI 10.1007/s00134-003-1844-6; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; MILLER LG, 2004, 42 ANN M INF DIS SOC; Mongkolrattanothai K, 2003, CLIN INFECT DIS, V37, P1050, DOI 10.1086/378277; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Osterlund A, 2002, SCAND J INFECT DIS, V34, P763, DOI 10.1080/0036554021000026927; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; PERDREAUREMINGT.F, 2003, 43 INT C ANT AG CHEM; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; Purcell K, 2002, PEDIATR INFECT DIS J, V21, P988, DOI 10.1097/00006454-200210000-00028; Rezende NA, 2002, AM J MED SCI, V323, P117, DOI 10.1097/00000441-200203000-00001; Roth A, 2003, ARCH ORTHOP TRAUM SU, V123, P429, DOI 10.1007/s00402-003-0535-7; Sande MA, 2004, SANFORD GUIDE ANTIMI; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Seal DV, 2001, CURR OPIN INFECT DIS, V14, P127, DOI 10.1097/00001432-200104000-00003; Siberry GK, 2003, CLIN INFECT DIS, V37, P1257, DOI 10.1086/377501; SIGURDSSON AF, 1989, SCAND J INFECT DIS, V21, P537, DOI 10.3109/00365548909037882; SWARTZ MN, 2000, MANDELL DOUGLAS BENN, P1037; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; WARD PD, 1980, INFECT IMMUN, V28, P393; Witte W., 2004, EUROSURVEILLANCE, V9, P1; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454, DOI 10.2106/00004623-200308000-00005; Wu Kun-Chan, 2002, Journal of Microbiology Immunology and Infection, V35, P53; 2003, MMWR MORB MORTAL WKL, V52, P793; 2003, MMWR MORB MORTAL WKL, V52, P992; 2003, JAMA, V289, P1377	67	731	757	1	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1445	1453		10.1056/NEJMoa042683	http://dx.doi.org/10.1056/NEJMoa042683			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814880				2022-12-01	WOS:000228145200008
J	Chacinska, A; Lind, M; Frazier, AE; Dudek, J; Meisinger, C; Geissler, A; Sickmann, A; Meyer, HE; Truscott, KN; Guiard, B; Pfanner, N; Rehling, P				Chacinska, A; Lind, M; Frazier, AE; Dudek, J; Meisinger, C; Geissler, A; Sickmann, A; Meyer, HE; Truscott, KN; Guiard, B; Pfanner, N; Rehling, P			Mitochondrial presequence translocase: Switching between TOM tethering and motor recruitment involves Tim21 and Tim17	CELL			English	Article							PROTEIN IMPORT MOTOR; PREPROTEIN TRANSLOCASE; INTERMEMBRANE SPACE; CONTACT SITES; MEMBRANES; MATRIX; TIM50; INNER; COCHAPERONE; COMPONENT	The presequence translocase of the inner mitochondrial membrane (TIM23 complex) operates at a central junction of protein import. It accepts preproteins from the outer membrane TOM complex and directs them to inner membrane insertion or, in cooperation with the presequence translocase-associated motor (PAM), to the matrix. Little is known of how the TIM23 complex coordinates these tasks. We have identified Tim21 (YGR033c) that interacts with the TOM complex. Tim21 is specific for a TIM23 form that cooperates with TOM and promotes inner membrane insertion. Protein translocation into the matrix requires a switch to a Tim21-free, PAM bound presequence translocase. Tim17 is crucial for the switch by performing two separable functions: promotion of inner membrane insertion and binding of Pam18 to form the functional TIM-PAM complex. Thus, the presequence translocase is not a static complex but switches between TOM tethering and PAM binding in a reaction cycle involving Tim21 and Tim17.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Uppsala Univ, Evolut Biol Ctr, Dept Comparat Physiol, SE-75236 Uppsala, Sweden; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany; Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; Univ Paris 06, CNRS, Lab Propre, F-91190 Gif Sur Yvette, France	University of Freiburg; Uppsala University; University of Freiburg; University of Wurzburg; Ruhr University Bochum; La Trobe University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; peter.rehling@biochemie.uni-freiburg.de	Meisinger, Chris/J-1110-2014; Pfanner, Nikolaus/AAV-7878-2021; Truscott, Kaye/D-3362-2012; Sickmann, Albert/A-1010-2011	Meisinger, Chris/0000-0002-8326-3548; Sickmann, Albert/0000-0002-2388-5265; Truscott, Kaye/0000-0002-5352-9835; Frazier, Ann/0000-0002-6491-3437; Chacinska, Agnieszka/0000-0002-2832-2568				Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	22	263	271	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					817	829		10.1016/j.cell.2005.01.011	http://dx.doi.org/10.1016/j.cell.2005.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797382	hybrid			2022-12-01	WOS:000228067500011
J	Fields, S; Johnston, M				Fields, S; Johnston, M			Whither model organism research?	SCIENCE			English	Editorial Material									Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Med, Seattle, WA 98195 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA.	fields@u.washington.edu; mj@genetics.wustl.edu	Johnston, Mark/R-6156-2019; Johnston, Mark/K-3543-2019	Johnston, Mark/0000-0002-4932-7229					0	79	85	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1885	1886		10.1126/science.1108872	http://dx.doi.org/10.1126/science.1108872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790833				2022-12-01	WOS:000227957300035
J	Choi, MH; Lee, IK; Kim, GW; Kim, BU; Han, YH; Yu, DY; Park, HS; Kim, KY; Lee, JS; Choi, CH; Bae, YS; Lee, BI; Rhee, SG; Kang, SW				Choi, MH; Lee, IK; Kim, GW; Kim, BU; Han, YH; Yu, DY; Park, HS; Kim, KY; Lee, JS; Choi, CH; Bae, YS; Lee, BI; Rhee, SG; Kang, SW			Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II	NATURE			English	Article							CYSTEINE-SULFINIC ACID; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; MAMMALIAN PEROXIREDOXIN; SITE CYSTEINE; ACTIVATION; MECHANISM; REQUIRES; RECEPTOR	Platelet-derived growth factor ( PDGF) is a potent mitogenic and migratory factor that regulates the tyrosine phosphorylation of a variety of signalling proteins via intracellular production of H2O2 (refs 1 - 3). Mammalian 2-Cys peroxiredoxin type II ( Prx II; gene symbol Prdx2) is a cellular peroxidase that eliminates endogenous H2O2 produced in response to growth factors such as PDGF and epidermal growth factor(4); however, its involvement in growth factor signalling is largely unknown. Here we show that Prx II is a negative regulator of PDGF signalling. Prx II deficiency results in increased production of H2O2, enhanced activation of PDGF receptor ( PDGFR) and phospholipase C gamma 1, and subsequently increased cell proliferation and migration in response to PDGF. These responses are suppressed by expression of wild-type Prx II, but not an inactive mutant. Notably, Prx II is recruited to PDGFR upon PDGF stimulation, and suppresses protein tyrosine phosphatase inactivation. Prx II also leads to the suppression of PDGFR activation in primary culture and a murine restenosis model, including PDGF-dependent neointimal thickening of vascular smooth muscle cells. These results demonstrate a localized role for endogenous H2O2 in PDGF signalling, and indicate a biological function of Prx II in cardiovascular disease.	Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Yonsei Univ, Coll Med, Dept Neurol, Seoul 120752, South Korea; Korea Res Inst Biosci & Biotechnol, Lab Human Genom, Taejon 305333, South Korea; Labfrontier Co Ltd, Inst Life Sci, Suwon 442766, Kyunggi Do, South Korea; NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA; Korea Adv Inst Sci & Technol, Dept Biosyst, Taejon 305701, South Korea	Ewha Womans University; Ewha Womans University; Yonsei University; Yonsei University Health System; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Korea Advanced Institute of Science & Technology (KAIST)	Rhee, SG (corresponding author), Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea.	sgrhee@nih.gov	Choi, Chulhee/C-1642-2011	Choi, Chulhee/0000-0001-5542-9136				Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Baxter RM, 1998, J BIOL CHEM, V273, P17050, DOI 10.1074/jbc.273.27.17050; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kang SW, 2004, J BIOL CHEM, V279, P2535, DOI 10.1074/jbc.M307698200; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Ohmi K, 1997, BIOCHEM BIOPH RES CO, V238, P154, DOI 10.1006/bbrc.1997.7218; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rosado JA, 2004, J BIOL CHEM, V279, P1665, DOI 10.1074/jbc.M307963200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Saito S, 2002, J BIOL CHEM, V277, P44695, DOI 10.1074/jbc.M208332200; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	23	310	326	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					347	353		10.1038/nature03587	http://dx.doi.org/10.1038/nature03587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902258				2022-12-01	WOS:000229185000046
J	Dworkin, MS				Dworkin, MS			Adults are whooping, but are internists listening?	ANNALS OF INTERNAL MEDICINE			English	Article							BORDETELLA-PERTUSSIS INFECTION; UNITED-STATES; PERSISTENT COUGH; ADOLESCENTS; OUTBREAK; EPIDEMIOLOGY; AZITHROMYCIN; PROPHYLAXIS; PREVALENCE; ILLNESS	Although studies have shown that pertussis is responsible for approximately 20% to 30% of cases of cough lasting more than 2 weeks in adults and adolescents, physicians have generally considered pertussis a disease that affects only children. Epidemiologic trends demonstrate that the incidence of pertussis has been rising, especially in adolescents and adults. Consequently, pertussis is not a "zebra" diagnosis but deserves a place among the community-acquired list of adult pathogens. Increased awareness among physicians about pertussis is important because adults may transmit the infection to infants, in whom the disease often leads to hospitalization and may result in death. Reporting this disease to the local health department is critical to its control because both case-patients and their close contacts should receive antimicrobial prophylaxis. A booster vaccine for adolescents and adults is likely to become available in the near future, so this is an important time to ensure that all physicians, not just pediatricians, are knowledgeable about the diagnosis, treatment, and reporting requirements for pertussis.	Illinois Dept Publ Hlth, Chicago, IL 60601 USA		Dworkin, MS (corresponding author), Illinois Dept Publ Hlth, 160 N LaSalle,7th Floor, Chicago, IL 60601 USA.	mdworkin@idph.state.il.us						ADDISS DG, 1991, J INFECT DIS, V164, P704, DOI 10.1093/infdis/164.4.704; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Baughman AL, 2004, CLIN DIAGN LAB IMMUN, V11, P1045, DOI 10.1128/CDLI.11.6.1045-1053.2004; Centers for Disease Control and Prevention (CDC) HIPAA Privacy Rule and Public Health, 2003, MMWR-MORBID MORTAL W, V52, P1; Cherry JD, 2004, CLIN INFECT DIS, V39, P1715, DOI 10.1086/425003; Cherry JD, 1998, ANN INTERN MED, V128, P64, DOI 10.7326/0003-4819-128-1-199801010-00010; Cloud JL, 2002, J CLIN MICROBIOL, V40, P3838, DOI 10.1128/JCM.40.10.3838-3840.2002; Dworkin MS, 1998, ANN INTERN MED, V128, P1047, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00025; DWORKIN MS, 2004, P 42 ANN M INF DIS S; DWORKIN MS, 1997, P 31 ANN NAT IMM C D; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; HERWALDT LA, 1991, ARCH INTERN MED, V151, P1510, DOI 10.1001/archinte.151.8.1510; HODDER SL, 1992, EPIDEMIOL REV, V14, P243, DOI 10.1093/oxfordjournals.epirev.a036089; Klass P, 2004, NEW ENGL J MED, V350, P2023, DOI 10.1056/NEJMp038243; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; Langley JM, 2004, PEDIATRICS, V114, pE96, DOI 10.1542/peds.114.1.e96; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Mannerstedt G, 1934, J PEDIATR-US, V5, P596, DOI 10.1016/S0022-3476(34)80039-X; Marchant CD, 2004, CLIN INFECT DIS, V39, P1581, DOI 10.1086/425012; Martinez SM, 2001, INFECT CONT HOSP EP, V22, P781, DOI 10.1086/501863; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; MORSE SI, 1968, ANN INTERN MED, V68, P953, DOI 10.7326/0003-4819-68-4-953; Nennig ME, 1996, JAMA-J AM MED ASSOC, V275, P1672, DOI 10.1001/jama.275.21.1672; *OKL STAT DEP HLTH, 2004, 2003 ANN SUMM INF DI; POSTELSMULTANI S, 1995, INFECTION, V23, P139, DOI 10.1007/BF01793853; Purdy KW, 2004, CLIN INFECT DIS, V39, P20, DOI 10.1086/421091; ROBERTSON PW, 1987, MED J AUSTRALIA, V146, P522, DOI 10.5694/j.1326-5377.1987.tb120392.x; ROSENTHAL S, 1995, J INFECT DIS, V171, P1650, DOI 10.1093/infdis/171.6.1650; SCHMITTGROHE S, 1995, CLIN INFECT DIS, V21, P860, DOI 10.1093/clinids/21.4.860; Senzilet LD, 2001, CLIN INFECT DIS, V32, P1691, DOI 10.1086/320754; STEKETEE RW, 1988, J INFECT DIS, V157, P434, DOI 10.1093/infdis/157.3.434; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044; 1995, MMWR MORB MORTAL WKL, V44, P74; 1997, MMWR MORB MORTAL WKL, V46, P822; 2004, MMWR MORB MORTAL WKL, V53, P131; 2002, MMWR MORB MORTAL WKL, V51, P616; 2002, MMWR MORB MORTAL WKL, V51, P73	38	22	22	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2005	142	10					832	835		10.7326/0003-4819-142-10-200505170-00008	http://dx.doi.org/10.7326/0003-4819-142-10-200505170-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926CE	15897533				2022-12-01	WOS:000229099600004
J	Seynaeve, C; Brekelmans, CTM				Seynaeve, C; Brekelmans, CTM			Tailoring breast cancer therapy to genetic status	LANCET			English	Editorial Material							20-YEAR FOLLOW-UP; CONSERVING TREATMENT; GERMLINE MUTATIONS; LUMPECTOMY; MASTECTOMY; BRCA2; WOMEN		Dr Daniel den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, NL-3075 AE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Seynaeve, C (corresponding author), Dr Daniel den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, NL-3075 AE Rotterdam, Netherlands.	c.seynaeve@erasmusmc.nl						Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Haffty BG, 2002, LANCET, V359, P1471, DOI 10.1016/S0140-6736(02)08434-9; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Robson M, 2005, CANCER, V103, P44, DOI 10.1002/cncr.20728; Seynaeve C, 2004, EUR J CANCER, V40, P1150, DOI 10.1016/j.ejca.2004.01.017; SEYNAEVE C, 2002, P ASCO, V21, pA426; Turner BC, 1999, J CLIN ONCOL, V17, P3017, DOI 10.1200/JCO.1999.17.10.3017; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1672	1673		10.1016/S0140-6736(05)66528-2	http://dx.doi.org/10.1016/S0140-6736(05)66528-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894086				2022-12-01	WOS:000229082300008
J	Flasar, FM; Achterberg, RK; Conrath, BJ; Gierasch, PJ; Kunde, VG; Nixon, CA; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Bezard, B; Coustenis, A; Irwin, PGJ; Teanby, NA; Brasunas, J; Pearl, JC; Segura, ME; Carlson, RC; Mamoutkine, A; Schinder, PJ; Barucci, A; Courtin, R; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Vinatier, S; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Orton, GS; Spilker, LJ; Owen, TC; Spencer, JR; Showalter, MR; Ferrari, C; Abbas, MM; Raulin, F; Edgington, S; Ade, P; Wishnow, EH				Flasar, FM; Achterberg, RK; Conrath, BJ; Gierasch, PJ; Kunde, VG; Nixon, CA; Bjoraker, GL; Jennings, DE; Romani, PN; Simon-Miller, AA; Bezard, B; Coustenis, A; Irwin, PGJ; Teanby, NA; Brasunas, J; Pearl, JC; Segura, ME; Carlson, RC; Mamoutkine, A; Schinder, PJ; Barucci, A; Courtin, R; Fouchet, T; Gautier, D; Lellouch, E; Marten, A; Prange, R; Vinatier, S; Strobel, DF; Calcutt, SB; Read, PL; Taylor, FW; Bowles, N; Samuelson, RE; Orton, GS; Spilker, LJ; Owen, TC; Spencer, JR; Showalter, MR; Ferrari, C; Abbas, MM; Raulin, F; Edgington, S; Ade, P; Wishnow, EH			Titan's atmospheric temperatures, winds, and composition	SCIENCE			English	Article							HETERODYNE OBSERVATIONS; VERTICAL PROFILE; POLAR VORTEX; PHOTOCHEMISTRY; OCCULTATION; STRATOSPHERE; MILLIMETER; CHEMISTRY; DYNAMICS; SYSTEM	Temperatures obtained from early Cassini infrared observations of Titan show a stratopause at an altitude of 310 kilometers (and 186 kelvin at 15 degrees S). Stratospheric temperatures are coldest in the winter northern hemisphere, with zonal winds reaching 160 meters per second. The concentrations of several stratospheric organic compounds are enhanced at mid- and high northern latitudes, and the strong zonal winds may, inhibit mixing between these latitudes and the rest of Titan. Above the south pole, temperatures in the stratosphere are 4 to 5 kelvin cooler than at the equator. The stratospheric mole fractions of methane and carbon monoxide are (1.6 +/- 0.5) x 10(-2) and (4.5 +/- 1.5) x 10(-5), respectively.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Sci Syst & Applicat, Lanham, MD 20706 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Observ Paris, LESIA, CNRS, UMR 8109, F-91925 Meudon, France; Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; QSS Grp, Lanham, MD 20706 USA; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; CEA, Serv Astrophys, F-91191 Gif Sur Yvette, France; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; Univ Paris 07, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Univ Paris 12, Lab Interuniv Syst Atmospher, CNRS, UMR 7583, F-94010 Creteil, France; Univ Cardiff, Dept Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; Univ Calif Berkeley, Space Sci Lab, Livermore, CA 94551 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Cornell University; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Oxford; Johns Hopkins University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; CEA; UDICE-French Research Universities; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Cardiff University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Flasar, FM (corresponding author), NASA, Goddard Space Flight Ctr, Code 693, Greenbelt, MD 20771 USA.	f.m.flasar@nasa.gov	brasunas, john/I-2798-2013; Fouchet, Thierry/C-6374-2017; Nixon, Conor A/A-8531-2009; Vinatier, Sandrine/AAB-8763-2019; Romani, Paul N/D-2729-2012; Flasar, F Michael/C-8509-2012; Orton, Glenn/AAD-9862-2020; Strobel, Darrell5/AAO-6643-2021; Jennings, Donald/D-7978-2012; Ferrari, Cécile/P-9735-2016; Simon, Amy/C-8020-2012; Bjoraker, Gordon L/D-5032-2012	Fouchet, Thierry/0000-0001-9040-8285; Nixon, Conor A/0000-0001-9540-9121; Vinatier, Sandrine/0000-0001-5541-2502; Strobel, Darrell5/0000-0002-0944-8675; Ferrari, Cécile/0000-0001-5962-7439; Simon, Amy/0000-0003-4641-6186; Taylor, Fred/0000-0002-0675-9769; Bezard, Bruno/0000-0002-5433-5661; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Ade, Peter/0000-0002-5127-0401; Achterberg, Richard/0000-0002-7643-7626; Calcutt, Simon/0000-0002-0102-3170; Teanby, Nicholas/0000-0003-3108-5775				BACMEISTER JT, 1995, J GEOPHYS RES-ATMOS, V100, P11669, DOI 10.1029/94JD02958; BEZARD B, 1995, ICARUS, V113, P267, DOI 10.1006/icar.1995.1023; BOUCHEZ AH, 2004, THESIS CALTECH; COUSTENIS A, 1995, ICARUS, V115, P126, DOI 10.1006/icar.1995.1084; Coustenis A, 2003, ICARUS, V161, P383, DOI 10.1016/S0019-1035(02)00028-3; COUSTENIS A, 1993, ICARUS, V102, P240, DOI 10.1006/icar.1993.1047; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; FLASAR FM, 1990, ICARUS, V85, P346, DOI 10.1016/0019-1035(90)90122-P; FLASAR FM, 1981, NATURE, V292, P693, DOI 10.1038/292693a0; Flasar FM, 1998, PLANET SPACE SCI, V46, P1125, DOI 10.1016/S0032-0633(97)00223-7; GURWELL MA, 1995, ICARUS, V117, P375, DOI 10.1006/icar.1995.1163; Hidayat T, 1998, ICARUS, V133, P109, DOI 10.1006/icar.1998.5908; Hourdin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002282; HOURDIN F, 1995, ICARUS, V117, P358, DOI 10.1006/icar.1995.1162; HUBBARD WB, 1993, ASTRON ASTROPHYS, V269, P541; Hunten D.M, 1984, SATURN, P671; KUNDE V, 1996, SPIE P, P162; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; Lellouch E, 2003, ICARUS, V162, P125, DOI 10.1016/S0019-1035(02)00079-9; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Marten A, 2002, ICARUS, V158, P532, DOI 10.1006/icar.2002.6897; Moses JI, 2000, ICARUS, V143, P244, DOI 10.1006/icar.1999.6270; Roe HG, 2004, ICARUS, V169, P440, DOI 10.1016/j.icarus.2004.01.002; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; SCHOEBERL MR, 1991, SCIENCE, V251, P46, DOI 10.1126/science.251.4989.46; Sicardy B, 1999, ICARUS, V142, P357, DOI 10.1006/icar.1999.6219; STROBEL DF, 1982, PLANET SPACE SCI, V30, P839, DOI 10.1016/0032-0633(82)90116-7; TOUBLANC D, 1995, ICARUS, V113, P2, DOI 10.1006/icar.1995.1002; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; YELLE RV, 1991, ASTROPHYS J, V383, P380, DOI 10.1086/170796; YUNG YL, 1987, ICARUS, V72, P468, DOI 10.1016/0019-1035(87)90186-2; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	33	277	278	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					975	978		10.1126/science.1111150	http://dx.doi.org/10.1126/science.1111150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15894528				2022-12-01	WOS:000229190700032
J	Moore, P				Moore, P			Hot from the vent	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					235	235		10.1038/435235b	http://dx.doi.org/10.1038/435235b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889099	Bronze			2022-12-01	WOS:000229021100049
J	Kolaczinski, J; Graham, K; Fahim, A; Brooker, S; Rowland, M				Kolaczinski, J; Graham, K; Fahim, A; Brooker, S; Rowland, M			Malaria control in Afghanistan: progress and challenges	LANCET			English	Article							INSECTICIDE-TREATED NETS; PLASMODIUM-FALCIPARUM MALARIA; PROVIDES PERSONAL PROTECTION; ANOPHELES-CULICIFACIES; SOUTHWEST AFGHANISTAN; CATTLE OWNERSHIP; REFUGEE CAMP; TOP-SHEETS; PAKISTAN; RESISTANCE	From the 1950s until 1979 malaria control in Afghanistan was implemented through a vertical programme managed by the government, but little of the original programme remained functional by the early 1990s. Delivery of basic health care including malaria diagnosis and treatment was done by non-governmental organisations (NGOs) and UN agencies, which organised cross-border operations from Pakistan and Iran and placed much less emphasis on vertical programming. From 1992 the situation in the east of Afghanistan became stable enough to allow the establishment of a network of NGO-supported clinics and to introduce standardised training and monitoring of microscopists and clinical staff, coordinated by a lead agency specialising in malaria. After the collapse of the Taliban in 2001 and the subsequent establishment of an interim government, the first steps in health-system rehabilitation have been taken. The gradual integration of malaria control into routine health-care delivery is planned. This process should be guided by the knowledge and experience gained during the complex emergency and a focus on malaria should be maintained until the disease is brought under control.	Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1E 7HT, England; HealthNet Int, Peshawar, Pakistan; Minist Hlth, Dept Hlth Care & Promot, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Kolaczinski, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	jan.kolaczinski@lshtm.ac.uk						Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Bhutta ZA, 2002, BMJ-BRIT MED J, V324, P349, DOI 10.1136/bmj.324.7333.349; BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7; BOUMA MJ, 1995, T ROY SOC TROP MED H, V89, P62, DOI 10.1016/0035-9203(95)90661-4; Brentlinger PE, 2003, LANCET INFECT DIS, V3, P467, DOI 10.1016/s1473-3099(03)00717-5; Buck A.A., 1972, HLTH DIS RURAL AFGHA; DELFINI LF, 1989, T ROY SOC TROP MED H, V83, P316, DOI 10.1016/0035-9203(89)90486-0; Dhir S. L., 1957, Indian Journal of Malariology, V11, P73; DJELANTIK AAM, 1975, EMMAL169; DY F J, 1954, Bull World Health Organ, V11, P725; ESHGHY N, 1978, MOSQ NEWS, V38, P97; ESHGHY N, 1978, MOSQ NEWS, V38, P268; Hewitt S, 1999, TROP MED INT HEALTH, V4, P481, DOI 10.1046/j.1365-3156.1999.00433.x; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hewitt SE, 1996, ANN TROP MED PARASIT, V90, P337, DOI 10.1080/00034983.1996.11813059; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; JOHNSON C, 1998, AFGHANISTAN LAND SHA; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; LINDBERG K., 1949, RIV MALARIOL, V28, P1; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; POLEVOY NI, 1973, WHOMAL73795; Rab MA, 2001, ANN TROP MED PARASIT, V95, P41, DOI 10.1080/00034980020035906; RAMACHANDRA T, 1951, Bull World Health Organ, V3, P639; Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4; Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3; Rowland M, 1997, TROP MED INT HEALTH, V2, P1049, DOI 10.1046/j.1365-3156.1997.d01-185.x; Rowland M, 2004, TROP MED INT HEALTH, V9, P343, DOI 10.1046/j.1365-3156.2003.01183.x; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Rowland M, 2002, TROP MED INT HEALTH, V7, P813, DOI 10.1046/j.1365-3156.2002.00940.x; Rowland M, 1996, T ROY SOC TROP MED H, V90, P357, DOI 10.1016/S0035-9203(96)90505-2; Rowland M, 1999, T ROY SOC TROP MED H, V93, P641, DOI 10.1016/S0035-9203(99)90081-0; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Rowland M, 2002, T ROY SOC TROP MED H, V96, P620, DOI 10.1016/S0035-9203(02)90331-7; Shah I, 1997, ANN TROP MED PARASIT, V91, P591, DOI 10.1080/00034989760680; Webster J, 2003, TROP MED INT HEALTH, V8, P196, DOI 10.1046/j.1365-3156.2003.01013.x; *WHO, 2003, WHOEMMAL289EG REG OF; *WHO, 2002, COUNTR UPD AFGH	38	42	45	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1506	1512		10.1016/S0140-6736(05)66423-9	http://dx.doi.org/10.1016/S0140-6736(05)66423-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850637				2022-12-01	WOS:000228651600031
J	Benes, CH; Wu, N; Elia, AEH; Dharia, T; Cantley, LC; Soltoff, SP				Benes, CH; Wu, N; Elia, AEH; Dharia, T; Cantley, LC; Soltoff, SP			The C2 domain of PKC delta is a phosphotyrosine binding domain	CELL			English	Article							PROTEIN-KINASE-C; HUMAN COLON-CANCER; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; SRC; CELLS; ACTIVATION; SALIVARY; RECEPTOR; REGION	In eukaryotic cells, the SH2 and PTB domains mediate protein-protein interactions by recognizing phosphotyrosine residues on target proteins. Here we make the unexpected finding that the C2 domain of PKC delta directly binds to phosphotyrosine peptides in a sequence-specific manner. We provide evidence that this domain mediates PKC delta interaction with a Src binding glycoprotein, CDCP1. The crystal structure of the PKC delta C2 domain in complex with an optimal phosphopeptide reveals a new mode of phosphotyrosine binding in which the phosphotyrosine moiety forms a ring-stacking interaction with a histidine residue of the C2 domain. This is also the first example of a protein Ser/Thr kinase containing a domain that binds phosphotyrosine.	Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, New Res Bldg,Room1030 J 330 Brookline Ave, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877, R21DE014721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE14721, DE10877] Funding Source: Medline; NIDDK NIH HHS [P30DK34854] Funding Source: Medline; NIGMS NIH HHS [GM56203, R01 GM056203] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Dekker LV, 1997, J BIOL CHEM, V272, P12747, DOI 10.1074/jbc.272.19.12747; DeMali KA, 1999, EXP CELL RES, V253, P271, DOI 10.1006/excr.1999.4669; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Irby R, 1997, CELL GROWTH DIFFER, V8, P1287; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Lopez-Lluch G, 2001, BIOCHEM J, V357, P39, DOI 10.1042/0264-6021:3570039; Malek RL, 2002, ONCOGENE, V21, P7256, DOI 10.1038/sj.onc.1205900; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SOLTOFF SP, 1995, J BIOL CHEM, V270, P13490, DOI 10.1074/jbc.270.22.13490; Soltoff SP, 1998, ANN NY ACAD SCI, V842, P100, DOI 10.1111/j.1749-6632.1998.tb09637.x; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523	40	213	229	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					271	280		10.1016/j.cell.2005.02.019	http://dx.doi.org/10.1016/j.cell.2005.02.019			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851033	Bronze			2022-12-01	WOS:000228705000014
J	Ting, SB; Caddy, J; Hislop, N; Wilanowski, T; Auden, A; Zhao, LL; Ellis, S; Kaur, P; Uchida, Y; Holleran, WM; Elias, PM; Cunningham, JM; Jane, SM				Ting, SB; Caddy, J; Hislop, N; Wilanowski, T; Auden, A; Zhao, LL; Ellis, S; Kaur, P; Uchida, Y; Holleran, WM; Elias, PM; Cunningham, JM; Jane, SM			A homolog of Drosophila grainy head is essential for epidermal integrity in mice	SCIENCE			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTORS; SKIN BARRIER FUNCTION; GENETIC-CONTROL; FAMILY; LACKING; TRANSGLUTAMINASE-1; IDENTIFICATION; MELANOGASTER; PROTEINS; FEATURES	The Drosophila cuticle is essential for maintaining the surface barrier defenses of the fly. Integral to cuticle resilience is the transcription factor grainy head, which regulates production of the enzyme required for covalent cross-linking of the cuticular structural components. We report that formation and maintenance of the epidermal barrier in mice are dependent on a mammalian homolog of grainy head, Grainy head-like 3. Mice tacking this factor display defective skin barrier function and deficient wound repair, accompanied by reduced expression of transglutaminase 1, the key enzyme involved in cross-linking the structural components of the superficial epidermis. These findings suggest that the functional mechanisms involving protein cross-linking that maintain the epidermal barrier and induce tissue repair are conserved across 700 million years of evolution.	Royal Melbourne Hosp PO, Rotary Bone Marrow Res Labs, Parkville, Vic 3050, Australia; Peter MacCallum Res Inst, Epithelial Stem cell Biol Lab, Microscopy Imaging Facil, Melbourne, Vic 3001, Australia; Univ Calif San Francisco, Dept Vet Affairs Med Ctr, Res Unit, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dermatol Serv, San Francisco, CA 94121 USA; Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94121 USA; St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN 38101 USA	Royal Melbourne Hospital; Peter Maccallum Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; St Jude Children's Research Hospital	Jane, SM (corresponding author), Royal Melbourne Hosp PO, Rotary Bone Marrow Res Labs, Grattan St, Parkville, Vic 3050, Australia.	jane@wehi.edu.au	Wilanowski, Tomasz/R-4077-2016; Jane, Stephen/D-6659-2011; Kaur, Pritinder/I-2605-2013	Ellis, Sarah/0000-0002-5772-6051; Kaur, Pritinder/0000-0002-4994-2782; Wilanowski, Tomasz/0000-0003-4447-8164; Uchida, Yoshikazu/0000-0002-4980-3416; Kelly, Nikki/0000-0003-1517-3249; Jane, Stephen Marsden/0000-0002-1045-0481	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA 21765] Funding Source: Medline; NHLBI NIH HHS [P01 HL53749-03] Funding Source: Medline; NIAMS NIH HHS [P01-AR39448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI13563; Lee HY, 2004, MECH DEVELOP, V121, P37, DOI 10.1016/j.mod.2003.11.002; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; MCCLUSKEY J, 1995, DEV BIOL, V170, P102, DOI 10.1006/dbio.1995.1199; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Ostrowski S, 2002, GENETICS, V161, P171; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Phillips Marjorie A, 2004, BMC Dermatol, V4, P2, DOI 10.1186/1471-5945-4-2; SCHAEFER J, 1987, SCIENCE, V235, P1200, DOI 10.1126/science.3823880; SCHOLNICK SB, 1986, SCIENCE, V234, P998, DOI 10.1126/science.3095924; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Takagi S, 2003, J CLIN INVEST, V112, P1372, DOI 10.1172/JCI200318513; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104	31	226	227	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					411	413		10.1126/science.1107511	http://dx.doi.org/10.1126/science.1107511			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831758				2022-12-01	WOS:000228492000052
J	Tanaka, M; Chien, P; Yonekura, K; Weissman, JS				Tanaka, M; Chien, P; Yonekura, K; Weissman, JS			Mechanism of cross-species prion transmission: An infectious conformation compatible with two highly divergent yeast prion proteins	CELL			English	Article							PROTEASE-RESISTANT FORMS; SINGLE AMINO-ACID; SACCHAROMYCES-CEREVISIAE; SUP35 PROTEIN; MOLECULAR-BASIS; IN-VITRO; MAMMALIAN PRIONS; STRUCTURAL BASIS; INCUBATION-TIME; PSI+ PRIONS	Efficiency of interspecies prion transmission decreases as the primary structures of the infectious proteins diverge. Yet, a single prion protein can misfold into multiple infectious conformations, and such differences in "strain conformation" also alter infection specificity. Here, we explored the relationship between prion strains and species barriers by creating distinct synthetic prion forms of the yeast prion protein Sup35. We identified a strain conformation of Sup35 that allows transmission from the S. cerevisiae (Sc) Sup35 to the highly divergent C. albicans (Ca) Sup35 both in vivo and in vitro. Remarkably, cross-species transmission leads to a novel Ca strain that in turn can infect the Sc protein. Structural studies reveal strain-specific conformational differences in regions of the prion domain that are involved in intermolecular contacts. Our findings support a model whereby strain conformation is the critical determinant of cross-species prion transmission while primary structure affects transmission specificity by altering the spectrum of preferred amyloid conformations.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	Tanaka, Motomasa/N-5064-2015; YONEKURA, Koji/N-5060-2015	Tanaka, Motomasa/0000-0002-2994-7703; Yonekura, Koji/0000-0001-5520-4391; Weissman, Jonathan/0000-0003-2445-670X				Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Baylis M, 2004, NATURE, V432, P810, DOI 10.1038/432810a; Bossers A, 1997, P NATL ACAD SCI USA, V94, P4931, DOI 10.1073/pnas.94.10.4931; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	52	150	154	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					49	62		10.1016/j.cell.2005.03.008	http://dx.doi.org/10.1016/j.cell.2005.03.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820678	Bronze			2022-12-01	WOS:000228348500009
J	Chapman, T				Chapman, T			Pure but not simple	NATURE			English	Article																			0	23	25	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					795	800		10.1038/434795a	http://dx.doi.org/10.1038/434795a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815637	Bronze			2022-12-01	WOS:000228160700049
J	Jaenicke, R				Jaenicke, R			Abundance of cellular material and proteins in the atmosphere	SCIENCE			English	Article							AEROSOLS		Univ Mainz, Inst Phys Atmosphare, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Jaenicke, R (corresponding author), Univ Mainz, Inst Phys Atmosphare, D-55099 Mainz, Germany.	jaenicke@uni-mainz.de	Jaenicke, Ruprecht/G-2296-2010					Andrews E, 2000, J AIR WASTE MANAGE, V50, P648, DOI 10.1080/10473289.2000.10464116; ARTAXO P, 1988, J GEOPHYS RES-ATMOS, V93, P1605, DOI 10.1029/JD093iD02p01605; BORODULIN AI, 2003, J AEROSOLS CI, V34, pS681; Graedel T. E., 1993, ATMOSPHERIC CHANGE E; Graham B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD004049; Kenny C. M., 1998, J AEROSOL SCI, V29, pS779, DOI [DOI 10.1016/S0021-8502(98)90572-9, 10.1016/S0021-8502(98)90572-9]; O'Dowd CD, 2004, NATURE, V431, P676, DOI 10.1038/nature02959; Penner JE, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P289	8	372	399	7	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					73	73		10.1126/science.1106335	http://dx.doi.org/10.1126/science.1106335			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802596				2022-12-01	WOS:000228221500034
J	Brixner, T; Stenger, J; Vaswani, HM; Cho, M; Blankenship, RE; Fleming, GR				Brixner, T; Stenger, J; Vaswani, HM; Cho, M; Blankenship, RE; Fleming, GR			Two-dimensional spectroscopy of electronic couplings in photosynthesis	NATURE			English	Article							PHOTON-ECHOES; FEMTOSECOND SPECTROSCOPY; INFRARED-SPECTROSCOPY; CHLOROBIUM-TEPIDUM; DIFFRACTIVE OPTICS; ANTENNA COMPLEXES; LINE-SHAPES; FMO COMPLEX; DYNAMICS; PROTEIN	Time-resolved optical spectroscopy is widely used to study vibrational and electronic dynamics by monitoring transient changes in excited state populations on a femtosecond timescale(1). Yet the fundamental cause of electronic and vibrational dynamics-the coupling between the different energy levels involved-is usually inferred only indirectly. Two-dimensional femtosecond infrared spectroscopy based on the heterodyne detection of three-pulse photon echoes(2-7) has recently allowed the direct mapping of vibrational couplings, yielding transient structural information. Here we extend the approach to the visible range(3,8) and directly measure electronic couplings in a molecular complex, the Fenna-Matthews-Olson photosynthetic light-harvesting protein(9,10). As in all photosynthetic systems, the conversion of light into chemical energy is driven by electronic couplings that ensure the efficient transport of energy from light-capturing antenna pigments to the reaction centre(11). We monitor this process as a function of time and frequency and show that excitation energy does not simply cascade stepwise down the energy ladder. We find instead distinct energy transport pathways that depend sensitively on the detailed spatial properties of the delocalized excited-state wavefunctions of the whole pigment-protein complex.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst Quantitat Biomed Res QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Korea Univ, Dept Chem, Seoul 136701, South Korea; Korea Univ, Div Chem & Mol Engn, Ctr Multidimens Spect, Seoul 136701, South Korea; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Korea University; Korea University; Arizona State University; Arizona State University-Tempe	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	grfleming@lbl.gov	Cho, Minhaeng/C-9983-2011; Brixner, Tobias/S-1451-2016	Cho, Minhaeng/0000-0003-1618-1056; Brixner, Tobias/0000-0002-6529-704X				[Anonymous], 2002, PHOTOSYNTHETICA; Asbury JB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.237402; Asplund MC, 2000, P NATL ACAD SCI USA, V97, P8219, DOI 10.1073/pnas.140227997; BLANKENSHIP RE, 2003, LIGHT HARVESTING ANT, P195; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Cervetto V, 2004, J CHEM PHYS, V121, P5935, DOI 10.1063/1.1778163; Cho MH, 2001, J CHEM PHYS, V115, P4424, DOI 10.1063/1.1389844; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; FENNA RE, 1975, NATURE, V258, P573, DOI 10.1038/258573a0; Goodno GD, 1998, J OPT SOC AM B, V15, P1791, DOI 10.1364/JOSAB.15.001791; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; Khalil M, 2003, J PHYS CHEM A, V107, P5258, DOI 10.1021/jp0219247; Kwac K, 2003, J PHYS CHEM A, V107, P5903, DOI 10.1021/jp034727w; Lepetit L, 1996, OPT LETT, V21, P564, DOI 10.1364/OL.21.000564; Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189; Maznev AA, 1998, OPT LETT, V23, P1319, DOI 10.1364/OL.23.001319; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Prall BS, 2004, J CHEM PHYS, V120, P2537, DOI 10.1063/1.1644794; Savikhin S, 1998, J PHYS CHEM B, V102, P5556, DOI 10.1021/jp981186f; Tian PF, 2003, SCIENCE, V300, P1553, DOI 10.1126/science.1083433; Tokmakoff A, 2000, J PHYS CHEM A, V104, P4247, DOI 10.1021/jp993207r; Van Amerongen H., 2000, PHOTOSYNTHETIC EXCIT; Vulto SIE, 1998, J PHYS CHEM B, V102, P9577, DOI 10.1021/jp982095l; Vulto SIE, 1999, J PHYS CHEM B, V103, P8153, DOI 10.1021/jp984702a; Wendling M, 2002, PHOTOSYNTH RES, V71, P99, DOI 10.1023/A:1014947732165; Wright JC, 2002, INT REV PHYS CHEM, V21, P185, DOI 10.1080/01442350210124506; Yang M, 2003, BIOPHYS J, V85, P140, DOI 10.1016/S0006-3495(03)74461-0; ZEWAIL AH, 1994, FEMTOCHEMISTRY; Zhang WM, 1998, J CHEM PHYS, V108, P7763, DOI 10.1063/1.476212	30	974	990	8	390	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					625	628		10.1038/nature03429	http://dx.doi.org/10.1038/nature03429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800619				2022-12-01	WOS:000228011000040
J	Reese, C; Heise, F; Mayer, A				Reese, C; Heise, F; Mayer, A			Trans-SNARE pairing can precede a hemifusion intermediate in intracellular membrane fusion	NATURE			English	Article							VACUOLE FUSION; INFLUENZA HEMAGGLUTININ; YEAST VACUOLES; VIRAL FUSION; LATE STEP; EXOCYTOSIS; DOCKING; PEPTIDES	The question concerning whether all membranes fuse according to the same mechanism has yet to be answered satisfactorily. During fusion of model membranes or viruses, membranes dock, the outer membrane leaflets mix ( termed hemifusion), and finally the fusion pore opens and the contents mix(1,2). Viral fusion proteins consist of a membrane-disturbing 'fusion peptide' and a helical bundle that pin the membranes together(2-4). Although SNARE ( soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complexes form helical bundles with similar topology, it is unknown whether SNARE-dependent fusion events on intracellular membranes proceed through a hemifusion state. Here we identify the first hemifusion state for SNARE-dependent fusion of native membranes, and place it into a sequence of molecular events: formation of helical bundles by SNAREs precedes hemifusion; further progression to pore opening requires additional peptides. Thus, SNARE-dependent fusion may proceed along the same pathway as viral fusion: both use a docking mechanism via helical bundles(5,6) and additional peptides to destabilize the membrane and efficiently induce lipid mixing(7-9). Our results suggest that a common lipidic intermediate(3) may underlie all fusion reactions of lipid bilayers.	Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany	University of Lausanne; Ruprecht Karls University Heidelberg	Mayer, A (corresponding author), Univ Lausanne, Dept Biochim, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	Andreas.Mayer@unil.ch	Mayer, Andreas/AAE-4315-2020	Mayer, Andreas/0000-0001-6131-313X				Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Coorssen JR, 2003, J CELL SCI, V116, P2087, DOI 10.1242/jcs.00374; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; REESE C, UNPUB J CELL BIOL; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Szule JA, 2003, J BIOL CHEM, V278, P24251, DOI 10.1074/jbc.C300197200; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; VOGEL SS, 1993, J BIOL CHEM, V268, P25764; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Zimmerberg J, 2001, TRENDS CELL BIOL, V11, P233, DOI 10.1016/S0962-8924(01)02003-7; Zimmerberg J, 1999, ADV DRUG DELIVER REV, V38, P197, DOI 10.1016/S0169-409X(99)00029-0	30	93	97	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					410	414		10.1038/nature03722	http://dx.doi.org/10.1038/nature03722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	15924133				2022-12-01	WOS:000230623400046
J	Stockinger, P; Kvitsiani, D; Rotkopf, S; Tirian, L; Dickson, BJ				Stockinger, P; Kvitsiani, D; Rotkopf, S; Tirian, L; Dickson, BJ			Neural circuitry that governs Drosophila male courtship behavior	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; SEXUAL-DIMORPHISM; TARGETED EXPRESSION; FRUITLESS GENE; TASTE NEURONS; PHEROMONE; PATTERNS; MAP; TRANSMISSION; ORIENTATION	Male-specific fruitless (fru) products (Fru(M)) are both necessary and sufficient to "hardwire" the potential for male courtship behavior into the Drosophila nervous system. Fru(M) is expressed in similar to 2% of neurons in the male nervous system, but not in the female. We have targeted the insertion of GAL4 into the fru locus, allowing us to visualize and manipulate the Fru(M-)expressing neurons in the male as well as their counterparts in the female. We present evidence that these neurons are directly and specifically involved in male courtship behavior and that at least some of them are interconnected in a circuit. This circuit includes olfactory neurons required for the behavioral response to sex pheromones. Anatomical differences in this circuit that might account for the dramatic differences in male and female sexual behavior are not apparent.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019; Stockinger, Petra/AAC-7359-2020	Dickson, Barry/0000-0003-0715-892X; Stockinger, Petra/0000-0002-9533-0437; Kvitsiani, Duda/0000-0003-3175-1774				Anholt RRH, 1996, GENETICS, V143, P293; AVERHOFF WW, 1974, BEHAV GENET, V4, P207, DOI 10.1007/BF01074155; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; HALDER N, 1964, GENETICS, V50, P1269; HALL JC, 1979, GENETICS, V92, P437; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HOFBAUER A, 1991, THESIS U WURZBURG WU; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kido A, 2002, J NEUROBIOL, V52, P302, DOI 10.1002/neu.10100; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; KULKARNI SJ, 1987, GENETICS, V115, P461; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlote, 1984, DROS INFORM SERV, V60, P210; SCHNEIDERMAN AM, 1982, NATURE, V298, P844, DOI 10.1038/298844a0; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; Song HJ, 2002, GENETICS, V162, P1703; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	49	410	421	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					795	807		10.1016/j.cell.2005.04.026	http://dx.doi.org/10.1016/j.cell.2005.04.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935765	Bronze			2022-12-01	WOS:000229658000017
J	Bartlett, S				Bartlett, S			Life, the universe, and everything	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Bartlett, S (corresponding author), Lancet, London NW1 7BY, England.							Adams Douglas, 1979, HITCHHIKERS GUIDE GA; *CHANDR XRAY OBS, 2005, PLAN PROT XRAY SUP F; *HUBBL, 1994, HUBBL CONF AB PROT D; WILGOREN J, 2005, NY TIMES        0506	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 28	2005	365	9474					1836	1836		10.1016/S0140-6736(05)66600-7	http://dx.doi.org/10.1016/S0140-6736(05)66600-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931JK	15924970				2022-12-01	WOS:000229481400009
J	Daley, DO; Rapp, M; Granseth, E; Melen, K; Drew, D; von Heijne, G				Daley, DO; Rapp, M; Granseth, E; Melen, K; Drew, D; von Heijne, G			Global topology analysis of the Escherichia coli inner membrane proteome	SCIENCE			English	Article							MULTIDRUG TRANSPORTER EMRE; GREEN FLUORESCENT PROTEIN; X-RAY-STRUCTURE; CONDUCTING CHANNEL; SELECTIVITY; PREDICTION; EVOLUTION; ANGSTROM; EFFLUX	The protein complement of cellular membranes is notoriously resistant to standard proteomic analysis and structural studies. As a result, membrane proteomes remain ill-defined. Here, we report a global topology analysis of the Escherichia coli inner membrane proteome. Using C-terminal tagging with the alkaline phosphatase and green fluorescent protein, we established the periplasmic or cytoplasmic locations of the C termini for 601 inner membrane proteins. By constraining a topology prediction algorithm with this data, we derived high-quality topology models for the 601 proteins, providing a firm foundation for future functional studies of this and other membrane proteomes. We also estimated the overexpression potential for 397 green fluorescent protein fusions; the results suggest that a large fraction of all inner membrane proteins can be produced in sufficient quantities for biochemical and structural work.	Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; AlbaNova, Stockholm Bioinformat Ctr, SE-10691 Stockholm, Sweden	Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Drew, David/AAY-3455-2020; Rapp, Mikaela/K-2298-2015; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569; Daley, Daniel/0000-0002-6425-5059; Drew, David/0000-0001-8866-6349				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; DREW D, IN PRESS PROTEIN SCI; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Shimizu T, 2004, J MOL BIOL, V339, P1, DOI 10.1016/j.jmb.2004.03.048; Ubarretxena-Belandia I, 2004, FEBS LETT, V564, P234, DOI 10.1016/S0014-5793(04)00228-5; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; WU JH, 1992, J BIOL CHEM, V267, P12570	25	385	1023	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1321	1323		10.1126/science.1109730	http://dx.doi.org/10.1126/science.1109730			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919996				2022-12-01	WOS:000229482300051
J	Vinuesa, CG; Cook, MC; Angelucci, C; Athanasopoulos, V; Rui, LX; Hill, KM; Yu, D; Domaschenz, H; Whittle, B; Lambe, T; Roberts, IS; Copley, RR; Bell, JI; Cornall, RJ; Goodnow, CC				Vinuesa, CG; Cook, MC; Angelucci, C; Athanasopoulos, V; Rui, LX; Hill, KM; Yu, D; Domaschenz, H; Whittle, B; Lambe, T; Roberts, IS; Copley, RR; Bell, JI; Cornall, RJ; Goodnow, CC			A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity	NATURE			English	Article							B-CELL; INDUCIBLE COSTIMULATOR; IN-VIVO; IMMUNE-RESPONSES; GERMINAL-CENTERS; DENDRITIC CELLS; CO-STIMULATION; CBL-B; ICOS; ACTIVATION	Despite the sequencing of the human and mouse genomes, few genetic mechanisms for protecting against autoimmune disease are currently known. Here we systematically screen the mouse genome for autoimmune regulators to isolate a mouse strain, sanroque, with severe autoimmune disease resulting from a single recessive defect in a previously unknown mechanism for repressing antibody responses to self. The sanroque mutation acts within mature T cells to cause formation of excessive numbers of follicular helper T cells and germinal centres. The mutation disrupts a repressor of ICOS, an essential co-stimulatory receptor for follicular T cells, and results in excessive production of the cytokine interleukin-21. sanroque mice fail to repress diabetes-causing T cells, and develop high titres of autoantibodies and a pattern of pathology consistent with lupus. The causative mutation is in a gene of previously unknown function, roquin (Rc3h1), which encodes a highly conserved member of the RING-type ubiquitin ligase protein family. The Roquin protein is distinguished by the presence of a CCCH zinc-finger found in RNA-binding proteins, and localization to cytosolic RNA granules implicated in regulating messenger RNA translation and stability.	Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia; Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia; Australian Phenom Facil, Canberra, ACT 2601, Australia; Univ Oxford, Oxford OX3 9DU, England; John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Australian National University; John Curtin School of Medical Research; Australian National University; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au; chris.goodnow@anu.edu.au	Lambe, Teresa/E-5733-2016; li, rui/GSD-4367-2022; Goodnow, Christopher C/V-8108-2018; Cook, matthew/F-4151-2019; rui, li/GYR-3791-2022; Vinuesa, Carola G/B-1108-2010; Yu, Di/C-2163-2009	Lambe, Teresa/0000-0001-7711-897X; Goodnow, Christopher C/0000-0001-5296-6155; Cook, matthew/0000-0002-3331-9363; Vinuesa, Carola G/0000-0001-9799-0298; Yu, Di/0000-0003-1721-8922; Athanasopoulos, Vicki/0000-0002-5764-5948				Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Anderson P, 2002, J CELL SCI, V115, P3227; Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Greve B, 2004, J IMMUNOL, V173, P157, DOI 10.4049/jimmunol.173.1.157; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Iwai H, 2003, J IMMUNOL, V171, P2848, DOI 10.4049/jimmunol.171.6.2848; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mills DM, 2003, SEMIN IMMUNOL, V15, P325, DOI 10.1016/j.smim.2003.09.004; Morking PA, 2004, BIOCHEM BIOPH RES CO, V319, P169, DOI [10.1016/S0006-291X(04)00873-3, 10.1016/j.bbrc.2004.04.162]; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Okamoto S, 2004, EUR J IMMUNOL, V34, P3176, DOI 10.1002/eji.200324755; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; SCHERER MT, 1995, J EXP MED, V182, P1493, DOI 10.1084/jem.182.5.1493; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Walker LSK, 2000, IMMUNOL TODAY, V21, P333, DOI 10.1016/S0167-5699(00)01636-4; Wickens M, 2003, SCIENCE, V300, P753, DOI 10.1126/science.1084512; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	665	700	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					452	458		10.1038/nature03555	http://dx.doi.org/10.1038/nature03555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917799				2022-12-01	WOS:000229337800045
J	Dierks, T; Dickmanns, A; Preusser-Kunze, A; Schmidt, B; Mariappan, M; von Figura, K; Ficner, R; Rudolph, MG				Dierks, T; Dickmanns, A; Preusser-Kunze, A; Schmidt, B; Mariappan, M; von Figura, K; Ficner, R; Rudolph, MG			Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme	CELL			English	Article							CYSTEINE-SULFENIC ACID; CRYSTAL-STRUCTURE; POSTTRANSLATIONAL FORMATION; BACTERIAL SULFATASES; PROTEIN MODIFICATION; ARYLSULFATASE; GENE; PEROXIDASE; CONVERSION; FAMILY	Sulfatases are enzymes essential for degradation and remodeling of sulfate esters. Formylglycine (FGly), the key catalytic residue in the active site, is unique to sulfatases. In higher eukaryotes, FGly is generated from a cysteine precursor by the FGly-generating enzyme (FGE). Inactivity of FGE results in multiple sulfatase deficiency (MSD), a fatal autosomal recessive syndrome. Based on the crystal structure, we report that FGE is a single-domain monomer with a surprising paucity of secondary structure and adopts a unique fold. The effect of all 18 missense mutations found in MSD patients is explained by the FGE structure, providing a molecular basis of MSD. The catalytic mechanism of FGly generation was elucidated by six high-resolution structures of FGE in different redox environments. The structures allow formulation of a novel oxygenase mechanism whereby FGE utilizes molecular oxygen to generate FGly via a cysteine sulfenic acid intermediate.	Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; Univ Gottingen, Dept Mol Struct Biol, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	von Figura, K (corresponding author), Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany.	kfigura@gwdg.de; markus.rudolph@bio.uni-goettingen.de	mariappan, malaiyalam/K-9024-2012; Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Rudolph, Markus/0000-0003-0447-1101				AHMED SA, 1989, J BIOL CHEM, V264, P19864; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dickmanns A, 2005, J BIOL CHEM, V280, P15180, DOI 10.1074/jbc.M414317200; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fang QH, 2004, J BIOL CHEM, V279, P14570, DOI 10.1074/jbc.M313855200; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; GILMOUR R, 1994, BIOCHEM J, V300, P907, DOI 10.1042/bj3000907; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; HASCHKE RH, 1978, BIOCHEM BIOPH RES CO, V80, P1039, DOI 10.1016/0006-291X(78)91350-5; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14225, DOI 10.1073/pnas.94.26.14225; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Luan P, 2000, TRAFFIC, V1, P270, DOI 10.1034/j.1600-0854.2000.010309.x; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Mariappan M, 2005, J BIOL CHEM, V280, P15173, DOI 10.1074/jbc.M413698200; Marquordt C, 2003, J BIOL CHEM, V278, P2212, DOI 10.1074/jbc.M209435200; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POULOS TL, 1993, J BIOL CHEM, V268, P4429; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Szameit C, 1999, J BIOL CHEM, V274, P15375, DOI 10.1074/jbc.274.22.15375; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Xin XN, 2004, J BIOL CHEM, V279, P48159, DOI 10.1074/jbc.M407486200; Yeh JI, 1996, BIOCHEMISTRY-US, V35, P9951, DOI 10.1021/bi961037s	54	145	161	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					541	552		10.1016/j.cell.2005.03.001	http://dx.doi.org/10.1016/j.cell.2005.03.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907468	Green Published, Bronze			2022-12-01	WOS:000229331200011
J	Hill, RA; Barton, RA				Hill, RA; Barton, RA			Red enhances human performance in contests	NATURE			English	Editorial Material							MALE COLORATION; MATE CHOICE; DOMINANCE; ANGER		Univ Durham, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England	Durham University	Hill, RA (corresponding author), Univ Durham, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England.	r.a.hill@durham.ac.uk	Hill, Russell/D-9113-2013	Hill, Russell/0000-0002-7601-5802				Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Cuthill IC, 1997, P ROY SOC B-BIOL SCI, V264, P1093, DOI 10.1098/rspb.1997.0151; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/10001-000, DOI 10.1037/10001-000]; Drummond PD, 1997, PERS INDIV DIFFER, V23, P575, DOI 10.1016/S0191-8869(97)00077-9; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1017/S004857720199095X; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Pryke SR, 2002, BEHAV ECOL, V13, P622, DOI 10.1093/beheco/13.5.622; Ryan Michael J., 1997, P179; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065	10	268	277	5	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2005	435	7040					293	293		10.1038/435293a	http://dx.doi.org/10.1038/435293a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902246	Bronze			2022-12-01	WOS:000229185000034
J	Rich-Edwards, JW; Kleinman, K; Michels, KB; Stampfer, MJ; Manson, JE; Rexrode, KM; Hibert, EN; Willett, WC				Rich-Edwards, JW; Kleinman, K; Michels, KB; Stampfer, MJ; Manson, JE; Rexrode, KM; Hibert, EN; Willett, WC			Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; FETAL ORIGINS; EARLY GROWTH; CHILDHOOD; DEATH; ASSOCIATION; COHORT	Objectives To determine whether birth weight and adult body size interact to predict coronary heart disease in women, as has been observed for men. To determine whether birth weight and adult body size interact to predict risk of stroke. Design Longitudinal cohort study. Setting and participants 66 111 female nurses followed since 1976 who were born of singleton, term pregnancies and reported their birth weight in 1992. Main outcome measures 1504 events of coronary heart disease (myocardial infarction or sudden cardiac death) and 1164 strokes. Results For each kilogram of higher birth weight, age adjusted hazard ratios from prospective analysis were 0.77 (95% confidence interval 0.69 to 0.87) for coronary heart disease and 0.89 (0.78 to 1.01) for total stroke. In combined prospective and retrospective analysis, hazard ratios were 0.84 (0.76 to 0.93) for total stroke, 0.83 (0.71 to 0.96) for ischaemic stroke, and 0.86 (0.66 to 1. 11) for haemorrhagic stroke. Exclusion of macrosomic infants (> 4536 g) yielded stronger estimates. Risk of coronary heart disease was especially high for women who crossed from a low centile of weight at birth to a high centile of body mass index. in adulthood. The association of lower birth weight with increased risk of stroke was apparent across categories of body mass index in adults and was not especially strong among heavier women. Conclusions Higher body mass index in adulthood is an especially strong risk factor for coronary heart disease among women who were small at birth. In this large cohort of women, size at birth and adiposity in adulthood interacted to predict events of coronary heart disease but not stroke events.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Harvard Univ, Sch Med, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rich-Edwards, JW (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave, Boston, MA 02215 USA.	janet_rich-edwards@hphc.org	Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429; Kleinman, Ken/0000-0002-5600-5834				Bailey SCC, 2002, J TURBUL, V3; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; COX DR, 1972, J R STAT SOC B, V34, P187; Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; FORSEN T, 1990, BRIT MED J, V314, P1403; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Koupilova I, 1999, J HYPERTENS, V17, P19, DOI 10.1097/00004872-199917010-00004; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P1386, DOI 10.2105/AJPH.94.8.1386; LEON D, 2001, BMJ-BRIT MED J, V323, P1033; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; OSMOND C, 1993, BRIT MED J, V307, P1919; Rich-Edwards J., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P87, DOI 10.1079/9780851998213.0087; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Tilling K, 2004, EPIDEMIOLOGY, V15, P557, DOI 10.1097/01.ede.0000135172.67293.60; TROY LM, 1995, INT J OBESITY, V19, P570	26	154	165	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1115	1118A		10.1136/bmj.38434.629630.E0	http://dx.doi.org/10.1136/bmj.38434.629630.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15857857	Green Published, Green Submitted			2022-12-01	WOS:000229166900017
J	Thangaraj, K; Chaubey, G; Kivisild, T; Reddy, AG; Singh, VK; Rasalkar, AA; Singh, L				Thangaraj, K; Chaubey, G; Kivisild, T; Reddy, AG; Singh, VK; Rasalkar, AA; Singh, L			Reconstructing the origin of Andaman Islanders	SCIENCE			English	Article							MODERN HUMANS		Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; Estonian Bioctr, EE-51010 Tartu, Estonia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Estonian Biocentre	Singh, L (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	lalji@ccmb.res.in	Chaubey, Gyaneshwer/AAC-6409-2019; Thangaraj, Kumarasamy/G-5596-2010; Chaubey, Gyaneshwer/H-2753-2012; Kivisild, Toomas/P-5889-2017; Rasalkar, Avinash Arvind/ABA-6519-2021	Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaubey, Gyaneshwer/0000-0003-2899-3852; Kivisild, Toomas/0000-0002-6297-7808; Rasalkar, Avinash Arvind/0000-0003-2277-9556; Thangaraj, Kumarasamy/0000-0002-0075-0106				Endicott P, 2003, AM J HUM GENET, V72, P1590, DOI 10.1086/375408; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; THANGARAJ K, UNPUB; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	9	215	222	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					996	996		10.1126/science.1109987	http://dx.doi.org/10.1126/science.1109987			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890876				2022-12-01	WOS:000229190700038
J	Sachs, JP; Anderson, RF				Sachs, JP; Anderson, RF			Increased productivity in the subantarctic ocean during Heinrich events	NATURE			English	Article							ICE CORE; THERMOHALINE CIRCULATION; CLIMATE-CHANGE; LABRADOR-SEA; TAYLOR DOME; IRON; SEDIMENT; MELTWATER; BIOMASS; RECORD	Massive iceberg discharges from the Northern Hemisphere ice sheets, 'Heinrich events', coincided with the coldest periods of the last ice age(1). There is widespread evidence for Heinrich events and their profound impact on the climate and circulation of the North Atlantic Ocean, but their influence beyond that region remains uncertain(1). Here we use a combination of molecular fingerprints of algal productivity and radioisotope tracers of sedimentation to document eight periods of increased productivity in the subpolar Southern Ocean during the past 70,000 years that occurred within 1,000-2,000 years of a Northern Hemisphere Heinrich event. We discuss possible causes for such a link, including increased supply of iron from upwelling and increased stratification during the growing season, which imply an alteration of the global ocean circulation during Heinrich events. The mechanisms linking North Atlantic iceberg discharges with subantarctic productivity remain unclear at this point. We suggest that understanding how the Southern Ocean was altered during these extreme climate perturbations is critical to understanding the role of the ocean in climate change.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Massachusetts Institute of Technology (MIT); Columbia University	Sachs, JP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave,Room E34-254, Cambridge, MA 02139 USA.	jsachs@mit.edu		Anderson, Robert/0000-0002-8472-2494				Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Boyd P, 1999, J GEOPHYS RES-OCEANS, V104, P13395, DOI 10.1029/1999JC900009; Chase Z, 2001, PALEOCEANOGRAPHY, V16, P468, DOI 10.1029/2000PA000542; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Little MG, 1997, PALEOCEANOGRAPHY, V12, P568, DOI 10.1029/97PA00823; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Nilsson J, 2003, J PHYS OCEANOGR, V33, P2781, DOI 10.1175/1520-0485(2003)033<2781:TTCAVM>2.0.CO;2; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27355, DOI 10.1029/2001JD000954; Rohling EJ, 2004, NATURE, V430, P1016, DOI 10.1038/nature02859; Sachs JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000862; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; Steig EJ, 2000, GEOGR ANN A, V82A, P213, DOI 10.1111/j.0435-3676.2000.00122.x; Stoner JS, 2000, EARTH PLANET SC LETT, V183, P161, DOI 10.1016/S0012-821X(00)00272-7; van Kreveld S, 2000, PALEOCEANOGRAPHY, V15, P425, DOI 10.1029/1999PA000464; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Watson AJ, 1999, TELLUS B, V51, P453, DOI 10.1034/j.1600-0889.1999.00022.x; Weaver PPE, 1998, PALEOCEANOGRAPHY, V13, P70, DOI 10.1029/97PA02982; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171	30	83	86	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1118	1121		10.1038/nature03544	http://dx.doi.org/10.1038/nature03544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858571				2022-12-01	WOS:000228693300040
J	Lee, JH; Paull, TT				Lee, JH; Paull, TT			ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex	SCIENCE			English	Article							DAMAGE; NBS1; AUTOPHOSPHORYLATION; PHOSPHORYLATION; REQUIREMENT; MRE11/RAD50; CHECKPOINT; BINDING; REPAIR; SMC1	The ataxia-tetangiectasia mutated (ATM) kinase signals the presence of DNA double-strand breaks in mammalian cells by phosphorylating proteins that initiate cell-cycle arrest, apoptosis, and DNA repair. We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN, leading to phosphorylation of the downstream cellular targets p53 and Chk2. ATM autophosphorylation was not required for monomerization of ATM by MRN. The unwinding of DNA ends by MRN was essential for ATM stimulation, which is consistent with the central role of single-stranded DNA as an evolutionarily conserved signal for DNA damage.	Univ Texas, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, 1 Univ Stn,A4800, Austin, TX 78712 USA.	tpaull@icmb.utexas.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X	NATIONAL CANCER INSTITUTE [R01CA094008] Funding Source: NIH RePORTER; NCI NIH HHS [CA094008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2003, MOL CANCER RES, V1, P674; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	18	1017	1057	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					551	554		10.1126/science.1108297	http://dx.doi.org/10.1126/science.1108297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15790808				2022-12-01	WOS:000228810500052
J	Schmittner, A				Schmittner, A			Decline of the marine ecosystem caused by a reduction in the Atlantic overturning circulation	NATURE			English	Article							NORTH-ATLANTIC; CLIMATE; PRODUCTIVITY; MODEL; SCALE; CO2	Reorganizations of the Atlantic meridional overturning circulation were associated with large and abrupt climatic changes in the North Atlantic region during the last glacial period(1-4). Projections with climate models suggest that similar reorganizations may also occur in response to anthropogenic global warming(5-7). Here I use ensemble simulations with a coupled climate-ecosytem model of intermediate complexity to investigate the possible consequences of such disturbances to the marine ecosystem. In the simulations, a disruption of the Atlantic meridional overturning circulation leads to a collapse of the North Atlantic plankton stocks to less than half of their initial biomass, owing to rapid shoaling of winter mixed layers and their associated separation from the deep ocean nutrient reservoir. Globally integrated export production declines by more than 20 per cent owing to reduced upwelling of nutrient-rich deep water and gradual depletion of upper ocean nutrient concentrations. These model results are consistent with the available high-resolution palaeorecord, and suggest that global ocean productivity is sensitive to changes in the Atlantic meridional overturning circulation.	Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Schmittner, A (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, 104 COAS Adm Bldg, Corvallis, OR 97331 USA.	aschmittner@coas.oregonstae.edu	Schmittner, Andreas/A-3101-2008; Schmittner, Andreas/O-9647-2015	Schmittner, Andreas/0000-0002-8376-0843				Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; Aumont O, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001745; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Conkright M., 2002, NOAA ATLAS NESDIS42; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Dokken TM, 1999, NATURE, V401, P458, DOI 10.1038/46753; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Hendy IL, 2003, QUATERNARY SCI REV, V22, P673, DOI 10.1016/S0277-3791(02)00186-5; KIEFER T, 1998, 90 U KIEL GEOL PAL I; Lebreiro SM, 1997, PALEOCEANOGRAPHY, V12, P718, DOI 10.1029/97PA01748; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; Ortiz JD, 2004, GEOLOGY, V32, P521, DOI 10.1130/G20234.1; Rasmussen TL, 2003, MAR MICROPALEONTOL, V47, P143, DOI 10.1016/S0377-8398(02)00115-9; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SARTHEIN M, 2001, NO N ATLANTIC, P45; Schartau M, 2003, J MAR RES, V61, P765, DOI 10.1357/002224003322981147; Schmittner A, 2003, QUATERNARY SCI REV, V22, P659, DOI 10.1016/S0277-3791(02)00184-1; SCHMITTNER A, IN PRESS GLOB BIOGEO; Schulte S, 2001, GEO-MAR LETT, V21, P168, DOI 10.1007/s003670100080; Simmons HL, 2004, OCEAN MODEL, V6, P245, DOI 10.1016/S1463-5003(03)00011-8; Six KD, 1996, GLOBAL BIOGEOCHEM CY, V10, P559, DOI 10.1029/96GB02561; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; THOMAS E, 1995, PALEOCEANOGRAPHY, V10, P545, DOI 10.1029/94PA03056; Vink A, 2001, PALEOCEANOGRAPHY, V16, P479, DOI 10.1029/2000PA000582; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Weinelt M., 2003, Z DTSCH GEOL GES, V154, P47, DOI DOI 10.1127/ZDGG/154/2003/47; Willamowski C, 2000, PALEOCEANOGRAPHY, V15, P515, DOI 10.1029/1999PA000467	28	212	216	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					628	633		10.1038/nature03476	http://dx.doi.org/10.1038/nature03476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800620				2022-12-01	WOS:000228011000041
J	Colosimo, PF; Hosemann, KE; Balabhadra, S; Villarreal, G; Dickson, M; Grimwood, J; Schmutz, J; Myers, RM; Schluter, D; Kingsley, DM				Colosimo, PF; Hosemann, KE; Balabhadra, S; Villarreal, G; Dickson, M; Grimwood, J; Schmutz, J; Myers, RM; Schluter, D; Kingsley, DM			Widespread parallel evolution in sticklebacks by repeated fixation of ectodysplasin alleles	SCIENCE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; THREESPINE STICKLEBACKS; GASTEROSTEUS-ACULEATUS; GENETIC ARCHITECTURE; SELECTIVE PREDATION; MITOCHONDRIAL-DNA; LATERAL PLATES; REDUCTION; POPULATIONS; MUTATIONS	Major phenotypic changes evolve in parallel in nature by molecular mechanisms that are largely unknown. Here, we use positional cloning methods to identify the major chromosome locus controlling armor plate patterning in wild threespine sticklebacks. Mapping, sequencing, and transgenic studies show that the Ectodysplasin (EDA) signaling pathway plays a key role in evolutionary change in natural populations and that parallel evolution. of stickleback low-plated phenotypes at most freshwater locations around the world has occurred by repeated selection of Eda alleles derived from an ancestral low-plated haplotype that first appeared more than two million years ago. Members of this clade of tow-plated alleles are present at tow frequencies in marine fish, which suggests that standing genetic variation can provide a molecular basis for rapid, parallel evolution of dramatic phenotypic change in nature.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Stanford Human Genome Ctr, Stanford, CA 94305 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of British Columbia; University of British Columbia	Colosimo, PF (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.		Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021	Schmutz, Jeremy/0000-0001-8062-9172; Schluter, Dolph/0000-0003-1683-7836	NHGRI NIH HHS [1P50HG02568] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AVISE JC, 1976, GENET RES, V27, P33, DOI 10.1017/S0016672300016219; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Bergstrom CA, 2002, CAN J ZOOL, V80, P207, DOI 10.1139/Z01-226; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; CUVIER G, 1829, HIST NATURELLE POISS; Deagle BE, 1996, CAN J ZOOL, V74, P1045, DOI 10.1139/z96-116; Futuyma D.J., 1998, EVOL BIOL; GILES N, 1983, J ZOOL, V199, P535; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; HAGEN DW, 1972, EVOLUTION, V26, P32, DOI 10.1111/j.1558-5646.1972.tb00172.x; HAGEN DW, 1973, HEREDITY, V30, P273, DOI 10.1038/hdy.1973.38; HEUTS MJ, 1947, EVOLUTION, V1, P89, DOI 10.2307/2405407; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Hosemann KE, 2004, BEHAVIOUR, V141, P1345, DOI 10.1163/1568539042948097; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kingsley DM, 2004, BEHAVIOUR, V141, P1331, DOI 10.1163/1568539042948150; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LINDSEY CC, 1962, CAN J ZOOLOG, V40, P271, DOI 10.1139/z62-028; MACLEAN J, 1980, CAN J ZOOL, V58, P2026, DOI 10.1139/z80-279; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; MOODIE GEE, 1973, BEHAVIOUR, V47, P95, DOI 10.1163/156853973X00292; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Paakkonen K, 2001, Hum Mutat, V17, P349, DOI 10.1002/humu.33; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Ransom DG, 1999, METHOD CELL BIOL, V60, P195; Reimchen TE, 2000, BEHAVIOUR, V137, P1081, DOI 10.1163/156853900502448; REIMCHEN TE, 1992, EVOLUTION, V46, P1224, DOI 10.1111/j.1558-5646.1992.tb00631.x; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Sire JY, 2003, BIOL REV, V78, P219, DOI 10.1017/S1464793102006073; Srivastava AK, 2001, HUM MOL GENET, V10, P2973, DOI 10.1093/hmg/10.26.2973; Taylor EB, 1999, BIOL J LINN SOC, V66, P271, DOI 10.1111/j.1095-8312.1999.tb01891.x; TAYLOR EB, 1986, CAN J ZOOL, V64, P416, DOI 10.1139/z86-064; THESLEFF I, 2002, SCI STKE, V131; Vincent MC, 2001, EUR J HUM GENET, V9, P355, DOI 10.1038/sj.ejhg.5200635; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Williams-Blangero S, 2002, P NATL ACAD SCI USA, V99, P5533, DOI 10.1073/pnas.082115999; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	43	1068	1092	9	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2005	307	5717					1928	1933		10.1126/science.1107239	http://dx.doi.org/10.1126/science.1107239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790847				2022-12-01	WOS:000227957300048
J	Dharmasiri, N; Dharmasiri, S; Estelle, M				Dharmasiri, N; Dharmasiri, S; Estelle, M			The F-box protein TIR1 is an auxin receptor	NATURE			English	Article							SCF UBIQUITIN-LIGASE; AUX/IAA PROTEINS; DEGRADATION; COMPLEX; MECHANISMS; EXPRESSION; BINDING; GROWTH; DOMAIN; GENES	The plant hormone auxin regulates diverse aspects of plant growth and development. Recent studies indicate that auxin acts by promoting the degradation of the Aux/IAA transcriptional repressors through the action of the ubiquitin protein ligase SCFTIR1. The nature of the signalling cascade that leads to this effect is not known. However, recent studies indicate that the auxin receptor and other signalling components involved in this response are soluble factors. Using an in vitro pull-down assay, we demonstrate that the interaction between transport inhibitor response 1 (TIR1) and Aux/IAA proteins does not require stable modification of either protein. Instead auxin promotes the Aux/IAA-SCFTIR1 interaction by binding directly to SCFTIR1. We further show that the loss of TIR1 and three related F-box proteins eliminates saturable auxin binding in plant extracts. Finally, TIR1 synthesized in insect cells binds Aux/IAA proteins in an auxin-dependent manner. Together, these results indicate that TIR1 is an auxin receptor that mediates Aux/IAA degradation and auxin-regulated transcription.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Estelle, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	maestell@indiana.edu	Estelle, Mark/ABD-6742-2021					BLATT MR, 1994, PLANT J, V5, P55, DOI 10.1046/j.1365-313X.1994.5010055.x; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Davies Peter J., 1995, P1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Frias I, 1996, PLANT CELL, V8, P1533; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Luthen H, 1999, PROG BOT, V60, P315; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Philippar K, 1999, P NATL ACAD SCI USA, V96, P12186, DOI 10.1073/pnas.96.21.12186; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; WENT F. W., 1928, REC TRAV BOT NEERL, V25, P1; Willemsen V, 2004, ANNU REV GENET, V38, P587, DOI 10.1146/annurev.genet.38.072902.092231; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	30	1430	1589	20	384	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					441	445		10.1038/nature03543	http://dx.doi.org/10.1038/nature03543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917797				2022-12-01	WOS:000229337800043
J	Holmes, MD; Chen, WY; Feskanich, D; Kroenke, CH; Colditz, GA				Holmes, MD; Chen, WY; Feskanich, D; Kroenke, CH; Colditz, GA			Physical activity and survival after breast cancer diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; ADJUVANT CHEMOTHERAPY; WEIGHT-GAIN; RISK; EXERCISE; VALIDITY; DISEASE; OBESITY	Context Physical activity has been shown to decrease the incidence of breast cancer, but the effect on recurrence or survival after a breast cancer diagnosis is not known. Objective To determine whether physical activity among women with breast cancer decreases their risk of death from breast cancer compared with more sedentary women. Design, Setting, and Participants Prospective observational study based on responses from 2987 female registered nurses in the Nurses' Health Study who were diagnosed with stage I, II, or III breast cancer between 1984 and 1998 and who were followed up until death or June 2002, whichever came first. Main Outcome Measure Breast cancer mortality risk according to physical activity category (<3, 3-8.9, 9-14.9,15-23.9, or >= 24 metabolic equivalenttask [MET] hours per week). Results Compared with women who engaged in less than 3 MET-hours per week of physical activity, the adjusted relative risk (RR) of death from breast cancer was 0.80 (95% confidence interval [CI], 0.60-1.06) for 3 to 8.9 MET-hours per week; 0.50 (95% Cl, 0.31-0.82) for 9 to 14.9 MET-hours per week; 0.56 (95% Cl, 0.38-0.84) for 15 to 23.9 MET-hours per week; and 0.60 (95% Cl, 0.40-0.89) for 24 or more MET-hours per week (P for trend =.004). Three MET-hours is equivalent to walking at average pace of 2 to 2.9 mph for 1 hour. The benefit of physical activity was particularly apparent among women with hormone-responsive tumors. The RR of breast cancer death for women with hormone-responsive tumors who engaged in 9 or more MET-hours per week of activity compared with women with hormone-responsive tumors who engaged in less than 9 MET-hours per week was 0.50 (95% Cl, 0.34-0.74). Compared with women who engaged in less than 3 MET-hours per week of activity, the absolute unadjusted mortality risk reduction was 6% at 10 years for women who engaged in 9 or more MET-hours per week. Conclusions Physical activity after a breast cancer diagnosis may reduce the risk of death from this disease. The greatest benefit occurred in women who performed the equivalent of walking 3 to 5 hours per week at an average pace, with little evidence of a correlation between increased benefit and greater energy expenditure. Women with breast cancer who follow US physical activity recommendations may improve their survival.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Holmes, MD (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	michelle.holmes@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Holmes, Michelle/0000-0002-8664-2172	NCI NIH HHS [CA87969] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; BASTARRACHEA J, 1994, ANN INTERN MED, V120, P18, DOI 10.7326/0003-4819-120-1-199401010-00004; Bean JF, 2004, ARCH PHYS MED REHAB, V85, pS31, DOI 10.1016/j.apmr.2004.03.010; Bianchini Franca, 2002, Obes Rev, V3, P5, DOI 10.1046/j.1467-789X.2002.00046.x; Blair SN, 2004, AM J CLIN NUTR, V79, P913; BROOCKS A, 1990, J APPL PHYSIOL, V68, P2083, DOI 10.1152/jappl.1990.68.5.2083; BULLEN BA, 1985, NEW ENGL J MED, V312, P1349, DOI 10.1056/NEJM198505233122103; CAMORIANO JK, 1990, J CLIN ONCOL, V8, P1327, DOI 10.1200/JCO.1990.8.8.1327; *CDCP, ACT DO AD NEED BE GA; Chang VT, 1998, CANCER, V83, P173, DOI 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T; Chlebowski RT, 2002, J CLIN ONCOL, V20, P1128, DOI 10.1200/JCO.20.4.1128; Daling JR, 2001, CANCER, V92, P720, DOI 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T; Demark-Wahnefried W, 2001, J CLIN ONCOL, V19, P2381, DOI 10.1200/JCO.2001.19.9.2381; DEMARKWAHNEFRIED W, 1993, J CLIN ONCOL, V11, P1418, DOI 10.1200/JCO.1993.11.7.1418; DemarkWahnefried W, 1997, AM J CLIN NUTR, V65, P1495, DOI 10.1093/ajcn/65.5.1495; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Galanis DJ, 1998, CANCER CAUSE CONTROL, V9, P217, DOI 10.1023/A:1008842613331; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goodwin PJ, 1999, J CLIN ONCOL, V17, P120, DOI 10.1200/JCO.1999.17.1.120; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Holmberg L, 2001, EUR J SURG ONCOL, V27, P152, DOI 10.1053/ejso.2000.1084; Holmes MD, 1999, CANCER, V86, P826, DOI 10.1002/(SICI)1097-0142(19990901)86:5&lt;826::AID-CNCR19&gt;3.0.CO;2-0; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu FB, 2001, ANN INTERN MED, V134, P96, DOI 10.7326/0003-4819-134-2-200101160-00009; Irwin ML, 2004, MED SCI SPORT EXER, V36, P1484, DOI 10.1249/01.MSS.0000074670.03001.98; Irwin ML, 2003, CANCER-AM CANCER SOC, V97, P1746, DOI 10.1002/cncr.11227; Jebb SA, 1999, MED SCI SPORT EXER, V31, pS534, DOI 10.1097/00005768-199911001-00008; Kramer JA, 2000, EUR J CANCER, V36, P1498, DOI 10.1016/S0959-8049(00)00144-1; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.079; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Lonning PE, 1996, BREAST CANCER RES TR, V39, P335, DOI 10.1007/BF01806162; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; McTiernan A, 2004, CANCER RES, V64, P2923, DOI 10.1158/0008-5472.CAN-03-3393; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Newman SC, 1997, INT J EPIDEMIOL, V26, P484, DOI 10.1093/ije/26.3.484; NIEMAN DC, 1994, MED SCI SPORT EXER, V26, P128, DOI 10.1249/00005768-199402000-00002; Obermair A, 1995, ANTICANCER RES, V15, P2265; Pinto BM, 1999, PSYCHO-ONCOL, V8, P191, DOI 10.1002/(SICI)1099-1611(199905/06)8:3<191::AID-PON355>3.0.CO;2-T; Reeves GK, 2000, INT J CANCER, V89, P293, DOI 10.1002/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO;2-R; Rich-Edwards JW, 2002, EPIDEMIOLOGY, V13, P184, DOI 10.1097/00001648-200203000-00013; Rockhill B, 1999, ARCH INTERN MED, V159, P2290, DOI 10.1001/archinte.159.19.2290; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; ROHAN TE, 1995, EUR J CANCER PREV, V4, P419, DOI 10.1097/00008469-199510000-00010; RUTQVIST LE, 1985, ACTA RADIOL ONCOL, V24, P385, DOI 10.3109/02841868509134405; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Sesso HD, 1998, CANCER CAUSE CONTROL, V9, P433, DOI 10.1023/A:1008827903302; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Steindorf K, 2003, AM J EPIDEMIOL, V157, P121, DOI 10.1093/aje/kwf181; Taylor AH, 2004, J SPORT SCI, V22, P703, DOI 10.1080/02640410410001712421; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; ZHANG SM, 1995, CANCER, V76, P275, DOI 10.1002/1097-0142(19950715)76:2<275::AID-CNCR2820760218>3.0.CO;2-6	57	1170	1191	4	108	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2005	293	20					2479	2486		10.1001/jama.293.20.2479	http://dx.doi.org/10.1001/jama.293.20.2479			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929BX	15914748	Bronze			2022-12-01	WOS:000229318200022
J	Quesenberry, PJ; Dooner, G; Dooner, M; Abedi, M				Quesenberry, PJ; Dooner, G; Dooner, M; Abedi, M			Ignoratio elenchi: Red herrings stem cell research	SCIENCE			English	Editorial Material							BONE-MARROW-CELLS; PLASTICITY; TRANSDIFFERENTIATE		Ctr Stem Cell Biol, Dept Res, Providence, RI 02908 USA		Quesenberry, PJ (corresponding author), Ctr Stem Cell Biol, Dept Res, Providence, RI 02908 USA.	pquesenberry@rwmc.org	Abedi, Mehrdad/ABC-3565-2021	Dooner, Mark/0000-0003-0653-6562				Abedi M, 2004, EXP HEMATOL, V32, P426, DOI 10.1016/j.exphem.2004.02.007; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; COLVIN GA, 2004, BLOOD, V104; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Keating A, 2005, BIOL BLOOD MARROW TR, V11, P2, DOI 10.1016/j.bbmt.2004.11.002; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lemischka I, 2002, EXP HEMATOL, V30, P848, DOI 10.1016/S0301-472X(02)00876-7; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wagers AJ, 2003, SCIENCE, V299, p1317B, DOI 10.1126/science.1079110	14	25	26	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1121	1122		10.1126/science.1104432	http://dx.doi.org/10.1126/science.1104432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905387				2022-12-01	WOS:000229293400028
J	Moore, P				Moore, P			Photocopiers for DNA	NATURE			English	Article																			0	0	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					237	237		10.1038/435237a	http://dx.doi.org/10.1038/435237a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889102	Bronze			2022-12-01	WOS:000229021100051
J	Wills, TJ; Lever, C; Cacucci, F; Burgess, N; O'Keefe, J				Wills, TJ; Lever, C; Cacucci, F; Burgess, N; O'Keefe, J			Attractor dynamics in the hippocampal representation of the local environment	SCIENCE			English	Article							COMPLEMENTARY-LEARNING-SYSTEMS; PLACE CELLS; NETWORK MODEL; MEMORY; CA3; DISTINCT; INTEGRATION; NEURONS; FIELDS; CODES	Memories are thought to be attractor states of neuronal representations, with the hippocampus a likely substrate for context-dependent episodic memories. However, such states have not been directly observed. For example, the hippocampal place cell representation of location was previously found to respond continuously to changes in environmental shape alone. We report that exposure to novel square and circular environments made of different materials creates attractor representations for both shapes: Place cells abruptly and simultaneously switch between representations as environmental shape changes incrementally. This enables study of attractor dynamics in a cognitive representation and may correspond to the formation of distinct contexts in context-dependent memory.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	O'Keefe, J (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	j.okeefe@ucl.ac.uk	Wills, Tom J/B-3621-2011; Burgess, Neil/B-2420-2009; Lever, Colin/B-4860-2008	Burgess, Neil/0000-0003-0646-6584; Lever, Colin/0000-0002-8955-2885; Cacucci, Francesca/0000-0002-1968-5156; Wills, Thomas/0000-0002-1331-2869	Medical Research Council [G117/433] Funding Source: Medline; Wellcome Trust [071248] Funding Source: Medline; MRC [G117/433] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Amit D. J., 1992, MODELLING BRAIN FUNC; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FYHN M, 2004, SOC NEUR ABSTR; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; LEUTGEB JK, 2004, SOC NEUR ABSTR; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004	31	395	400	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					873	876		10.1126/science.1108905	http://dx.doi.org/10.1126/science.1108905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879220	Green Accepted, Green Submitted			2022-12-01	WOS:000228986500054
J	Lane, TW; Saito, MA; George, GN; Pickering, IJ; Prince, RC; Morel, FMM				Lane, TW; Saito, MA; George, GN; Pickering, IJ; Prince, RC; Morel, FMM			A cadmium enzyme from a marine diatom	NATURE			English	Editorial Material									Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA; Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 5E2, Canada; ExxonMobile Res & Engn Co, Annandale, NJ 08801 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Sandia National Laboratories; Woods Hole Oceanographic Institution; University of Saskatchewan; Exxon Mobil Corporation; Princeton University	Lane, TW (corresponding author), Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA.	mak@whoi.edu	Pickering, Ingrid J/A-4547-2013; George, Graham N/E-3290-2013; Saito, Mak/ADT-4986-2022; Morel, Francois M M/A-8107-2008	Pickering, Ingrid J/0000-0002-0936-2994; George, Graham/0000-0002-0420-7493; Lane, Todd/0000-0002-5816-2649; Prince, Roger/0000-0002-5174-4216					0	431	449	5	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					42	42		10.1038/435042a	http://dx.doi.org/10.1038/435042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875011	Bronze			2022-12-01	WOS:000228864600032
J	Sack, AT; Camprodon, JA; Pascual-Leone, A; Goebel, R				Sack, AT; Camprodon, JA; Pascual-Leone, A; Goebel, R			The dynamics of interhemispheric compensatory processes in mental imagery	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE NEUROSCIENCE; FUNCTIONAL-ANATOMY; SPATIAL ATTENTION; MINDS IMAGE; PARIETAL; TRACKING; CLOCKS	The capacity to generate and analyze mental visual images is essential for many cognitive abilities. We combined triple-pulse transcranial magnetic Stimulation (tpTMS) and repetitive TMS (rTMS) to determine which distinct aspect of mental imagery is carried out by the left and right parietal lobe and to reveal interhemispheric compensatory interactions. The left parietal lobe was predominant in generating mental images, whereas the right parietal lobe was specialized in the spatial comparison of the imagined content. Furthermore, in case of an rTMS-induced left parietal lesion, the right parietal cortex could immediately compensate such a left parietal disruption by taking over the specific function of the left hemisphere.	Maastricht Univ, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Beth Israel Deaconess Med Ctr, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Maastricht University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Sack, AT (corresponding author), Maastricht Univ, Fac Psychol, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	a.sack@psychology.unimaas.nl	Pascual-Leone, Alvaro/AAC-5101-2019; Camprodon, Joan Albert/M-9093-2017; Pascual-Leone, Alvaro/G-6566-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; Camprodon, Joan Albert/0000-0003-1282-9257; Goebel, Rainer/0000-0003-1780-2467; Sack, Alexander/0000-0002-1471-0885	NCRR NIH HHS [NCRR MO1 RR01032, K24 RR018875] Funding Source: Medline; NIMH NIH HHS [R01MH60734] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060734] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		FARAH MJ, 1989, TRENDS NEUROSCI, V12, P395, DOI 10.1016/0166-2236(89)90079-9; FARAH MJ, 1985, NEUROPSYCHOLOGIA, V23, P115, DOI 10.1016/0028-3932(85)90049-1; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; KOSSLYN SM, 1980, IMAE MIND; Mellet E, 1996, J NEUROSCI, V16, P6504; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; PAIVIO A, 1978, J EXP PSYCHOL HUMAN, V4, P61, DOI 10.1037/0096-1523.4.1.61; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sack AT, 2002, NEURON, V35, P195, DOI 10.1016/S0896-6273(02)00745-6; Thut G, 2003, CLIN NEUROPHYSIOL, V114, P2071, DOI 10.1016/S1388-2457(03)00205-0; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; WALSH V, 2003, NEUROCHRONOMETRICS M	17	151	155	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					702	704		10.1126/science.1107784	http://dx.doi.org/10.1126/science.1107784			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	922BO	15860630				2022-12-01	WOS:000228810900052
J	Sonder, GJB; Regez, RM; Brinkman, K; Prins, JM; Mulder, JW; Spaargaren, J; Coutinho, RA; van den Hoek, A				Sonder, GJB; Regez, RM; Brinkman, K; Prins, JM; Mulder, JW; Spaargaren, J; Coutinho, RA; van den Hoek, A			Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USE; POSTEXPOSURE PROPHYLAXIS	Problem Prophylactic treatment and follow-up after exposure to HIV, hepatitis B, and hepatitis C outside hospital needs to be improved. Background and setting Until January 2000, people in Amsterdam Could report exposure outside hospital to either a hospital or the municipal health service. If they reported to the municipal health service, they were then referred to hospitals for HIV prophylaxis, whereas the municipal health service handled treatment and follow-up related to hepatitis B and hepatitis C and traced sources. For cases reported to a hospital, hospital staff often did not trace HIV sources or follow up patients for hepatitis B and hepatitis C. Key measures for improvement Providing adequate treatment for HIV, hepatitis B and hepatitis C after exposure for all reported exposures outside hospital. Strategies for change On 1 January 2000, a new protocol was introduced in which three Amsterdam hospitals and the municipal health service collaborated in the treatment and follow-up of exposures outside hospital. Both municipal health service and hospitals can decide whether HIV prophylaxis is necessary and prescribe accordingly. All people exposed in the community who report to hospitals are subsequently referred to the municipal health service for further treatment and follow-up. Effects of change The protocol is effective in that most people comply with treatment and follow-up. When indicated, HIV prophylaxis is started soon after exposure. In nearly two thirds of cases the municipal health service traced and tested tire source. Lessons learnt Provision of treatment and follow-up in one place enables treatment, tracing and testing sources, and follow-tip, including counselling and registration of all reported exposures in Amsterdam, which allows for swift identification of emerging epidemiological trends. Since May 2004 all Amsterdam hospitals have participated in the protocol.	Dept Infect Dis, NL-1018 WT Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Internal Med, Dept Clin Res, NL-1091 HA Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; Slotervaart Hosp, Dept Internal Med, NL-1066 EC Amsterdam, Netherlands; Municipal Hlth Lab, Amsterdam, Netherlands; Municipal Hlth Serv Amsterdam, Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Slotervaart Hospital	Sonder, GJB (corresponding author), Dept Infect Dis, Nieuwe Achtergracht 100, NL-1018 WT Amsterdam, Netherlands.	gsonder@gggd.amsterdam.nl	Prins, Jan M./AAF-4945-2020					Almeda J, 2004, Euro Surveill, V9, P35; COLOMBO C, 2004, EUROSURVEILLANCE, V9, P40; Giele CM, 2002, SEX TRANSM INFECT, V78, P130, DOI 10.1136/sti.78.2.130; Kahn JO, 2001, J INFECT DIS, V183, P707, DOI 10.1086/318829; Katz MH, 1997, NEW ENGL J MED, V336, P1097, DOI 10.1056/NEJM199704103361512; Laporte A, 2002, AIDS, V16, P397, DOI 10.1097/00002030-200202150-00011; Tubiana Roland, 2004, Euro Surveill, V9, P3; van der Ende ME, 2002, INT J STD AIDS, V13, P30, DOI 10.1258/095646202762226137; VANSTEENBERGEN JE, 1999, LANDELIJKE COORDINAT	9	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2005	330	7495					825	829		10.1136/bmj.330.7495.825	http://dx.doi.org/10.1136/bmj.330.7495.825			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915BZ	15817550	Green Published			2022-12-01	WOS:000228273900019
J	Goddard, MR; Godfray, HCJ; Burt, A				Goddard, MR; Godfray, HCJ; Burt, A			Sex increases the efficacy of natural selection in experimental yeast populations	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MEIOSIS-I; RECOMBINATION; FITNESS; EVOLUTION; GENE; CHLAMYDOMONAS; PERSPECTIVE; ADAPTATION; MUTATIONS	Why sex evolved and persists is a problem for evolutionary biology, because sex disrupts favourable gene combinations and requires an expenditure of time and energy(1). Further, in organisms with unequal-sized gametes, the female transmits her genes at only half the rate of an asexual equivalent ( the twofold cost of sex)(2). Many modern theories that provide an explanation for the advantage of sex incorporate an idea originally proposed by Weismann more than 100 years ago: sex allows natural selection to proceed more effectively because it increases genetic variation(3-5). Here we test this hypothesis, which still lacks robust empirical support, with the use of experiments on yeast populations. Capitalizing on recent advances in the molecular biology of recombination in yeast, we produced by genetic manipulation strains that differed only in their capacity for sexual reproduction. We show that, as predicted by the theory, sex increases the rate of adaptation to a new harsh environment but has no measurable effect on fitness in a new benign environment where there is little selection.	Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Imperial College London	Goddard, MR (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.	m.goddard@auckland.ac.nz	Goddard, Matthew/C-7462-2014	Burt, Austin/0000-0001-5146-9640; Goddard, Matthew/0000-0002-7482-4438				BAGANZ F, 1997, YEAST, V13, P1536; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE; BERRY DR, 1982, BIOL YEASTS; Birdsell J, 1996, P NATL ACAD SCI USA, V93, P908, DOI 10.1073/pnas.93.2.908; Bruggeman J, 2003, GENETICS, V164, P479; Burke D., 2000, METHODS YEAST GENETI; Burt A, 2000, EVOLUTION, V54, P337; BURT A, 1995, EVOLUTION, V49, P1, DOI 10.1111/j.1558-5646.1995.tb05954.x; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Goho S, 2000, P ROY SOC B-BIOL SCI, V267, P123, DOI 10.1098/rspb.2000.0976; Greig D, 1998, P ROY SOC B-BIOL SCI, V265, P1017, DOI 10.1098/rspb.1998.0393; GREWAL NS, 1972, CAN J MICROBIOL, V18, P1897, DOI 10.1139/m72-295; Kaltz O, 2002, EVOLUTION, V56, P1743; KLAPHOLZ S, 1985, GENETICS, V110, P187; Marini A, 1999, CURR GENET, V35, P77, DOI 10.1007/s002940050435; Michod R, 1988, EVOLUTION SEX EXAMIN; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pinheiro JC., 2000, MIXED EFFECTS MODELS, V43, P111; Rice WR, 2001, SCIENCE, V294, P555, DOI 10.1126/science.1061380; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; STEELE DF, 1991, GENETICS, V127, P53; Wach A, 1998, METHOD MICROBIOL, V26, P67; WANG HT, 1987, MOL CELL BIOL, V7, P1425, DOI 10.1128/MCB.7.4.1425; WEISMANN A, 1904, EVOLUTION THEORY, V2; Zeyl C, 2001, GENETICS, V157, P53	29	313	320	0	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					636	640		10.1038/nature03405	http://dx.doi.org/10.1038/nature03405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800622				2022-12-01	WOS:000228011000043
J	Schweitzer, MH; Wittmeyer, JL; Horner, JR; Toporski, JK				Schweitzer, MH; Wittmeyer, JL; Horner, JR; Toporski, JK			Soft-tissue vessels and cellular preservation in Tyrannosaurus rex	SCIENCE			English	Article							DINOSAUR	Soft tissues are preserved within hindlimb elements of Tyrannosaurus rex (Museum of the Rockies specimen 1125). Removal of the mineral phase reveals transparent, flexible, hollow blood vessels containing small round microstructures that can be expressed from the vessels into solution. Some regions of the demineralized bone matrix are highly fibrous, and the matrix possesses elasticity and resilience. Three populations of microstructures have cell-like morphology. Thus, some dinosaurian soft tissues may retain some of their original flexibility, elasticity, and resilience.	N Carolina State Univ, Dept Marine Earth Atmospher Sci, Raleigh, NC 27695 USA; N Carolina State Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20018 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman; Carnegie Institution for Science	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Marine Earth Atmospher Sci, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; 				Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Dal Sasso C, 1998, NATURE, V392, P383; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Higby Schweitzer Mary, 1999, Annales de Paleontologie, V85, P179, DOI 10.1016/S0753-3969(99)80013-5; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; Martill David M., 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V2, P118; MURPHY NL, 2002, J VERTEBR PALEONTOL, V33, pA91; MUYZER G, 1992, GEOLOGY, V20, P871, DOI 10.1130/0091-7613(1992)020<0871:POTBPO>2.3.CO;2; Pawlicki R, 1998, ANN ANAT, V180, P73, DOI 10.1016/S0940-9602(98)80140-4; PAWLICKI R, 1966, NATURE, V211, P655, DOI 10.1038/211655a0; SCHWEITZER M, UNPUB; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Schweitzer MH, 1997, P NATL ACAD SCI USA, V94, P6291, DOI 10.1073/pnas.94.12.6291; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; WEINER S, 1989, APPL GEOCHEM, V4, P231; Wuttke M., 1988, Senckenberg-Buch, V64, P265; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769	20	105	127	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1952	1955		10.1126/science.1108397	http://dx.doi.org/10.1126/science.1108397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790853				2022-12-01	WOS:000227957300054
J	Sonnenburg, JL; Xu, J; Leip, DD; Chen, CH; Westover, BP; Weatherford, J; Buhler, JD; Gordon, JI				Sonnenburg, JL; Xu, J; Leip, DD; Chen, CH; Westover, BP; Weatherford, J; Buhler, JD; Gordon, JI			Glycan foraging in vivo by an intestine-adapted bacterial symbiont	SCIENCE			English	Article							HOST-MICROBIAL INTERACTIONS; BACTEROIDES-THETAIOTAOMICRON; ECOSYSTEM; ENVIRONMENT; COMMENSAL; STARCH	Germ-free mice were maintained on polysaccharide-rich or simple-sugar diets and colonized for 10 days with an organism also found in human guts, Bacteroides thetaiotaomicron, followed by whole-genome transcriptional profiling of bacteria and mass spectrometry of cecal glycans. We found that these bacteria assembled on food particles and mucus, selectively induced outer-membrane polysaccharide-binding proteins and glycoside hydrolases, prioritized the consumption of liberated hexose sugars, and revealed a capacity to turn to host mucus glycans when polysaccharides were absent from the diet. This flexible foraging behavior should contribute to ecosystem stability and functional diversity.	Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63108 USA; Washington Univ, Dept Comp Sci & Engn, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@molecool.wustl.edu	Xu, Jian/G-8430-2012; Xu, Jian/A-6831-2008	Xu, Jian/0000-0002-0548-8477; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R37DK030292, P30DK052574] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30292, DK052574] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Cho KH, 2001, J BACTERIOL, V183, P7198, DOI 10.1128/JB.183.24.7198-7205.2001; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; SALYERS AA, 1979, AM J CLIN NUTR, V32, P158, DOI 10.1093/ajcn/32.1.158; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; WESTOVER BP, 2004, BIOINFORMATICS  1111; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	16	772	810	6	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1955	1959		10.1126/science.1109051	http://dx.doi.org/10.1126/science.1109051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790854				2022-12-01	WOS:000227957300055
J	Schriner, SE; Linford, NJ; Martin, GM; Treuting, P; Ogburn, CE; Emond, M; Coskun, PE; Ladiges, W; Wolf, N; Van Remmen, H; Wallace, DC; Rabinovitch, PS				Schriner, SE; Linford, NJ; Martin, GM; Treuting, P; Ogburn, CE; Emond, M; Coskun, PE; Ladiges, W; Wolf, N; Van Remmen, H; Wallace, DC; Rabinovitch, PS			Extension of murine life span by overexpression of catalase targeted to mitochondria	SCIENCE			English	Article							SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; IN-VIVO; THIOREDOXIN; EXPRESSION; LONGEVITY; INCREASE	To determine the, role of reactive oxygen species in mammalian longevity, we generated transgenic mice that overexpress human catalase localized to the peroxisome, the nucleus, or mitochondria (MCAT). Median and maximum life spans were maximally increased (averages of 5 months and 5.5 months, respectively) in MCAT animals. Cardiac pathology and cataract development were delayed, oxidative damage was reduced, H2O2 production and H2O2-induced aconitase inactivation were attenuated, and the development of mitochondria) deletions was reduced. These results support the free radical theory of aging and reinforce the importance of mitochondria as a source of these radicals.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio	Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	petersr@u.washington.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519	NIA NIH HHS [AG001751, AG13280] Funding Source: Medline; NIEHS NIH HHS [ES07033] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG013280, P01AG001751] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BURNS TR, 1990, MODERN PATHOL, V3, P336; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5; Jiang JJ, 2003, J BIOCHEM, V133, P423, DOI 10.1093/jb/mvg055; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X; Sun JT, 2002, GENETICS, V161, P661	20	1261	1323	2	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1909	1911		10.1126/science.1106653	http://dx.doi.org/10.1126/science.1106653			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15879174				2022-12-01	WOS:000230120000040
J	Que, LG; Liu, LM; Yan, Y; Whitehead, GS; Gavett, SH; Schwartz, DA; Stamler, JS				Que, LG; Liu, LM; Yan, Y; Whitehead, GS; Gavett, SH; Schwartz, DA; Stamler, JS			Protection from experimental asthma by an endogenous bronchodilator	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN S-NITROSYLATION; AIRWAY HYPERRESPONSIVENESS; CYSTIC-FIBROSIS; NITROGEN-OXIDES; EXHALED AIR; NITROSOTHIOLS; DISEASE; INFLAMMATION; INHIBITION	Mechanisms that protect against asthma remain poorly understood. S-nitrosoglutathione (GSNO), an endogenous bronchodilator, is depleted from asthmatic airways, suggesting a protective role. We report that, following allergen challenge, witd-type mice exhibiting airway hyperresponsivity have increased airway levels of the enzyme GSNO reductase (GSNOR) and are depleted of lung S-nitrosothiols (SNOs). In contrast, mice with genetic deletion of GSNOR exhibit increases in lung SNOs and are protected from airway hyperresponsivity. Our results indicate that endogenous SNOs, governed by GSNOR, are critical regulators of airway responsivity and may provide new therapeutic approaches to asthma.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; US EPA, Expt Toxicol Div, Res Triangle Pk, NC 27711 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; United States Environmental Protection Agency	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	STAML001@mc.duke.edu		Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [K08 HL004171, K08 HL004171-05, HL004171] Funding Source: Medline; NIEHS NIH HHS [P01 ES012496, P01 ES012496-010004, ES012496] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES012496, Z01ES101945] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALVING K, 1993, EUR RESPIR J, V6, P1368; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; De Sanctis GT, 1999, J EXP MED, V189, P1621, DOI 10.1084/jem.189.10.1621; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Grasemann H, 1999, J PEDIATR-US, V135, P770, DOI 10.1016/S0022-3476(99)70101-0; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Koarai A, 2000, PULM PHARMACOL THER, V13, P267, DOI 10.1006/pupt.2000.0254; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; QUE LG, UNPUB; Saleh D, 1998, FASEB J, V12, P929, DOI 10.1096/fasebj.12.11.929; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Whalen EJ, 2000, HYPERTENSION, V36, P376, DOI 10.1161/01.HYP.36.3.376; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xiong YL, 1999, J IMMUNOL, V162, P445	25	246	264	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1618	1621		10.1126/science.1108228	http://dx.doi.org/10.1126/science.1108228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15919956	Green Accepted			2022-12-01	WOS:000229827000054
J	Nelson, MR; Liew, D; Bertram, M; Vos, T				Nelson, MR; Liew, D; Bertram, M; Vos, T			Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COST-EFFECTIVENESS; RISK; EVENTS; PANEL	Objective To investigate the routine use of low dose aspirin in people aged ! 70 without overt cardiovascular disease. Design Epidemiological modelling in a hypothetical population. Setting Reference populations of men and women in the year 2000 from the state of Victoria, Australia. Subjects 10 000 men and 10 000 women aged 70-74 with no cardiovascular disease. Main outcome measures First ever myocardial infarction or unstable angina, ischaemic or haemorrhagic stroke, and major gastrointestinal haemorrhage. Health adjusted years of life lived. Results The proportional benefit gained from the use of low dose aspirin by the prevention of myocardial infarctions (- 389 in men, - 321 in women) and ischaemic stroke (- 19 in men and - 35 in women) is offset by excess gastrointestinal (499 in men, 572 in women) and intracranial (76 in men, 54 in women) bleeding. The results in health adjusted years of life lived (which take into account length and quality of life) are equivocal for aspirin causing net harm or net benefit. Conclusion Epidemiological modelling suggests that any benefits of low dose aspirin on risk of cardiovascular disease in people aged ! 70 are offset by adverse events. These findings are tempered by wide confidence intervals, indicating that the overall outcome could be beneficial or adverse.	Univ Tasmania, Sch Med, Discipline Gen Practice, Hobart, Tas 7001, Australia; Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; WHO, CH-1211 Geneva, Switzerland; Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Tasmania; Florey Institute of Neuroscience & Mental Health; Monash University; World Health Organization; University of Queensland	Nelson, MR (corresponding author), Univ Tasmania, Sch Med, Discipline Gen Practice, Hobart, Tas 7001, Australia.	Mark.Nelson@utas.edu.au	matt, peter/AFR-0434-2022; Vos, Theo/F-3324-2010	matt, peter/0000-0002-6855-3440; Liew, Danny/0000-0002-0131-623X				Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Bonita R, 1997, STROKE, V28, P1898, DOI 10.1161/01.STR.28.10.1898; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; *DEP HUM SERV VICT, 2000, VICT ADM EV DAT; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Liew D, 2002, MED J AUSTRALIA, V177, P364, DOI 10.5694/j.1326-5377.2002.tb04839.x; Lilford RJ, 1998, BMJ-BRIT MED J, V317, P405; MATHERS C, 1999, 17 AIHW PHE; MCELDUFF P, 2000, 11 AIHW CVD; Meade TW, 1998, LANCET, V351, P233; Nelson MR, 2003, DRUG AGING, V20, P897, DOI 10.2165/00002512-200320120-00004; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROSS R, 1999, NEW ENGL J MED, V143, P683; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; *STEER COMM PHYS H, 1980, NEW ENGL J MED, V321, P129; Sturmer T, 1996, AM J EPIDEMIOL, V143, P683; Thrift AG, 2000, STROKE, V31, P2087, DOI 10.1161/01.STR.31.9.2087; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; *VICT DEP HUM SERV, 1999, VICT BURD DIS STUD M; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1996, JAMA-J AM MED ASSOC, V276, P1353	31	44	44	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1306	1308A		10.1136/bmj.38456.676806.8F	http://dx.doi.org/10.1136/bmj.38456.676806.8F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15908442	Green Published, Bronze			2022-12-01	WOS:000229655700024
J	Dong, JH; Yang, GY; Mchaourab, HS				Dong, JH; Yang, GY; Mchaourab, HS			Structural basis of energy transduction in the transport cycle of MsbA	SCIENCE			English	Article							RESISTANCE P-GLYCOPROTEIN; BINDING CASSETTE TRANSPORTERS; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; ATP-BINDING; ESCHERICHIA-COLI; TRANSMEMBRANE DOMAINS; CROSS-LINKING; MECHANISM; CONFORMATION	We used site-directed spin-labeling and electron paramagnetic resonance spectroscopy to characterize the conformational motion that couples energy expenditure to substrate translocation in the multidrug transporter MsbA. In liposomes, ligand-free MsbA samples conformations that depart from the crystal structures, including looser packing and water penetration along the periplasmic side. Adenosine triphosphate (ATP) binding closes the substrate chamber to the cytoplasm while increasing hydration at the periplasmic side, consistent with an alternating access model. Accentuated by ATP hydrolysis, the changes in the chamber dielectric environment and its geometry provide the likely driving force for flipping amphipathic substrates and a potential exit pathway. These results establish the structural dynamic basis of the power stroke in multidrug-resistant ATP-binding cassette (MDR ABC) transporters.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu		Dong, Jinhui/0000-0003-4542-7756				Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong J.-K., UNPUB; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Higgins CF, 1997, SEMIN CANCER BIOL, V8, P135, DOI 10.1006/scbi.1997.0067; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; MITCHELL P, 1990, RES MICROBIOL, V141, P286, DOI 10.1016/0923-2508(90)90002-8; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poelarends GJ, 2002, J BIOL CHEM, V277, P42891, DOI 10.1074/jbc.M206508200; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Seigneuret M, 2003, J BIOL CHEM, V278, P30115, DOI 10.1074/jbc.M302443200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; van Veen HW, 1998, ADV EXP MED BIOL, V456, P145; van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5; van Veen HW, 2001, RES MICROBIOL, V152, P365, DOI 10.1016/S0923-2508(01)01208-6; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	32	127	132	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1023	1028		10.1126/science.1106592	http://dx.doi.org/10.1126/science.1106592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890883				2022-12-01	WOS:000229190700047
J	Cho, PF; Poulin, F; Cho-Park, YA; Cho-Park, IB; Chicoine, JD; Lasko, P; Sonenberg, N				Cho, PF; Poulin, F; Cho-Park, YA; Cho-Park, IB; Chicoine, JD; Lasko, P; Sonenberg, N			A new paradigm for translational control: Inhibition via 5 '-3 ' mRNA tethering by Bicoid and the eIF4E cognate 4EHP	CELL			English	Article							BINDING-PROTEIN; INITIATION-FACTOR; POLY(A)-BINDING PROTEIN; DROSOPHILA CUP; CAP; REPRESSION; RECOGNITION; RECRUITMENT; OSKAR; MOTIF	Translational control is a key genetic regulatory mechanism implicated in regulation of cell and organismal growth and early embryonic development. Initiation at the mRNA 5' cap structure recognition step is frequently targeted by translational control mechanisms. In the Drosophila embryo, cap-dependent translation of the uniformly distributed caudal (cad) mRNA is inhibited in the anterior by Bicoid (Bcd) to create an asymmetric distribution of Cad protein. Here, we show that d4EHP, an eIF4E-related cap binding protein, specifically interacts with Bcd to suppress cad translation. Translational inhibition depends on the Bcd binding region (BBR) present in the cad 3' untranslated region. Thus, simultaneous interactions of d4EHP with the cap structure and of Bcd with BBR renders cad mRNA translationally inactive. This example of cap-dependent translational control that is not mediated by canonical eIF4E defines a new paradigm for translational inhibition involving tethering of the mRNA 5' and 3' ends.	McGill Univ, Dept Biochem, Mcgill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Poulin, F (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	fpoulin@berkeley.edu; nahum.sonenberg@mcgill.ca	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501				Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Chan SK, 1997, NATURE, V388, P634, DOI 10.1038/41692; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kobayashi S, 1999, ADV MOLEC BIOL, P426; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Niessing D, 1999, EMBO J, V18, P1966, DOI 10.1093/emboj/18.7.1966; Niessing D, 2002, GENE DEV, V16, P2576, DOI 10.1101/gad.240002; Poulin F, 2003, MOL B INT U, P280; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; STJOHNSTON D, 1992, CELL, V68, P201; Svitkin YV, 2001, RNA, V7, P1743; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088	48	176	177	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					411	423		10.1016/j.cell.2005.02.024	http://dx.doi.org/10.1016/j.cell.2005.02.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882623	Bronze, Green Published			2022-12-01	WOS:000229031600011
J	Tsubouchi, T; Roeder, GS				Tsubouchi, T; Roeder, GS			A synaptonemal complex protein promotes homology-independet centromere coupling	SCIENCE			English	Article							MEIOTIC CHROMOSOMES; BUDDING YEAST; PH1 LOCUS; MEIOSIS; RECOMBINATION; INITIATION; SYNAPSIS; LINK	We describe a process in meiotic cells of budding yeast in which chromosomes become joined together in pairs at their centromeres independent of chromosomal homology. These centromeric interactions depend on the synaptonemal complex component Zip1. During meiosis in wild-type diploids, centromere couples are initially nonhomologous and then undergo switching until all couples involve homologs. This transition to homologous coupling depends on Spo11, a protein required for the initiation of meiotic recombination. Regions of synaptonemal complex assembled early in meiosis are often centromere-associated. We propose that centromere coupling facilitates homolog pairing and promotes synapsis initiation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Roeder, GS (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	shirleen.roeder@yale.edu		Tsubouchi, Tomomi/0000-0001-9960-3888	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Maestra B, 2002, CHROMOSOME RES, V10, P655, DOI 10.1023/A:1021564327226; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; NAG DK, 1995, GENETICS, V141, P75; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407	18	124	129	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					870	873		10.1126/science.1108283	http://dx.doi.org/10.1126/science.1108283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879219				2022-12-01	WOS:000228986500053
J	Mattapallil, JJ; Douek, DC; Hill, B; Nishimura, Y; Martin, M; Roederer, M				Mattapallil, JJ; Douek, DC; Hill, B; Nishimura, Y; Martin, M; Roederer, M			Massive infection and loss of memory CD4(+) T cells in multiple tissues during acute SIV infection	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; GASTROINTESTINAL-TRACT; HIV-1 INFECTION; RHESUS-MONKEYS; EXPRESSION; DEPLETION; DYNAMICS; TRANSMISSION; REPLICATION; LYMPHOCYTES	It has recently been established that both acute human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are accompanied by a dramatic and selective loss of memory CD4(+) T cells predominantly from the mucosal surfaces. The mechanism underlying this depletion of memory CD4(+) T cells (that is, T-helper cells specific to previously encountered pathogens) has not been defined. Using highly sensitive, quantitative polymerase chain reaction together with precise sorting of different subsets of CD4(+) T cells in various tissues, we show that this loss is explained by a massive infection of memory CD4(+) T cells by the virus. Specifically, 30-60% of CD4(+) memory T cells throughout the body are infected by SIV at the peak of infection, and most of these infected cells disappear within four days. Furthermore, our data demonstrate that the depletion of memory CD4(+) T cells occurs to a similar extent in all tissues. As a consequence, over one-half of all memory CD4(+) T cells in SIV-infected macaques are destroyed directly by viral infection during the acute phase-an insult that certainly heralds subsequent immunodeficiency. Our findings point to the importance of reducing the cell-associated viral load during acute infection through therapeutic or vaccination strategies.	NIAID, Immunotechnol Sect, NIH, Bethesda, MD 20892 USA; NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roederer, M (corresponding author), NIAID, Immunotechnol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Roederer@nih.gov	Roederer, Mario/G-1887-2011	Mattapallil, Joseph/0000-0002-7412-9507	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000190, Z01AI005034, ZIAAI000415, ZIAAI005019, Z01AI000190, ZIAAI005034, Z01AI000415, Z01AI005019] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chen ZW, 1997, J VIROL, V71, P2705, DOI 10.1128/JVI.71.4.2705-2714.1997; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcon L, 1997, J VIROL, V71, P2522, DOI 10.1128/JVI.71.3.2522-2527.1997; Mattapallil JJ, 2004, AIDS, V18, P13, DOI 10.1097/00002030-200401020-00002; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Mengozzi M, 2001, P NATL ACAD SCI USA, V98, P11644, DOI 10.1073/pnas.211205098; MORI K, 1992, J VIROL, V66, P2067, DOI 10.1128/JVI.66.4.2067-2075.1992; Nishimura Y, 2004, P NATL ACAD SCI USA, V101, P12324, DOI 10.1073/pnas.0404620101; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	25	1002	1041	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1093	1097		10.1038/nature03501	http://dx.doi.org/10.1038/nature03501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15793563				2022-12-01	WOS:000228693300033
J	Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH				Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH			Excess deaths associated with underweight, overweight, and obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FOLLOW-UP; BREAST-CANCER; ALL-CAUSE; MORTALITY; GUIDELINES; FITNESS; PREVALENCE; CHILDREN; SMOKING	Context As the prevalence of obesity increases in the United States, concern over the association of body weight with excess mortality has also increased. Objective To estimate deaths associated with underweight (body mass index [BMI] <18.5), overweight (BMI 25 to <30), and obesity (BMI >= 30) in the United States in 2000. Design, Setting, and Participants We estimated relative risks of mortality associated with different levels of BMI (calculated as weight in kilograms divided by the square of height in meters) from the nationally representative National Health and Nutrition Examination Survey (NHANES) 1 (1971-1975) and NHANES II (1976-1980), with follow-up through 1992, and from NHANES 111 (1988-1994), with follow-up through 2000. These relative risks were applied to the distribution of BMI and other covariates from NHANES 1999-2002 to estimate attributable fractions and number of excess deaths, adjusted for confounding factors and for effect modification by age. Main Outcome Measures Number of excess deaths in 2000 associated with given BMI levels. Results Relative to the normal weight category (BMI 18.5 to <25), obesity (BMI >= 30) was associated with 111 909 excess deaths (95% confidence interval [CI], 53 754170064) and underweight with 33 746 excess deaths (95% Cl, 15726-51766). Overweight was not associated with excess mortality (-86094 deaths; 95% Cl, -161223 to -10966). The relative risks of mortality associated with obesity were lower in NHANES 11 and NHANES III than in NHANES I. Conclusions Underweight and obesity, particularly higher levels of obesity, were associated with increased mortality relative to the normal weight category. The impact of obesity on mortality may have decreased over time, perhaps because of improvements in public health and medical care. These findings are consistent with the increases in life expectancy in the United States and the declining mortality rates from ischemic heart disease.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Univ Calif Berkeley, Ctr Weight & Hlth, Berkeley, CA 94720 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4311, Hyattsville, MD 20782 USA.	kflegal@cdc.gov	Young, Alexander/A-1523-2009; Flegal, Katherine M/A-4608-2013	Young, Alexander/0000-0002-9367-9213; Flegal, Katherine/0000-0002-0838-469X				Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Banegas JR, 2003, EUR J CLIN NUTR, V57, P201, DOI 10.1038/sj.ejcn.1601538; BENICHOU J, 1998, AM J PUBLIC HEALTH, V88, P15; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; COHEN JS, 1987, TRADITION, V22, P1; Cox C S, 1997, Vital Health Stat 1, P1; Dorn JM, 1997, AM J EPIDEMIOL, V146, P919, DOI 10.1093/oxfordjournals.aje.a009218; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; Engel A, 1978, Vital Health Stat 1, P1; Farrell SW, 2002, OBES RES, V10, P417, DOI 10.1038/oby.2002.58; Flegal KM, 2004, AM J PUBLIC HEALTH, V94, P1486, DOI 10.2105/AJPH.94.9.1486; Flegal KM, 2004, AM J EPIDEMIOL, V160, P331, DOI 10.1093/aje/kwh222; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Korn E, 1999, ANAL HLTH SURVEYS; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; LORIA CM, 1999, VITAL HLTH STAT 1, V38, P1; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MCDOWELL A, 1981, VITAL HLTH STAT, V1, P15; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; MILLIMAN JD, 1973, BIOL GEOLOGY CORAL R, V1, P1; Minino Arialdi M, 2002, Natl Vital Stat Rep, V50, P1; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; *NAT CTR HLTH STAT, HLTH US 2004 CHARTB; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SHAH BV, 2004, SURV METHODOL, V30, P31; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; STURGEON SR, 1995, J NATL CANCER I, V87, P1846, DOI 10.1093/jnci/87.24.1846; Troiano RP, 1996, INT J OBESITY, V20, P63; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; [No title captured]; 1994, VITAL HLTH STAT, V1, P32	41	1999	2044	2	357	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1861	1867		10.1001/jama.293.15.1861	http://dx.doi.org/10.1001/jama.293.15.1861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840860				2022-12-01	WOS:000228401700024
J	Gregg, EW; Cheng, YLJ; Cadwell, BL; Imperatore, G; Williams, DE; Flegal, KM; Narayan, KMV; Williamson, DF				Gregg, EW; Cheng, YLJ; Cadwell, BL; Imperatore, G; Williams, DE; Flegal, KM; Narayan, KMV; Williamson, DF			Secular trends in cardiovascular disease risk factors according to body mass index in US adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; FACTOR SURVEILLANCE SYSTEM; CORONARY-HEART-DISEASE; UNITED-STATES; NATIONAL-HEALTH; PREVALENCE; OBESITY; OVERWEIGHT; DISABILITY	Context Prevalence of obesity in the United States has increased dramatically in recent decades, but the magnitude of change in cardiovascular disease (CVD) risk factors among the growing proportion of overweight and obese Americans remains unknown. Objective To examine 40-year trends in CVD risk factors by body mass index (BMI) groups among US adults aged 20 to 74 years. Design, Setting, and Participants Analysis of 5 cross-sectional, nationally representative surveys: National Health Examination Survey (1960-1962); National Health and Nutrition Examination Survey (NHANES) I (1971-1975), II (1976-1980), and III (1988-1994); and NHANES 1999-2000. Main Outcome Measures Prevalence of high cholesterol level (>= 240 mg/dL [>= 6.2 mmol/L] regardless of treatment), high blood pressure (>= 140/90 mm Hg regardless of treatment), current smoking, and total diabetes (diagnosed and undiagnosed combined) according to BMI group (lean, <25; overweight, 25-29; and obese, >= 30). Results The prevalence of all risk factors except diabetes decreased overtime across all BMI groups, with the greatest reductions observed among overweight and obese groups. Compared with obese persons in 1960-1962, obese persons in 1999-2000 had a 21-percentage-point lower prevalence of high cholesterol level (39% in 19601962 vs 18% in 1999-2000), an 18-percentage-point lower prevalence of high blood pressure (from 42% to 24%), and a 12-percentage-point lower smoking prevalence (from 32% to 20%). Survey X BMI group interaction terms indicated that compared with-the first survey, the prevalence of high cholesterol in the fifth survey had fallen more in obese and overweight persons than in lean persons (P < .05). Survey X BMI changes in blood pressure and smoking were not statistically significant. Changes in risk factors were accompanied by increases in lipid-lowering and antihypertensive medication use, particularly among obese persons. Total diabetes prevalence was stable within BMI groups over time, as nonsignificant 1- to 2-percentage-point increases occurred between 1976-1980 and 1999-2000. Conclusions Except for diabetes, CVD risk factors have declined considerably over the past 40 years in all BMI groups. Although obese persons still have higher risk factor levels than lean persons, the levels of these risk factors are much lower than in previous decades.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov	Cheng, Yiling J/A-6547-2009; Flegal, Katherine M/A-4608-2013; Narayan, K.M. Venkat/J-9819-2012	Cheng, Yiling J/0000-0002-5053-0814; Narayan, K.M. Venkat/0000-0001-8621-5405; Flegal, Katherine/0000-0002-0838-469X; Gregg, Edward/0000-0003-2381-6822				[Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833; [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; *CDCP, 1980, CDCP PREV DIAGN DIAB; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Cooper R, 2000, CIRCULATION, V102, P3137; ERNST ND, 1997, AM J CLIN NUTR S, V66, P9725; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FLEGAL KM, 1991, DIABETES CARE, V14, P628, DOI 10.2337/diacare.14.7.628; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Korn E, 1999, ANAL HLTH SURVEYS; Kumanyika SK, 1998, AM J EPIDEMIOL, V148, P528; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; *LIP RES CLIN PROG, 1982, MAN LAB OP, V1; MAXWELL MH, 1982, LANCET, V2, P33; McDowell A, 1981, Vital Health Stat 1, P1; Miller SI, 2001, AM J ADDICTION, V10, P1, DOI 10.1080/10550490150504083; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; *NHANES NAT CTR HL, 1999 2000 DAT FIL DA; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; *RES TRIANGL I, 2003, SUDAAN US MAN; RISSANEN A, 1990, BRIT MED J, V301, P835, DOI 10.1136/bmj.301.6756.835; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; *SAS I INC, 1999, SAS PROC GUID; Siegel D, 2000, AM J MED, V108, P496, DOI 10.1016/S0002-9343(00)00319-3; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; Sturm R, 2004, HEALTH AFFAIR, V23, P199, DOI 10.1377/hlthaff.23.2.199; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; [No title captured]; 1965, VITAL HLTH STAT 1, V4, P1	48	663	684	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1868	1874		10.1001/jama.293.15.1868	http://dx.doi.org/10.1001/jama.293.15.1868			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840861	Bronze			2022-12-01	WOS:000228401700025
J	Khimich, D; Nouvian, R; Pujol, R; Dieck, ST; Egner, A; Gundelfinger, ED; Moser, T				Khimich, D; Nouvian, R; Pujol, R; Dieck, ST; Egner, A; Gundelfinger, ED; Moser, T			Hair cell synaptic ribbons are essential for synchronous auditory signalling	NATURE			English	Article							ZONE PROTEIN BASSOON; AFFERENT SYNAPSE; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; ACTIVE ZONES; EXOCYTOSIS; VESICLES; ENDOCYTOSIS; MICROSCOPE; MEMBRANE	Hearing relies on faithful synaptic transmission at the ribbon synapse of cochlear inner hair cells (IHCs)(1-3). At present, the function of presynaptic ribbons at these synapses is still largely unknown(1,4). Here we show that anchoring of IHC ribbons is impaired in mouse mutants for the presynaptic scaffolding protein Bassoon. The lack of active-zone-anchored synaptic ribbons reduced the presynaptic readily releasable vesicle pool, and impaired synchronous auditory signalling as revealed by recordings of exocytic IHC capacitance changes and sound-evoked activation of spiral ganglion neurons. Both exocytosis of the hair cell releasable vesicle pool and the number of synchronously activated spiral ganglion neurons co-varied with the number of anchored ribbons during development. Interestingly, ribbon-deficient IHCs were still capable of sustained exocytosis with normal Ca2+-dependence. Endocytic membrane retrieval was intact, but an accumulation of tubular and cisternal membrane profiles was observed in ribbon-deficient IHCs. We conclude that ribbon-dependent synchronous release of multiple vesicles at the hair cell afferent synapse is essential for normal hearing.	Univ Goettingen, Dept Otolaryngol, D-37099 Gottingen, Germany; Univ Goettingen, Ctr Mol Physiol Brain, D-37099 Gottingen, Germany; Univ Montpellier, INSERM, U583, INM, F-34091 Montpellier, France; Univ Montpellier, CRIC, F-34091 Montpellier, France; Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Leibniz Institut fur Neurobiologie (LIN); Max Planck Society	Moser, T (corresponding author), Univ Goettingen, Dept Otolaryngol, D-37099 Gottingen, Germany.	tmoser@gwdg.de	Nouvian, Regis/AFQ-8065-2022; Nouvian, Regis/AAW-4207-2021; Moser, Tobias/L-5068-2014	Nouvian, Regis/0000-0002-0901-4666; Nouvian, Regis/0000-0002-0901-4666; Moser, Tobias/0000-0001-7145-0533; Egner, Alexander/0000-0001-5248-3858; Pujol, Remy/0000-0002-7837-7129				Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Edmonds BW, 2004, J PHYSIOL-LONDON, V560, P439, DOI 10.1113/jphysiol.2004.066035; Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HELL S, 1992, J OPT SOC AM A, V9, P2159, DOI 10.1364/JOSAA.9.002159; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Lagnado L, 2003, CURR BIOL, V13, pR631, DOI 10.1016/S0960-9822(03)00566-9; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Paillart C, 2003, J NEUROSCI, V23, P4092; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Shnerson A, 1981, Brain Res, V254, P77; SMITH CA, 1961, J ULTRA MOL STRUCT R, V5, P184, DOI 10.1016/S0022-5320(61)90013-2; SMITH JE, 1980, J EXP BIOL, V89, P19; Spassova MA, 2004, JARO-J ASSOC RES OTO, V5, P376, DOI 10.1007/s10162-004-5003-8; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; TOMDIECK S, IN PRESS J CELL 0222, DOI DOI 10.1083/JCB.2001.200408157; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	30	360	382	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					889	894		10.1038/nature03418	http://dx.doi.org/10.1038/nature03418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829963	Green Published			2022-12-01	WOS:000228327600039
J	Heymann, DL; Sutter, RW; Aylward, RB				Heymann, DL; Sutter, RW; Aylward, RB			A global call for new polio vaccines	NATURE			English	Editorial Material									WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	World Health Organization	Heymann, DL (corresponding author), WHO, Global Polio Eradicat Initiat, 20 Ave Appia, CH-1211 Geneva, Switzerland.							Fine P E, 2001, Dev Biol (Basel), V105, P129; Heymann DL, 2004, LANCET, V363, P1566, DOI 10.1016/S0140-6736(04)16234-X; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Mulders MN, 1997, J INFECT DIS, V176, P617, DOI 10.1086/514081; Savolainen C, 2003, LANCET, V361, P1145, DOI 10.1016/S0140-6736(03)12965-0; *WHO, 2002, GLOB ACT PLAN LAB CO; *WHO, IN PRESS REP WHO CON	7	48	53	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					699	700		10.1038/434699a	http://dx.doi.org/10.1038/434699a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815604	Bronze, Green Published			2022-12-01	WOS:000228160700017
J	Saadoun, S; Papadopoulos, MC; Hara-Chikuma, M; Verkman, AS				Saadoun, S; Papadopoulos, MC; Hara-Chikuma, M; Verkman, AS			Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption	NATURE			English	Article							WATER CHANNELS; EXPRESSION; RECEPTOR; GROWTH; MICE; PERMEABILITY; PROTEIN	Aquaporin-1 (AQP1) is a water channel protein expressed widely in vascular endothelia, where it increases cell membrane water permeability(1-3). The role of AQP1 in endothelial cell function is unknown. Here we show remarkably impaired tumour growth in AQP1-null mice after subcutaneous or intracranial tumour cell implantation, with reduced tumour vascularity and extensive necrosis. A new mechanism for the impaired angiogenesis was established from cell culture studies. Although adhesion and proliferation were similar in primary cultures of aortic endothelia from wild-type and from AQP1-null mice, cell migration was greatly impaired in AQP1-deficient cells, with abnormal vessel formation in vitro. Stable transfection of non-endothelial cells with AQP1 or with a structurally different water-selective transletters porter (AQP4) accelerated cell migration and wound healing in vitro. Motile AQP1-expressing cells had prominent membrane ruffles at the leading edge with polarization of AQP1 protein to lamellipodia, where rapid water fluxes occur. Our findings support a fundamental role of water channels in cell migration, which is central to diverse biological phenomena including angiogenesis, wound healing, tumour spread and organ regeneration.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA.	verkman@itsa.ucsf.edu		Papadopoulos, Marios/0000-0001-9174-4176; Saadoun, Samira/0000-0002-5480-5678				Carter EP, 1998, BIOPHYS J, V74, P2121, DOI 10.1016/S0006-3495(98)77919-6; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; HASEGAWA H, 1994, AM J PHYSIOL, V266, pC893, DOI 10.1152/ajpcell.1994.266.4.C893; Ishida T, 2003, J BIOL CHEM, V278, P34598, DOI 10.1074/jbc.M304890200; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Miao WM, 2001, CANCER RES, V61, P7830; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Ribatti D, 2002, ANAT REC, V268, P85, DOI 10.1002/ar.10123; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Steinle JJ, 2002, J BIOL CHEM, V277, P43830, DOI 10.1074/jbc.M207221200; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Yang BX, 1996, J BIOL CHEM, V271, P4577; Yao L, 1999, BLOOD, V93, P1612, DOI 10.1182/blood.V93.5.1612.405a13_1612_1621	28	579	674	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					786	792		10.1038/nature03460	http://dx.doi.org/10.1038/nature03460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815633				2022-12-01	WOS:000228160700046
J	Demoly, P; Daures, JP				Demoly, P; Daures, JP			Managing asthma during pregnancy	LANCET			English	Editorial Material							RHINITIS		Univ Hosp Montpellier, Hop Arnaud Villeneuve, INSERM, U454, F-34295 Montpellier, France; Univ Montpellier I, Inst Univ Rech Clin Montpellier, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Demoly, P (corresponding author), Univ Hosp Montpellier, Hop Arnaud Villeneuve, INSERM, U454, F-34295 Montpellier, France.	dernoly@rnontp.inserm.fr	Demoly, Pascal/Y-9938-2019	Demoly, Pascal/0000-0001-7827-7964				Bochner BS, 2005, J ALLERGY CLIN IMMUN, V115, P953, DOI 10.1016/j.jaci.2005.02.032; Bousquet J, 2003, ALLERGY, V58, P691, DOI 10.1034/j.1398-9995.2003.00105.x; Demoly P, 2003, DRUGS, V63, P1813, DOI 10.2165/00003495-200363170-00004; Demoly P, 2003, EXPERT OPIN PHARMACO, V4, P1019, DOI 10.1517/14656566.4.7.1019; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; Global Initiative for Asthma, 2004, GLOB STRAT ASTHM MAN; Martel MJ, 2005, BMJ-BRIT MED J, V330, P230, DOI 10.1136/bmj.38313.624352.8F; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1212	1213		10.1016/S0140-6736(05)74791-7	http://dx.doi.org/10.1016/S0140-6736(05)74791-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811441				2022-12-01	WOS:000228107600008
J	Griffiths, PD; Paley, MNJ; Whitby, EH				Griffiths, PD; Paley, MNJ; Whitby, EH			Post-mortern MRI as an adjunct to fetal or neonatal autopsy	LANCET			English	Review							PERINATAL PATHOLOGY; CLINICAL-TRIAL; ATTITUDES; CONTEXT	Context Understanding what was wrong with a dead fetus or why a newborn child died can help the parents to grieve, while any findings can be used to inform the parents if there is a risk to future pregnancies and the level of risk. This information is mainly obtained from autopsies, but the number of parents agreeing to autopsy has dropped, which has prompted the search for adjuncts to autopsy. Starting point The UK's Chief Medical Officer outlined the rationale for exploring alternatives to autopsy in 2000 and 2001. After wide consultation, MRI was deemed to offer the most realistic chance of making a contribution. Results so far are promising, but of insufficient depth and quality to make firm recommendations about providing a service in the future. In 2004, the UK Department of Health therefore tendered for this research to be done in fetal and neonatal (and adult) cases, and this work is due to start in 2005. Where next? High-quality anatomical information about the brain and spine of fetuses and neonates can be easily obtained with standard MRI scanners. Most developmental and acquired abnormalities can be seen on postmortem MRI. More work needs to be done on organs not in the central nervous system, and heart malformations, in particular, might present diagnostic problems. A possible outcome could be whole-body MRI plus targeted biopsies of abnormalities taken under image guidance as an adjunct to formal autopsy.	Univ Sheffield, Sect Acad Radiol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Griffiths, PD (corresponding author), Univ Sheffield, Sect Acad Radiol, Sheffield S10 2JF, S Yorkshire, England.	p.griffiths@sheffield.ac.uk	Whitby, Elspeth/G-5517-2010	Whitby, Elspeth/0000-0002-8912-8013				Alderliesten ME, 2003, BJOG-INT J OBSTET GY, V110, P378, DOI 10.1016/S1470-0328(02)02076-1; Brookes JAS, 1996, LANCET, V348, P1139, DOI 10.1016/S0140-6736(96)02287-8; Chief Medical Officer, 2001, REM RET US HUM ORG T; Griffiths PD, 2003, AM J NEURORADIOL, V24, P22; Huisman TAGM, 2002, FETAL DIAGN THER, V17, P58, DOI 10.1159/000048008; Larroche, 1987, DEV CERVEAU FOETAL H; Parker A, 2004, LESS INVASIVE AUTOPS; Snowdon C, 2004, ARCH DIS CHILD-FETAL, V89, pF208, DOI 10.1136/adc.2003.041392; Snowdon C, 2004, ARCH DIS CHILD-FETAL, V89, pF204, DOI 10.1136/adc.2002.012732; The Chief Medical Officer, 2000, REP CENS ORG TISS RE; Whitby EH, 2004, BJOG-INT J OBSTET GY, V111, P784, DOI 10.1111/j.1471-0528.2004.00149.x; Woodward PJ, 1997, AM J ROENTGENOL, V168, P41, DOI 10.2214/ajr.168.1.8976917	12	86	90	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 2	2005	365	9466					1271	1273		10.1016/S0140-6736(05)74816-9	http://dx.doi.org/10.1016/S0140-6736(05)74816-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811461				2022-12-01	WOS:000228107600031
J	Bailis, R; Ezzati, M; Kammen, DM				Bailis, R; Ezzati, M; Kammen, DM			Mortality and greenhouse gas impacts of biomass and petroleum energy futures in Africa	SCIENCE			English	Article							BIRTH-WEIGHT; EXPOSURE; SMOKE	We analyzed the mortality impacts and greenhouse gas (GHG) emissions produced by household energy use in Africa. Under a business-as-usual (BAU) scenario, household indoor air pollution will cause an estimated 9.8 million premature deaths by the year 2030. Gradual and rapid transitions to charcoal would delay 1.0 million and 2.8 million deaths, respectively; similar transitions to petroleum fuels would delay 1.3 million and 3.7 million deaths. Cumulative BAU GHG emissions will be 6.7 billion tons of carbon by 2050, which is 5.6% of Africa's total emissions. Large shifts to the use of fossil fuels would reduce GHG emissions by 1 to 10%. Charcoal-intensive future scenarios using current practices increase emissions by 140 to 190%; the increase can be reduced to 5 to 36% using currently available technologies for sustainable production or potentially reduced even more with investment in technological innovation.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	mezzati@hsph.harvard.edu; kammen@berkeley.edu	Bailis, Rob/B-9779-2015; Bailis, Robert/O-6643-2019	Bailis, Rob/0000-0002-4111-3760; Bailis, Robert/0000-0002-4111-3760	NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01-AG17625] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1996, GLOBAL BURDEN DIS; [Anonymous], WORLD HLTH REP 2002; [Anonymous], 2004, WORLD POP PROSP 2002; Bailis R, 2003, ENVIRON SCI TECHNOL, V37, P2051, DOI 10.1021/es026058q; Bond T. C., 2004, ENERGY SUSTAIN DEV, V3, P20, DOI DOI 10.1016/S0973-0826(08)60464-0; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2000, ENVIRON SCI TECHNOL, V34, P578, DOI 10.1021/es9905795; FERREIRA OC, 2000, EC ENERGY        MAY, P20; *GOV IND, 2001, CENS IND 2001; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; IEA, 2002, WORLD EN OUTL, P365; *IEA, 2004, EN STAT NONOECD COUN; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Karekezi S, 2002, ENERG POLICY, V30, P915, DOI 10.1016/S0301-4215(02)00047-2; Ministry of Energy, 2002, STUD KEN EN DEM SUPP; Mishra V, 2004, ANN EPIDEMIOL, V14, P740, DOI 10.1016/j.annepidem.2004.01.009; Smith KR, 2002, SCIENCE, V298, P1847, DOI 10.1126/science.298.5600.1847; Smith KR, 2004, COMP QUANTIFICATION, V2, P1435; SMITH KR, 2000, GREENHOUSE GASES SMA; SMITH KR, 1999, EPA600R99109 US EPA; *UN FAO, 2004, FAOSTAT DAT; *WORLD BANK, 2000, AFR DEV IND SER	23	206	214	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					98	103		10.1126/science.1106881	http://dx.doi.org/10.1126/science.1106881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802601				2022-12-01	WOS:000228221500041
J	Brown, RH				Brown, RH			Amyotrophic lateral sclerosis - A new role for old drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Brown, RH (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180	1	7	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2005	352	13					1376	1378		10.1056/NEJMcibr050274	http://dx.doi.org/10.1056/NEJMcibr050274			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JL	15800236				2022-12-01	WOS:000227998300019
J	Sauerwald, A; Zhu, WH; Major, TA; Roy, H; Palioura, S; Jahn, D; Whitman, WB; Yates, JR; Ibba, M; Soll, D				Sauerwald, A; Zhu, WH; Major, TA; Roy, H; Palioura, S; Jahn, D; Whitman, WB; Yates, JR; Ibba, M; Soll, D			RNA-Dependent cysteine biosynthesis in archaea	SCIENCE			English	Article							GENETIC-CODE ORIGIN; METHANOCOCCUS-JANNASCHII; IN-VIVO; SYNTHETASE; CYSTEINYL-TRNA(CYS); PYRROLYSINE; ACID	Several methanogenic archaea lack cysteinyl-transfer RNA (tRNA) synthetase (CysRS), the essential enzyme that provides Cys-tRNA(Cys) for translation in most organisms. Partial purification of the corresponding activity from Methanocaldococcus jannaschii indicated that tRNA(Cys) becomes acylated with O-phosphoserine (Sep) but not with cysteine. Further analyses identified a class II-type O-phosphoseryl-tRNA synthetase (SepRS) and Sep-tRNA:Cys-tRNA synthase (SepCysS). SepRS specifically forms Sep-tRNA(Cys), which is then converted to Cys-tRNA(Cys) by SepCysS. Comparative genomic analyses suggest that this pathway, encoded in all organisms lacking CysRS, can also act as the sole route for cysteine biosynthesis. This was proven for Methanococcus maripaludis, where deletion of the SepRS-encoding gene resulted in cysteine auxotrophy. As the conversions of Sep-tRNA to Cys-tRNA or to selenocysteinyl-tRNA are chemically analogous, the catalytic activity of SepCysS provides a means by which both cysteine and selenocysteine may have originally been added to the genetic code.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, D-38106 Braunschweig, Germany	Yale University; Yale University; Scripps Research Institute; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University; Braunschweig University of Technology	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	soll@trna.chem.yale.edu	Whitman, William/AAC-5896-2020	Jahn, Dieter/0000-0002-4064-9205; Whitman, William/0000-0003-1229-0423				Ambrogelly A, 2004, CELL MOL LIFE SCI, V61, P2437, DOI 10.1007/s00018-004-4194-9; AVALOS J, 1991, FEBS LETT, V286, P176, DOI 10.1016/0014-5793(91)80968-9; BALCH WE, 1979, J BACTERIOL, V137, P264, DOI 10.1128/JB.137.1.264-273.1979; Basurko MJ, 1999, IUBMB LIFE, V48, P525, DOI 10.1080/713803557; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; BOCK A, 2004, AMINOACYL TRNA SYNTH, P320; Brooks DJ, 2002, MOL CELL PROTEOMICS, V1, P125, DOI 10.1074/mcp.M100001-MCP200; CALENDAR R, 1966, PROG NUCL ACID RES M, V1, P375; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Das R, 1999, BIOCHIMIE, V81, P1037, DOI 10.1016/S0300-9084(99)00332-6; Di Giulio M, 1999, J MOL EVOL, V49, P1, DOI 10.1007/PL00006522; Di Giulio M, 2002, J MOL EVOL, V55, P616, DOI 10.1007/s00239-002-2357-6; Fabrega C, 2001, NATURE, V411, P110, DOI 10.1038/35075121; Farahi K, 2004, J MOL EVOL, V58, P615, DOI 10.1007/s00239-004-2582-2; Giometti CS, 2002, J CHROMATOGR B, V782, P227, DOI 10.1016/S1570-0232(02)00568-8; Ibba M, 2000, TRENDS BIOCHEM SCI, V25, P311, DOI 10.1016/S0968-0004(00)01600-5; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Kim HS, 1998, J BACTERIOL, V180, P6446, DOI 10.1128/JB.180.24.6446-6449.1998; Li T, 1999, FEBS LETT, V462, P302, DOI 10.1016/S0014-5793(99)01550-1; Lipman RSA, 2000, BIOCHEMISTRY-US, V39, P7792, DOI 10.1021/bi0004955; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Mino K, 2003, FEBS LETT, V551, P133, DOI 10.1016/S0014-5793(03)00913-X; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Ruan BF, 2004, J BACTERIOL, V186, P8, DOI 10.1128/JB.186.1.8-14.2004; SAUERWALD A, UNPUB; Sethi A, 2005, P NATL ACAD SCI USA, V102, P4045, DOI 10.1073/pnas.0409715102; Stathopoulos C, 2000, SCIENCE, V287, P479, DOI 10.1126/science.287.5452.479; Stathopoulos C, 2001, P NATL ACAD SCI USA, V98, P14292, DOI 10.1073/pnas.201540498; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; White RH, 2003, BBA-GEN SUBJECTS, V1624, P46, DOI 10.1016/j.bbagen.2003.09.005; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Zhang Chun-Mei, 2004, RNA Biol, V1, P35	32	185	195	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1969	1972		10.1126/science.1108329	http://dx.doi.org/10.1126/science.1108329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790858				2022-12-01	WOS:000227957300059
J	Gros, J; Manceau, M; Thome, V; Marcelle, C				Gros, J; Manceau, M; Thome, V; Marcelle, C			A common somitic origin for embryonic muscle progenitors and satellite cells	NATURE			English	Article							MYOGENIC PROGENITORS; SKELETAL-MUSCLE; CHICK; REGENERATION; MYOTOME	In the embryo and in the adult, skeletal muscle growth is dependent on the proliferation and the differentiation of muscle progenitors present within muscle masses. Despite the importance of these progenitors, their embryonic origin is unclear(1,2). Here we use electroporation of green fluorescent protein in chick somites(3), video confocal microscopy analysis of cell movements, and quail-chick grafting experiments to show that the dorsal compartment of the somite, the dermomyotome, is the origin of a population of muscle progenitors that contribute to the growth of trunk muscles during embryonic and fetal life. Furthermore, long-term lineage analyses indicate that satellite cells, which are known progenitors of adult skeletal muscles(4), derive from the same dermomyotome cell population. We conclude that embryonic muscle progenitors and satellite cells share a common origin that can be traced back to the dermomyotome.	Univ Mediterranee, CNRS,UMR 6545, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marcelle, C (corresponding author), Univ Mediterranee, CNRS,UMR 6545, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, Campus Luminy,Case 907, F-13288 Marseille, France.	marcelle@ibdm.univ-mrs.fr		Gros, Jerome/0000-0002-2264-2851				ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; FELDMAN JL, 1992, DEV BIOL, V153, P217, DOI 10.1016/0012-1606(92)90107-R; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; HAUSCHKA SD, 1994, MYOLOGY, P3; Huang RJ, 2000, ANAT EMBRYOL, V202, P369, DOI 10.1007/s004290000130; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Scaal M, 2004, ANAT EMBRYOL, V208, P411, DOI 10.1007/s00429-004-0417-y; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; TOSNEY KW, 1994, DEV BIOL, V163, P389, DOI 10.1006/dbio.1994.1157	20	416	457	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					954	958		10.1038/nature03572	http://dx.doi.org/10.1038/nature03572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15843802				2022-12-01	WOS:000229799700049
J	Kratchmarova, I; Blagoev, B; Haack-Sorensen, M; Kassem, M; Mann, M				Kratchmarova, I; Blagoev, B; Haack-Sorensen, M; Kassem, M; Mann, M			Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation	SCIENCE			English	Article							RECEPTOR TYROSINE KINASES; ACTIVATED PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; OSTEOBLAST DIFFERENTIATION; QUANTITATIVE PROTEOMICS; PROGENITOR CELLS; EXPRESSION; IDENTIFICATION; ENDOCYTOSIS; INHIBITION	Closely related signals often lead to very different cellular outcomes. We found that the differentiation of human mesenchymal stem cells into bone-forming cells is stimulated by epidermal growth factor (EGF) but not platelet-derived growth factor (PDGF). We used mass spectrometry-based proteomics to comprehensively compare proteins that were tyrosine phosphorylated in response to EGF and PDGF and their associated partners. More than 90% of these signaling proteins were used by both ligands, whereas the phosphatidylinositol 3-kinase (PI3K) pathway was exclusively activated by PDGF, implicating it as a possible control point. Indeed, chemical inhibition of PI3K in PDGF-stimulated cells removed the differential effect of the two growth factors, bestowing full differentiation effect onto PDGF. Thus, quantitative proteomics can directly compare entire signaling networks and discover critical differences capable of changing cell fate.	Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Mann, M (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense, Denmark.	mann@bmb.sdu.dk	Kassem, Moustapha/O-3819-2019; Kassem, Moustapha/J-7688-2013; Mann, Matthias/A-3454-2013	Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Mann, Matthias/0000-0003-1292-4799; Kratchmarova, Irina/0000-0001-6613-7315; Blagoev, Blagoy/0000-0002-3596-0066				Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fukuyama R, 2004, BIOCHEM BIOPH RES CO, V315, P636, DOI 10.1016/j.bbrc.2004.01.104; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; OKADA T, 1994, J BIOL CHEM, V269, P3563; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Reyes M, 2001, ANN NY ACAD SCI, V938, P231; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Szymkiewicz I, 2004, BIOCHEM J, V383, P1, DOI 10.1042/BJ20040913; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7	31	462	499	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1472	1477		10.1126/science.1107627	http://dx.doi.org/10.1126/science.1107627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933201				2022-12-01	WOS:000229619300055
J	Reverter, D; Lima, CD				Reverter, D; Lima, CD			Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex	NATURE			English	Article							SUMO CONJUGATION; ENZYME UBC9; PROTEIN; NUCLEOPORIN; RANBP2; RANGAP1; DOMAIN	SUMO-1 ( for small ubiquitin-related modifier) belongs to the ubiquitin (Ub) and ubiquitin-like (Ubl) protein family. SUMO conjugation occurs on specific lysine residues within protein targets, regulating pathways involved in differentiation, apoptosis, the cell cycle and responses to stress by altering protein function through changes in activity or cellular localization or by protecting substrates from ubiquitination(1,2). Ub/Ubl conjugation occurs in sequential steps and requires the concerted action of E2 conjugating proteins and E3 ligases(1,2). In addition to being a SUMO E3, the nucleoporin Nup358/RanBP2 localizes SUMO-conjugated RanGAP1 to the cytoplasmic face of the nuclear pore complex by means of interactions in a complex that also includes Ubc9, the SUMO E2 conjugating protein(3-6). Here we describe the 3.0-angstrom crystal structure of a four-protein complex of Ubc9, a Nup358/RanBP2 E3 ligase domain ( IR1-M) and SUMO-1 conjugated to the carboxy-terminal domain of RanGAP1. Structural insights, combined with biochemical and kinetic data obtained with additional substrates, support a model in which Nup358/ RanBP2 acts as an E3 by binding both SUMO and Ubc9 to position the SUMO - E2- thioester in an optimal orientation to enhance conjugation.	Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, New York, NY 10021 USA.	limac@mskcc.org	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Lima, Christopher/0000-0002-9163-6092	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM065872] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	29	368	386	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					687	692		10.1038/nature03588	http://dx.doi.org/10.1038/nature03588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931224	Green Accepted			2022-12-01	WOS:000229476200053
J	Ware, DM; Thomson, RE				Ware, DM; Thomson, RE			Bottom-up ecosystem trophic dynamics determine fish production in the northeast Pacific	SCIENCE			English	Article							WEST-COAST; WATERS	We addressed the question of bottom-up versus top-down control of marine ecosystem trophic interactions by using annual fish catch data and satellite-derived (SeaWiFS) chlorophyll a measurements for the continental margin of western North America. Findings reveal a marked alongshore variation in retained primary production that is highly correlated with the alongshore variation in resident fish yield. The highest productivity occurs off, the coasts of Washington and southern British Columbia. Zooplankton data for coastal British Columbia confirm strong bottom-up trophic linkages between phytoplankton, zooplankton, and resident fish, extending to regional areas as small as 10,000 square kilometers.	Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; Aquat Ecosyst Associates, Nanaimo, BC V9T 1M2, Canada; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada	Fisheries & Oceans Canada; University of British Columbia; Simon Fraser University; University of Victoria	Thomson, RE (corresponding author), Fisheries Oceans Canada Inst Ocean Sci, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.	thomsonr@pac.dfo-mpo.gc.ca						DORMAN CE, 1995, J GEOPHYS RES-OCEANS, V100, P16029, DOI 10.1029/95JC00964; Gregg WW, 2004, REMOTE SENS ENVIRON, V93, P463, DOI 10.1016/j.rse.2003.12.012; *I OC SCI, UNPUB; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; LYNDE MVH, 1986, NMFSNWC103 NOAA; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Perry M. J., 1989, COASTAL OCEANOGRAPHY, P117, DOI DOI 10.1016/S0422-9894(08)70347-7; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; ROYER TC, 1982, J GEOPHYS RES-OCEANS, V87, P2017, DOI 10.1029/JC087iC03p02017; Ruddick KG, 2000, APPL OPTICS, V39, P897, DOI 10.1364/AO.39.000897; Scheffer M, 2000, CAN J FISH AQUAT SCI, V57, P1208, DOI 10.1139/cjfas-57-6-1208; Stabeno PJ, 2004, CONT SHELF RES, V24, P859, DOI 10.1016/j.csr.2004.02.007; STRUB PT, 1991, J GEOPHYS RES-OCEANS, V96, P14743, DOI 10.1029/91JC01024; TANASICHUK RW, 1991, CAN J FISH AQUAT SCI, V48, P2118, DOI 10.1139/f91-251; TASSAN S, 1994, APPL OPTICS, V33, P2369, DOI 10.1364/AO.33.002369; Ware D.M., 1989, CAN SPEC PUBL FISH A, V108, P359	17	506	532	8	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1280	1284		10.1126/science.1109049	http://dx.doi.org/10.1126/science.1109049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15845876				2022-12-01	WOS:000229482300038
J	Fouchier, R; Kuiken, T; Rimmelzwaan, G; Osterhaus, A				Fouchier, R; Kuiken, T; Rimmelzwaan, G; Osterhaus, A			Global task force for influenza	NATURE			English	Editorial Material									Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands; Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Fouchier, R (corresponding author), Erasmus MC, Natl Influenza Ctr, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049				de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier Ron Am, 2005, Curr Opin Infect Dis, V18, P141; Kuiken T, 2003, CURR OPIN BIOTECH, V14, P641, DOI 10.1016/j.copbio.2003.10.010; Stohr K, 2004, SCIENCE, V306, P2195, DOI 10.1126/science.1108165; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	7	38	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					419	420		10.1038/435419a	http://dx.doi.org/10.1038/435419a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917779	Green Published, Bronze			2022-12-01	WOS:000229337800025
J	Law, M; Morris, JK; Wald, N; Luczynska, C; Burney, P				Law, M; Morris, JK; Wald, N; Luczynska, C; Burney, P			Changes in atopy over a quarter of a century, based on cross sectional data at three time periods	BRITISH MEDICAL JOURNAL			English	Article							POPULATION		Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England; Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Publ Hlth Sci, Div Primary Care & Publ Hlth Sci, London SE1 3QD, England	University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Law, M (corresponding author), Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England.	m.r.law@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Morris, Joan/AAT-9211-2020	Morris, Joan/0000-0002-7164-612X; Burney, Peter/0000-0001-8635-5678				Kosunen TU, 2002, CLIN EXP ALLERGY, V32, P373, DOI 10.1046/j.1365-2222.2002.01330.x; Krause TG, 2002, LANCET, V360, P691, DOI 10.1016/S0140-6736(02)09841-0; Linneberg A, 2000, J ALLERGY CLIN IMMUN, V106, P247, DOI 10.1067/mai.2000.108312; NAKAGOMI T, 1994, LANCET, V343, P121, DOI 10.1016/S0140-6736(94)90854-0; POTTS J, 2002, EUR RESP J S38, V20, pS120	5	79	82	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1187	1188		10.1136/bmj.38435.582975.AE	http://dx.doi.org/10.1136/bmj.38435.582975.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15833748	Green Published, Bronze			2022-12-01	WOS:000229320500020
J	Cheng, J; Kapranov, P; Drenkow, J; Dike, S; Brubaker, S; Patel, S; Long, J; Stern, D; Tammana, H; Helt, G; Sementchenko, V; Piccolboni, A; Bekiranov, S; Bailey, DK; Ganesh, M; Ghosh, S; Bell, I; Gerhard, DS; Gingeras, TR				Cheng, J; Kapranov, P; Drenkow, J; Dike, S; Brubaker, S; Patel, S; Long, J; Stern, D; Tammana, H; Helt, G; Sementchenko, V; Piccolboni, A; Bekiranov, S; Bailey, DK; Ganesh, M; Ghosh, S; Bell, I; Gerhard, DS; Gingeras, TR			Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution	SCIENCE			English	Article							TRANS-ACTING SIRNAS; HUMAN GENOME; BINDING SITES; CDNA; ANNOTATION; HUMAN-CHROMOSOME-21; BROWSER; GENES; RNAS	Sites of transcription of polyadenylated and nonpolyadenylated RNAs for 10 human chromosomes were mapped at 5-base pair resolution in eight cell lines. Unannotated, nonpotyadenylated transcripts comprise the major proportion of the transcriptional output of the human genome. Of all transcribed sequences, 19.4, 43.7, and 36.9% were observed to be polyadenytated, nonpolyadenylated, and bimorphic, respectively. Half of all transcribed sequences are found only in the nucleus and for the most part are unannotated. Overall, the transcribed portions of the human genome are predominantly composed of interlaced networks of both poly A+ and poly A- annotated transcripts and unannotated transcripts of unknown function. This organization has important implications for interpreting genotype-phenotype associations, regulation of gene expression, and the definition of a gene.	Affymetrix Inc, Santa Clara, CA 95051 USA; NCI, Off Canc Genom, Bethesda, MD 20892 USA	Affymetrix; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Gingeras, TR (corresponding author), Affymetrix Inc, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com		Kapranov, Philipp/0000-0003-2647-4856; Gingeras, Thomas/0000-0001-9106-3573				Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Bono H, 2003, GENOME RES, V13, P1318, DOI 10.1101/gr.1075103; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; EDMONDS M, 1969, J BIOL CHEM, V244, P1314; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; GEOGHEGAN TE, 1978, BIOCHEMISTRY-US, V17, P4200, DOI 10.1021/bi00613a014; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; INHORN RC, 1986, BIOCHEM BIOPH RES CO, V137, P431, DOI 10.1016/0006-291X(86)91228-3; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; Seki M, 2004, J EXP BOT, V55, P213, DOI 10.1093/jxb/erh007; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; SNIDER BJ, 1992, BRAIN RES REV, V17, P263, DOI 10.1016/0165-0173(92)90019-I; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	35	878	988	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1149	1154		10.1126/science.1108625	http://dx.doi.org/10.1126/science.1108625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15790807				2022-12-01	WOS:000229293400038
J	Nakayama, M; Abiru, N; Moriyama, H; Babaya, N; Liu, E; Miao, DM; Yu, LP; Wegmann, DR; Hutton, JC; Elliott, JF; Eisenbarth, GS				Nakayama, M; Abiru, N; Moriyama, H; Babaya, N; Liu, E; Miao, DM; Yu, LP; Wegmann, DR; Hutton, JC; Elliott, JF; Eisenbarth, GS			Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice	NATURE			English	Article							T-CELL-CLONES; MOUSE; TOLERANCE; MELLITUS; PEPTIDE; SUSCEPTIBILITY; DECARBOXYLASE; POPULATION; EXPRESSION; PREVENT	A fundamental question about the pathogenesis of spontaneous autoimmune diabetes is whether there are primary autoantigens. For type 1 diabetes it is clear that multiple islet molecules are the target of autoimmunity in man and animal models(1,2). It is not clear whether any of the target molecules are essential for the destruction of islet beta cells. Here we show that the proinsulin/ insulin molecules have a sequence that is a primary target of the autoimmunity that causes diabetes of the non-obese diabetic ( NOD) mouse. We created insulin 1 and insulin 2 gene knockouts combined with a mutated proinsulin transgene ( in which residue 16 on the B chain was changed to alanine) in NOD mice. This mutation abrogated the T-cell stimulation of a series of the major insulin autoreactive NOD T-cell clones(3). Female mice with only the altered insulin did not develop insulin autoantibodies, insulitis or autoimmune diabetes, in contrast with mice containing at least one copy of the native insulin gene. We suggest that proinsulin is a primary autoantigen of the NOD mouse, and speculate that organ-restricted autoimmune disorders with marked major histocompatibility complex (MHC) restriction of disease are likely to have specific primary autoantigens.	Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan; Univ Alberta, Edmonton, AB T6G 2S2, Canada	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Nagasaki University; Kobe University; University of Alberta	Eisenbarth, GS (corresponding author), Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA.	george.eisenbarth@uchsc.edu		Babaya, Naru/0000-0003-2466-1228	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, R01AI039213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032083, R01DK062718, R01DK055969] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI050864, R01 AI039213] Funding Source: Medline; NIDDK NIH HHS [R01 DK055969, R01 DK062718, R01 DK032083] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Birk OS, 1996, P NATL ACAD SCI USA, V93, P1032, DOI 10.1073/pnas.93.3.1032; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; Chatenoud L, 1997, J IMMUNOL, V158, P2947; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; DiLorenzo TP, 2002, CLIN IMMUNOL, V105, P332, DOI 10.1006/clim.2002.5298; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Ellerman KE, 2000, DIABETOLOGIA, V43, P890, DOI 10.1007/s001250051466; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; Jaeckel E, 2003, J EXP MED, V197, P1635, DOI 10.1084/jem.20030215; Kash SF, 1999, HORM METAB RES, V31, P340, DOI 10.1055/s-2007-978750; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kubosaki A, 2004, DIABETOLOGIA, V47, P149, DOI 10.1007/s00125-003-1252-z; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Moriyama H, 2003, P NATL ACAD SCI USA, V100, P10376, DOI 10.1073/pnas.1834450100; Mukherjee R, 2003, J AUTOIMMUN, V21, P221, DOI 10.1016/S0896-8411(03)00114-8; Nakayama M, 2004, ANN NY ACAD SCI, V1037, P193, DOI 10.1196/annals.1337.031; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wong FS, 2002, P NATL ACAD SCI USA, V99, P5551, DOI 10.1073/pnas.072037299; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	28	539	570	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					220	223		10.1038/nature03523	http://dx.doi.org/10.1038/nature03523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889095	Green Accepted			2022-12-01	WOS:000229021100044
J	Genin, A; Jaffe, JS; Reef, R; Richter, C; Franks, PJS				Genin, A; Jaffe, JS; Reef, R; Richter, C; Franks, PJS			Swimming against the flow: A mechanism of zooplankton aggregation	SCIENCE			English	Article							NEAR-BOTTOM DEPLETION; HYDROSTATIC-PRESSURE; VANCOUVER-ISLAND; GEORGES BANK; CORAL-REEFS; PLANKTON; SHELF; SEA; INVERTEBRATES; CIRCULATION	Zooplankton reside in a constantly flowing environment. However, information about their response to ambient flow has remained elusive, because of the difficulties of following the individual motions of these minute, nearly transparent animals in the ocean. Using a three-dimensional acoustic imaging system, we tracked >375,000 zooplankters at two coastal sites in the Red Sea. Resolution of their motion from that of the water showed that the animals effectively maintained their depth by swimming against upwelling and downwelling currents moving at rates of up to tens of body lengths per second, causing their accumulation at frontal zones. This mechanism explains how oceanic fronts become major feeding grounds for predators and targets for fishermen.	Interuniv Inst Marine Sci, Elat, Israel; Hebrew Univ Jerusalem, Elat, Israel; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Ctr Trop Marine Ecol, Bremen, Germany	Hebrew University of Jerusalem; University of California System; University of California San Diego; Scripps Institution of Oceanography; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Genin, A (corresponding author), Interuniv Inst Marine Sci, Elat, Israel.	amatzia@vms.huji.ac.il	Richter, Claudio/AAT-1212-2020	Richter, Claudio/0000-0002-8182-6896; Reef, Ruth/0000-0001-6639-520X				Bottger R., 1987, Biological Oceanography, V4, P383; BULLOCK TH, 1997, MAR FRESHW BEHAV PHY, V28, P1; Cowles T. J., 1998, OCEANOGRAPHY, V11, P4, DOI DOI 10.5670/0CEAN0G.1998.08; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; ENRIGHT JT, 1962, COMP BIOCHEM PHYSIOL, V7, P131, DOI 10.1016/0010-406X(62)90035-X; Epstein AW, 2001, DEEP-SEA RES PT II, V48, P395, DOI 10.1016/S0967-0645(00)00086-2; Etnoyer Peter, 2004, Oceanography, V17, P90; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; FORWARD RB, 1989, MAR ECOL PROG SER, V57, P267, DOI 10.3354/meps057267; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Gallager SM, 2004, MAR ECOL PROG SER, V267, P27, DOI 10.3354/meps267027; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Genin Amatzia, 2002, Oceanography, V15, P90; HARDY AC, 1954, J MAR BIOL ASSOC UK, V33, P409, DOI 10.1017/S0025315400008456; HARDY AC, 1936, DISCOVERY REP, V11, P513; HEALEY MC, 1990, CAN J FISH AQUAT SCI, V47, P1846, DOI 10.1139/f90-210; JAFFE JS, 1995, DEEP-SEA RES PT I, V42, P1495, DOI 10.1016/0967-0637(95)00030-A; LASKER R, 1970, MAR BIOL, V5, P345; Lavoie D, 2000, CAN J FISH AQUAT SCI, V57, P1853, DOI 10.1139/cjfas-57-9-1853; LINCOLN RJ, 1971, J EXP BIOL, V54, P677; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; MACDONALD AG, 1972, J MAR BIOL ASSOC UK, V52, P213, DOI 10.1017/S002531540001866X; Mackas DL, 1997, CAN J FISH AQUAT SCI, V54, P2080, DOI 10.1139/cjfas-54-9-2080; Mauchline J., 1998, ADV MARINE BIOL, V33; Mohammadian MA, 1997, MAR ECOL PROG SER, V150, P113, DOI 10.3354/meps150113; Motro R, 2005, CORAL REEFS, V24, P95, DOI 10.1007/s00338-004-0451-5; Niemann H, 2004, MAR ECOL PROG SER, V269, P91, DOI 10.3354/meps269091; Olson D, 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Pershing AJ, 2001, DEEP-SEA RES PT II, V48, P283, DOI 10.1016/S0967-0645(00)00122-3; Shanks AL, 2000, LIMNOL OCEANOGR, V45, P230, DOI 10.4319/lo.2000.45.1.0230; SIMARD Y, 1986, MAR ECOL PROG SER, V32, P203, DOI 10.3354/meps032203; WISHNER KF, 1995, CONT SHELF RES, V15, P475, DOI 10.1016/0278-4343(94)00057-T; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0	34	182	185	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					860	862		10.1126/science.1107834	http://dx.doi.org/10.1126/science.1107834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879218				2022-12-01	WOS:000228986500050
J	Opelz, G				Opelz, G		Gerhard Opelz Collaborative Transp	Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies	LANCET			English	Article							CLASS-I; CROSS-MATCH; PRESENSITIZATION; ALLOANTIBODIES; RECIPIENTS; ANTIGENS; ELISA; ASSAY	Background The presence of panel-reactive antibodies (PRA) against HLA antigens before transplantation is associated with early rejection of kidney grafts from cadaver donors. Transplants from HLA-identical sibling donors do not provide a target for antibodies to HLA antigens and should therefore not be affected by PRA. Methods Data from the Collaborative Transplant Study were used to examine the influence of PRA on graft survival. Uncensored graft survival and death-censored graft survival were calculated, and the data were analysed by multivariate Cox's regression methods. Findings Among recipients of HLA-identical sibling transplants, 3001 patients with no PRA had significantly higher 10-year graft survival (72.4% [SE 1.1]) than 803 patients with 1-50% PRA (63.3% [2.5]; p=0.0006) or 244 patients with more than 50% PRA (55.5% [4.0]; p<0.0001). The effect of PRA became apparent after the first post-transplant year and was, therefore, strikingly different from the early steep decline in graft survival during the first year associated with PRA in recipients of cadaver kidneys. We could not discern whether graft loss was a direct effect of non-HLA humoral sensitisation or whether PRA served as an indicator of heightened immunity against non-HLA transplantation antigens. Interpretation PRA reactivity is strongly associated with long-term graft loss in kidney transplants from HLA-identical sibling donors. Relevance to practice Our findings suggest that non-HLA immunity has a much stronger role in clinical transplantation than previously thought. In contrast to immunity against HLA mediated by antibodies present before transplantation, which leads to early acute graft rejection, non-HLA immunity is associated with chronic graft loss. The possibility of identifying recipients at increased risk of late graft loss before transplantation could be used to devise specific immunosuppressive strategies for these patients.	Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Opelz, G (corresponding author), Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	gerhard.opelz@med.uni-heidelberg.de						BARGER B, 1989, TRANSPLANTATION, V47, P240; Bryan CF, 2001, CLIN TRANSPLANT, V15, P28, DOI 10.1034/j.1399-0012.2001.00005.x; Buelow R, 1995, TRANSPLANTATION, V60, P1594, DOI 10.1097/00007890-199560120-00037; COX DR, 1972, J R STAT SOC B, V34, P187; DUNN OJ, 1974, APPLIED STATISTICS A, P236; Fuller TC, 1997, HUM IMMUNOL, V56, P94, DOI 10.1016/S0198-8859(97)00174-2; GALE RP, 1978, LANCET, V1, P170; KAO KJ, 1993, TRANSPLANTATION, V55, P192, DOI 10.1097/00007890-199301000-00036; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KATZNELSON S, 1998, CLIN TRANS, P285; OPELZ G, 1987, TRANSPLANT P, V19, P3737; OPELZ G, 1992, REV IMMUNOGENET, V1, P334; Pei R, 2003, TRANSPLANTATION, V75, P43, DOI 10.1097/00007890-200301150-00008; Perez-Rodriguez M, 2002, TISSUE ANTIGENS, V59, P440, DOI 10.1034/j.1399-0039.2002.590516.x; PETTAWAY CA, 1987, TRANSPLANTATION, V44, P529, DOI 10.1097/00007890-198710000-00014; RODEY GE, 1994, HUM IMMUNOL, V39, P272, DOI 10.1016/0198-8859(94)90270-4; Simpson E, 2001, EUR J IMMUNOGENET, V28, P505, DOI 10.1046/j.0960-7420.2001.00252.x; Susal C, 2002, TRANSPLANTATION, V73, P1269; TALBOT D, 1989, TRANSPLANTATION, V47, P552, DOI 10.1097/00007890-198903000-00030; TERASAKI PI, 1971, POSTGRAD MED J, V47, P89, DOI 10.1136/pgmj.47.544.89; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; *U HEID, COLL TRANSPL STUD; Zachary AA, 2001, HUM IMMUNOL, V62, P236, DOI 10.1016/S0198-8859(00)00253-6	23	259	269	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1570	1576		10.1016/S0140-6736(05)66458-6	http://dx.doi.org/10.1016/S0140-6736(05)66458-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866311				2022-12-01	WOS:000228754800029
J	Falsey, AR; Hennessey, PA; Formica, MA; Cox, C; Walsh, EE				Falsey, AR; Hennessey, PA; Formica, MA; Cox, C; Walsh, EE			Respiratory syncytial virus infection in elderly and high-risk adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSE TRANSCRIPTION-PCR; DISEASE BURDEN; VIRAL CULTURE; UNITED-STATES; INFLUENZA; COMMUNITY; PNEUMONIA; MORTALITY; ILLNESS; VACCINATION	BACKGROUND: Respiratory syncytial virus (RSV) is an increasingly recognized cause of illness in adults. Data on the epidemiology and clinical effects in community-dwelling elderly persons and high-risk adults can help in assessing the need for vaccine development. METHODS: During four consecutive winters, we evaluated all respiratory illnesses in prospective cohorts of healthy elderly patients (greater/equal 65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions. RSV infection and influenza A were diagnosed on the basis of culture, reverse-transcriptase polymerase chain reaction, and serologic studies. RESULTS: A total of 608 healthy elderly patients and 540 high-risk adults were enrolled in prospective surveillance, and 1388 hospitalized patients were enrolled. A total of 2514 illnesses were evaluated. RSV infection was identified in 102 patients in the prospective cohorts and 142 hospitalized patients, and influenza A was diagnosed in 44 patients in the prospective cohorts and 154 hospitalized patients. RSV infection developed annually in 3 to 7 percent of healthy elderly patients and in 4 to 10 percent of high-risk adults. Among healthy elderly patients, RSV infection generated fewer office visits than influenza; however, the use of health care services by high-risk adults was similar in the two groups. In the hospitalized cohort, RSV infection and influenza A resulted in similar lengths of stay, rates of use of intensive care (15 percent and 12 percent, respectively), and mortality (8 percent and 7 percent, respectively). On the basis of the diagnostic codes of the International Classification of Diseases, 9th Revision, Clinical Modification at discharge, RSV infection accounted for 10.6 percent of hospitalizations for pneumonia, 11.4 percent for chronic obstructive pulmonary disease, 5.4 percent for congestive heart failure, and 7.2 percent for asthma. CONCLUSIONS: RSV infection is an important illness in elderly and high-risk adults, with a disease burden similar to that of nonpandemic influenza A in a population in which the prevalence of vaccination for influenza is high. An effective RSV vaccine may offer benefits for these adults.	Rochester Gen Hosp, Infect Dis Unit, Dept Med, Rochester, NY 14621 USA; Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; NICHHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA	Rochester General Hospital; University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Falsey, AR (corresponding author), Rochester Gen Hosp, Infect Dis Unit, Dept Med, 1425 Portland Ave, Rochester, NY 14621 USA.	ann.falsey@viahealth.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045969] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI-45969] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRAUNWALD E, 2001, HEART DIS TXB CARDIO, P640; *CDCP, INFL SEAS SUMM 1999; Centers for Disease Control and Prevention, INFL SEAS SUMM; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 2003, J CLIN MICROBIOL, V41, P4160, DOI 10.1128/JCM.41.9.4160-4165.2003; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Falsey AR, 2002, J CLIN MICROBIOL, V40, P817, DOI 10.1128/JCM.40.3.817-820.2002; FALSEY AR, 1992, J AM GERIATR SOC, V40, P115, DOI 10.1111/j.1532-5415.1992.tb01929.x; Fleiss J, 1981, STAT METHODS RATES P, V2nd, P113; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Harmon M., 1989, DIAGNOSTIC PROCEDURE, P631; HART RJC, 1984, J INFECTION, V8, P259, DOI 10.1016/S0163-4453(84)94075-1; JOHNSON KM, 1962, NEW ENGL J MED, V267, P68, DOI 10.1056/NEJM196207122670204; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LaMontagne JR, 1997, LANCET, V349, P149, DOI 10.1016/S0140-6736(05)60974-9; LAWTON MP, 1971, J AM GERIATR SOC, V19, P465, DOI 10.1111/j.1532-5415.1971.tb01206.x; MCINTOSH K, 1970, AM J EPIDEMIOL, V91, P585, DOI 10.1093/oxfordjournals.aje.a121171; Morens DM, 2003, JAMA-J AM MED ASSOC, V289, P227, DOI 10.1001/jama.289.2.227; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; POPOVIC JR, 2001, DHHS PUBLICATION; Simoes EAF, 2001, LANCET, V358, P1382, DOI 10.1016/S0140-6736(01)06488-1; SORVILLO FJ, 1984, J INFECTION, V9, P252, DOI 10.1016/S0163-4453(84)90530-9; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; VIKERFORS T, 1987, AM REV RESPIR DIS, V136, P561, DOI 10.1164/ajrccm/136.3.561; Walsh EE, 2002, J AM GERIATR SOC, V50, P1498, DOI 10.1046/j.1532-5415.2002.50404.x; Walsh EE, 2001, J MED VIROL, V63, P259, DOI 10.1002/1096-9071(200103)63:3&lt;259::AID-JMV1010&gt;3.0.CO;2-X; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; 1983, BR MED J CLIN RES ED, V287, P1618	38	1271	1317	1	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1749	1759		10.1056/NEJMoa043951	http://dx.doi.org/10.1056/NEJMoa043951			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858184				2022-12-01	WOS:000228689000005
J	Renehan, AG				Renehan, AG			Preventing cancer, cardiovascular disease, and diabetes	LANCET			English	Editorial Material							BREAST-CANCER; RISK; MECHANISMS; SERUM		Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England; Christie Hosp NHS Trust, Canc Res UK Dept Med Oncol, Manchester M20 4BX, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Cancer Research UK; Christie NHS Foundation Trust; Christie Hospital	Renehan, AG (corresponding author), Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England.	arenehan@picr.man.ac.uk	; Renehan, Andrew/K-5992-2015	Howell, Anthony/0000-0002-6233-719X; Renehan, Andrew/0000-0003-4309-4396				*AM CANC SOC, CANC FACTS FIG 2005; American Diabetes Association, DIAB STAT; American Stroke Association American Heart Association, HEART DIS STROK STAT; Amir E, 2003, J MED GENET, V40, P807, DOI 10.1136/jmg.40.11.807; ANDERSON RM, 2002, NATL VITAL STAT REPO, V53; *BHF, BHF COR HEART DIS ST; *BHF, EC COSTS CHD; Bosanquet N, 2004, LANCET ONCOL, V5, P568, DOI 10.1016/S1470-2045(04)01569-4; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; *CANC RES UK, 2004, CANCERSTATS INC UK; *DIAB UK, 3 DIAB UK; *DIAB UK, GETS DIAB WHAT CAUS; Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908; Dowsett M, 2002, NAT MED, V8, P1341, DOI 10.1038/nm1202-1341; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Eyre H, 2004, CA-CANCER J CLIN, V54, P190, DOI 10.3322/canjclin.54.4.190; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kreeger Karen, 2003, Nature, V424, P1090, DOI 10.1038/nj6952-1090a; McTiernan A, 1998, CANCER CAUSE CONTROL, V9, P487, DOI 10.1023/A:1008853601471; *NAT CANC RES I, 2002, STRAT AN OV CANC RES; *NAT CANC RES I, 2004, PREV RISK RES UK REP; *OFF NAT STAT, 2003, MORT STAT CAUS DH2, V30; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Vainio H., 2002, IARC HDB CANC PREVEN; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	26	29	30	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1449	1451		10.1016/S0140-6736(05)66399-4	http://dx.doi.org/10.1016/S0140-6736(05)66399-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850618				2022-12-01	WOS:000228651600009
J	Skilton, MR; Evans, N; Griffiths, KA; Harmer, JA; Celermajer, DS				Skilton, MR; Evans, N; Griffiths, KA; Harmer, JA; Celermajer, DS			Aortic wall thickness in newborns with intrauterine growth restriction	LANCET			English	Article							MEDIA THICKNESS; HEART-DISEASE; RISK-FACTORS; ATHEROSCLEROSIS; CHILDREN; WEIGHT; INTIMA; ADULTS; ARTERY	Much epidemiological evidence has linked low birthweight with late cardiovascular risk. We measured aortic wall thickness (a marker of early atherosclerosis) by ultrasonography in 25 newborn babies with intrauterine growth restriction and 25 with normal birthweight. Maximum aortic thicknesses were significantly higher in the babies with intrauterine growth restriction (810 mu m [SD 113]) than in those without (743 mu m [76], p=0.02), more so after adjustment for birthweight (300 mu m/kg [45] vs 199 mu m/kg [29], p<0.0001). Newborn babies with growth restriction have significant aortic thickening, suggesting that prenatal events might predispose to later cardiovascular risk.	Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Royal Prince Alfred Hosp, Dept Newborn Care, Sydney, NSW, Australia; Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Celermajer, DS (corresponding author), Univ Sydney, Dept Med, Sydney, NSW 2006, Australia.	david.celermajer@email.cs.nsw.gov.au		Skilton, Michael/0000-0003-2793-2388				BARKER DJP, 1989, LANCET, V2, P577; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Leeson CPM, 2001, CIRCULATION, V103, P1264; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103	6	217	228	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1484	1486		10.1016/S0140-6736(05)66419-7	http://dx.doi.org/10.1016/S0140-6736(05)66419-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850633				2022-12-01	WOS:000228651600027
J	Bichot, NP; Rossi, AF; Desimone, R				Bichot, NP; Rossi, AF; Desimone, R			Parallel and serial neural mechanisms for visual search in macaque area V4	SCIENCE			English	Article							SELECTIVE ATTENTION; PREFRONTAL CORTEX; WORKING-MEMORY; RESPONSES; SYNCHRONIZATION; SPACE; V2	To find a target object in a crowded scene, a face in a crowd for example, the visual system might turn the neural representation of each object on and off in a serial fashion, testing each representation against a template of the target item. Alternatively, it might allow the processing of all objects in parallel but bias activity in favor of those neurons that represent critical features of the target, until the target emerges from the background. To test these possibilities, we recorded neurons in area V4 of monkeys freely scanning a complex array to find a target defined by color, shape, or both. Throughout the period of searching, neurons gave enhanced responses and synchronized their activity in the gamma range whenever a preferred stimulus in their receptive field matched a feature of the target, as predicted by parallel models. Neurons also gave enhanced responses to candidate targets that were selected for saccades, or foveation, reflecting a serial component of visual search. Thus, serial and parallel mechanisms of response enhancement and neural synchrony work together to identify objects in a scene.	NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Vanderbilt University; Massachusetts Institute of Technology (MIT)	Bichot, NP (corresponding author), NIMH, Neuropsychol Lab, NIH, Bldg 9, Bethesda, MD 20892 USA.	bichotn@mail.nih.gov	Desimone, Robert/G-1121-2018		NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BUFFALO EA, UNPUB; Cave Kyle R., 2005, P547, DOI 10.1016/B978-012375731-9/50094-X; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Miller EK, 1996, J NEUROSCI, V16, P5154; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	27	463	468	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					529	534		10.1126/science.1109676	http://dx.doi.org/10.1126/science.1109676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845848				2022-12-01	WOS:000228810500046
J	Tu, D; Blaha, G; Moore, PB; Steitz, TA				Tu, D; Blaha, G; Moore, PB; Steitz, TA			Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOMES; ERYTHROMYCIN RESISTANCE; BACTERIAL-RIBOSOMES; MACROLIDE ANTIBIOTICS; BOND FORMATION; BINDING-SITE; RNA; MUTANTS; VIRGINIAMYCIN	Crystal structures of H. marismortui large ribosomal subunits containing the mutation G2099A (A2058 in E. coli) with erythromycin, azithromycin, clindamycin, virginiamycin S, and telithromycin bound explain why eubacterial ribosomes containing the mutation A2058G are resistant to them. Azithromycin binds almost identically to both G2099A and wild-type subunits, but the erythromycin affinity increases by more than 10(4)-fold, implying that desolvation of the N2 of 62099 accounts for the low wild-type affinity for macrolides. All macrolides bind similarly to the H. marismortui subunit, but their binding differs significantly from what has been reported in the D. radioidurans subunit. The synergy in the binding of streptogramins A and B appears to result from a reorientation of the base of A2103 (A2062, E. coli) that stacks between them. The structure of large subunit containing a three residue deletion mutant of L22 shows a change in the L22 structure and exit tunnel shape that illuminates its macrolide resistance phenotype.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NIGMS NIH HHS [GM022778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agouridas C, 1998, J MED CHEM, V41, P4080, DOI 10.1021/jm980240d; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Berisio R, 2003, J BACTERIOL, V185, P4276, DOI 10.1128/JB.185.14.4276-4279.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; Clark C, 2002, ANTIMICROB AGENTS CH, V46, P2956, DOI 10.1128/AAC.46.9.2956-2962.2002; COCITO C, 1978, MOL GEN GENET, V166, P53, DOI 10.1007/BF00379729; COCITO C, 1979, MICROBIOL REV, V43, P145, DOI 10.1128/MMBR.43.2.145-192.1979; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; DECLERCQ JP, 1978, ACTA CRYSTALLOGR B, V34, P3644, DOI 10.1107/S0567740878011796; DOUTHWAITE S, 1993, J MOL BIOL, V232, P725, DOI 10.1006/jmbi.1993.1426; ENNIS HL, 1971, BIOCHEMISTRY-US, V10, P1265, DOI 10.1021/bi00783a025; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Garza-Ramos G, 2001, J BACTERIOL, V183, P6898, DOI 10.1128/JB.183.23.6898-6907.2001; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; Harms JM, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARLE IL, 1990, ACTA CRYSTALLOGR C, V46, P303, DOI 10.1107/S0108270189006906; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kosutic-Hulita N, 2001, CROAT CHEM ACTA, V74, P327; KREBS MP, 1993, P NATL ACAD SCI USA, V90, P1987, DOI 10.1073/pnas.90.5.1987; LEBAN I, 1994, ACTA CHIM SLOV, V0041; Malbruny B, 2002, ANTIMICROB AGENTS CH, V46, P2200, DOI 10.1128/AAC.46.7.2200-2207.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARFAIT R, 1978, MOL GEN GENET, V166, P45, DOI 10.1007/BF00379728; PESTKA S, 1974, ANTIMICROB AGENTS CH, V6, P474, DOI 10.1128/AAC.6.4.474; SANZ JL, 1993, CAN J MICROBIOL, V39, P311, DOI 10.1139/m93-044; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/BF00217518; Stephenson GA, 1997, J PHARM SCI, V86, P1239, DOI 10.1021/js9701667; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; VANNUFFEL P, 1992, J BIOL CHEM, V267, P16114; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; WITTMANN HG, 1973, MOL GEN GENET, V127, P175, DOI 10.1007/BF00333665; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x	44	335	347	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					257	270		10.1016/j.cell.2005.02.005	http://dx.doi.org/10.1016/j.cell.2005.02.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851032	Bronze			2022-12-01	WOS:000228705000013
J	Rosvold, EA; Tyssen, R				Rosvold, EA; Tyssen, R			Should physicians' self-prescribing be restricted by law?	LANCET			English	Editorial Material							MENTAL-HEALTH PROBLEMS; DOCTORS; CARE		Univ Oslo, Fac Med, Inst Gen Practice & Community Med, N-0318 Oslo, Norway; Univ Oslo, Fac Med, Dept Behav Sci Med, Inst Basic Med Sci, N-0318 Oslo, Norway	University of Oslo; University of Oslo	Rosvold, EA (corresponding author), Univ Oslo, Fac Med, Inst Gen Practice & Community Med, N-0318 Oslo, Norway.	e.o.rosvold@medisin.uio.no						Forsythe M, 1999, BRIT MED J, V319, P605, DOI 10.1136/bmj.319.7210.605; Fromme E, 2003, JAMA-J AM MED ASSOC, V290, P2048, DOI 10.1001/jama.290.15.2048; Garfinkel PE, 1997, CAN J PSYCHIAT, V42, P764, DOI 10.1177/070674379704200710; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; Ingstad B., 2001, ANTHROPOL MED, V8, P201, DOI [DOI 10.HTTP://DX.D0I.0RG/10.1080/13648470120101372, 10.1080/13648470120101372, DOI 10.1080/13648470120101372]; Kay Margaret, 2005, Aust Fam Physician, V34, P94; LOTT DA, 2001, PSYCHIAT TIMES, V18; ROSVOLD EO, 2002, THESIS U OSLO OSLO N; Schneck SA, 1998, JAMA-J AM MED ASSOC, V280, P2039, DOI 10.1001/jama.280.23.2039; STOUDEMIRE A, 1983, ANN INTERN MED, V98, P654, DOI 10.7326/0003-4819-98-5-654; Toyry S, 2000, ARCH FAM MED, V9, P1079, DOI 10.1001/archfami.9.10.1079; Tyssen R, 2004, SOC PSYCH PSYCH EPID, V39, P989, DOI 10.1007/s00127-004-0831-8; Tyssen R, 2002, HARVARD REV PSYCHIAT, V10, P154, DOI 10.1080/10673220216218	13	15	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1372	1374		10.1016/S0140-6736(05)66353-2	http://dx.doi.org/10.1016/S0140-6736(05)66353-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916QY	15836873				2022-12-01	WOS:000228401900009
J	Rosenberg, GA				Rosenberg, GA			Matrix metalloproteinases biomarkers in multiple sclerosis	LANCET			English	Editorial Material							MATRIX-METALLOPROTEINASE-9; GELATINASE; TIMP-1; INTERFERON-BETA-1A; MMP-9; BETA; MRI		Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Physiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Rosenberg, GA (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA.	grosenberg@salud.unm.edu						Dubois B, 2003, J NEUROL, V250, P1037, DOI 10.1007/s00415-003-0110-8; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; Karabudak R, 2004, J NEUROL, V251, P279, DOI 10.1007/s00415-004-0285-7; Lee MA, 1999, BRAIN, V122, P191, DOI 10.1093/brain/122.2.191; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Liuzzi GM, 2002, MULT SCLER, V8, P222, DOI 10.1191/1352458502ms800oa; Rosenberg GA, 1996, NEUROLOGY, V46, P1626, DOI 10.1212/WNL.46.6.1626; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Waubant E, 1999, NEUROLOGY, V53, P1397, DOI 10.1212/WNL.53.7.1397; Waubant E, 2003, NEUROLOGY, V60, P52, DOI 10.1212/WNL.60.1.52; Yong VW, 1998, NEUROLOGY, V51, P682; Yushchenko M, 2003, J NEUROL, V250, P1224, DOI 10.1007/s00415-003-0191-4	12	29	32	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1291	1293		10.1016/S0140-6736(05)61008-2	http://dx.doi.org/10.1016/S0140-6736(05)61008-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823367				2022-12-01	WOS:000228219600009
J	Demir, E; Dickson, BJ				Demir, E; Dickson, BJ			fruitless splicing specifies male courtship behavior in Drosophila	CELL			English	Article							DETERMINATION GENE FRUITLESS; MALE-SPECIFIC MUSCLE; AXON GUIDANCE; EXPRESSION PATTERNS; SEXUAL ORIENTATION; FEMALE DROSOPHILA; MUTANT DROSOPHILA; MELANOGASTER; DOUBLESEX; PROTEIN	All animals exhibit innate behaviors that are specified during their development. Drosophila melanogaster males (but not females) perform an elaborate and innate courtship ritual directed toward females (but not males). Male courtship requires products of the fruitless (fru) gene, which is spliced differently in males and females. We have generated alleles of fru that are constitutively spliced in either the male or the female mode. We show that male splicing is essential for male courtship behavior and sexual orientation. More importantly, male splicing is also sufficient to generate male behavior in otherwise normal females. These females direct their courtship toward other females (or males engineered to produce female pheromones). The splicing of a single neuronal gene thus specifies essentially all aspects of a complex innate behavior.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	barry.dickson@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Anand A, 2001, GENETICS, V158, P1569; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Billeter JC, 2002, ADV GENET, V47, P87, DOI 10.1016/S0065-2660(02)47003-4; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; CURRIE DA, 1995, DEVELOPMENT, V121, P2549; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; GAILEY DA, 1991, DEVELOPMENT, V113, P879; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; Goodwin SF, 2000, GENETICS, V154, P725; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Kido A, 2002, J NEUROBIOL, V52, P302, DOI 10.1002/neu.10100; LAWRENCE PA, 1984, CELL, V36, P775, DOI 10.1016/0092-8674(84)90357-X; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Ogilvie AD, 1996, LANCET, V347, P731, DOI 10.1016/S0140-6736(96)90079-3; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Schlote, 1984, DROS INFORM SERV, V60, P210; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TAYLOR BJ, 1992, DEVELOPMENT, V114, P625; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; TAYLOR BJ, 1992, GENETICS, V132, P179; Tinbergen N., 1951, STUDY INSTINCT; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Villella A, 1996, GENETICS, V143, P331; Villella A, 1997, GENETICS, V147, P1107; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475	52	328	336	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					785	794		10.1016/j.cell.2005.04.027	http://dx.doi.org/10.1016/j.cell.2005.04.027			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935764	Bronze			2022-12-01	WOS:000229658000016
J	Gigant, B; Wang, CG; Ravelli, RBG; Roussi, F; Steinmetz, MO; Curmi, PA; Sobel, A; Knossow, M				Gigant, B; Wang, CG; Ravelli, RBG; Roussi, F; Steinmetz, MO; Curmi, PA; Sobel, A; Knossow, M			Structural basis for the regulation of tubulin by vinblastine	NATURE			English	Article							STATHMIN-LIKE DOMAIN; VINCA ALKALOIDS; BETA-TUBULIN; BINDING-SITE; MICROTUBULE; COLCHICINE; MECHANISM; CRYSTALLOGRAPHY; LOCALIZATION; INHIBITION	Vinblastine is one of several tubulin-targeting Vinca alkaloids that have been responsible for many chemotherapeutic successes since their introduction in the clinic as antitumour drugs(1). In contrast with the two other classes of small tubulin-binding molecules (Taxol(2) and colchicine(3)), the binding site of vinblastine is largely unknown and the molecular mechanism of this drug has remained elusive. Here we report the X-ray structure of vinblastine bound to tubulin in a complex with the RB3 protein stathmin-like domain (RB3-SLD). Vinblastine introduces a wedge at the interface of two tubulin molecules and thus interferes with tubulin assembly. Together with electron microscopical and biochemical data, the structure explains vinblastine-induced tubulin self-association into spiral aggregates at the expense of microtubule growth(4). It also shows that vinblastine and the amino-terminal part of RB3-SLD binding sites share a hydrophobic groove on the alpha-tubulin surface that is located at an intermolecular contact in microtubules. This is an attractive target for drugs designed to perturb microtubule dynamics by interfacial interference, for which tubulin seems ideally suited because of its propensity to self-associate.	Lab Enzymol & Biochim Struct, CNRS, UPR 9063, F-91198 Gif Sur Yvette, France; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; Paul Scherrer Inst, CH-5232 Villigen, Switzerland; Inst Fer Moulin, UPMC, INSERM, U706, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Knossow, M (corresponding author), Lab Enzymol & Biochim Struct, CNRS, UPR 9063, Batiment 34,1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	knossow@lebs.cnrs-gif.fr	CURMI, Patrick/G-4036-2013; Steinmetz, Michel O/AAA-3349-2022	Steinmetz, Michel O/0000-0001-6157-3687; CURMI, Patrick A./0000-0001-5045-8501; Ravelli, Raimond/0000-0001-6056-5888; Gigant, Benoit/0000-0002-5946-6759				Bau R, 2000, J CHEM SOC PERK T 1, P2079, DOI 10.1039/b001855o; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Ennifar E, 2002, ACTA CRYSTALLOGR D, V58, P1262, DOI 10.1107/S0907444902009526; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; HASKINS KM, 1981, J CELL SCI, V47, P237; HIMES RH, 1991, PHARMACOL THERAPEUT, V51, P257, DOI 10.1016/0163-7258(91)90081-V; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1991, CANCER RES, V51, P2212; Lobert S, 2000, BIOCHEMISTRY-US, V39, P12053, DOI 10.1021/bi001038r; Mitra A, 2004, BIOCHEMISTRY-US, V43, P13955, DOI 10.1021/bi0487387; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; NA GC, 1986, BIOCHEMISTRY-US, V25, P6214, DOI 10.1021/bi00368a057; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2003, CURR OPIN STRUC BIOL, V13, P256, DOI 10.1016/S0959-440X(03)00029-0; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Rai SS, 1996, J BIOL CHEM, V271, P14707, DOI 10.1074/jbc.271.25.14707; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; SACKETT DL, 1995, BIOCHEMISTRY-US, V34, P7010, DOI 10.1021/bi00021a012; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TROUET ABL, 1987, Patent No. 4639456; Usui T, 2004, CHEM BIOL, V11, P799, DOI 10.1016/j.chembiol.2004.03.028; WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3	30	531	554	1	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					519	522		10.1038/nature03566	http://dx.doi.org/10.1038/nature03566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917812				2022-12-01	WOS:000229337800059
J	Morimoto, M; Takahashi, Y; Endo, M; Saga, Y				Morimoto, M; Takahashi, Y; Endo, M; Saga, Y			The Mesp2 transcription factor establishes segmental borders by suppressing Notch activity	NATURE			English	Article							LUNATIC-FRINGE EXPRESSION; SOMITE BOUNDARY FORMATION; VERTEBRATE SEGMENTATION; RETINOIC ACID; CLOCK; GENE; SOMITOGENESIS; MESODERM; GLYCOSYLTRANSFERASE; PATHWAY	The serially segmented ( metameric) structures of vertebrates are based on somites that are periodically formed during embryogenesis. A 'clock and wavefront' model has been proposed to explain the underlying mechanism of somite formation(1), in which the periodicity is generated by oscillation of Notch components ( the clock) in the posterior pre-somitic mesoderm (PSM)(2-6). This temporal periodicity is then translated into the segmental units in the 'wavefront'(7,8). The wavefront is thought to exist in the anterior PSM and progress backwards at a constant rate; however, there has been no direct evidence as to whether the levels of Notch activity really oscillate and how such oscillation is translated into a segmental pattern in the anterior PSM. Here, we have visualized endogenous levels of Notch1 activity in mice, showing that it oscillates in the posterior PSM but is arrested in the anterior PSM. Somite boundaries formed at the interface between Notch1-activated and - repressed domains. Genetic and biochemical studies indicate that this interface is generated by suppression of Notch activity by mesoderm posterior 2 (Mesp2) through induction of the lunatic fringe gene (Lfng). We propose that the oscillation of Notch activity is arrested and translated in the wavefront by Mesp2.	Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan; Natl Inst Hlth Sci, Cellular & Mol Toxicol Div, Setagaya Ku, Tokyo 1588501, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Health Sciences - Japan	Saga, Y (corresponding author), Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan.	ysaga@lab.nig.ac.jp						Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; Sparrow DB, 1998, DEVELOPMENT, V125, P2041; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062	29	194	205	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					354	359		10.1038/nature03591	http://dx.doi.org/10.1038/nature03591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902259				2022-12-01	WOS:000229185000047
J	Gostin, LO				Gostin, LO			Ethics, the constitution, and the dying process - The case of Theresa Marie Schiavo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CRUZAN; DEATH; LIFE		Georgetown Univ, Ctr Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*AM MED ASS, 1986, WITHH WITHDR LIF PRO; *AM NURS ASS, 1988, GUID WITHDR WITHH FO; BABINGTON C, 2005, WASH POST       0908, pA6; CERMINARA KL, KEY EVENTS CASE TM S; GOSTIN L, 1991, MILBANK Q, V69, P143, DOI 10.2307/3350124; Gostin LO, 1997, JAMA-J AM MED ASSOC, V278, P1523, DOI 10.1001/jama.278.18.1523; HULSE C, 2005, NY TIMES        0519, pA1; JOHNSON HM, 2005, WASHINGTON POST 0325, pA19; MEISEL A, 2004, RIGHT DIE LAW END LI; *PRES COMM STUD ET, 1983, DEC FOR LIF SUST TRE; SANGER D, 2003, NY TIMES, pA23; Wolfson Jay, 2003, REPORT GOVERNOR J BU	12	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2403	2407		10.1001/jama.293.19.2403	http://dx.doi.org/10.1001/jama.293.19.2403			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	926JX	15900011				2022-12-01	WOS:000229120600028
J	Elachi, C; Wall, S; Allison, M; Anderson, Y; Boehmer, R; Callahan, P; Encrenaz, P; Flamini, E; Franceschetti, G; Gim, Y; Hamilton, G; Hensley, S; Janssen, M; Johnson, W; Kelleher, K; Kirk, R; Lopes, R; Lorenz, R; Lunine, J; Muhleman, D; Ostro, S; Paganelli, F; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Soderblom, L; Stiles, B; Stofan, E; Vetrella, S; West, R; Wood, C; Wye, L; Zebker, H				Elachi, C; Wall, S; Allison, M; Anderson, Y; Boehmer, R; Callahan, P; Encrenaz, P; Flamini, E; Franceschetti, G; Gim, Y; Hamilton, G; Hensley, S; Janssen, M; Johnson, W; Kelleher, K; Kirk, R; Lopes, R; Lorenz, R; Lunine, J; Muhleman, D; Ostro, S; Paganelli, F; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Soderblom, L; Stiles, B; Stofan, E; Vetrella, S; West, R; Wood, C; Wye, L; Zebker, H			Cassini radar views the surface of Titan	SCIENCE			English	Article							SATELLITES; GANYMEDE	The Cassini Titan Radar Mapper imaged about 1% of Titan's surface at a resolution of similar to 0.5 kilometer, and larger areas of the globe in lower resolution modes. The images reveal a complex surface, with areas of low relief and a variety of geologic features suggestive of dome-like volcanic constructs, flows, and sinuous channels. The surface appears to be young, with few impact craters. Scattering and dielectric properties are consistent with porous ice or organics. Dark patches in the radar images show high brightness temperatures and high emissivity and are consistent with frozen hydrocarbons.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Observ Paris, F-75014 Paris, France; Agenzia Spaziale Italiana, I-00198 Rome, Italy; Fac Ingn, I-80125 Naples, Italy; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Roma La Sapienza, I-00184 Rome, Italy; Politecn Bari, INFM, I-70126 Bari, Italy; Politecn Bari, Dipartimento Interateneo Fis, I-70126 Bari, Italy; Proxemy Res, Laytonville, MD 20882 USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Stanford Univ, Stanford, CA 94305 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Agenzia Spaziale Italiana (ASI); United States Department of the Interior; United States Geological Survey; University of Arizona; California Institute of Technology; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Politecnico di Bari; Politecnico di Bari; Stanford University	Wall, S (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	steve.wall@jpl.nasa.gov	Lorenz, Ralph D/B-8759-2016; Lopes, Rosaly M.C./D-1608-2016	Lorenz, Ralph D/0000-0001-8528-4644; Lopes, Rosaly M.C./0000-0002-7928-3167; Lunine, Jonathan/0000-0003-2279-4131; zebker, howard/0000-0001-9931-5237				Black GJ, 2004, SCIENCE, V304, P553, DOI 10.1126/science.1096470; Black GJ, 2001, ICARUS, V151, P167, DOI 10.1006/icar.2001.6616; BOTT DC, 1986, HDB CONDUCTING POLYM, P1191; BUTLER BJ, 2004, B AM ASTRON SOC, V36, P1075; Campbell BA., 2002, RADAR REMOTE SENSING; Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; ENGEL S, 1995, PLANET SPACE SCI, V43, P1059, DOI 10.1016/0032-0633(95)00044-6; GROSSMAN AW, 1992, B AM ASTRON SOC, V24, P954; Harmon JK, 1999, PLANET SPACE SCI, V47, P1409, DOI 10.1016/S0032-0633(99)00068-9; JANKOWSKI DG, 1988, SCIENCE, V241, P1322, DOI 10.1126/science.241.4871.1322; Lorenz RD, 1996, PLANET SPACE SCI, V44, P1021, DOI 10.1016/0032-0633(95)00139-5; Lorenz RD, 2003, PLANET SPACE SCI, V51, P353, DOI 10.1016/S0032-0633(02)00148-4; Lorenz RD, 1997, PLANET SPACE SCI, V45, P1009, DOI 10.1016/S0032-0633(97)00085-8; LUNINE J, 2005, 36 ANN LUN PLAN SCI; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; MCCAULEY JF, 1982, SCIENCE, V218, P1004, DOI 10.1126/science.218.4576.1004; MUHLEMAN DO, 1995, ANNU REV EARTH PL SC, V23, P337, DOI 10.1146/annurev.earth.23.1.337; OSTRO SJ, 1992, J GEOPHYS RES-PLANET, V97, P18227, DOI 10.1029/92JE01992; OSTRO SJ, 1993, REV MOD PHYS, V65, P1235, DOI 10.1103/RevModPhys.65.1235; Pappalardo RT, 2004, CAMB PLANET, P363; Patel JG, 1999, J GEOPHYS RES-PLANET, V104, P24057, DOI 10.1029/1998JE001021; PETERS KJ, 1992, PHYS REV B, V46, P801, DOI 10.1103/PhysRevB.46.801; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; SAUNDERS RS, 1992, J GEOPHYS RES-PLANET, V97, P13067, DOI 10.1029/92JE01397; Seidelmann PK, 2002, CELEST MECH DYN ASTR, V82, P83, DOI 10.1023/A:1013939327465; THOMPSON WR, 1990, ICARUS, V86, P336, DOI 10.1016/0019-1035(90)90224-W; TOMASKO M, IN PRESS NATURE	27	187	189	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					970	974		10.1126/science.1109919	http://dx.doi.org/10.1126/science.1109919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890871	Green Submitted			2022-12-01	WOS:000229190700031
J	Tanaka, Y; Okada, Y; Hirokawa, N				Tanaka, Y; Okada, Y; Hirokawa, N			FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; INTRAFLAGELLAR TRANSPORT; MOUSE; SHH; PATHWAYS; MICE; PROTEINS; POPULATIONS; INDUCTION; RECEPTOR	The precise specification of left - right asymmetry is an essential process for patterning internal organs in vertebrates. In mouse embryonic development, the symmetry-breaking process in left - right determination is initiated by a leftward extraembryonic fluid flow on the surface of the ventral node. However, it is not known whether the signal transduction mechanism of this flow is chemical or mechanical. Here we show that fibroblast growth factor (FGF) signalling triggers secretion of membrane-sheathed objects 0.3 - 5 mu m in diameter termed 'nodal vesicular parcels' (NVPs) that carry Sonic hedgehog and retinoic acid. These NVPs are transported leftward by the fluid flow and eventually fragment close to the left wall of the ventral node. The silencing effects of the FGF-receptor inhibitor SU5402 on NVP secretion and on a downstream rise in Ca2+ were sufficiently reversed by exogenous Sonic hedgehog peptide or retinoic acid, suggesting that FGF-triggered surface accumulation of cargo morphogens may be essential for launching NVPs. Thus, we propose that NVP flow is a new mode of extracellular transport that forms a left - right gradient of morphogens.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689; Tanaka, Yosuke/0000-0001-5376-5726				Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kos FJ, 2002, IMMUNOL CELL BIOL, V80, P364, DOI 10.1046/j.1440-1711.2002.01098.x; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; STURM K, 1993, METHOD ENZYMOL, V225, P164; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TANAKA Y, 1992, BRAIN RES, V596, P269, DOI 10.1016/0006-8993(92)91557-U; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yokoyama Takahiko, 2004, Anatomical Science International, V79, P47, DOI 10.1111/j.1447-073x.2004.00072.x; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	32	395	411	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					172	177		10.1038/nature03494	http://dx.doi.org/10.1038/nature03494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889083				2022-12-01	WOS:000229021100031
J	Hoepfner, S; Severin, F; Cabezas, A; Habermann, B; Runge, A; Giilooly, D; Stenmark, H; Zerial, M				Hoepfner, S; Severin, F; Cabezas, A; Habermann, B; Runge, A; Giilooly, D; Stenmark, H; Zerial, M			Modulation of receptor recycling and degradation by the endosomal kinesin KIF16B	CELL			English	Article							MEMBRANE-TRANSPORT; SUPERFAMILY PROTEINS; AXONAL-TRANSPORT; CELL-SURFACE; MOTOR; MICROTUBULES; DYNACTIN; IDENTIFICATION; MYOSIN; OVEREXPRESSION	Different classes of endosomes exhibit a characteristic intracellular steady-state distribution governed by interactions with the cytoskeleton. We found a kinesin-3, KIF16B, that transports early endosomes to the plus end of microtubules in a process regulated by the small GTPase Rab5 and its effector, the phosphatidylinositol-3-OH kinase hVPS34. In vivo, KIF16B overexpression relocated early endosomes to the cell periphery and inhibited transport to the degradative pathway. Conversely, expression of dominant-negative mutants or ablation of KIF16B by RNAi caused the clustering of early endosomes to the perinuclear region, delayed receptor recycling to the plasma membrane, and accelerated degradation. These results suggest that KIF16B, by regulating the plus end motility of early endosomes, modulates the intracellular localization of early endosomes and the balance between receptor recycling and degradation. We propose that this mechanism could have important implications for signaling.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Norwegian Radium Hosp, Dept Biochem, N-0310 Oslo, Norway; Univ Penn, Ctr Canc, HHMI, Philadelphia, PA 19104 USA	Max Planck Society; University of Oslo; Howard Hughes Medical Institute; University of Pennsylvania	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Severin, Fedor/AAD-5444-2019; Habermann, Bianca/N-4886-2016; Cabezas, Alicia/K-6564-2014; Stenmark, Harald/B-8868-2008	Habermann, Bianca/0000-0002-2457-7504; Cabezas, Alicia/0000-0002-2908-9147; Severin, Fedor/0000-0001-6703-1256				Allan V, 2000, CURR BIOL, V10, pR432, DOI 10.1016/S0960-9822(00)00550-9; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Dalby B., 1996, Molecular Biology of the Cell, V7, p487A; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Goodson HV, 1997, CURR OPIN CELL BIOL, V9, P18, DOI 10.1016/S0955-0674(97)80147-0; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HYMAN AA, 1991, J CELL SCI, P125; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miki H, 2003, GENOME RES, V13, P1455, DOI 10.1101/gr.984503; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pollock N, 1999, J CELL BIOL, V147, P493, DOI 10.1083/jcb.147.3.493; Reilein AR, 2001, INT REV CYTOL, V204, P179, DOI 10.1016/S0074-7696(01)04005-0; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; VONMASSOW A, 1989, CELL MOTIL CYTOSKEL, V14, P562, DOI 10.1002/cm.970140413; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yang ZH, 2001, MOL CELL BIOL, V21, P2463, DOI 10.1128/MCB.21.7.2463-2466.2001; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	52	235	245	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					437	450		10.1016/j.cell.2005.02.017	http://dx.doi.org/10.1016/j.cell.2005.02.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882625	Bronze			2022-12-01	WOS:000229031600013
J	Sato, T; Cheng, YN; Wu, XC; Zelenitsky, DK; Hsiao, YF				Sato, T; Cheng, YN; Wu, XC; Zelenitsky, DK; Hsiao, YF			A pair of shelled eggs inside a female dinosaur	SCIENCE			English	Article							CHINA; NEST		Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; Natl Museum Nat Hist, Taichung, Taiwan; Univ Calgary, Dept Geol & Geophys, Calgary, AB T2N 1N4, Canada; Paleowonders Fossil & Mineral Museum, Taipei, Taiwan	University of Calgary	Sato, T (corresponding author), Canadian Museum Nat, POB 3443,Stn D, Ottawa, ON K1P 6P4, Canada.	tsato@mus-nature.ca; xcwu@mus-nature.ca						Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Clark James M., 1999, American Museum Novitates, V3265, P1; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215	6	95	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					375	375		10.1126/science.1110578	http://dx.doi.org/10.1126/science.1110578			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831749				2022-12-01	WOS:000228492000041
J	Bartkova, J; Horejsi, Z; Koed, K; Kramer, A; Tort, F; Zieger, K; Guldberg, P; Sehested, M; Nesland, JM; Lukas, C; Orntoft, T; Lukas, J; Bartek, J				Bartkova, J; Horejsi, Z; Koed, K; Kramer, A; Tort, F; Zieger, K; Guldberg, P; Sehested, M; Nesland, JM; Lukas, C; Orntoft, T; Lukas, J; Bartek, J			DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis	NATURE			English	Article							CELL-CYCLE CONTROL; CHROMOSOME INSTABILITY; GENOMIC INSTABILITY; BREAST-CANCER; HISTONE H2AX; PHOSPHORYLATION; REPLICATION; PROTEIN; ATM; P53	During the evolution of cancer, the incipient tumour experiences 'oncogenic stress', which evokes a counter- response to eliminate such hazardous cells. However, the nature of this stress remains elusive, as does the inducible anti-cancer barrier that elicits growth arrest or cell death. Here we show that in clinical specimens from different stages of human tumours of the urinary bladder, breast, lung and colon, the early precursor lesions ( but not normal tissues) commonly express markers of an activated DNA damage response. These include phosphorylated kinases ATM and Chk2, and phosphorylated histone H2AX and p53. Similar checkpoint responses were induced in cultured cells upon expression of different oncogenes that deregulate DNA replication. Together with genetic analyses, including a genome-wide assessment of allelic imbalances, our data indicate that early in tumorigenesis ( before genomic instability and malignant conversion), human cells activate an ATR/ATM- regulated DNA damage response network that delays or prevents cancer. Mutations compromising this checkpoint, including defects in the ATM - Chk2 p53 pathway, might allow cell proliferation, survival, increased genomic instability and tumour progression.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus, Denmark; Univ Copenhagen Hosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway; Acad Sci Czech Republ, Inst Genet Mol, CZ-16637 Prague, Czech Republic	Danish Cancer Society; Danish Cancer Society; Aarhus University; University of Copenhagen; University of Oslo; Czech Academy of Sciences	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk	Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X; Tort, Frederic/0000-0003-2733-1603; Lukas, Claudia/0000-0001-7169-6883; Licenikova Horejsi, Zuzana/0000-0002-9943-1649				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Cangi MG, 2000, J CLIN INVEST, V106, P753, DOI 10.1172/JCI9174; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lindstrom MS, 2003, ONCOGENE, V22, P4993, DOI 10.1038/sj.onc.1206659; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	2117	2195	6	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					864	870		10.1038/nature03482	http://dx.doi.org/10.1038/nature03482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829956				2022-12-01	WOS:000228327600032
J	Caballero, B				Caballero, B			A nutrition paradox - Uderweight and obesity in developing countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSITION; BURDEN		Johns Hopkins Univ, Ctr Human Nutr, Baltimore, MD 21218 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Caballero, B (corresponding author), Johns Hopkins Univ, Ctr Human Nutr, Baltimore, MD 21218 USA.							[Anonymous], 2002, WORLD HLTH REP 2002; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Ruel M. T., 2001, Nutrition and health in developing countries, P465	5	234	248	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1514	1516		10.1056/NEJMp048310	http://dx.doi.org/10.1056/NEJMp048310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	915SH	15829531				2022-12-01	WOS:000228324200002
J	Burton, MJ; Holland, MJ; Makalo, P; Aryee, EAN; Alexander, NDE; Sillah, A; Faal, H; West, SK; Foster, A; Johnson, GJ; Mabey, DCW; Bailey, RL				Burton, MJ; Holland, MJ; Makalo, P; Aryee, EAN; Alexander, NDE; Sillah, A; Faal, H; West, SK; Foster, A; Johnson, GJ; Mabey, DCW; Bailey, RL			Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; AZITHROMYCIN; DIAGNOSIS; CHILDREN; AREA	Background Community-wide mass antibiotic treatment is a central component of trachoma control. The optimum frequency and duration of treatment are unknown. We measured the effect of mass treatment on the conjunctival burden of Chlamydia trachomatis in a Gambian community with low to medium trachoma prevalence and investigated the rate, route, and determinants of re-emergent infection. Methods 14 trachoma-endemic villages in rural Gambia were examined and conjunctival swabs obtained at baseline, 2, 6, 12, and 17 months. Mass antibiotic treatment with azithromycin was given to the community at baseline. C trachomatis was detected by qualitative PCR and individual infection load then estimated by real-time quantitative PCR. Findings C trachomatis was detected in 95 (7%) of 1319 individuals at baseline. Treatment coverage was 83% of the population (1328 of 1595 people). The effect of mass treatment was heterogeneous. In 12 villages all baseline infections (34 [3%] of 1062 individuals) resolved, and prevalence (three [0.3%]) and infection load remained low throughout the study. Two villages (baseline infection: 61 [24%] of 257 individuals) had increased infection 2 months after treatment (74 [30%]), after extensive contact with other untreated communities. Subsequently, this value reduced to less than half of that before treatment (25 [11%]). Interpretation Mass antibiotic treatment generally results in effective, longlasting control of C trachomatis in this environment. For low prevalence regions, one treatment episode might be sufficient. Infection can be reintroduced through contact with untreated populations. Communities need to be monitored for treatment failure and control measures implemented over wide geographical areas.	Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1E 7HT, England; MRC Labs, Fajara, Gambia; Natl Eye Care Programme, Banjul, Gambia; Johns Hopkins Univ, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA; Inst Ophthalmol, Div Epidemiol & Int Eye Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; Johns Hopkins University; University of London; University College London	Burton, MJ (corresponding author), Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Keppel St, London WC1E 7HT, England.	matthew.burton@lshtm.ac.uk	Holland, Martin J/K-6502-2012	Holland, Martin J/0000-0002-5828-6318; Mabey, David/0000-0002-0031-8276; Burton, Matthew/0000-0003-1872-9169; Foster, Allen/0000-0003-2368-4436	Medical Research Council [MC_U190081961] Funding Source: Medline; MRC [MC_U190081961] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bailey R, 1999, EPIDEMIOL INFECT, V123, P479, DOI 10.1017/S0950268899003076; BAILEY RL, 1993, LANCET, V342, P453, DOI 10.1016/0140-6736(93)91591-9; Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461; Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Burton MJ, 2003, INVEST OPHTH VIS SCI, V44, P4215, DOI 10.1167/iovs.03-0107; Dawson CR, 1981, GUIDE TRACHOMA CONTR; Dolin PJ, 1998, BRIT J OPHTHALMOL, V82, P930, DOI 10.1136/bjo.82.8.930; Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; Fraser-Hurt N, 2001, B WORLD HEALTH ORGAN, V79, P632; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Moalic E, 2000, PEDIATR INFECT DIS J, V19, P979, DOI 10.1097/00006454-200010000-00008; Munoz B, 2003, INVEST OPHTH VIS SCI, V44, P1464, DOI 10.1167/iovs.02-0234; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Smith A, 2001, Ophthalmic Epidemiol, V8, P127, DOI 10.1076/opep.8.2.127.4164; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; Sterne J., 1988, ESSENTIAL MED STAT; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; WARD M, 1990, SCAND J INFECT DIS, P137; WEST S, 1993, INVEST OPHTH VIS SCI, V34, P3194; WEST S, 1995, LANCET, V345, P155, DOI 10.1016/S0140-6736(95)90167-1; *WHO, 1997, WHOPBL9656; *WHO, 2001, 6 M WHO ALL GLOB EL	25	109	109	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2005	365	9467					1321	1328		10.1016/S0140-6736(05)61029-X	http://dx.doi.org/10.1016/S0140-6736(05)61029-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823382				2022-12-01	WOS:000228219600027
J	Dupont, S; Zacchigna, L; Cordenonsi, M; Soligo, S; Adorno, M; Rugge, M; Piccolo, S				Dupont, S; Zacchigna, L; Cordenonsi, M; Soligo, S; Adorno, M; Rugge, M; Piccolo, S			Germ-layer specification and control of cell growth by ectodermin, a Smad4 ubiquitin ligase	CELL			English	Article							TGF-BETA; COLORECTAL-CANCER; SPEMANNS ORGANIZER; TUMOR SUPPRESSORS; XENOPUS; MUTATIONS; INDUCTION; PATHWAY; GENE; BMP	TGF-beta signaling is essential for development and proliferative homeostasis. During embryogenesis, maternal determinants act in concert with TGF-beta signals to form mesoderm and endoderm. In contrast, ectoderm specification requires the TGF-beta response to be attenuated, although the mechanisms by which this is achieved remain unknown. In a functional screen for ectoderm determinants, we have identified Ecto-dermin (Ecto). In Xenopus embryos, Ecto is essential for the specification of the ectoderm and acts by restricting the mesoderm-inducing activity of TGF-beta signals to the mesoderm and favoring neural induction. Ecto is a RING-type ubiquitin ligase for Smad4, a TGF-beta signal transducer. Depletion of Ecto in human cells enforces TGF-beta-induced cytostasis and, moreover, plays a causal role in limiting the antimitogenic effects of Smad4 in tumor cells. We propose that Ectodermin is a key switch in the control of TGF-beta gene responses during early embryonic development and cell proliferation.	Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, I-35121 Padua, Italy; Univ Padua, Dept Oncol & Surg Sci, Pathol Sect, I-35121 Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua	Piccolo, S (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, I-35121 Padua, Italy.	piccolo@civ.bio.unipd.it	Cordenonsi, Michelangelo/K-7692-2016; Rugge, Massimo/K-7525-2016; Dupont, Sirio/AAP-8133-2021	Cordenonsi, Michelangelo/0000-0002-8253-5724; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004	Telethon [GGP04030] Funding Source: Medline	Telethon(Fondazione Telethon)		Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howell M, 1999, DEV BIOL, V214, P354, DOI 10.1006/dbio.1999.9430; LeSueur JA, 2002, DEV CELL, V2, P771, DOI 10.1016/S1534-5807(02)00172-7; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Takaku K, 1999, CANCER RES, V59, P6113; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wessely O, 2000, DEVELOPMENT, V127, P2053; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	32	256	276	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					87	99		10.1016/j.cell.2005.01.033	http://dx.doi.org/10.1016/j.cell.2005.01.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820681	Bronze			2022-12-01	WOS:000228348500012
J	King-Casas, B; Tomlin, D; Anen, C; Camerer, CF; Quartz, SR; Montague, PR				King-Casas, B; Tomlin, D; Anen, C; Camerer, CF; Quartz, SR; Montague, PR			Getting to know you: Reputation and trust in a two-person economic exchange	SCIENCE			English	Article							TEMPORAL DIFFERENCE MODELS; NEURAL BASIS; FMRI; COOPERATION; PREDICTION; EVOLUTION; STRIATUM; ERRORS; ROLES; BRAIN	Using a multiround version of an economic exchange (trust game), we report that reciprocity expressed by one player strongly predicts future trust expressed by their partner - a behavioral finding mirrored by neural responses in the dorsal striatum. Here, analyses within and between brains revealed two signals - one encoded by response magnitude, and the other by response timing. Response magnitude correlated with the "intention to trust" on the next play of the game, and the peak of these "intention to trust" responses shifted its time of occurrence by 14 seconds as player reputations developed. This temporal transfer resembles a similar shift of reward prediction errors common to reinforcement learning models, but in the context of a social exchange. These data extend previous model-based functional magnetic resonance imaging, studies into the social domain and broaden our view of the spectrum of functions implemented by the dorsal striatum.	Baylor Coll Med, Dept Neurosci, Human Neuroimaging Lab, Houston, TX 77030 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; CALTECH, Div Humanities & Social Sci 228 77, Social Cognit Neurosci Lab, Pasadena, CA 91125 USA	Baylor College of Medicine; Baylor College of Medicine; California Institute of Technology	Montague, PR (corresponding author), Baylor Coll Med, Dept Neurosci, Human Neuroimaging Lab, 1 Baylor Plaza, Houston, TX 77030 USA.	read@bcm.tmc.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723, R21DA014883] Funding Source: NIH RePORTER; NIDA NIH HHS [DA11723, DA14883] Funding Source: Medline; NIMH NIH HHS [MH52797] Funding Source: Medline; NINDS NIH HHS [NS045790] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; CAMERER CF, 2003, BEHAV GAME THEORY EX, P60; Coleman James S., 1990, FDN SOCIAL THEORY, P177; Dayan P., 2001, THEORETICAL NEUROSCI; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; DICKINSON A, 2002, STEVENS HDB EXPT PSY, V3, P26; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; FEHR E, 1993, Q J ECON, V108, P437, DOI 10.2307/2118338; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Johnson PA, 2003, J NEUROPSYCH CLIN N, V15, P397, DOI 10.1176/appi.neuropsych.15.4.397; Lee KH, 2004, PSYCHOL MED, V34, P391, DOI 10.1017/S0033291703001284; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; OREILLY RC, 1999, WMODELS WORKING MEMO, P375; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Rachlin H, 2002, BEHAV BRAIN SCI, V25, P239, DOI 10.1017/S0140525X02000055; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	32	797	827	14	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					78	83		10.1126/science.1108062	http://dx.doi.org/10.1126/science.1108062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914IQ	15802598	Green Published			2022-12-01	WOS:000228221500036
J	Poole, JH; Tyack, PL; Stoeger-Horwath, AS; Watwood, S				Poole, JH; Tyack, PL; Stoeger-Horwath, AS; Watwood, S			Elephants are capable of vocal learning	NATURE			English	Editorial Material							AFRICAN ELEPHANTS		Amboseli Trust Elephants, ElephantVoices, Nairobi, Kenya; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Univ Vienna, Inst Zool, A-1090 Vienna, Austria	Woods Hole Oceanographic Institution; University of Vienna	Poole, JH (corresponding author), Amboseli Trust Elephants, ElephantVoices, POB 15135,Langata 00509, Nairobi, Kenya.	ptyack@whoi.edu	Watwood, Stephanie/AAE-7191-2019; Tyack, Peter/AAC-4513-2019; Tyack, Peter L/D-6209-2013	Tyack, Peter/0000-0002-8409-4790; Tyack, Peter L/0000-0002-8409-4790; Stoeger, Angela S/0000-0002-6714-8291				GARSTANG M, 1995, J EXP BIOL, V198, P939; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Tyack PL, 2003, ANIMAL SOCIAL COMPLEXITY, P342	7	171	175	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					455	456		10.1038/434455a	http://dx.doi.org/10.1038/434455a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791244				2022-12-01	WOS:000227836000029
J	Duan, NH				Duan, NH			Listening to consumers and HIV vaccine preparedness	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; TRIAL; AIDS; SWITZERLAND; RISK; IF		Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Duan, NH (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	naihua@mednet.ucla.edu		Duan, Naihua/0000-0001-9411-2924				[Anonymous], 1995, MARKETING SOCIAL CHA; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; CELENTANO DD, 1995, AIDS, V9, P1079, DOI 10.1097/00002030-199509000-00015; Chang ML, 2003, AIDS, V17, pW1, DOI [10.1097/01.aids.0000076356.20434.a0, 10.1097/00002030-200310170-00025]; Dubois-Arber F, 1999, AIDS, V13, P2571, DOI 10.1097/00002030-199912240-00011; DUBOIS-ARBER F, 1988, World Health Forum, V9, P376; DuboisArber F, 1997, AM J PUBLIC HEALTH, V87, P558, DOI 10.2105/AJPH.87.4.558; Esparza J, 2002, VACCINE, V20, P1897, DOI 10.1016/S0264-410X(02)00062-2; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; Newman PA, 2004, AIDS PATIENT CARE ST, V18, P691, DOI 10.1089/apc.2004.18.691; Newman PA, 2004, JAIDS-J ACQ IMM DEF, V37, P1393, DOI 10.1097/01.qai.0000127064.84325.ad; Streefland PH, 2003, VACCINE, V21, P1304, DOI 10.1016/S0264-410X(02)00685-0; Tucker T, 2003, LANCET, V362, P995, DOI 10.1016/S0140-6736(03)14374-7; Urban G. L., 1993, DESIGN MARKETING NEW; WOODS DR, 1991, PUBLIC HEALTH REP, V106, P616; Zimet GD, 1999, J PEDIATR PSYCHOL, V24, P67, DOI 10.1093/jpepsy/24.1.67; [No title captured]	18	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2005	365	9465					1119	1121		10.1016/S0140-6736(05)71857-2	http://dx.doi.org/10.1016/S0140-6736(05)71857-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	910DD	15794955				2022-12-01	WOS:000227909500008
J	Pfander, B; Moldovan, GL; Sacher, M; Hoege, C; Jentsch, S				Pfander, B; Moldovan, GL; Sacher, M; Hoege, C; Jentsch, S			SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase	NATURE			English	Article							DAMAGE-INDUCED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; DNA HELICASE; POSTREPLICATION REPAIR; UBIQUITIN CONJUGATION; RAD6 PATHWAY; YEAST; REPLICATION; MUTANTS; PROTEIN	Damaged DNA, if not repaired before replication, can lead to replication fork stalling and genomic instability(1-3); however, cells can switch to different damage bypass modes that permit replication across lesions. Two main bypasses are controlled by ubiquitin modification of proliferating cell nuclear antigen ( PCNA), a homotrimeric DNA-encircling protein that functions as a polymerase processivity factor and regulator of replication-linked functions(4,5). Upon DNA damage, PCNA is modified at the conserved lysine residue 164 by either mono-ubiquitin or a lysine-63-linked multi-ubiquitin chain(5), which induce error-prone or error-free replication bypasses of the lesions(5,6). In S phase, even in the absence of exogenous DNA damage, yeast PCNA can be alternatively modified by the small ubiquitin-related modifier protein SUMO5; however the consequences of this remain controversial(5-7). Here we show by genetic analysis that SUMO-modified PCNA functionally cooperates with Srs2, a helicase that blocks recombinational repair by disrupting Rad51 nucleoprotein filaments(8,9). Moreover, Srs2 displays a preference for interacting directly with the SUMO-modified form of PCNA, owing to a specific binding site in its carboxy-terminal tail. Our finding suggests a model in which SUMO-modified PCNA recruits Srs2 in S phase in order to prevent unwanted recombination events of replicating chromosomes.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Pfander, Boris/A-8703-2013	George-Lucian, Moldovan/0000-0003-3825-149X; Pfander, Boris/0000-0003-2180-5054				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; AGUILERA A, 1988, GENETICS, V119, P779; Aylon Y, 2004, MUTAT RES-REV MUTAT, V566, P231, DOI 10.1016/j.mrrev.2003.10.001; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; PALLADINO F, 1992, GENETICS, V132, P23; RONG L, 1993, J BIOL CHEM, V268, P1252; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SCHIESTL RH, 1990, GENETICS, V124, P817; Smirnova M, 2003, MUTAT RES-FUND MOL M, V532, P117, DOI 10.1016/j.mrfmmm.2003.08.026; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	28	462	478	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					428	433		10.1038/nature03665	http://dx.doi.org/10.1038/nature03665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	15931174				2022-12-01	WOS:000230623400050
J	de Oliveira, AM; White, KL; Leschinsky, DP; Beecham, BD; Vogt, TM; Moolenaar, RL; Perz, JF; Safranek, TJ				de Oliveira, AM; White, KL; Leschinsky, DP; Beecham, BD; Vogt, TM; Moolenaar, RL; Perz, JF; Safranek, TJ			An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; TRANSMISSION	Background: Approximately 2.7 million persons in the United States have chronic hepatitis C virus (HCV) infection. Health care-associated HCV transmission can occur if aseptic technique is not followed. The authors suspected a health care-associated HCV outbreak after the report of 4 HCV infections among patients at the same hematology/oncology clinic. Objective: To determine the extent and mechanism of HCV transmission among clinic patients. Design: Epidemiologic analysis through a cohort study. Setting: Hematology/oncology clinic in eastern Nebraska. Participants: Patients who visited the clinic from March 2000 through December 2001. Measurements: HCV infection status, relevant medical history, and clinic-associated exposures. Bivariate analysis and logistic regression were used to identify risk factors for HCV infection. Results: Of 613 clinic patients contacted, 494 (81%) underwent HCV testing. The authors documented infection in 99 patients who lacked previous evidence of HCV infection; all had begun treatment at the clinic before July 2001. Hepatitis C virus genotype 3a was present in all 95 genotyped samples and presumably originated from a patient with chronic hepatitis C who began treatment in March 2000. Infection with HCV was statistically significantly associated with receipt of saline flushes (P < 0.001). Shared saline bags were probably contaminated when syringes used to draw blood from venous catheters were reused to withdraw saline solution. The clinic corrected this procedure in July 2001. Limitation: The delay between outbreak and investigation (> 1 year) may have contributed to an underestimate of cases. Conclusions: This large health care-associated HCV outbreak was related to shared saline bags contaminated through syringe reuse. Effective infection-control programs are needed to ensure high standards of care in outpatient care facilities, such as hematology/oncology clinics.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; Nebraska Hlth & Human Serv Syst, Lincoln, NE USA	Centers for Disease Control & Prevention - USA	de Oliveira, AM (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway,MS F-22, Atlanta, GA 30341 USA.	acq7@cdc.gov						Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bruguera M, 2002, J CLIN MICROBIOL, V40, P4363, DOI 10.1128/JCM.40.11.4363-4366.2002; CHIARELLO LA, 2001, SEMIN INFECT CONTROL, V1, P44; Delarocque-Astagneau E, 2002, INFECT CONT HOSP EP, V23, P328, DOI 10.1086/502060; Desenclos JC, 2001, INFECT CONT HOSP EP, V22, P701, DOI 10.1086/501849; Esteban JI, 1996, NEW ENGL J MED, V334, P555, DOI 10.1056/NEJM199602293340902; Garner JS, 1996, INFECT CONT HOSP EP, V17, P54, DOI 10.1017/S0195941700006123; Herwaldt LA, 1998, INFECT CONT HOSP EP, V19, P41; Jarvis WR, 2001, EMERG INFECT DIS, V7, P170, DOI 10.3201/eid0702.010202; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Nguyen GT, 2000, AM J INFECT CONTROL, V28, P392, DOI 10.1067/mic.2000.110298; Widell A, 1999, ANN INTERN MED, V130, P130, DOI 10.7326/0003-4819-130-2-199901190-00007; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; 2001, EMERG INFECT DIS, V7, P170; 1998, MMWR MORB MORTAL REC, V47, P1; 2003, MMWR MORB MORTAL WKL, V52, P901; 1992, MMWR MORB MORAL WKLY, V41, P783	19	67	68	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					898	902		10.7326/0003-4819-142-11-200506070-00007	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941696				2022-12-01	WOS:000229556300003
J	Chesebro, B; Trifilo, M; Race, R; Meade-White, K; Teng, C; LaCasse, R; Raymond, L; Favara, C; Baron, G; Priola, S; Caughey, B; Masliah, E; Oldstone, M				Chesebro, B; Trifilo, M; Race, R; Meade-White, K; Teng, C; LaCasse, R; Raymond, L; Favara, C; Baron, G; Priola, S; Caughey, B; Masliah, E; Oldstone, M			Anchorless prion protein results in infectious amyloid disease without clinical scrapie	SCIENCE			English	Article							CELL-FREE FORMATION; SPONGIFORM ENCEPHALOPATHIES; PRECURSOR PROTEIN; NEURONAL PRP; MICE; RESISTANT; BRAIN; CONVERSION; PATHOLOGY; PLAQUES	In prion and Alzheimer's diseases, the roles played by amyloid versus nonamyloid deposits in brain damage remain unresolved. In scrapie-infected transgenic mice expressing prion protein (PrP) lacking the glycosylphosphatidylinositol (GPI) membrane anchor, abnormal protease-resistant PrPres was deposited as amyloid plaques, rather than the usual nonamyloid form of PrPres. Although PrPres amyloid plaques induced brain damage reminiscent of Alzheimer's disease, clinical manifestations were minimal. In contrast, combined expression of anchorless and wild-type PrP produced accelerated clinical scrapie. Thus, the PrP GPI anchor may play a role in the pathogenesis of prion diseases.	NIAID, Rocky Mt Labs, Lab Persistent Viral Dis, Hamilton, MT 59840 USA; Scripps Res Inst, Dept Neuropharmacol, Div Virol, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Chesebro, B (corresponding author), NIAID, Rocky Mt Labs, Lab Persistent Viral Dis, Hamilton, MT 59840 USA.	bchesebro@niaid.nih.gov			NIA NIH HHS [AG004342] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000752, Z01AI000580, Z01AI000265, ZIAAI000752, ZIAAI000580, ZIAAI000937, Z01AI000937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CHANDLER RL, 1961, LANCET, V1, P1378; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1973, LANCET, V1, P617; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Masliah E, 1996, J NEUROSCI, V16, P5795; Masliah E, 2001, J NEUROPATH EXP NEUR, V60, P357, DOI 10.1093/jnen/60.4.357; McBride PA, 1998, EXP NEUROL, V149, P447, DOI 10.1006/exnr.1997.6740; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Rall GF, 1997, P NATL ACAD SCI USA, V94, P4659, DOI 10.1073/pnas.94.9.4659; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; SNOW AD, 1989, ACTA NEUROPATHOL, V77, P337, DOI 10.1007/BF00687367; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	40	494	507	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2005	308	5727					1435	1439		10.1126/science.1110837	http://dx.doi.org/10.1126/science.1110837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933194				2022-12-01	WOS:000229619300044
J	King-Jones, K; Charles, JP; Lam, G; Thummel, CS				King-Jones, K; Charles, JP; Lam, G; Thummel, CS			The ecdysone-induced DHR4 orphan nuclear receptor coordinates growth and maturation in Drosophila	CELL			English	Article							STEROID-HORMONE ECDYSONE; DNA-BINDING PROPERTIES; MANDUCA-SEXTA L; TOBACCO HORNWORM; GENE-EXPRESSION; INDUCIBLE GENE; BROAD-COMPLEX; BODY-SIZE; FAT-BODY; MOLECULAR ANALYSIS	A critical determinant of insect body size is the time at which the larva stops feeding and initiates wandering in preparation for metamorphosis. No genes have been identified that regulate growth by contributing to this key developmental decision to terminate feeding. We show here that mutations in the DHR4 orphan nuclear receptor result in larvae that precociously leave the food to form premature prepupae, resulting in abbreviated larval development that translates directly into smaller and lighter animals. In addition, we show that DHR4 plays a central role in the genetic cascades triggered by the steroid hormone ecdysone at the onset of metamorphosis, acting as both a repressor of the early ecdysone-induced regulatory genes and an inducer of the beta FTZ-Fl midprepupal competence factor. We propose that DHR4 coordinates growth and maturation in Drosophila by mediating endocrine responses to the attainment of critical weight during larval development.	Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Bourgogne 1, CNRS, UMR 5548, Fac Sci Gabriel, F-21000 Dijon, France	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Thummel, CS (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, 15 N 2030 E Room 5100, Salt Lake City, UT 84112 USA.	carl.thummel@genetics.utah.edu	CHARLES, jean-philippe/Q-2427-2017	CHARLES, jean-philippe/0000-0001-7285-5532				ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Ashburner M, 1974, Cold Spring Harb Symp Quant Biol, V38, P655; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; Britton JS, 1998, DEVELOPMENT, V125, P2149; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; CARROLL SB, 1987, DNA CLONING, P89; Charles JP, 1999, EUR J BIOCHEM, V266, P181, DOI 10.1046/j.1432-1327.1999.00842.x; Chen JH, 2002, INSECT BIOCHEM MOLEC, V32, P657, DOI 10.1016/S0965-1748(01)00144-8; CLEVER U, 1964, SCIENCE, V146, P794, DOI 10.1126/science.146.3645.794; Crossgrove K, 1996, DEV BIOL, V180, P745, DOI 10.1006/dbio.1996.0343; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; DIBELLO PR, 1991, GENETICS, V129, P385; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Hiruma K, 2001, DEV BIOL, V232, P265, DOI 10.1006/dbio.2001.0165; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Kageyama Y, 1997, GENES CELLS, V2, P559, DOI 10.1046/j.1365-2443.1997.1460344.x; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; KISS I, 1988, GENETICS, V118, P247; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Lam GT, 1997, DEVELOPMENT, V124, P1757; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; MARONI G, 1983, DROS INFORM SERV, V59, P142; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; RESTIFO LL, 1992, ROUX ARCH DEV BIOL, V201, P221, DOI 10.1007/BF00188753; Riddiford LM, 2001, VITAM HORM, V60, P1; Riddiford Lynn M., 1993, P899; ROUNTREE DB, 1986, J EXP BIOL, V120, P41; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Sokolowski MB, 2003, NEURON, V39, P6, DOI 10.1016/S0896-6273(03)00398-2; Stern D, 2003, CURR BIOL, V13, pR267, DOI 10.1016/S0960-9822(03)00197-0; Stern DL, 1999, DEVELOPMENT, V126, P1091; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Urness LD, 1995, EMBO J, V14, P6239, DOI 10.1002/j.1460-2075.1995.tb00314.x; Weller J, 2001, INSECT BIOCHEM MOLEC, V31, P827, DOI 10.1016/S0965-1748(00)00188-0; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; WOODARD CT, 1994, CELL, V79, P607, DOI 10.1016/0092-8674(94)90546-0; Yamada M, 2000, DEVELOPMENT, V127, P5083; Zinke I, 1999, DEVELOPMENT, V126, P5275	50	82	88	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					773	784		10.1016/j.cell.2005.03.030	http://dx.doi.org/10.1016/j.cell.2005.03.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935763	Bronze			2022-12-01	WOS:000229658000015
J	Tian, F; Toon, OB; Pavlov, AA; De Sterck, H				Tian, F; Toon, OB; Pavlov, AA; De Sterck, H			A hydrogen-rich early Earth atmosphere	SCIENCE			English	Article							NONTHERMAL ESCAPE; PHOTOCHEMISTRY; FORMALDEHYDE; OXIDATION; ORIGIN; WATER; LIFE; SUN; HCN; CO2	We show that the escape of hydrogen from early Earth's atmosphere likely occurred at rates slower by two orders of magnitude than previously thought. The balance between slow hydrogen escape and volcanic outgassing could have maintained a hydrogen. mixing ratio of more than 30%. The production of prebiotic organic compounds in such an atmosphere would have been more efficient than either exogenous delivery or synthesis in hydrothermal systems. The organic soup in the oceans and ponds on early Earth would have been a more favorable place for the origin of life than previously thought.	Univ Colorado, Astrophys & Planetary Sci Dept, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Colorado, Program Atmospher & Ocean Sci, Boulder, CO 80309 USA; Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Waterloo	Tian, F (corresponding author), Univ Colorado, Astrophys & Planetary Sci Dept, Boulder, CO 80309 USA.	tian@colorado.edu	Tian, Feng/C-1344-2015; Pavlov, Alexander A./F-3779-2012	Tian, Feng/0000-0002-9607-560X; Pavlov, Alexander A./0000-0001-8771-1646; De Sterck, Hans/0000-0002-1641-932X				ABELSON PH, 1966, P NATL ACAD SCI USA, V55, P1365, DOI 10.1073/pnas.55.6.1365; Anbar AD, 2001, J GEOPHYS RES-PLANET, V106, P3219, DOI 10.1029/2000JE001272; CANUTO VM, 1983, NATURE, V305, P281, DOI 10.1038/305281a0; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; CHYBA CF, 1997, COMETS ORIGIN EVOLUT, P00147, DOI DOI 10.1002/2017JE005406; de Pater I, 2001, PLANETARY SCI, P66; Delano JW, 2001, ORIGINS LIFE EVOL B, V31, P311, DOI 10.1023/A:1011895600380; Dobson CM, 2000, P NATL ACAD SCI USA, V97, P11864, DOI 10.1073/pnas.200366897; DORREN JD, 1994, ASTROPHYS J, V428, P805, DOI 10.1086/174289; Ehrenfreund P, 2002, REP PROG PHYS, V65, P1427, DOI 10.1088/0034-4885/65/10/202; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; HUNTEN DM, 1982, PLANET SPACE SCI, V30, P773, DOI 10.1016/0032-0633(82)90110-6; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KUMAR S, 1983, ICARUS, V55, P369, DOI 10.1016/0019-1035(83)90109-4; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; LOVE SG, 1993, SCIENCE, V262, P550, DOI 10.1126/science.262.5133.550; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Pavlov AA, 2001, GEOLOGY, V29, P1003, DOI 10.1130/0091-7613(2001)029<1003:OHIESE>2.0.CO;2; Pierazzo E, 1999, METEORIT PLANET SCI, V34, P909, DOI 10.1111/j.1945-5100.1999.tb01409.x; PINTO JP, 1980, SCIENCE, V210, P183, DOI 10.1126/science.210.4466.183; Ryder G, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001583; SCHLESINGER G, 1983, J MOL EVOL, V19, P376, DOI 10.1007/BF02101642; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; TURCOTTE DL, 1980, EARTH PLANET SC LETT, V48, P53, DOI 10.1016/0012-821X(80)90169-7; Walker J. C. G., 1977, EVOLUTION ATMOSPHERE; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZUILEN MA, 2002, NATURE, V418, P627	29	278	295	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1014	1017		10.1126/science.1106983	http://dx.doi.org/10.1126/science.1106983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15817816				2022-12-01	WOS:000229190700044
J	Korkegian, A; Black, ME; Baker, D; Stoddard, BL				Korkegian, A; Black, ME; Baker, D; Stoddard, BL			Computational thermostabilization of an enzyme	SCIENCE			English	Article							PROTEIN DESIGN; CYTOSINE DEAMINASE; GENE-THERAPY; STABILITY; YEAST; SPECIFICITY; SEQUENCES; RECEPTOR; CANCER; ANALOG	Thermostabilizing an enzyme while maintaining its activity for industrial or biomedical applications can be difficult with traditional selection methods. We describe a rapid computational approach that identified three mutations within a model enzyme that produced a 10 degrees C increase in apparent melting temperature T(m) and a 30-fold increase in half-life at 50 degrees C, with no reduction in catalytic efficiency. The effects of the mutations were synergistic, giving an increase in excess of the sum of their individual effects. The redesigned enzyme induced an increased, temperature-dependent bacterial growth rate under conditions that required its activity, thereby coupling molecular and metabolic engineering.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Pullman, WA 99164 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington State University	Stoddard, BL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bstoddar@fhcrc.org	Black, Margaret/I-2957-2015; Baker, David/K-8941-2012	Black, Margaret/0000-0002-3152-5112; Baker, David/0000-0001-7896-6217	NCI NIH HHS [R01 CA097328, R01 CA085939, CA85939, CA97328] Funding Source: Medline; NIGMS NIH HHS [T32-GM08268, GM59224, T32 GM008268, GM49857, R01 GM049857, R01 GM059224] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085939, R01CA097328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268, R01GM059224] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benson DE, 2002, BIOCHEMISTRY-US, V41, P3262, DOI 10.1021/bi011359i; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Black ME, 2001, GENET ENG P, V23, P113; Dahiyat BI, 1999, CURR OPIN BIOTECH, V10, P387, DOI 10.1016/S0958-1669(99)80070-6; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Eidsness MK, 1997, BIOCHEMISTRY-US, V36, P10406, DOI 10.1021/bi970110r; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Gordon DB, 1999, CURR OPIN STRUC BIOL, V9, P509, DOI 10.1016/S0959-440X(99)80072-4; Greco O, 2001, J CELL PHYSIOL, V187, P22, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H; Hubbard S., 1993, NACCESS DEP BIOCH MO; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; KATSURAGI T, 1989, AGR BIOL CHEM TOKYO, V53, P1313, DOI 10.1080/00021369.1989.10869490; Kievit E, 1999, CANCER RES, V59, P1417; KORKEGIAN A, UNPUB; Kraemer-Pecore CM, 2001, CURR OPIN CHEM BIOL, V5, P690, DOI 10.1016/S1367-5931(01)00267-8; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Luo P, 2002, PROTEIN SCI, V11, P1218, DOI 10.1110/ps.4580102; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mendes J, 2002, CURR OPIN STRUC BIOL, V12, P441, DOI 10.1016/S0959-440X(02)00345-7; REES DC, 1995, STRUCTURE, V3, P251, DOI 10.1016/S0969-2126(01)00155-1; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530	35	282	306	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					857	860		10.1126/science.1107387	http://dx.doi.org/10.1126/science.1107387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879217	Green Accepted			2022-12-01	WOS:000228986500049
J	Meier, T; Polzer, P; Diederichs, K; Welte, W; Dimroth, P				Meier, T; Polzer, P; Diederichs, K; Welte, W; Dimroth, P			Structure of the rotor ring of F-type Na+-ATPase from Ilyobacter tartaricus	SCIENCE			English	Article							ESCHERICHIA-COLI; SUBUNIT C; MOLECULAR ARCHITECTURE; ROTARY MOTOR; O MOTOR; SYNTHASE; ROTATION; MECHANISM; SELECTIVITY; GENERATION	In the crystal structure of the membrane-embedded rotor ring of the sodium ion-translocating adenosine 5'-triphosphate (ATP) synthase of llyobacter tartaricus at 2.4 angstrom resolution, 11 c subunits are assembled into an hourglass-shaped cylinder with 11-fold symmetry. Sodium ions are bound in a locked conformation close to the outer surface of the cylinder near the middle of the membrane. The structure supports an ion-translocation mechanism in the intact ATP synthase in which the binding site converts from the locked conformation into one that opens toward subunit a as the rotor ring moves through the subunit a/c interface.	Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; ETH, Inst Mikrobiol, CH-8093 Zurich, Switzerland	University of Konstanz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Diederichs, K (corresponding author), Univ Konstanz, Fachbereich Biol, M656, D-78457 Constance, Germany.	kay.diederichs@uni-konstanz.de; dimroth@micro.biol.ethz.ch						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2003, STRUCTURE, V11, P1469, DOI 10.1016/j.str.2003.11.011; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; KAIM G, 1993, EUR J BIOCHEM, V218, P937, DOI 10.1111/j.1432-1033.1993.tb18450.x; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.bb.20.060191.001411; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Wehrle F, 2002, J MOL BIOL, V322, P369, DOI 10.1016/S0022-2836(02)00731-3; Xing JH, 2004, BIOPHYS J, V87, P2148, DOI 10.1529/biophysj.104.042093	34	316	326	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					659	662		10.1126/science.1111199	http://dx.doi.org/10.1126/science.1111199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860619	Green Submitted			2022-12-01	WOS:000228810900039
J	James, C; Ugo, V; Le Couedic, JP; Staerk, J; Delhommeau, F; Lacout, C; Garcon, L; Raslova, H; Berger, R; Bennaceur-Griscelli, A; Villeval, JL; Constantinescu, SN; Casadevall, N; Vainchenker, W				James, C; Ugo, V; Le Couedic, JP; Staerk, J; Delhommeau, F; Lacout, C; Garcon, L; Raslova, H; Berger, R; Bennaceur-Griscelli, A; Villeval, JL; Constantinescu, SN; Casadevall, N; Vainchenker, W			A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera	NATURE			English	Article							ERYTHROID PROGENITORS; PSEUDOKINASE DOMAIN; TYROSINE KINASE; T-CELL; ERYTHROPOIETIN; EXPRESSION; LEUKEMIA; JANUS-KINASE-2; INTERFERON; RESPONSES	Myeloproliferative disorders are clonal haematopoietic stem cell malignancies characterized by independency or hypersensitivity of haematopoietic progenitors to numerous cytokines(1,2). The molecular basis of most myeloproliferative disorders is unknown. On the basis of the model of chronic myeloid leukaemia, it is expected that a constitutive tyrosine kinase activity could be at the origin of these diseases. Polycythaemia vera is an acquired myeloproliferative disorder, characterized by the presence of polycythaemia diversely associated with thrombocytosis, leukocytosis and splenomegaly(3). Polycythaemia vera progenitors are hypersensitive to erythropoietin and other cytokines(4,5). Here, we describe a clonal and recurrent mutation in the JH2 pseudo-kinase domain of the Janus kinase 2 (JAK2) gene in most (>80%) polycythaemia vera patients. The mutation, a valine-to-phenylalanine substitution at amino acid position 617, leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity and induces erythrocytosis in a mouse model. As this mutation is also found in other myeloproliferative disorders, this unique mutation will permit a new molecular classification of these disorders and novel therapeutical approaches.	Univ Paris 11, Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France; CHU Brest, Hematol Lab, F-29609 Brest, France; Hop Hotel Dieu, Hematol Lab, F-75181 Paris, France; Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; Catholic Univ Louvain, MEXP Unit, B-1200 Brussels, Belgium; Hop Necker Enfants Malad, INSERM, E0210, F-75743 Paris, France; Inst Gustave Roussy, Hematol Lab, F-94805 Villejuif, France; Hop St Louis, Polyclin Hematol, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Brest; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Vainchenker, W (corresponding author), Univ Paris 11, Inst Gustave Roussy, INSERM, U362, PR1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	verpre@igr.fr	Constantinescu, Stefan N/E-5277-2012; Raslova, Hana/N-3562-2018; james, chloe/A-2015-2012	Raslova, Hana/0000-0001-8846-5299; Villeval, Jean-Luc/0000-0002-0562-925X; Vainchenker, William/0000-0003-4705-202X; Ugo, Valerie/0000-0002-4678-2138; bennaceur griscelli, annelise/0000-0002-3557-4499; Constantinescu, Stefan N./0000-0002-8599-2699; Staerk, Judith/0000-0001-8698-6998; Delhommeau, Francois/0000-0002-4915-0734; James, Chloe/0000-0001-9553-2701				Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; CASADEVALL N, 1982, BLOOD, V59, P447; Chagraoui C, 2003, BLOOD, V101, P2983, DOI 10.1182/blood-2002-09-2839; Cools J, 1999, CYTOGENET CELL GENET, V85, P260, DOI 10.1159/000015308; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kralovics R, 2003, BLOOD, V102, P3793, DOI 10.1182/blood-2003-03-0885; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; LECONIAT M, 1995, GENE CHROMOSOME CANC, V14, P204; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Pearson TC, 1996, LEUKEMIA LYMPHOMA, V22, P87; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Prchal JT, 2005, CURR OPIN HEMATOL, V12, P112, DOI 10.1097/01.moh.0000154029.05396.d2; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Spivak JL, 2004, SEMIN HEMATOL, V41, P1, DOI 10.1053/j.seminhematol.2004.02.011; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Zhao SM, 2002, EMBO J, V21, P2159, DOI 10.1093/emboj/21.9.2159	27	2621	2882	0	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1144	1148		10.1038/nature03546	http://dx.doi.org/10.1038/nature03546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15793561				2022-12-01	WOS:000228693300046
J	Tilley, SJ; Orlova, EV; Gilbert, RJC; Andrew, PW; Saibil, HR				Tilley, SJ; Orlova, EV; Gilbert, RJC; Andrew, PW; Saibil, HR			Structural basis of pore formation by the bacterial toxin pneumolysin	CELL			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PERFRINGOLYSIN-O; CLOSTRIDIUM-PERFRINGENS; THETA-TOXIN; TRYPTOPHAN RESIDUES; MEMBRANE INSERTION; PREPORE COMPLEX; STREPTOLYSIN-O; FORMING TOXIN; BINDING	The bacterial toxin pneumolysin is released as a soluble monomer that kills target cells by assembling into large oligomeric rings and forming pores in cholesterol-containing membranes. Using cryo-EM and image processing, we have determined the structures of membrane-surface bound (prepore) and inserted-pore oligomer forms, providing a direct observation of the conformational transition into the pore form of a cholesterol-dependent cytolysin. In the pore structure, the domains of the monomer separate and double over into an arch, forming a wall sealing the bilayer around the pore. This transformation is accomplished by substantial refolding of two of the four protein domains along with deformation of the membrane. Extension of protein density into the bilayer supports earlier predictions that the protein inserts beta hairpins into the membrane. With an oligomer size of up to 44 subunits in the pore, this assembly creates a transmembrane channel 260 angstrom in diameter lined by 176 beta strands.	Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Univ London Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England; Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Ctr Mol Sci, Cent Chem Lab, Oxford OX1 3QU, England; Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of London; Birkbeck University London; University of London; Birkbeck University London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Leicester	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Sch Crystallog, Malet St, London WC1E 7HX, England.	h.saibil@mail.cryst.bbk.ac.uk	Orlova, Elena/CAF-8290-2022; Andrew, Peter W/G-7526-2012	Orlova, Elena/0000-0003-3371-415X	Biotechnology and Biological Sciences Research Council [B13531] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexander JE, 1998, MICROB PATHOGENESIS, V24, P167, DOI 10.1006/mpat.1997.0185; Alouf JE, 2000, INT J MED MICROBIOL, V290, P351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1998, J MOL BIOL, V284, P1223, DOI 10.1006/jmbi.1998.2258; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; HILL J, 1994, INFECT IMMUN, V62, P757, DOI 10.1128/IAI.62.2.757-758.1994; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Jacobs T, 1998, MOL MICROBIOL, V28, P1081, DOI 10.1046/j.1365-2958.1998.00858.x; Korchev YE, 1998, BIOCHEM J, V329, P571; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; MITCHELL TJ, 1992, ZBL BAKT, V23, P429; MORGAN PJ, 1995, FEBS LETT, V371, P77, DOI 10.1016/0014-5793(95)00887-F; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nakamura M, 1998, J BIOCHEM, V123, P1145; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; OHNOIWASHITA Y, 1988, EUR J BIOCHEM, V176, P95, DOI 10.1111/j.1432-1033.1988.tb14255.x; OLOFSSON A, 1993, FEBS LETT, V319, P125, DOI 10.1016/0014-5793(93)80050-5; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Palmer M, 2001, TOXICON, V39, P1681, DOI 10.1016/S0041-0101(01)00155-6; PATON JC, 1984, INFECT IMMUN, V43, P1085, DOI 10.1128/IAI.43.3.1085-1087.1984; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; SekinoSuzuki N, 1996, EUR J BIOCHEM, V241, P941, DOI 10.1111/j.1432-1033.1996.00941.x; SEKIYA K, 1993, J BACTERIOL, V175, P5953, DOI 10.1128/JB.175.18.5953-5961.1993; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015	40	315	326	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					247	256		10.1016/j.cell.2005.02.033	http://dx.doi.org/10.1016/j.cell.2005.02.033			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851031	Bronze			2022-12-01	WOS:000228705000012
J	Duraisingh, MT; Voss, TS; Marty, AJ; Duffy, MF; Good, RT; Thompson, JK; Freitas-Junior, LH; Scherf, A; Crabb, BS; Cowman, AF				Duraisingh, MT; Voss, TS; Marty, AJ; Duffy, MF; Good, RT; Thompson, JK; Freitas-Junior, LH; Scherf, A; Crabb, BS; Cowman, AF			Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium faiciparum	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ANTIGENIC VARIATION; HUMAN ERYTHROCYTES; FALCIPARUM; EXPRESSION; MALARIA; ORGANIZATION; PROTEINS; RECOMBINATION; TRANSCRIPTION	The malaria parasite Plasmodium falciparum undergoes antigenic variation to evade host immune responses through switching expression of variant surface proteins encoded by the var gene family. We demonstrate that both a subtelomeric transgene and var genes are subject to reversible gene silencing. Var gene silencing involves the SIR complex as gene disruption of PfSIR2 results in activation of this gene family. We also demonstrate that perinuclear gene activation involves chromatin alterations and repositioning into a location that may be permissive for transcription. Together, this implies that locus repositioning and heterochromatic silencing play important roles in the epigenetic regulation of virulence genes in P. falciparum.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; Inst Pasteur, Paris, France; Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; Monash University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	crabb@wehi.edu.au	Scherf, Artur/A-9674-2014; Cowman, Alan F/C-7642-2013; Crabb, Brendan/F-5287-2013; Duffy, Michael/A-8618-2012; Freitas-Junior, Lucio H/C-8677-2011; Jackson, Allison/D-6528-2012	Cowman, Alan F/0000-0001-5145-9004; Duffy, Michael/0000-0001-5635-4033; Freitas-Junior, Lucio H/0000-0002-8904-7897; Jackson, Allison/0000-0002-9614-6471; Scherf, Artur/0000-0003-2411-3328				Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; ASLUND L, 1985, J MOL BIOL, V185, P509, DOI 10.1016/0022-2836(85)90067-1; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; DUFFY MF, 2005, IN PRESS MOL MICROB; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Ersfeld K, 1998, CHROMOSOMA, V107, P237, DOI 10.1007/s004120050302; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Figueiredo LM, 2000, MOL BIOCHEM PARASIT, V106, P169, DOI 10.1016/S0166-6851(99)00199-1; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.3.CO;2-4; HENIKOFF S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P1; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TELFORD DJ, 1989, INT J BIOCHEM, V21, P127, DOI 10.1016/0020-711X(89)90100-6; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x	38	361	369	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					13	24		10.1016/j.cell.2005.01.036	http://dx.doi.org/10.1016/j.cell.2005.01.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820675	Bronze			2022-12-01	WOS:000228348500006
J	Marquardt, T; Shirasaki, R; Ghosh, S; Andrews, SE; Carter, N; Hunter, T; Pfaff, SL				Marquardt, T; Shirasaki, R; Ghosh, S; Andrews, SE; Carter, N; Hunter, T; Pfaff, SL			Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains	CELL			English	Article							MOTOR-NEURONS; AXON GUIDANCE; LIPID RAFTS; INTERMEDIATE TARGET; TYROSINE KINASES; FAMILY; MECHANISMS; MORPHOGENESIS; EXPRESSION; REQUIRES	Contact-dependent signaling between membrane-linked ligands and receptors such as the ephrins and Eph receptor tyrosine kinases controls a wide range of developmental and pathological processes. Paradoxically, many cell types coexpress both ligands and receptors, raising the question of how specific signaling readouts are achieved under these conditions. Here, we studied the signaling activities exerted by coexpressed EphA receptors and GPI-linked ephrin-A ligands in spinal motor neuron growth cones. We demonstrate that coexpressed Eph and ephrin proteins segregate laterally into distinct membrane domains from which they signal opposing effects on the growth cone: EphAs direct growth cone collapse/repulsion and ephrin-As signal motor axon growth/attraction. This subcellular arrangement of Eph-ephrin proteins enables axons to discriminate between cis- versus trans-configurations of ligand/receptor proteins, thereby allowing the utilization of both Ephs and ephrins as functional guidance receptors within the same neuronal growth cone.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu		Ghosh, Sourav/0000-0001-5990-8708	NCI NIH HHS [CA82683] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082683] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Kamiguchi H, 2000, CURR OPIN CELL BIOL, V12, P598, DOI 10.1016/S0955-0674(00)00138-1; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Knoll B, 2001, DEVELOPMENT, V128, P895; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lemke G, 1997, MOL CELL NEUROSCI, V9, P331, DOI 10.1006/mcne.1997.0630; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	44	193	197	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					127	139		10.1016/j.cell.2005.01.020	http://dx.doi.org/10.1016/j.cell.2005.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820684	Bronze			2022-12-01	WOS:000228348500015
J	Goldenberg, NA; Jacobson, L; Manco-Johnson, MJ				Goldenberg, NA; Jacobson, L; Manco-Johnson, MJ			Brief communication: Duration of platelet dysfunction after a 1-day course of ibuprofen	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTION ANALYZER; BLEEDING-TIME; BLOOD-LOSS; ASPIRIN; PFA-100(TM); VOLUNTEERS; DRUGS	Background: Despite a paucity of evidence, clinicians routinely advise that patients discontinue using nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, at least 1 week before most surgical procedures. Objective: To define the duration of ibuprofen-induced platelet dysfunction. Design: Prospective cohort study. Setting: Denver/Aurora, Colorado. Participants: 11 healthy adult volunteers. Measurements: individuals were tested at baseline and serially after completion of a 7-day course of ibuprofen (600 mg orally every 8 hours). The platelet function analyzer (PFA-100, Dade Behring, Newark, Delaware, a test that has replaced the bleeding time in many clinical settings, was used. Results: All participants exhibited normal platelet function before starting ibuprofen. Platelet dysfunction was apparent after completion of the ibuprofen course in 7 of the 11 participants and normalized by 24 hours after the last ibuprofen dose. Limitations: The sample size in this study was small, and no participants had a major illness. Correlation between PFA-100 results and clinical bleeding has not been established. Conclusions: Platelet function seems to normalize within 24 hours after cessation of regular ibuprofen use in healthy individuals. Further studies are warranted to provide a rational basis for timing of NSAID withdrawal in a range of patients undergoing surgery.	Univ Colorado, Hlth Sci Ctr, Mt States Hemophilia & Thrombosis Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Goldenberg, NA (corresponding author), Univ Colorado, Hlth Sci Ctr, Mt States Hemophilia & Thrombosis Ctr, POB 6507,Mail Stop F416, Aurora, CO 80045 USA.	neil.goidenberg@uchsc.edu						FERRARIS VA, 1983, SURG GYNECOL OBSTET, V156, P439; FERRARIS VA, 1988, ANN THORAC SURG, V45, P71, DOI 10.1016/S0003-4975(10)62401-0; Fressinaud E, 1998, BLOOD, V91, P1325, DOI 10.1182/blood.V91.4.1325; *I CLIN SYST IMPR, 2003, HLTH CAR GUID PREOP; Kadakia SC, 1996, GASTROINTEST ENDOSC, V44, P309, DOI 10.1016/S0016-5107(96)70170-0; Knijff-Dutmer EAJ, 2003, QJM-INT J MED, V96, P513, DOI 10.1093/qjmed/hcg090; KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106; Leese PT, 2000, J CLIN PHARMACOL, V40, P124, DOI 10.1177/00912700022008766; Leese PT, 2002, AM J EMERG MED, V20, P275, DOI 10.1053/ajem.2002.32635; Mammen EF, 1998, SEMIN THROMB HEMOST, V24, P195, DOI 10.1055/s-2007-995840; Munsterhjelm E, 2003, BRIT J ANAESTH, V91, P357, DOI 10.1093/bja/aeg195; NADELL J, 1974, J CLIN PHARMACOL, V14, P176, DOI 10.1002/j.1552-4604.1974.tb01395.x; Peterson P, 1998, ARCH SURG-CHICAGO, V133, P134, DOI 10.1001/archsurg.133.2.134; Schafer AI, 2003, CIRCULATION, V108, P910, DOI 10.1161/01.CIR.0000088843.52678.8A; Sonksen JR, 1999, BRIT J ANAESTH, V82, P360, DOI 10.1093/bja/82.3.360; Spell NO, 2001, MED CLIN N AM, V85, P1117, DOI 10.1016/S0025-7125(05)70367-9; TOROSIAN M, 1978, ANN INTERN MED, V89, P325, DOI 10.7326/0003-4819-89-3-325; Wuillemin WA, 2002, SWISS MED WKLY, V132, P443	18	56	59	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2005	142	7					506	509		10.7326/0003-4819-142-7-200504050-00009	http://dx.doi.org/10.7326/0003-4819-142-7-200504050-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913QL	15809462				2022-12-01	WOS:000228167800004
J	Fenton, KA; Mercer, CH; McManus, S; Erens, B; Wellings, K; Macdowall, W; Byron, CL; Copas, AJ; Nanchahal, K; Field, J; Johnson, AM				Fenton, KA; Mercer, CH; McManus, S; Erens, B; Wellings, K; Macdowall, W; Byron, CL; Copas, AJ; Nanchahal, K; Field, J; Johnson, AM			Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey	LANCET			English	Article							HIV TRANSMISSION; GONORRHEA; LONDON; RACE; EPIDEMIOLOGY; PARTNERSHIPS; CHLAMYDIA; EDUCATION; PATTERNS; HEALTH	Background Ethnic variations in the rate of diagnosed sexually transmitted infections (STIs) have been reported in many developed countries. We used data from the second British National Survey of Sexual Attitudes and Lifestyles (Natsal 2000) to investigate the frequency of high-risk sexual behaviours and, adverse sexual health outcomes in five ethnic groups in Great Britain. Methods We did a stratified probability sample survey of 11161 men and women aged 16-44 years, resident in Great Britain, using computer-assisted interviews. Additional sampling enabled us to do more detailed analyses for 949 black Caribbean, black African, Indian, and Pakistani respondents. We used logistic regression to assess reporting of STI diagnoses in the past 5 years, after controlling for demographic and behavioural variables. Findings We rioted striking variations in number of sexual partnerships by ethnic group and between men and women. Reported numbers of sexual partnerships in a lifetime were highest in black Caribbean (median 9 [IQR 4-20]) and black African (9 [3-20]) men, and in white (5 [2-9]) and black Caribbean (4 [2-7]) women. Indian and Pakistani men and women reported fewer sexual partnerships, later first intercourse, and substantially lower prevalence of diagnosed STIs than did other groups. We recorded a significant association between ethnic origin and reported STIs in the past 5 years with increased risk in sexually active black Caribbean (OR 2.74 [95% CI 1.22-6.15]) and black African (2.95 [1.45-5.99]) men compared with white men, and black Caribbean (2.41 [1.35-4.28]) women compared with white women. odds ratios changed little after controlling for age, number of sexual partnerships, homosexual and overseas partnerships, and condom use at last sexual intercourse. Interpretation Individual sexual behaviour is a key determinant of STI transmission risk, but alone does not explain the varying risk across ethnic groups. Our findings suggest a need for targeted and culturally competent prevention interventions.	UCL, Ctr Sexual Hlth & HIV Res, Dept Primary Care & Populat Sci, London, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, HIV & STI Dept, London, England; Natl Ctr Social Res, London, England; London Sch Hyg & Trop Med, Ctr Sexual & Reprod Hlth Res, London WC1, England	University of London; University College London; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine	Fenton, KA (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, HIV & Sexually Transmitted Infect Dept, London NW9 5EQ, England.	Kevin.fenton@hpa.org.uk	McManus, Sally/S-4697-2019	McManus, Sally/0000-0003-2711-0819; Mercer, Catherine/0000-0002-4220-5034; Erens, Bob/0000-0002-4430-954X; Nanchahal, Kiran/0000-0001-8812-7628; Johnson, Anne/0000-0003-1330-7100; Erens, Robert/0000-0002-3054-504X; Copas, Andrew/0000-0001-8968-5963; Macdowall, Wendy/0000-0001-5868-8336				Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415; Buzi RS, 1998, ADOLESCENCE, V33, P313; CHINOUYA M, 2000, SEXUAL ATTITUDES LIF; Choi KH, 2003, AIDS EDUC PREV, V15, P53, DOI 10.1521/aeap.15.1.5.53.23609; Cliffe S, 1999, Ethn Health, V4, P5; Copas AJ, 1997, AIDS, V11, P783, DOI 10.1097/00002030-199706000-00011; Department of Health, 2001, NAT STRAT SEX HLTH H, P1; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Elam G., 1999, EXPLORING ETHNICITY, P1; Erens B, 2001, NATL SURVEY SEXUAL A; Fenton K, 1997, BRIT MED J, V314, P1703, DOI 10.1136/bmj.314.7096.1703; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Fenton KA, 2001, AIDS, V15, P1442, DOI 10.1097/00002030-200107270-00017; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; HOLMES KK, 1984, UROL CLIN N AM, V11, P3; HOOYKAAS C, 1991, GENITOURIN MED, V67, P378; Hughes G, 2001, SEX TRANSM DIS, V28, P379, DOI 10.1097/00007435-200107000-00004; *ISD SCIEH HLTH PR, 2003, REN FOC HIV OTH SEX; JAMES NJ, 1991, AIDS, V5, P333, DOI 10.1097/00002030-199103000-00016; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 1994, SEXUAL ATTITUDES LIF; Jonsson M, 1997, INT J STD AIDS, V8, P501, DOI 10.1258/0956462971920659; Lacey CJN, 1997, BRIT MED J, V314, P1715, DOI 10.1136/bmj.314.7096.1715; LAUMANN EO, 2000, SEX TRANSM DIS, V26, P264; Low N, 2001, SEX TRANSM INFECT, V77, P15, DOI 10.1136/sti.77.1.15; Low N, 1997, BRIT MED J, V314, P1719, DOI 10.1136/bmj.314.7096.1719; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; McFarlane M, 1999, J ADOLESCENT HEALTH, V25, P199, DOI 10.1016/S1054-139X(98)00156-6; *OFF NAT STAT, 2000, POP EST 1999; Rogstad KE, 2004, BRIT MED J, V329, P214, DOI 10.1136/bmj.329.7459.214; Ross MW, 1998, SEX TRANSM INFECT, V74, P2; Santelli JS, 2000, AM J PUBLIC HEALTH, V90, P1582, DOI 10.2105/AJPH.90.10.1582; Sinka K, 2003, AIDS, V17, P1683, DOI 10.1097/00002030-200307250-00013; STATA, 2001, STAT STAT SOFTW REL; Stephenson JM, 2003, CONTROL CLIN TRIALS, V24, P643, DOI 10.1016/S0197-2456(03)00070-9; THOMAS JC, 2000, SOC SCI MED, V49, P1084; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; Wight D, 2002, BMJ-BRIT MED J, V324, P1430, DOI 10.1136/bmj.324.7351.1430; Williams DR, 2002, AM J PUBLIC HEALTH, V92, P588, DOI 10.2105/AJPH.92.4.588	40	122	122	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1246	1255		10.1016/S0140-6736(05)74813-3	http://dx.doi.org/10.1016/S0140-6736(05)74813-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	912VI	15811458				2022-12-01	WOS:000228107600028
J	Baines, CP; Kaiser, RA; Purcell, NH; Blair, NS; Osinska, H; Hambleton, MA; Brunskill, EW; Sayen, MR; Gottlieb, RA; Dorn, GW; Robbins, J; Molkentin, JD				Baines, CP; Kaiser, RA; Purcell, NH; Blair, NS; Osinska, H; Hambleton, MA; Brunskill, EW; Sayen, MR; Gottlieb, RA; Dorn, GW; Robbins, J; Molkentin, JD			Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death	NATURE			English	Article							CYTOCHROME-C RELEASE; CYCLOSPORINE-A; LETHAL INJURY; PORE COMPLEX; BAX; APOPTOSIS; ISCHEMIA; TRANSLOCATOR; HEPATOCYTES; ACTIVATION	Mitochondria play a critical role in mediating both apoptotic and necrotic cell death. The mitochondrial permeability transition (mPT) leads to mitochondrial swelling, outer membrane rupture and the release of apoptotic mediators. The mPT pore is thought to consist of the adenine nucleotide translocator, a voltage-dependent anion channel, and cyclophilin D (the Ppif gene product), a prolyl isomerase located within the mitochondrial matrix(1,2). Here we generated mice lacking Ppif and mice overexpressing cyclophilin D in the heart. Ppif null mice are protected from ischaemia/reperfusion-induced cell death in vivo, whereas cyclophilin D-overexpressing mice show mitochondrial swelling and spontaneous cell death. Mitochondria isolated from the livers, hearts and brains of Ppif null mice are resistant to mitochondrial swelling and permeability transition in vitro. Moreover, primary hepatocytes and fibroblasts isolated from Ppif null mice are largely protected from Ca2+-overload and oxidative stress-induced cell death. However, Bcl-2 family member-induced cell death does not depend on cyclophilin D, and Ppif null fibroblasts are not protected from staurosporine or tumour-necrosis factor-alpha-induced death. Thus, cyclophilin D and the mitochondrial permeability transition are required for mediating Ca2+-and oxidative damage-induced cell death, but not Bcl-2 family member-regulated death.	Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Mol Genet, Cincinnati, OH 45229 USA; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Med, Cincinnati, OH 45229 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Scripps Research Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529; Gottlieb, Roberta/0000-0002-1432-006X; Baines, Christopher/0000-0002-4473-3869				Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Crompton M, 2003, CURR MED CHEM, V10, P1473, DOI 10.2174/0929867033457197; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; IMBERTI R, 1993, J PHARMACOL EXP THER, V265, P392; Kagawa S, 2000, GENE THER, V7, P75, DOI 10.1038/sj.gt.3301048; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030	27	1730	1791	7	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					658	662		10.1038/nature03434	http://dx.doi.org/10.1038/nature03434			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800627				2022-12-01	WOS:000228011000048
J	Oelschlaegel, T; Schwickart, M; Matos, J; Bogdanova, A; Camasses, A; Havlis, J; Shevchenko, A; Zachariae, W				Oelschlaegel, T; Schwickart, M; Matos, J; Bogdanova, A; Camasses, A; Havlis, J; Shevchenko, A; Zachariae, W			The yeast APC/C subunit Mnd2 prevents premature sister chromatid separation triggered by the meiosis-specific APC/C-Ama1	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; CHROMOSOME SEGREGATION; FISSION YEAST; CENTROMERIC COHESION; SPORE FORMATION; PROTEIN FAMILY; KINASE CDC5; CLEAVAGE; MITOSIS; PROTEOLYSIS	Cohesion established between sister chromatids during pre-meiotic DNA replication mediates two rounds of chromosome segregation. The first division is preceded by an extended prophase wherein homologous chromosomes undergo recombination. The persistence of cohesion during prophase is essential for recombination and both meiotic divisions. Here we show that Mnd2, a subunit of the anaphase-promoting complex (APC/C) from budding yeast, is essential to prevent premature destruction of cohesion in meiosis. During S- and prophase, Mnd2 prevents activation of the APC/C by a melosis-specific activator called Ama1. In cells lacking Mnd2 the APC/C-Ama1 enzyme triggers degradation of Pds1, which causes premature sister chromatid separation due to unrestrained separase activity. In vitro, Mnd2 inhibits ubiquitination of Pds1 by APC/C-Ama1 but not by other APC/C holo-enzymes. We conclude that chromosome segregation in meiosis depends on the selective inhibition of a meiosis-specific form of the APC/C.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Zachariae, W (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	Zachariae@mpi-cbg.de; Zachariae@mpi-cbg.de	Havlis, Jan/AAC-9525-2019; Havliš, Jan/D-9508-2012; Matos, Joao/C-1488-2014	Havlis, Jan/0000-0001-7822-2023; Havliš, Jan/0000-0001-7822-2023; Matos, Joao/0000-0002-3754-3709				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blanco MA, 2001, J CELL SCI, V114, P2135; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Chu T, 2001, GENESIS, V29, P141, DOI 10.1002/gene.1017; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jacobs HW, 2002, CURR BIOL, V12, P1435, DOI 10.1016/S0960-9822(02)01074-6; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1985, GENETICS, V110, P187; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe Y, 2004, J CELL SCI, V117, P4017, DOI 10.1242/jcs.01352; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	51	69	73	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					773	788		10.1016/j.cell.2005.01.032	http://dx.doi.org/10.1016/j.cell.2005.01.032			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797379	Bronze			2022-12-01	WOS:000228067500008
J	Cliffe, LJ; Humphreys, NE; Lane, TE; Potten, CS; Booth, C; Grencis, RK				Cliffe, LJ; Humphreys, NE; Lane, TE; Potten, CS; Booth, C; Grencis, RK			Accelerated intestinal epithelial cell turnover: A new mechanism of parasite expulsion	SCIENCE			English	Article							TRICHURIS-MURIS; INFECTION; RESISTANCE; IL-13; MICE	The functional integrity of the intestinal epithelial barrier forms a major defense against invading pathogens, including gastrointestinal-dwelting nematodes, which are ubiquitous in their distribution worldwide. Here, we show that an increase in the rate of epithelial. cell turnover in the large intestine acts like an "epithelia[ escalator" to expel Trichuris and that the rate of epithelial cell movement is under immune control by the cytokine interieukin-13 and the chemokine CXCL10. This host protective mechanism against intestinal pathogens has implications for our wider understanding of the multifunctional role played by intestinal epithelium in mucosal defense.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Epistem Ltd, Manchester M13 9XX, Lancs, England	University of Manchester; University of California System; University of California Irvine	Grencis, RK (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	Richard.K.Grencis@manchester.ac.uk	Eckhardt, Erik/G-1567-2010		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 1999, EXP PARASITOL, V92, P144, DOI 10.1006/expr.1999.4407; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Bancroft AJ, 1998, J IMMUNOL, V160, P3453; Betts CJ, 1999, PARASITE IMMUNOL, V21, P45, DOI 10.1046/j.1365-3024.1999.00200.x; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Koyama K, 2002, PARASITE IMMUNOL, V24, P527, DOI 10.1046/j.1365-3024.2002.00497.x; LEE TDG, 1983, INT J PARASITOL, V13, P349, DOI 10.1016/S0020-7519(83)80039-3; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; Montresor A, 2002, HELMINTH CONTROL SCH; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1	12	307	315	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1463	1465		10.1126/science.1108661	http://dx.doi.org/10.1126/science.1108661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933199				2022-12-01	WOS:000229619300052
J	Mahawar, KK				Mahawar, KK			Misguided enthusiasm	LANCET			English	Editorial Material									Arrowe Pk Hosp, Wirral CH49 5PE, Merseyside, England		Mahawar, KK (corresponding author), Arrowe Pk Hosp, Wirral CH49 5PE, Merseyside, England.	kamal_mahawat@hotmail.com	Mahawar, Kamal/L-1884-2019	Mahawar, Kamal/0000-0003-2551-3462					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2005	365	9474					1901	1901		10.1016/S0140-6736(05)66624-X	http://dx.doi.org/10.1016/S0140-6736(05)66624-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931JK	15924989				2022-12-01	WOS:000229481400031
J	Ward, H; Cassell, J; Williams, S; Aylin, P				Ward, H; Cassell, J; Williams, S; Aylin, P			Dr Foster's case notes - Hospital indicators of poor sexual health	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Ward, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Ward, Helen/A-1836-2009; Aylin, Paul/A-1073-2014	Ward, Helen/0000-0001-8238-5036; Aylin, Paul/0000-0003-4589-1743; Cassell, Jackie/0000-0003-0777-0385				Department of Health, 2004, CHOOS HLTH MAK HLTH; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P204, DOI 10.1111/j.1471-0528.2001.00037.x; 2004, FOCUS PREVENTION HIV	4	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1173	+		10.1136/bmj.330.7501.1173	http://dx.doi.org/10.1136/bmj.330.7501.1173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15905255	Green Published			2022-12-01	WOS:000229320500014
J	Charras, GT; Yarrow, JC; Horton, MA; Mahadevan, L; Mitchison, TJ				Charras, GT; Yarrow, JC; Horton, MA; Mahadevan, L; Mitchison, TJ			Non-equilibration of hydrostatic pressure in blebbing cells	NATURE			English	Article							MEMBRANE; EXTENSION; MIGRATION; MOTILITY; KINASE; FLOW	Current models for protrusive motility in animal cells focus on cytoskeleton-based mechanisms, where localized protrusion is driven by local regulation of actin biochemistry(1-3). In plants and fungi, protrusion is driven primarily by hydrostatic pressure(4-6). For hydrostatic pressure to drive localized protrusion in animal cells(7,8), it would have to be locally regulated, but current models treating cytoplasm as an incompressible viscoelastic continuum(9) or viscous liquid(10) require that hydrostatic pressure equilibrates essentially instantaneously over the whole cell. Here, we use cell blebs as reporters of local pressure in the cytoplasm. When we locally perfuse blebbing cells with cortex-relaxing drugs to dissipate pressure on one side, blebbing continues on the untreated side, implying non-equilibration of pressure on scales of approximately 10 mu m and 10 s. We can account for localization of pressure by considering the cytoplasm as a contractile, elastic network infiltrated by cytosol. Motion of the fluid relative to the network generates spatially heterogeneous transients in the pressure field, and can be described in the framework of poroelasticity(11,12).	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; UCL, London Ctr Nanotechnol, London WC1E 6JF, England; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of London; University College London; Harvard University; Harvard University	Charras, GT (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	gcharras@hms.harvard.edu	Charras, Guillaume/F-8571-2014	Charras, Guillaume/0000-0002-7902-0279	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048027] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM048027] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBRECHTBUEHLER G, 1981, COLD SPRING HARB SYM, V46, P45; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Boal D., 2002, MECH CELL; Burton K, 1997, NATURE, V385, P450, DOI 10.1038/385450a0; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Drury JL, 1999, BIOPHYS J, V76, P110, DOI 10.1016/S0006-3495(99)77183-3; EVANS E, 1984, J CELL BIOL, V98, P1201, DOI 10.1083/jcb.98.4.1201; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Harold FM, 2002, FUNGAL GENET BIOL, V37, P271, DOI 10.1016/S1087-1845(02)00528-5; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; Messerli MA, 2003, PLANTA, V217, P147, DOI 10.1007/s00425-003-0972-0; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; MONEY NP, 1992, P NATL ACAD SCI USA, V89, P4245, DOI 10.1073/pnas.89.10.4245; O'Connell CB, 2001, CURR BIOL, V11, P702, DOI 10.1016/S0960-9822(01)00181-6; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Takayama S, 2003, CHEM BIOL, V10, P123, DOI 10.1016/S1074-5521(03)00019-X; TILNEY LG, 1985, J CELL BIOL, V100, P1273, DOI 10.1083/jcb.100.4.1273; TRINKAUS JP, 1973, DEV BIOL, V30, P68, DOI 10.1016/0012-1606(73)90049-3; Wang HF, 2000, PRI SER GEO; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	29	455	467	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					365	369		10.1038/nature03550	http://dx.doi.org/10.1038/nature03550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902261	Green Accepted			2022-12-01	WOS:000229185000049
J	Pop, VJ; Vulsma, T				Pop, VJ; Vulsma, T			Maternal hypothyroxinaemia during (early) gestation	LANCET			English	Editorial Material							SUBCLINICAL THYROID-DYSFUNCTION; CLINICAL ENDOCRINOLOGISTS; AMERICAN ASSOCIATION; JOINT STATEMENT; FOLLOW-UP; PREGNANCY; DEFICIENCY; MANAGEMENT; DISORDERS		Tilburg Univ, Dept Clin Hlth Psychol, NL-5000 LE Tilburg, Netherlands; Univ Amsterdam, Emma Childrens Hosp AMC, Dept Paediat Endocrinol, Amsterdam, Netherlands	Tilburg University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Pop, VJ (corresponding author), Tilburg Univ, Dept Clin Hlth Psychol, NL-5000 LE Tilburg, Netherlands.	v.j.m.pop@uvt.nl						de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Mandel SJ, 2005, THYROID, V15, P44, DOI 10.1089/thy.2005.15.44; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Utiger RD, 1999, NEW ENGL J MED, V341, P601, DOI 10.1056/NEJM199908193410809; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vermiglio F, 2004, J CLIN ENDOCR METAB, V89, P6054, DOI 10.1210/jc.2004-0571; ZIMMERMANN M, 2005, P WHO TECHN CONS CON	10	33	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1604	1606		10.1016/S0140-6736(05)66489-6	http://dx.doi.org/10.1016/S0140-6736(05)66489-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885283	Green Submitted			2022-12-01	WOS:000228933700008
J	Schellenberg, D; Menendez, C; Aponte, JJ; Kahigwa, E; Tanner, M; Mshinda, H; Alonso, P				Schellenberg, D; Menendez, C; Aponte, JJ; Kahigwa, E; Tanner, M; Mshinda, H; Alonso, P			Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial	LANCET			English	Article							MALARIA	Stopping antimalarial chemoprophylaxis can be followed by increased risk of malaria, suggesting that it interferes with the development of antimalarial immunity. We report analysis of extended follow-up until age 2 years of a randomised, placebo-controlled double-blind trial of intermittent preventive antimalarial treatment in infants. The rate of clinical malaria (events per person-year at risk, starting 1 month after final dose of intermittent treatment) was 0.28 in the sulfadoxine-pyrimethamine group and 0.43 in the placebo group (protective effect 36%, 95% Cl 11-53). Intermittent treatment produced a sustained reduction in the risk of clinical malaria extending well beyond the duration of the pharmacological effects of the drugs, excluding a so-called rebound effect and suggesting that such treatment could facilitate development of immunity against Plasmodium falciparum.	Hosp Clin Barcelona, IDIBAPS, Ctr Int Hlth, Barcelona, Spain; Ifakara Hlth Res & Dev Ctr, Kilombero, Tanzania; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Swiss Trop Inst, CH-4002 Basel, Switzerland	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute	Schellenberg, D (corresponding author), IHRDC, POB 78373, Dar Es Salaam, Tanzania.	dmschellenberg@aol.com	Alonso, Pedro L/AAZ-3645-2020; Menéndez, Clara/Q-3446-2016	Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Schellenberg, David/0000-0001-8222-0186				Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; 1999, COMPENDIUM DATA SHEE	7	122	124	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1481	1483		10.1016/S0140-6736(05)66418-5	http://dx.doi.org/10.1016/S0140-6736(05)66418-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850632				2022-12-01	WOS:000228651600026
J	Adolfsson, J; Mansson, R; Buza-Vidas, N; Hultquist, A; Liuba, K; Jensen, CT; Bryder, D; Yang, LP; Borge, OJ; Thoren, LAM; Anderson, K; Sitnicka, E; Sasaki, Y; Sigvardsson, M; Jacobsen, SEW				Adolfsson, J; Mansson, R; Buza-Vidas, N; Hultquist, A; Liuba, K; Jensen, CT; Bryder, D; Yang, LP; Borge, OJ; Thoren, LAM; Anderson, K; Sitnicka, E; Sasaki, Y; Sigvardsson, M; Jacobsen, SEW			Identification of Flt3(+) lympho-myeloid stem cells lacking erythro-megakaryocytic potential: A revised road map for adult blood lineage commitment	CELL			English	Article							HEMATOPOIETIC PROGENITOR CELLS; MOUSE BONE-MARROW; SELF-RENEWAL; B-CELL; TRANSCRIPTION FACTORS; REPOPULATING ACTIVITY; DENDRITIC CELLS; DEFICIENT MICE; FETAL LIVER; IN-VITRO	All blood cell lineages derive from a common hematopoietic stem cell (HSC). The current model implicates that the first lineage commitment step of adult pluripotent HSCs results in a strict separation into common lymphoid and common myeloid precursors. We present evidence for a population of cells which, although sustaining a high proliferative and combined lympho-myeloid differentiation potential, have lost the ability to adopt erythroid and megakaryocyte lineage fates. Cells in the Lin-Sca-1+c-kit+ HSC compartment coexpressing high levels of the tyrosine kinase receptor Flt3 sustain granulocyte, monocyte, and B and T cell potentials but in contrast to Lin-Sca-1(+)ckit(+)Flt3(-) HSCs fail to produce significant erythroid and megakaryocytic progeny. This distinct lineage restriction site is accompanied by downregulation of genes for regulators of erythroid and megakaryocyte development. In agreement with representing a lymphoid primed progenitor, Lin(-)Sca-l(+)c-kit(+)CD34(+)Flt3(+) cells display upregulated IL-7 receptor gene expression. Based on these observations, we propose a revised road map for adult blood lineage development.	Lund Univ, Hematopoiet Stem Cell Lab, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden	Lund University	Jacobsen, SEW (corresponding author), Lund Univ, Hematopoiet Stem Cell Lab, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Bryder, David/Q-6292-2019; Jacobsen, Sten Eirik W/D-3974-2018; Mansson, Robert/D-4372-2014	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Mansson, Robert/0000-0003-0738-0328; Sigvardsson, Mikael/0000-0001-8527-7276; Bryder, David/0000-0002-8761-4237; Hultquist, Anne/0000-0003-4355-230X				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Ema H, 2003, CURR OPIN GENET DEV, V13, P508, DOI 10.1016/j.gde.2003.08.011; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; KEMPF RA, 1980, INT J RADIAT ONCOL, V6, P252, DOI 10.1016/0360-3016(80)90047-4; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; METCALF D, 1993, BLOOD, V82, P3515; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; OGAWA M, 1993, BLOOD, V81, P2844; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Veiby OP, 1996, BLOOD, V88, P1256, DOI 10.1182/blood.V88.4.1256.bloodjournal8841256; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; WHITNEY JB, 1978, BIOCH GENET, V271, P67; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	54	871	890	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					295	306		10.1016/j.cell.2005.02.013	http://dx.doi.org/10.1016/j.cell.2005.02.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851035	Bronze			2022-12-01	WOS:000228705000016
J	Almond, CSD; Shin, AY; Fortescue, EB; Mannix, RC; Wypij, D; Binstadt, BA; Duncan, CN; Olson, DP; Salerno, AE; Newburger, JW; Greenes, DS				Almond, CSD; Shin, AY; Fortescue, EB; Mannix, RC; Wypij, D; Binstadt, BA; Duncan, CN; Olson, DP; Salerno, AE; Newburger, JW; Greenes, DS			Hyponatremia among runners in the Boston Marathon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY-EDEMA; EXERCISE; ILLNESS	Background Hyponatremia has emerged as an important cause of race-related death and life-threatening illness among marathon runners. We studied a cohort of marathon runners to estimate the incidence of hyponatremia and to identify the principal risk factors. Methods Participants in the 2002 Boston Marathon were recruited one or two days before the race. Subjects completed a survey describing demographic information and training history. After the race, runners provided a blood sample and completed a questionnaire detailing their fluid consumption and urine output during the race. Prerace and postrace weights were recorded. Multivariate regression analyses were performed to identify risk factors associated with hyponatremia. Results Of 766 runners enrolled, 488 runners (64 percent) provided a usable blood sample at the finish line. Thirteen percent had hyponatremia (a serum sodium concentration of 135 mmol per liter or less); 0.6 percent had critical hyponatremia (120 mmol per liter or less). On univariate analyses, hyponatremia was associated with substantial weight gain, consumption of more than 3 liters of fluids during the race, consumption of fluids every mile, a racing time of >4:00 hours, female sex, and low body-mass index. On multivariate analysis, hyponatremia was associated with weight gain (odds ratio, 4.2; 95 percent confidence interval, 2.2 to 8.2), a racing time of >4:00 hours (odds ratio for the comparison with a time of <3:30 hours, 7.4; 95 percent confidence interval, 2.9 to 23.1), and body-mass-index extremes. Conclusions Hyponatremia occurs in a substantial fraction of nonelite marathon runners and can be severe. Considerable weight gain while running, a long racing time, and body-mass-index extremes were associated with hyponatremia, whereas female sex, composition of fluids ingested, and use of nonsteroidal antiinflammatory drugs were not.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Clin Res Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Almond, CSD (corresponding author), Childrens Hosp, Dept Cardiol, Bader 2,300 Longwood Ave, Boston, MA 02115 USA.	christopher.almond@childrens.harvard.edu	Hug, Balthasar L./G-1568-2010; Binstadt, Bryce/N-1305-2013; Mannix, Rebekah/AAD-8702-2020	Binstadt, Bryce/0000-0003-3127-3856; Mannix, Rebekah/0000-0003-3608-2792; Wypij, David/0000-0001-8367-8711	NCRR NIH HHS [RR-02172] Funding Source: Medline; NHLBI NIH HHS [T32 HL007572] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ayus JC, 2000, ANN INTERN MED, V132, P711, DOI 10.7326/0003-4819-132-9-200005020-00005; Backer HD, 1999, AM J EMERG MED, V17, P532, DOI 10.1016/S0735-6757(99)90191-2; CASA DJ, 2003, PROPER HYDRATION DIS; Davis DP, 2001, J EMERG MED, V21, P47, DOI 10.1016/S0736-4679(01)00320-1; FRIZZELL RT, 1986, JAMA-J AM MED ASSOC, V255, P772, DOI 10.1001/jama.255.6.772; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; Hastie TJ, 1990, GEN ADDITIVE MODELS; Hew TD, 2003, CLIN J SPORT MED, V13, P41, DOI 10.1097/00042752-200301000-00008; HILLMAN M, CLOSE CALL HYPONATRE; Hsieh M, 2002, MED SCI SPORT EXER, V34, P185, DOI 10.1097/00005768-200202000-00001; IRVING RA, 1991, J APPL PHYSIOL, V70, P342, DOI 10.1152/jappl.1991.70.1.342; NEARMAN S, 2002, WASHINGTON TIME 1030; Noakes T, 2003, CLIN J SPORT MED, V13, P309, DOI 10.1097/00042752-200309000-00007; NOAKES TD, 1990, MED SCI SPORT EXER, V22, P165; Noakes TD, 2003, BRIT MED J, V327, P113, DOI 10.1136/bmj.327.7407.113; NOALES TD, 2004, BRIT J SPORT MED, V38, pE16; O'Brien KK, 2001, MIL MED, V166, P405, DOI 10.1093/milmed/166.5.405; Roberts WO, 2000, MED SCI SPORT EXER, V32, P1549; SMITH S, 2002, NY TIMES        0813; Speedy D B, 2001, Emerg Med (Fremantle), V13, P17, DOI 10.1046/j.1442-2026.2001.00173.x; Speedy DB, 1999, MED SCI SPORT EXER, V31, P809, DOI 10.1097/00005768-199906000-00008; Steinberg D., 2003, WASH POST, pA1; *TRACK FIELD RUNN, RUNN US; YOUNG M, 1987, AM REV RESPIR DIS, V136, P737, DOI 10.1164/ajrccm/136.3.737	24	349	357	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1550	1556		10.1056/NEJMoa043901	http://dx.doi.org/10.1056/NEJMoa043901			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915SH	15829535				2022-12-01	WOS:000228324200007
J	Robinson, DA; Kearns, AM; Holmes, A; Morrison, D; Grundmann, H; Edwards, G; O'Brien, FG; Tenover, FC; McDougal, LK; Monk, AB; Enright, MC				Robinson, DA; Kearns, AM; Holmes, A; Morrison, D; Grundmann, H; Edwards, G; O'Brien, FG; Tenover, FC; McDougal, LK; Monk, AB; Enright, MC			Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone	LANCET			English	Article							PANTON-VALENTINE LEUKOCIDIN; EMERGENCE; STRAINS	During the 1950s, the notorious penicillin-resistant clone of Staphylococcus aureus known as phage type 80/81 emerged and caused serious hospital-acquired and community-acquired infections worldwide. This clone was largely eliminated in the 1960s, concurrent with the widespread use of penicillinase-resistant beta lactams. We investigated whether early 80/81 isolates had the genes for Panton-Valentine leucocidin, a toxin associated with virulence in healthy young people. Multilocus sequence analysis suggested that descendants of 80/81 have acquired meticillin resistance, are re-emerging as a community-acquired meticillin-resistant S aureus (MRSA) clone, and represent a sister lineage to pandemic hospital-acquired MRSA.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Hlth Protect Agcy, Lab Healthcare Associated Infect, Specialist & Reference Microbiol Div, London, England; Stobhill Hosp, Dept Microbiol, Scottish MRSA Reference Lab, Glasgow, Lanark, Scotland; Natl Inst Publ Hlth & Environm, RIVM, Dept Infect Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands; Curtin Univ Technol, Sch Biomed Sci, Perth, WA 6001, Australia; Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA	University of Bath; Health Protection Agency; Netherlands National Institute for Public Health & the Environment; Curtin University; Centers for Disease Control & Prevention - USA	Enright, MC (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	m.c.enright@bath.ac.uk		Enright, Mark/0000-0001-5273-8750				DONAHUE JA, 1966, J INFECT DIS, V116, P324, DOI 10.1093/infdis/116.3.324; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; ROUNTREE Phyllis M., 1958, Medical Journal of Australia, V2, P789; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978	5	199	206	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1256	1258		10.1016/S0140-6736(05)74814-5	http://dx.doi.org/10.1016/S0140-6736(05)74814-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811459				2022-12-01	WOS:000228107600029
J	Garcia, CM; Ramirez, E				Garcia, CM; Ramirez, E			Evidence that sensory traps can evolve into honest signals	NATURE			English	Article							SEXUAL SELECTION; FEMALE CHOICE; MATING PREFERENCES; MATE CHOICE; CAROTENOIDS; EVOLUTION; BIASES; MALES	Conventional models(1-4) explaining extreme sexual ornaments propose that these reflect male genetic quality(2-4) or are arbitrary results of genetic linkage between female preference and the ornament(1). The chase-away model(5) emphasizes sexual conflict: male signals attract females because they exploit receiver biases(6-9). As males gain control of mating decisions, females may experience fitness costs through suboptimal mating rates or post-copulatory exploitation. Elaboration of male signals is expected if females increase their response threshold to resist such exploitation. If ornaments target otherwise adaptive biases such as feeding responses(8-10), selection on females might eventually separate sexual and non-sexual responses to the signal. Here we show that the terminal yellow band (TYB) of several Goodeinae species evokes both feeding and sexual responses; sexual responsiveness phylogenetically pre-dates the expression of the TYB in males and is comparable across taxa, yet feeding responsiveness decreases in species with more elaborated TYBs. Displaying a TYB is costly, and thus provides an example where a trait arose as a sensory trap but has evolved into an honest signal.	Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Garcia, CM (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, AP 70-275, Mexico City 04510, DF, Mexico.	maciasg@servidor.unam.mx	Garcia, Constantino Macias/S-1948-2019; Garcia, Constantino Macías/A-9399-2010	Garcia, Constantino Macías/0000-0003-3242-4214; Ramirez-Carrillo, Elvia/0000-0001-8447-0971				ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Basolo AL, 2002, BEHAV ECOL, V13, P832, DOI 10.1093/beheco/13.6.832; Basolo AL, 1998, P ROY SOC B-BIOL SCI, V265, P2223, DOI 10.1098/rspb.1998.0563; Burton BG, 2003, J EXP BIOL, V206, P3963, DOI 10.1242/jeb.00600; Cordero C, 2003, J EVOLUTION BIOL, V16, P1, DOI 10.1046/j.1420-9101.2003.00506.x; Cordoba-Aguilar A, 2002, AM NAT, V160, P594, DOI 10.1086/342819; Dawkins MS, 1996, AM NAT, V148, P937, DOI 10.1086/285964; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; FISHER RA, 1958, GENETICAL THEORY NAT, P146; Grether GF, 2002, SCIENCE, V296, P847; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Jayasooriya AP, 2002, SCIENCE, V296, P847; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; LeBas NR, 2003, P ROY SOC B-BIOL SCI, V270, P2159, DOI 10.1098/rspb.2003.2482; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Partridge L, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P130; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; [No title captured], DOI DOI 10.1086/285303)	26	110	113	0	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					501	505		10.1038/nature03363	http://dx.doi.org/10.1038/nature03363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791255				2022-12-01	WOS:000227836000041
J	Wienholds, E; Kloosterman, WP; Miska, E; Alvarez-Saavedra, E; Berezikov, E; de Bruijn, E; Horvitz, HR; Kauppinen, S; Plasterk, RHA				Wienholds, E; Kloosterman, WP; Miska, E; Alvarez-Saavedra, E; Berezikov, E; de Bruijn, E; Horvitz, HR; Kauppinen, S; Plasterk, RHA			MicroRNA expression in zebrafish embryonic development	SCIENCE			English	Article								MicroRNAs (miRNAs) are small noncoding RNAs, about 21 nucleotides in length, that can regulate gene expression by base-pairing to partially complementary mRNAs. Regulation by miRNAs can play essential roles in embryonic development. We determined the temporal and spatial expression patterns of 115 conserved vertebrate miRNAs in zebrafish embryos by microarrays and by in situ hybridizations, using locked-nucleic acid-modified oligonucleotide probes. Most miRNAs were expressed in a highly tissue-specific manner during segmentation and later stages, but not early in development, which suggests that their role is not in tissue fate establishment but in differentiation or maintenance of tissue identity.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Univ Cambridge, Canc Res UK, Gurdon Inst, Wellcome Trust, Cambridge CB2 1QN, England; Univ Copenhagen, Inst Med Biochem & Genet, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen, Denmark	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Copenhagen	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	; Berezikov, Eugene/D-3363-2013	Miska, Eric/0000-0002-4450-576X; Berezikov, Eugene/0000-0002-1145-2884				Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	8	1243	1367	3	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					310	311		10.1126/science.1114519	http://dx.doi.org/10.1126/science.1114519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	15919954				2022-12-01	WOS:000230449800048
J	Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM				Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM			Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIPHOSPHOLIPID SYNDROME; PHOSPHOLIPIDS; EPITOPE; ANTICARDIOLIPIN; AUTOANTIBODIES; LA	The design of a human immunodeficiency virus-1 (HIV-1) immunogen that can induce broadly reactive neutralizing antibodies is a major goal of HIV-1 vaccine development. Although rare human monoclonal antibodies (mAbs) exist that broadly neutralize HIV-1, HIV-1 envelope immunogens do not induce these antibody specificities. Here we demonstrate that the two most broadly reactive HIV-1 envelope gp41 human mAbs, 2175 and 4E10, are polyspecific autoantibodies reactive with the phospholipid cardiolipin. Thus, current HIV-1 vaccines may not induce these types of antibodies because of autoantigen mimicry of the conserved membrane-proximal epitopes of the virus. These results may have important implications for generating effective neutralizing, antibody responses by using HIV-1 vaccines.	Duke Univ, Sch Med, Durham, NC 27710 USA; Univ Agr Vienna, Inst Appl Microbiol, Vienna, Austria; Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Duke University; University of Natural Resources & Life Sciences, Vienna; Tulane University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Durham, NC 27710 USA.	hayne002@mc.duke.edu	Kunert, Renate E/B-9185-2018; Alam, S. Munir/AAC-6711-2019	Kunert, Renate E/0000-0002-3397-3621; Staats, Herman/0000-0003-1039-1087	NIAID NIH HHS [P0-1 AI52816, AI51445] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI052816, P30AI051445] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abuaf N, 1997, THROMB HAEMOSTASIS, V77, P856; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; BEVERS EM, 1991, THROMB HAEMOSTASIS, V66, P629; Bouvet JP, 1998, INFECT IMMUN, V66, P1; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; DELGADO AJ, 2002, ARTHRITIS RHEUM, V46, P2686, DOI DOI 10.1371/JOURNAL.PONE.0186513; Douvas A, 1996, AIDS RES HUM RETROV, V12, P1509, DOI 10.1089/aid.1996.12.1509; Fenger M, 2004, CLIN CHEM, V50, P2141, DOI 10.1373/clinchem.2004.038422; Fox RA, 1997, ARTHRITIS RHEUM-US, V40, P1168, DOI 10.1002/art.1780400623; Guerin J, 1998, BRIT J HAEMATOL, V102, P896, DOI 10.1046/j.1365-2141.1998.00876.x; HAYNES BF, UNPUB; Kessler JA, 1997, AIDS RES HUM RETROV, V13, P575, DOI 10.1089/aid.1997.13.575; Kunert RE, 2002, AIDS, V16, P667, DOI 10.1097/00002030-200203080-00020; Loizou S, 2003, ANN RHEUM DIS, V62, P1106, DOI 10.1136/ard.62.11.1106; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI200113051; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Opalka D, 2004, J IMMUNOL METHODS, V287, P49, DOI 10.1016/j.jim.2004.01.016; Palacios R, 2004, INT J STD AIDS, V15, P277, DOI 10.1258/095646204773557857; Petrovas C, 1999, J AUTOIMMUN, V13, P347, DOI 10.1006/jaut.1999.0324; Radway-Bright EL, 2000, RHEUMATOLOGY, V39, P427, DOI 10.1093/rheumatology/39.4.427; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Shaw Gerald Sinclair, COMMUNICATION; Stiegler G, 2003, J ANTIMICROB CHEMOTH, V51, P757, DOI 10.1093/jac/dkg172; WEISS L, 1995, CLIN IMMUNOL IMMUNOP, V77, P69, DOI 10.1016/0090-1229(95)90138-8; Zhu M, 1999, BRIT J HAEMATOL, V105, P102, DOI 10.1111/j.1365-2141.1999.01292.x	29	608	649	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1906	1908		10.1126/science.1111781	http://dx.doi.org/10.1126/science.1111781			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15860590				2022-12-01	WOS:000230120000039
J	Sun, T; Patoine, C; Abu-Khalil, A; Visvader, J; Sum, E; Cherry, TJ; Orkin, SH; Geschwind, DH; Walsh, CA				Sun, T; Patoine, C; Abu-Khalil, A; Visvader, J; Sum, E; Cherry, TJ; Orkin, SH; Geschwind, DH; Walsh, CA			Early asymmetry of gene transcription in embryonic human left and right cerebral cortex	SCIENCE			English	Article							HUMAN-BRAIN; HANDEDNESS; SPEECH; LATERALITY; EVOLUTION; MICE	The human left and right cerebral hemispheres are anatomically and functionally asymmetric. To test whether human cortical asymmetry has a molecular basis, we studied gene expression levels between the left and right embryonic hemispheres using serial analysis of gene expression (SAGE). We identified and verified 27 differentialty expressed genes, which suggests that human cortical asymmetry is accompanied by early, marked transcriptional asymmetries. LMO4 is consistently more highly expressed in the right perisylvian human cerebral cortex than in the left and is essential for cortical development in mice, suggesting that human left-right specialization reflects asymmetric cortical development at early stages.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Calif Los Angeles, Dept Neurol, Program Neurogenet, Sch Med, Los Angeles, CA 90095 USA; Walter & Eliza Hall Inst Med Res, Victorian Breast Canc Res Consortium Lab, Melbourne, Vic 3050, Australia; Boston Childrens Hosp, Howard Hughes Med Inst, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Walter & Eliza Hall Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, New Res Bldg Room 0266,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu		Walsh, Christopher/0000-0002-0156-2238	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060233, R56MH060233, R37MH060233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R37NS035129] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH060233, R56 MH060233, R37 MH060233, MH60233] Funding Source: Medline; NINDS NIH HHS [R37 NS035129, R37 NS035129-05, R01 NS035129-03, R01 NS035129, R01 R37 NS35129] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; BARNEOUD P, 1993, P NATL ACAD SCI USA, V90, P3246, DOI 10.1073/pnas.90.8.3246; BIDDLE FG, 1993, GENOME, V36, P935, DOI 10.1139/g93-123; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; COLLINS RL, 1991, BRAIN RES, V564, P194, DOI 10.1016/0006-8993(91)91455-A; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; FALKAI P, 1992, SCHIZOPHR RES, V7, P23, DOI 10.1016/0920-9964(92)90070-L; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; GALABURDA AM, 1994, P NATL ACAD SCI USA, V91, P8010, DOI 10.1073/pnas.91.17.8010; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Geschwind DH, 2001, AM J MED GENET, V101, P370; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Hugdahl K, 1998, SCAND AUDIOL, V27, P26, DOI 10.1080/010503998420621; Kennedy DN, 1999, NEUROLOGY, V53, P1260, DOI 10.1212/WNL.53.6.1260; LEMAY M, 1972, NEW ENGL J MED, V287, P168, DOI 10.1056/NEJM197207272870404; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; RIDDLE DR, 1995, J NEUROSCI, V15, P4184; Sidman RL, 1982, HISTOLOGY HISTOPATHO; SIGNORE P, 1991, PHYSIOL BEHAV, V49, P701, DOI 10.1016/0031-9384(91)90305-8; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009	23	268	272	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1794	1798		10.1126/science.1110324	http://dx.doi.org/10.1126/science.1110324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15894532	Green Accepted			2022-12-01	WOS:000229926800057
J	Draper, G; Vincent, T; Kroll, ME; Swanson, J				Draper, G; Vincent, T; Kroll, ME; Swanson, J			Childhood cancer in relation to distance from high voltage power lines in England and Wales: a case-control study	BRITISH MEDICAL JOURNAL			English	Article							MAGNETIC-FIELDS; POOLED ANALYSIS; LEUKEMIA; CHILDREN; RISK	Objective To determine whether there is an association between distance of home address at birth from high voltage power lines and the incidence of leukaemia and other cancers in children in England and Wales. Design Case-control study. Setting Cancer registry and National Grid records. Subjects Records of 29 081 children with cancer, including 9700 with leukaemia. Children were aged 0-14 years and born in England and Wales, 1962-95. Controls were individually matched for sex, approximate date of birth, and birth registration district. No active participation was required. Main outcome measures Distance from home address at birth to the nearest high voltage overhead power line in existence at the time. Results Compared with those who lived > 600 m from a line at birth, children who lived within 200 m had a relative risk of leukaemia of 1.69 (95% confidence interval 1.13 to 2.53); those born between 200 and 600 m had a relative risk of 1.23 (1.02 to 1.49). There was a significant (P < 0.01) trend in risk in relation to the reciprocal of distance from the line. No excess risk in relation to proximity to lines was found for other childhood cancers. Conclusions There is an association between childhood leukaemia and proximity of home address at birth to high voltage power lines, and the apparent risk extends to a greater distance than would have been expected from previous studies. About 4% of children in England and Wales live within 600 in of high voltage lines at birth. If the association is causal, about 1% of childhood leukaemia in England and Wales would be attributable to these lines, though this estimate has considerable statistical uncertainty. There is no accepted biological mechanism to explain the epidemiological results; indeed, the relation may be due to chance or confounding.	Univ Oxford, Childhood Canc Res Grp, Oxford OX2 6HJ, England; Natl Grid Transco Plc, London WC2N 5EH, England	University of Oxford	Draper, G (corresponding author), Univ Oxford, Childhood Canc Res Grp, Oxford OX2 6HJ, England.	gerald.draper@ccrg.ox.ac.uk						Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376; Cheng KK, 2000, BRIT J CANCER, V83, P1573, DOI 10.1054/bjoc.2000.1550; Dockerty JD, 2001, INT J EPIDEMIOL, V30, P1428, DOI 10.1093/ije/30.6.1428; DRAPER GJ, OPCS STUDIES MED POP, V53; Fews AP, 1999, INT J RADIAT BIOL, V75, P1523, DOI 10.1080/095530099139124; FEYCHTING M, 1993, AM J EPIDEMIOL, V138, P467, DOI 10.1093/oxfordjournals.aje.a116881; Greenland S, 2000, EPIDEMIOLOGY, V11, P624, DOI 10.1097/00001648-200011000-00003; Kinlen L, 2004, BRIT J CANCER, V91, P1, DOI 10.1038/sj.bjc.6601982; Kleinerman RA, 2000, AM J EPIDEMIOL, V151, P512, DOI 10.1093/oxfordjournals.aje.a010237; MADDOCK BJ, 1992, POWER ENG        SEP, P217; McBride ML, 1999, AM J EPIDEMIOL, V149, P831, DOI 10.1093/oxfordjournals.aje.a009899; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; OLSEN JH, 1993, BRIT MED J, V307, P891, DOI 10.1136/bmj.307.6909.891; Tynes T, 1997, AM J EPIDEMIOL, V145, P219, DOI 10.1093/oxfordjournals.aje.a009094; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681	15	206	218	0	45	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 4	2005	330	7503					1290	1292A		10.1136/bmj.330.7503.1290	http://dx.doi.org/10.1136/bmj.330.7503.1290			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15933351	Green Published, Bronze			2022-12-01	WOS:000229655700014
J	Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; Pettengell, R; Dogan, A; Thomson, KJ; Morris, EC; Hale, G; Waldmann, H; Goldstone, AH; Linch, DC; Mackinnon, S				Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; Pettengell, R; Dogan, A; Thomson, KJ; Morris, EC; Hale, G; Waldmann, H; Goldstone, AH; Linch, DC; Mackinnon, S			Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation	LANCET			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW TRANSPLANTS; POSITRON-EMISSION-TOMOGRAPHY; DONOR LEUKOCYTE INFUSIONS; HIGH-DOSE CHEMOTHERAPY; ADOPTIVE IMMUNOTHERAPY; STATISTICAL-METHODS; DISEASE; THERAPY; BLOOD	Background In patients with multiply relapsed Hodgkin's lymphoma allogeneic stem-cell transplantation has been limited by prohibitive non-relapse-related mortality rates and by a lack of definitive evidence for a therapeutic graft-versus-tumour effect. Therefore, we aimed to assess the graft-versus-tumour effect of reduced-intensity allogeneic transplantation. Methods We undertook reduced-intensity transplantation in 49 patients with multiply relapsed Hodgkin's lymphoma, 44 (90%) of whom had progression of disease after previous autologous transplantation (median age 32 years [range 18-51], number of previous treatment courses was five [range 3-8], and time from diagnosis 4.8 years [range 0.6-4.8]). 31 patients had HLA-matched donors who were related and 18 had donors who were unrelated. Median follow-up was 967 days (range 102-2232). The primary endpoints were engraftment, toxic effects, non-relapse-related mortality, incidence of graft-versus-host disease (GVHD), and the toxic effects of adjuvant donor-lymphocyte infusion. Findings All patients engrafted. Eight of 49 (16%) had grade II-IV acute GVHD and seven (14%) had chronic GVHD before donor-lymphocyte infusion. 16 (33%) patients received donor-lymphocyte infusion from 3 months after transplantation for residual disease or progression. Six (38%) of the 16 developed grade II-IV acute GVHD and five developed chronic GVHD. Nine (56%) showed disease responses after infusion (eight complete, one partial). Non-relapse-related mortality was 16.3% at 730 days (7.2% for patients who had related donors vs 34.1% for those with unrelated donors, p=0.0206). Projected 4-year overall and progression-free survival were 55.7% and 39.0%, respectively (62.0% and 41.5% for related donors). Interpretation These data show the potential for durable responses in patients who have previously had substantial treatment for Hodgkin's lymphoma. The low non-relapse-related mortality suggests the procedure could be undertaken earlier in the course of the disease.	Royal Free & UCL, Dept Haematol, London WC1E 6HX, England; Leicester Royal Infirm, Dept Haematol, Leicester, Leics, England; Christie Hosp, Dept Haematol, Manchester, Lancs, England; Glasgow Royal Infirm, Dept Haematol, Glasgow, Lanark, Scotland; Queen Elizabeth Hosp, Dept Haematol, Birmingham, W Midlands, England; Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5ST, W Midlands, England; UCL Hosp, Dept Haematol, London, England; UCL Hosp, Dept Histopathol, London, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England	University of London; University College London; University of Leicester; Christie NHS Foundation Trust; Christie Hospital; University of Glasgow; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Oxford	Peggs, KS (corresponding author), Royal Free & UCL, Dept Haematol, London WC1E 6HX, England.	kpeggs@hotmail.com	Mackinnon, Stephen/C-5559-2008; waldmann, herman/F-7412-2011; PEGGS, Karl/B-3869-2009; waldmann, herman/W-8051-2019	Waldmann, Herman/0000-0001-7519-6720; Morris, Emma/0000-0003-4834-1130; Craddock, Charles/0000-0001-5041-6678; Parker, Anne/0000-0002-4905-6860; Hale, Geoff/0000-0001-9473-423X				Akpek G, 2001, J CLIN ONCOL, V19, P4314, DOI 10.1200/JCO.2001.19.23.4314; Anderlini P, 2000, BONE MARROW TRANSPL, V26, P615, DOI 10.1038/sj.bmt.1702580; Anderlini P, 2004, BONE MARROW TRANSPL, V34, P511, DOI 10.1038/sj.bmt.1704621; ANDERSON JE, 1993, J CLIN ONCOL, V11, P2342, DOI 10.1200/JCO.1993.11.12.2342; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Branson K, 2002, J CLIN ONCOL, V20, P4022, DOI 10.1200/JCO.2002.11.088; Carella AM, 2001, HAEMATOLOGICA, V86, P1121; CHOPRA R, 1993, BLOOD, V81, P1137; Claviez A, 2004, ANN HEMATOL, V83, P237, DOI 10.1007/s00277-003-0814-y; Gajewski JL, 1996, J CLIN ONCOL, V14, P572, DOI 10.1200/JCO.1996.14.2.572; Hiddemann W, 1994, Drugs, V47 Suppl 6, P50; Johnston LJ, 2000, BIOL BLOOD MARROW TR, V6, P289, DOI 10.1016/S1083-8791(00)70054-1; JONES RJ, 1991, BLOOD, V77, P649; Josting A, 2000, BLOOD, V96, P1280, DOI 10.1182/blood.V96.4.1280.h8001280_1280_1286; Klein JP, 2001, BONE MARROW TRANSPL, V28, P909, DOI 10.1038/sj.bmt.1703260; Klein JP, 2001, BONE MARROW TRANSPL, V28, P1001, DOI 10.1038/sj.bmt.1703271; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Milpied N, 1996, J CLIN ONCOL, V14, P1291, DOI 10.1200/JCO.1996.14.4.1291; Morris EC, 2003, BLOOD, V102, P404, DOI 10.1182/blood-2002-09-2687; Porter DL, 1999, J CLIN ONCOL, V17, P1234, DOI 10.1200/JCO.1999.17.4.1234; Porter DL, 2003, BONE MARROW TRANSPL, V31, P739, DOI 10.1038/sj.bmt.1703895; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; SALISBURY JR, 1994, J CLIN PATHOL, V47, P313, DOI 10.1136/jcp.47.4.313; Schmitz N, 2002, LANCET, V359, P2065, DOI 10.1016/S0140-6736(02)08938-9; Spaepen K, 2003, BLOOD, V102, P53, DOI 10.1182/blood-2002-12-3842; Spaepen K, 2001, BRIT J HAEMATOL, V115, P272, DOI 10.1046/j.1365-2141.2001.03169.x; Sureda A, 2002, ANN ONCOL, V13, P128, DOI 10.1093/annonc/13.S1.128; Tarella C, 2003, CANCER-AM CANCER SOC, V97, P2748, DOI 10.1002/cncr.11414	29	210	220	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1934	1941		10.1016/S0140-6736(05)66659-7	http://dx.doi.org/10.1016/S0140-6736(05)66659-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936420				2022-12-01	WOS:000229587800027
J	Oltersdorf, T; Elmore, SW; Shoemaker, AR; Armstrong, RC; Augeri, DJ; Belli, BA; Bruncko, M; Deckwerth, TL; Dinges, J; Hajduk, PJ; Joseph, MK; Kitada, S; Korsmeyer, SJ; Kunzer, AR; Letai, A; Li, C; Mitten, MJ; Nettesheim, DG; Ng, S; Nimmer, PM; O'Connor, JM; Oleksijew, A; Petros, AM; Reed, JC; Shen, W; Tahir, SK; Thompson, CB; Tomaselli, KJ; Wang, BL; Wendt, MD; Zhang, HC; Fesik, SW; Rosenberg, SH				Oltersdorf, T; Elmore, SW; Shoemaker, AR; Armstrong, RC; Augeri, DJ; Belli, BA; Bruncko, M; Deckwerth, TL; Dinges, J; Hajduk, PJ; Joseph, MK; Kitada, S; Korsmeyer, SJ; Kunzer, AR; Letai, A; Li, C; Mitten, MJ; Nettesheim, DG; Ng, S; Nimmer, PM; O'Connor, JM; Oleksijew, A; Petros, AM; Reed, JC; Shen, W; Tahir, SK; Thompson, CB; Tomaselli, KJ; Wang, BL; Wendt, MD; Zhang, HC; Fesik, SW; Rosenberg, SH			An inhibitor of Bcl-2 family proteins induces regression of solid tumours	NATURE			English	Article							SMALL-MOLECULE INHIBITORS; CELL-DEATH; RATIONAL DESIGN; BH3 DOMAIN; APOPTOSIS; DISCOVERY; BCL-X(L); EXPRESSION; ANTISENSE; COMPOUND	Proteins in the Bcl-2 family are central regulators of programmed cell death(1), and members that inhibit apoptosis, such as Bcl-X-L and Bcl-2, are overexpressed in many cancers and contribute to tumour initiation, progression and resistance to therapy(2). Bcl-X-L expression correlates with chemo-resistance of tumour cell lines(3), and reductions in Bcl-2 increase sensitivity to anticancer drugs(4) and enhance in vivo survival(5). The development of inhibitors of these proteins as potential anti-cancer therapeutics has been previously explored(6-15), but obtaining potent small-molecule inhibitors has proved difficult owing to the necessity of targeting a protein - protein interaction. Here, using nuclear magnetic resonance (NMR)-based screening, parallel synthesis and structure-based design, we have discovered ABT-737, a small-molecule inhibitor of the anti-apoptotic proteins Bcl-2, Bcl-X-L and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compounds(7-15). Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation. ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumours, and produces cures in a high percentage of the mice.	Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA; Idun Pharmaceut, San Diego, CA 92121 USA; Burnham Inst, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Abbott Laboratories; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Rosenberg, SH (corresponding author), Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA.	stephen.fesik@abbott.com; saul.rosenberg@abbott.com						Amundson SA, 2000, CANCER RES, V60, P6101; Baell JB, 2002, BIOCHEM PHARMACOL, V64, P851, DOI 10.1016/S0006-2952(02)01148-6; Becattini B, 2004, CHEM BIOL, V11, P389, DOI 10.1016/j.chembiol.2004.02.020; BRUNGER AT, 1992, XPLOR VERSION 3 1; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Klasa RJ, 2002, ANTISENSE NUCLEIC A, V12, P193, DOI 10.1089/108729002760220798; Kutzki O, 2002, J AM CHEM SOC, V124, P11838, DOI 10.1021/ja026861k; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Mao HY, 2000, PROTEIN EXPRES PURIF, V20, P492, DOI 10.1006/prep.2000.1330; Mao HY, 2001, J AM CHEM SOC, V123, P10429, DOI 10.1021/ja015955b; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Reed JC, 1997, J NATL CANCER I, V89, P988, DOI 10.1093/jnci/89.14.988; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhang HC, 2002, ANAL BIOCHEM, V307, P70, DOI 10.1016/S0003-2697(02)00028-3	30	2757	2917	5	507	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					677	681		10.1038/nature03579	http://dx.doi.org/10.1038/nature03579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15902208				2022-12-01	WOS:000229476200051
J	Rieder, MJ; Reiner, AP; Gage, BF; Nickerson, DA; Eby, CS; McLeod, HL; Blough, DK; Thummel, KE; Veenstra, DL; Rettie, AE				Rieder, MJ; Reiner, AP; Gage, BF; Nickerson, DA; Eby, CS; McLeod, HL; Blough, DK; Thummel, KE; Veenstra, DL; Rettie, AE			Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METABOLISM; PHARMACOGENETICS; ASSOCIATION; POPULATION; REDUCTASE; PREDICT; GENE	BACKGROUND: The management of warfarin therapy is complicated by a wide variation among patients in drug response. Variants in the gene encoding vitamin K epoxide reductase complex 1 (VKORC1) may affect the response to warfarin. METHODS: We conducted a retrospective study of European-American patients receiving long-term warfarin maintenance therapy. Multiple linear-regression analysis was used to determine the effect of VKORC1 haplotypes on the warfarin dose. We determined VKORC1 haplotype frequencies in African-American, European-American, and Asian-American populations and VKORC1 messenger RNA (mRNA) expression in human liver samples. RESULTS: We identified 10 common noncoding VKORC1 single-nucleotide polymorphisms and inferred five major haplotypes. We identified a low-dose haplotype group (A) and a high-dose haplotype group (B). The mean (+/-SE) maintenance dose of warfarin differed significantly among the three haplotype group combinations, at 2.7+/-0.2 mg per day for A/A, 4.9+/-0.2 mg per day for A/B, and 6.2+/-0.3 mg per day for B/B (P<0.001). VKORC1 haplotype groups A and B explained approximately 25 percent of the variance in dose. Asian Americans had a higher proportion of group A haplotypes and African Americans a higher proportion of group B haplotypes. VKORC1 mRNA levels varied according to the haplotype combination. CONCLUSIONS: VKORC1 haplotypes can be used to stratify patients into low-, intermediate-, and high-dose warfarin groups and may explain differences in dose requirements among patients of different ancestries. The molecular mechanism of this warfarin dose response appears to be regulated at the transcriptional level.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; Washington Univ, Dept Med, St Louis, MO USA; Washington Univ, Dept Pathol & Immunol, St Louis, MO USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL)	Rieder, MJ (corresponding author), Univ Washington, Dept Genome Sci, Box 357730, Seattle, WA 98195 USA.	mrieder@u.washington.edu	Rieder, Michael J/L-2397-2013; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232; Gage, Brian/0000-0002-4727-8742	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074724, U01HL066682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340, R01GM068797, P01GM032165] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL074724, U01 HL66682] Funding Source: Medline; NIEHS NIH HHS [P30ES07033] Funding Source: Medline; NIGMS NIH HHS [GM068797, GM63340, GM32165] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Absher RK, 2002, ANN PHARMACOTHER, V36, P1512, DOI 10.1345/aph.1C025; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Ansell J, 2005, CHEST, V127, P415; Chenhsu RY, 2000, ANN PHARMACOTHER, V34, P1395; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Lesko LJ, 2004, NAT REV DRUG DISCOV, V3, P763, DOI 10.1038/nrd1499; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; MARKETOS M, 2004, DRUG TOPICS, V148, P76; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Voora D, 2005, THROMB HAEMOSTASIS, V93, P700, DOI 10.1160/TH04-08-0542; Yu HCM, 1996, QJM-MON J ASSOC PHYS, V89, P127	22	1066	1170	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2005	352	22					2285	2293		10.1056/NEJMoa044503	http://dx.doi.org/10.1056/NEJMoa044503			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930VY	15930419				2022-12-01	WOS:000229446400005
J	Nimmerjahn, A; Kirchhoff, F; Helmchen, F				Nimmerjahn, A; Kirchhoff, F; Helmchen, F			Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo	SCIENCE			English	Article							ADULT CORTEX; ACTIVATION; CNS; NEOCORTEX; MOTILITY; PROTEIN; ACTIN	Microglial cells represent the immune system of the mammalian brain and therefore are critically involved in various injuries and diseases. Little is known about their role in the healthy brain and their immediate reaction to brain damage. By using in vivo two-photon imaging in neocortex, we found that microglial cells are highly active in their presumed resting state, continually surveying their microenvironment with extremely motile processes and protrusions. Furthermore, blood-brain barrier disruption provoked immediate and focal activation of microglia, switching their behavior from patroling to shielding of the injured site. Microglia thus are busy and vigilant housekeepers in the adult brain.	Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany; Max Planck Inst Expt Med, Abt Neurogenet, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Helmchen, F (corresponding author), Max Planck Inst Med Res, Zellphysiol Abt, Jahnstr 29, D-69120 Heidelberg, Germany.	fritjof@mpimf-heidelberg.mpg.de	Kirchhoff, Frank/B-9335-2008; Helmchen, Fritjof/A-6255-2008	Kirchhoff, Frank/0000-0002-2324-2761; Helmchen, Fritjof/0000-0002-8867-9569				Capani F, 2001, BRAIN RES, V923, P1, DOI 10.1016/S0006-8993(01)03189-4; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LEHMENKUHLER A, 1993, NEUROSCIENCE, V55, P339, DOI 10.1016/0306-4522(93)90503-8; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010	17	3641	3753	18	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1314	1318		10.1126/science.1110647	http://dx.doi.org/10.1126/science.1110647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15831717				2022-12-01	WOS:000229482300049
J	McElwain, JC; Wade-Murphy, J; Hesselbo, SP				McElwain, JC; Wade-Murphy, J; Hesselbo, SP			Changes in carbon dioxide during an oceanic anoxic event linked to intrusion into Gondwana coals	NATURE			English	Article							CENOMANIAN-TURONIAN BOUNDARY; ATMOSPHERIC CO2; MASS EXTINCTION; GAS-HYDRATE; TOARCIAN; DISSOCIATION; ANTARCTICA; METHANE	The marine sedimentary record exhibits evidence for episodes of enhanced organic carbon burial known as 'oceanic anoxic events' (OAEs)(1,2). They are characterized by carbon-isotope excursions in marine(3) and terrestrial(4) reservoirs and mass extinction of marine faunas(5). Causal mechanisms for the enhancement of organic carbon burial during OAEs are still debated(6,7), but it is thought that such events should draw down significant quantities of atmospheric carbon dioxide(7). In the case of the Toarcian OAE (similar to 183 million years ago), a short-lived negative carbon-isotope excursion in oceanic and terrestrial reservoirs has been interpreted to indicate raised atmospheric carbon dioxide(4) caused by oxidation of methane catastrophically released from either marine gas hydrates(4) or magma-intruded organic-rich rocks(8). Here we test these two leading hypotheses(4,8) for a negative carbon isotopic excursion marking the initiation of the Toarcian OAE using a high-resolution atmospheric carbon dioxide record obtained from fossil leaf stomatal frequency(9,10). We find that coincident with the negative carbon-isotope excursion carbon dioxide is first drawn down by 350 +/- 100 p. p. m. v. and then abruptly elevated by 1,200 6 400 p. p. m. v, and infer a global cooling and greenhouse warming of 2.5 +/- 0.1 degrees C and 6.5 +/- 1 degrees C, respectively. The pattern and magnitude of carbon dioxide change are difficult to reconcile with catastrophic input of isotopically light methane from hydrates(5) as the cause of the negative isotopic signal. Our carbon dioxide record better supports a magma-intrusion hypothesis(8), and suggests that injection of isotopically light carbon from the release of thermogenic methane occurred owing to the intrusion of Gondwana coals by Toarcian-aged Karoo-Ferrar dolerites.	Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	Field Museum of Natural History (Chicago); University of Chicago; University of Oxford	McElwain, JC (corresponding author), Field Museum Nat Hist, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	jmcelwain@fieldmuseum.org	McElwain, Jennifer/B-1735-2009; McElwain, Jennifer/AAX-1605-2020	McElwain, Jennifer/0000-0002-1729-6755; 				ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Bailey TR, 2003, EARTH PLANET SC LETT, V212, P307, DOI 10.1016/S0012-821X(03)00278-4; Ballance PF, 2002, NEW ZEAL J GEOL GEOP, V45, P71, DOI 10.1080/00288306.2002.9514960; Beerling DJ, 2002, AM J SCI, V302, P28, DOI 10.2475/ajs.302.1.28; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cohen AS, 2004, GEOLOGY, V32, P157, DOI 10.1130/G20158.1; Elliot DH, 2004, GONDWANA RES, V7, P223, DOI 10.1016/S1342-937X(05)70322-1; Harries PJ, 1999, PALAEOGEOGR PALAEOCL, V154, P39, DOI 10.1016/S0031-0182(99)00086-3; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; JENKYNS HC, 1988, AM J SCI, V288, P101, DOI 10.2475/ajs.288.2.101; Jenkyns HC, 2002, J GEOL SOC LONDON, V159, P351, DOI 10.1144/0016-764901-130; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Kerr AC, 1998, J GEOL SOC LONDON, V155, P619, DOI 10.1144/gsjgs.155.4.0619; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Koppelhus Eva Bundgaard, 1994, Palynology, V18, P139; Kothavala Z, 1999, GEOPHYS RES LETT, V26, P209, DOI 10.1029/1998GL900275; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Kurschner WM, 1997, REV PALAEOBOT PALYNO, V96, P1, DOI 10.1016/S0034-6667(96)00051-6; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; McElwain JC, 1998, PHILOS T R SOC B, V353, P83, DOI 10.1098/rstb.1998.0193; McElwain JC, 2002, J QUATERNARY SCI, V17, P21, DOI 10.1002/jqs.664.abs; MICHELSON O, 2003, JURASSIC DENMARK GRE, P147; Milkov AV, 2004, EARTH-SCI REV, V66, P183, DOI 10.1016/j.earscirev.2003.11.002; Palfy J, 2000, GEOLOGY, V28, P747, DOI 10.1130/0091-7613(2000)028<0747:SBEJEO>2.3.CO;2; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; Royer DL, 2001, EARTH-SCI REV, V54, P349, DOI 10.1016/S0012-8252(00)00042-8; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Vakhrameev V.A., 1991, JURASSIC CRETACEOUS; Veevers J. J., 1994, PERMIAN TRIASSIC PAN, P331	30	364	378	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					479	482		10.1038/nature03618	http://dx.doi.org/10.1038/nature03618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917805				2022-12-01	WOS:000229337800051
J	Ndayimirije, N; Kindhauser, MK				Ndayimirije, N; Kindhauser, MK			Marburg hemorrhagic fever in Angola - Fighting fear and a lethal pathogen.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Brazzaville, Rep Congo; WHO, Geneva, Switzerland	World Health Organization; World Health Organization	Ndayimirije, N (corresponding author), WHO, Brazzaville, Rep Congo.								0	25	25	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2155	2157		10.1056/NEJMp058115	http://dx.doi.org/10.1056/NEJMp058115			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917379	Bronze			2022-12-01	WOS:000229333300001
J	Nilsson, DE; Gislen, L; Coates, MM; Skogh, C; Garm, A				Nilsson, DE; Gislen, L; Coates, MM; Skogh, C; Garm, A			Advanced optics in a jellyfish eye	NATURE			English	Article							PRIMARY VISUAL-CORTEX; TRIPEDALIA-CYSTOPHORA; CRYSTALLINE LENS; PHOTORECEPTORS; CUBOZOA; BRAIN; MODEL	Cubozoans, or box jellyfish, differ from all other cnidarians by an active fish-like behaviour and an elaborate sensory apparatus(1,2). Each of the four sides of the animal carries a conspicuous sensory club ( the rhopalium), which has evolved into a bizarre cluster of different eyes(3). Two of the eyes on each rhopalium have long been known to resemble eyes of higher animals, but the function and performance of these eyes have remained unknown(4). Here we show that box-jellyfish lenses contain a finely tuned refractive index gradient producing nearly aberration-free imaging. This demonstrates that even simple animals have been able to evolve the sophisticated visual optics previously known only from a few advanced bilaterian phyla. However, the position of the retina does not coincide with the sharp image, leading to very wide and complex receptive fields in individual photoreceptors. We argue that this may be useful in eyes serving a single visual task. The findings indicate that tailoring of complex receptive fields might have been one of the original driving forces in the evolution of animal lenses.	Lund Univ, Dept Cell & Organism Biol, S-22362 Lund, Sweden; Lund Univ, Dept Theoret Phys, SE-22362 Lund, Sweden	Lund University; Lund University	Nilsson, DE (corresponding author), Lund Univ, Dept Cell & Organism Biol, Zool Bldg,Helgonavagen 3, S-22362 Lund, Sweden.	dan-e.nilsson@cob.lu.se	Garm, Anders/K-4362-2014	Garm, Anders/0000-0002-2080-735X				Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Bartels A, 1998, P ROY SOC B-BIOL SCI, V265, P2327, DOI 10.1098/rspb.1998.0579; Berger E. W., 1898, J COMP NEUROL, V8, P223; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; FLETCHER A, 1954, PROC R SOC LON SER-A, V223, P216, DOI 10.1098/rspa.1954.0110; Jagger WS, 1999, VISION RES, V39, P2841, DOI 10.1016/S0042-6989(99)00012-7; KROGER RHH, 1994, VISION RES, V34, P1815, DOI 10.1016/0042-6989(94)90306-9; Land M.F., 2002, ANIMAL EYES; LASKA G, 1984, ZOOMORPHOLOGY, V104, P163, DOI 10.1007/BF00312135; Laska G., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P107; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; NILSSON DE, 1983, J MICROSC-OXFORD, V132, P21, DOI 10.1111/j.1365-2818.1983.tb04705.x; Nilsson DE, 2004, CURR OPIN NEUROBIOL, V14, P407, DOI 10.1016/j.conb.2004.07.004; Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp; Piatigorsky J, 2001, P NATL ACAD SCI USA, V98, P12362, DOI 10.1073/pnas.231310698; PIATIGORSKY J, 1993, J BIOL CHEM, V268, P11894; Schweigart G, 2002, EUR J NEUROSCI, V15, P1585, DOI 10.1046/j.1460-9568.2002.01996.x; STANGE G, 1981, J COMP PHYSIOL, V141, P335, DOI 10.1007/BF00609936; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Suder K, 2002, EXP BRAIN RES, V144, P430, DOI 10.1007/s00221-002-1061-5; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0	24	163	166	5	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					201	205		10.1038/nature03484	http://dx.doi.org/10.1038/nature03484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889091				2022-12-01	WOS:000229021100039
J	Hochedlinger, K; Yamada, Y; Beard, C; Jaenisch, R				Hochedlinger, K; Yamada, Y; Beard, C; Jaenisch, R			Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues	CELL			English	Article							EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; GENE-EXPRESSION; SOMATIC-CELLS; BETA-CATENIN; HAIR FOLLICLE; SELF-RENEWAL; ES CELLS; INTESTINAL EPITHELIUM; TRANSCRIPTION FACTOR	The POU-domain transcription factor Oct-4 is normally expressed in pluripotent cells of the mammalian embryo. In addition, germ-cell tumors and a few somatic tumors show detectable expression of Oct-4. While Oct-4's role during preimplantation development is to maintain embryonic cells in a pluripotent state, little is known about its potential oncogenic properties. Here we investigate the effect of ectopic Oct-4 expression on somatic tissues of adult mice using a doxycycline-dependent expression system. Activation of Oct-4 results in dysplastic growths in epithelial tissues that are dependent on continuous Oct-4 expression. Dysplastic lesions show an expansion of progenitor cells and increased beta-catenin transcriptional activity. In the intestine, Oct-4 expression causes dysplasia by inhibiting cellular differentiation in a manner similar to that in embryonic cells. These data show that certain adult progenitors remain competent to interpret key embryonic signals and support the notion that progenitor cells are a driving force in tumorigenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02141 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA 84198, R01 CA 87869] Funding Source: Medline; NICHD NIH HHS [R01 HD 445022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072; Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Belting HG, 2001, DEVELOPMENT, V128, P4165; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Brickman JM, 2002, NAT GENET, V32, P557, DOI 10.1038/ng1202-557; Burgess S, 2002, DEVELOPMENT, V129, P905; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheng L, 2004, CANCER-AM CANCER SOC, V101, P2006, DOI 10.1002/cncr.20566; Cheng L, 2004, AM J SURG PATHOL, V28, P1341, DOI 10.1097/01.pas.0000135528.03942.1f; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CIARDIELLO F, 1991, CANCER RES, V51, P1051; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Honecker F, 2004, WORLD J UROL, V22, P15, DOI 10.1007/s00345-004-0399-7; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones TD, 2004, AM J SURG PATHOL, V28, P935, DOI 10.1097/00000478-200407000-00014; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Looijenga LHJ, 2003, APMIS, V111, P161, DOI 10.1034/j.1600-0463.2003.11101201.x; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OGUIN WM, 1992, J INVEST DERMATOL, V98, P24, DOI 10.1111/1523-1747.ep12494172; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ramos-Mejia V, 2005, DEV DYNAM, V232, P180, DOI 10.1002/dvdy.20211; Reim G, 2002, DEVELOPMENT, V129, P917; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SHIMAZAKI T, 1993, EMBO J, V12, P4489, DOI 10.1002/j.1460-2075.1993.tb06138.x; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Steingart RA, 2002, LIFE SCI, V71, P2543, DOI 10.1016/S0024-3205(02)02082-9; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wang PX, 2003, BIOCHEM J, V375, P199, DOI 10.1042/BJ20030579; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Yamaguchi S, 2005, GENE CHROMOSOME CANC, V43, P217, DOI 10.1002/gcc.20171; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	83	648	698	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					465	477		10.1016/j.cell.2005.02.018	http://dx.doi.org/10.1016/j.cell.2005.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882627	Bronze			2022-12-01	WOS:000229031600015
J	Fung, E; Wong, WW; Suen, JK; Bulter, T; Lee, SG; Liao, JC				Fung, E; Wong, WW; Suen, JK; Bulter, T; Lee, SG; Liao, JC			A synthetic gene-metabolic oscillator	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; CELL-CELL COMMUNICATION; ESCHERICHIA-COLI; GLYCOLYTIC OSCILLATIONS; TOGGLE SWITCH; NETWORKS; EXPRESSION; REGULATORS; CLOCK; YEAST	Autonomous oscillations found in gene expression and metabolic, cardiac and neuronal systems(1-4) have attracted significant attention both because of their obvious biological roles and their intriguing dynamics. In addition, de novo designed(5-12) oscillators(13,14) have been demonstrated, using components that are not part of the natural oscillators. Such oscillators are useful in testing the design principles and in exploring potential applications not limited by natural cellular behaviour(15). To achieve transcriptional and metabolic integration characteristic of natural oscillators, here we designed and constructed a synthetic circuit in Escherichia coli K12, using glycolytic flux to generate oscillation through the signalling metabolite acetyl phosphate. If two metabolite pools are interconverted by two enzymes that are placed under the transcriptional control of acetyl phosphate, the system oscillates when the glycolytic rate exceeds a critical value. We used bifurcation analysis to identify the boundaries of oscillation, and verified these experimentally. This work demonstrates the possibility of using metabolic flux as a control factor in system-wide oscillation, as well as the predictability of a de novo gene - metabolic circuit designed using nonlinear dynamic analysis.	Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA.	liaoj@ucla.edu		Liao, James/0000-0002-4580-7276; Bulter, Thomas/0000-0002-7968-5844				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bier M, 2000, BIOPHYS J, V78, P1087, DOI 10.1016/S0006-3495(00)76667-7; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; Ferry G, 2000, J BIOL CHEM, V275, P8794, DOI 10.1074/jbc.275.12.8794; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hess B, 2000, NATURWISSENSCHAFTEN, V87, P199, DOI 10.1007/s001140050704; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Joseph D., 1989, ELEMENTARY STABILITY; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Rines DR, 2002, METHOD ENZYMOL, V351, P16; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	29	294	312	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					118	122		10.1038/nature03508	http://dx.doi.org/10.1038/nature03508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875027				2022-12-01	WOS:000228864600050
J	Crawford, ED				Crawford, ED			PSA testing: what is the use?	LANCET			English	Editorial Material							PROSTATE-SPECIFIC ANTIGEN; UNITED-STATES; CANCER; FINASTERIDE; MEN		Univ Colorado, Denver, CO 80262 USA	University of Colorado System; University of Colorado Denver	Crawford, ED (corresponding author), Univ Colorado, Denver, CO 80262 USA.	david.crawford@uchsc.edu						Andriole GL, 2005, JNCI-J NATL CANCER I, V97, P433, DOI 10.1093/jnci/dji065; Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212; Crawford ED, 1999, PROSTATE, V38, P296; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Oottamasathien S, 2003, ARCH INTERN MED, V163, P661, DOI 10.1001/archinte.163.6.661; Raaijmakers R, 2004, UROLOGY, V63, P316, DOI 10.1016/j.urology.2003.09.028; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Wilson SS, 2004, UROL CLIN N AM, V31, P219, DOI 10.1016/j.ucl.2004.01.002	11	16	18	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1447	1449		10.1016/S0140-6736(05)66398-2	http://dx.doi.org/10.1016/S0140-6736(05)66398-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850617				2022-12-01	WOS:000228651600008
J	Heil, M; Rattke, J; Boland, W				Heil, M; Rattke, J; Boland, W			Postsecretory hydrolysis of nectar sucrose and specialization in ant/plant mutualism	SCIENCE			English	Article							IMPORTED FIRE ANT; DIGESTIVE ENZYMES; AMINO-ACIDS; HYMENOPTERA; SUGARS; FORMICIDAE; BEHAVIOR	Obligate Acacia ant plants house mutualistic ants as a defense mechanism and provide them with extrafloral nectar (EFN). Ant/plant mutualisms are widespread, but little is known about the biochemical basis of their species specificity. Despite its importance in these and other plant/animal interactions, little attention has been paid to the control of the chemical composition of nectar. We found high invertase (sucrose-cleaving) activity in Acacia EFN, which thus contained no sucrose. Sucrose, a disaccharide common in other EFNs, usually attracts nonsymbiotic ants. The EFN of the ant acacias was therefore unattractive to such ants. The Pseudomyrmex ants that are specialized to live on Acacia had almost no invertase activity in their digestive tracts and preferred sucrose-free EFN. Our results demonstrate postsecretory regulation of the carbohydrate composition of nectar.	Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany	Max Planck Society	Heil, M (corresponding author), Univ Duisburg Essen, FB Biogeoallgemeine Bot Pflanzenokol 9, Univ Str 5, D-45117 Essen, Germany.	Heil_Martin@web.de	Heil, Martin/AAC-2730-2022; Heil, Martin/I-1797-2012; Boland, Wilhelm/K-7762-2012; Heil, Martin/T-3960-2019	Boland, Wilhelm/0000-0001-6784-2534; Heil, Martin/0000-0001-8036-8697				AYRE GL, 1967, CAN ENTOMOL, V99, P408, DOI 10.4039/Ent99408-4; Baker H.G., 1982, BIOCH ASPECTS EVOL B, V131, P171; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; BENTLEY B, 1983, BIOL NECTARIES; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Boeve JL, 2003, OECOLOGIA, V136, P508, DOI 10.1007/s00442-003-1249-9; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Brouat C, 2001, P ROY SOC B-BIOL SCI, V268, P2131, DOI 10.1098/rspb.2001.1763; Carter C, 2004, TRENDS PLANT SCI, V9, P320, DOI 10.1016/j.tplants.2004.05.008; Cornelius ML, 1996, ANZ SCHADLINGSKD PFL, V69, P41, DOI 10.1007/BF01907668; Elias T. S., 1983, The biology of nectaries, P174; Ghazoul J, 2001, ECOL LETT, V4, P295, DOI 10.1046/j.1461-0248.2001.00229.x; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; Heil M, 2004, NATURE, V430, P205, DOI 10.1038/nature02703; Heil M, 2004, J TROP ECOL, V20, P201, DOI 10.1017/S026646740300110X; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hoeksema JD, 2000, OECOLOGIA, V125, P321, DOI 10.1007/s004420000496; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; LANZA J, 1991, ECOL ENTOMOL, V16, P203, DOI 10.1111/j.1365-2311.1991.tb00210.x; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; Peumans WJ, 1997, PLANTA, V201, P298, DOI 10.1007/s004250050070; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; RICKS BL, 1972, ENTOMOL EXP APPL, V15, P329, DOI 10.1007/BF00428298; Roshchina V.V., 1993, EXCRETORY FUNCTION H, DOI 10.1007/978-3-642-78130-8; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Stapel JO, 1997, ENVIRON ENTOMOL, V26, P617, DOI 10.1093/ee/26.3.617; SVATOS A, UNPUB; Thornburg RW, 2003, PLANT SYST EVOL, V238, P211, DOI 10.1007/s00606-003-0282-9; VANDERMEER RK, 1995, FLA ENTOMOL, V78, P144, DOI 10.2307/3495679; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x	33	122	129	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					560	563		10.1126/science.1107536	http://dx.doi.org/10.1126/science.1107536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845855				2022-12-01	WOS:000228810500055
J	Louie, T				Louie, T			The pastor and the party of the century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tedlouie@msn.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1835	1836		10.1001/jama.293.15.1835	http://dx.doi.org/10.1001/jama.293.15.1835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840843				2022-12-01	WOS:000228401700001
J	Cabinum-Foeller, E; Frasier, L				Cabinum-Foeller, E; Frasier, L			Bruising in children	LANCET			English	Editorial Material									E Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA; TEDI BEAR Childrens Advocacy Ctr, Greenville, NC USA; Univ Utah, Sch Med, Primary Childrens Med Ctr, Ctr Safe & Healthy Families, Salt Lake City, UT USA	University of North Carolina; East Carolina University; Utah System of Higher Education; University of Utah	Cabinum-Foeller, E (corresponding author), E Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA.	cabinumfoellere@mail.ecu.edu						Bariciak ED, 2003, PEDIATRICS, V112, P804, DOI 10.1542/peds.112.4.804; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C., 2001, CHILD ABUSE MED DIAG, P23; Maguire S, 2005, ARCH DIS CHILD, V90, P182, DOI 10.1136/adc.2003.044065; Maguire S, 2005, ARCH DIS CHILD, V90, P187, DOI 10.1136/adc.2003.044073; Schwartz AJ, 1996, PEDIATRICS, V97, P254; Sirotnak AP, 2004, PEDIATR REV, V25, P264, DOI 10.1542/pir.25-8-264; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399	8	3	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1369	1370		10.1016/S0140-6736(05)66351-9	http://dx.doi.org/10.1016/S0140-6736(05)66351-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836871				2022-12-01	WOS:000228401900007
J	Koniaris, LG; Zimmers, TA; Lubarsky, DA; Sheldon, JP				Koniaris, LG; Zimmers, TA; Lubarsky, DA; Sheldon, JP			Inadequate anaesthesia in lethal injection for execution	LANCET			English	Article								Anaesthesia. during lethal injection is essential to minimise suffering and to maintain public acceptance of the practice. Lethal injection is usually done by sequential administration of thiopental, pancuronium, and potassium chloride. Protocol information from Texas and Virginia showed that executioners had no anaesthesia training, drugs were administered remotely with no monitoring for anaesthesia, data were not recorded and no peer-review was done. Toxicology reports from Arizona, Georgia, North Carolina, and South Carolina showed that post-mortem concentrations of thiopental in the blood were lower than that required for surgery in 43 of 49 executed inmates (88%); 21 (43%) inmates had concentrations consistent with awareness. Methods of lethal injection anaesthesia are flawed and some inmates might experience awareness and suffering during execution.	Univ Miami, Dewitt Daughtry Family Dept Surg, Miami, FL 33152 USA; Univ Miami, Dept Anaesthesiol Perioperat Med & Pain Managemen, Miami, FL 33152 USA; Univ Miami, Sch Business, Dept Management, Miami, FL 33152 USA; Law Off Jonathan P Sheldon, Arlington, VA USA	University of Miami; University of Miami; University of Miami	Koniaris, LG (corresponding author), Sylvester Comprehens Canc Ctr 3550 310T, 1475 NW 12th Ave, Miami, FL 33136 USA.	LKoniaris@med.miami.edu	Zimmers, Teresa/AAD-5461-2019	Zimmers, Teresa/0000-0001-7872-0540				Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Denno, 2002, OHIO ST LJ, V63, P63; HUNG OR, 1992, ANESTHESIOLOGY, V77, P237, DOI 10.1097/00000542-199208000-00003; Khan A, 2002, J FORENSIC SCI, V47, P847; Martens-Lobenhoffer J, 1999, PHARMAZIE, V54, P597	5	47	47	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2005	365	9468					1412	1414		10.1016/S0140-6736(05)66377-5	http://dx.doi.org/10.1016/S0140-6736(05)66377-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836890				2022-12-01	WOS:000228401900030
J	Sommer, C; Weishaupt, A; Brinkhoff, J; Biko, L; Wessig, C; Gold, R; Toyka, KV				Sommer, C; Weishaupt, A; Brinkhoff, J; Biko, L; Wessig, C; Gold, R; Toyka, KV			Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin	LANCET			English	Article							MOTOR-NERVE TERMINALS; MUSCLE HYPERALGESIA; MYASTHENIC SYNDROME; MOUSE; AUTOANTIBODIES; ENCEPHALOMYELITIS; ENDOCYTOSIS; THERAPY; NEURONS; GRAVIS	Background Stiff-person syndrome (SPS) with antibodies to amphiphysin is a paraneoplastic disorder of the central nervous system with a putative autoimmune pathogenesis. Proof of a causal role of the antibodies is still lacking for this and all other antibody-associated paraneoplastic syndromes of the central nervous system. Methods We obtained the plasma filtrate of a patient with breast cancer and SPS that responded to therapeutic plasmapheresis. The purified IgG fraction included high-titre antibodies to the synaptic protein amphiphysin. In a cotransfer design, this IgG fraction was injected intraperitoneally into female Lewis rats that had received encephalitogenic T-helper (Th) lymphocytes specific for myelin basic protein, to induce an immune-mediated leaky blood-brain barrier. The rats were followed up with behavioural tests, video photography, and electromyography. Findings The injection of the IgG fraction including antibodies to amphiphysin resulted in a dose-dependent stiffness with spasms resembling human SPS. Control IgG injected into rats that had received the same encephalitogenic Th cells had no effect. IgG binding was demonstrated in the central nervous system of rats that Showed signs of the disorder. Interpretation These experiments support the hypothesis of a pathogenetic role of antibodies to amphiphysin, thus adding paraneoplastic SPS to the group of antibody-mediated autoimmune disorders. Relevance to practice These findings provide a strong argument for a direct pathogenetic role of anti-amphiphysin in this type of SPS and support therapeutic attempts to eliminate these autoantibodies by plasmapheresis. The experimental approach used could help to elucidate the role of autoantibodies in other paraneoplastic syndromes, such as SPS with antibodies to glutamic acid decarboxylase, and others including anti-Hu-associated subacute cerebellar degeneration and limbic encephalitis.	Univ Wurzburg, Neurol Klin, Dept Neurol, D-97080 Wurzburg, Germany; Univ Gottingen, Inst MS Forsch, Bereich Humanmed, D-3400 Gottingen, Germany; Gemeinnutzige Hertie Stiftung, Gottingen, Germany	University of Wurzburg; University of Gottingen	Sommer, C (corresponding author), Univ Wurzburg, Neurol Klin, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	sommer@mail.uni-wuemburg.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002				BRASHEAR HR, 1991, NEUROLOGY, V41, P1588, DOI 10.1212/WNL.41.10.1588; Buchwald B, 1998, EUR J NEUROSCI, V10, P281, DOI 10.1046/j.1460-9568.1998.00053.x; Dropcho EJ, 1998, J NEUROL SCI, V153, P264, DOI 10.1016/S0022-510X(97)00296-7; FOLLI F, 1993, NEW ENGL J MED, V328, P546, DOI 10.1056/NEJM199302253280805; FUKUNAGA H, 1983, P NATL ACAD SCI-BIOL, V80, P7636, DOI 10.1073/pnas.80.24.7636; Kehl LJ, 2000, PAIN, V85, P333, DOI 10.1016/S0304-3959(99)00282-1; Kittler JT, 2000, J NEUROSCI, V20, P7972; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; LANG B, 1983, J PHYSIOL-LONDON, V344, P335, DOI 10.1113/jphysiol.1983.sp014943; LININGTON C, 1988, AM J PATHOL, V130, P443; Meinck HM, 2002, MOVEMENT DISORD, V17, P853, DOI 10.1002/mds.10279; Meinck HM, 2001, CNS DRUGS, V15, P515, DOI 10.2165/00023210-200115070-00002; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Saiz A, 1999, J NEUROL NEUROSUR PS, V66, P214, DOI 10.1136/jnnp.66.2.214; Schafers M, 2003, PAIN, V104, P579, DOI 10.1016/S0304-3959(03)00115-5; Schmidt J, 2000, BRAIN, V123, P1431, DOI 10.1093/brain/123.7.1431; Schmierer K, 1998, NEUROLOGY, V51, P250, DOI 10.1212/WNL.51.1.250; TORO C, 1994, SEMIN NEUROL, V14, P154, DOI 10.1055/s-2008-1041073; TOYKA KV, 1980, J NEUROL NEUROSUR PS, V43, P836, DOI 10.1136/jnnp.43.9.836; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Vasconcelos Olavo M., 2003, Curr Treat Options Neurol, V5, P79, DOI 10.1007/s11940-003-0024-x; Voltz R, 2002, LANCET NEUROL, V1, P294, DOI 10.1016/S1474-4422(02)00135-7; Wessig C, 2003, NEUROLOGY, V61, P195, DOI 10.1212/01.WNL.0000073143.53337.DD; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8	24	146	154	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1406	1411		10.1016/S0140-6736(05)66376-3	http://dx.doi.org/10.1016/S0140-6736(05)66376-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836889				2022-12-01	WOS:000228401900029
J	Baughman, RH				Baughman, RH			Playing nature's game with artificial muscles	SCIENCE			English	Editorial Material							TECHNOLOGY; ACTUATORS; STRAIN		Univ Texas, NanoTech Inst, Richardson, TX 75083 USA; Univ Texas, Dept Chem, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas, NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018	Baughman, Ray/0000-0001-5845-5137				Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; BAUGHMAN RH, 2003, Patent No. 6555945; EBRON VH, UNPUB; Hara S, 2004, J MATER CHEM, V14, P1516, DOI 10.1039/b404232h; HARA S, IN PRESS SYNTH METAL; Kaneko D, 2002, J MATER CHEM, V12, P2169, DOI 10.1039/b109981g; Lu W, 2002, SCIENCE, V297, P983, DOI 10.1126/science.1072651; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Nemat-Nasser S, 2003, J APPL PHYS, V93, P5255, DOI 10.1063/1.1563300; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Schreyer HB, 2000, BIOMACROMOLECULES, V1, P642, DOI 10.1021/bm005557l; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; SMELA E, 1995, SCIENCE, V268, P1735, DOI 10.1126/science.268.5218.1735; Spinks GM, 2002, ADV MATER, V14, P1728, DOI 10.1002/1521-4095(20021203)14:23<1728::AID-ADMA1728>3.0.CO;2-8; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	17	200	206	4	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					63	65		10.1126/science.1099010	http://dx.doi.org/10.1126/science.1099010			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802593				2022-12-01	WOS:000228221500031
J	Viner, RM; Cole, TJ				Viner, RM; Cole, TJ			Adult socioeconomic, educational, social, and psychological outcomes of childhood obesity: a national birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; SELF-REPORTED HEIGHT; YOUNG ADULTHOOD; OVERWEIGHT; WEIGHT; HEALTH; CONSEQUENCES; ADOLESCENCE; DEPRESSION; VALIDITY	Objectives To assess adult socioeconomic, educational, social, and psychological outcomes of childhood obesity by using nationally representative data. Design 1970 British birth cohort. Participants 16 567 babies born in Great Britain 5-11 April 1970 and followed up at 5, 10, and 29-30 years. Main outcome measures Obesity at age 10 and 30 years. Self reported socioeconomic, educational, psychological, and social outcomes at 30 years. Odds ratios were calculated for the risk of each adult outcome associated with obesity in childhood only, obesity in adulthood only, and persistent child and adult obesity, compared with those obese at neither period. Results Of the 8490 participants with data on body mass index at 10 and 30 years, 4.3% were obese at 10 years and 16.3% at 30 years. Obesity in childhood only was not associated with adult social class, income, years of schooling, educational attainment, relationships, or psychological morbidity in either sex after adjustment for confounding factors. Persistent obesity was not associated with any adverse adult outcomes in men, though it was associated among women with a higher risk of never having been gainfully employed (odds ratio 1.9, 95% confidence interval 1.1 to 3.3) and not having a current partner (2.0, 1.3 to 3.3). Conclusions Obesity limited to childhood has little impact on adult outcomes. Persistent obesity in women is associated with poorer employment and relationship outcomes. Efforts to reduce the socioeconomic and psychosocial burden of obesity in adult life should focus on prevention of the persistence of obesity from childhood into adulthood.	UCL, Dept Paediat, Royal Free & Univ Coll Med Sch, London NW3 2PF, England; UCL, Ctr Paediat Edpidemiol & Biostat, Inst Child Hlth, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Viner, RM (corresponding author), UCL, Dept Paediat, Royal Free & Univ Coll Med Sch, London NW3 2PF, England.	R.Viner@ich.ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	MRC [G9827821] Funding Source: UKRI; Medical Research Council [G9827821(62595), G9827821] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Butler NR, 2000, 1970 BRIT BIRTH COHO; BYNNER J, 2002, 1 CLS I ED; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CRAWLEY HF, 1995, INT J OBESITY, V19, P579; Elliot C. D., 1983, BRIT ABILITY SCALES; Ferraro KF, 2003, J GERONTOL B-PSYCHOL, V58, pS110, DOI 10.1093/geronb/58.2.S110; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Goodman E, 2003, J ADOLESCENT HEALTH, V33, P140, DOI 10.1016/S1054-139X(03)00247-7; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; Laitinen J, 2002, INT J OBESITY, V26, P1329, DOI 10.1038/sj.ijo.0802134; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; MAXWELL SE, 1993, PSYCHOL BULL, V113, P181, DOI 10.1037/0033-2909.113.1.181; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Power C, 2003, INT J OBESITY, V27, P1081, DOI 10.1038/sj.ijo.0802323; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; SARGENT JD, 1994, ARCH PEDIAT ADOL MED, V148, P681, DOI 10.1001/archpedi.1994.02170070019003; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Wright CM, 2001, BMJ-BRIT MED J, V323, P1280, DOI 10.1136/bmj.323.7324.1280	23	129	132	1	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 11	2005	330	7504					1354	1357		10.1136/bmj.38453.422049.E0	http://dx.doi.org/10.1136/bmj.38453.422049.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	936FE	15901644	Green Published, Green Submitted			2022-12-01	WOS:000229840100016
J	Hegde, SS; Vetting, MW; Roderick, SL; Mitchenall, LA; Maxwell, A; Takiff, HE; Blanchard, JS				Hegde, SS; Vetting, MW; Roderick, SL; Mitchenall, LA; Maxwell, A; Takiff, HE; Blanchard, JS			A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA	SCIENCE			English	Article							MEDIATED QUINOLONE RESISTANCE; ESCHERICHIA-COLI; MICROCIN B17; CRYSTAL-STRUCTURE; GYRASE; PLASMID; INHIBITOR; MOXIFLOXACIN; MUTATIONS; SEQUENCE	Fluoroquinolones are gaining increasing importance in the treatment of tuberculosis. The expression of MfpA, a member of the pentapeptide repeat family of proteins from Mycobacterium tuberculosis, causes resistance to ciprofloxacin and sparfloxacin. This protein binds to DNA gyrase and inhibits its activity. Its three-dimensional structure reveals a fold, which we have named the right-handed quadrilateral beta helix, that exhibits size, shape, and electrostatic similarity to B-form DNA. This represents a form of DNA mimicry and explains both its inhibitory effect on DNA gyrase and fluoroquinolone resistance resulting from the protein's expression in vivo.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Mol Genet Lab, Caracas 1020A, Venezuela	Yeshiva University; Albert Einstein College of Medicine; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Venezuelan Institute Science Research	Blanchard, JS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	btanchar@aecom.yu.edu		Maxwell, Anthony/0000-0002-5756-6430; Mitchenall, Lesley/0000-0002-0063-1991	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007501, R01AI060899, R01AI033696] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: Medline; NIAID NIH HHS [AI33696, AI60899, T32 AI07501] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aubry A, 2004, ANTIMICROB AGENTS CH, V48, P1281, DOI 10.1128/AAC.48.4.1281-1288.2004; Bateman A, 1998, PROTEIN SCI, V7, P1477, DOI 10.1002/pro.5560070625; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; CAMBAU E, 1994, J INFECT DIS, V170, P479, DOI 10.1093/infdis/170.2.479; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crofton J., 1997, GUIDELINES MANAGEMEN; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; GARRIDO MD, 1988, EMBO J, V7, P1853, DOI 10.1002/j.1460-2075.1988.tb03018.x; Guillemin I, 1998, ANTIMICROB AGENTS CH, V42, P2084, DOI 10.1128/AAC.42.8.2084; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; HEGDE S, UNPUB; Jacoby GA, 2003, ANTIMICROB AGENTS CH, V47, P559, DOI 10.1128/AAC.47.2.559-562.2003; Ji BH, 1998, ANTIMICROB AGENTS CH, V42, P2066, DOI 10.1128/AAC.42.8.2066; Jonas D, 2005, ANTIMICROB AGENTS CH, V49, P773, DOI 10.1128/AAC.49.2.773-775.2005; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Montero C, 2001, ANTIMICROB AGENTS CH, V45, P3387, DOI 10.1128/AAC.45.12.3387-3392.2001; Nakanishi A, 2002, J BIOL CHEM, V277, P8949, DOI 10.1074/jbc.M111278200; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Parsons LX, 2004, PROTEINS, V54, P375, DOI 10.1002/prot.10607; Pierrat OA, 2003, J BIOL CHEM, V278, P35016, DOI 10.1074/jbc.M304516200; Romanowski MJ, 2002, PROTEINS, V47, P403, DOI 10.1002/prot.10102; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SULLIVAN EA, 1995, LANCET, V345, P1148, DOI 10.1016/S0140-6736(95)90980-X; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Walkinshaw MD, 2002, MOL CELL, V9, P187, DOI 10.1016/S1097-2765(02)00435-5; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127	32	198	215	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1480	1483		10.1126/science.1110699	http://dx.doi.org/10.1126/science.1110699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933203				2022-12-01	WOS:000229619300057
J	Rickert, M; Wang, XQ; Boulanger, MJ; Goriatcheva, N; Garcia, KC				Rickert, M; Wang, XQ; Boulanger, MJ; Goriatcheva, N; Garcia, KC			The structure of interleukin-2 complexed with its alpha receptor	SCIENCE			English	Article							CRYSTAL-STRUCTURE; IL-2 RECEPTOR; BINDING; IDENTIFICATION; LOCALIZATION; COMPONENT; ANTIBODY; CHAIN; P55	Interleukin-2 (IL-2) is an immunoregulatory cytokine that binds sequentially to the alpha (IL-2R alpha), beta (IL-2R beta), and common gamma chain (gamma(c)) receptor subunits. Here we present the 2.8 angstrom crystal structure of a complex between human IL-2 and IL-2R alpha, which-interact in a docking mode distinct from that of other cytokine receptor complexes. IL-2R alpha is composed of strand-swapped "sushi-like" domains, unlike the classical cytokine receptor fold. As a result of this domain swap, IL-2R alpha uses a composite surface to dock into a groove on IL-2 that also serves as a binding site for antagonist drugs. With this complex, we now have representative structures for each class of hematopoietic cytokine receptor-docking modules.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, 299 Campus Dr,Fairchild D319, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER; NIAID NIH HHS [AI51321] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; BAMBOROUGH P, 1994, STRUCTURE, V2, P839, DOI 10.1016/S0969-2126(94)00085-9; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1992, SCIENCE, V257, P410, DOI 10.1126/science.1631562; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRANDHUBER BJ, 1987, SCIENCE, V238, P1707, DOI 10.1126/science.3500515; Church AC, 2003, QJM-INT J MED, V96, P91, DOI 10.1093/qjmed/hcg014; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Eklund JW, 2004, CURR OPIN ONCOL, V16, P542, DOI 10.1097/01.cco.0000142070.45097.68; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; LAMBERT G, 1989, J BIOL CHEM, V264, P12730; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; Liparoto SF, 1999, J MOL RECOGNIT, V12, P316, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<316::AID-JMR468>3.0.CO;2-1; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.iy.11.040193.001333; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; ROBB RJ, 1988, P NATL ACAD SCI USA, V85, P5654, DOI 10.1073/pnas.85.15.5654; SAUVE K, 1991, P NATL ACAD SCI USA, V88, P4636, DOI 10.1073/pnas.88.11.4636; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; SHACKELFORD DA, 1986, EMBO J, V5, P3275, DOI 10.1002/j.1460-2075.1986.tb04639.x; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Theze J, 1996, IMMUNOL TODAY, V17, P481, DOI 10.1016/0167-5699(96)10057-C; Tilley JW, 1997, J AM CHEM SOC, V119, P7589, DOI 10.1021/ja970702x; Tsytsikov VN, 1996, J BIOL CHEM, V271, P23055, DOI 10.1074/jbc.271.38.23055; UCHIYAMA T, 1985, J CLIN INVEST, V76, P446, DOI 10.1172/JCI111992; Waldmann TA, 1998, CURR OPIN IMMUNOL, V10, P507, DOI 10.1016/S0952-7915(98)80215-X; WU ZN, 1995, J BIOL CHEM, V270, P16039, DOI 10.1074/jbc.270.27.16039; ZURAWSKI SM, 1990, EMBO J, V9, P3899, DOI 10.1002/j.1460-2075.1990.tb07610.x	31	162	177	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1477	1480		10.1126/science.1109745	http://dx.doi.org/10.1126/science.1109745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933202				2022-12-01	WOS:000229619300056
J	Kumar, S; Regan, F				Kumar, S; Regan, F			Management of pregnancies with RhD alloimmunisation	BRITISH MEDICAL JOURNAL			English	Review							RED-CELL ALLOIMMUNIZATION; RHESUS HEMOLYTIC-DISEASE; INTRAUTERINE TRANSFUSIONS; FETAL TRANSFUSION; LATE ANEMIA; BLOOD; ISOIMMUNIZATION; ERYTHROPOIESIS; PREDICTION; HYDROPS		Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Hammersmith Hosp NHS Trust, Ctr Fetal Care, London W12 0HS, England; Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Hammersmith Hosp NHS Trust, Dept Haematol, London W12 0HS, England	Imperial College London; Imperial College London	Kumar, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Hammersmith Hosp NHS Trust, Ctr Fetal Care, London W12 0HS, England.	sailesh.kumar@imperial.ac.uk	Kumar, Sailesh/M-3207-2014; Kumar, Sailesh/A-9203-2011	Kumar, Sailesh/0000-0003-0832-4811; 				BERGER HM, 1990, LANCET, V335, P933, DOI 10.1016/0140-6736(90)90997-J; Bowman J M, 1988, Transfus Med Rev, V2, P129, DOI 10.1016/S0887-7963(88)70039-5; BOWMAN JM, 1986, VOX SANG, V51, P117, DOI 10.1111/j.1423-0410.1986.tb00226.x; Bullock R, 2005, ULTRASOUND OBST GYN, V25, P331, DOI 10.1002/uog.1886; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; De Groot CJM, 2000, EARLY HUM DEV, V57, P205, DOI 10.1016/S0378-3782(99)00063-8; Finning KM, 2002, TRANSFUSION, V42, P1079, DOI 10.1046/j.1537-2995.2002.00165.x; Grab D, 1999, OBSTET GYNECOL, V93, P165, DOI 10.1016/S0029-7844(98)00421-9; Hudon L, 1998, AM J OBSTET GYNECOL, V179, P858, DOI 10.1016/S0002-9378(98)70178-4; Klumper FJ, 2000, EUR J OBSTET GYN R B, V92, P91, DOI 10.1016/S0301-2115(00)00430-9; LANDSTEINER KARL, 1940, PROC SOC EXP BIOL AND MED, V43, P223; LILEY AW, 1961, AM J OBSTET GYNECOL, V82, P1359; LO YMD, 1994, ANN NY ACAD SCI, V731, P229, DOI 10.1111/j.1749-6632.1994.tb55774.x; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; MAXWELL DJ, 1991, BRIT J OBSTET GYNAEC, V98, P892, DOI 10.1111/j.1471-0528.1991.tb13511.x; MILLARD DD, 1990, J PEDIATR-US, V117, P447, DOI 10.1016/S0022-3476(05)81096-0; *NAT I CLIN EXC, 2002, GUID PREGN ROUT ANT; NICOLAIDES KH, 1992, BRIT MED J, V304, P1155, DOI 10.1136/bmj.304.6835.1155; Ovali F, 1996, PEDIATR RES, V39, P831, DOI 10.1203/00006450-199605000-00015; PATTISON NS, 1992, ULTRASOUND OBST GYN, V2, P329, DOI 10.1046/j.1469-0705.1992.02050329.x; PETEREC SM, 1995, CLIN PERINATOL, V22, P561; *ROYAL COLL OBST G, 2002, GREEN TOP GUID ANT I; SAADE GR, 1993, FETAL DIAGN THER, V8, P161, DOI 10.1159/000263816; SCARADAVOU A, 1993, J PEDIATR-US, V123, P279, DOI 10.1016/S0022-3476(05)81704-4; Schumacher B, 1996, OBSTET GYNECOL, V88, P137, DOI 10.1016/0029-7844(96)00113-5; TRONCEK DF, 2001, IMMUNOHEMATOLOGY, V17, P37; van Kamp IL, 2001, AM J OBSTET GYNECOL, V185, P668, DOI 10.1067/mob.2001.116690; Voto LS, 1997, J PERINAT MED, V25, P85, DOI 10.1515/jpme.1997.25.1.85; Whitecar PW, 2002, AM J OBSTET GYNECOL, V187, P977, DOI 10.1067/mob.2002.126960	29	44	44	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 28	2005	330	7502					1255	1258		10.1136/bmj.330.7502.1255	http://dx.doi.org/10.1136/bmj.330.7502.1255			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15920129	Green Published			2022-12-01	WOS:000229448900023
J	Ribeiro, RC; Pui, C				Ribeiro, RC; Pui, C			Saving the children - Improving childhood cancer treatment in developing countrie.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA		St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Leukemia Lymphoma Div, Memphis, TN 38105 USA; Amer Canc Soc, Atlanta, GA 30329 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; American Cancer Society	Ribeiro, RC (corresponding author), St Jude Childrens Res Hosp, Int Outreach Program, 332 N Lauderdale St, Memphis, TN 38105 USA.		Pui, Ching-Hon/N-8076-2018	Pui, Ching-Hon/0000-0003-0303-5658				Howard SC, 2004, JAMA-J AM MED ASSOC, V291, P2471, DOI 10.1001/jama.291.20.2471; Kazembe P, 2003, MED PEDIATR ONCOL, V40, P23, DOI 10.1002/mpo.10190; Pui C-H, 2004, Leukemia, V18, P1043, DOI 10.1038/sj.leu.2403365; Pui CH, 2003, NEW ENGL J MED, V349, P1299; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2003, INT J HEMATOL, V78, P383, DOI 10.1007/BF02983810	6	115	120	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2158	2160		10.1056/NEJMp048313	http://dx.doi.org/10.1056/NEJMp048313			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917380				2022-12-01	WOS:000229333300002
J	Webster, R; Hulse, D				Webster, R; Hulse, D			Controlling avian flu at the source	NATURE			English	Editorial Material							INFLUENZA-VIRUS; H5N1 INFLUENZA		St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, R (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.							deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746	4	34	37	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					415	416		10.1038/435415a	http://dx.doi.org/10.1038/435415a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917777	Bronze, Green Published			2022-12-01	WOS:000229337800023
J	Reijman, M; Hazes, JMW; Pols, HAP; Bernsen, RMD; Koes, BW; Bierma-Zeinstra, SMA				Reijman, M; Hazes, JMW; Pols, HAP; Bernsen, RMD; Koes, BW; Bierma-Zeinstra, SMA			Role of radiography in predicting progression of osteoarthritis of the hip: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISABILITY; DISEASE; KNEE; DETERMINANTS; JOINT	Objectives To investigate which variables identify people at high risk of progression of osteoarthritis of the hip. Design Population based cohort study. Setting Ommoord district in Rotterdam, Netherlands. Participants 1904 men and women aged 55 years and older from the Rotterdam study were selected on the basis of the presence of osteoarthritic signs on radiography at baseline, as defined by a Kellgren and Lawrence score >= grade 1. Main outcome measures Radiological progression of osteoarthritis of the hip, defined as a decrease of joint space width (>= 1.0 mm) at follow-up or the presence of a total hip replacement. Methods Potential determinants of progression of hip osteoarthritis were collected at baseline. x Ray films of the hip at baseline and follow-up (mean follow-up time 6.6 years) were evaluated. Multivariate logistic regression models were used to assess the association between potential risk factors and progression of hip osteoarthritis. Results In 13.1% (1904 subjects) of the study population (mean age 66.2 years), progression of hip osteoarthritis was evident on the radiograph. Starting with a simple model of only directly obtainable variables, the Kellgren and Lawrence score at baseline, when added to the model, was a strong predictor (odds ratio 5.8, 95% confidence interval 4.0 to 8.4), increasing to 24.3 (11.3 to 52.1) in subjects with hip pain at baseline. Conclusions The Kellgren and Lawrence score at baseline was by far the strongest predictor for progression of hip osteoarthritis, especially in patients with existing hip pain at baseline. In patients with hip pain, a radiograph has strong additional value in identifying those at high risk of progression of hip osteoarthritis.	Erasmus MC, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Reijman, M (corresponding author), Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.reijman@erasmusmc.nl	Reijman, Max/AFO-6451-2022; Koes, Bart w/K-4614-2016; Bierma-Zeinstra, Sita/AAF-2122-2019	Koes, Bart w/0000-0002-0450-9969; 				Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 2004, OSTEOARTHR CARTILAGE, V12, P515, DOI 10.1016/j.joca.2004.04.004; ALUNAN RD, 1996, OSTEOARTHR CARTILAGE, V4, P217; Auleley GR, 2000, ANN RHEUM DIS, V59, P422, DOI 10.1136/ard.59.6.422; Bergink AP, 2003, ARTHRITIS RHEUM, V48, P1913, DOI 10.1002/art.11046; Birrell F, 2003, BRIT J GEN PRACT, V53, P26; *CENTR BUR STAT, 1985, STAND BER; Chalmers J, 1999, J HYPERTENS, V17, P151; CROFT P, 1990, AM J EPIDEMIOL, V132, P514, DOI 10.1093/oxfordjournals.aje.a115687; Dahaghin S, 2005, ANN RHEUM DIS, V64, P99, DOI 10.1136/ard.2003.017087; Dougados M, 1999, J RHEUMATOL, V26, P855; Dougados M, 1996, ANN RHEUM DIS, V55, P356, DOI 10.1136/ard.55.6.356; Dougados M, 1996, ANN RHEUM DIS, V55, P552; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kellgren JH, 1963, EPIDEMIOLOGY CHRONIC; Lievense AM, 2002, ARTHRIT RHEUM-ARTHR, V47, P556, DOI 10.1002/art.10660; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; Reijman M, 2004, ANN RHEUM DIS, V63, P1427, DOI 10.1136/ard.2003.016477; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Weel AEAM, 1999, J CLIN ENDOCR METAB, V84, P3146, DOI 10.1210/jc.84.9.3146; World Health Organization, 1985, TECHN REP SER WHO; Zhang YQ, 1996, J RHEUMATOL, V23, P1130	25	47	49	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2005	330	7501					1183	1185		10.1136/bmj.38442.457488.8F	http://dx.doi.org/10.1136/bmj.38442.457488.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15894555	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000229320500018
J	Seagroatt, V				Seagroatt, V			MMR vaccine and Crohn's disease: ecological study of hospital admissions in England, 1991 to 2002	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY-BOWEL-DISEASE; MEASLES VACCINATION; RISK		Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Seagroatt, V (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.	valerie.seagroatt@dphpc.ox.ac.uk						Davis RL, 2001, ARCH PEDIAT ADOL MED, V155, P354, DOI 10.1001/archpedi.155.3.354; Department of Health, HOSP EP STAT; *HLTH PROT AG, COMPL PRIM COURS VAC; Montgomery SM, 1999, GASTROENTEROLOGY, V116, P796, DOI 10.1016/S0016-5085(99)70062-4; Pebody RG, 1998, BRIT MED J, V316, P1745; Seagroatt V, 2003, J EPIDEMIOL COMMUN H, V57, P883, DOI 10.1136/jech.57.11.883; Smeeth L, 2004, LANCET, V364, P963, DOI 10.1016/S0140-6736(04)17020-7; THOMPSON NP, 1995, LANCET, V345, P1071, DOI 10.1016/S0140-6736(95)90816-1; WHEELER JG, 2001, JOINT C SOC SOC MED	9	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1120	1121		10.1136/bmj.38449.476759.AE	http://dx.doi.org/10.1136/bmj.38449.476759.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15837703	Bronze, Green Published			2022-12-01	WOS:000229166900019
J	Mitchell, DG; Brandt, PC; Roelof, EC; Dandouras, J; Krimigis, SM; Mauk, BH				Mitchell, DG; Brandt, PC; Roelof, EC; Dandouras, J; Krimigis, SM; Mauk, BH			Energetic neutral atom emissions from Titan interaction with Saturn's magnetosphere	SCIENCE			English	Article							UPPER-ATMOSPHERE; EXOSPHERE; MIMI	The Cassini Magnetospheric Imaging Instrument (MIMI) observed the interaction of Saturn's largest moon, Titan, with Saturn's magnetosphere during two close flybys of Titan on 26 October and 13 December 2004. The MIMI Ion and Neutral Camera (INCA) continuously imaged the energetic neutral atoms (ENAs) generated by charge exchange reactions between the energetic, singly ionized trapped magnetospheric ions and the outer atmosphere, or exosphere, of Titan. The images reveal a halo of variable ENA emission about Titan's nearly collisionless outer atmosphere that fades at larger distances as the exospheric density decays exponentially. The attitude of the emissions varies, and they are not symmetrical about the moon, reflecting the complexity of the interactions between Titan's upper atmosphere and Saturn's space environment.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21042 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Mitchell, DG (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21042 USA.	don.mitchell@jhuapl.edu	Brandt, Pontus C/N-1218-2016; Mauk, Barry H/E-8420-2017; Mitchell, Donald G/H-4601-2016; Dandouras, Iannis/V-2709-2017; Roelof, Edmond/G-6654-2019; Krimigis, Stamatios/G-4591-2019	Brandt, Pontus C/0000-0002-4644-0306; Mauk, Barry H/0000-0001-9789-3797; Mitchell, Donald G/0000-0003-1960-2119; Dandouras, Iannis/0000-0002-7121-1118; Roelof, Edmond/0000-0002-2270-0652; Krimigis, Stamatios/0000-0003-2781-2386				Amsif A, 1997, J GEOPHYS RES-SPACE, V102, P22169, DOI 10.1029/97JA01597; Dandouras J, 1999, PLANET SPACE SCI, V47, P1355, DOI 10.1016/S0032-0633(99)00057-4; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; YELLE RV, 1991, ASTROPHYS J, V383, P380, DOI 10.1086/170796	6	35	36	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					989	992		10.1126/science.1109805	http://dx.doi.org/10.1126/science.1109805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890874				2022-12-01	WOS:000229190700036
J	Acar, M; Becskei, A; van Oudenaarden, A				Acar, M; Becskei, A; van Oudenaarden, A			Enhancement of cellular memory by reducing stochastic transitions	NATURE			English	Article							EUKARYOTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; POSITIVE-FEEDBACK; TOGGLE SWITCH; NETWORK; NOISE; MULTISTABILITY; METABOLISM; STABILITY	On induction of cell differentiation, distinct cell phenotypes are encoded by complex genetic networks(1-3). These networks can prevent the reversion of established phenotypes even in the presence of significant fluctuations. Here we explore the key parameters that determine the stability of cellular memory by using the yeast galactose-signalling network as a model system. This network contains multiple nested feedback loops. Of the two positive feedback loops, only the loop mediated by the cytoplasmic signal transducer Gal3p is able to generate two stable expression states with a persistent memory of previous galactose consumption states. The parallel loop mediated by the galactose transporter Gal2p only increases the expression difference between the two states. A negative feedback through the inhibitor Gal80p reduces the strength of the core positive feedback. Despite this, a constitutive increase in the Gal80p concentration tunes the system from having destabilized memory to having persistent memory. A model reveals that fluctuations are trapped more efficiently at higher Gal80p concentrations. Indeed, the rate at which single cells randomly switch back and forth between expression states was reduced. These observations provide a quantitative understanding of the stability and reversibility of cellular differentiation states.	MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; Acar, Murat/AIB-8244-2022	Becskei, Attila/0000-0002-9462-0934				Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BHAT PJ, 1991, GENETICS, V128, P233; Bialek W, 2001, ADV NEUR IN, V13, P103; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mizutani A, 2003, EMBO J, V22, P2178, DOI 10.1093/emboj/cdg220; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sillje HHW, 1997, J BACTERIOL, V179, P6560, DOI 10.1128/jb.179.21.6560-6565.1997; SuzukiFujimoto T, 1996, MOL CELL BIOL, V16, P2504; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	30	384	392	6	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					228	232		10.1038/nature03524	http://dx.doi.org/10.1038/nature03524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889097				2022-12-01	WOS:000229021100046
J	Horton, JR; Liebert, K; Hattman, S; Jeltsch, A; Cheng, XD				Horton, JR; Liebert, K; Hattman, S; Jeltsch, A; Cheng, XD			Transition from nonspecific to specific DNA interactions along the substrate-recognition pathway of Dam methyltransferase	CELL			English	Article							ADENINE METHYLASE MUTANTS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TARGET BASE; YERSINIA-PSEUDOTUBERCULOSIS; HETEROLOGOUS SEROVARS; SEQUENCE SPECIFICITY; BACTERIOPHAGE-T4 DAM; IMMUNE-RESPONSES; GENE-EXPRESSION	DNA methyltransferases methylate target bases within specific nucleotide sequences. Three structures are described for bacteriophage T4 DNA-adenine methyltransferase (T4Dam) in ternary complexes with partially and fully specific DNA and a methyl-donor analog. We also report the effects of substitutions in the related Escherichia coli DNA methyltransferase (EcoDam), altering residues corresponding to those involved in specific interaction with the canonical GATC target sequence in T4Dam. We have identified two types of protein-DNA interactions: discriminatory contacts, which stabilize the transition state and accelerate methylation of the cognate site, and antidiscriminatory contacts, which do not significantly affect methylation of the cognate site but disfavor activity at noncognate sites. These structures illustrate the transition in enzyme-DNA interaction from nonspecific to specific interaction, suggesting that there is a temporal order for formation of specific contacts.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Int Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Emory University; University of Rochester	Jeltsch, A (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	a.jeltsch@iu-bremen.de; xcheng@emory.edu	Horton, John R/ABB-4770-2020; Hu, Ruogu/B-2203-2008; Jeltsch, Albert/O-7404-2014; Horton, John/F-2375-2010	Jeltsch, Albert/0000-0001-6113-9290; Horton, John/0000-0001-9749-8068	NIGMS NIH HHS [R01 GM049245, GM 49245, GM 29227, R01 GM049245-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BW, 1999, BIOCHEMISTRY-US, V38, P5308, DOI 10.1021/bi9900020; Beck C, 2002, BIOCHEMISTRY-US, V41, P14103, DOI 10.1021/bi025979a; BROOKS JE, 1978, J MOL BIOL, V126, P381, DOI 10.1016/0022-2836(78)90047-5; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Chen L, 2003, MICROBIOL-SGM, V149, P2283, DOI 10.1099/mic.0.26251-0; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Dueger EL, 2003, INT J FOOD MICROBIOL, V80, P153, DOI 10.1016/S0168-1605(02)00152-6; Dueger EL, 2001, INFECT IMMUN, V69, P7950, DOI 10.1128/IAI.69.12.7950-7954.2001; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hattman S, 2004, PROG NUCLEIC ACID RE, V77, P67, DOI 10.1016/S0079-6603(04)77003-8; HATTMAN S, 1970, VIROLOGY, V42, P359, DOI 10.1016/0042-6822(70)90279-5; HATTMAN S, 1978, J MOL BIOL, V126, P367, DOI 10.1016/0022-2836(78)90046-3; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; HATTMAN S, 1985, J BACTERIOL, V164, P932, DOI 10.1128/JB.164.2.932-937.1985; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Heithoff DM, 2001, INFECT IMMUN, V69, P6725, DOI 10.1128/IAI.69.11.6725-6730.2001; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Horton NC, 2002, NAT STRUCT BIOL, V9, P42, DOI 10.1038/nsb741; Julio SM, 2002, INFECT IMMUN, V70, P1006, DOI 10.1128/IAI.70.2.1006-1009.2002; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; KOSSYKH VG, 1995, J BIOL CHEM, V270, P14389, DOI 10.1074/jbc.270.24.14389; Krabbe M, 2000, BACTERIAL STRESS RESPONSES, P305; LACKS S, 1977, J MOL BIOL, V114, P153, DOI 10.1016/0022-2836(77)90289-3; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LAUSTER R, 1987, FEBS LETT, V220, P167, DOI 10.1016/0014-5793(87)80897-9; Liebert K, 2004, J MOL BIOL, V341, P443, DOI 10.1016/j.jmb.2004.05.033; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Malygin EG, 1999, NUCLEIC ACIDS RES, V27, P1135, DOI 10.1093/nar/27.4.1135; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; MINER Z, 1989, NUCLEIC ACIDS RES, V17, P8149, DOI 10.1093/nar/17.20.8149; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Roth M, 2001, NUCLEIC ACIDS RES, V29, P3137, DOI 10.1093/nar/29.15.3137; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; Tsutakawa SE, 1999, CELL, V99, P615, DOI 10.1016/S0092-8674(00)81550-0; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Yang W, 2000, MUTAT RES-DNA REPAIR, V460, P245, DOI 10.1016/S0921-8777(00)00030-6; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; Zinoviev VV, 2003, J BIOL CHEM, V278, P7829, DOI 10.1074/jbc.M210769200	53	73	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					349	361		10.1016/j.cell.2005.02.021	http://dx.doi.org/10.1016/j.cell.2005.02.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882618	Green Accepted, Bronze			2022-12-01	WOS:000229031600006
J	Zimov, SA				Zimov, SA			Pleistocene park: Return of the mammoth's ecosystem	SCIENCE			English	Article									Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Far E Branch, Cherskii 678830, Republic Sakha, Russia	Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences	Zimov, SA (corresponding author), Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Far E Branch, POB 18, Cherskii 678830, Republic Sakha, Russia.		Zimov, Sergey/K-3009-2018	Zimov, Sergey/0000-0002-0053-6599					0	134	143	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					796	798		10.1126/science.1113442	http://dx.doi.org/10.1126/science.1113442			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879196				2022-12-01	WOS:000228986500025
J	Min, MS; Yang, SY; Bonett, RM; Vieites, DR; Brandon, RA; Wake, DB				Min, MS; Yang, SY; Bonett, RM; Vieites, DR; Brandon, RA; Wake, DB			Discovery of the first Asian plethodontid salamander	NATURE			English	Article							LIFE-HISTORY EVOLUTION; EASTERN NORTH-AMERICA	Nearly 70% of the 535 species of salamanders in the world are members of a single family, the Plethodontidae, or lungless salamanders(1). The centre of diversity for this clade is North and Middle America, where the vast majority (99%) of species salamander, from montane woodlands in southwestern Korea. The new species superficially resembles members of North American genera, in particular the morphologically conservative genus Plethodon. However, phylogenetic analysis of the nuclear encoded gene Rag-1 shows the new taxon to be widely divergent from Plethodon. The new salamander differs osteologically from putative relatives, especially with respect to the tongue ( attached protrusible) and the derived tarsus(2-6). We place the species in a new genus on the basis of the morphological and molecular data. The distribution of the new salamander adds to the enigma of Old World plethodontids, which are otherwise restricted to the western Mediterranean region(7,8), suggesting a more extensive past distribution of the family.	Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; Seoul Natl Univ, Sch Agr Biotechnol, Conservat Genome Resource Bank Korean Wildlife, Seoul 151742, South Korea; Seoul Natl Univ, Sch Agr Biotechnol, Brain Korea 21, Seoul 151742, South Korea; Inha Univ, Dept Biol, Inchon 402751, South Korea; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA	University of California System; University of California Berkeley; Seoul National University (SNU); Seoul National University (SNU); Inha University; University of California System; University of California Berkeley; Southern Illinois University System; Southern Illinois University	Wake, DB (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	wakelab@uclink.berkeley.edu	Vieites, David/B-4481-2009	Vieites, David/0000-0001-5551-7419				BRODIE E D JR, 1970, Herpetologica, V26, P468; Chippindale PT, 2004, EVOLUTION, V58, P2809; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; Larson Allan, 2003, P31; LOMBARD RE, 1977, J MORPHOL, V153, P39; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; Rasmuseen D.L, 2003, CENOZOIC SYSTEMS ROC, P479; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; TIHEN JA, 1981, J HERPETOL, V15, P35, DOI 10.2307/1563644; Wake David B., 2000, P95, DOI 10.1016/B978-012632590-4/50005-8; WAKE DAVID B., 1966, MEM S CALIF ACAD SCI, V4, P1; WAKE DB, 1978, EVOLUTION, V32, P529, DOI 10.1111/j.1558-5646.1978.tb04595.x; WAKE DB, 1983, NATURAL HIST MUSEUM, V345, P1; Wallace SC, 2004, NATURE, V431, P556, DOI 10.1038/nature02819; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; 2005, AMPHIBIAWEB	18	81	90	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					87	90		10.1038/nature03474	http://dx.doi.org/10.1038/nature03474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875021				2022-12-01	WOS:000228864600043
J	Fogassi, L; Ferrari, PF; Gesierich, B; Rozzi, S; Chersi, F; Rizzolatti, G				Fogassi, L; Ferrari, PF; Gesierich, B; Rozzi, S; Chersi, F; Rizzolatti, G			Parietal lobe: From action organization to intention understanding	SCIENCE			English	Article							CORTEX; NEURONS; MONKEY; REPRESENTATION; RECOGNITION; PROJECTIONS; MECHANISMS; AFFERENT; OBJECTS	Inferior parietal lobule (IPL) neurons were studied when monkeys performed motor acts embedded in different actions and when they observed similar acts done by an experimenter. Most motor IPL neurons coding a specific act (e.g., grasping) showed markedly different activations when this act was part of different actions (e.g., for eating or for placing). Many motor IPL neurons also discharged during the observation of acts done by others. Most responded differentially when the same observed act was embedded in a specific action. These neurons fired during the observation of an act, before the beginning of the subsequent acts specifying the action. Thus, these neurons not only code the observed motor act but also allow the observer to understand the agent's intentions.	Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy	University of Parma; University of Parma	Fogassi, L (corresponding author), Univ Parma, Dipartimento Psicol, Borgo Carissimi 10, I-43100 Parma, Italy.	fogassi@unipr.it	Ferrari, Pier Francesco/G-5547-2017; Rozzi, Stefano/F-9915-2019; FOGASSI, Leonardo/K-3541-2018	Rozzi, Stefano/0000-0002-6147-1530; FOGASSI, Leonardo/0000-0003-3348-039X				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BAIZER JS, 1991, J NEUROSCI, V11, P168; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; COLBY CL, 1996, INFORMATION INTEGRAT, V14, P157; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; *EU, 2002, QLG3CT200200746 EU; FERRARI PF, 2003, SOC NEUR ABS, V919; FERRARI PF, UNPUB; FOGASSI L, 1998, SOC NEUR ABS, V257; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jellema T., 2002, IMITATIVE MIND DEV E, P267; LUPPINO G, 2004, FENS ABSTR; Luria AR., 1973, WORKING BRAIN; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; PERRETT DI, 1989, J EXP BIOL, V146, P87; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Sakata Hideo, 1994, Current Opinion in Neurobiology, V4, P847, DOI 10.1016/0959-4388(94)90133-3; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; TANAKA M, 2004, SOC NEUR ABS, V82; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Yokochi H, 2003, SOMATOSENS MOT RES, V20, P115, DOI 10.1080/0899022031000105145	33	1302	1346	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					662	667		10.1126/science.1106138	http://dx.doi.org/10.1126/science.1106138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860620				2022-12-01	WOS:000228810900040
J	Castilla, J; Saa, P; Hetz, C; Soto, C				Castilla, J; Saa, P; Hetz, C; Soto, C			In vitro generation of infectious scrapie prions	CELL			English	Article							CYCLIC AMPLIFICATION; ALPHA-HELICES; PROTEIN; CONVERSION; CONFORMATIONS; PROPAGATION; DISEASES	Prions are unconventional infectious agents responsible for transmissible spongiform encephalopathy (TSE) diseases. They are thought to be composed exclusively of the protease-resistant prion protein (PrPres) that replicates in the body by inducing the misfolding of the cellular prion protein (PrPc). Although compelling evidence supports this hypothesis, generation of infectious prion particles in vitro has not been convincingly demonstrated. Here we show that PrPc -> PrPres conversion can be mimicked in vitro by cyclic amplification of protein misfolding, resulting in indefinite amplification of PrPres. The in vitro-generated forms of PrPres share similar biochemical and structural properties with PrPres derived from sick brains. Inoculation of wild-type hamsters with in vitro-produced PrPres led to a scrapie disease identical to the illness produced by brain infectious material. These findings demonstrate that prions can be generated in vitro and provide strong evidence in support of the protein-only hypothesis of prion transmission.	Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA; Univ Autonoma Madrid, Ctr Mol Biol, E-28049 Madrid, Spain; Univ Chile, Inst Ciencias Biomed, Santiago, Chile	University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid; Universidad de Chile	Soto, C (corresponding author), Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA.	clsoto@utmb.edu	Saa, Paula/AAB-6607-2019; Castilla, Joaquín/J-8414-2019; Hetz, Claudio/I-1900-2013; Hetz, Claudio/ABD-7514-2021; Castilla, Joaquin/D-5261-2011	Saa, Paula/0000-0001-6077-4532; Castilla, Joaquín/0000-0002-2216-1361; Hetz, Claudio/0000-0001-7724-1767; Castilla, Joaquin/0000-0002-2216-1361	NIA NIH HHS [R03 AG0224642] Funding Source: Medline; PHS HHS [R01 N549173] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2004, TECHNIQUES PRION RES, P198, DOI [10.1007/978-3-0348-7949-1_14, DOI 10.1007/978-3-0348-7949-1_14]; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chen YM, 2000, J LAW ECON ORGAN, V16, P209, DOI 10.1093/jleo/16.1.209; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; May BCH, 2004, TRENDS BIOCHEM SCI, V29, P162, DOI 10.1016/j.tibs.2004.02.008; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Mestel R, 1996, SCIENCE, V273, P184, DOI 10.1126/science.273.5272.184; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Piening N, 2005, BIOCHEM BIOPH RES CO, V326, P339, DOI 10.1016/j.bbrc.2004.11.039; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SIGURDSSON BJORN, 1954, BRIT VET JOUR, V110, P255; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wille H, 2000, J STRUCT BIOL, V130, P323, DOI 10.1006/jsbi.2000.4242; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	45	623	655	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					195	206		10.1016/j.cell.2005.02.011	http://dx.doi.org/10.1016/j.cell.2005.02.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851027	Bronze			2022-12-01	WOS:000228705000008
J	Segev, DL; Gentry, SE; Warren, DS; Reel, B; Montgomery, RA				Segev, DL; Gentry, SE; Warren, DS; Reel, B; Montgomery, RA			Kidney paired donation and optimizing the use of live donor organs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-TRANSPLANTATION; CADAVERIC KIDNEYS; HLA ANTIGENS; PLASMAPHERESIS; RECIPIENTS; REJECTION; ALGORITHM; SURVIVAL; GLOBULIN; ANTIBODY	Context Blood type and crossmatch incompatibility will exclude at least one third of patients in need from receiving a live donor kidney transplant. Kidney paired donation (KPD) offers incompatible donor/recipient pairs the opportunity to match for compatible transplants. Despite its increasing popularity, very few transplants have resulted from KPD. Objective To determine the potential impact of improved matching schemes on the number and quality of transplants achievable with KPD. Design, Setting, and Population We developed a model that simulates pools of incompatible donor/recipient pairs. We designed a mathematically verifiable optimized matching algorithm and compared it with the scheme currently used in some centers and regions. Simulated patients from the general community with characteristics drawn from distributions describing end-stage renal disease patients eligible for renal transplantation and their willing and eligible live donors. Main Outcome Measures Number of kidneys matched, HLA mismatch of matched kidneys, and number of grafts surviving 5 years after transplantation. Results A national optimized matching algorithm would result in more transplants (47.7% vs 42.0%, P < .001), better HLA concordance (3.0 vs 4.5 mismatched antigens; P < .001), more grafts surviving at 5 years (34.9% vs 28.7%; P < .001), and a reduction in the number of pairs required to travel (2.9% vs 18.4%; P < .001) when compared with an extension of the currently used first-accept scheme to a national level. Furthermore, highly sensitized patients would benefit 6-fold from a national optimized scheme (2.3% vs 14.1% successfully matched; P < .001). Even if only 7% of patients awaiting kidney transplantation participated in an optimized national KPD program, the health care system could save as much as $750 million. Conclusions The combination of a national KPD program and a mathematically optimized matching algorithm yields more matches with lower HLA disparity. Optimized matching affords patients the flexibility of customizing their matching priorities and the security of knowing that the greatest number of high-quality matches will be found and distributed equitably.	Johns Hopkins Univ, Sch Med, Dept Surg, Div Transplantat, Baltimore, MD 21287 USA; MIT, Informat & Decis Syst Lab, Cambridge, MA 02139 USA	Johns Hopkins University; Massachusetts Institute of Technology (MIT)	Segev, DL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Div Transplantat, 720 Rutland Ave,Ross 765, Baltimore, MD 21287 USA.	dorry@jhmi.edu	Gentry, Sommer/H-7101-2019	Gentry, Sommer/0000-0003-4530-8917				Delmonico FL, 2004, AM J TRANSPLANT, V4, P1628, DOI 10.1111/j.1600-6143.2004.00572.x; Doxiadis IIN, 1996, LANCET, V348, P850, DOI 10.1016/S0140-6736(96)02296-9; Doxiadis IIN, 1996, TRANSPLANT P, V28, P224; Duquesnoy RJ, 2002, HUM IMMUNOL, V63, P339, DOI 10.1016/S0198-8859(02)00382-8; EDMONDS J, 1965, CANADIAN J MATH, V17, P449, DOI 10.4153/CJM-1965-045-4; GJERTSON DW, 1991, NEW ENGL J MED, V324, P1032, DOI 10.1056/NEJM199104113241505; Jordan Stanley C, 2003, Clin Transpl, P193; LEFFELL MS, 1994, TRANSPLANTATION, V58, P1119, DOI 10.1097/00007890-199411270-00011; LOVASZ L, 1986, MATCHING THEORY, P369; MARTIN S, 1993, TRANSPLANT P, V25, P265; Montgomery RA, 2004, AM J TRANSPLANT, V4, P1011, DOI 10.1111/j.1600-6143.2004.00496.x; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Montgomery Robert A, 2003, Clin Transpl, P199; Opelz G, 1997, TRANSPLANTATION, V64, P1473, DOI 10.1097/00007890-199711270-00017; Ross LF, 1997, NEW ENGL J MED, V336, P1752, DOI 10.1056/NEJM199706123362412; Ross LF, 2000, TRANSPLANTATION, V69, P1539; Roth AE, 2004, Q J ECON, V119, P457, DOI 10.1162/0033553041382157; Sonnenday CJ, 2004, AM J TRANSPLANT, V4, P1315, DOI 10.1111/j.1600-6143.2004.00507.x; Stegall MD, 2004, TRANSPLANTATION, V78, P635, DOI 10.1097/01.tp.0000136263.46262.0d; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Thompson JS, 2002, TRANSPLANTATION, V73, P1274, DOI 10.1097/00007890-200204270-00015; *UNOS, 2004, CONC PROP NAT LIV DO; *UNOS, UNOS ORG PROC TRANSP; *US REN DAT SYST, 2003, US REN DAT SYST ANN; Warren DS, 2004, AM J TRANSPLANT, V4, P561, DOI 10.1111/j.1600-6143.2004.00364.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zachary AA, 2003, TRANSPLANTATION, V76, P1519, DOI 10.1097/01.TP.0000090868.88895.E0; Zenios SA, 2002, MANAGE SCI, V48, P328, DOI 10.1287/mnsc.48.3.328.7732; Zenios SA, 2001, TRANSPLANTATION, V72, P648, DOI 10.1097/00007890-200108270-00015	30	291	294	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1883	1890		10.1001/jama.293.15.1883	http://dx.doi.org/10.1001/jama.293.15.1883			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840863	Bronze			2022-12-01	WOS:000228401700027
J	Mace, KA; Pearson, JC; McGinnis, W				Mace, KA; Pearson, JC; McGinnis, W			An epidermal barrier wound repair pathway in Drosophila is mediated by grainy head	SCIENCE			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTORS; DOPA DECARBOXYLASE GENE; HOMEOTIC GENES; MELANOGASTER; CUTICLE; FAMILY; IDENTIFICATION; EXPRESSION; INDUCTION; IMMUNITY	We used wounded Drosophila embryos to define an evolutionarily conserved pathway for repairing the epidermal surface barrier. This pathway includes a wound response enhancer from the Ddc gene that requires grainy head (grh) function and binding sites for the Grh transcription factor. At the signaling level, tyrosine kinase and extracellular signal-regulated kinase (ERK) activities are induced in epidermal cells near wounds, and activated ERK is required for a robust wound response. The conservation of this Grh-dependent pathway suggests that the repair of insect cuticle and mammal skin is controlled by an ancient, shared control system for constructing and heating the animal body surface barrier.	Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	wmcginnis@ucsd.edu			NICHD NIH HHS [R01HD28315] Funding Source: Medline; NIGMS NIH HHS [T32GM07240] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Chen L, 2002, MECH DEVELOP, V114, P95, DOI 10.1016/S0925-4773(02)00064-3; Dieckgraefe BK, 1999, AM J PHYSIOL-GASTR L, V276, pG322, DOI 10.1152/ajpgi.1999.276.2.G322; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Lee HY, 2004, MECH DEVELOP, V121, P37, DOI 10.1016/j.mod.2003.11.002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Macias A, 1996, EMBO J, V15, P334, DOI 10.1002/j.1460-2075.1996.tb00363.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ostrowski S, 2002, GENETICS, V161, P171; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; SCHAEFER J, 1987, SCIENCE, V235, P1200, DOI 10.1126/science.3823880; SCHOLNICK SB, 1986, SCIENCE, V234, P998, DOI 10.1126/science.3095924; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Walsh PN, 2002, ESSAYS BIOCHEM, V38, P95, DOI 10.1042/bse0380095; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Wright TRF, 1996, J HERED, V87, P175, DOI 10.1093/oxfordjournals.jhered.a022983	38	178	180	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					381	385		10.1126/science.1107573	http://dx.doi.org/10.1126/science.1107573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831751				2022-12-01	WOS:000228492000043
J	Emison, ES; McCallion, AS; Kashuk, CS; Bush, RT; Grice, E; Lin, S; Portnoy, ME; Cutler, DJ; Green, ED; Chakravarti, A				Emison, ES; McCallion, AS; Kashuk, CS; Bush, RT; Grice, E; Lin, S; Portnoy, ME; Cutler, DJ; Green, ED; Chakravarti, A			A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk	NATURE			English	Article							GENOME-WIDE ASSOCIATION; DIABETES-MELLITUS; HIV-1 INFECTION; MOUSE MODEL; EXPRESSION; HAPLOTYPE; GENE; TRANSMISSION; DISEQUILIBRIUM; IDENTIFICATION	The identification of common variants that contribute to the genesis of human inherited disorders remains a significant challenge. Hirschsprung disease (HSCR) is a multifactorial, non-mendelian disorder in which rare high-penetrance coding sequence mutations in the receptor tyrosine kinase RET contribute to risk in combination with mutations at other genes. We have used family-based association studies to identify a disease interval, and integrated this with comparative and functional genomic analysis to prioritize conserved and functional elements within which mutations can be sought. We now show that a common non-coding RET variant within a conserved enhancer-like sequence in intron 1 is significantly associated with HSCR susceptibility and makes a 20-fold greater contribution to risk than rare alleles do. This mutation reduces in vitro enhancer activity markedly, has low penetrance, has different genetic effects in males and females, and explains several features of the complex inheritance pattern of HSCR. Thus, common low-penetrance variants, identified by association studies, can underlie both common and rare diseases.	Johns Hopkins Univ, Sch Med, KcKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, KcKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Lin, Shin/0000-0003-0118-0413; Grice, Elizabeth/0000-0003-3939-2200	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000196, Z01HG000060, ZIAHG000060, ZIBHG000196] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; ALLISON AC, 1961, BRIT MED J, V5236, P1346; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Cann HM, 2002, SCIENCE, V296, P261; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P251; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2003, J MED GENET, V40; Haldane JBS., 1949, HEREDITAS S, V35, P267, DOI DOI 10.1111/J.1601-5223.1949.TB03339.X; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lin S, 2004, GENOME RES, V14, P1624, DOI 10.1101/gr.2204604; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Nobrega MA, 2004, J PHYSIOL-LONDON, V554, P31, DOI 10.1113/jphysiol.2003.050948; Pitera JE, 2001, AM J PATHOL, V159, P2321, DOI 10.1016/S0002-9440(10)63082-9; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sancandi M, 2003, J MED GENET, V40, P714, DOI 10.1136/jmg.40.9.714; Sato Takeshi, 2000, Research Communications in Biochemistry and Cell and Molecular Biology, V4, P3; Shepherd IT, 2004, DEVELOPMENT, V131, P241, DOI 10.1242/dev.00912; Shepherd IT, 2001, DEV BIOL, V231, P420, DOI 10.1006/dbio.2000.0145; Shoba T, 2002, NEUROSCI LETT, V318, P129, DOI 10.1016/S0304-3940(01)02491-0; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	42	337	349	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					857	863		10.1038/nature03467	http://dx.doi.org/10.1038/nature03467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829955				2022-12-01	WOS:000228327600031
J	Hunt, JH; Amdam, GV				Hunt, JH; Amdam, GV			Bivoltinism as an antecedent to eusociality in the paper wasp genus Polistes	SCIENCE			English	Article							SOCIAL WASP; HYMENOPTERA; DIAPAUSE; BEHAVIOR; MOTH; PROTEINS; CASTE; FOOD	To learn the evolutionary trajectories of caste differentiation in eusocial species is a major goal of sociobiology. We present an explanatory framework for caste evolution in the eusocial wasp genus Polistes (Vespidae), which is a model system for insect eusocial evolution. We hypothesize that Polistes worker and gyne castes stem from two developmental pathways that characterized the bivoltine life cycle of a solitary ancestor. Through individual-based simulations, we show that our mechanistic framework can reproduce colony-level characteristics of Polistes and, thereby, that social castes can emerge from solitary regulatory pathways. Our explanatory framework illustrates, by specific example, a changed perspective for understanding insect social evolution.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway	University of Missouri System; University of Missouri Saint Louis; University of California System; University of California Davis; Norwegian University of Life Sciences	Hunt, JH (corresponding author), Univ Missouri, Dept Biol, 1 Univ Blvd, St Louis, MO 63121 USA.	jimhunt@umst.edu; gvamdam@ucdavis.edu	Hunt, James/D-1740-2009		NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG022500, P01 AG022500-03, P01 AG 22500] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; BOHM MK, 1972, J INSECT PHYSIOL, V18, P1875, DOI 10.1016/0022-1910(72)90158-8; BOYNE JV, 1986, J ENTOMOL SCI, V21, P301, DOI 10.18474/0749-8004-21.4.301; Cervo Rita, 1996, P98; Cowan D.P., 1991, P33; DAPPORTO L, IN PRESS ANN ZOOL FE; Eickwort G.C., 1981, P199; Field J, 1999, BEHAV ECOL SOCIOBIOL, V45, P378, DOI 10.1007/s002650050574; Gadagkar R, 2001, SOCIAL BIOL ROPALIDI; Godlewski J, 2001, J INSECT PHYSIOL, V47, P759, DOI 10.1016/S0022-1910(01)00050-6; Hunt J.H., 1991, P426; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Hunt JH, 2002, ECOL ENTOMOL, V27, P467, DOI 10.1046/j.1365-2311.2002.00369.x; HUNT JH, 1982, EVOLUTION, V36, P1318, DOI 10.1111/j.1558-5646.1982.tb05501.x; ISHAY J, 1968, ANIM BEHAV, V16, P298, DOI 10.1016/0003-3472(68)90013-4; Karsai I, 2002, ENVIRON ENTOMOL, V31, P99, DOI 10.1603/0046-225X-31.1.99; Marchal P., 1897, Compte Rendu des Seances de la Societe de Biologie, P557; MEAD F, 1995, INSECT SOC, V42, P385, DOI 10.1007/BF01242167; Michener C.D., 1990, P77; Munyiri FN, 2004, J INSECT PHYSIOL, V50, P295, DOI 10.1016/j.jinsphys.2004.01.005; O'Donnell S, 1998, ANNU REV ENTOMOL, V43, P323, DOI 10.1146/annurev.ento.43.1.323; ONeill K. M., 2001, CORNELL S ARTHR BIOL; PAGE RE, 1989, AM NAT, V134, P731, DOI 10.1086/285008; Reeve HK, 1998, P NATL ACAD SCI USA, V95, P13737, DOI 10.1073/pnas.95.23.13737; Roubaud E, 1916, ANN SCI NATUR Z, V1, P1; SEGER J, 1983, NATURE, V301, P59, DOI 10.1038/301059a0; STEINBERG S, 1992, ENTOMOL EXP APPL, V62, P269, DOI 10.1007/BF00353446; STRASSMANN JE, 1983, ANIM BEHAV, V31, P431, DOI 10.1016/S0003-3472(83)80063-3; STRASSMANN JE, 1989, J KANSAS ENTOMOL SOC, V62, P353; STRASSMANN JE, 1981, BEHAV ECOL SOCIOBIOL, V8, P55, DOI 10.1007/BF00302844; Suzuki T, 1998, ETHOL ECOL EVOL, V10, P347, DOI 10.1080/08927014.1998.9522848; West Eberhard M. J., 1969, Miscellaneous Publications Museum of Zoology University of Michigan, VNo. 140, P1; WEST-EBERHARD M J, 1978, Journal of the Kansas Entomological Society, V51, P832; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536	34	122	123	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					264	267		10.1126/science.1109724	http://dx.doi.org/10.1126/science.1109724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821094	Green Accepted			2022-12-01	WOS:000228273700057
J	Maizel, A; Busch, MA; Tanahashi, T; Perkovic, J; Kato, M; Hasebe, M; Weigel, D				Maizel, A; Busch, MA; Tanahashi, T; Perkovic, J; Kato, M; Hasebe, M; Weigel, D			The floral regulator LEAFY evolves by substitutions in the DNA binding domain	SCIENCE			English	Article							HOMEOTIC GENE; HOX PROTEIN; EVOLUTION; ARABIDOPSIS; EXPRESSION; DIVERSIFICATION; REPRESSION; INDUCTION; PRIMORDIA; HOMOLOGS	The plant-specific transcription factor LEAFY controls general aspects of the life cycle in a basal plant, the moss Physcomitrella patens. In contrast, LEAFY has more specialized functions in angiosperms, where it specifically induces floral fate during the reproductive phase. This raises the question of a concomitant change in the biochemical function of LEAFY during the evolution of land plants. We report that the DNA binding domain of LEAFY, although largely conserved, has diverged in activity. On the contrary, other, more rapidly evolving portions of the protein have few effects on LEAFY activity.	Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Max Planck Society; Salk Institute; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weiget@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Maizel, Alexis/D-3560-2012	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Maizel, Alexis/0000-0001-6843-1059; Hasebe, Mitsuyasu/0000-0001-7425-8758				Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Frohlich MW, 2000, MOL BIOL EVOL, V17, P1914, DOI 10.1093/oxfordjournals.molbev.a026293; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; Himi S, 2001, J MOL EVOL, V53, P387, DOI 10.1007/s002390010228; Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3; Lamb RS, 2002, DEVELOPMENT, V129, P2079; Litt A, 2003, GENETICS, V165, P821; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Lynch M, 2000, GENETICS, V154, P459; Mellerowicz EJ, 1998, PLANTA, V206, P619, DOI 10.1007/s004250050440; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Tanahashi T, 2005, DEVELOPMENT, V132, P1727, DOI 10.1242/dev.01709; Wada M, 2002, PLANT MOL BIOL, V49, P567, DOI 10.1023/A:1015544207121; William DA, 2004, P NATL ACAD SCI USA, V101, P1775, DOI 10.1073/pnas.0307842100	21	146	163	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					260	263		10.1126/science.1108229	http://dx.doi.org/10.1126/science.1108229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821093				2022-12-01	WOS:000228273700056
J	Hillier, LW; Graves, TA; Fulton, RS; Fulton, LA; Pepin, KH; Minx, P; Wagner-McPherson, C; Layman, D; Wylie, K; Sekhon, M; Becker, MC; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Kremitzki, C; Oddy, L; Du, H; Sun, H; Bradshaw-Cordum, H; Ali, J; Carter, J; Cordes, M; Harris, A; Isak, A; van Brunt, A; Nguyen, C; Du, FY; Courtney, L; Kalicki, J; Ozersky, P; Abbott, S; Armstrong, J; Belter, EA; Caruso, L; Cedroni, M; Cotton, M; Davidson, T; Desai, A; Elliott, G; Erb, T; Fronick, C; Gaige, T; Haakenson, W; Haglund, K; Holmes, A; Harkins, R; Kim, K; Kruchowski, SS; Strong, CM; Grewal, N; Goyea, E; Hou, S; Levy, A; Martinka, S; Mead, K; McLellan, MD; Meyer, R; Maher, JR; Tomlinson, C; Kohlberg, SD; Kozlowicz-Reilly, A; Shah, N; Swearengen-Shahid, S; Snider, J; Strong, JT; Thompson, J; Yoakum, M; Leonard, S; Pearman, C; Trani, L; Radionenko, M; Waligorski, JE; Wang, CY; Rock, SM; Tin-Wollam, AM; Maupin, R; Latreille, P; Wendl, MC; Yang, SP; Pohl, C; Wallis, JW; Spieth, J; Bieri, TA; Berkowicz, N; Nelson, JO; Osborne, J; Ding, L; Meyer, R; Sabo, A; Shotland, Y; Sinha, P; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Jones, TA; She, XW; Ciccarelli, FD; Izaurralde, E; Taylor, J; Schmutz, J; Myers, RM; Cox, DR; Huang, XQ; McPherson, JD; Mardis, ER; Clifton, SW; Warren, WC; Chinwalla, AT; Eddy, SR; Marra, MA; Ovcharenko, I; Furey, TS; Miller, W; Eichler, EE; Bork, P; Suyama, M; Torrents, D; Waterston, RH; Wilson, RK				Hillier, LW; Graves, TA; Fulton, RS; Fulton, LA; Pepin, KH; Minx, P; Wagner-McPherson, C; Layman, D; Wylie, K; Sekhon, M; Becker, MC; Fewell, GA; Delehaunty, KD; Miner, TL; Nash, WE; Kremitzki, C; Oddy, L; Du, H; Sun, H; Bradshaw-Cordum, H; Ali, J; Carter, J; Cordes, M; Harris, A; Isak, A; van Brunt, A; Nguyen, C; Du, FY; Courtney, L; Kalicki, J; Ozersky, P; Abbott, S; Armstrong, J; Belter, EA; Caruso, L; Cedroni, M; Cotton, M; Davidson, T; Desai, A; Elliott, G; Erb, T; Fronick, C; Gaige, T; Haakenson, W; Haglund, K; Holmes, A; Harkins, R; Kim, K; Kruchowski, SS; Strong, CM; Grewal, N; Goyea, E; Hou, S; Levy, A; Martinka, S; Mead, K; McLellan, MD; Meyer, R; Maher, JR; Tomlinson, C; Kohlberg, SD; Kozlowicz-Reilly, A; Shah, N; Swearengen-Shahid, S; Snider, J; Strong, JT; Thompson, J; Yoakum, M; Leonard, S; Pearman, C; Trani, L; Radionenko, M; Waligorski, JE; Wang, CY; Rock, SM; Tin-Wollam, AM; Maupin, R; Latreille, P; Wendl, MC; Yang, SP; Pohl, C; Wallis, JW; Spieth, J; Bieri, TA; Berkowicz, N; Nelson, JO; Osborne, J; Ding, L; Meyer, R; Sabo, A; Shotland, Y; Sinha, P; Wohldmann, PE; Cook, LL; Hickenbotham, MT; Eldred, J; Williams, D; Jones, TA; She, XW; Ciccarelli, FD; Izaurralde, E; Taylor, J; Schmutz, J; Myers, RM; Cox, DR; Huang, XQ; McPherson, JD; Mardis, ER; Clifton, SW; Warren, WC; Chinwalla, AT; Eddy, SR; Marra, MA; Ovcharenko, I; Furey, TS; Miller, W; Eichler, EE; Bork, P; Suyama, M; Torrents, D; Waterston, RH; Wilson, RK			Generation and annotation of the DNA sequences of human chromosomes 2 and 4	NATURE			English	Article							HUMAN-GENOME; CPG ISLANDS; GENE; MAP; MOUSE; INTEGRATION; ALIGNMENTS; EVOLUTION; INSIGHTS; QUALITY	Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes. Chromosome 4 has received attention primarily related to the search for the Huntington's disease gene, but also for genes associated with Wolf-Hirschhorn syndrome, polycystic kidney disease and a form of muscular dystrophy. Here we present approximately 237 million base pairs of sequence for chromosome 2, and 186 million base pairs for chromosome 4, representing more than 99.6% of their euchromatic sequences. Our initial analyses have identified 1,346 protein-coding genes and 1,239 pseudogenes on chromosome 2, and 796 protein-coding genes and 778 pseudogenes on chromosome 4. Extensive analyses confirm the underlying construction of the sequence, and expand our understanding of the structure and evolution of mammalian chromosomes, including gene deserts, segmental duplications and highly variant regions.	Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Penn State Univ, Dept Biol, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Comp Sci, University Pk, PA 16802 USA; Stanford Univ, Sch Med, Dept Genet, Stanford Human Genome Ctr, Stanford, CA 94305 USA; Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; Lawrence Livermore Natl Lab, EEBI Div, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Genome Biol Div, Livermore, CA 94550 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Iowa State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	rwilson@watson.wustl.edu	Taylor, James/F-1026-2011; Izaurralde, Elisa/G-3239-2012; Mardis, Elaine/W-2202-2019; Wendl, Michael C/A-2741-2008; Schmutz, Jeremy/N-3173-2013; Sekhon, Mandeep/L-4665-2018; Marra, Marco A/B-5987-2008; Bork, Peer/F-1813-2013; McPherson, John D/D-2633-2017; Wilson, Richard K./AAF-4139-2019; Torrents, David/G-5785-2015; Ciccarelli, Francesca/D-5380-2014	Taylor, James/0000-0001-5079-840X; Schmutz, Jeremy/0000-0001-8062-9172; Sekhon, Mandeep/0000-0002-9993-6938; Marra, Marco A/0000-0001-7146-7175; Bork, Peer/0000-0002-2627-833X; McPherson, John D/0000-0001-8049-9347; Wilson, Richard K./0000-0002-1992-1358; Chinwalla, Asif/0000-0001-7831-3996; Waligorski, Jason/0000-0001-8422-6004; Izaurralde, Elisa/0000-0001-7365-2649; MCLELLAN, MICHAEL/0000-0002-2703-8784; Eddy, Sean/0000-0001-6676-4706; Kremitzki, Colin/0000-0001-9175-3136; Suyama, Mikita/0000-0001-9526-3193; Torrents, David/0000-0002-6086-9037; Furey, Terry/0000-0001-5546-9672; Shiina, Takashi/0000-0002-2067-6708; Ciccarelli, Francesca/0000-0002-9325-0900				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Ashburner M, 2001, GENOME RES, V11, P1425; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Fan Y, 2002, GENOME RES, V12, P1651, DOI 10.1101/gr.337602; Felsenfeld A, 1999, GENOME RES, V9, P1; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schmutz J, 2003, COLD SPRING HARB SYM, V68, P31, DOI 10.1101/sqb.2003.68.31; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suyama M, 2004, BIOINFORMATICS, V20, P1968, DOI 10.1093/bioinformatics/bth172; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005	50	59	1622	3	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					724	731		10.1038/nature03466	http://dx.doi.org/10.1038/nature03466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815621	Bronze			2022-12-01	WOS:000228160700031
J	Honda, K; Yanai, H; Negishi, H; Asagiri, M; Sato, M; Mizutani, T; Shimada, N; Ohba, Y; Takaoka, A; Yoshida, N; Taniguchi, T				Honda, K; Yanai, H; Negishi, H; Asagiri, M; Sato, M; Mizutani, T; Shimada, N; Ohba, Y; Takaoka, A; Yoshida, N; Taniguchi, T			IRF-7 is the master regulator of type-I interferon-dependent immune responses	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; POSITIVE FEEDBACK; ALPHA PRODUCTION; DISTINCT; RECOGNITION; INDUCTION; MYD88	The type-I interferon (IFN-alpha/beta) response is critical to immunity against viruses and can be triggered in many cell types by cytosolic detection of viral infection, or in differentiated plasmacytoid dendritic cells by the Toll-like receptor 9 (TLR9) subfamily, which generates signals via the adaptor MyD88 to elicit robust IFN induction(1-4). Using mice deficient in the Irf7 gene (Irf7(-/-) mice), we show that the transcription factor IRF-7 is essential for the induction of IFN-alpha/beta genes via the virus-activated, MyD88-independent pathway and the TLR-activated, MyD88-dependent pathway. Viral induction of MyD88-independent IFN-alpha/beta genes is severely impaired in Irf7(-/-) fibroblasts. Consistently, Irf7(-/-) mice are more vulnerable than Myd88(-/-) mice to viral infection, and this correlates with a marked decrease in serum IFN levels, indicating the importance of the IRF-7-dependent induction of systemic IFN responses for innate antiviral immunity. Furthermore, robust induction of IFN production by activation of the TLR9 subfamily in plasmacytoid dendritic cells is entirely dependent on IRF-7, and this MyD88-IRF-7 pathway governs the induction of CD8(+) T-cell responses. Thus, all elements of IFN responses, whether the systemic production of IFN in innate immunity or the local action of IFN from plasmacytoid dendritic cells in adaptive immunity, are under the control of IRF-7.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Tokyo 1130033, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; JST, PRESTO, Informat & Cell Funct, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Mizutani, Tatsuaki/AAA-5044-2021; Yang, Chen/G-1379-2010; Ohba, Yusuke/E-7944-2011; Honda, Kenya/N-5297-2015; Yanai, Hideyuki/AGK-5933-2022	Mizutani, Tatsuaki/0000-0002-4323-4347; Yanai, Hideyuki/0000-0002-0115-9000; Honda, Kenya/0000-0001-8937-9835				Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wagner H, 2004, CURR OPIN BIOTECH, V15, P538, DOI 10.1016/j.copbio.2004.09.006; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	30	1654	1729	2	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					772	777		10.1038/nature03464	http://dx.doi.org/10.1038/nature03464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15800576				2022-12-01	WOS:000228160700043
J	Glasson, SS; Askew, R; Sheppard, B; Carito, B; Blanchet, T; Ma, HL; Flannery, CR; Peluso, D; Kanki, K; Yang, ZY; Majumdar, MK; Morris, EA				Glasson, SS; Askew, R; Sheppard, B; Carito, B; Blanchet, T; Ma, HL; Flannery, CR; Peluso, D; Kanki, K; Yang, ZY; Majumdar, MK; Morris, EA			Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis	NATURE			English	Article							HUMAN SYNOVIAL-FLUID; AGGRECAN FRAGMENTS; EXPLANTS; CLONING; CLEAVES	Human osteoarthritis is a progressive disease of the joints characterized by degradation of articular cartilage. Although disease initiation may be multifactorial, the cartilage destruction appears to be a result of uncontrolled proteolytic extracellular matrix destruction. A major component of the cartilage extracellular matrix is aggrecan, a proteoglycan that imparts compressive resistance to the tissue. Aggrecan is cleaved at a specific 'aggrecanase' site in human osteoarthritic cartilage(1-2); this cleavage can be performed by several members of ADAMTS family of metalloproteases(3-9). The relative contribution of individual ADAMTS proteases to cartilage destruction during osteoarthritis has not been resolved. Here we describe experiments with a genetically modified mouse in which the catalytic domain of ADAMTS5 (aggrecanase-2) was deleted. After surgically induced joint instability, there was significant reduction in the severity of cartilage destruction in the ADAMTS5 knockout mice compared with wild-type mice. This is the first report of a single gene deletion capable of abrogating the course of cartilage destruction in an animal model of osteoarthritis. These results demonstrate that ADAMTS5 is the primary 'aggrecanase' responsible for aggrecan degradation in a murine model of osteoarthritis, and suggest rational strategies for therapeutic intervention in osteoarthritis.	Wyeth Res, Dept Womens Hlth & Bone, Cambridge, MA 02140 USA; Wyeth Res, Genom, Cambridge, MA 02140 USA; Wyeth Res, Drug Safety & Metab, Cambridge, MA 02140 USA	Pfizer; Pfizer; Pfizer	Morris, EA (corresponding author), Wyeth Res, Dept Womens Hlth & Bone, 200 CambridgePk Dr, Cambridge, MA 02140 USA.	Emorris@Wyeth.com						Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Chambers MG, 2001, ARTHRITIS RHEUM-US, V44, P1455, DOI 10.1002/1529-0131(200106)44:6<1455::AID-ART241>3.0.CO;2-J; Clements KM, 2003, ARTHRITIS RHEUM-US, V48, P3452, DOI 10.1002/art.11355; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Hughes Clare E, 2003, Methods Mol Biol, V225, P89; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Little CB, 2003, T ORTHOP RES SOC, V28, P699; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; YAMAJI N, 2004, Patent No. 6716613	16	931	994	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					644	648		10.1038/nature03369	http://dx.doi.org/10.1038/nature03369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800624				2022-12-01	WOS:000228011000045
J	Nakagawa, T; Shimizu, S; Watanabe, T; Yamaguchi, O; Otsu, K; Yamagata, H; Inohara, H; Kubo, T; Tsujimoto, Y				Nakagawa, T; Shimizu, S; Watanabe, T; Yamaguchi, O; Otsu, K; Yamagata, H; Inohara, H; Kubo, T; Tsujimoto, Y			Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death	NATURE			English	Article							CYTOCHROME-C RELEASE; CYCLOSPORINE-A; PORE; RAT; BAX; DYSFUNCTION; ACTIVATION; CA2+	Mitochondria play an important role in energy production, Ca2+ homeostasis and cell death. In recent years, the role of the mitochondria in apoptotic and necrotic cell death has attracted much attention(1,2). In apoptosis and necrosis, the mitochondrial permeability transition (mPT), which leads to disruption of the mitochondrial membranes and mitochondrial dysfunction, is considered to be one of the key events, although its exact role in cell death remains elusive. We therefore created mice lacking cyclophilin D (CypD), a protein considered to be involved in the mPT, to analyse its role in cell death. CypD-deficient mice were developmentally normal and showed no apparent anomalies, but CypD-deficient mitochondria did not undergo the cyclosporin A-sensitive mPT. CypD-deficient cells died normally in response to various apoptotic stimuli, but showed resistance to necrotic cell death induced by reactive oxygen species and Ca2+ overload. In addition, CypD-deficient mice showed a high level of resistance to ischaemia/reperfusion-induced cardiac injury. Our results indicate that the CypD-dependent mPT regulates some forms of necrotic death, but not apoptotic death.	Osaka Univ, Sch Med, Dept Postgenom & Dis, Mol Genet Lab, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Otolaryngol & Sensory Organ Surg, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, SORST, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Tsujimoto, Y (corresponding author), Osaka Univ, Sch Med, Dept Postgenom & Dis, Mol Genet Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsujimot@gene.med.osaka-u.ac.jp	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605; Yamaguchi, Osamu/0000-0002-7461-369X				BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Byrne AM, 1999, HEPATOLOGY, V29, P1523, DOI 10.1002/hep.510290521; Crompton M, 2003, CURR MED CHEM, V10, P1473, DOI 10.2174/0929867033457197; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 2004, NATURE, V430, DOI 10.1038/nature02816; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SHIMIZU S, 1994, TRANSPLANTATION, V57, P1562; Shimizu S, 1996, ONCOGENE, V12, P2251; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	30	1267	1325	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					652	658		10.1038/nature03317	http://dx.doi.org/10.1038/nature03317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800626				2022-12-01	WOS:000228011000047
J	Patel, V; Kirkwood, B; Weiss, H; Pednekar, S; Fernandes, J; Pereira, B; Upadhye, M; Mabey, D				Patel, V; Kirkwood, B; Weiss, H; Pednekar, S; Fernandes, J; Pereira, B; Upadhye, M; Mabey, D			Chronic fatigue in developing countries: population based survey of women in India	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; PSYCHIATRIC-DISORDER; SOMATIC SYMPTOMS; DEPRESSION; EPIDEMIOLOGY; COMMUNITY; MORBIDITY; POVERTY; WORLD; GOA	Objectives To describe the prevalence of and risk factors for chronic fatigue in a developing country; in particular, to determine the association of anaemia, mental health, and gender disadvantage factors with chronic fatigue. Design Community survey. Setting Primary health centre catchment area in Goa, India. Participants 3000 randomly sampled women aged 18 to 50 years. Main outcome measures Data on the primary outcome (reporting of fatigue for at least six months) and psychosocial exposures elicited by structured interview; presence of anaemia determined from a blood sample. Results 2494 (83%) women consented to participate; 12.1% (95% confidence interval 10.8 to 13.4%) complained of chronic fatigue. In multivariate analyses, older women (P=0.03) and those experiencing socioeconomic deprivation-less education (P < 0.001), families in debt (P=0.09), hunger in the past three months(P=0.03)-were more likely to report chronic fatigue. After adjustment for these factors, factors indicating gender disadvantage (notably sexual violence by the husband; P < 0.001) and poor mental health (P < 0.001) were strongly associated with chronic fatigue. Although women with a high body mass index had a reduced risk, suggesting an influence of poor nutrition, no association was found between chronic fatigue and haemoglobin concentrations. Conclusions Chronic fatigue was commonly reported by women in this community study from India. The strongest associations with chronic fatigue were for psychosocial factors indicative of poor mental health and gender disadvantage.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Sangath, Porvorim, Goa, India	University of London; London School of Hygiene & Tropical Medicine	Patel, V (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Vikram.patel@lshtm.ac.uk	weiss, helen/ABC-7823-2021; Pednekar, Sulochana/GVS-0184-2022	weiss, helen/0000-0003-3547-7936; Mabey, David/0000-0002-0031-8276; Patel, Vikram/0000-0003-1066-8584; Kirkwood, Betty/0000-0001-5274-6072; Pednekar, Sulochana/0000-0002-4538-4795				Araya R, 2001, BRIT J PSYCHIAT, V178, P228, DOI 10.1192/bjp.178.3.228; Astbury J., 2001, MENTAL HLTH CALL ACT, P73; BHATIA JC, 1995, STUD FAMILY PLANN, V26, P203, DOI 10.2307/2137846; Chaturvedi S K, 1987, Indian J Psychiatry, V29, P337; DINESHKUMAR B, 1995, PHARMACOECONOMICS, V7, P332, DOI 10.2165/00019053-199507040-00007; GUREJE O, 1992, ACTA PSYCHIAT SCAND, V86, P223, DOI 10.1111/j.1600-0447.1992.tb03256.x; *INT I POP SCI, 2001, NAT FAM HLTH SURV, V2; ISAAC M, 1995, PSYCHOTHER PSYCHOSOM, V64, P88, DOI 10.1159/000288996; *IUSSP COMM REPR H, 1997, GEND REPR HLTH WEAKN; Krenzischek D A, 1996, Am J Crit Care, V5, P427; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Patel V, 1998, BRIT J PSYCHIAT, V172, P533, DOI 10.1192/bjp.172.6.533; Patel V, 2004, TROP MED INT HEALTH, V9, P539, DOI 10.1111/j.1365-3156.2004.01243.x; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 1998, PSYCHOL MED, V28, P135, DOI 10.1017/S0033291797005941; SHIVA M, 1992, STATE INDIAS HLTH, P265; Skapinakis P, 2003, INT REV PSYCHIATR, V15, P57, DOI 10.1080/0954026021000045958; Skapinakis P, 2003, BRIT J PSYCHIAT, V182, P205, DOI 10.1192/bjp.182.3.205; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; USTUN TB, 1995, MENTAL ILLNESS GEN H, P347; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1996, AM J PSYCHIAT, V153, P1050; WESSELY S, 1995, EPIDEMIOL REV, V17, P139, DOI 10.1093/oxfordjournals.epirev.a036170	24	47	47	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1190	1193		10.1136/bmj.38442.636181.E0	http://dx.doi.org/10.1136/bmj.38442.636181.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	929CU	15870118	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000229320500022
J	Tellinghuisen, TL; Marcotrigiano, J; Rice, CM				Tellinghuisen, TL; Marcotrigiano, J; Rice, CM			Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase	NATURE			English	Article							PROTEIN; NS5A; BOND	Hepatitis C virus (HCV) is a human pathogen affecting nearly 3% of the world's population(1). Chronic infections can lead to cirrhosis and liver cancer. The RNA replication machine of HCV is a multi-subunit membrane-associated complex. The nonstructural protein NS5A is an active component of HCV replicase(2,3), as well as a pivotal regulator of replication(2,4) and a modulator of cellular processes ranging from innate immunity to dysregulated cell growth(5,6). NS5A is a large phosphoprotein (56 - 58 kDa) with an amphipathic alpha-helix at its amino terminus that promotes membrane association(7-9). After this helix region, NS5A is organized into three domains(10). The N-terminal domain ( domain I) coordinates a single zinc atom per protein molecule(10). Mutations disrupting either the membrane anchor(7,8) or zinc binding(10) of NS5A are lethal for RNA replication. However, probing the role of NS5A in replication has been hampered by a lack of structural information about this multifunctional protein. Here we report the structure of NS5A domain I at 2.5-angstrom resolution, which contains a novel fold, a new zinc-coordination motif and a disulphide bond. We use molecular surface analysis to suggest the location of protein-, RNA- and membrane-interaction sites.	Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA	Rockefeller University	Marcotrigiano, J (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, 1230 York Ave Box 64, New York, NY 10021 USA.	marcotj@rockefeller.edu; ricec@rockefeller.edu	Marcotrigiano, Joseph/K-6697-2016	Marcotrigiano, Joseph/0000-0003-0346-3353	NCI NIH HHS [R01 CA057973] Funding Source: Medline; NIAID NIH HHS [F32 AI051820] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341	28	372	405	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					374	379		10.1038/nature03580	http://dx.doi.org/10.1038/nature03580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902263	Green Accepted			2022-12-01	WOS:000229185000051
J	Jouven, X; Empana, JP; Schwartz, PJ; Desnos, M; Courbon, D; Ducimetiere, P				Jouven, X; Empana, JP; Schwartz, PJ; Desnos, M; Courbon, D; Ducimetiere, P			Heart-rate profile during exercise as a predictor of sudden death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; BAROREFLEX SENSITIVITY; VENTRICULAR-TACHYCARDIA; RATE-VARIABILITY; CARDIAC DEATH; NERVOUS-SYSTEM; RATE RECOVERY; MORTALITY; RISK; REFLEXES	BACKGROUND: Changes in heart rate during exercise and recovery from exercise are mediated by the balance between sympathetic and vagal activity. Since alterations in the neural control of cardiac function contribute to the risk of sudden death, we tested the hypothesis that among apparently healthy persons, sudden death is more likely to occur in the presence of abnormal heart-rate profiles during exercise and recovery. METHODS: A total of 5713 asymptomatic working men (between the ages of 42 and 53 years), none of whom had clinically detectable cardiovascular disease, underwent standardized graded exercise testing between 1967 and 1972. We examined data on the subjects' resting heart rates, the increase in rate from the resting level to the peak exercise level, and the decrease in rate from the peak exercise level to the level one minute after the termination of exercise. RESULTS: During a 23-year follow-up period, 81 subjects died suddenly. The risk of sudden death from myocardial infarction was increased in subjects with a resting heart rate that was more than 75 beats per minute (relative risk, 3.92; 95 percent confidence interval, 1.91 to 8.00); in subjects with an increase in heart rate during exercise that was less than 89 beats per minute (relative risk, 6.18; 95 percent confidence interval, 2.37 to 16.11); and in subjects with a decrease in heart rate of less than 25 beats per minute after the termination of exercise (relative risk, 2.20; 95 percent confidence interval, 1.02 to 4.74). After adjustment for potential confounding variables, these three factors remained strongly associated with an increased risk of sudden death, with a moderate but significantly increased risk of death from any cause but not of nonsudden death from myocardial infarction. CONCLUSIONS: The heart-rate profile during exercise and recovery is a predictor of sudden death.	Univ Paris 05, Hop Europeen Georges Pompidou, Fac Rene Descartes, Serv Cardiol, F-75015 Paris, France; Hop Paul Brousse, INSERM, Avenir Unite 258, Villejuif, France; Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ricovera & Cura Carattere, I-27100 Pavia, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pavia; IRCCS Fondazione San Matteo	Jouven, X (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, Fac Rene Descartes, Serv Cardiol, 20 Rue Leblanc, F-75015 Paris, France.	xavier.jouven@egp.aphp.fr	Schwartz, Peter J/J-4267-2016; Empana, Jean-Philippe/AAF-6923-2021	Schwartz, Peter J/0000-0003-0367-1048; Empana, Jean-Philippe/0000-0002-1469-7772				Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; BILLMAN GE, 1984, CIRCULATION, V69, P1182, DOI 10.1161/01.CIR.69.6.1182; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; DEVREEDESWAGEMAKER, 1997, J AM COLL CARDIOL, V30, P1500; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Ghuran A, 2002, AM J CARDIOL, V89, P184, DOI 10.1016/S0002-9149(01)02198-1; HULL SS, 1994, CIRCULATION, V89, P548, DOI 10.1161/01.CIR.89.2.548; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Jouven X, 2001, CARDIOVASC RES, V50, P373, DOI 10.1016/S0008-6363(01)00230-9; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Landolina M, 1997, J AM COLL CARDIOL, V29, P568, DOI 10.1016/S0735-1097(96)00533-5; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; LOWN B, 1976, NEW ENGL J MED, V294, P1165; MALLIANI A, 1969, AM J PHYSIOL, V217, P703, DOI 10.1152/ajplegacy.1969.217.3.703; SCHWARTZ PJ, 1988, CIRCULATION, V78, P969, DOI 10.1161/01.CIR.78.4.969; Schwartz PJ, 1998, EUR HEART J, V19, pF72; SCHWARTZ PJ, 1992, CIRCULATION, V85, P77; Schwartz PJ, 2001, J CARDIOVASC ELECTR, V12, P500, DOI 10.1046/j.1540-8167.2001.00500.x; Smith ML, 1996, CIRCULATION, V93, P1033, DOI 10.1161/01.CIR.93.5.1033; SMITH ML, 1991, J AM COLL CARDIOL, V18, P1015, DOI 10.1016/0735-1097(91)90761-W; VANOLI E, 1995, J AM COLL CARDIOL, V25, P1609, DOI 10.1016/0735-1097(95)00046-7; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; Weaver WD, 2002, NEW ENGL J MED, V347, P1223, DOI 10.1056/NEJMp020108; *WHO, 1967, INT CLASS DIS MAN IN, V1, P3	29	749	781	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1951	1958		10.1056/NEJMoa043012	http://dx.doi.org/10.1056/NEJMoa043012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888695				2022-12-01	WOS:000229017100005
J	Klimanskaya, I; Chung, Y; Meisner, L; Johnson, J; West, MD; Lanza, R				Klimanskaya, I; Chung, Y; Meisner, L; Johnson, J; West, MD; Lanza, R			Human embryonic stem cells derived without feeder cells	LANCET			English	Article							GROWTH; CULTURE; LINES	Background Human embryonic stem cells are likely to play an important role in the future of regenerative medicine. However, exposure of existing human embryonic stem-cell lines to live animal cells and serum risks contamination with pathogens that could lead to human health risks. We aimed to derive an embryonic stem-cell line without exposure to cells or serum. Methods Frozen cleavage-stage embryos were thawed and cultured to the blastocyst stage. Inner cell masses were isolated by immunosurgery and plated onto extraceflular-matrix-coated plates that can be easily sterilised. Six established human embryonic stem-cell lines were also maintained with this serum and feeder free culture system. Findings A new stem-cell line was derived from human embryos under completely cell and serum free conditions. The cells maintained normal karyotype and markers of pluripotency, including octamer binding protein 4 (Oct-4), stage-specific embryonic antigen (SSEA)-3, SSEA-4, tumour-rejection antigen (TRA)-1-60, TRA-1-81, and alkaline phosphatase. After more than 6 months of undifferentiated proliferation, these cells retained the potential to form derivatives of all three embryonic germ layers both in vitro and in teratomas. These properties were also successfully maintained (for more than 30 passages) with the established stem-cell lines. Interpretation This system eliminates exposure of human embryonic stem cells and their progeny to animal and human feeder layers, and thus the risk of contamination with pathogenic agents capable of transmitting diseases to patients..	Adv Cell Technol, Worcester, MA 01605 USA; Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI USA; Wisconsin State Lab Hyg, Cytogenet Lab, Madison, WI USA; Wake Forest Univ, Bowman Gray Sch Med, Inst Regenerat Med, Winston Salem, NC USA	University of Wisconsin System; University of Wisconsin Madison; Wake Forest University; Wake Forest Baptist Medical Center	Lanza, R (corresponding author), Adv Cell Technol, 381 Plantat St, Worcester, MA 01605 USA.	rlanza@advancedcell.com		West, Michael/0000-0002-4842-5468; Lanza, Robert/0000-0002-3047-3074				Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; COOPER DKC, 2000, XENO PROMISE TRANSPL; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Klimanskaya I, 2004, HDB STEM CELLS, V1, P437; Lanzendorf SE, 2001, FERTIL STERIL, V76, P132, DOI 10.1016/S0015-0282(01)01825-8; Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolreprod.104.033480; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; *US DEP HHS FDA CB, 2002, INF REC PHYS INV COC; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744	20	249	341	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1636	1641		10.1016/S0140-6736(05)66473-2	http://dx.doi.org/10.1016/S0140-6736(05)66473-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885296				2022-12-01	WOS:000228933700028
J	DasGupta, R; Kaykas, A; Moon, RT; Perrimon, N				DasGupta, R; Kaykas, A; Moon, RT; Perrimon, N			Functional genomic analysis of the Wnt-Wingless signaling pathway	SCIENCE			English	Article							BETA-CATENIN; MORPHOGEN GRADIENT; WNT/BETA-CATENIN; DROSOPHILA; PROTEIN; CELL; TRANSDUCTION; REPRESSION; ARMADILLO; FAMILY	The Wnt-Wingless (Wg) pathway is one of a core set of evolutionarily conserved signaling pathways that regulates many aspects of metazoan development. Aberrant Writ signaling has been linked to human disease. In the present study, we used a genomewide RNA interference (RNAi) screen in Drosophila cells to screen for regulators of the Writ pathway. We identified 238 potential regulators, which include known pathway components, genes with functions not previously linked to this pathway, and genes with no previously assigned functions. Reciprocal-Best-Blast analyses reveal that 50% of the genes identified in the screen have human orthologs, of which similar to 18% are associated with human disease. Functional assays of selected genes from the cell-based screen in Drosophila, mammalian cells, and zebrafish embryos demonstrated that these genes have evolutionarily conserved functions in Writ signaling. High-throughput RNAi screens in cultured cells, followed by functional analyses in model organisms, prove to be a rapid means of identifying regulators of signaling pathways implicated in development and disease.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol,Ctr Dev Biol, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	DasGupta, R (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Res Bldg 339,77 Ave Louis Pasteur, Boston, MA 02115 USA.	rdasgupt@genetics.med.harvard.edu; rtmoon@u.washington.edu; perrimon@receptor.med.harvard.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Perrimon, Norbert/0000-0001-7542-472X; Dasgupta, Ramanuj/0000-0001-9015-3729				Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Dasgupta R, 2004, ONCOGENE, V23, P8359, DOI 10.1038/sj.onc.1208028; DASGUPTA R, UNPUB; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Greaves S, 1999, GENETICS, V153, P1753; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Jung CY, 2004, CANCER RES, V64, P3046, DOI 10.1158/0008-5472.CAN-03-2614; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; LOGAN CY, 2004, ANN REV CELL DEV BIO; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Matsubayashi H, 2004, MOL CELL BIOL, V24, P2012, DOI 10.1128/MCB.24.5.2012-2024.2004; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miller AS, 2000, IN VITRO CELL DEV-AN, V36, P180; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MOON RT, UNPUB; MOON RT, 2005, SCI STKE         APR; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; PEEL DJ, 1990, TISSUE CELL, V22, P749, DOI 10.1016/0040-8166(90)90069-L; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRIMON N, 2005, SCI STKE         APR; Polakis P, 2000, GENE DEV, V14, P1837; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Su MA, 2001, GENETICS, V157, P717; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tang AH, 2001, DEVELOPMENT, V128, P801; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087	52	266	287	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					826	833		10.1126/science.1109374	http://dx.doi.org/10.1126/science.1109374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15817814	Green Submitted			2022-12-01	WOS:000228986500041
J	Orimo, A; Gupta, PB; Sgroi, DC; Arenzana-Seisdedos, F; Delaunay, T; Naeem, R; Carey, VJ; Richardson, AL; Weinberg, RA				Orimo, A; Gupta, PB; Sgroi, DC; Arenzana-Seisdedos, F; Delaunay, T; Naeem, R; Carey, VJ; Richardson, AL; Weinberg, RA			Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion	CELL			English	Article							ENDOTHELIAL PROGENITOR CELLS; EPITHELIAL-CELLS; CANCER-CELLS; MALIGNANT BREAST; PROGNOSTIC VALUE; TGF-BETA; CXCR4; SDF-1; STEM; RECRUITMENT	Fibroblasts often constitute the majority of the stromal cells within a breast carcinoma, yet the functional contributions of these cells to tumorigenesis are poorly understood. Using a coimplantation tumor xenograft model, we demonstrate that carcinoma-associated fibroblasts (CAFs) extracted from human breast carcinomas promote the growth of admixed breast carcinoma cells significantly more than do normal mammary fibroblasts derived from the same patients. The CAFs, which exhibit the traits of myofibroblasts, play a central role in promoting the growth of tumor cells through their ability to secrete stromal cell-derived factor 1 (SDF-1); CAFs promote angiogenesis by recruiting endothelial progenitor cells (EPCs) into carcinomas, an effect mediated in part by SDF-1. CAF-secreted SDF-1 also stimulates tumor growth directly, acting through the cognate receptor, CXCR4, which is expressed by carcinoma cells. Our findings indicate that fibroblasts within invasive breast carcinomas contribute to tumor promotion in large part through the secretion of SDF-1.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Mol Pathol Res Unit,Massachusetts Gen Hosp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat & Pathol, Houston, TX 77030 USA; Inst Pasteur, Unite Immunol Virale, F-75724 Paris, France; INRA, F-33883 Villenave Dornon, France	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Texas Children's Cancer Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Sgroi, Dennis/AAV-2487-2021; Arenzana-Seisdedos, Fernando/E-5835-2016; Thomson, Axel/A-7893-2013	Orimo, Akira/0000-0001-5330-7282	NATIONAL CANCER INSTITUTE [R21CA087081] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA 87081-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anderson J, 2003, AIDS RES HUM RETROV, V19, P699, DOI 10.1089/088922203322280928; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bertolini F, 2003, CANCER RES, V63, P4342; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Cardone A, 1997, PANMINERVA MED, V39, P174; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; DOUGLAS MR, 2002, EXPERT REV MOL MED, P1; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Moinfar F, 2000, CANCER RES, V60, P2562; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pinheiro JC., 2000, MIXED EFFECTS MODELS, V43, P111; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; SIEWEKE MH, 1990, SCIENCE, V248, P1656, DOI 10.1126/science.2163544; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	60	2758	2880	4	277	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					335	348		10.1016/j.cell.2005.02.034	http://dx.doi.org/10.1016/j.cell.2005.02.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882617	Bronze			2022-12-01	WOS:000229031600005
J	Su, I; Dobenecker, MW; Dickinson, E; Oser, M; Basavaraj, A; Marqueron, R; Viale, A; Reinberg, D; Wulfing, C; Tarakhovsky, A				Su, I; Dobenecker, MW; Dickinson, E; Oser, M; Basavaraj, A; Marqueron, R; Viale, A; Reinberg, D; Wulfing, C; Tarakhovsky, A			Polycomb group protein Ezh2 controls actin polymerization and cell signaling	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; T-CELLS; IMMUNOLOGICAL SYNAPSE; LYSINE METHYLATION; GENE-EXPRESSION; RECEPTOR SIGNAL; VAV FAMILY; B-CELLS; TRANSDUCTION; CYTOSKELETON	Polycomb group protein Ezh2, one of the key regulators of development in organisms from flies to mice, exerts its epigenetic function through regulation of histone methylation. Here, we report the existence of the cytosolic Ezh2-containing methyltransferase complex and tie the function of this complex to regulation of actin polymerization in various cell types. Genetic evidence supports the essential role of cytosolic Ezh2 in actin polymerization-dependent processes such as antigen receptor signaling in T cells and PDGF-induced dorsal circular ruffle formation in fibroblasts. Revealed function of Ezh2 points to a broader usage of lysine methylation in regulation of both nuclear and extra-nuclear signaling processes.	Rockefeller Univ, Lab Lymphoocyte Signaling, New York, NY 10021 USA; Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst, Div Nucle Acids Enzymol, Piscataway, NJ 08854 USA; Mem Sloan Kettering Canc Ctr, Dept Mol Biol, Genom Core Lab, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA	Rockefeller University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Su, I (corresponding author), Rockefeller Univ, Lab Lymphoocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	sui@mail.rockefeller.edu; tarakho@mail.rockefeller.edu	Su, I-hsin/A-2207-2011; Margueron, Raphael F/B-9996-2015	Su, I-hsin/0000-0002-5894-9580; Margueron, Raphael F/0000-0002-9093-7977; Wuelfing, Christoph/0000-0002-6156-9861; Reinberg, Danny/0000-0003-4288-2016; Basavaraj, Ashwin/0000-0002-9904-6230	NIAID NIH HHS [5R01 AI 053545, 5R01 AI 050867] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053545, R01AI050867] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hobert O, 1996, MOL CELL BIOL, V16, P3066; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8	48	286	290	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					425	436		10.1016/j.cell.2005.02.029	http://dx.doi.org/10.1016/j.cell.2005.02.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882624	Bronze			2022-12-01	WOS:000229031600012
J	Zong, H; Espinosa, S; Su, HH; Muzumdar, MD; Luo, LQ				Zong, H; Espinosa, S; Su, HH; Muzumdar, MD; Luo, LQ			Mosaic analysis with double markers in mice	CELL			English	Article							SITE-SPECIFIC RECOMBINATION; PROGENITOR-CELL MAINTENANCE; TAMOXIFEN-INDUCIBLE FORM; RED FLUORESCENT PROTEIN; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; NERVOUS-SYSTEM; LOXP RECOMBINATION; MOUSE CHROMOSOMES; CRE RECOMBINASE	We describe a method termed MADM (mosaic analysis with double markers) in mice that allows simultaneous labeling and gene knockout in clones of somatic cells or isolated single cells in vivo. Two reciprocally chimeric genes, each containing the N terminus of one marker and the C terminus of the other marker interrupted by a loxP-containing intron, are knocked in at identical locations on homologous chromosomes. Functional expression of markers requires Cre-mediated interchromosomal recombination. MADM reveals that interchromosomal recombination can be induced efficiently in vivo in both mitotic and postmitotic cells in all tissues examined. It can be used to create conditional knockouts in small populations of labeled cells, to determine cell lineage, and to trace neuronal connections. To illustrate the utility of MADM, we show that cerebellar granule cell progenitors are fated at an early stage to produce granule cells with axonal projections limited to specific sublayers of the cerebellar cortex.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Muzumdar, Mandar/0000-0001-7424-7223				Altman J., 1997, DEV CEREBELLAR SYSTE; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Badea TC, 2003, J NEUROSCI, V23, P2314; BONNEROT C, 1993, CR ACAD SCI III-VIE, V316, P1207; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grueber WB, 2002, DEVELOPMENT, V129, P2867; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; Hashimoto M, 2004, J NEUROSCI, V24, P286, DOI 10.1523/JNEUROSCI.2529-03.2004; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kimmel RA, 2000, GENE DEV, V14, P1377; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koike H, 2002, EMBO REP, V3, P433, DOI 10.1093/embo-reports/kvf097; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; XU T, 1993, DEVELOPMENT, V117, P1223; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199; Zugates CT, 2004, CURR OPIN NEUROBIOL, V14, P647, DOI 10.1016/j.conb.2004.08.005	67	385	393	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					479	492		10.1016/j.cell.2005.02.012	http://dx.doi.org/10.1016/j.cell.2005.02.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882628	Bronze			2022-12-01	WOS:000229031600016
J	Kapitein, LC; Peterman, EJG; Kwok, BH; Kim, JH; Kapoor, TM; Schmidt, CF				Kapitein, LC; Peterman, EJG; Kwok, BH; Kim, JH; Kapoor, TM; Schmidt, CF			The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks	NATURE			English	Article							CELL-DIVISION; SPINDLES; MOTOR; DROSOPHILA; TUBULIN; MITOSIS; FAMILY; FLUX; NCD	During cell division, mitotic spindles are assembled by microtubule-based motor proteins(1,2). The bipolar organization of spindles is essential for proper segregation of chromosomes, and requires plus-end-directed homotetrameric motor proteins of the widely conserved kinesin-5 ( BimC) family(3). Hypotheses for bipolar spindle formation include the 'push-pull mitotic muscle' model, in which kinesin-5 and opposing motor proteins act between overlapping microtubules(2,4,5). However, the precise roles of kinesin-5 during this process are unknown. Here we show that the vertebrate kinesin-5 Eg5 drives the sliding of microtubules depending on their relative orientation. We found in controlled in vitro assays that Eg5 has the remarkable capability of simultaneously moving at similar to 20 nm s(-1) towards the plus-ends of each of the two microtubules it crosslinks. For anti-parallel microtubules, this results in relative sliding at similar to 40 nm s(-1), comparable to spindle pole separation rates in vivo(6). Furthermore, we found that Eg5 can tether microtubule plus-ends, suggesting an additional microtubule-binding mode for Eg5. Our results demonstrate how members of the kinesin-5 family are likely to function in mitosis, pushing apart interpolar microtubules as well as recruiting microtubules into bundles that are subsequently polarized by relative sliding.	Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rockefeller University	Peterman, EJG (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	erwinp@nat.vu.nl; kapoor@mail.rockefeller.edu	Peterman, Erwin/G-5529-2010; Kapitein, Lukas C/J-4776-2016; Schmidt, Christoph F/G-3787-2011	Peterman, Erwin/0000-0003-1058-249X; Kapitein, Lukas C/0000-0001-9418-6739; Schmidt, Christoph F/0000-0003-2864-6973				Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Chui KK, 2000, J BIOL CHEM, V275, P38005, DOI 10.1074/jbc.M005948200; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; GIBBONS IR, 1979, J BIOL CHEM, V254, P187; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HYMAN AA, 1991, J CELL SCI, P125; Kapoor TM, 1999, P NATL ACAD SCI USA, V96, P9106, DOI 10.1073/pnas.96.16.9106; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCINTOSH JR, 1969, NATURE, V224, P659, DOI 10.1038/224659a0; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Stock MF, 2003, J BIOL CHEM, V278, P52315, DOI 10.1074/jbc.M309419200; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376	27	488	495	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					114	118		10.1038/nature03503	http://dx.doi.org/10.1038/nature03503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875026				2022-12-01	WOS:000228864600049
J	Basu, S; Gerchman, Y; Collins, CH; Arnold, FH; Weiss, R				Basu, S; Gerchman, Y; Collins, CH; Arnold, FH; Weiss, R			A synthetic multicellular system for programmed pattern formation	NATURE			English	Article							GENE-EXPRESSION; VIBRIO-FISCHERI; BACTERIA; LUXR; NETWORKS; LACTONES; GROWTH	Pattern formation is a hallmark of coordinated cell behaviour in both single and multicellular organisms(1-3). It typically involves cell-cell communication and intracellular signal processing. Here we show a synthetic multicellular system in which genetically engineered 'receiver' cells are programmed to formring-like patterns of differentiation based on chemical gradients of an acyl-homoserine lactone (AHL) signal that is synthesized by 'sender' cells. In receiver cells, 'band-detect' gene networks respond to user-defined ranges of AHL concentrations. By fusing different fluorescent proteins as outputs of network variants, an initially undifferentiated 'lawn' of receivers is engineered to form a bullseye pattern around a sender colony. Other patterns, such as ellipses and clovers, are achieved by placing senders in different configurations. Experimental and theoretical analyses reveal which kinetic parameters most significantly affect ring development over time. Construction and study of such synthetic multicellular systems can improve our quantitative understanding of naturally occurring developmental processes and may foster applications in tissue engineering, biomaterial fabrication and biosensing.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Princeton University; Princeton University; California Institute of Technology	Weiss, R (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.	rweiss@princeton.edu	Gerchman, Yoram/H-4698-2019; Gerchman, Yoram/F-5226-2015	Gerchman, Yoram/0000-0002-8637-9589; Collins, Cynthia/0000-0003-1647-860X; Arnold, Frances H./0000-0002-4027-364X				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; BENJACOB E, 1995, PHYS REV LETT, V75, P2899, DOI 10.1103/PhysRevLett.75.2899; Choi S. H., 1992, Molecular Marine Biology and Biotechnology, V1, P408; Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Golden JW, 1998, CURR OPIN MICROBIOL, V1, P623, DOI 10.1016/S1369-5274(98)80106-9; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; PTASHNE M, 1986, GENETIC SWITCH PHAGE; SCHERRER R, 1986, CAN J MICROBIOL, V32, P607, DOI 10.1139/m86-113; WEISS R, 2002, NSC 1 1 WORKSH NON S; WEISS R, 2001, THESIS MIT; WEISS R, 2000, DNA6 6 INT M DNA BAS, P1; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002	18	746	784	5	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1130	1134		10.1038/nature03461	http://dx.doi.org/10.1038/nature03461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858574				2022-12-01	WOS:000228693300043
J	Blackstone, E; Morrison, M; Roth, MB				Blackstone, E; Morrison, M; Roth, MB			H2S induces a suspended animation-like state in mice	SCIENCE			English	Article							HIBERNATION		Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98105 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Roth, MB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98105 USA.	mroth@fhcrc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG00057] Funding Source: Medline; NIGMS NIH HHS [GM48435] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; BLACKSTONE E, UNPUB; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Nystul TG, 2004, P NATL ACAD SCI USA, V101, P9133, DOI 10.1073/pnas.0403312101; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; STOREY KB, 1990, Q REV BIOL, V65, P145, DOI 10.1086/416717	8	611	651	1	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					518	518		10.1126/science.1108581	http://dx.doi.org/10.1126/science.1108581			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845845				2022-12-01	WOS:000228810500043
J	Lecellier, CH; Dunoyer, P; Arar, K; Lehmann-Che, J; Eyquem, S; Himber, C; Saib, A; Voinnet, O				Lecellier, CH; Dunoyer, P; Arar, K; Lehmann-Che, J; Eyquem, S; Himber, C; Saib, A; Voinnet, O			A cellular MicroRNA mediates antiviral defense in human cells	SCIENCE			English	Article							SMALL INTERFERING RNA; VIRAL SUPPRESSOR; GENES; IDENTIFICATION; RECOGNITION; ANTISENSE	In eukaryotes, 21- to 24-nucteotide-long RNAs engage in sequence-specific interactions that inhibit gene expression by RNA silencing. This process has regulatory roles involving microRNAs and, in plants and insects, it also forms the basis of a defense mechanism directed by small interfering RNAs that derive from replicative or integrated viral genomes. We show that a cellular microRNA effectively restricts the accumulation of the retrovirus primate foamy virus type 1 (PFV-1) in human cells. PFV-1 also encodes a protein, Tas, that suppresses microRNA-directed functions in mammalian cells and displays cross-kingdom antisilencing activities. Therefore, through fortuitous recognition of foreign nucleic acids, cellular microRNAs have direct antiviral effects in addition to their regulatory functions.	CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France; Proligo, Paris, France; Hop St Louis, CNRS, UPR9051, Paris, France; Hop St Louis, INSERM, U462, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lecellier, CH (corresponding author), CNRS, Inst Biol Mol Plantes, UPR 2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	charles.lecellier@infobiogen.fr; olivier.voinnet@ibmp-ulp.u-strasbg.fr		Lehmann-Che, jacqueline/0000-0001-6685-3354; Voinnet, Olivier/0000-0001-6982-9544				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUNACH G, 1993, J VIROL, V67, P5411, DOI 10.1128/JVI.67.9.5411-5418.1993; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Heinkelein M, 2000, EMBO J, V19, P3436, DOI 10.1093/emboj/19.13.3436; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Llave C, 2004, MOL PLANT PATHOL, V5, P361, DOI 10.1111/j.1364-3703.2004.00227.x; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Schramke V, 2004, CURR OPIN GENET DEV, V14, P174, DOI 10.1016/j.gde.2004.02.006; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213	22	726	850	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					557	560		10.1126/science.1108784	http://dx.doi.org/10.1126/science.1108784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845854				2022-12-01	WOS:000228810500054
J	Pocai, A; Lam, TKT; Gutierrez-Juarez, R; Obici, S; Schwartz, GJ; Bryan, J; Aguilar-Bryan, L; Rossetti, L				Pocai, A; Lam, TKT; Gutierrez-Juarez, R; Obici, S; Schwartz, GJ; Bryan, J; Aguilar-Bryan, L; Rossetti, L			Hypothalamic K-ATP channels control hepatic glucose production	NATURE			English	Article							SENSITIVE POTASSIUM CHANNELS; FOOD-INTAKE; BODY-WEIGHT; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; ARCUATE NUCLEUS; MICE; INHIBITION; OBESITY; LEPTIN	Obesity is the driving force behind the worldwide increase in the prevalence of type 2 diabetes mellitus(1,2). Hyperglycaemia is a hallmark of diabetes and is largely due to increased hepatic gluconeogenesis(3). The medial hypothalamus is a major integrator of nutritional and hormonal signals(1,2,4), which play pivotal roles not only in the regulation of energy balance but also in the modulation of liver glucose output(5,6). Bidirectional changes in hypothalamic insulin signalling therefore result in parallel changes in both energy balance(7-10) and glucose metabolism(5). Here we show that activation of ATP-sensitive potassium (K-ATP) channels(11) in the mediobasal hypothalamus is sufficient to lower blood glucose levels through inhibition of hepatic gluconeogenesis. Finally, the infusion of a K-ATP blocker within the mediobasal hypothalamus, or the surgical resection of the hepatic branch of the vagus nerve, negates the effects of central insulin and halves the effects of systemic insulin on hepatic glucose production. Consistent with these results, mice lacking the SUR1 subunit of the K-ATP channel(12) are resistant to the inhibitory action of insulin on gluconeogenesis. These findings suggest that activation of hypothalamic K-ATP channels normally restrains hepatic gluconeogenesis, and that any alteration within this central nervous system/liver circuit can contribute to diabetic hyperglycaemia.	Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Neurosci, Diabet Res Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Diabet Res Ctr, Bronx, NY 10461 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine	Rossetti, L (corresponding author), Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu						Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chutkow WA, 2001, P NATL ACAD SCI USA, V98, P11760, DOI 10.1073/pnas.201390398; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; la Fleur SE, 2003, DIABETES, V52, P2321, DOI 10.2337/diabetes.52.9.2321; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Massillon D, 1995, AM J PHYSIOL-ENDOC M, V269, pE1037, DOI 10.1152/ajpendo.1995.269.6.E1037; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	29	478	493	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1026	1031		10.1038/nature03439	http://dx.doi.org/10.1038/nature03439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846348				2022-12-01	WOS:000228524600040
J	Freitas-Junior, LH; Hernandez-Rivas, R; Ralph, SA; Montiel-Condado, D; Ruvalcaba-Salazar, OK; Rojas-Meza, AP; Mancio-Silva, L; Leal-Silvestre, RJ; Gontijo, AM; Shorte, S; Scherf, A				Freitas-Junior, LH; Hernandez-Rivas, R; Ralph, SA; Montiel-Condado, D; Ruvalcaba-Salazar, OK; Rojas-Meza, AP; Mancio-Silva, L; Leal-Silvestre, RJ; Gontijo, AM; Shorte, S; Scherf, A			Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites	CELL			English	Article							PLASMODIUM-FALCIPARUM; GENOME SEQUENCE; VARIANT ANTIGEN; TRANSCRIPTION; RECOMBINATION; ERYTHROCYTES; PROTEINS; ORGANIZATION; COMPARTMENT; PHENOTYPES	Malaria parasites use antigenic variation to avoid immune clearance and increase the duration of infection in the human host. Variation at the surface of P. falciparurn-infected erythrocytes is mediated by the differential control of a family of surface antigens encoded by var genes. Switching of var gene expression occurs in situ, mostly from telomere-associated loci, without detectable DNA alterations, suggesting that it is controlled by chromatin structure. We have identified chromatin modifications at telomeres that spread far into telomere-proximal regions, including var gene loci (> 50 kb). One type of modification is mediated by a protein homologous to yeast Sir2 called PfSir2, which forms a chromosomal gradient of heterochromatin structure and histone hypoacetylation. Upon activation of a specific telomere-associated var gene, PfSir2 is removed from the promoter region and acetylation of histone occurs. Our data demonstrate that mutually exclusive transcription of var genes is linked to the dynamic remodeling of chromatin.	Inst Pasteur, Biol Host Parasite Interact Unit, CNRS, URA2581, F-75724 Paris, France; Dynam Imaging Platform, F-75724 Paris, France; IPN, Dept Mol Biomed, Ctr Invest & Estudios Avanzados, Mexico City 07360, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Scherf, A (corresponding author), Inst Pasteur, Biol Host Parasite Interact Unit, CNRS, URA2581, 25 Rue Dr Roux, F-75724 Paris, France.	ascherf@pasteur.fr	Scherf, Artur/A-9674-2014; Gontijo, Alisson/G-6719-2011; Freitas-Junior, Lucio H/C-8677-2011; Silva, Liliana Mancio/AAB-2192-2020; Silvestre, Ricardo/C-7243-2011; Mancio-Silva, Liliana/F-9905-2013; Ralph, Stuart/C-8590-2014	Gontijo, Alisson/0000-0002-2530-3708; Freitas-Junior, Lucio H/0000-0002-8904-7897; Silva, Liliana Mancio/0000-0002-5585-018X; Silvestre, Ricardo/0000-0002-9270-2717; Mancio-Silva, Liliana/0000-0002-5585-018X; Ralph, Stuart/0000-0003-0114-7808; MONTIEL CONDADO, DVORAK/0000-0003-0338-2764; Scherf, Artur/0000-0003-2411-3328; Shorte, Spencer/0000-0002-2125-8663				Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; Andrews KT, 2003, MOL MICROBIOL, V49, P655, DOI 10.1046/j.1365-2958.2003.03595.x; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; BOZDECH Z, 2003, PLOS BIOL, V109; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Fan Q, 2004, EUKARYOT CELL, V3, P264, DOI 10.1128/EC.3.2.264-276.2004; Figueiredo LM, 2000, MOL BIOCHEM PARASIT, V106, P169, DOI 10.1016/S0166-6851(99)00199-1; Figueiredo LM, 2005, NUCLEIC ACIDS RES, V33, P1111, DOI 10.1093/nar/gki260; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hediger F, 2002, NAT CELL BIOL, V4, pE53, DOI 10.1038/ncb0302-e53; Horrocks P, 2004, MOL BIOCHEM PARASIT, V134, P193, DOI 10.1016/j.molbiopara.2003.11.016; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaviratne Mallika, 2003, P291, DOI 10.1016/B978-012194851-1/50039-1; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; PRENSIER G, 1986, J PARASITOL, V72, P731, DOI 10.2307/3281465; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Sambrook J, 1988, MOL CLONING LAB MANU; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; Voss TS, 2000, MOL BIOCHEM PARASIT, V107, P103, DOI 10.1016/S0166-6851(00)00176-6; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045	47	375	386	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 8	2005	121	1					25	36		10.1016/j.cell.2005.01.037	http://dx.doi.org/10.1016/j.cell.2005.01.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820676	Bronze			2022-12-01	WOS:000228348500007
J	Esashi, F; Christ, N; Gannon, J; Liu, YL; Hunt, T; Jasin, M; West, SC				Esashi, F; Christ, N; Gannon, J; Liu, YL; Hunt, T; Jasin, M; West, SC			CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; DOUBLE-STRAND BREAKS; CANCER SUSCEPTIBILITY; DNA-DAMAGE; RADIATION HYPERSENSITIVITY; CELL-CYCLE; RAD51; REPEATS; GENE; BINDING	Inherited mutations in BRCA2 are associated with a predisposition to early-onset breast cancers. The underlying basis of tumorigenesis is thought to be linked to defects in DNA double-strand break repair by homologous recombination. Here we show that the carboxy-terminal region of BRCA2, which interacts directly with the essential recombination protein RAD51, contains a site (serine 3291; S3291) that is phosphorylated by cyclin-dependent kinases. Phosphorylation of S3291 is low in S phase when recombination is active, but increases as cells progress towards mitosis. This modification blocks C-terminal interactions between BRCA2 and RAD51. However, DNA damage overcomes cell cycle regulation by decreasing S3291 phosphorylation and stimulating interactions with RAD51. These results indicate that S3291 phosphorylation might provide a molecular switch to regulate RAD51 recombination activity, providing new insight into why BRCA2 C-terminal deletions lead to radiation sensitivity and cancer predisposition.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	West, SC (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk		West, Stephen/0000-0001-8848-9418; Esashi, Fumiko/0000-0003-0902-2364	Wellcome Trust [101009] Funding Source: Medline; Breast Cancer Now [2002:445] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now		Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bertwistle D, 1997, CANCER RES, V57, P5485; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Godthelp BC, 2002, ONCOGENE, V21, P5002, DOI 10.1038/sj.onc.1205656; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Tutt A, 2003, ONCOGENE, V22, P2926, DOI 10.1038/sj.onc.1206522; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; WEST SC, 2003, NATURE REV MOL CELL, V4, P1, DOI DOI 10.1038/NRM1127; Wohlschlegel JA, 2001, MOL CELL BIOL, V21, P4868, DOI 10.1128/MCB.21.15.4868-4874.2001; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547	48	335	345	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					598	604		10.1038/nature03404	http://dx.doi.org/10.1038/nature03404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800615				2022-12-01	WOS:000228011000035
J	Rappas, M; Schumacher, J; Beuron, F; Niwa, H; Bordes, P; Wigneshweraraj, S; Keetch, CA; Robinson, CV; Buck, M; Zhang, XD				Rappas, M; Schumacher, J; Beuron, F; Niwa, H; Bordes, P; Wigneshweraraj, S; Keetch, CA; Robinson, CV; Buck, M; Zhang, XD			Structural insights into the activity of enhancer-binding proteins	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; ANGSTROM RESOLUTION; MOLECULAR MACHINE; ESCHERICHIA-COLI; CENTRAL DOMAIN; SIGMA(54); ATPASES; AAA(+); SIGMA-54; NTRC	Activators of bacterial sigma(54)-RNA polymerase holoenzyme are mechanochemical proteins that use adenosine triphosphate (ATP) hydrolysis to activate transcription. We have determined by cryogenic electron microscopy (cryo-EM) a 20 angstrom resolution structure of an activator, phage shock protein IF [PspF((1-275))], which is bound to an ATP transition state analog in complex with its basal factor, sigma(54). By fitting the crystal structure of PspF((1-275)) at 1.75 angstroms into the EM map, we identified two loops involved in binding sigma(54). Comparing enhancer-binding structures in different nucleotide states and mutational analysis led us to propose nucleotide-dependent conformational changes that free the loops for association with sigma(54)..	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Ctr Struct Biol, London SW7 2AZ, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Imperial College London; Imperial College London; University of London; Institute of Cancer Research - UK; University of Cambridge	Zhang, XD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England.	xiaodong.zhang@imperial.ac.uk		Bordes, Patricia/0000-0002-5746-0556; robinson, carol/0000-0001-7829-5505; Zhang, Xiaodong/0000-0001-9786-7038; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029	Biotechnology and Biological Sciences Research Council [B17129] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bordes P, 2004, BIOCHEM J, V378, P735, DOI 10.1042/BJ20031464; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Burrows PC, 2003, J BIOL CHEM, V278, P29728, DOI 10.1074/jbc.M303596200; Cannon W, 2003, J BIOL CHEM, V278, P19815, DOI 10.1074/jbc.M301296200; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Gonzalez V, 1998, MOL MICROBIOL, V28, P55, DOI 10.1046/j.1365-2958.1998.00772.x; Lee DerNan, 1997, Journal of the Chinese Society of Animal Science, V26, P373; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Li JL, 1999, J BACTERIOL, V181, P5443, DOI 10.1128/JB.181.17.5443-5454.1999; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Svergun DI, 2000, J BIOL CHEM, V275, P4210, DOI 10.1074/jbc.275.6.4210; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Wang YK, 1997, J BACTERIOL, V179, P5812, DOI 10.1128/jb.179.18.5812-5819.1997; WEDEL A, 1995, GENE DEV, V9, P2042, DOI 10.1101/gad.9.16.2042; Xu H, 2001, CURR OPIN MICROBIOL, V4, P138, DOI 10.1016/S1369-5274(00)00179-X; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	27	135	139	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1972	1975		10.1126/science.1105932	http://dx.doi.org/10.1126/science.1105932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790859	Green Accepted			2022-12-01	WOS:000227957300060
J	Murata, Y; Iwasaki, H; Sasaki, M; Inaba, K; Okamura, Y				Murata, Y; Iwasaki, H; Sasaki, M; Inaba, K; Okamura, Y			Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor	NATURE			English	Article							ASCIDIAN CIONA-INTESTINALIS; RECTIFYING K+ CHANNELS; ION CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; POTASSIUM CHANNELS; TUMOR-SUPPRESSOR; PTEN; ACTIVATION; IDENTIFICATION; PERSPECTIVE	Changes in membrane potential affect ion channels and transporters, which then alter intracellular chemical conditions. Other signalling pathways coupled to membrane potential have been suggested(1-3) but their underlying mechanisms are unknown. Here we describe a novel protein from the ascidian Ciona intestinalis that has a transmembrane voltage-sensing domain homologous to the S1 - S4 segments of voltage-gated channels and a cytoplasmic domain similar to phosphatase and tensin homologue. This protein, named C. intestinalis voltage-sensor-containing phosphatase (Ci-VSP), displays channel-like 'gating' currents and directly translates changes in membrane potential into the turnover of phosphoinositides. The activity of the phosphoinositide phosphatase in Ci-VSP is tuned within a physiological range of membrane potential. Immunocytochemical studies show that Ci-VSP is expressed in Ciona sperm tail membranes, indicating a possible role in spermfunction or morphology. Our data demonstrate that voltage sensing can function beyond channel proteins and thus more ubiquitously than previously realized.	Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Aichi 4448787, Japan; Natl Inst Nat Sci, Natl Inst Physiol Sci, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Okamura, Y (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Higashiyama 5-1,Myodaiji Cho, Aichi 4448787, Japan.	yokamura@nips.ac.jp		Iwasaki, Hirohide/0000-0002-7432-5938; Murata, Yoshimichi/0000-0002-2070-7949				BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dong XY, 2003, BRIT J CANCER, V89, P291, DOI 10.1038/sj.bjc.6601062; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Izumi H, 1999, DEV BIOL, V213, P246, DOI 10.1006/dbio.1999.9367; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Padma P, 2003, MOL BIOL CELL, V14, P774, DOI 10.1091/mbc.02-06-0089; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; SCHULTZ JE, 1992, SCIENCE, V255, P600, DOI 10.1126/science.1371017; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Yoshida M, 2002, P NATL ACAD SCI USA, V99, P14831, DOI 10.1073/pnas.242470599; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	29	523	540	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1239	1243		10.1038/nature03650	http://dx.doi.org/10.1038/nature03650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15902207				2022-12-01	WOS:000230140500045
J	Tomita, S; Adesnik, H; Sekiguchi, M; Zhang, W; Wada, K; Howe, JR; Nicoll, RA; Bredt, DS				Tomita, S; Adesnik, H; Sekiguchi, M; Zhang, W; Wada, K; Howe, JR; Nicoll, RA; Bredt, DS			Stargazin modulates AMPA receptor gating and trafficking by distinct domains	NATURE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR GRANULE CELLS; NON-NMDA RECEPTOR; SYNAPTIC PLASTICITY; SUBUNIT STOICHIOMETRY; EXCITATORY SYNAPSES; MOUSE STARGAZER; GAMMA-SUBUNIT; ION CHANNELS; MUTANT MOUSE	AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors mediate fast excitatory synaptic transmission in the brain. These ion channels rapidly deactivate and desensitize, which determine the time course of synaptic transmission. Here, we find that the AMPA receptor interacting protein, stargazin, not only mediates AMPA receptor trafficking but also shapes synaptic responses by slowing channel deactivation and desensitization. The cytoplasmic tail of stargazin determines receptor trafficking, whereas the ectodomain controls channel properties. Stargazin alters AMPA receptor kinetics by increasing the rate of channel opening. Disrupting the interaction of stargazin ectodomain with hippocampal AMPA receptors alters the amplitude and shape of synaptic responses, establishing a crucial function for stargazin in controlling the efficacy of synaptic transmission in the brain.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; National Center for Neurology & Psychiatry - Japan	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu; bredt@itsa.ucsf.edu	zhang, wei/V-6712-2018; Zhang, Wei/AAV-4253-2020	zhang, wei/0000-0001-9825-0371; Zhang, Wei/0000-0001-9825-0371				Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dingledine R, 1999, PHARMACOL REV, V51, P7; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Goff DC, 2001, J CLIN PSYCHOPHARM, V21, P484, DOI 10.1097/00004714-200110000-00005; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; KOH JY, 1990, J NEUROSCI, V10, P693; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Lynch G, 1997, EXP NEUROL, V145, P89, DOI 10.1006/exnr.1997.6447; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; O'Neill MJ, 2004, EUR J PHARMACOL, V486, P163, DOI 10.1016/j.ejphar.2003.12.023; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Robert A, 2003, J NEUROSCI, V23, P847; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sekiguchi M, 2002, BRIT J PHARMACOL, V136, P1033, DOI 10.1038/sj.bjp.0704804; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Smith TC, 2000, J NEUROSCI, V20, P2073; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; Stein V, 2003, J NEUROSCI, V23, P5503; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; WYLLIE DJA, 1993, J PHYSIOL-LONDON, V463, P193, DOI 10.1113/jphysiol.1993.sp019591; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	43	373	385	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1052	1058		10.1038/nature03624	http://dx.doi.org/10.1038/nature03624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15858532				2022-12-01	WOS:000229970400039
J	Turner, PC; Sylla, A; Gong, YY; Diailo, MS; Sutcliffe, AE; Hall, AJ; Wild, CP				Turner, PC; Sylla, A; Gong, YY; Diailo, MS; Sutcliffe, AE; Hall, AJ; Wild, CP			Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study	LANCET			English	Article							HEPATOCELLULAR-CARCINOMA; PRIMARY PREVENTION; DIETARY AFLATOXIN; YOUNG-CHILDREN; LIVER-CANCER; BENIN; RISK; INFECTION; GROWTH; TOGO	Background Aflatoxins are fungal metabolites that frequently contaminate staple foods in much of sub-Saharan Africa, and are associated with increased risk of liver cancer and impaired growth in young children. We aimed to assess whether postharvest measures to restrict aflatoxin contamination of groundnut crops could reduce exposure in west African villages. Methods We undertook an intervention study at subsistence farms in the lower Kindia region of Guinea. Farms from 20 villages were included, ten of which implemented a package of postharvest measures to restrict aflatoxin contamination of the groundnut crop; ten controls followed usual postharvest practices. We measured the concentrations of blood aflatoxin-albumin adducts from 600 people immediately after harvest and at 3 months and 5 months postharvest to monitor the effectiveness of the intervention. Findings In control villages mean aflatoxin-albumin concentration increased postharvest (from 5.5 pg/mg [95% CI 4.7-6.1] immediately after harvest to 18.7 pg/mg [17.0-20.6] 5 months later). By contrast, mean aflatoxin-albumin concentration in intervention villages after 5 months of groundnut storage was much the same as that immediately postharvest (7.2 pg/mg [6.2-8.4] vs 8.0 pg/mg [7.0-9.2]). At 5 months, mean adduct concentration in intervention villages was less than 50% of that in control villages (8.0 pg/mg [7.2-9.2] vs 18.7 pg/mg [17.0-20.6], p<0.0001). About a third of the number of people had non-detectable aflatoxin-albumin concentrations at harvest. At 5 months, five (2%) people in the control villages had non-detectable adduct concentrations compared with 47 (20%) of those in the intervention group (p<0.0001). Mean concentrations of aflatoxin B1 in groundnuts in household stores in intervention and control villages were consistent with measurements of aflatoxin-albumin adducts. Interpretation Use of low-technology approaches at the subsistence-farm level in sub-Saharan Africa could substantially reduce the disease burden caused by aflatoxin exposure.	Univ Leeds, Ctr Biostat & Epidemiol, Leeds Inst Genet Hlth & Therpaeut, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England; Univ London, London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London, England; Inst Pasteur Guinee, Kindia, Guinea	University of Leeds; University of London; London School of Hygiene & Tropical Medicine	Wild, CP (corresponding author), Univ Leeds, Ctr Biostat & Epidemiol, Leeds Inst Genet Hlth & Therpaeut, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England.	c.p.wild@leeds.ac.uk	Wild, Christopher/ABC-6260-2020; Gong, Yun Yun/C-8412-2018; Gong, Yun Yun/L-7094-2016; Turner, Paul C/A-6152-2011; Turner, Paul C/B-8131-2013	Wild, Christopher/0000-0003-0249-8669; Gong, Yun Yun/0000-0003-4927-5526; Gong, Yun Yun/0000-0003-4927-5526; 	NIEHS NIH HHS [ES06052] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES006052] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P426, DOI 10.1016/0035-9203(92)90253-9; *ASS OFF AN CHEM, 1990, OFF METH AN AOAC NAT, P1184; Chapot B., 1991, TECHNIQUES DIAGNOSTI, P135; CROMPTON JAF, 1993, TROP SCI, V33, P283; Diallo Mamadou S., 1995, Natural Toxins, V3, P6, DOI 10.1002/nt.2620030103; Egner PA, 2001, P NATL ACAD SCI USA, V98, P14601, DOI 10.1073/pnas.251536898; Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954; Gong YY, 2003, INT J EPIDEMIOL, V32, P556, DOI 10.1093/ije/dyg109; Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20; Hall AJ, 2003, BRIT MED J, V326, P994, DOI 10.1136/bmj.326.7397.994; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC Monogr Eval Carcinog Risks Hum, V82, P1; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3; RAISUDDIN S, 1993, MYCOPATHOLOGIA, V124, P189, DOI 10.1007/BF01103737; Sylla A, 1999, MUTAT RES-FUND MOL M, V428, P187, DOI 10.1016/S1383-5742(99)00046-0; Turner PC, 2002, J GASTROEN HEPATOL, V17, pS441, DOI 10.1046/j.1440-1746.17.s4.7.x; Turner PC, 2003, ENVIRON HEALTH PERSP, V111, P217, DOI 10.1289/ehp.5753; Wang LY, 1996, INT J CANCER, V67, P620, DOI 10.1002/(SICI)1097-0215(19960904)67:5&lt;620::AID-IJC5&gt;3.0.CO;2-W; *WHO, 1998, FOOD ADDITIVES SERIE, P359; *WHO INT AG RES CA, 2003, IARC SCI PUBL, V153, P299; Wild CP, 2002, MUTAGENESIS, V17, P471, DOI 10.1093/mutage/17.6.471; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2	22	189	194	2	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2005	365	9475					1950	1956		10.1016/S0140-6736(05)66661-5	http://dx.doi.org/10.1016/S0140-6736(05)66661-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936422				2022-12-01	WOS:000229587800029
J	Kim, MG; da Cunha, L; McFall, AJ; Belkhadir, Y; DebRoy, S; Dangl, JL; Mackey, D				Kim, MG; da Cunha, L; McFall, AJ; Belkhadir, Y; DebRoy, S; Dangl, JL; Mackey, D			Two Pseudomonas syringae type III effectors inhibit RIM-regulated basal defense in Arabidopsis	CELL			English	Article							DISEASE-RESISTANCE; HYPERSENSITIVE RESPONSE; SECRETION SYSTEM; GENOMEWIDE IDENTIFICATION; CALLOSE SYNTHASE; GENE-PRODUCT; BACTERIAL; AVRRPT2; VIRULENCE; PROTEINS	Plant cells have two defense systems that detect bacterial pathogens. One is a basal defense system that recognizes complex pathogen-associated molecular patterns (PAMPs). A second system uses diseaseresistance (R) proteins to recognize type III effector proteins that are delivered into the plant cell by the pathogen's type III secretion system. Here we show that these two pathways are linked. We find that two Pseudomonas syringae type III effectors, AvrRpt2 and AvrRpm1, inhibit PAMP-induced signaling and thus compromise the host's basal defense system. RIN4 is an Arabidopsis protein targeted by AvrRpt2 and AvrRpm1 for degradation and phosphorylation, respectively. We find that RIN4 is itself a regulator of PAMP signaling. The R proteins, RPS2 and RPM1, sense type III effector-induced perturbations of RIN4. Thus, R proteins guard the plant against type III effectors that inhibit PAMP signaling and provide a mechanistic link between the two plant defense systems.	Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; Ohio State Univ, Dept Plant Cellular & Mol Biol, Columbus, OH 43210 USA; Ohio State Univ, Program Plant Mol Biol & Biotechnol, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; Michigan State Univ, Dept Energy, Plant Res Lab, Cell & Mol Biol Program, E Lansing, MI 48824 USA; Univ N Carolina, Carolina Ctr Genome Sci, Curriculum Genet, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Curriculum Genet, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mackey, D (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Room 306C Kottman Hall, Columbus, OH 43210 USA.	mackey.86@osu.edu	Belkhadir, Youssef/GXM-6743-2022	Belkhadir, Youssef/0000-0001-7149-7139				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Chen ZY, 2004, PLANT J, V37, P494, DOI 10.1111/j.1365-313X.2003.01984.x; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deng WL, 1998, J BACTERIOL, V180, P4523, DOI 10.1128/JB.180.17.4523-4531.1998; Espinosa A, 2004, CELL MICROBIOL, V6, P1027, DOI 10.1111/j.1462-5822.2004.00452.x; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; JAKOBEK JL, 1993, PLANT CELL, V5, P57, DOI 10.1105/tpc.5.1.57; Jin P, 2003, PLANT PHYSIOL, V133, P1072, DOI 10.1104/pp.103.025999; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Keshavarzi M, 2004, MOL PLANT MICROBE IN, V17, P805, DOI 10.1094/MPMI.2004.17.7.805; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lehmann Przemyslaw, 2002, Journal of Applied Genetics, V43, P403; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Qureshi ST, 2003, GENES IMMUN, V4, P87, DOI 10.1038/sj.gene.6363937; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Rohmer L, 2003, MOL MICROBIOL, V47, P1545, DOI 10.1046/j.1365-2958.2003.03402.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	54	360	376	1	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					749	759		10.1016/j.cell.2005.03.025	http://dx.doi.org/10.1016/j.cell.2005.03.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935761	Bronze			2022-12-01	WOS:000229658000013
J	Schweitzer, MH; Wittmeyer, JL; Horner, JR				Schweitzer, MH; Wittmeyer, JL; Horner, JR			Gender-specific reproductive tissue in ratites and Tyrannosaurus rex	SCIENCE			English	Article							MALE JAPANESE QUAIL; MEDULLARY BONE; AVIAN BONE; ESTROGEN; EVOLUTION; CALCIUM; BIRDS; OSTEOGENESIS; ORIGIN; MODEL	Unambiguous indicators of gender in dinosaurs are usually lost during fossilization, along with other aspects of soft tissue anatomy. We report the presence of endosteally derived bone tissues lining the interior marrow cavities of portions of Tyrannosaurus rex (Museum of the Rockies specimen number 1125) hindlimb elements, and we hypothesize that these tissues are homologous to specialized avian tissues known as medullary bone. Because medullary bone is unique to female birds, its discovery in extinct dinosaurs solidifies the link between dinosaurs and birds, suggests similar reproductive strategies, and provides an objective means of gender differentiation in dinosaurs.	N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; N Carolina State Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; 				Arias JL, 2001, WORLD POULTRY SCI J, V57, P349, DOI 10.1079/WPS20010024; ASCENZI A, 1963, J ULTRA MOL STRUCT R, V8, P491, DOI 10.1016/S0022-5320(63)80051-9; BLOOM MA, 1958, AM J ANAT, V102, P411, DOI 10.1002/aja.1001020304; BONUCCI E, 1975, CELL TISSUE RES, V163, P81; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; CARPENTER K, 1999, EGGS NESTS BAYB DINO; CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; Chinsamy A, 1997, J VERTEBR PALEONTOL, V17, P450, DOI 10.1080/02724634.1997.10010993; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Cracraft J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P143; DACKE CG, 1993, J EXP BIOL, V184, P63; ELSEY RM, 1986, COMP BIOCHEM PHYS A, V84, P107, DOI 10.1016/0300-9629(86)90050-2; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Knott L, 1999, BRIT POULTRY SCI, V40, P371, DOI 10.1080/00071669987476; Martill DM, 1996, NATURE, V379, P778, DOI 10.1038/379778a0; Mikhailov K.E., 1997, SPEC PAP PALAEONTOL, V56, P1; MILLER SC, 1981, DEV BIOL, V87, P52, DOI 10.1016/0012-1606(81)90060-9; OHASHI T, 1987, BRIT POULTRY SCI, V28, P727, DOI 10.1080/00071668708417008; Padian K, 1998, SCI AM, V278, P38, DOI 10.1038/scientificamerican0298-38; SATO T, SCIENCE, V308, P375; SCHRAER H, 1985, COMP BIOCHEM PHYS A, V82, P13, DOI 10.1016/0300-9629(85)90697-8; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2001, J EXP ZOOL, V291, P317, DOI 10.1002/jez.1132; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sugiyama T, 2001, ASIAN AUSTRAL J ANIM, V14, P82; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193; Wilson S, 1998, CALCIFIED TISSUE INT, V62, P506, DOI 10.1007/s002239900470; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Yamamoto T, 2001, ANAT REC, V264, P25, DOI 10.1002/ar.1101; [No title captured]	32	106	133	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2005	308	5727					1456	1460		10.1126/science.1112158	http://dx.doi.org/10.1126/science.1112158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933198	Green Submitted			2022-12-01	WOS:000229619300050
J	Hsieh, CH; Glaser, SM; Lucas, AJ; Sugihara, G				Hsieh, CH; Glaser, SM; Lucas, AJ; Sugihara, G			Distinguishing random environmental fluctuations from ecological catastrophes for the North Pacific Ocean	NATURE			English	Article							DETECTING REGIME SHIFTS; TIME-SERIES; STABLE POINTS; CHAOS; VARIABILITY; POPULATIONS; CALIFORNIA; MODELS; ERROR	The prospect of rapid dynamic changes in the environment is a pressing concern that has profound management and public policy implications(1,2). Worries over sudden climate change and irreversible changes in ecosystems are rooted in the potential that nonlinear systems have for complex and 'pathological' behaviours(1,2). Nonlinear behaviours have been shown in model systems(3) and in some natural systems(1,4-8), but their occurrence in large-scale marine environments remains controversial(9,10). Here we show that time series observations of key physical variables(11-14) for the North Pacific Ocean that seem to show these behaviours are not deterministically nonlinear, and are best described as linear stochastic. In contrast, we find that time series for biological variables(5,15-17) having similar properties exhibit a low-dimensional nonlinear signature. To our knowledge, this is the first direct test for nonlinearity in large-scale physical and biological data for the marine environment. These results address a continuing debate over the origin of rapid shifts in certain key marine observations as coming from essentially stochastic processes or from dominant nonlinear mechanisms(1,9,10,18-20). Our measurements suggest that large-scale marine ecosystems are dynamically nonlinear, and as such have the capacity for dramatic change in response to stochastic fluctuations in basin-scale physical states.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272; Lucas, Andrew/0000-0001-7722-7252				deYoung B, 2004, PROG OCEANOGR, V60, P143, DOI 10.1016/j.pocean.2004.02.017; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Dixon PA, 2001, NONLINEAR DYNAMICS AND STATISTICS, P339; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Hastings H. M., 1993, FRACTALS USERS GUIDE; HSIEH CH, UNPUB PROG OCEANOGR; HURRELL J, 2003, N PACIFIC NP INDEX I; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Mantua N, 2004, PROG OCEANOGR, V60, P165, DOI 10.1016/j.pocean.2004.02.016; MANTUA NJ, 2004, PACIFIC DECADAL OSCI; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; McGowan JA, 2003, DEEP-SEA RES PT II, V50, P2567, DOI 10.1016/S0967-0645(03)00135-8; *NAT CTR ATM RES, 2004, SO OSC IND; Patil DAS, 2001, MON WEATHER REV, V129, P2116, DOI 10.1175/1520-0493(2001)129<2116:ILDNBI>2.0.CO;2; Rebstock GA, 2002, GLOBAL CHANGE BIOL, V8, P71, DOI 10.1046/j.1365-2486.2002.00456.x; Rudnick DL, 2003, DEEP-SEA RES PT I, V50, P691, DOI 10.1016/S0967-0637(03)00053-0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; STEELE JH, 1984, SCIENCE, V224, P985, DOI 10.1126/science.224.4652.985; Sugihara G, 1996, P NATL ACAD SCI USA, V93, P2608, DOI 10.1073/pnas.93.6.2608; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Sugihara G, 1999, P NATL ACAD SCI USA, V96, P14210, DOI 10.1073/pnas.96.25.14210; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; *WA DEP FISH WILDL, 2004, STAT REP COL RIV FIS; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; [No title captured]	29	245	250	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					336	340		10.1038/nature03553	http://dx.doi.org/10.1038/nature03553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902256				2022-12-01	WOS:000229185000044
J	Shlipak, MG; Sarnak, MJ; Katz, R; Fried, LF; Seliger, SL; Newman, AB; Siscovick, DS; Stehman-Breen, C				Shlipak, MG; Sarnak, MJ; Katz, R; Fried, LF; Seliger, SL; Newman, AB; Siscovick, DS; Stehman-Breen, C			Cystatin C and the risk of death and cardiovascular events among elderly persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; RENAL-INSUFFICIENCY; MYOCARDIAL-INFARCTION; OLDER-ADULTS; MORTALITY; OUTCOMES; DYSFUNCTION; HOSPITALIZATION; PREDICTION	BACKGROUND: Cystatin C is a serum measure of renal function that appears to be independent of age, sex, and lean muscle mass. We compared creatinine and cystatin C levels as predictors of mortality from cardiovascular causes and from all causes in the Cardiovascular Health Study, a cohort study of elderly persons living in the community. METHODS: Creatinine and cystatin C were measured in serum samples collected from 4637 participants at the study visit in 1992 or 1993; follow-up continued until June 30, 2001. For each measure, the study population was divided into quintiles, with the fifth quintile subdivided into thirds (designated 5a, 5b, and 5c). RESULTS: Higher cystatin C levels were directly associated, in a dose-response manner, with a higher risk of death from all causes. As compared with the first quintile, the hazard ratios (and 95 percent confidence intervals) for death were as follows: second quintile, 1.08 (0.86 to 1.35); third quintile, 1.23 (1.00 to 1.53); fourth quintile, 1.34 (1.09 to 1.66); quintile 5a, 1.77 (1.34 to 2.26); 5b, 2.18 (1.72 to 2.78); and 5c, 2.58 (2.03 to 3.27). In contrast, the association of creatinine categories with mortality from all causes appeared to be J-shaped. As compared with the two lowest quintiles combined (cystatin C level, lessthan/equal 0.99 mg per liter), the highest quintile of cystatin C (greater/equal 1.29 mg per liter) was associated with a significantly elevated risk of death from cardiovascular causes (hazard ratio, 2.27 [1.73 to 2.97]), myocardial infarction (hazard ratio, 1.48 [1.08 to 2.02]), and stroke (hazard ratio, 1.47 [ 1.09 to 1.96]) after multivariate adjustment. The fifth quintile of creatinine, as compared with the first quintile, was not independently associated with any of these three outcomes. CONCLUSIONS: Cystatin C, a serum measure of renal function, is a stronger predictor of the risk of death and cardiovascular events in elderly persons than is creatinine.	Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Tufts New England Med Ctr, Dept Med, Div Nephrol, Boston, MA USA; Collaborat Hlth Studies Coordinating Ctr, Seattle, WA USA; Vet Affairs Pittsburgh Healthcare Syst, Med Serv, Renal Sect, Pittsburgh, PA USA; Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Div Geriatr Med, Pittsburgh, PA USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Amgen Inc, Thousand Oaks, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tufts Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Amgen	Shlipak, MG (corresponding author), Vet Affairs Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	shlip@itsa.ucsf.edu	Newman, Anne B./C-6408-2013; Katz, Ronit/ABA-1880-2021	Newman, Anne B./0000-0002-0106-1150; Seliger, Stephen/0000-0002-1693-0734	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC085083, N01HC035129, N01HC015103, N01HC085085, N01HC085079, N01HC085084, N01HC085081, N01HC085082, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073208] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-85086, N01-HC-85081, N01-HC-85085, N01-HC-85082, N01-HC-85083, N01 HC-15103, N01-HC-85084, N01-HC-35129, R01 HL073208-01, N01-HC-85079, N01-HC-85080] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; Chertow GM, 1997, CIRCULATION, V95, P878; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Erlandsen EJ, 1999, SCAND J CLIN LAB INV, V59, P1, DOI 10.1080/00365519950185940; Fliser D, 2001, AM J KIDNEY DIS, V37, P79, DOI 10.1053/ajkd.2001.20591; Fricker M, 2003, KIDNEY INT, V63, P1944, DOI 10.1046/j.1523-1755.2003.00925.x; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Garg AX, 2004, KIDNEY INT, V65, P649, DOI 10.1111/j.1523-1755.2004.00412.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Herget-Rosenthal S, 2000, AM J NEPHROL, V20, P97, DOI 10.1159/000013564; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jayagopal V, 2003, CLIN CHEM, V49, P680, DOI 10.1373/49.4.680; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Price T R, 1993, Ann Epidemiol, V3, P504; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2004, J AM SOC NEPHROL, V15, P2195, DOI 10.1097/01.ASN.0000135121.81744.75; Singer MA, 2001, AM J KIDNEY DIS, V37, P164, DOI 10.1016/S0272-6386(01)80073-1; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Wiesli P, 2003, CLIN CHIM ACTA, V338, P87, DOI 10.1016/j.cccn.2003.07.022	28	953	1011	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2005	352	20					2049	2060		10.1056/NEJMoa043161	http://dx.doi.org/10.1056/NEJMoa043161			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GJ	15901858				2022-12-01	WOS:000229180100003
J	Talbot, TR; Hartert, TV; Mitchel, E; Halasa, NB; Arbogast, PG; Poehling, KA; Schaffner, W; Craig, AS; Griffin, MR				Talbot, TR; Hartert, TV; Mitchel, E; Halasa, NB; Arbogast, PG; Poehling, KA; Schaffner, W; Craig, AS; Griffin, MR			Asthma as a risk factor for invasive pneumococcal disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYSACCHARIDE VACCINE; OLDER-ADULTS; INFECTIONS; HEALTH	BACKGROUND: The risk of invasive pneumococcal disease among persons with asthma is unknown. METHODS: We conducted a nested case-control study to examine the association between asthma and invasive pneumococcal disease. The study population included persons 2 to 49 years of age who were enrolled in Tennessee's Medicaid program (TennCare) for more than one year during the study period (1995 through 2002) and who resided in counties participating in a prospective laboratory-based program of surveillance for invasive pneumococcal disease. For each subject with invasive pneumococcal disease, 10 age-matched controls without invasive pneumococcal disease were randomly selected from the same population. TennCare files were queried to identify the presence of coexisting conditions that confer a high risk of pneumococcal disease. For the purpose of our study, asthma was defined by documentation of one or more inpatient or emergency-department diagnoses of asthma, two outpatient diagnoses, or the use of asthma-related medications. High-risk asthma was defined as asthma requiring admission to a hospital or a visit to an emergency department, the use of rescue therapy or long-term use of oral corticosteroids, or the dispensing of three or more prescriptions for (beta)-agonists within the year before enrollment in the study. RESULTS: A total of 635 persons with invasive pneumococcal disease and 6350 controls were identified, of whom 114 (18.0 percent) and 516 (8.1 percent), respectively, had asthma. Persons with asthma had an increased risk of invasive pneumococcal disease (adjusted odds ratio, 2.4; 95 percent confidence interval, 1.9 to 3.1) as compared with controls. Among those without coexisting conditions, the annual incidence of invasive pneumococcal disease was 4.2 episodes per 10,000 persons with high-risk asthma and 2.3 episodes per 10,000 persons with low-risk asthma, as compared with 1.2 episodes per 10,000 persons without asthma. CONCLUSIONS: Asthma is an independent risk factor for invasive pneumococcal disease. The risk among persons with asthma was at least double that among controls.	Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; Tennessee Dept Hlth, Nashville, TN USA; Vet Affairs Tennessee Valley Healthcare Syst, Ctr Geriatr Res Educ & Clin, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tennessee Department Health; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Talbot, TR (corresponding author), A-4103C Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	tom.talbot@vanderbilt.edu		Talbot, Thomas/0000-0002-6139-212X	NCRR NIH HHS [M01 RR00095, K12 RR-017697] Funding Source: Medline; NHLBI NIH HHS [UO1HL72471] Funding Source: Medline; NIAID NIH HHS [R01 AI 50884, KO8 AI 001582] Funding Source: Medline; ODCDC CDC HHS [U50/CCU416123] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095, K12RR017697] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050884, K08AI001582] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ODCDC CDC HHS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; BARDIN PG, 1994, CLIN EXP ALLERGY, V24, P457, DOI 10.1111/j.1365-2222.1994.tb00934.x; BURMAN LA, 1985, REV INFECT DIS, V7, P133; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP, 2002, ACT BACT COR SURV EM; Fahy J V, 2000, Curr Opin Pulm Med, V6, P15, DOI 10.1097/00063198-200001000-00004; HART AC, 2002, INT CLASSIFICATION D, V1; HART AC, 2002, INT CLASSIFICATION D, V3; HART AC, 2002, INT CLASSIFICATION D, V2; Hartert T V, 2000, Curr Opin Pulm Med, V6, P4, DOI 10.1097/00063198-200001000-00002; Hartert TV, 2000, J AM GERIATR SOC, V48, P651, DOI 10.1111/j.1532-5415.2000.tb04723.x; Hartert TV, 2002, ANN ALLERG ASTHMA IM, V89, P467, DOI 10.1016/S1081-1206(10)62083-2; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; LIPSKY BA, 1986, ARCH INTERN MED, V146, P2179, DOI 10.1001/archinte.146.11.2179; Message SD, 2004, J LEUKOCYTE BIOL, V75, P5, DOI 10.1189/jlb.0703315; MIRVIS DM, 1995, JAMA-J AM MED ASSOC, V274, P1235, DOI 10.1001/jama.274.15.1235; *NAT ASTHM ED PREV, 1997, NIH PUBL; National Asthma Education and Prevention Program, 2003, J ALLERGY CLIN IMMUN, V111, P466, DOI DOI 10.1542/PEDS.2007-3825; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Plouffe JF, 1996, JAMA-J AM MED ASSOC, V275, P194, DOI 10.1001/jama.275.3.194; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Talbot TR, 2004, PEDIATR INFECT DIS J, V23, P726, DOI 10.1097/01.inf.0000133046.60555.de; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; US CENSUS 2000 STAT; 2004, MMWR MORB MORTAL WKL, V53, P145	32	299	313	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2005	352	20					2082	2090		10.1056/NEJMoa044113	http://dx.doi.org/10.1056/NEJMoa044113			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GJ	15901861	Bronze			2022-12-01	WOS:000229180100006
J	Kanaya, AM; Herrington, D; Vittinghoff, E; Lin, F; Bittner, V; Cauley, JA; Hulley, S; Barrett-Connor, E				Kanaya, AM; Herrington, D; Vittinghoff, E; Lin, F; Bittner, V; Cauley, JA; Hulley, S; Barrett-Connor, E			Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-DISEASE; RISK-FACTOR; ESTROGEN/PROGESTIN REPLACEMENT; DIABETES-MELLITUS; HYPERGLYCEMIA; MORTALITY; ASSOCIATION; POPULATION; PREVENTION; INFARCTION	Background: Type 2 diabetes increases risk for cardiovascular disease. Persons with impaired fasting glucose levels may also have increased risk. Objective: To evaluate the association between glucose status and cardiovascular outcomes and the effect of lowering the fasting glucose level criterion for impaired fasting glucose from a lower limit of 6.1 mmol/L (110 mg/dL) to 5.6 mmol/L (100 mg/dL). Design: Prospective cohort study. Setting: 20 U.S. clinical centers. Patients: 2763 postmenopausal women with established coronary heart disease (CHD) who were followed for 6.8 years. Measurements: Any CHD event (nonfatal myocardial infarction or CHD death), stroke or transient ischemic attack (TIA), congestive heart failure (CHF) hospitalization, and any cardiovascular event. Results: During follow-up, 583 women had a CHD event, 329 women had a stroke or TIA, and 348 women were hospitalized for CHF. Women with diabetes were at an approximately 75% increased risk for each outcome compared with normoglycemic women. The 218 women with impaired fasting glucose according to the 1997 definition (fasting glucose level, 6.1 to 6.9 mmol/L [110 to 125 mg/dL]) had increased risk for any CHID event (hazard ratio, 1.37 [95% CI, 1.08 to 1.74]), while the 698 women with impaired fasting glucose according to the 2003 definition (fasting glucose level, 5.6 to 6.9 mmol/L [100 to 125 mg/dL]) were not at increased risk (hazard ratio, 1.09 [CI, 0.90 to 1.34]). Most of the women (n = 480) with fasting glucose levels between 5.6 mmol/L (100 mg/dL) and 6.0 mmol/L (109 mg/dL) had no increased risk for CHD (hazard ratio, 0.90 [CI, 0.73 to 1.12]). Women with impaired fasting glucose according to either definition were not at increased risk for stroke or TIA or CHF. Limitations: These findings may not be generalizable to men or women without existing heart disease. Conclusions: Among postmenopausal women with coronary artery disease, the 2003 definition for impaired fasting glucose was not associated with increased risk for new CHID, stroke or TIA, or CHF.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; Wake Forest University; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Kanaya, AM (corresponding author), Womens Hlth Clin Res Ctr, 1635 Divisadero St,Suite 600, San Francisco, CA 94115 USA.	alkak@itsa.ucsf.edu	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Bittner, Vera/0000-0001-9456-850X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K12AR047659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG015272] Funding Source: NIH RePORTER; NIAMS NIH HHS [5 K12 AR47659] Funding Source: Medline; NIA NIH HHS [P30-AG15272] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833; Arcavi L, 2004, AM HEART J, V147, P239, DOI 10.1016/j.ahj.2003.09.013; BELL DSH, 1995, DIABETES CARE, V18, P708, DOI 10.2337/diacare.18.5.708; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Borch-Johnsen K, 1999, LANCET, V354, P617; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davidson MB, 2003, DIABETES CARE, V26, P3329, DOI 10.2337/diacare.26.12.3329; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Fisman EZ, 2001, AM HEART J, V141, P485, DOI 10.1067/mhj.2001.113219; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Harris MI, 1997, DIABETES CARE, V20, P1859, DOI 10.2337/diacare.20.12.1859; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Lindsberg PJ, 2004, STROKE, V35, P363, DOI 10.1161/01.STR.0000115297.92132.84; PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463; Qureshi AI, 1998, STROKE, V29, P1329, DOI 10.1161/01.STR.29.7.1329; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tuomilehto J, 1996, STROKE, V27, P210, DOI 10.1161/01.STR.27.2.210; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x	28	60	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2005	142	10					813	820		10.7326/0003-4819-142-10-200505170-00006	http://dx.doi.org/10.7326/0003-4819-142-10-200505170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926CE	15897531				2022-12-01	WOS:000229099600002
J	Wahlund, JE; Bostrom, R; Gustafsson, G; Gurnett, DA; Kurth, WS; Pedersen, A; Averkamp, TF; Hospodarsky, GB; Persoon, AM; Canu, P; Neubauer, FM; Dougherty, MK; Eriksson, AI; Morooka, MW; Gill, R; Andre, M; Eliasson, L; Muller-Wodarg, I				Wahlund, JE; Bostrom, R; Gustafsson, G; Gurnett, DA; Kurth, WS; Pedersen, A; Averkamp, TF; Hospodarsky, GB; Persoon, AM; Canu, P; Neubauer, FM; Dougherty, MK; Eriksson, AI; Morooka, MW; Gill, R; Andre, M; Eliasson, L; Muller-Wodarg, I			Cassini measurements of cold plasma in the ionosphere of Titan	SCIENCE			English	Article							WAVE OBSERVATIONS; MARS; MAGNETOSPHERE; SATURN; RADIO	The Cassini Radio and Plasma Wave Science (RPWS) Langmuir probe (LP) sensor observed the cold plasma environment around Titan during the first two flybys. The data show that conditions in Saturn's magnetosphere affect the structure and dynamics deep in the ionosphere of Titan. The maximum measured ionospheric electron number density reached 3800 per cubic centimeter near closest approach, and a complex chemistry was indicated. The electron temperature profiles are consistent with electron heat conduction from the hotter Titan wake. The ionospheric escape flux was estimated to be 10(25) ions per second.	Swedish Inst Space Phys, SE-75121 Uppsala, Sweden; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Univ Oslo, Dept Phys, NO-0316 Oslo, Norway; Inst Pierre Simon Laplace, CNRS, Ctr Etud Environm Terr & Planetaires, F-78140 Velizy Villacoublay, France; Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BW, England; Swedish Inst Space Phys, SE-98128 Kiruna, Sweden	University of Iowa; University of Oslo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Cologne; Imperial College London	Wahlund, JE (corresponding author), Swedish Inst Space Phys, Box 537, SE-75121 Uppsala, Sweden.	jwe@irfu.se	Wahlund, Jan-Erik/AAL-6439-2021; Hospodarsky, George B/A-7996-2015; Morooka, Michiko/AAO-8594-2020; Eriksson, Anders I/C-2887-2009; Mueller-Wodarg, Ingo C. F./M-9945-2014; Kurth, William/AAA-7334-2019	Hospodarsky, George B/0000-0001-9200-9878; Morooka, Michiko/0000-0001-9958-0241; Eriksson, Anders I/0000-0003-2926-6761; Mueller-Wodarg, Ingo C. F./0000-0001-6308-7826; Kurth, William/0000-0002-5471-6202				Backes H, 2005, SCIENCE, V308, P992, DOI 10.1126/science.1109763; BACKES H, 2004, AM GEOPH UN FALL M S; Blanc M, 2002, SPACE SCI REV, V104, P253, DOI 10.1023/A:1023605110711; COATES A, 2004, AM GEOPH UN FALL M S; CRAVENS TE, UNPUB; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; GURNETT DA, 1982, J GEOPHYS RES-SPACE, V87, P1395, DOI 10.1029/JA087iA03p01395; Kallio E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020344; KELLER CN, 1994, J GEOPHYS RES-SPACE, V99, P6527, DOI 10.1029/93JA02681; Ledvina SA, 2004, ADV SPACE RES-SERIES, V33, P2092, DOI 10.1016/j.asr.2003.07.056; Lundin R, 2004, ADV SPACE RES-SERIES, V33, P1945, DOI 10.1016/j.asr.2003.07.054; Nagy AF, 2004, SPACE SCI REV, V111, P33, DOI 10.1023/B:SPAC.0000032718.47512.92; Nagy AF, 2001, J GEOPHYS RES-SPACE, V106, P6151, DOI 10.1029/2000JA000183; ROBOZ A, 1994, J GEOPHYS RES-SPACE, V99, P2087, DOI 10.1029/93JA02286; Vignes D, 2000, GEOPHYS RES LETT, V27, P49, DOI 10.1029/1999GL010703	16	163	163	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					986	989		10.1126/science.1109807	http://dx.doi.org/10.1126/science.1109807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15894529				2022-12-01	WOS:000229190700035
J	Marcus, GM; Gerber, IL; McKeown, BH; Vessey, JC; Jordan, MV; Huddleston, M; McCulloch, CE; Foster, E; Chatterjee, K; Michaels, AD				Marcus, GM; Gerber, IL; McKeown, BH; Vessey, JC; Jordan, MV; Huddleston, M; McCulloch, CE; Foster, E; Chatterjee, K; Michaels, AD			Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							JUGULAR VENOUS-PRESSURE; INTEROBSERVER AGREEMENT; NATRIURETIC PEPTIDE; GALLOP SOUNDS; FAILURE; AUSCULTATION; DISEASE; FLOW	Context The third (S-3) and fourth (S-4) heart sounds detected by phonocardiography are considered to represent the criterion standards of the gallop sounds, but their test characteristics have not been explored. Objective To determine the diagnostic test characteristics of the S-3 and S-4 for prediction of left ventricular dysfunction using a computerized heart sound detection algorithm. Design, Setting, and Participants Prospective study of 90 adult patients undergoing elective left-sided heart catheterization at a single US teaching hospital between August 2003 and June 2004. The mean age was 62 (SD, 13) years (range, 24-90 years) and 61 (68%) were male. Within a 4-hour period, participants underwent computerized heart sound phonocardiographic analysis, cardiac catheterization, transthoracic echocardiography, and blood sampling for assessment of an S-3/S-4, left ventricular end-diastolic pressure (LVEDP), left ventricular ejection fraction (LVEF), and B-type natriuretic peptide (BNP), respectively. Main Outcome Measures Diagnostic test characteristics of the computerized phonocardiographic S-3 and S-4 using markers of left ventricular function as criterion standards. Results Mean (SD) LVEDP was significantly elevated (18.4 [6.9] mm Hg vs 12.1 [7.3] mm Hg; P<.001), mean (SD) LVEF was reduced (49.4% [20.2%] vs 63.6% (14.8%]; P<.001), and median (interquartile range) BNP was elevated (330 [98-1155] pg/mL vs 86 [41-192] pg/mL; P<.001) in those with an S-3, S-4, or both compared with patients without a diastolic heart sound. The sensitivities of these heart sounds to detect an elevated LVEDP, reduced LVEF, or elevated BNP were 41%, 52%, and 32% for an S-3, and 46%, 43 %, and 40% for an S-4, respectively. For abnormal levels of the same markers of ventricular function, the specificities of the S-3 were 92 %, 87%, and 92 %, while the specificities of the S-4 were 80%, 72%, and 78%, respectively. Conclusions Neither the phonocardiographic S-3 nor the S-4 is a sensitive marker of left ventricular dysfunction. The phonocardiographic S-3 is specific for left ventricular dysfunction and appears to be superior to the moderate specificity of the phonocardiographic S-4.	Univ Calif San Francisco, Med Ctr, Div Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Michaels, AD (corresponding author), Univ Calif San Francisco, Med Ctr, Div Cardiol, 505 Parnassus Ave,Box 0124, San Francisco, CA 94143 USA.	andrewm@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696	NCRR NIH HHS [K23 RR018319-01 A1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR018319] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AREVALO F, 1964, AM J PHYSIOL, V207, P319, DOI 10.1152/ajplegacy.1964.207.2.319; BAIM DS, 2000, GROSSMANS CARDIAC CA; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Drazner MH, 2003, AM J MED, V114, P431, DOI 10.1016/S0002-9343(03)00058-5; GLOWER DD, 1992, J AM COLL CARDIOL, V19, P450, DOI 10.1016/0735-1097(92)90504-G; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; HOMMA S, 1991, CLIN CARDIOL, V14, P671, DOI 10.1002/clc.4960140809; ISHMAIL AA, 1987, CHEST, V91, P870, DOI 10.1378/chest.91.6.870; KONO T, 1993, J AM COLL CARDIOL, V21, P419, DOI 10.1016/0735-1097(93)90684-S; KUPARI M, 1994, CIRCULATION, V89, P1189, DOI 10.1161/01.CIR.89.3.1189; Lok CE, 1998, CHEST, V114, P1283, DOI 10.1378/chest.114.5.1283; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; MAISEL AS, 1985, J AM COLL CARDIOL, V6, P731, DOI 10.1016/S0735-1097(85)80474-5; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; MANSON AL, 1995, CIRCULATION, V92, P388, DOI 10.1161/01.CIR.92.3.388; Marcus GM, 2004, AM J CARDIOL, V93, P1312, DOI 10.1016/j.amjcard.2004.01.074; OZAWA Y, 1983, CIRCULATION, V67, P399, DOI 10.1161/01.CIR.67.2.399; PATEL R, 1993, WESTERN J MED, V158, P606; Potain P., 1880, GAZ D HOP, V53, P529; RIHAL CS, 1995, AM J CARDIOL, V75, P220, DOI 10.1016/0002-9149(95)80023-L; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SHAH PM, 1968, NEW ENGL J MED, V278, P753, DOI 10.1056/NEJM196804042781402; STEFADOUROS MA, 1980, ARCH INTERN MED, V140, P537, DOI 10.1001/archinte.140.4.537; VANDEWERF F, 1984, J CLIN INVEST, V73, P1400, DOI 10.1172/JCI111344	25	81	99	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2238	2244		10.1001/jama.293.18.2238	http://dx.doi.org/10.1001/jama.293.18.2238			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886379				2022-12-01	WOS:000228981100025
J	Murray, SA; Kendall, M; Boyd, K; Sheikh, A				Murray, SA; Kendall, M; Boyd, K; Sheikh, A			Illness trajectories and palliative care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROSPECTIVE QUALITATIVE INTERVIEW; LUNG-CANCER; PEOPLE; LIFE; FAILURE; END		Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland.	Scott.Murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078				Asbring P, 2004, QUAL HEALTH RES, V14, P226, DOI 10.1177/1049732303260682; BALLAM M, 2001, CUMULATIVE TRIVIA EX; BUCTOW S, 2001, PATIENT EDUC COUNS, V45, P181; Burke S O, 2000, Can J Nurs Res, V32, P19; CASSELL EJ, 1991, NATURE SUFFERING; ELLERSHAW J., 2003, CARE DYING PATHWAY E; GLARE PA, 2004, OXFORD TXB PALLIATIV; Hardin SB, 2004, ARCH INTERN MED, V164, P1531, DOI 10.1001/archinte.164.14.1531; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Higgs R, 1999, J ROY COLL PHYS LOND, V33, P110; KITE S, 2001, PALLIATIVE MED, V15, P413; Lehman R, 2004, BRIT J GEN PRACT, V54, P892; Levenson JW, 2000, J AM GERIATR SOC, V48, pS101, DOI 10.1111/j.1532-5415.2000.tb03119.x; LUNNEY JR, 2003, JAMA-J AM MED ASSOC, V298, P2387; Lynn J, 2000, JAMA-J AM MED ASSOC, V284, P2508, DOI 10.1001/jama.284.19.2508; Lynn J, 2003, LIVING WELL END LIFE; McKinley RK, 2004, BRIT J GEN PRACT, V54, P909; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murtagh FEM, 2004, CLIN MED, V4, P39, DOI 10.7861/clinmedicine.4-1-39; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Thomas K., 2003, CARING DYING HOME CO; WILLIAMS R, 1992, SOC SCI MED, V34, P763, DOI 10.1016/0277-9536(92)90363-U; World Health Organization, 2004, PALL CAR SOL FACTS	24	824	832	3	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1007	1011		10.1136/bmj.330.7498.1007	http://dx.doi.org/10.1136/bmj.330.7498.1007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860828	Green Submitted, Green Published			2022-12-01	WOS:000228935100024
J	Audibert, F				Audibert, F			Screening for pre-eclampsia: the quest for the Holy Grail?	LANCET			English	Editorial Material							DOPPLER VELOCIMETRY; EARLY PREDICTION; PREVENTION; ULTRASOUND; RISK		Univ Montreal, Hop St Justine, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada	Universite de Montreal	Audibert, F (corresponding author), Univ Montreal, Hop St Justine, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada.	francois.audibert@umontreal.ca	Audibert, François/AAL-1265-2020	Audibert, Francois/0000-0002-2697-3826				Audibert F, 2005, FETAL DIAGN THER, V20, P48, DOI 10.1159/000081369; Audibert F, 2001, ULTRASOUND OBST GYN, V18, P26, DOI 10.1046/j.1469-0705.2001.00457.x; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Conde-Agudelo A, 2004, OBSTET GYNECOL, V104, P1367, DOI 10.1097/01.AOG.0000147599.47713.5d; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; Florio P, 2003, ULTRASOUND OBST GYN, V21, P165, DOI 10.1002/uog.29; Harrington K, 1997, BRIT J OBSTET GYNAEC, V104, P674, DOI 10.1111/j.1471-0528.1997.tb11977.x; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Salomon LJ, 2003, AM J OBSTET GYNECOL, V189, P1517, DOI 10.1016/S0002-9378(03)00902-5; Sibai BM, 1998, AM J OBSTET GYNECOL, V179, P1275, DOI 10.1016/S0002-9378(98)70146-2	10	12	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1367	1369		10.1016/S0140-6736(05)66350-7	http://dx.doi.org/10.1016/S0140-6736(05)66350-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836870				2022-12-01	WOS:000228401900006
J	Frost, KR				Frost, KR			Ensuring the safety of HIV/AIDS generics	LANCET			English	Editorial Material									Amer Fdn AIDS Res, Global Initiat, New York, NY 10005 USA		Frost, KR (corresponding author), Amer Fdn AIDS Res, Global Initiat, New York, NY 10005 USA.	kevin.frost@amfar.org						ADELMAN C, 2004, WALL STREET J E 1209; *AM FDN AIDS RES, 2004, EXP AV HIV AIDS DRUG; BROWN D, 2004, WASHINGTON POST 0327, P3; BUCKLEY S, 2000, WASHINGTON POST 0917, P22; DSILVA J, 2004, EC TIMES NEW DE 1030; MASON A, 2004, SAN FRANCISCO C 1201, pB11; MCNEIL DG, 2005, NY TIMES        0126, pA9; SOLOMON J, 2004, OFFICIALS KNEW AIDS; VERJEE N, 2004, TIMES LOND      1120, P66; WHALEN J, 2004, WALL STREET J   1110, pB1	10	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1290	1291		10.1016/S0140-6736(05)61007-0	http://dx.doi.org/10.1016/S0140-6736(05)61007-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823366				2022-12-01	WOS:000228219600008
J	Rasmann, S; Kollner, TG; Degenhardt, J; Hiltpold, I; Toepfer, S; Kuhlmann, U; Gershenzon, J; Turlings, TCJ				Rasmann, S; Kollner, TG; Degenhardt, J; Hiltpold, I; Toepfer, S; Kuhlmann, U; Gershenzon, J; Turlings, TCJ			Recruitment of entomopathogenic nematodes by insect-damaged maize roots	NATURE			English	Article							CORN-ROOTWORM COLEOPTERA; SESQUITERPENE HYDROCARBONS; VOLATILE EMISSIONS; BIOLOGICAL-CONTROL; PLANTS; STEINERNEMATIDAE; CARPOCAPSAE; VARIABILITY; PARASITISM; EFFICACY	Plants under attack by arthropod herbivores often emit volatile compounds from their leaves that attract natural enemies of the herbivores. Here we report the first identification of an insect-induced belowground plant signal, (E)-beta-caryophyllene, which strongly attracts an entomopathogenic nematode. Maize roots release this sesquiterpene in response to feeding by larvae of the beetle Diabrotica virgifera virgifera, a maize pest that is currently invading Europe. Most North American maize lines do not release (E)-beta-caryophyllene, whereas European lines and the wild maize ancestor, teosinte, readily do so in response to D. v. virgifera attack. This difference was consistent with striking differences in the attractiveness of representative lines in the laboratory. Field experiments showed a fivefold higher nematode infection rate of D. v. virgifera larvae on a maize variety that produces the signal than on a variety that does not, whereas spiking the soil near the latter variety with authentic (E)-beta-caryophyllene decreased the emergence of adult D. v. virgifera to less than half. North American maize lines must have lost the signal during the breeding process. Development of new varieties that release the attractant in adequate amounts should help enhance the efficacy of nematodes as biological control agents against root pests like D. v. virgifera.	Univ Neuchatel, Inst Zool, Lab Anim Ecol & Entomol, CH-2007 Neuchatel, Switzerland; Max Planck Inst Chem Ecol, D-07745 Jena, Germany; CABI Biosci Switzerland Ctr, CH-2800 Delemont, Switzerland	University of Neuchatel; Max Planck Society	Turlings, TCJ (corresponding author), Univ Neuchatel, Inst Zool, Lab Anim Ecol & Entomol, CP 2, CH-2007 Neuchatel, Switzerland.	ted.turlings@unine.ch	Gershenzon, Jonathan/K-1331-2013; Hiltpold, Ivan/AAH-6805-2021; Hiltpold, Ivan/D-1666-2016; Köllner, Tobias G/H-3375-2014; Rasmann, Sergio/T-5376-2017; Turlings, Ted CJ/E-8671-2012	Gershenzon, Jonathan/0000-0002-1812-1551; Hiltpold, Ivan/0000-0001-6374-6684; Hiltpold, Ivan/0000-0001-6374-6684; Köllner, Tobias G/0000-0002-7037-904X; Rasmann, Sergio/0000-0002-3120-6226; Turlings, Ted CJ/0000-0002-8315-785X				Agrawal AA, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P251; [Anonymous], 1986, METHODS STUDY PEST D; Baufeld P, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P285, DOI 10.1079/9780851998176.0285; Boff MIC, 2001, ENTOMOL EXP APPL, V98, P329, DOI 10.1023/A:1018907812376; CURRAN J, 1992, J NEMATOL, V24, P631; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Degen T, 2004, PLANT PHYSIOL, V135, P1928, DOI 10.1104/pp.104.039891; DICKE M, 1988, NETH J ZOOL, V38, P148, DOI 10.1163/156854288X00111; Ellsbury MM, 1996, J ECON ENTOMOL, V89, P74, DOI 10.1093/jee/89.1.74; Fedoroff NV, 2003, SCIENCE, V302, P1158, DOI 10.1126/science.1092042; GAUGLER R, 1988, AGR ECOSYST ENVIRON, V24, P351, DOI 10.1016/0167-8809(88)90078-3; Gouinguene S, 2001, CHEMOECOLOGY, V11, P9, DOI 10.1007/PL00001832; GREWAL PS, 1994, PARASITOLOGY, V108, P207, DOI 10.1017/S003118200006830X; Grewal PS, 1997, J CHEM ECOL, V23, P503, DOI 10.1023/B:JOEC.0000006374.95624.7e; Hammack L, 2001, J CHEM ECOL, V27, P1373, DOI 10.1023/A:1010365225957; Hass B, 1999, J NEMATOL, V31, P508; Jackson JJ, 1996, J ECON ENTOMOL, V89, P366, DOI 10.1093/jee/89.2.366; Jaenicke-Despres V, 2003, SCIENCE, V302, P1206, DOI 10.1126/science.1089056; Journey AM, 2000, ENVIRON ENTOMOL, V29, P822, DOI 10.1603/0046-225X-29.4.822; Karban R., 2007, INDUCED RESPONSES HE; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; Konig WA, 1999, FLAVOUR FRAG J, V14, P367, DOI 10.1002/(SICI)1099-1026(199911/12)14:6&lt;367::AID-FFJ856&gt;3.0.CO;2-4; Kuhlmann Ulrich, 1998, Biocontrol News and Information, V19, p59N; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; LEWIS EE, 1995, PARASITOLOGY, V110, P207, DOI 10.1017/S0031182000063976; LEWIS EE, 1993, CAN J ZOOL, V71, P765, DOI 10.1139/z93-101; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; OSTEEN C, 2003, AGR RESOURCES ENV IN, P1; POINAR GO, 1983, PROT ECOL, V5, P337; Sotelo A., 1997, FUNCTIONALITY FOOD P, P89; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Turlings TCJ, 2004, PHYSIOL ENTOMOL, V29, P45, DOI 10.1111/j.1365-3032.2004.0362.x; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van Tol RWHM, 2001, ECOL LETT, V4, P292, DOI 10.1046/j.1461-0248.2001.00227.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	40	867	926	11	472	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					732	737		10.1038/nature03451	http://dx.doi.org/10.1038/nature03451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815622	Green Submitted			2022-12-01	WOS:000228160700032
J	Lee, KY; D'Acquisto, F; Hayden, MS; Shim, JH; Ghosh, S				Lee, KY; D'Acquisto, F; Hayden, MS; Shim, JH; Ghosh, S			PDK1 nucleates T cell receptor-induced signaling complex for NF-kappa B activation	SCIENCE			English	Article							KINASE-C-THETA; COSTIMULATION; UBIQUITINATION; INHIBITION; PATHWAY; CARMA1; BCL10	Activation of the transcription factor NF-kappa B after engagement of the T cell receptor (TCR) is important for T cell proliferation and activation during the adaptive immune response. Recent reports have elucidated a signaling pathway that involves the protein kinase C theta (PKC theta), the scaffold protein CARD11 (also called CARMA-1), the caspase recruitment domain (CARD)-containing protein Bcl10, and the paracaspase (protease related to caspases) MALT1 as critical intermediates linking the TCR to the I kappa B kinase (IKK) complex. However, the events proximal to the TCR that initiate the activation of this signaling pathway remain poorly defined. We demonstrate that 3-phosphoinositide-dependent kinase 1 (PDK1) has an essential role in this pathway by regulating the activation of PKC theta and through signal-dependent recruiting of both PKC theta and CARD11 to lipid rafts. PDK1-associated PKC theta recruits the IKK complex, whereas PDK1-associated CARD11 recruits the Bcl10-MALT1 complex, thereby allowing activation of the IKK complex through Bcl10-MALT1-dependent ubiquitination of the IKK complex subunit known as NEMO (NF-kappa B essential modifier). Hence, PDK1 plays a critical role by nucleating the TCR-induced NF-kappa B activation pathway in T cells.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	Sankar.ghosh@yale.edu	D'Acquisto, Fulvio/E-7204-2018; Hayden, Matthew/C-1263-2008	D'Acquisto, Fulvio/0000-0002-4513-1608; 	NIAID NIH HHS [R37 AI033443, R37-AI33443] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Flynn P, 2000, CURR BIOL, V10, P1439, DOI 10.1016/S0960-9822(00)00801-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee K. T., UNPUB; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Sparatore B, 2003, FEBS LETT, V554, P35, DOI 10.1016/S0014-5793(03)01073-1; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	23	198	210	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					114	118		10.1126/science.1107107	http://dx.doi.org/10.1126/science.1107107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802604				2022-12-01	WOS:000228221500045
J	Ohinata, Y; Payer, B; O'Carroll, D; Ancelin, K; Ono, Y; Sano, M; Barton, SC; Obukhanych, T; Nussenzweig, M; Tarakhovsky, A; Saitou, M; Surani, MA				Ohinata, Y; Payer, B; O'Carroll, D; Ancelin, K; Ono, Y; Sano, M; Barton, SC; Obukhanych, T; Nussenzweig, M; Tarakhovsky, A; Saitou, M; Surani, MA			Blimp1 is a critical determinant of the germ cell lineage in mice	NATURE			English	Article							CLONAL ANALYSIS; MOUSE EMBRYO; GENE-EXPRESSION; SPECIFICATION; FATE; GASTRULATION; MATURATION; GENERATION; EXCISION; PROGRAM	Germ cell fate in mice is induced in pluripotent epiblast cells in response to signals from extraembryonic tissues. The specification of approximately 40 founder primordial germ cells and their segregation from somatic neighbours are important events in early development. We have proposed that a critical event during this specification includes repression of a somatic programme that is adopted by neighbouring cells. Here we show that Blimp1 ( also known as Prdm1), a known transcriptional repressor, has a critical role in the foundation of the mouse germ cell lineage, as its disruption causes a block early in the process of primordial germ cell formation. Blimp1-deficient mutant embryos form a tight cluster of about 20 primordial germ cell-like cells, which fail to show the characteristic migration, proliferation and consistent repression of homeobox genes that normally accompany specification of primordial germ cells. Furthermore, our genetic lineage-tracing experiments indicate that the Blimp1-positive cells originating from the proximal posterior epiblast cells are indeed the lineage-restricted primordial germ cell precursors.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; RIKEN Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto 6068502, Japan	University of Cambridge; RIKEN; Howard Hughes Medical Institute; Rockefeller University; Japan Science & Technology Agency (JST); Kyoto University	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	saitou@cdb.riken.jp; as10021@mole.bio.cam.ac.uk	Payer, Bernhard/F-7353-2010; Ancelin, Katia/R-1719-2019; Nussenzweig, Michel/AAE-7292-2019	Payer, Bernhard/0000-0002-4694-2082; O'Carroll, Donal/0000-0002-8626-2217; Surani, Azim/0000-0002-8640-4318; Ancelin, Katia/0000-0002-2117-9754	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Behringer R., 2003, MANIPULATING MOUSE E; Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; LAWSON KA, 1991, DEVELOPMENT, V113, P891; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mesnard D, 2004, CURR BIOL, V14, P184, DOI 10.1016/j.cub.2004.01.026; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Perea-Gomez A, 2004, CURR BIOL, V14, P197, DOI 10.1016/j.cub.2004.01.030; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361	34	738	783	1	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					207	213		10.1038/nature03813	http://dx.doi.org/10.1038/nature03813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	15937476				2022-12-01	WOS:000230459500030
J	Relaix, F; Rocancourt, D; Mansouri, A; Buckingham, M				Relaix, F; Rocancourt, D; Mansouri, A; Buckingham, M			A Pax3/Pax7-dependent population of skeletal muscle progenitor cells	NATURE			English	Article							PAX-3 EXPRESSION; SATELLITE CELLS; MYF-5; SPECIFICATION; DERMOMYOTOME; MIGRATION	During vertebrate development, successive phases of embryonic and fetal myogenesis lead to the formation and growth of skeletal muscles(1). Although the origin and molecular regulation of the earliest embryonic muscle cells is well understood(2), less is known about later stages of myogenesis. We have identified a new cell population that expresses the transcription factors Pax3 and Pax7 (paired box proteins 3 and 7) but no skeletal-muscle-specific markers. These cells are maintained as a proliferating population in embryonic and fetal muscles of the trunk and limbs throughout development. Using a stable green fluorescent protein (GFP) reporter targeted to Pax3, we demonstrate that they constitute resident muscle progenitor cells that subsequently become myogenic and form skeletal muscle. Late in fetal development, these cells adopt a satellite cell position characteristic of progenitor cells in postnatal muscle. In the absence of both Pax3 and Pax7, further muscle development is arrested and only the early embryonic muscle of the myotome forms. Cells failing to express Pax3 or Pax7 die or assume a non-myogenic fate. We conclude that this resident Pax3/Pax7-dependent progenitor cell population constitutes a source of myogenic cells of prime importance for skeletal muscle formation, a finding also of potential value in the context of cell therapy for muscle disease.	Inst Pasteur, CNRS, URA 2578, Dept Dev Biol, F-75724 Paris, France; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Max Planck Society	Relaix, F (corresponding author), Inst Pasteur, CNRS, URA 2578, Dept Dev Biol, F-75724 Paris, France.	frelaix@pasteur.fr; margab@pasteur.fr		Relaix, Frederic/0000-0003-1270-1472				ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; BOBER E, 1994, DEVELOPMENT, V120, P603; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; COSSU G, 2001, ADV DEV BIOL BIOCH, P127; GOULDING M, 1994, DEVELOPMENT, V120, P957; GROS J, 2005, NATURE          0420, DOI DOI 10.1038/NATURE03572; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Mansouri A, 1996, DEVELOPMENT, V122, P831; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schubert FR, 2001, DEV DYNAM, V222, P506, DOI 10.1002/dvdy.1211; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785	25	772	801	0	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					948	953		10.1038/nature03594	http://dx.doi.org/10.1038/nature03594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15843801	Green Published			2022-12-01	WOS:000229799700048
J	Eckburg, PB; Bik, EM; Bernstein, CN; Purdom, E; Dethlefsen, L; Sargent, M; Gill, SR; Nelson, KE; Relman, DA				Eckburg, PB; Bik, EM; Bernstein, CN; Purdom, E; Dethlefsen, L; Sargent, M; Gill, SR; Nelson, KE; Relman, DA			Diversity of the human intestinal microbial flora	SCIENCE			English	Article							GUT MICROBIOTA; COMMUNITIES; SEQUENCE; BACTERIA; MUCOSA	The human endogenous intestinal microflora is an essential "organ" in providing nourishment, regulating epithelial. development, and instructing innate immunity; yet, surprisingly, basic features remain poorly described. We examined 13,355 prokaryotic ribosomal RNA gene sequences from multiple colonic mucosal sites and feces of healthy subjects to improve our understanding of gut microbial diversity. A majority of the bacterial sequences corresponded to uncultivated species and novel microorganisms. We discovered significant intersubject variability and differences between stool and mucosa community composition. Characterization of this immensely diverse ecosystem is the first step in elucidating its role in health and disease.	Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Manitoba, Dept Med, Gastroenterol Sect, Winnipeg, MB R3A 1R9, Canada; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Inst Genom Res, Rockville, MD 20850 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; University of Manitoba; Stanford University; J. Craig Venter Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Eckburg, PB (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Room S-169,300 Pasteur Dr, Stanford, CA 94305 USA.	eckburg1@stanford.edu; relman@stanford.edu	Bik, Elisabeth M/A-1204-2007; Dethlefsen, Les/R-2220-2018	Bik, Elisabeth M/0000-0001-5477-0324; Dethlefsen, Les/0000-0001-9622-1630; Relman, David A./0000-0001-8331-1354	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051259] Funding Source: NIH RePORTER; NIAID NIH HHS [AI51259, R01 AI051259] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Colwell R. K., 2004, ESTIMATES VERSION 7; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Relman DA, 2001, TRENDS MICROBIOL, V9, P206, DOI 10.1016/S0966-842X(01)02041-8; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	22	5043	5529	74	1744	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1635	1638		10.1126/science.1110591	http://dx.doi.org/10.1126/science.1110591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15831718	Green Accepted, Green Submitted			2022-12-01	WOS:000229827000059
J	Yarovinsky, F; Zhang, DK; Andersen, JF; Bannenberg, GL; Serhan, CN; Hayden, MS; Hieny, S; Sutterwala, FS; Flavell, RA; Ghosh, S; Sher, A				Yarovinsky, F; Zhang, DK; Andersen, JF; Bannenberg, GL; Serhan, CN; Hayden, MS; Hieny, S; Sutterwala, FS; Flavell, RA; Ghosh, S; Sher, A			TLR11 activation of dendritic cells by a protozoan profilin-like protein	SCIENCE			English	Article							TOXOPLASMA-GONDII INFECTION; TOLL-LIKE RECEPTOR-5; CUTTING EDGE; STRANDED-RNA; IL-12; RECOGNITION; RESISTANCE; PARASITE; IMMUNITY; GENE	Mammalian Toll-like receptors (TLRs) play an important role in the innate recognition of pathogens by dendritic cells (DCs). Although TLRs are clearly involved in the detection of bacteria and viruses, relatively little is known about. their function in the innate response to eukaryotic microorganisms. Here we identify a profilin-like molecule from the protozoan parasite Toxoplasma gondii that generates a potent interleukin-12 (IL-12) response in murine DCs that is dependent on myeloid differentiation factor 88. T. gondii profilin activates DCs through TLR11 and is the first chemically defined ligand for this TLR. Moreover, TLR11 is required in vivo for parasite-induced IL-12 production and optimal resistance to infection, thereby establishing a role for the receptor in host recognition of protozoan pathogens.	NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Med Entomol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Yarovinsky, F (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	fyarovinsky@niaid.nih.gov; asher@niaid.nih.gov	Bannenberg, Gerard/AAF-6216-2020; Hayden, Matthew/C-1263-2008; Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; Yarovinsky, Felix/0000-0001-5825-8002; Bannenberg, Gerard/0000-0001-7763-6224	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005093, R01AI045806, R01AI059440, Z01AI000579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI05093, R01-AI59440, 1R01AI045806-01A1] Funding Source: Medline; NIGMS NIH HHS [R01-GM38765] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; POLLARD TD, 1994, ANNU REV CELL BIOL, V10, P207, DOI 10.1146/annurev.cb.10.110194.001231; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; YAROVINSKY F, UNPUB; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	28	707	774	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1626	1629		10.1126/science.1109893	http://dx.doi.org/10.1126/science.1109893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15860593				2022-12-01	WOS:000229827000057
J	Mattson, MP				Mattson, MP			The need for controlled studies of the effects of meal frequency on health	LANCET			English	Editorial Material							DIETARY RESTRICTION; GLUCOSE-METABOLISM; DISEASE; TERM		NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE ON AGING [ZIAAG000315, Z01AG000315] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adlouni A, 1997, ANN NUTR METAB, V41, P242, DOI 10.1159/000177999; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Aybak M, 1996, EUR J APPL PHYSIOL, V73, P552, DOI 10.1007/BF00357678; BEAUCHENE RE, 1986, J GERONTOL, V41, P13, DOI 10.1093/geronj/41.1.13; Bell HE, 1997, ACTA MATH HUNG, V77, P57, DOI 10.1023/A:1006531605931; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; FABRY P, 1964, LANCET, V2, P614; GEHRIG JJ, 1988, KIDNEY INT, V34, P620, DOI 10.1038/ki.1988.226; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; HOFMEKLER O, 2001, WARRIOR DIET; JENKINS DJA, 1989, NEW ENGL J MED, V321, P929, DOI 10.1056/NEJM198910053211403; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Martin A, 2000, BRIT J NUTR, V84, P337, DOI 10.1017/S0007114500001616; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; Mattson MP, 2003, J NEUROCHEM, V84, P417, DOI 10.1046/j.1471-4159.2003.01586.x; Rocha NS, 2002, TERATOGEN CARCIN MUT, V22, P129, DOI 10.1002/tcm.10005; Rollo F, 2002, P NATL ACAD SCI USA, V99, P12594, DOI 10.1073/pnas.192184599; Speechly DP, 1999, APPETITE, V33, P285, DOI 10.1006/appe.1999.0265; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wan RQ, 2003, J NUTR, V133, P1921, DOI 10.1093/jn/133.6.1921; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhu HY, 1999, BRAIN RES, V842, P224, DOI 10.1016/S0006-8993(99)01827-2; Zimmet P, 2003, J INTERN MED, V254, P114, DOI 10.1046/j.1365-2796.2003.01170.x	26	47	47	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2005	365	9475					1978	1980		10.1016/S0140-6736(05)66667-6	http://dx.doi.org/10.1016/S0140-6736(05)66667-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936428				2022-12-01	WOS:000229587800035
J	Wyers, F; Rougemaille, M; Badis, G; Rousselle, JC; Dufour, ME; Boulay, J; Regnault, B; Devaux, F; Namane, A; Seraphin, B; Libri, D; Jacquier, A				Wyers, F; Rougemaille, M; Badis, G; Rousselle, JC; Dufour, ME; Boulay, J; Regnault, B; Devaux, F; Namane, A; Seraphin, B; Libri, D; Jacquier, A			Cryptic Pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase	CELL			English	Article							MESSENGER-RNA; RIBOSOMAL-RNA; YEAST EXOSOME; PROTEIN; POLYADENYLATION; DEGRADATION; COMPLEXES; CYTOPLASM; INHIBIT; FAMILY	Since detection of an RNA molecule is the major criterion to define transcriptional activity, the fraction of the genome that is expressed is generally considered to parallel the complexity of the transcriptome. We show here that several supposedly silent intergenic regions in the genome of S. cerevisiae are actually transcribed by RNA polymerase 11, suggesting that the expressed fraction of the genome is higher than anticipated. Surprisingly, however, RNAs originating from these regions are rapidly degraded by the combined action of the exosome and a new poly(A) polymerase activity that is defined by the Trf4 protein and one of two RNA binding proteins, Air1p or Air2p. We show that such a polyadenylation-assisted degradation mechanism is also responsible for the degradation of several Pol I and Pol III transcripts. Our data strongly support the existence of a posttranscriptional quality control mechanism limiting inappropriate expression of genetic information.	Inst Pasteur, URA 2171, CNRS, Unite Genet Interact Macromol, F-75724 Paris, France; Inst Pasteur, URA 2185, CNRS, PT Proteom, F-75724 Paris, France; Inst Pasteur, PT Puces ADN, F-75724 Paris, France; CNRS, UPR 2167, Ctr Mol Genet, F-99190 Gif Sur Yvette, France; CNRS, UPR 2167, Equipe Labelisee Ligue, F-99190 Gif Sur Yvette, France; CNRS, Ecole Normale Super, Genet Mol Lab, UMR 8541, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Seraphin, B (corresponding author), Inst Pasteur, URA 2171, CNRS, Unite Genet Interact Macromol, F-75724 Paris, France.	bertrand.seraphin@cgm.cnrs-gif.fr; dominico.libri@cgm.cnrs-gif.fr; jacquier@pasteur.fr	Namane, Abdelkader/O-1857-2013; Badis-Breard, Gwenael/AAE-3783-2019; DEVAUX, Frédéric/N-2288-2019	Namane, Abdelkader/0000-0001-7180-7619; DEVAUX, Frédéric/0000-0002-0039-9096; JACQUIER, ALAIN/0000-0001-5707-9184; Rougemaille, Mathieu/0000-0002-9675-3888; REGNAULT, Beatrice/0000-0002-3914-1914; Badis-Breard, Gwenael/0000-0003-2078-3076; Seraphin, Bertrand/0000-0002-5168-1921				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Aloy P, 2002, EMBO REP, V3, P628, DOI 10.1093/embo-reports/kvf135; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; EGYHAZI E, 1976, CELL, V7, P507, DOI 10.1016/0092-8674(76)90201-4; Fleischmann J, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-17; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liang S, 1996, MOL CELL BIOL, V16, P5139; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Westendorp RGJ, 2004, EMBO REP, V5, P2, DOI 10.1038/sj.embor.7400059	40	665	680	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					725	737		10.1016/j.cell.2005.04.030	http://dx.doi.org/10.1016/j.cell.2005.04.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935759	Bronze			2022-12-01	WOS:000229658000011
J	Dalziel, SR; Walker, NK; Parag, V; Martell, C; Rea, HH; Rodgers, A; Harding, JE				Dalziel, SR; Walker, NK; Parag, V; Martell, C; Rea, HH; Rodgers, A; Harding, JE			Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randornised controlled trial	LANCET			English	Article							BIRTH-WEIGHT; GLUCOCORTICOID TREATMENT; PRENATAL EXPOSURE; BLOOD-PRESSURE; INDEX; AGE	Background Antenatal betamethasone treatment is widely used for the prevention of neonatal respiratory distress syndrome in preterm infants and substantially reduces neonatal mortality and morbidity. Fetal exposure to excess glucocorticoids has been proposed as one of the core mechanisms of the fetal origins of adult disease hypothesis. We assessed whether antenatal exposure to betamethasone for the prevention of neonatal respiratory distress syndrome affects cardiovascular risk factors at 30 years of age. Methods We followed up at age 30 years 534 individuals whose mothers participated in a double-blind, placebo-controlled, randomised trial of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome. Mothers received two doses of betamethasone or placebo given by intramuscular injection 24 h apart. Follow-up assessments included anthropometry; measurement of blood pressure, blood lipids (after overnight fasting), and early morning cortisol levels; and a 75 g oral glucose tolerance test. Findings There were no differences between those exposed to betamethasone and to placebo in body size, blood lipids, blood pressure, plasma cortisol, prevalence of diabetes, or history of cardiovascular disease. After a 75 g oral glucose tolerance test, participants exposed to betamethasone had higher plasma insulin concentrations at 30 min (60.5 vs 52.0 mIU/L; ratio of geometric means 1.16 [95% CI 1.03 to 1.31], p=0.02) and lower glucose concentrations at 120 min (4.8 vs 5.1 mmol/L; difference -0.26 mmol/L [-0.53 to 0.001, p=0.05) than did those exposed to placebo. Interpretation Antenatal exposure to betamethasone might result in insulin resistance in adult offspring, but has no clinical effect on cardiovascular risk factors at 30 years of age. Thus, obstetricians should continue to use a single course of antenatal betamethasone for the prevention of neonatal respiratory distress syndrome.	Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand; Univ Auckland, Div Maori & Pacific Hlth, Auckland 1, New Zealand; Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland 1, New Zealand.	j.harding@auckland.ac.nz	Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Rodgers, Anthony/0000-0003-1282-1896				Aghajafari F, 2002, AM J OBSTET GYNECOL, V186, P843, DOI 10.1067/mob.2002.121624; [Anonymous], 1994, NIH Consens Statement, V12, P1; [Anonymous], 1999, SAS SYST WIND; [Anonymous], 2002, WORLD HLTH REP 2002; Barker D.J.P., 1998, MOTHERS BABIES HLTH; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Crowley P., 1996, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000065, DOI 10.1002/14651858.CD000065]; Davis P, 1999, AUST NZ J PUBL HEAL, V23, P27, DOI 10.1111/j.1467-842X.1999.tb01201.x; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Doyle LW, 2000, CLIN SCI, V98, P137, DOI 10.1042/CS19990211; Erickson K, 2001, OBSTET GYNECOL, V97, P140, DOI 10.1016/S0029-7844(00)01122-4; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Halliday HL, 2003, COCHRANE DB SYST REV, V1; Howie RN, 1977, PRE TERM LAB P 5 STU, p:281; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Kind KL, 2002, EXP PHYSIOL, V87, P469, DOI 10.1111/j.1469-445X.2002.tb00060.x; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Liu L, 2001, AM J PHYSIOL-ENDOC M, V280, pE729, DOI 10.1152/ajpendo.2001.280.5.E729; MACARTHUR BA, 1982, PEDIATRICS, V70, P99; MACEWAN I, 1995, UPPER LIMITS RESPONS; Martin Joyce A, 2003, Natl Vital Stat Rep, V52, P1; Meadow WL, 2003, OBSTET GYNECOL, V102, P356, DOI 10.1016/S0029-7844(03)00510-6; NORTONK, 1996, ANTHROPOMETRICA; Nyirenda MJ, 2001, J ENDOCRINOL, V170, P653, DOI 10.1677/joe.0.1700653; Phillips DIW, 2000, HYPERTENSION, V35, P1301, DOI 10.1161/01.HYP.35.6.1301; THOMPSON JMD, 1994, NEW ZEAL MED J, V107, P1	31	321	330	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2005	365	9474					1856	1862		10.1016/S0140-6736(05)66617-2	http://dx.doi.org/10.1016/S0140-6736(05)66617-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931JK	15924982				2022-12-01	WOS:000229481400024
J	Skotheim, JM; Mahadevan, L				Skotheim, JM; Mahadevan, L			Physical limits and design principles for plant and fungal movements	SCIENCE			English	Article								The typical scales for plant and fungal movements vary over many orders of magnitude in time and length, but they are ultimately based on hydraulics and mechanics. We show that quantification of the length and time scales involved in plant and fungal motions leads to a natural classification, whose physical basis can be understood through an analysis of the mechanics of water transport through an elastic tissue. Our study also suggests a design principle for nonmuscular hydraulically actuated structures: Rapid actuation requires either small size or the enhancement of motion on large scales via elastic instabilities.	Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Harvard Univ, Biol Labs, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; University of Cambridge; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Div Engn & Appl Sci, Pierce Hall,29 Oxford St, Cambridge, MA 02138 USA.	lm@deas.harvard.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820				ASHIDA JOJI, 1934, MEM COLL SCI KYOTO IMP UNIV SER B, V9, P141; Attenborough D, 1995, PRIVATE LIFE PLANTS; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Comandon J, 1938, CR SOC BIOL, V129, P620; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; FRENSCH J, 1989, PLANT PHYSIOL, V91, P719, DOI 10.1104/pp.91.2.719; HEATH O. V. S., 1938, NEW PHYTOL, V37, P385, DOI 10.1111/j.1469-8137.1938.tb06954.x; PAGE RM, 1964, SCIENCE, V146, P925, DOI 10.1126/science.146.3646.925; Skotheim JM, 2004, P ROY SOC A-MATH PHY, V460, P1995, DOI 10.1098/rspa.2003.1270; SWAINE MD, 1977, NEW PHYTOL, V78, P695, DOI 10.1111/j.1469-8137.1977.tb02174.x	10	218	223	5	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1308	1310		10.1126/science.1107976	http://dx.doi.org/10.1126/science.1107976			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919993				2022-12-01	WOS:000229482300047
J	Nee, S				Nee, S			The great chain of being	NATURE			English	Editorial Material									Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Nee, S (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.							Dawkins R., 2004, THE ANCESTORS TALE; Gee H, 2002, NATURE, V420, P611, DOI 10.1038/420611a; Lovejoy A. O., 1965, GREAT CHAIN BEING; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Nee S, 2004, NATURE, V429, P804, DOI 10.1038/429804a	5	21	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					429	429		10.1038/435429a	http://dx.doi.org/10.1038/435429a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917787	Bronze			2022-12-01	WOS:000229337800032
J	Poynter, JN; Gruber, SB; Higgins, PDR; Almog, R; Bonner, JD; Rennert, HS; Low, M; Greenson, JK; Rennert, G				Poynter, JN; Gruber, SB; Higgins, PDR; Almog, R; Bonner, JD; Rennert, HS; Low, M; Greenson, JK; Rennert, G			Statins and the risk of colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIINFLAMMATORY DRUG-USE; COENZYME-A REDUCTASE; INDUCED APOPTOSIS; RANDOMIZED-TRIAL; PRAVASTATIN; PREVENTION; INHIBITORS; ASPIRIN; TOLERABILITY; DISEASE	Background Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and effective lipid-lowering agents. Statins inhibit the growth of colon-cancer cell lines, and secondary analyses of some, but not all, clinical trials suggest that they reduce the risk of colorectal cancer. Methods The Molecular Epidemiology of Colorectal Cancer study is a population-based case-control study of patients who received a diagnosis of colorectal cancer in northern Israel between 1998 and 2004 and controls matched according to age, sex, clinic, and ethnic group. We used a structured interview to determine the use of statins in the two groups and verified self-reported statin use by examining prescription records in a subgroup of patients for whom prescription records were available. Results In analyses including 1953 patients with colorectal cancer and 2015 controls, the use of statins for at least five years (vs. the nonuse of statins) was associated with a significantly reduced relative risk of colorectal cancer (odds ratio, 0.50; 95 percent confidence interval, 0.40 to 0.63). This association remained significant after adjustment for the use or nonuse of aspirin or other nonsteroidal antiinflammatory drugs; the presence or absence of physical activity, hypercholesterolemia, and a family history of colorectal cancer; ethnic group; and level of vegetable consumption (odds ratio, 0.53; 95 percent confidence interval, 0.38 to 0.74). The use of fibric-acid derivatives was not associated with a significantly reduced risk of colorectal cancer (odds ratio, 1.08; 95 percent confidence interval, 0.59 to 2.01). Self-reported statin use was confirmed for 276 of the 286 participants (96.5 percent) who reported using statins and whose records were available. Conclusions The use of statins was associated with a 47 percent relative reduction in the risk of colorectal cancer after adjustment for other known risk factors. Because the absolute risk reduction is likely low, further investigation of the overall benefits of statins in preventing colorectal cancer is warranted.	Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Technion Israel Inst Technol, Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Natl Canc Control Ctr, Clalit Hlth Serv, Haifa, Israel	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services	Gruber, SB (corresponding author), Univ Michigan, Div Med & Mol Genet, 4301 MSRB 3, Ann Arbor, MI 48109 USA.	sgruber@umich.edu		Poynter, Jenny/0000-0002-8460-3938; Rennert, Gad/0000-0002-8512-068X	NATIONAL CANCER INSTITUTE [R01CA081488] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA81488, R01 CA081488] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agarwal B, 1999, GASTROENTEROLOGY, V117, P838, DOI 10.1016/S0016-5085(99)70342-2; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BAT L, 1986, CANCER-AM CANCER SOC, V58, P1167, DOI 10.1002/1097-0142(19860901)58:5<1167::AID-CNCR2820580532>3.0.CO;2-R; Bernini F, 2001, CARDIOVASC DRUG THER, V15, P211, DOI 10.1023/A:1011908004965; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; BUCHWALD H, 1992, LANCET, V339, P1154, DOI 10.1016/0140-6736(92)90744-N; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Downs JR, 2001, AM J CARDIOL, V87, P1074, DOI 10.1016/S0002-9149(01)01464-3; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hentosh P, 2001, MOL CARCINOGEN, V32, P154, DOI 10.1002/mc.1074; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; KELSEY JL, 1996, METHODS OBSERVATIONA, P239; Niell BL, 2003, AM J HUM GENET, V73, P1250, DOI 10.1086/379926; PELEG II, 1994, ARCH INTERN MED, V154, P394, DOI 10.1001/archinte.154.4.394; Pfeffer MA, 2002, CIRCULATION, V105, P2341, DOI 10.1161/01.CIR.0000017634.00171.24; Rao CV, 2002, CANCER DETECT PREV, V26, P419, DOI 10.1016/S0361-090X(02)00119-8; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Swamy MV, 2002, INT J ONCOL, V20, P753; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; 2005, ISRAEL NATL CANC REG	34	607	630	1	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2184	2192		10.1056/NEJMoa043792	http://dx.doi.org/10.1056/NEJMoa043792			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917383				2022-12-01	WOS:000229333300006
J	Djiane, A; Yogev, S; Mlodzik, M				Djiane, A; Yogev, S; Mlodzik, M			The apical determinants aPKC and dPatj regulate Frizzled-dependent planar cell polarity in the Drosophila eye	CELL			English	Article							PROTEIN-KINASE-C; EPITHELIAL POLARITY; DISCS LOST; ASYMMETRIC LOCALIZATION; SIGNALING SPECIFICITY; TISSUE POLARITY; PDZ DOMAIN; CRUMBS; NEUROBLASTS; COMPLEXES	Planar cell polarity (PCP) is a common feature of many vertebrate and invertebrate epithelia and is perpendicular to their apical/basal (A/B) polarity axis. While apical localization of PCP determinants such as Frizzled (Fz1) is critical for their function, the link between A/B polarity and PCP is poorly understood. Here, we describe a direct molecular link between A/B determinants and Fz1-mediated PCP establishment in the Drosophila eye. We demonstrate that dPatj binds the cytoplasmic tail of Fz1 and propose that it recruits aPKC, which in turn phosphorylates and inhibits Fz1. Accordingly, components of the aPKC complex and dPatj produce PCP defects in the eye. We also show that during PCP signaling, aPKC and dPatj are downregulated, while Bazooka is upregulated, suggesting an antagonistic effect of Bazooka on dPatj/aPKC. We propose a model whereby the dPatj/aPKC complex regulates PCP by inhibiting Fz1 in cells where it should not be active.	Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Mlodzik, M (corresponding author), Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA.	marek.mlodzik@mssm.edu		Djiane, Alexandre/0000-0001-6210-2713				Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Axelrod JD, 2001, GENE DEV, V15, P1182; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Hong Y, 2003, P NATL ACAD SCI USA, V100, P12712, DOI 10.1073/pnas.2135347100; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Li YH, 2004, EMBO J, V23, P2723, DOI 10.1038/sj.emboj.7600294; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pielage J, 2003, DEV CELL, V5, P841, DOI 10.1016/S1534-5807(03)00358-7; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wolff Tanya, 1993, P1277; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu J, 2004, PLOS BIOL, V2, P1004, DOI 10.1371/journal.pbio.0020158	45	143	146	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 20	2005	121	4					621	631		10.1016/j.cell.2005.03.014	http://dx.doi.org/10.1016/j.cell.2005.03.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907474	Bronze			2022-12-01	WOS:000229331200017
J	Bissell, P; Anderson, C				Bissell, P; Anderson, C			Enhanced access to emergency contraception	LANCET			English	Editorial Material							PREGNANCY		Univ Nottingham, Sch Pharm, Ctr Pharm Hlth & Soc, Nottingham NG7 2RD, England	University of Nottingham	Bissell, P (corresponding author), Univ Nottingham, Sch Pharm, Ctr Pharm Hlth & Soc, Nottingham NG7 2RD, England.	Paul.Bissell@nottingham.ac.uk		Anderson, Claire/0000-0002-5406-2296				ANDERSON C, 2001, MANCHESTER SALFORD T; Bissell P, 2003, SOC SCI MED, V57, P2367, DOI 10.1016/S0277-9536(03)00129-1; *IND ADV GROUP SEX, 2004, ANN REP 2003 2004; Litt IF, 2005, JAMA-J AM MED ASSOC, V293, P98, DOI 10.1001/jama.293.1.98; MARSH B, 2003, DAILY MAIL      1018; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Stammers T, 2001, BRIT MED J, V322, P1245, DOI 10.1136/bmj.322.7296.1245; Ziebland S, 2005, SOC SCI MED, V60, P1767, DOI 10.1016/j.socscimed.2004.08.022; Ziebland S, 1999, SOC SCI MED, V49, P1409, DOI 10.1016/S0277-9536(99)00249-X	10	6	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2005	365	9472					1668	1670		10.1016/S0140-6736(05)66526-9	http://dx.doi.org/10.1016/S0140-6736(05)66526-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	925VV	15894084				2022-12-01	WOS:000229082300006
J	Eghbali-Fatourechi, GZ; Lamsam, J; Fraser, D; Nagel, D; Riggs, BL; Khosla, S				Eghbali-Fatourechi, GZ; Lamsam, J; Fraser, D; Nagel, D; Riggs, BL; Khosla, S			Circulating osteoblast-lineage cells in humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE TURNOVER; GROWTH; BLOOD	BACKGROUND: Although current evidence suggests that only a minuscule number of osteoblast-lineage cells are present in peripheral blood, we hypothesized that such cells circulate but that their concentration has been vastly underestimated owing to the use of assays that required adherence to plastic. We further reasoned that the concentration of these cells is elevated during times of increased bone formation, such as during pubertal growth. METHODS: We used flow cytometry with antibodies to bone-specific proteins to identify circulating osteoblast-lineage cells in 11 adolescent males and 11 adult males (mean [+/-SD] age, 14.5+/-0.7 vs. 37.7+/-7.6 years). Gene expression and in vitro and in vivo bone-forming assays were used to establish the osteoblastic lineage of sorted cells. RESULTS: Cells positive for osteocalcin and cells positive for bone-specific alkaline phosphatase were detected in the peripheral blood of adult subjects (1 to 2 percent of mononuclear cells). There were more than five times as many cells positive for osteocalcin in the circulation of adolescent boys (whose markers of bone formation were clearly increased as a result of pubertal growth) as compared with adult subjects (P<0.001). The percentage of cells positive for osteocalcin correlated with markers of bone formation. Sorted osteocalcin-positive cells expressed osteoblastic genes, formed mineralized nodules in vitro, and formed bone in an in vivo transplantation assay. Increased values were also found in three adults with recent fractures. CONCLUSIONS: Osteoblast-lineage cells circulate in physiologically significant numbers, correlate with markers of bone formation, and are markedly higher during pubertal growth; therefore, they may represent a previously unrecognized circulatory component to the process of bone formation.	Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Khosla, S (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, 200 1st St SW,5-194 Joseph, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024901, P01AG004875] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00585] Funding Source: Medline; NIA NIH HHS [AG-024901, AG-004875] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; EASTELL R, 1992, CLIN SCI, V83, P375, DOI 10.1042/cs0830375; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; FRIERSON HF, 1990, DIAGN CYTOPATHOL, V6, P243, DOI 10.1002/dc.2840060404; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Ingle BM, 1999, OSTEOPOROSIS INT, V10, P399, DOI 10.1007/s001980050246; KASSEM M, 1991, APMIS, V99, P262, DOI 10.1111/j.1699-0463.1991.tb05148.x; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; LONG MW, 1990, J CLIN INVEST, V86, P1387, DOI 10.1172/JCI114852; LONG MW, 1995, J CLIN INVEST, V96, P2541; LONG MW, 1995, J CLIN INVEST, V95, P881, DOI 10.1172/JCI117738; Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; STEWART CA, 1974, PATHOLOGY, V6, P287, DOI 10.3109/00313027409068999; THIEDE MA, 1994, ENDOCRINOLOGY, V135, P929, DOI 10.1210/en.135.3.929; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	21	304	320	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1959	1966		10.1056/NEJMoa044264	http://dx.doi.org/10.1056/NEJMoa044264			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888696				2022-12-01	WOS:000229017100006
J	Calin, GA; Trapasso, F; Shimizu, M; Dumitru, CD; Yendamuri, S; Godwin, AK; Ferracin, M; Bernardi, G; Chatterjee, D; Baldassarre, G; Rattan, S; Alder, H; Mabuchi, H; Shiraishi, T; Hansen, LL; Overgaard, J; Herlea, V; Mauro, FR; Dighiero, G; Movsas, B; Rassenti, L; Kipps, T; Baffa, R; Fusco, A; Mori, M; Russo, G; Liu, CG; Neuberg, D; Bullrich, F; Negrini, M; Croce, CM				Calin, GA; Trapasso, F; Shimizu, M; Dumitru, CD; Yendamuri, S; Godwin, AK; Ferracin, M; Bernardi, G; Chatterjee, D; Baldassarre, G; Rattan, S; Alder, H; Mabuchi, H; Shiraishi, T; Hansen, LL; Overgaard, J; Herlea, V; Mauro, FR; Dighiero, G; Movsas, B; Rassenti, L; Kipps, T; Baffa, R; Fusco, A; Mori, M; Russo, G; Liu, CG; Neuberg, D; Bullrich, F; Negrini, M; Croce, CM			Familial cancer associated with a polymorphism in ARLTS1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR LOCUS; DOWN-REGULATION; 13Q14; GENE; SEQUENCE; REGION; IDENTIFICATION; EXPRESSION; DELETIONS	BACKGROUND: The finding of hemizygous or homozygous deletions at band 14 on chromosome 13 in a variety of neoplasms suggests the presence of a tumor-suppressor locus telomeric to the RB1 gene. METHODS: We studied samples from 216 patients with various types of sporadic tumors or idiopathic pancytopenia, peripheral-blood samples from 109 patients with familial cancer or multiple cancers, and control blood samples from 475 healthy people or patients with diseases other than cancer. We performed functional studies of cell lines lacking ARLTS1 expression with the use of both the full-length ARLTS1 gene and a truncated variant. RESULTS: We found a gene at 13q14, ARLTS1, a member of the ADP-ribosylation factor family, with properties of a tumor-suppressor gene. We analyzed 800 DNA samples from tumors and blood cells from patients with sporadic or familial cancer and controls and found that the frequency of a nonsense polymorphism, G446A (Trp149Stop), was similar in controls and patients with sporadic tumors but was significantly more common among patients with familial cancer than among those in the other two groups (P=0.02; odds ratio, 5.7; 95 percent confidence interval, 1.3 to 24.8). ARLTS1 was down-regulated by promoter methylation in 25 percent of the primary tumors we analyzed. Transfection of wild-type ARLTS1 into A549 lung-cancer cells suppressed tumor formation in immunodeficient mice and induced apoptosis, whereas transfection of truncated ARLTS1 had a limited effect on apoptosis and tumor suppression. Microarray analysis revealed that the wild-type and Trp149Stop-transfected clones had different expression profiles. CONCLUSIONS: A genetic variant of ARLTS1 predisposes patients to familial cancer.	Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Ferrara, I-44100 Ferrara, Italy; Natl Canc Inst, Aviano, Italy; Aarhus Univ, Aarhus, Denmark; Fundeni Clin Hosp, Bucharest, Romania; Univ Roma La Sapienza, Rome, Italy; Inst Pasteur, Paris, France; Univ Calif San Diego, La Jolla, CA 92093 USA; Univ Catanzaro, Catanzaro, Italy; Kyushu Univ, Beppu, Oita, Japan; Ist Ricovero & Cura Carattere Sci, Rome, Italy; Dana Farber Canc Inst, Boston, MA 02115 USA	Jefferson University; Fox Chase Cancer Center; University of Ferrara; Aarhus University; Institutul Clinic Fundeni; Sapienza University Rome; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California San Diego; Magna Graecia University of Catanzaro; Kyushu University; Harvard University; Dana-Farber Cancer Institute	Croce, CM (corresponding author), Ohio State Univ, Ctr Comprehens Canc, 385K Wiseman Hall,400 W 12th Ave, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Calin, George/E-9390-2011; Baldassarre, Gustavo/K-1350-2016; Ferracin, Manuela/K-2097-2016; herlea, vlad/AAT-3967-2021; Hansen, Lise Lotte/I-3377-2016; Russo, Giandomenico/K-9566-2016; Negrini, Massimo/J-2377-2016; Young, Richard A/F-6495-2012	Baldassarre, Gustavo/0000-0002-9750-8825; Ferracin, Manuela/0000-0002-1595-6887; Hansen, Lise Lotte/0000-0001-7915-2506; Russo, Giandomenico/0000-0002-7718-9687; Negrini, Massimo/0000-0002-0007-1920; Young, Richard A/0000-0001-8855-8647; Fusco, Alfredo/0000-0003-3332-5197; Yendamuri, Sai/0000-0001-6654-3487; Calin, George/0000-0001-6704-5615; Mauro, Francesca Romana/0000-0003-2425-9474	NCI NIH HHS [P30CA56036, P01CA81534, P01CA76259] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA056036, P01CA076259, P01CA081534] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abudugupur A, 2002, CELL DEATH DIFFER, V9, P158, DOI 10.1038/sj.cdd.4400942; BROWN AG, 1993, NAT GENET, V3, P67, DOI 10.1038/ng0193-67; Bullrich F, 1996, BLOOD, V88, P3109, DOI 10.1182/blood.V88.8.3109.bloodjournal8883109; Bullrich F, 2001, CANCER RES, V61, P6640; Bullrich F, 2001, CHRONIC LYMPHOCYTIC, P9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Dahlen A, 2003, INT J CANCER, V103, P616, DOI 10.1002/ijc.10864; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Ghosh K, 1999, BIOCHEM CELL BIOL, V77, P165; Goggins M, 1996, CANCER RES, V56, P5360; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Houlston RS, 2003, LEUKEMIA RES, V27, P871, DOI 10.1016/S0145-2126(03)00023-7; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; La Starza R, 1998, BLOOD, V91, P231, DOI 10.1182/blood.V91.1.231.231_231_237; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mabuchi H, 2001, CANCER RES, V61, P2870; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Mertens D, 2002, BLOOD, V99, P4116, DOI 10.1182/blood.V99.11.4116; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Ramakrishnan R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e30; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rondeau Gaelle, 2001, Mutation Research, V458, P55, DOI 10.1016/S0027-5107(01)00219-6; Sambrook J., 1989, MOL CLONING LAB MANU, V3; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Venter JC, 2001, SCIENCE, V292, P1838; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yin ZN, 1999, ONCOGENE, V18, P7576, DOI 10.1038/sj.onc.1203203	30	104	113	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1667	1676		10.1056/NEJMoa042280	http://dx.doi.org/10.1056/NEJMoa042280			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843669				2022-12-01	WOS:000228515200008
J	Provoost, V; Cools, F; Mortier, F; Bilsen, J; Ramet, J; Vandenplas, Y; Deliens, L				Provoost, V; Cools, F; Mortier, F; Bilsen, J; Ramet, J; Vandenplas, Y; Deliens, L		Neonatal Intensive Care Consortium	Medical end-of-life decisions in neonates and infants in Flanders	LANCET			English	Article							SELF-REPORTED PRACTICES; INTENSIVE-CARE; ATTITUDES; EUTHANASIA; NEWBORNS	Background Paediatricians are increasingly confronted with end-of-life decisions in critically ill neonates and infants. little is known about the frequency and characteristics of end-of-life decisions in this population, nor about the relation with clinical and patients' characteristics. Methods A death-certificate study was done for all deaths of neonates and infants in the whole of Flanders over a 12-month period (August, 1999, to July, 2000). We sent an anonymous questionnaire by mail to the attending physician for each of the 292 children who died under the age of 1 year. Information on patients was obtained from national registers. An attitude study was done for all physicians who attended at least one death during the study period. Findings 253 (87%) of the 292 questionnaires were returned, and 121 (69%) of the 175 physicians involved completed the attitude questions. An end-of-life decision was possible in 194 (77%; 95% CI 70.4-82.4) of the 253 deaths studied, and such a decision was made in 143 cases (57%; 48.9-64.0). Lethal drugs were administered in 15 cases among 117 early neonatal deaths and in two cases among 77 later deaths (13% vs 3%; p=0.018). The attitude study showed that 95 (79%; 70.1-85.5) of the 121 physicians thought that their professional duty sometimes includes the prevention of unnecessary suffering by hastening death and 69 (58%; 48.1-66.5) of 120 supported legalisation of life termination in some cases. Interpretation Death of neonates and infants is commonly preceded by an end-of-life decision. The type of decision varied substantially according to the age of the child. Most physicians favour legalisation of the use of lethal drugs in some cases.	Free Univ Brussels, End Life Care Res Grp, B-1090 Brussels, Belgium; Free Univ Brussels, Univ Hosp, Dept Paediat, Brussels, Belgium; Univ Ghent, Ctr Bioeth, B-9000 Ghent, Belgium; Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Inst Res Extramural Med, Amsterdam, Netherlands	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Deliens, L (corresponding author), Free Univ Brussels, End Life Care Res Grp, Laarbeeklaan 103, B-1090 Brussels, Belgium.	luc.deliens@vub.ac.be	Provoost, Veerle/H-4214-2011	Mortier, Freddy/0000-0002-5390-3508; Cools, Filip/0000-0002-6581-7009; Deliens, Luc/0000-0002-8158-2422				*BRIT MED ASS, 1999, WITHH WITHDR LIF PRO; Cantagrel S, 2000, ARCH PEDIATRIE, V7, P725, DOI 10.1016/S0929-693X(00)80152-9; Cook L A, 1996, J Perinatol, V16, P133; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; de Leeuw R, 2000, J PEDIATR-US, V137, P608, DOI 10.1067/mpd.2000.109144; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Doron MW, 1998, PEDIATRICS, V102, P574, DOI 10.1542/peds.102.3.574; DUFF RS, 1973, NEW ENGL J MED, V289, P890, DOI 10.1056/NEJM197310252891705; *EUR WORK GROUP, 2001, 7 SCI PUBL HLTH EUR; Garel M, 1997, ARCH PEDIATRIE, V4, P662, DOI 10.1016/S0929-693X(97)83370-2; HARRIS J, 1985, VALUE LIFE INTRO MED, P34; Kollee LAA, 1999, SEMIN PERINATOL, V23, P234, DOI 10.1016/S0146-0005(99)80068-8; McCallum DE, 2000, J PAIN SYMPTOM MANAG, V20, P417, DOI 10.1016/S0885-3924(00)00212-8; McHaffie HE, 1999, J MED ETHICS, V25, P440, DOI 10.1136/jme.25.6.440; McHugh-Strong CM, 2000, AM J PERINAT, V17, P27, DOI 10.1055/s-2000-7291; Norup M, 1998, ACTA PAEDIATR, V87, P896, DOI 10.1080/080352598750013707; Norup M, 1999, ACTA PAEDIATR, V88, P438, DOI 10.1080/08035259950169846; POWDERLY KE, 1999, ETHICS CRITICAL CARE, P475; Rebagliato M, 2000, JAMA-J AM MED ASSOC, V284, P2451, DOI 10.1001/jama.284.19.2451; Sklansky M, 2001, J MED ETHICS, V27, P5, DOI 10.1136/jme.27.1.5; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5	24	47	47	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2005	365	9467					1315	1320		10.1016/S0140-6736(05)61028-8	http://dx.doi.org/10.1016/S0140-6736(05)61028-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823381				2022-12-01	WOS:000228219600026
J	Dejardin, J; Rappailles, A; Cuvier, O; Grimaud, C; Decoville, M; Locker, D; Cavalli, G				Dejardin, J; Rappailles, A; Cuvier, O; Grimaud, C; Decoville, M; Locker, D; Cavalli, G			Recruitment of Drosophila Polycomb group proteins to chromatin by DSP1	NATURE			English	Article							HMG-LIKE PROTEIN; RESPONSE ELEMENT; HOMEOTIC GENE; BITHORAX COMPLEX; ENGRAILED GENE; DNA; MELANOGASTER; REPRESSION; REGION; GAGA	Polycomb and trithorax group (PcG and trxG) proteins maintain silent and active transcriptional states, respectively, throughout development(1). In Drosophila, PcG and trxG proteins associate with DNA regions named Polycomb and trithorax response elements (PRE and TRE), but the mechanisms of recruitment are unknown. We previously characterized a minimal element from the regulatory region of the Abdominal-B gene, termed Ab-Fab. Ab-Fab contains a PRE and a TRE and is able to maintain repressed or active chromatin states during development(2). Here we show that the Dorsal switch protein 1 (DSP1), a Drosophila HMGB2 homologue, binds to a sequence present within Ab-Fab and in other characterized PREs. Addition of this motif to an artificial sequence containing Pleiohomeotic and GAGA factor consensus sites is sufficient for PcG protein recruitment in vivo. Mutations that abolish DSP1 binding to Ab-Fab and to a PRE from the engrailed locus lead to loss of PcG protein binding, loss of silencing, and switching of these PREs into constitutive TREs. The binding of DSP1 to PREs is therefore important for the recruitment of PcG proteins.	CNRS, Inst Human Genet, F-34396 Montpellier, France; Univ Orleans, CNRS, Ctr Biophys Mol, F-45071 Orleans, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Cavalli, G (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier, France.	giacomo.cavalli@igh.cnrs.fr	Cuvier, Olivier/ADO-0657-2022; CUVIER, Olivier/AAC-4693-2019; cavalli, giacomo/Z-2754-2019; grimaud, charlotte/Y-6689-2019; Cavalli, Giacomo/A-7958-2008	CUVIER, Olivier/0000-0003-0644-2734; cavalli, giacomo/0000-0003-3709-3469; grimaud, charlotte/0000-0001-7944-5931; Cavalli, Giacomo/0000-0003-3709-3469; DEJARDIN, Jerome/0000-0003-0151-1104				Americo J, 2002, GENETICS, V160, P1561; Brickman JM, 1999, P NATL ACAD SCI USA, V96, P10679, DOI 10.1073/pnas.96.19.10679; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Busturia A, 2001, DEVELOPMENT, V128, P2163; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Decoville M, 2001, GENETICS, V157, P237; Dejardin J, 2004, EMBO J, V23, P857, DOI 10.1038/sj.emboj.7600108; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; FAUVARQUE MO, 1993, GENE DEV, V7, P1508, DOI 10.1101/gad.7.8.1508; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Fritsch C, 1999, DEVELOPMENT, V126, P3905; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Hagstrom K, 1997, GENETICS, V146, P1365; Kassis JA, 2002, ADV GENET, V46, P421; KASSIS JA, 1994, GENETICS, V136, P1025; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Mosrin-Huaman C, 1998, DEV GENET, V23, P324; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Shimell MJ, 2000, DEV BIOL, V218, P38, DOI 10.1006/dbio.1999.9576; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	29	121	124	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					533	538		10.1038/nature03386	http://dx.doi.org/10.1038/nature03386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791260				2022-12-01	WOS:000227836000048
J	Khan, SM; Franke-Fayard, B; Mair, GR; Lasonder, E; Janse, CJ; Mann, M; Waters, AP				Khan, SM; Franke-Fayard, B; Mair, GR; Lasonder, E; Janse, CJ; Mann, M; Waters, AP			Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology	CELL			English	Article							HUMAN MALARIA PARASITE; GENE-EXPRESSION; FLOW-CYTOMETRY; DNA-SYNTHESIS; FALCIPARUM; KINASE; BERGHEI; IDENTIFICATION; TRANSMISSION; PURIFICATION	Gametocytes, the precursor cells of malaria-parasite gametes, circulate in the blood and are responsible for transmission from host to mosquito vector. The individual proteomes of male and female gametocytes were analyzed using mass spectrometry, following separation by flow sorting of transgenic parasites expressing green fluorescent protein, in a sex-specific manner. Promoter tagging in transgenic parasites confirmed the designation of stage and sex specificity of the proteins. The male proteome contained 36% (236 of 650) male-specific and the female proteome 19% (101 of 541) female-specific proteins, but they share only 69 proteins, emphasizing the diverged features of the sexes. Of all the malaria life-cycle stages analyzed, the male gametocyte has the most distinct proteome, containing many proteins involved in flagellar-based motility and rapid genome replication. By identification of gender-specific protein kinases and phosphatases and using targeted gene disruption of two kinases, new sex-specific regulatory pathways were defined.	Leiden Univ, Ctr Med, Dept Parasitol, Leiden, Netherlands; Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, Odense, Denmark; Univ Nijmegen, Dept Mol Biol, NCMLS 191, Nijmegen, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Southern Denmark; Radboud University Nijmegen	Mann, M (corresponding author), Leiden Univ, Ctr Med, Dept Parasitol, Leiden, Netherlands.	mann@bmb.sdu.dk; waters@lumc.nl	Mann, Matthias/A-3454-2013; Waters, Andy P/C-9377-2009	Mann, Matthias/0000-0003-1292-4799; Waters, Andy P/0000-0001-8900-2982; Mair, Gunnar/0000-0002-5187-3691; , Blandine/0000-0001-6041-4182; Janse, Chris J/0000-0002-6410-6205; Khan, Shahid/0000-0002-0533-4670; Lasonder, Edwin/0000-0003-2582-3444	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Carter R, 2001, VACCINE, V19, P2309, DOI 10.1016/S0264-410X(00)00521-1; Chen A, 1999, GENE, V234, P127, DOI 10.1016/S0378-1119(99)00165-1; CREASEY A, 1994, MOL BIOCHEM PARASIT, V65, P95, DOI 10.1016/0166-6851(94)90118-X; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; Dorin D, 2005, MOL MICROBIOL, V55, P184, DOI 10.1111/j.1365-2958.2004.04393.x; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Horrocks P, 1998, MOL BIOCHEM PARASIT, V95, P171, DOI 10.1016/S0166-6851(98)00110-8; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; JANSE CJ, 1987, EXP PARASITOL, V64, P88, DOI 10.1016/0014-4894(87)90012-9; Janse CJ, 2004, MALARIA PARASITES: GENOMES AND MOLECULAR BIOLOGY, P445; JANSE CJ, 1986, T ROY SOC TROP MED H, V80, P154, DOI 10.1016/0035-9203(86)90219-1; JANSE CJ, 1985, PARASITOLOGY, V91, P19, DOI 10.1017/S0031182000056481; JANSE CJ, 1989, EXP PARASITOL, V68, P274, DOI 10.1016/0014-4894(89)90109-4; JANSE CJ, 1986, MOL BIOCHEM PARASIT, V20, P173, DOI 10.1016/0166-6851(86)90029-0; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Kaslow DC, 1997, INT J PARASITOL, V27, P183, DOI 10.1016/S0020-7519(96)00148-8; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lu K P, 1995, Prog Cell Cycle Res, V1, P187; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Sinden RE, 2004, MALARIA PARASITES: GENOMES AND MOLECULAR BIOLOGY, P475; SINDEN RE, 1991, ACT LEIDENS, V60, P19; VAIDYA AB, 1993, MOL CELL BIOL, V13, P7349, DOI 10.1128/MCB.13.12.7349; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Spaendonk RML, 2001, J BIOL CHEM, V276, P22638, DOI 10.1074/jbc.M101234200; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3	44	273	285	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					675	687		10.1016/j.cell.2005.03.027	http://dx.doi.org/10.1016/j.cell.2005.03.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935755	Bronze			2022-12-01	WOS:000229658000007
J	Lambert, S; Watson, A; Sheedy, DM; Martin, B; Carr, AM				Lambert, S; Watson, A; Sheedy, DM; Martin, B; Carr, AM			Gross chromosomal rearrangements and elevated recombination at an inducible site-specific replication fork barrier	CELL			English	Article							DNA-REPLICATION; RIBOSOMAL DNA; FISSION YEAST; S-PHASE; ESCHERICHIA-COLI; FRAGILE SITE; MATING-TYPE; SACCHAROMYCES-CEREVISIAE; CHECKPOINT RESPONSE; DELAYED REPLICATION	Genomic rearrangements linked to aberrant recombination are associated with cancer and human genetic diseases. Such recombination has indirectly been linked to replication fork stalling. Using fission yeast, we have developed a genetic system to block replication forks at nonhistone/DNA complexes located at a specific euchromatic site. We demonstrate that stalled replication forks lead to elevated intrachromosomal and ectopic recombination promoting site-specific gross chromosomal rearrangements. We show that recombination is required to promote cell viability when forks are stalled, that recombination proteins associate with sites of fork stalling, and that recombination participates in deleterious site-specific chromosomal rearrangements. Thus, recombination is a "double-edged sword," preventing cell death when the replisome disassembles at the expense of genetic stability.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Carr, AM (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.m.carr@sussex.ac.uk	; lambert, sarah/K-7750-2017	Carr, Antony Michael/0000-0002-2028-2389; lambert, sarah/0000-0002-1403-3204; Watson, Adam/0000-0002-8140-8205	Medical Research Council [G0001129] Funding Source: Medline; MRC [G0001129] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; Arcangioli B, 2000, EMBO REP, V1, P145, DOI 10.1093/embo-reports/kvd023; Arcangioli B, 2000, EMBO J, V19, P1389, DOI 10.1093/emboj/19.6.1389; ARIT MF, 2003, GENOME RES, V100, P92; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Codlin S, 2003, EMBO J, V22, P3431, DOI 10.1093/emboj/cdg330; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dalgaard JZ, 2001, GENE DEV, V15, P2060, DOI 10.1101/gad.200801; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GAME JC, 1973, MUTAT RES, V20, P35, DOI 10.1016/0027-5107(73)90095-X; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gruber M, 2000, MOL CELL BIOL, V20, P5777, DOI 10.1128/MCB.20.15.5777-5787.2000; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KEIL RL, 1984, CELL, V39, P377, DOI 10.1016/0092-8674(84)90016-3; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Lee BS, 2004, MOL CELL BIOL, V24, P9813, DOI 10.1128/MCB.24.22.9813-9822.2004; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Muriana PM, 1996, J FOOD PROTECT, P54, DOI 10.4315/0362-028X-59.13.54; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Rothstein R, 2000, GENE DEV, V14, P1; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Straube A, 2004, EUR J NEUROL, V11, P83, DOI 10.1046/j.1468-1331.2003.00754.x; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; Subramanian PS, 1996, AM J HUM GENET, V59, P407; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Virgin JB, 2001, GENETICS, V157, P63; Ward TR, 2000, MOL CELL BIOL, V20, P4948, DOI 10.1128/MCB.20.13.4948-4957.2000; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	66	209	211	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					689	702		10.1016/j.cell.2005.03.022	http://dx.doi.org/10.1016/j.cell.2005.03.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935756	Bronze			2022-12-01	WOS:000229658000008
J	Sullivan, CS; Grundhoff, AT; Tevethia, S; Pipas, JM; Ganem, D				Sullivan, CS; Grundhoff, AT; Tevethia, S; Pipas, JM; Ganem, D			SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells	NATURE			English	Article							INTERFERING RNAS; MESSENGER-RNA; VIRUS; ANTIGEN; SV40	MicroRNAs ( miRNAs) are small (similar to 22-nucleotide) RNAs that in lower organisms serve important regulatory roles in development and gene expression, typically by forming imperfect duplexes with target messenger RNAs1. miRNAs have also been described in mammalian cells and in infections with Epstein - Barr virus (EBV), but the function of most of them is unknown. Although one EBV miRNA probably altered the processing of a viral mRNA(2), the regulatory significance of this event is uncertain, because other transcripts exist that can supply the targeted function(3). Here we report the identification of miRNAs encoded by simian virus 40 (SV40) and define their functional significance for viral infection. SVmiRNAs accumulate at late times in infection, are perfectly complementary to early viral mRNAs, and target those mRNAs for cleavage. This reduces the expression of viral T antigens but does not reduce the yield of infectious virus relative to that generated by a mutant lacking SVmiRNAs. However, wild-type SV40-infected cells are less sensitive than the mutant to lysis by cytotoxic T cells, and trigger less cytokine production by such cells. Thus, viral evolution has taken advantage of the miRNA pathway to generate effectors that enhance the probability of successful infection.	Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, George Williams Hooper Fdn, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, George Williams Hooper Fdn, Dept Med, San Francisco, CA 94143 USA; Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ganem, D (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu		Grundhoff, Adam/0000-0003-0940-7045	NATIONAL CANCER INSTITUTE [R01CA073506] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA073506] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALWINE JC, 1980, J VIROL, V36, P701, DOI 10.1128/JVI.36.3.701-708.1980; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BATES MP, 1988, VIROLOGY, V162, P197, DOI 10.1016/0042-6822(88)90409-6; FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Tremblay JD, 2001, METH MOL B, V165, P1; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	14	492	559	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					682	686		10.1038/nature03576	http://dx.doi.org/10.1038/nature03576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931223				2022-12-01	WOS:000229476200052
J	Osterholm, MT				Osterholm, MT			A weapon the world needs	NATURE			English	Editorial Material									Univ Minnesota, Acad Hlth Ctr, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Acad Hlth Ctr, Ctr Infect Dis Res & Policy, 420 Delaware St SE,MMC 263, Minneapolis, MN 55455 USA.							Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068	1	7	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					417	418		10.1038/435417a	http://dx.doi.org/10.1038/435417a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917778	Green Published			2022-12-01	WOS:000229337800024
J	Liou, GG; Tanny, JC; Kruger, RG; Walz, T; Moazed, D				Liou, GG; Tanny, JC; Kruger, RG; Walz, T; Moazed, D			Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation	CELL			English	Article							SILENT MATING LOCI; SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; PROTEIN SIR2; SIR2/SIR4 COMPLEX; MOLECULAR-MODEL; N-TERMINUS; YEAST; CHROMATIN; GENE	Assembly of silent chromatin domains in budding yeast involves the deacetylation of histone tails by Sir2 and the association of the Sir3 and Sir4 proteins with hypoacetylated histone tails. Sir2 couples deacetylation to NAD hydrolysis and the synthesis of a metabolite, O-acetyl-ADP-ribose (AAR), but the functional significance of NAD hydrolysis or AAR, if any, is unknown. Here we examine the association of the Sir2, Sir3, and Sir4 proteins with each other and histone tails. Our analysis reveals that deacetylation of histone H4-lysine 16 (K16), which is critical for silencing in vivo, is also critical for the binding of Sir3 and Sir4 to histone H4 peptides in vitro. Moreover, AAR itself promotes the association of multiple copies of Sir3 with Sir2/Sir4 and induces a dramatic structural rearrangement in the SIR complex. These results suggest that Sir2 activity modulates the assembly of the SIR complex through both histone deacetylation and AAR synthesis.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol & Biochem, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Tanny, Jason/AAD-3624-2022; Liou, Gunn‐Guang/AAI-9787-2020; Liou, Gan-Guang/E-3976-2010	Walz, Thomas/0000-0003-2606-2835				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Chang JF, 2003, STRUCTURE, V11, P637, DOI 10.1016/S0969-2126(03)00093-5; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Enomoto S, 2000, GENETICS, V155, P523; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Ghidelli S, 2001, EMBO J, V20, P4522, DOI 10.1093/emboj/20.16.4522; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; KLAR AJS, 1979, GENETICS, V93, P37; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Neuwald AF, 1999, GENOME RES, V9, P27; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; RINE J, 1987, GENETICS, V116, P9; RUDNER AD, 2005, IN PRESS MOL CELL BI; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Straube A, 2004, EUR J NEUROL, V11, P83, DOI 10.1046/j.1468-1331.2003.00754.x; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016	57	208	213	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					515	527		10.1016/j.cell.2005.03.035	http://dx.doi.org/10.1016/j.cell.2005.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907466	Bronze			2022-12-01	WOS:000229331200009
J	Merrifield, CJ; Perrais, D; Zenisek, D				Merrifield, CJ; Perrais, D; Zenisek, D			Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells	CELL			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; DYNAMIC ACTIN; IMAGING ACTIN; N-WASP; ACIDIFICATION; LAMELLIPODIA; PROTEIN; SITES; ASSOCIATION; POPULATION	During clathrin-mediated endocytosis, membrane scission marks the isolation of a cargo-laden clathrin-coated pit (CCP) from the cell exterior. Here we used live-cell imaging of a pH-sensitive cargo to visualize the formation of clathrin-coated vesicles (CCVs) at single CCPs with a time resolution of seconds. We show that CCPs are highly dynamic and can produce multiple vesicles in succession. Using alternating evanescent field and epifluorescence illumination, we show that CCP invagination and scission are tightly coupled, with scission coinciding with maximal displacement of CCPs from the plasma membrane and with peak recruitment of cortactin-DsRed, a dynamin and F-actin binding protein. Finally, perturbing actin polymerization with latrunculin-B drastically reduces the efficiency of membrane scission and affects many aspects of CCP dynamics. We propose that CCP invagination, actin polymerization, and CCV formation are highly coordinated for efficient endocytosis.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; CNRS, UMR 5091, Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France; Univ Bordeaux 2, Inst Francois Magendie, F-33077 Bordeaux, France; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Yale University	Merrifield, CJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	cjm@mrc-lmb.cam.ac.uk	Zenisek, David/C-6555-2011; Perrais, David/W-9360-2019	Perrais, David/0000-0002-5878-5408	MRC [MC_U105178789] Funding Source: UKRI; Medical Research Council [MC_U105178789] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BRETSCHER MS, 1984, SCIENCE, V224, P681, DOI 10.1126/science.6719108; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mise-Omata S, 2003, BIOCHEM BIOPH RES CO, V301, P704, DOI 10.1016/S0006-291X(02)02972-8; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Rappoport JZ, 2003, J BIOL CHEM, V278, P47357, DOI 10.1074/jbc.C300390200; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Santini F, 2002, NAT CELL BIOL, V4, pE230, DOI 10.1038/ncb1002-e230; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WILLINGHAM MC, 1983, P NATL ACAD SCI-BIOL, V80, P5617, DOI 10.1073/pnas.80.18.5617; WILLINGHAM MC, 1981, J HISTOCHEM CYTOCHEM, V29, P1003, DOI 10.1177/29.9.6169759; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774	47	359	363	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					593	606		10.1016/j.cell.2005.03.015	http://dx.doi.org/10.1016/j.cell.2005.03.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907472	Bronze			2022-12-01	WOS:000229331200015
J	Ramanan, S				Ramanan, S			An act of unkindness	LANCET			English	Editorial Material									St Francis Hosp & Med Ctr, Hartford, CT 06105 USA	Saint Francis Hospital & Medical Center	Ramanan, S (corresponding author), St Francis Hosp & Med Ctr, 114 Woodland St, Hartford, CT 06105 USA.	sramanan@stfranciscare.org							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1743	1743		10.1016/S0140-6736(05)66548-8	http://dx.doi.org/10.1016/S0140-6736(05)66548-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894101				2022-12-01	WOS:000229082300026
J	Edwards, J; Whitaker, D; Klionsky, S; Laskowski, MJ				Edwards, J; Whitaker, D; Klionsky, S; Laskowski, MJ			Botany - A record-breaking pollen catapult	NATURE			English	Article							BIOMECHANICS; POLLINATION; MECHANISM		Williams Coll, Dept Biol, Williamstown, MA 01267 USA; Williams Coll, Dept Phys, Williamstown, MA 01267 USA; Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA	Williams College; Williams College; Oberlin College	Edwards, J (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	joan.edwards@williams.edu						BARRETT SCH, 1987, CAN J BOT, V65, P2036, DOI 10.1139/b87-278; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kelly D, 1996, NATURE, V384, P615, DOI 10.1038/384615a0; LOVELL JH, 1898, B TORREY BOT CLUB, V25, P382; Marie-Victorin F. E. C., 1935, FLORE LAURENTIENNE; MOSQUIN T, 1985, CAN FIELD NAT, V99, P1; Patek SN, 2004, NATURE, V428, P819, DOI 10.1038/428819a; Voet D., 2004, BIOCHEMISTRY-US	10	87	92	7	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					164	164		10.1038/435164a	http://dx.doi.org/10.1038/435164a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889081				2022-12-01	WOS:000229021100029
J	Griesinger, CB; Richards, CD; Ashmore, JF				Griesinger, CB; Richards, CD; Ashmore, JF			Fast vesicle replenishment allows indefatigable signalling at the first auditory synapse	NATURE			English	Article							INNER HAIR-CELLS; RELEASABLE POOL; RIBBON SYNAPSE; EFFERENT SYNAPSES; AFFERENT SYNAPSE; ACTIVE ZONES; GUINEA-PIG; EXOCYTOSIS; ENDOCYTOSIS; COCHLEA	Ribbon-type synapses in inner hair cells of the mammalian cochlea encode the complexity of auditory signals by fast and tonic release through fusion of neurotransmitter-containing vesicles. At any instant, only about 100 vesicles are tethered to the synaptic ribbon, and about 14 of these are docked to the plasma membrane(1,2), constituting the readily releasable pool(3). Although this pool contains about the same number of vesicles as that of conventional synapses(4,5), ribbon release sites operate at rates of about two orders of magnitude higher(3,6,7) and with submillisecond precision(8-11). How these sites replenish their vesicles so efficiently remains unclear(3,12,13). We show here, using two-photon imaging of single release sites in the intact cochlea, that preformed vesicles derived from cytoplasmic vesicle-generating compartments(14) participate in fast release and replenishment. Vesicles were released at a maximal initial rate of 3 per millisecond during a depolarizing pulse, and were replenished at a rate of 1.9 per millisecond. We propose that such rapid resupply of vesicles enables temporally precise and sustained release rates. This may explain how the first auditory synapse can encode with indefatigable precision without having to rely on the slow, local endocytic vesicle cycle(7).	UCL, Dept Physiol, London WC1E 6BT, England; UCL, UCL Ear Inst, London WC1E 6BT, England; Univ Freiburg, Inst Physiol 2, D-79104 Freiburg, Germany	University of London; University College London; University of London; University College London; University of Freiburg	Griesinger, CB (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	claudius.griesinger@physiologie.uni-freiburg.de; j.ashmore@ucl.ac.uk						Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Edmonds BW, 2004, J PHYSIOL-LONDON, V560, P439, DOI 10.1113/jphysiol.2004.066035; Eisen MD, 2004, J NEUROPHYSIOL, V91, P2422, DOI 10.1152/jn.01130.2003; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; KIANG NYS, 1965, ACTA OTOLARYNG STOCK, V59, P186, DOI DOI 10.3109/00016486509124552; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SAITO K, 1980, J ULTRA MOL STRUCT R, V71, P222, DOI 10.1016/S0022-5320(80)90108-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEWELL WF, 1996, SPR HDB AUD, V8, P503; SIEGEL JH, 1981, BRAIN RES, V220, P188, DOI 10.1016/0006-8993(81)90224-9; Slepecky NB, 2000, HEARING RES, V144, P124, DOI 10.1016/S0378-5955(00)00055-1; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Spicer SS, 1999, J COMP NEUROL, V409, P424; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	30	97	99	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					212	215		10.1038/nature03567	http://dx.doi.org/10.1038/nature03567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15829919				2022-12-01	WOS:000229021100042
J	Zykov, V; Mytilinaios, E; Adams, B; Lipson, H				Zykov, V; Mytilinaios, E; Adams, B; Lipson, H			Self-reproducing machines	NATURE			English	Article									Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA; Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA; Cornell Univ, Dept Math, Ithaca, NY 14853 USA; Cornell Univ, Dept Comp & Informat Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Zykov, V (corresponding author), Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA.	hod.lipson@cornell.edu						Adams B, 2003, LECT NOTES ARTIF INT, V2801, P1; Butler Z, 2002, DISTRIBUTED AUTONOMOUS ROBOTIC SYSTEMS 5, P37; Chirikjian GS, 2002, IEEE-ASME T MECH, V7, P462, DOI 10.1109/TMECH.2002.806232; EFSTATHIOS M, 2004, P 9 INT C ART LIF, P15; Jackman RJ, 1998, SCIENCE, V280, P2089, DOI 10.1126/science.280.5372.2089; LANGTON CG, 1984, PHYSICA D, V10, P135, DOI 10.1016/0167-2789(84)90256-2; Lohn J. D., 1997, IEEE Transactions on Evolutionary Computation, V1, P165, DOI 10.1109/4235.661547; Merkle R. C, 2004, KINEMATIC SELF REPLI; PENROSE LS, 1959, SCI AM, V200, P105, DOI 10.1038/scientificamerican0659-105; RUBENSTEIN M, 2004, P IROS 2004, P2661; Sipper M, 2001, SCI AM, V285, P34, DOI 10.1038/scientificamerican0801-34; VONNEUMANN J, 1970, ESSAYS CELLULAR AUTO, P4; Yim M, 2002, IEEE SPECTRUM, V39, P30, DOI 10.1109/6.981854	13	207	213	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					163	164		10.1038/435163a	http://dx.doi.org/10.1038/435163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889080				2022-12-01	WOS:000229021100028
J	Gomes, ER; Jani, S; Gundersen, GG				Gomes, ER; Jani, S; Gundersen, GG			Nuclear movement regulated by Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating cells	CELL			English	Article							MICROTUBULE-ORGANIZING CENTER; CYTOPLASMIC DYNEIN; SELECTIVE STABILIZATION; CDC42-BINDING KINASE; MITOTIC SPINDLE; GOLGI-APPARATUS; LEADING-EDGE; PHOSPHORYLATION; CENTROSOME; LIS1	The microtubule-organizing center (MTOC) is reoriented between the nucleus and the leading edge in many migrating cells and contributes to directional migration. Models suggest that the MTOC is moved to its position during reorientation. By direct imaging of wound-edge fibroblasts after triggering MTOC reorientation with soluble factors, we found instead that the nucleus moved away from the leading edge to reorient the MTOC, while the MTOC remained stationary. Rearward nuclear movement was coupled with actin retrograde flow and was regulated by a pathway involving Cdc42, MRCK, myosin, and actin. Nuclear movement was unaffected by the inhibition of dynein, Par6, or PKC zeta, yet these components were essential for MTOC reorientation, as they maintained the MTOC at the cell centroid. These results show that nuclear repositioning is an initial polarizing event in migrating cells and that the positions of the nucleus and the MTOC are established by separate regulatory pathways.	Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA.	ggg1@columbia.edu	Gomes, Edgar/ABH-7441-2020; Gomes, Edgar r/D-9000-2015	Gomes, Edgar/0000-0002-6941-4872; Gomes, Edgar r/0000-0002-6941-4872	NIGMS NIH HHS [GM 062938] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062938] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; EUTENEUER U, 1992, J CELL BIOL, V116, P1157, DOI 10.1083/jcb.116.5.1157; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; GOTLIEB AI, 1981, J CELL BIOL, V91, P589, DOI 10.1083/jcb.91.2.589; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303; Morris NR, 2003, CURR OPIN CELL BIOL, V15, P54, DOI 10.1016/S0955-0674(02)00004-2; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sakurada K, 1998, AM J PHYSIOL-CELL PH, V274, pC1563, DOI 10.1152/ajpcell.1998.274.6.C1563; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schliwa Manfred, 1993, Trends in Cell Biology, V3, P377; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; VONDASSOW G, 1994, J CELL BIOL, V127, P1637, DOI 10.1083/jcb.127.6.1637; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	60	450	454	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					451	463		10.1016/j.cell.2005.02.022	http://dx.doi.org/10.1016/j.cell.2005.02.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882626	Bronze			2022-12-01	WOS:000229031600014
J	You, LR; Lin, FJ; Lee, CT; DeMayo, FJ; Tsai, MJ; Tsai, SY				You, LR; Lin, FJ; Lee, CT; DeMayo, FJ; Tsai, MJ; Tsai, SY			Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity	NATURE			English	Article							STEM-CELL NICHE; CARDIOVASCULAR DEVELOPMENT; EMBRYONIC ANGIOGENESIS; VESSEL FORMATION; RECEPTOR; MICE; PATHWAY; LIGAND; MOUSE; DIFFERENTIATION	Arteries and veins are anatomically, functionally and molecularly distinct. The current model of arterial - venous identity proposes that binding of vascular endothelial growth factor to its heterodimeric receptor - Flk1 and neuropilin 1 (NP-1; also called Nrp1) - activates the Notch signalling pathway in the endothelium, causing induction of ephrin B2 expression and suppression of ephrin receptor B4 expression to establish arterial identity(1-4). Little is known about vein identity except that it involves ephrin receptor B4 expression, because Notch signalling is not activated in veins; an unresolved question is how vein identity is regulated. Here, we show that COUP-TFII ( also known as Nr2f2), a member of the orphan nuclear receptor superfamily, is specifically expressed in venous but not arterial endothelium. Ablation of COUP-TFII in endothelial cells enables veins to acquire arterial characteristics, including the expression of arterial markers NP-1 and Notch signalling molecules, and the generation of haematopoietic cell clusters. Furthermore, ectopic expression of COUP-TFII in endothelial cells results in the fusion of veins and arteries in transgenic mouse embryos. Thus, COUP-TFII has a critical role in repressing Notch signalling to maintain vein identity, which suggests that vein identity is under genetic control and is not derived by a default pathway.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dev Biol Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Tsai, MJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.tmc.edu; stsai@bcm.tmc.edu	Hsiao, Wei-Hung/B-9931-2013; DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; LIN, FU-JUNG/0000-0003-4065-0983; You, Li-Ru/0000-0003-1775-0097				Adams RH, 2003, J ANAT, V202, P105, DOI 10.1046/j.1469-7580.2003.00137.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hogan B., 2014, MANIPULATING MOUSE E; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Krebs LT, 2000, GENE DEV, V14, P1343; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	27	439	453	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					98	104		10.1038/nature03511	http://dx.doi.org/10.1038/nature03511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875024				2022-12-01	WOS:000228864600046
J	Albertsen, PC; Hanley, JA; Fine, J				Albertsen, PC; Hanley, JA; Fine, J			20-year outcomes following conservative management of clinically localized prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADICAL PROSTATECTOMY; NATURAL-HISTORY; UNITED-STATES; MEN; TRIAL; DEATH	Context The appropriate therapy for men with clinically localized prostate cancer is uncertain. A recent study suggested an increasing prostate cancer mortality rate for men who are alive more than 15 years following diagnosis. Objective To estimate 20-year survival based on-a competing risk analysis of men who were diagnosed with clinically localized prostate cancer and treated with observation or androgen withdrawal therapy alone, stratified by age at diagnosis and histological findings. Design, Setting, and Patients A retrospective population-based cohort study using Connecticut Tumor Registry data supplemented by hospital record and histology review of 767 men aged 55 to 74 years with clinically localized prostate cancer diagnosed between January 1, 1971, and December 31, 1984. Patients were treated with either observation or immediate or delayed androgen withdrawal therapy, with a median observation of 24 years. Main Outcome Measures Probability of mortality from prostate cancer or other competing medical conditions, given a patient's age at diagnosis and tumor grade. Results The prostate cancer mortality rate was 33 per 1000 person-years during the first 15 years of follow-up (95% confidence interval [CI], 28-38) and 18 per 1000 person-years after 15 years of follow-up (95% Cl, 10-29). The mortality rates for these 2 follow-up periods were not statistically different, after adjusting for differences in tumor histology (rate ratio, 1.1; 95% Cl, 0.6-1.9). Men with low-grade prostate cancers have a minimal risk of dying from prostate cancer during 20 years of follow-up (Gleason score of 2-4, 6 deaths per 1000 person-years; 95% Cl, 2-11). Men with high-grade prostate cancers have a high probability of dying from prostate cancer within 10 years of diagnosis (Gleason score of 8-10, 121 deaths per 1000 person-years; 95% Cl, 90156). Men with Gleason score of 5 or 6 tumors have an intermediate risk of prostate cancer death. Conclusion The annual mortality rate from prostate cancer appears to remain stable after 15 years from diagnosis, which does not support aggressive treatment for localized low-grade prostate cancer.	Univ Connecticut, Ctr Hlth, Div Urol, Farmington, CT 06030 USA; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	University of Connecticut; McGill University	Albertsen, PC (corresponding author), Univ Connecticut, Ctr Hlth, Div Urol, 263 Farmington Ave, Farmington, CT 06030 USA.	albertsen@nso.uchc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009578] Funding Source: NIH RePORTER; AHRQ HHS [HS09578] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Albertsen PC, 2000, J UROLOGY, V163, P519, DOI 10.1016/S0022-5347(05)67915-3; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Donovan J, 2003, Health Technol Assess, V7, P1; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; ESPOSTI P L, 1971, Scandinavian Journal of Urology and Nephrology, V5, P199, DOI 10.3109/00365597109133601; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; MURPHY GP, 1982, J UROLOGY, V127, P928, DOI 10.1016/S0022-5347(17)54135-X; Penson DF, 2001, J NATL CANCER I, V93, P1822, DOI 10.1093/jnci/93.23.1822; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Schroder FH, 1997, BRIT J UROL, V79, P68, DOI 10.1111/j.1464-410X.1997.tb00804.x; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Wilt T J, 1997, Oncology (Williston Park), V11, P1133	17	893	925	1	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2095	2101		10.1001/jama.293.17.2095	http://dx.doi.org/10.1001/jama.293.17.2095			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870412				2022-12-01	WOS:000228808200018
J	Zhou, FQ; Snider, WD				Zhou, FQ; Snider, WD			GSK-3 beta and microtubule assembly in axons	SCIENCE			English	Editorial Material							GSK3-BETA PHOSPHORYLATION; NEURONAL POLARITY; GROWTH; GUIDANCE; PROTEIN; KINASE; MULTITASKING; MECHANISMS; UPSTREAM; BINDING		Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhou, FQ (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA.	wsnider@med.unc.edu						Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; ZHOU F, UNPUB; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	20	132	135	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					211	+		10.1126/science.1110301	http://dx.doi.org/10.1126/science.1110301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15825222				2022-12-01	WOS:000228273700038
J	Shimmi, O; Umulis, D; Othmer, H; O'Connor, MB				Shimmi, O; Umulis, D; Othmer, H; O'Connor, MB			Facilitated transport of a Dpp/Scw heterodimer by Sog/Tsg leads to robust patterning of the Drosophila blastoderm embryo	CELL			English	Article							SHORT GASTRULATION GENE; DORSAL-VENTRAL PATTERN; TWISTED GASTRULATION; ACTIVITY GRADIENT; GROWTH-FACTOR; BETA FAMILY; MORPHOGEN GRADIENT; I RECEPTORS; DPP; SOG	Patterning the dorsal surface of the Drosophila blastoderm embryo requires Decapentaplegic (Dpp) and Screw (Scw), two BMP family members. Signaling by these ligands is regulated at the extracellular level by the BMP binding proteins Sog and Tsg. We demonstrate that Tsg and Sog play essential roles in transporting Dpp to the dorsal-most cells. Furthermore, we provide biochemical and genetic evidence that a heterodimer of Dpp and Scw, but not the Dpp homodimer, is the primary transported ligand and that the heterodimer signals synergistically through the two type I BMP receptors Tkv and Sax. We propose that the use of broadly distributed Dpp homodimers and spatially restricted Dpp/Scw heterodimers produces the biphasic signal that is responsible for specifying the two dorsal tissue types. Finally, we demonstrate mathematically that heterodimer levels can be less sensitive to changes in gene dosage than homodimers, thereby providing further selective advantage for using heterodimers as morphogens.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Math, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@mail.med.umn.edu	Umulis, David/AAB-1312-2021; O'Connor, Michael B/C-9977-2014; , 0000-0001-6341-9130/P-9094-2018	O'Connor, Michael B/0000-0002-3067-5506; , 0000-0001-6341-9130/0000-0001-6341-9130	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029123] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM029123, GM29123] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; Decotto E, 2001, DEVELOPMENT, V128, P3831; Dorfman R, 2001, DEVELOPMENT, V128, P965; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Massague J, 2000, GENE DEV, V14, P627; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Raftery LA, 2003, TRENDS GENET, V19, P701, DOI 10.1016/j.tig.2003.10.009; RAY RP, 1991, DEVELOPMENT, V113, P35; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schmid B, 2000, DEVELOPMENT, V127, P957; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; WHARTON KA, 1993, DEVELOPMENT, V117, P807	33	228	235	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					873	886		10.1016/j.cell.2005.02.009	http://dx.doi.org/10.1016/j.cell.2005.02.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797386	Green Accepted, Bronze			2022-12-01	WOS:000228067500015
J	LaCava, J; Houseley, J; Saveanu, C; Petfalski, E; Thompson, E; Jacquier, A; Tollervey, D				LaCava, J; Houseley, J; Saveanu, C; Petfalski, E; Thompson, E; Jacquier, A; Tollervey, D			RNA degradation by the exosome is promoted by a nuclear polyade nylation complex	CELL			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; YEAST NUCLEOLAR PROTEIN; 3' END FORMATION; HUMAN PM-SCL; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; ESCHERICHIA-COLI; GLOBAL ANALYSIS; POLYADENYLATION	The exosome complex of 3'-5' exonucleases participates in RNA maturation and quality control and can rapidly degrade RNA-protein complexes in vivo. However, the purified exosome showed weak in vitro activity, indicating that rapid RNA degradation requires activating cofactors. This work identifies a nuclear polyadenylation complex containing a known exosome cofactor, the RNA helicase Mtr4p; a poly(A) polymerase, Trf4p; and a zinc knuckle protein, Air2p. In vitro, the Trf4p/Air2p/Mtr4p polyadenylation complex (TRAMP) showed distributive RNA polyadenylation activity. The presence of the exosome suppressed poly(A) tail addition, while TRAMP stimulated exosome degradation through structured RNA substrates. In vivo analyses showed that TRAMP is required for polyadenylation and degradation of rRNA and snoRNA precursors that are characterized exosome substrates. Poly(A) tails stimulate RNA degradation in bacteria, suggesting that this is their ancestral function. We speculate that this function was maintained in eukaryotic nuclei, while cytoplasmic mRNA poly(A) tails acquired different roles in translation.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Inst Pasteur, CNRS, Genet Interact Macromol URA 2171, F-75015 Paris, France	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Tollervey, David/AAR-6662-2020; Saveanu, Cosmin/K-6494-2015; LaCava, John P/H-2840-2013; Houseley, Jon/AAF-7409-2021; Saveanu, Cosmin/Q-1251-2019	Tollervey, David/0000-0003-2894-2772; Saveanu, Cosmin/0000-0002-1677-7936; LaCava, John P/0000-0002-6307-7713; Saveanu, Cosmin/0000-0002-1677-7936; Houseley, Jonathan/0000-0001-8509-1500; JACQUIER, ALAIN/0000-0001-5707-9184	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; KRUPP G, 1991, J MOL BIOL, V217, P637, DOI 10.1016/0022-2836(91)90522-8; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Li ZW, 1998, P NATL ACAD SCI USA, V95, P12158, DOI 10.1073/pnas.95.21.12158; Liang S, 1996, MOL CELL BIOL, V16, P5139; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mohanty BK, 2002, MOL MICROBIOL, V45, P1315, DOI 10.1046/j.1365-2958.2002.03097.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Shevchenko A, 1997, J PROTEIN CHEM, V16, P481, DOI 10.1023/A:1026361427575; SYERS F, 2005, CELL, V121, P725; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000	41	697	705	3	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					713	724		10.1016/j.cell.2005.04.029	http://dx.doi.org/10.1016/j.cell.2005.04.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935758	Bronze			2022-12-01	WOS:000229658000010
J	Moore, BD; Foley, WJ				Moore, BD; Foley, WJ			Tree use by koalas in a chemically complex landscape	NATURE			English	Article							PHASCOLARCTOS-CINEREUS; FOLIAR CHEMISTRY; FOOD PREFERENCE; SNOWSHOE HARE; VARIED DIETS; EUCALYPTUS; HERBIVORY; SELECTION; POPULATIONS; NUTRIENTS	Although defence against herbivores is often argued to be the main action of plant secondary metabolites (PSMs)(1), very few examples have demonstrated that intraspecific variation in PSM concentrations influences foraging by wild vertebrate herbivores(2,3). Experiments with captive animals often indicate that PSM concentrations influence how much herbivores eat from individual plants(3-7), but these experiments do not replicate the subtle tradeoffs in diet selection faced by wild animals, which must avoid predators and extremes of weather, interact with conspecifics, and achieve a balanced, nutritious diet, while avoiding intoxication by PSMs. We characterized the foliar chemistry of every tree from two Eucalyptus species available to a population of koalas (Phascolarctos cinereus) and considered rates of tree visitation over a ten-year period. We show that visitation rate was most strongly influenced by tree size, but that koalas also visited trees less frequently if the foliage contained either high concentrations of deterrent PSMs known as formylated phloroglucinol compounds, or low concentrations of nitrogen. Consequently, plant chemistry restricts the use of trees by this herbivore, and thus limits the food available to koalas and potentially influences koala populations.	Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	Australian National University	Moore, BD (corresponding author), James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia.	Ben.Moore@jcu.edu.au	Foley, William J/C-8069-2009; Moore, Ben D/C-3447-2008; Moore, Ben/AAE-7885-2020	Foley, William J/0000-0001-8587-1814; Moore, Ben D/0000-0002-6995-4721; Moore, Ben/0000-0002-6995-4721				BRYANT JP, 1983, SCIENCE, V222, P1023, DOI 10.1126/science.222.4627.1023; DANELL K, 1991, ECOLOGY, V72, P1350, DOI 10.2307/1941107; DEGABRIELE R, 1981, AUST J ECOL, V6, P139, DOI 10.1111/j.1442-9993.1981.tb01284.x; DEGABRIELE R, 1983, AUST J ECOL, V8, P75, DOI 10.1111/j.1442-9993.1983.tb01520.x; DUNCAN AJ, 1994, CAN J ZOOL, V72, P1715, DOI 10.1139/z94-231; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; FARENTINOS RC, 1981, SCIENCE, V213, P1273, DOI 10.1126/science.213.4513.1273; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; HUME ID, 1999, MARSUPIAL NUTR, pCH5; Lawler IR, 2000, ECOLOGY, V81, P1327, DOI 10.1890/0012-9658(2000)081[1327:FCOAST]2.0.CO;2; MARTIN RW, 1985, AUST WILDLIFE RES, V12, P355; MARTIN RW, 1999, KOALA NATURAL HIST C, pCH4; McIlwee AM, 2001, OECOLOGIA, V128, P539, DOI 10.1007/s004420100692; Moore BD, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P549; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, ECOL MONOGR, V74, P553, DOI 10.1890/03-4038; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; SCHMITZ OJ, 1992, OIKOS, V65, P295, DOI 10.2307/3545021; Scrivener NJ, 2004, EVOL ECOL RES, V6, P77; ULLREY DE, 1981, AUST J ZOOL, V29, P839, DOI 10.1071/ZO9810839; Villalba JJ, 2002, OIKOS, V97, P282, DOI 10.1034/j.1600-0706.2002.970214.x; Vourc'h G, 2001, OECOLOGIA, V126, P84, DOI 10.1007/s004420000491; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; White T.C., 1993, INADEQUATE ENV NITRO	29	134	141	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					488	490		10.1038/nature03551	http://dx.doi.org/10.1038/nature03551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917807				2022-12-01	WOS:000229337800053
J	Backes, H; Neubauer, FM; Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Bertucci, C; Jones, GH; Khurana, KK; Russell, CT; Wennmacher, A				Backes, H; Neubauer, FM; Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Bertucci, C; Jones, GH; Khurana, KK; Russell, CT; Wennmacher, A			Titan's magnetic field signature during the first Cassini encounter	SCIENCE			English	Article							MHD MODEL; IONOSPHERE; MAGNETOSPHERE; SIMULATION; SATURN	The magnetic field signature obtained by Cassini during its first close encounter with Titan on 26 October 2004 is presented and explained in terms of an advanced model. Titan was inside the saturnian magnetosphere. A magnetic field minimum before closest approach marked Cassini's entry into the magnetic ionopause layer. Cassini then left the northern and entered the southern magnetic tail lobe. The magnetic field before and after the encounter was approximately constant for &SIM; 20 Titan radii, but the field orientation changed exactly at the location of Titan's orbit. No evidence of an internal magnetic field at Titan was detected.	Univ Cologne, Inst Geophys & Meteorol, D-50678 Cologne, Germany; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; Univ Toulouse 3, Ctr Etud Spatiale Rayonnements, F-31062 Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of Cologne; Imperial College London; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Backes, H (corresponding author), Univ Cologne, Inst Geophys & Meteorol, Albertus Magnus Pl, D-50678 Cologne, Germany.	backes@geo.uni-koeln.de	Bertucci, Cesar/GOG-8941-2022; Russell, Christopher T/E-7745-2012; Jones, Geraint H./C-1682-2008; Achilleos, Nicholas/C-1647-2008; Arridge, Christopher S/A-2894-2009	Russell, Christopher T/0000-0003-1639-8298; Jones, Geraint H./0000-0002-5859-1136; Arridge, Christopher S/0000-0002-0431-6526; Achilleos, Nicholas/0000-0002-5886-3509; Khurana, Krishan/0000-0002-2856-1171; Bertucci, Cesar/0000-0002-2540-5384				ALFVEN H, 1957, TELLUS, V9, P92, DOI 10.1111/j.2153-3490.1957.tb01855.x; BACKES H, 2004, THESIS U COLOGNE GER; Brecht SH, 2000, J GEOPHYS RES-SPACE, V105, P13119, DOI 10.1029/1999JA900490; Cravens TE, 1998, PLANET SPACE SCI, V46, P1193, DOI 10.1016/S0032-0633(98)00051-8; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; HARTLE RE, 1982, J GEOPHYS RES-SPACE, V87, P1383, DOI 10.1029/JA087iA03p01383; IP WH, 1990, ASTROPHYS J, V362, P354, DOI 10.1086/169271; Kabin K, 1999, J GEOPHYS RES-SPACE, V104, P2451, DOI 10.1029/1998JA900080; KELLER CN, 1994, J GEOPHYS RES-SPACE, V99, P6511, DOI 10.1029/93JA02680; KELLER CN, 1992, J GEOPHYS RES-SPACE, V97, P12117, DOI 10.1029/92JA00231; KIVELSON MG, 1983, J GEOPHYS RES-SPACE, V88, P49, DOI 10.1029/JA088iA01p00049; Ledvina SA, 1998, PLANET SPACE SCI, V46, P1175, DOI 10.1016/S0032-0633(98)00052-X; Nagy AF, 2001, J GEOPHYS RES-SPACE, V106, P6151, DOI 10.1029/2000JA000183; NESS NF, 1982, J GEOPHYS RES-SPACE, V87, P1369, DOI 10.1029/JA087iA03p01369; Neubauer F.M., 1984, SATURN, P760; RICHARDS PG, 1994, J GEOPHYS RES-SPACE, V99, P8981, DOI 10.1029/94JA00518; SCHARDT AW, 1984, SATURN, P417; Wahlund JE, 2005, SCIENCE, V308, P986, DOI 10.1126/science.1109807	19	116	116	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					992	995		10.1126/science.1109763	http://dx.doi.org/10.1126/science.1109763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890875				2022-12-01	WOS:000229190700037
J	Mahaffy, PR				Mahaffy, PR			Intensive Titan exploration begins	SCIENCE			English	Article								The Cassini Orbiter spacecraft first skimmed through the tenuous upper atmosphere of Titan on 26 October 2004. This moon of Saturn is unique in our solar system, with a dense nitrogen atmosphere that is cold enough in places to rain methane, the feedstock for the atmospheric chemistry that produces hydrocarbons, nitrite compounds, and Titan's orange haze. The data returned from this flyby supply new information on the magnetic field and plasma environment around Titan, expose new facets of the dynamics and chemistry of Titan's atmosphere, and provide the first glimpses of what appears to be a complex, fluid-processed, geologically young Titan surface.	NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mahaffy, PR (corresponding author), NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Code 661, Greenbelt, MD 20771 USA.	paul.r.mahaffy@nasa.gov	Mahaffy, Paul/E-4609-2012	Mahaffy, Paul/0000-0003-1896-1726				Backes H, 2005, SCIENCE, V308, P992, DOI 10.1126/science.1109763; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Lorenz R. D., 2002, LIFTING TITANS VEIL; Mitchell DG, 2005, SCIENCE, V308, P989, DOI 10.1126/science.1109805; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; Owen T, 2002, SPACE SCI REV, V104, P347, DOI 10.1023/A:1023684406168; Shemansky DE, 2005, SCIENCE, V308, P978, DOI 10.1126/science.1111790; Wahlund JE, 2005, SCIENCE, V308, P986, DOI 10.1126/science.1109807; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wolf AA, 2002, SPACE SCI REV, V104, P101, DOI 10.1023/A:1023692724823	12	18	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					969	970		10.1126/science.1113205	http://dx.doi.org/10.1126/science.1113205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890870				2022-12-01	WOS:000229190700030
J	Arribas, J				Arribas, J			Matrix metalloproteases and tumor invasion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER CELLS; RECEPTOR		Vall Hebron Univ Hosp Res Inst, Med Oncol Res Program, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Arribas, J (corresponding author), Vall Hebron Univ Hosp Res Inst, Med Oncol Res Program, Barcelona, Spain.		Arribas, Joaquin/M-4482-2014	Arribas, Joaquin/0000-0002-0504-0664				Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Kamath L, 2001, CANCER RES, V61, P5933	5	14	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					2020	2021		10.1056/NEJMcibr055002	http://dx.doi.org/10.1056/NEJMcibr055002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888705				2022-12-01	WOS:000229017100016
J	Umina, PA; Weeks, AR; Kearney, MR; McKechnie, SW; Hoffmann, AA				Umina, PA; Weeks, AR; Kearney, MR; McKechnie, SW; Hoffmann, AA			A rapid shift in a classic clinal pattern in Drosophila reflecting climate change	SCIENCE			English	Article							METABOLICALLY RELATED ADH; ALCOHOL-DEHYDROGENASE; NATURAL-POPULATIONS; INVERSION POLYMORPHISMS; LATITUDINAL CLINES; TPI POLYMORPHISMS; MELANOGASTER; GENETICS; GPDH; ASSOCIATIONS	Geographical clines in genetic polymorphisms are widely used as evidence of climatic selection and are expected to shift with climate change. We show that the classic latitudinal cline in the alcohol dehydrogenase polymorphism of Drosophila melanogaster has shifted over 20 years in eastern coastal Austratia. Southern high-latitude populations now have the genetic constitution of more northerly populations, equivalent to a shift of 40 in latitude. A similar shift was detected for a genetically independent inversion polymorphism, whereas two other linked polymorphisms exhibiting weaker clinal patterns have remained relatively stable. These genetic changes are likely to reflect increasingly warmer and drier conditions and may serve as sensitive biomarkers for climate change.	La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia; Monash Univ, Sch Biol Sci, Ctr Environm Stress & Adaptat Res, Clayton, Vic 3800, Australia	La Trobe University; Monash University	Hoffmann, AA (corresponding author), La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia.	ary@unimelb.edu.au	Hoffmann, Ary/C-2961-2011; Weeks, Andrew/ABC-3048-2020; Hoffmann, Ary/R-2972-2019; Kearney, Michael/R-3404-2017	Hoffmann, Ary/0000-0001-9497-7645; Kearney, Michael/0000-0002-3349-8744; Weeks, Andrew/0000-0003-3081-135X; Umina, Paul/0000-0002-1835-3571				ALAHIOTIS SN, 1982, GENETICA, V59, P81, DOI 10.1007/BF00133290; ANDERSON AR, IN PRESS MOL ECOL; ANDERSON PR, 1987, GENETICA, V75, P81, DOI 10.1007/BF00055251; ANDERSON PR, 1984, NATURE, V308, P729, DOI 10.1038/308729a0; Andolfatto P, 1999, GENETICS, V153, P1297; BERRY A, 1993, GENETICS, V134, P869; BOCK IR, 1981, GENET BIOL DROSOPHIL, P299; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; COYNE JA, 1987, GENETICS, V117, P727; DAVID JR, 1975, EXPERIENTIA, V31, P164, DOI 10.1007/BF01990682; Dobzhansky T, 1943, GENETICS, V28, P162; Endler J.A., 1986, Monographs in Population Biology, pviii; Etges WJ, 2004, BIOL J LINN SOC, V81, P395, DOI 10.1111/j.1095-8312.2004.00306.x; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kamping A, 1999, J EVOLUTION BIOL, V12, P809, DOI 10.1046/j.1420-9101.1999.00083.x; Kennington WJ, 2003, GENETICS, V165, P667; KNIBB WR, 1982, GENETICA, V58, P213, DOI 10.1007/BF00128015; MCKENZIE JA, 1983, GENETIC STUDIES DROS, P201; NIELSEN KM, 1985, GENET SEL EVOL, V17, P41, DOI 10.1186/1297-9686-17-1-41; OAKESHOTT JG, 1984, GENETICA, V63, P21, DOI 10.1007/BF00137461; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Rodriguez-Trelles F, 1998, EVOL ECOL, V12, P829, DOI 10.1023/A:1006546616462; 't Land JV, 2000, EVOLUTION, V54, P201, DOI 10.1554/0014-3820(2000)054[0201:LVFTEL]2.0.CO;2; VANDELDEN W, 1978, GENETICS, V90, P161; VANDELDEN W, 1984, POPULATION BIOL EVOL, P127; VIGUE CL, 1973, BIOCHEM GENET, V9, P213, DOI 10.1007/BF00485735; Weeks AR, 2002, ECOL LETT, V5, P756, DOI 10.1046/j.1461-0248.2002.00380.x; ZILLMAN JW, 2003, YB AUSTR	29	288	305	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					691	693		10.1126/science.1109523	http://dx.doi.org/10.1126/science.1109523			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860627				2022-12-01	WOS:000228810900049
J	Lawrence, T; Bebien, M; Liu, GY; Nizet, V; Karin, M				Lawrence, T; Bebien, M; Liu, GY; Nizet, V; Karin, M			IKK alpha limits macrophage NF-kappa B activation and contributes to the resolution of inflammation	NATURE			English	Article							C-REL; PHOSPHORYLATION; KINASE; TRANSCRIPTION; RECOGNITION; UBIQUITINATION; DEGRADATION; EXPRESSION; RECEPTORS; EXCHANGE	Inflammation and innate immunity involve signalling pathways leading to the production of inflammatory mediators. Usually such responses are self-limiting, but aberrant resolution of inflammation results in chronic diseases(1). Much attention has focused on pro-inflammatory signalling but little is known about the mechanisms that resolve inflammation. The I kappa B kinase (IKK) complex contains two catalytic subunits, IKK alpha and IKK beta, and controls the activation of NF-kappa B transcription factors, which play a pivotal role in inflammation(2). Ample evidence indicates that IKK beta mediates NF-kappa B activation in response to pro-inflammatory cytokines and microbial products. IKK alpha regulates an alternative pathway important for lymphoid organogenesis(2), but the role of IKK alpha in inflammation is unknown. Here we describe a new role for IKK alpha in the negative regulation of macrophage activation and inflammation. IKK alpha contributes to suppression of NF-kappa B activity by accelerating both the turnover of the NF-kappa B subunits RelA and c-Rel, and their removal from pro-inflammatory gene promoters. Inactivation of IKK alpha in mice enhances inflammation and bacterial clearance. Hence, the two IKK catalytic subunits have evolved opposing but complimentary roles needed for the intricate control of inflammation and innate immunity.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Div Paediat Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Lawrence, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst, 1 Aspenlea Rd, London W6 8LH, England.	t.lawrence@imperial.ac.uk	Nizet, Victor/AAF-3190-2019; Lawrence, Toby/GLU-3895-2022	Lawrence, Toby/0000-0003-0967-6122; Nizet, Victor/0000-0003-3847-0422				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen E, 1998, J BIOL CHEM, V273, P35201, DOI 10.1074/jbc.273.52.35201; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Fognani C, 2000, ONCOGENE, V19, P2224, DOI 10.1038/sj.onc.1203543; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Martin AG, 2000, J BIOL CHEM, V275, P24383, DOI 10.1074/jbc.M909396199; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Puliti M, 2004, INFECT IMMUN, V72, P4891, DOI 10.1128/IAI.72.8.4891-4894.2004; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	30	536	569	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1138	1143		10.1038/nature03491	http://dx.doi.org/10.1038/nature03491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858576				2022-12-01	WOS:000228693300045
J	Sharp, SP; McGowan, A; Wood, MJ; Hatchwell, BJ				Sharp, SP; McGowan, A; Wood, MJ; Hatchwell, BJ			Learned kin recognition cues in a social bird	NATURE			English	Article							LONG-TAILED TITS; AEGITHALOS-CAUDATUS; SEYCHELLES WARBLER; KINSHIP; DISCRIMINATION; BEHAVIOR; FITNESS; HELPERS; CALLS	In many cooperatively breeding birds, kin selection has an important role in the evolution and maintenance of social behaviour, and 'helpers' can maximize indirect fitness gains by preferentially allocating care to close relatives(1-3). Although there is evidence for kin-biased helping behaviour in several species(1,4,5), the mechanism of kin recognition underlying this behaviour is poorly understood(2). Vocalizations are the most commonly used cues in avian recognition systems(6,7), but the effectiveness of vocal signals as reliable recognition cues must depend on how they are acquired(6-9). However, there have been no experimental studies of the development of vocal recognition cues in cooperative birds; indeed, the ontogeny of all bird vocalizations other than song is poorly known in any species(10-12). Here, we show that cooperatively breeding long-tailed tits (Aegithalos caudatus) can discriminate between kin and non-kin according to the individual-specific characteristics of contact calls, and show experimentally that individuals learn these calls from provisioning adults during the nestling period. Finally, we show that the pattern of cooperative behaviour in this species is consistent with the use of recognition cues learned through association.	Univ Sheffield, Dept Anim & Plant Sci, Evolut & Behav Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Exeter Cornwall, Ctr Ecol & Conservat, Marine Turtle Res Grp, Penryn TR10 9EZ, England; Univ Oxford, Dept Zool, Edward Grey Inst Field Ornithol, Oxford OX1 3PS, England	University of Sheffield; University of Exeter; University of Oxford	Sharp, SP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Evolut & Behav Grp, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	s.sharp@sheffield.ac.uk	Sharp, Stuart P/F-8246-2014; Hatchwell, Ben J/C-5433-2016; Wood, Matthew/HDN-1469-2022; Wood, Matthew J/B-6124-2011	Sharp, Stuart P/0000-0002-3059-2532; Hatchwell, Ben J/0000-0002-1039-4782; Wood, Matthew J/0000-0003-0920-8396; Wood, Matthew/0000-0002-5436-6011	Natural Environment Research Council [NER/A/S/2002/00779] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baptista Luis F., 1996, P39; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; BrittanPowell EF, 1997, J COMP PSYCHOL, V111, P226; Dickinson Janis L., 2004, P48, DOI 10.1017/CBO9780511606816.004; EMLEN ST, 1988, BEHAV ECOL SOCIOBIOL, V23, P305, DOI 10.1007/BF00300577; GASTON AJ, 1973, IBIS, V115, P330, DOI 10.1111/j.1474-919X.1973.tb01974.x; HALPIN ZT, 1991, KIN RECOGNITION, P220; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; Hatchwell BJ, 2002, ANIM BEHAV, V64, P55, DOI 10.1006/anbe.2002.3033; Hatchwell BJ, 2001, J ANIM ECOL, V70, P820, DOI 10.1046/j.0021-8790.2001.00541.x; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; Hughes M, 1998, ETHOLOGY, V104, P232; Komdeur J, 2004, P ROY SOC B-BIOL SCI, V271, P963, DOI 10.1098/rspb.2003.2665; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; Maccoll ADC, 2004, J ANIM ECOL, V73, P1137, DOI 10.1111/j.0021-8790.2004.00887.x; MacColl ADC, 2003, ANIM BEHAV, V66, P955, DOI 10.1006/anbe.2003.2268; MacColl ADC, 2002, AM NAT, V160, P186, DOI 10.1086/341013; Marler P., 1971, P389; Price JJ, 1998, P ROY SOC B-BIOL SCI, V265, P497, DOI 10.1098/rspb.1998.0322; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Sherman Paul W., 1997, P69; WALDMAN B, 1987, J THEOR BIOL, V128, P159, DOI 10.1016/S0022-5193(87)80167-4	23	191	197	1	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1127	1130		10.1038/nature03522	http://dx.doi.org/10.1038/nature03522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858573				2022-12-01	WOS:000228693300042
J	Lindor, NM; Rabe, K; Petersen, GM; Haile, R; Casey, G; Baron, J; Gallinger, S; Bapat, B; Aronson, M; Hopper, J; Jass, J; LeMarchand, L; Grove, J; Potter, J; Newcomb, P; Terdiman, JP; Conrad, P; Moslein, G; Goldberg, R; Ziogas, A; Anton-Culver, H; de Andrade, M; Siegmund, K; Thibodeau, SN; Boardman, LA; Seminara, D				Lindor, NM; Rabe, K; Petersen, GM; Haile, R; Casey, G; Baron, J; Gallinger, S; Bapat, B; Aronson, M; Hopper, J; Jass, J; LeMarchand, L; Grove, J; Potter, J; Newcomb, P; Terdiman, JP; Conrad, P; Moslein, G; Goldberg, R; Ziogas, A; Anton-Culver, H; de Andrade, M; Siegmund, K; Thibodeau, SN; Boardman, LA; Seminara, D			Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency - Familial colorectal cancer type X	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MICROSATELLITE INSTABILITY; MUTATION CARRIERS; KINDREDS; GENES	Context Approximately 60% of families that meet the Amsterdam-I criteria (AC-I) for hereditary nonpolyposis colorectal cancer (HNPCC) have a hereditary abnormality in a DNA mismatch repair (MMR) gene. Cancer incidence in AC-I families with MMR gene mutations is reported to be very high, but cancer incidence for individuals in AC-I families with no evidence of an MMR defect is unknown. Objective To determine if cancer risks in AC-I families with no apparent deficiency in DNA MMR are different from cancer risks in AC-I families with DNA MMR abnormalities. Design, Setting, and Participants Identification (1997-2001) of 161 AC-I pedigrees from multiple population- and clinic-based sources,in North America and Germany, with families grouped into those with (group A) or without (group B) MMR deficiency by tumor testing. A total of 3422 relatives were included in the analyses. Main Outcome Measures Cancer incidence in groups A and B (excluding the 3 affected members used to define each pedigree as AC-I) and computed age- and sex-adjusted standardized incidence ratios (SIRs) using Surveillance, Epidemiology, and End Results data. Results Group A families from both population- and clinic-based series showed increased incidence of the HNPCC-related cancers. Group B families showed increased incidence only for colorectal cancer (SIR, 2.3; 95% confidence interval,. 1.7-3.0) and to a lesser extent than group A (SIR, 6.1; 95% confidence interval, 5.2-7.2) (P<.001). Conclusions Families who fulfill AC-I criteria but who have no evidence of a DNA MMR defect do not share the same cancer incidence as families with HNPCC-Lynch syndrome (ie, hereditary MMR deficiency). Relatives in such families have a lower incidence of colorectal cancer than those in families with HNPCC-Lynch syndrome, and incidence may not be increased for other cancers. These families should not be described or counseled as having HNPCC-Lynch syndrome. To facilitate distinguishing these entities, the designation of "familial colorectal cancer type V is suggested to describe this type of familial aggregation of colorectal cancer.	Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Gastroenterol, Rochester, MN 55905 USA; Univ So Calif, Los Angeles, CA USA; Cleveland Clin, Cleveland, OH 44106 USA; Dartmouth Coll Sch Med, Hanover, NH USA; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Melbourne, Melbourne, Vic, Australia; McGill Univ, Montreal, PQ, Canada; Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; Univ San Francisco, Dept Canc Biol, San Francisco, CA 94117 USA; Univ Dusseldorf, Dept Surg, D-4000 Dusseldorf, Germany; Univ N Carolina, Chapel Hill, NC USA; Univ Calif Irvine, Irvine, CA USA; NCI, Div Canc Control & Populat Sci, Clin & Genet Epidemiol Res Branch, NIH, Bethesda, MD 20892 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Southern California; Cleveland Clinic Foundation; Dartmouth College; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Melbourne; McGill University; Cancer Research Center of Hawaii; University of Hawaii System; Fred Hutchinson Cancer Center; University of San Francisco; Heinrich Heine University Dusseldorf; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lindor, NM (corresponding author), Mayo Clin & Mayo Fdn, Dept Med Genet, 200 1st St SW, Rochester, MN 55905 USA.	nlindor@mayo.edu	Bapat, Bharati/B-5839-2014; Gallinger, Steven/E-4575-2013	Potter, John/0000-0001-5439-1500; de Andrade, Mariza/0000-0003-2329-2686	NCI NIH HHS [U01 CA074800, UO1 CA074799, UO1 CA097735, UO1 CA074783, UO1 CA074800, U01 CA074799, U01 CA074783, CA-95-011, UO1 CA074794, U24 CA074800-13, U01 CA074806, U24 CA074800, U01 CA097735, UO1 CA078296, UO1 CA074806, U01 CA078296, U01 CA074794] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA074800, U01CA097735, K22CA095011, U01CA078296, U01CA074783, U01CA074799, U01CA074794, U01CA074800, U01CA074806] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L; BERGSTALH EJ, 1986, SAS I INC TECHNICAL, V31; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Buttin BM, 2004, AM J HUM GENET, V74, P1262, DOI 10.1086/421332; COX DR, 1953, BIOMETRIKA, V40, P354, DOI 10.1093/biomet/40.3-4.354; Efron B., 1982, REGIONAL C SERIES AP, V38; Jarvinen HJ, 2000, ANN CHIR GYNAECOL, V89, P207; JASS JR, 1995, LANCET, V346, P1200, DOI 10.1016/S0140-6736(95)92902-9; Kakar S, 2003, CANCER-AM CANCER SOC, V97, P1421, DOI 10.1002/cncr.11206; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lucci-Cordisco E, 2001, Fam Cancer, V1, P93; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; *NAT CANC I, 2003, SURV EP END RES SEER; *NAT COMPR CANC NE, 2005, NAT COMPR CANC NETW; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#	18	406	421	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					1979	1985		10.1001/jama.293.16.1979	http://dx.doi.org/10.1001/jama.293.16.1979			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855431	Green Accepted, Bronze			2022-12-01	WOS:000228651500023
J	Emerson, BC; Kolm, N				Emerson, BC; Kolm, N			Species diversity can drive speciation	NATURE			English	Article							ADAPTIVE RADIATION; ISLANDS; AREA; ENDEMISM	A fundamental question in evolutionary ecology and conservation biology is: why do some areas contain greater species diversity than others? Island biogeographic theory has identified the roles of immigration and extinction in relation to area size and proximity to source areas(1,2), and the role of speciation is also recognized as an important factor(3-6). However, one as yet unexplored possibility is that species diversity itself might help to promote speciation, and indeed the central tenets of island biogeographic theory support such a prediction. Here we use data for plants and arthropods of the volcanic archipelagos of the Canary and Hawaiian Islands to address whether there is a positive relationship between species diversity and rate of diversification. Our index of diversification for each island is the proportion of species that are endemic, and we test our prediction that this increases with increasing species number. We show that even after controlling for several important physical features of islands, diversification is strongly related to species number.	Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Emerson, BC (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	b.emerson@uea.ac.uk		Emerson, Brent/0000-0003-4067-9858; Kolm, Niclas/0000-0001-5791-336X				Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Carson Hampton L., 1995, P14; DRAPER NR, 1979, COMMUN STAT A-THEOR, V8, P99, DOI 10.1080/03610927908827741; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GINOVES JRA, IN PRESS LISTA ESPEC; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Hobohm C, 2000, FLORA, V195, P9; Hubbell Stephen P., 2001, V32, pi; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Nishida G. M., 2002, BISHOP MUSEUM HAWAII; OROMI P, IN PRESS LISTA ESPEC; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Price JP, 2004, J BIOGEOGR, V31, P487, DOI 10.1046/j.0305-0270.2003.00990.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Roos MC, 2004, J BIOGEOGR, V31, P1893, DOI 10.1111/j.1365-2699.2004.01154.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Tokeshi M., 1999, SPECIES COEXISTENCE	21	224	235	1	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1015	1017		10.1038/nature03450	http://dx.doi.org/10.1038/nature03450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846345				2022-12-01	WOS:000228524600037
J	Gu, DF; Reynolds, K; Wu, XG; Chen, F; Duan, XF; Reynolds, RF; Whelton, PK; He, J				Gu, DF; Reynolds, K; Wu, XG; Chen, F; Duan, XF; Reynolds, RF; Whelton, PK; He, J		InterASIA Collaborative Grp	Prevalence of the metabolic syndrome and overweight among adults in China	LANCET			English	Article							REPUBLIC-OF-CHINA; CARDIOVASCULAR-DISEASES; BLOOD-PRESSURE; GLOBAL BURDEN; RISK-FACTORS; LIPOPROTEIN CHOLESTEROL; GEOGRAPHIC VARIATIONS; DIABETES-MELLITUS; NATIONAL-HEALTH; PART I	Background The metabolic syndrome and obesity are major risk factors for cardiovascular disease. Little information exists on the prevalence of the metabolic syndrome in China. We aimed to provide up-to-date estimates of the prevalence of the metabolic syndrome and overweight in the general adult population in China. Methods We did a cross-sectional survey in a nationally representative sample of 15 540 Chinese adults aged 35-74 years in 2000-01. Metabolic syndrome was defined according to guidelines from the US National Cholesterol Education Program. Overweight was defined as body-mass index of 25.0 kg/m(2) or greater. Findings The age-standardised prevalence of metabolic syndrome was 9.8% (95% CI 9.0-10.6) in men and 17.8% (16.6-19.0) in women. The age-standardised prevalence of overweight was 26.9% (25.7-28.1) in men and 31.1% (29.7-32.5) in women. The prevalence of the metabolic syndrome and overweight was higher in northern than in southern China, and higher in urban than rural residents. Interpretation Our results indicate that a large proportion of Chinese adults have the metabolic syndrome and that overweight has become an important public health problem in China. These findings emphasise the urgent need to develop national strategies for the prevention, detection, and treatment of overweight and the metabolic syndrome, to reduce the societal burden of cardiovascular disease in China.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China; Pfizer Inc, New York, NY USA	Tulane University; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pfizer	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave SL18, New Orleans, LA 70112 USA.	jhe@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652				*3 NAT HLTH NUTR E, 1994, VITAL HLTH STAT, V32, P1; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chuang SY, 2002, ACTA CARDIOL SIN, V18, P16; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Further Study Of Risk Factors For Stroke And Coronary Heart Disease group, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P298; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; HE J, 1995, STROKE, V26, P2222, DOI 10.1161/01.STR.26.12.2222; HUANG ZD, 1994, J HYPERTENS, V12, P1103; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Krauss R M, 1998, Circulation, V98, P1472; Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Liese AD, 1998, EPIDEMIOL REV, V20, P157, DOI 10.1093/oxfordjournals.epirev.a017978; Lopez Alan D., 1993, World Health Statistics Quarterly, V46, P91; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; MOON OR, 2002, OBES REV, V3, P191, DOI DOI 10.1046/J.1467-789X.2002.00073.X; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; *NIH, 1997, OBES RES S2, V6, pS51; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Popkin BM, 1998, NUTR REV, V56, P106; POPKIN BM, 1993, EUR J CLIN NUTR, V47, P333; POPKIN BM, 1995, AM J PUBLIC HEALTH, V85, P690, DOI 10.2105/AJPH.85.5.690; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Saw S. M., 1997, Annals Academy of Medicine Singapore, V26, P489; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; TAO SQ, 1995, CHINESE MED J-PEKING, V108, P483; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; *WHO W PAC REG INT, 2000, AS PAC PERSP RED OB; World Health Organization, 2000, WHO TECHN REP SER, V894, pi, DOI DOI 10.1016/J.BBI.2016.02.019; World Health Organization, DEF DIAGN CLASS DI 1; Wu XG, 1996, J HYPERTENS, V14, P1267, DOI 10.1097/00004872-199611000-00003; Wu ZS, 2001, CIRCULATION, V103, P462; Yao C, 1993, World Health Stat Q, V46, P113; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; ZHOU BF, 1995, INT J EPIDEMIOL, V24, P528, DOI 10.1093/ije/24.3.528; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245; 2000, ARCH INTERN MED, V160, P898	52	733	887	2	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2005	365	9468					1398	1405		10.1016/S0140-6736(05)66375-1	http://dx.doi.org/10.1016/S0140-6736(05)66375-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15836888				2022-12-01	WOS:000228401900028
J	Ma, JB; Yuan, YR; Meister, G; Pei, Y; Tuschl, T; Patel, DJ				Ma, JB; Yuan, YR; Meister, G; Pei, Y; Tuschl, T; Patel, DJ			Structural basis for 5 '-end-specific recognition of guide RNA by the A-fulgidus Piwi protein	NATURE			English	Article							CRYSTAL-STRUCTURE; ARGONAUTE2; MICRORNA; BINDING; INTERFERENCE; MECHANISMS; CLEAVAGE	RNA interference (RNAi) is a conserved sequence-specific gene regulatory mechanism(1-3) mediated by the RNA-induced silencing complex ( RISC), which is composed of a single-stranded guide RNA and an Argonaute protein. The PIWI domain, a highly conserved motif within Argonaute, has been shown to adopt an RNase H fold(4,5) critical for the endonuclease cleavage activity of RISC4-6. Here we report the crystal structure of Archaeoglobus fulgidus Piwi protein bound to double-stranded RNA, thereby identifying the binding pocket for guide-strand 5 '-end recognition and providing insight into guide-strand-mediated messenger RNA target recognition. The phosphorylated 5 ' end of the guide RNA is anchored within a highly conserved basic pocket, supplemented by the carboxy-terminal carboxylate and a bound divalent cation. The first nucleotide from the 5 ' end of the guide RNA is unpaired and stacks over a conserved tyrosine residue, whereas successive nucleotides form a four-base-pair RNA duplex. Mutation of the corresponding amino acids that contact the 5 ' phosphate in human Ago2 resulted in attenuated mRNA cleavage activity. Our structure of the Piwi-RNA complex, and that determined elsewhere(7), provide direct support for the 5 ' region of the guide RNA serving as a nucleation site for pairing with target mRNA and for a fixed distance separating the RISC-mediated mRNA cleavage site from the anchored 5 ' end of the guide RNA.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org	Pei, Yi/D-8998-2011	Pei, Yi/0000-0002-3466-760X	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIAID NIH HHS [R01 AI068776] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Sagar MB, 2004, RNA, V10, P772, DOI 10.1261/rna.5266504; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	29	469	511	4	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					666	670		10.1038/nature03514	http://dx.doi.org/10.1038/nature03514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800629	Green Accepted			2022-12-01	WOS:000228011000050
J	Harrison, CJ; Corley, SB; Moylan, EC; Alexander, DL; Scotland, RW; Langdale, JA				Harrison, CJ; Corley, SB; Moylan, EC; Alexander, DL; Scotland, RW; Langdale, JA			Independent recruitment of a conserved developmental mechanism during leaf evolution	NATURE			English	Article							KNOTTED1-LIKE HOMEOBOX GENE; COMPOUND LEAF; ROUGH-SHEATH2 GENE; KNOX GENES; EXPRESSION; LEAVES; TOMATO; ARABIDOPSIS; PLANTS; PRIMORDIA	Vascular plants evolved in the Middle to Late Silurian period, about 420 million years ago(1). The fossil record indicates that these primitive plants had branched stems with sporangia but no leaves. Leaf-like lateral outgrowths subsequently evolved on at least two independent occasions(2-4). In extant plants, these events are represented by microphyllous leaves in lycophytes (clubmosses, spikemosses and quillworts) and megaphyllous leaves in euphyllophytes ( ferns, gymnosperms and angiosperms). Our current understanding of how leaves develop is restricted to processes that operate during megaphyll formation. Because microphylls and megaphylls evolved independently, different mechanisms might be required for leaf formation. Here we show that this is not so. Gene expression data from a microphyllous lycophyte, phylogenetic analyses, and a cross-species complementation experiment all show that a common developmental mechanism can underpin both microphyll and megaphyll formation. We propose that this mechanism might have operated originally in the context of primitive plant apices to facilitate bifurcation. Recruitment of this pathway to formleaves occurred independently and in parallel in different plant lineages.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Langdale, JA (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	jane.langdale@plants.ox.ac.uk	Moylan, Elizabeth C/J-5611-2019; Langdale, Jane A./AAE-8343-2019	Langdale, Jane/0000-0001-7648-3924; Harrison, Jill/0000-0002-5228-600X	Biotechnology and Biological Sciences Research Council [G19201] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BIERHORST DW, 1977, AM J BOT, V64, P125, DOI 10.2307/2442101; Boyce CK, 2002, PALEOBIOLOGY, V28, P70, DOI 10.1666/0094-8373(2002)028&lt;0070:EODPAT&gt;2.0.CO;2; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; EDWARDS D, 1983, BOT J LINN SOC, V86, P19, DOI 10.1111/j.1095-8339.1983.tb00715.x; Gifford EM, 1989, MORPHOLOGY EVOLUTION; Golz JF, 2002, CURR BIOL, V12, P515, DOI 10.1016/S0960-9822(02)00721-2; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hofer J, 2001, PLANT MOL BIOL, V45, P387, DOI 10.1023/A:1010739812836; JACKSON D, 1994, DEVELOPMENT, V120, P405; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Kim M, 2003, DEVELOPMENT, V130, P4405, DOI 10.1242/dev.00655; Kim M, 2003, NATURE, V424, P438, DOI 10.1038/nature01820; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; McHale NA, 2004, PLANT CELL, V16, P1251, DOI 10.1105/tpc.019307; Muller J, 2001, PLANT J, V27, P13, DOI 10.1046/j.1365-313x.2001.01064.x; Nishimura A, 1999, PLANT J, V18, P337, DOI 10.1046/j.1365-313X.1999.00457.x; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Pautot W, 2001, PLANT CELL, V13, P1719, DOI 10.1105/tpc.13.8.1719; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; Sentoku N, 1999, PLANT CELL, V11, P1651, DOI 10.1105/tpc.11.9.1651; SMITH LG, 1992, DEVELOPMENT, V116, P21; STEEVES TA, 1957, AM J BOT, V44, P665, DOI 10.2307/2438631; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 2003, NAT REV GENET, V4, P169, DOI 10.1038/nrg1002; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	30	152	159	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					509	514		10.1038/nature03410	http://dx.doi.org/10.1038/nature03410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791256				2022-12-01	WOS:000227836000043
J	Takano, A; Endo, T; Yoshihisa, T				Takano, A; Endo, T; Yoshihisa, T			tRNA actively shuttles between the nucleus and cytosol in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPORT; TRANSPORT; AMINOACYLATION; TRANSCRIPTION; TRANSLATION; CYTOPLASM; PATHWAY	Previous evidence suggested that transfer RNAs (tRNAs) cross the nuclear envelope to the cytosol only once after maturing in the nucleus. We now present evidence for nuclear import of tRNAs in yeast. Several export mutants accumulate mature tRNAs in the nucleus even in the absence of transcription. Import requires energy but not the Ran cycle. These results indicate that tRNAs shuttle between the nucleus and cytosol.	Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Core Res Evolut Sci & Technol, Japan Sci & Technol Corp, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Yoshihisa, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	tyoshihi@biochem.chem.nagoya-u.ac.jp						Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; AZPIROZ R, 1993, MOL BIOL CELL, V4, P21, DOI 10.1091/mbc.4.1.21; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Feng WQ, 2002, P NATL ACAD SCI USA, V99, P5412, DOI 10.1073/pnas.082682699; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grosshans H, 2000, GENE DEV, V14, P830; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; WILLIS I, 1984, EMBO J, V3, P1573, DOI 10.1002/j.1460-2075.1984.tb02013.x; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.e02-11-0757	19	130	136	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					140	142		10.1126/science.1113346	http://dx.doi.org/10.1126/science.1113346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15905365				2022-12-01	WOS:000230212800078
J	Ram, RJ; VerBerkmoes, NC; Thelen, MP; Tyson, GW; Baker, BJ; Blake, RC; Shah, M; Hettich, RL; Banfield, JF				Ram, RJ; VerBerkmoes, NC; Thelen, MP; Tyson, GW; Baker, BJ; Blake, RC; Shah, M; Hettich, RL; Banfield, JF			Community proteomics of a natural microbial biofilm	SCIENCE			English	Article							ACID-MINE DRAINAGE; LEPTOSPIRILLUM-FERROOXIDANS; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; YEAST PROTEOME; IRON; IDENTIFICATION; CHROMATOGRAPHY; METABOLISM; PEPTIDE	Using genomic and mass spectrometry-based proteomic methods, we evaluated gene expression, identified key activities, and examined partitioning of metabolic functions in a natural acid mine drainage (AMD) microbial biofilm community. We detected 2033 proteins from the five most abundant species in the biofilm, including 48% of the predicted proteins from the dominant biofilm organism, Leptospirillum group II. Proteins involved in protein refolding and response to oxidative stress appeared to be highly expressed, which suggests that damage to biomolecules is a key challenge for survival. We validated and estimated the relative abundance and cellular localization of 357 unique and 215 conserved novel proteins and determined that one abundant novel protein is a cytochrome central to iron oxidation and AMD formation.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Tennessee, Grad Sch Genome Sci & Technol, Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA; Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN 37831 USA; Lawrence Livermore Natl Lab, Biosci Directorate, Livermore, CA 94551 USA; Xavier Univ, Coll Pharm, New Orleans, LA 70125 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Xavier University of Louisiana	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jill@seismo.berkeley.edu	Baker, Brett/P-1783-2014; Hettich, Robert L/N-1458-2016; Thelen, Michael/C-6834-2008; Tyson, Gene/C-6558-2013	Baker, Brett/0000-0002-5971-1021; Hettich, Robert L/0000-0001-7708-786X; Thelen, Michael/0000-0002-2479-5480; Banfield, Jill/0000-0001-8203-8771; Tyson, Gene/0000-0001-8559-9427				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLAKE R, 2000, ENV MICROBE METAL IN, P53; BLAKE RC, 1993, FEMS MICROBIOL REV, V11, P9; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/10635150118513; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Essader AS, 2005, PROTEOMICS, V5, P24, DOI 10.1002/pmic.200400888; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HART A, 1991, FEMS MICROBIOL LETT, V81, P89; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Parro V, 2003, P NATL ACAD SCI USA, V100, P7883, DOI 10.1073/pnas.1230487100; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; RAM RS, UNPUB; Standing KG, 2003, CURR OPIN STRUC BIOL, V13, P595, DOI 10.1016/j.sbi.2003.09.005; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; VerBerkmoes NC, 2002, J PROTEOME RES, V1, P239, DOI 10.1021/pr025508a; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Zhu WH, 2004, J PROTEOME RES, V3, P538, DOI 10.1021/pr034109s	26	501	539	1	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1915	1920		10.1126/science. 1109070	http://dx.doi.org/10.1126/science. 1109070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15879173				2022-12-01	WOS:000230120000042
J	Reilly, JJ; Armstrong, J; Dorosty, AR; Emmett, PM; Ness, A; Rogers, I; Steer, C; Sherriff, A				Reilly, JJ; Armstrong, J; Dorosty, AR; Emmett, PM; Ness, A; Rogers, I; Steer, C; Sherriff, A		Avon Longitudinal Study Parents Ch	Early life risk factors for obesity in childhood: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; ADULT OBESITY; CHILDREN; WEIGHT; PREVENTION; OVERWEIGHT; ADIPOSITY; BEHAVIORS; EXPOSURE; UK	Objective To identify risk factors in early life (up to 3 years of age) for obesity in children in the United Kingdom. Design Prospective cohort study. Setting Avon longitudinal study of parents and children, United Kingdom. Participants 8234 children in cohort aged 7 years and a subsample of 909 children (children in focus) with data on additional early growth related risk factors for obesity. Main outcome measures Obesity at age 7 years, defined as a body mass index >= 95th centile relative to reference data for the UK population in 1990. Results Eight of 25 putative risk factors were associated with a risk of obesity in the final models: parental obesity (both parents: adjusted odds ratio, 10.44, 95% confidence interval 5.11 to 21.32), very early (by 43 months) body mass index or adiposity rebound (15.00, 5.32 to 42.30), more than eight hours spent watching television per week at age 3 years (1.55, 1.13 to 2.12), catch-up growth (2.60, 1.09 to 6.16), standard deviation score for weight at age 8 months (3.13, 1.43 to 6.85) and 18 months (2.65, 1, 25 to 5.59); weight gain in first year (1.06, 1.02 to 1.10 per 100 g increase); birth weight, per 100 g (1.05, 1.03 to 1.07); and short (< 10.5 hours) sleep duration at age 3 years (1.45, 1.10 to 1.89). Conclusion Eight factors in early life are associated with an increased risk of obesity in childhood.	Univ Glasgow, Div Dev Med, Yorkhill Hosp, Glasgow G3 8SJ, Lanark, Scotland; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Inst Child Hlth, Bristol BS8 1TH, Avon, England; Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran	University of Glasgow; University of Bristol; Tehran University of Medical Sciences	Reilly, JJ (corresponding author), Univ Glasgow, Div Dev Med, Yorkhill Hosp, Glasgow G3 8SJ, Lanark, Scotland.	jjr2y@clinmed.gla.ac.uk	Emmett, Pauline/AAL-6815-2021; Dorosty-Motlagh, Ahmad-Reza/E-1003-2018; Ness, Andy R/M-7612-2013	Dorosty-Motlagh, Ahmad-Reza/0000-0002-6937-7776; Ness, Andy R/0000-0003-3548-9523; Rogers, Imogen/0000-0001-7275-2437; sherriff, andrea/0000-0002-1016-037X; Emmett, Pauline/0000-0003-1076-4779	Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2; Birch LL, 1998, PEDIATRICS, V101, P539; Bogen DL, 2004, OBES RES, V12, P1527, DOI 10.1038/oby.2004.190; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dietz WH, 2000, AM J CLIN NUTR, V72, P335; Dietz WH, 1997, J NUTR, V127, pS1884, DOI 10.1093/jn/127.9.1884S; Dietz WH, 2001, JAMA-J AM MED ASSOC, V285, P2506, DOI 10.1001/jama.285.19.2506; Dorosty AR, 2000, PEDIATRICS, V105, P1115, DOI 10.1542/peds.105.5.1115; Francis LA, 2003, OBES RES, V11, P143, DOI 10.1038/oby.2003.23; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Grove KL, 2001, J CLIN ENDOCR METAB, V86, P5420, DOI 10.1210/jc.86.11.5420; North K, 2000, EUR J CLIN NUTR, V54, P73, DOI 10.1038/sj.ejcn.1600896; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Reilly JJ, 2002, ARCH DIS CHILD, V86, P392, DOI 10.1136/adc.86.6.392; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Reilly JJ, 1999, LANCET, V354, P1874, DOI 10.1016/S0140-6736(99)04555-9; Reilly JJ, 2000, INT J OBESITY, V24, P1623, DOI 10.1038/sj.ijo.0801436; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; STEULER N, 2002, PEDIATRICS, V109, P194; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Whitaker RC, 2003, ARCH PEDIAT ADOL MED, V157, P725, DOI 10.1001/archpedi.157.8.725	25	1088	1126	1	196	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2005	330	7504					1357	1359		10.1136/bmj.38470.670903.E0	http://dx.doi.org/10.1136/bmj.38470.670903.E0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936FE	15908441	Green Published			2022-12-01	WOS:000229840100017
J	Cooke, CA; Best, RM				Cooke, CA; Best, RM			Intraocular glasses	LANCET			English	Editorial Material									Royal Victoria Hosp, Dept Ophthalmol, Belfast B12 6BA, Antrim, North Ireland		Cooke, CA (corresponding author), Royal Victoria Hosp, Dept Ophthalmol, Belfast B12 6BA, Antrim, North Ireland.	carolecooke322@ntlworld.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1960	1960		10.1016/S0140-6736(05)66663-9	http://dx.doi.org/10.1016/S0140-6736(05)66663-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936425				2022-12-01	WOS:000229587800031
J	Sullivan, AK; Curtis, H; Sabin, CA; Johnson, MA				Sullivan, AK; Curtis, H; Sabin, CA; Johnson, MA			Newly diagnosed FHV infections: review in UK and Ireland	BRITISH MEDICAL JOURNAL			English	Review									Chelsea & Westminster Healthcare NHS Trust, London SW10 9NH, England; British HIV Assoc, London, England; UCL Royal Free & Univ Coll Med Sch, London, England; UCL Royal Free Hampstead NHS Trust, London, England	University of London; University College London; UCL Medical School; University of London; University College London	Sullivan, AK (corresponding author), Chelsea & Westminster Healthcare NHS Trust, London SW10 9NH, England.	Ann.Sullivan@Chelwest.nhs.uk	Sabin, Caroline/C-2464-2008	Sabin, Caroline/0000-0001-5173-2760; Curtis, Hilary/0000-0002-1440-1812				Curtis H, 2003, HIV Med, V4, P11, DOI 10.1046/j.1468-1293.2003.00137.x; Miners A H, 2001, HIV Med, V2, P52, DOI 10.1046/j.1468-1293.2001.00048.x; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; POZNIAK A, 2003, HIV MED S, V4, pS1	4	119	127	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 4	2005	330	7503					1301	1302		10.1136/bmj.38398.590602.E0	http://dx.doi.org/10.1136/bmj.38398.590602.E0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15894552	Bronze, Green Published			2022-12-01	WOS:000229655700021
J	Merchant, RC; Mayer, KH				Merchant, RC; Mayer, KH			Perspectives on new recommendations for nonoccupational HIV postexposure prophylaxis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EXPOSURE		Brown Med Sch, Dept Emergency Med, Providence, RI USA; Brown Med Sch, Dept Med, Providence, RI USA; Brown Med Sch, Dept Community Hlth, Providence, RI USA	Brown University; Brown University; Brown University	Merchant, RC (corresponding author), Rhode Isl Hosp, Dept Emergency Med, 593 Eddy St,Potter 228, Providence, RI 02903 USA.	rmerchant@lifespan.org						*AIDS I NEW YORK D, 1998, HIV PROPH FOLL SEX A; *AIDS I NEW YORK S, 2004, HIV PROPH FOLL NON E; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Bassett IV, 2004, CLIN INFECT DIS, V39, P395, DOI 10.1086/422459; *CAL TASK FORC NON, 2005, OFF HIV POST EXP PRO; *DEP HLTH COMM MAS, 2000, CLIN ADV HIV PROPH N; Merchant RC, 2003, ACAD EMERG MED, V10, P1345, DOI 10.1197/S1069-6563(03)00537-2; MERCHANT RC, 2002, NONOCCUPATIONAL HIV; MYLES JE, 2001, OFFERING HIV PROPHYL; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; *PAN CLIN PRACT TR, 2004, GUID US ANT AG HIV 1; Rey D, 2000, AIDS CARE, V12, P695, DOI 10.1080/09540120020014228; 1996, MMWR MORB MORTAL WKL, V45, P468	14	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2407	2409		10.1001/jama.293.19.2407	http://dx.doi.org/10.1001/jama.293.19.2407			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15900012				2022-12-01	WOS:000229120600029
J	Mansour, D; Fraser, IS				Mansour, D; Fraser, IS			Missed contraceptive pills and the critical pill-free interval	LANCET			English	Editorial Material									Newcastle Primary Care Trust, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Sydney, Dept Obstet & Gynaecol, Sydney, NSW 2006, Australia	University of Sydney	Mansour, D (corresponding author), Newcastle Primary Care Trust, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	diana.mansour@newcastle-pct.nhs.uk						[Anonymous], 2004, SEL PRACT REC CONTR; Baer WC, 2004, J AM PLANN ASSOC, V70, P371; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Creinin MD, 2002, CONTRACEPTION, V66, P147, DOI 10.1016/S0010-7824(02)00344-X; HAMILTON CJCM, 1989, AM J OBSTET GYNECOL, V161, P1159, DOI 10.1016/0002-9378(89)90655-8; KORVER T, 1995, BRIT J OBSTET GYNAEC, V102, P601; LANDGREN BM, 1991, CONTRACEPTION, V43, P149, DOI 10.1016/0010-7824(91)90042-E; Pierson RA, 2003, FERTIL STERIL, V80, P34, DOI 10.1016/S0015-0282(03)00556-9; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; *WHO, 2004, MED EL CRIT CONTR; 2005, J FAM PLANN REPROD H, V31, P153	11	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1670	1671		10.1016/S0140-6736(05)66527-0	http://dx.doi.org/10.1016/S0140-6736(05)66527-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894085				2022-12-01	WOS:000229082300007
J	Ramaekers, VT; Rothenberg, SP; Sequeira, JM; Opladen, T; Blau, N; Quadros, EV; Selhub, J				Ramaekers, VT; Rothenberg, SP; Sequeira, JM; Opladen, T; Blau, N; Quadros, EV; Selhub, J			Autoantibodies to folate receptors in the cerebral folate deficiency syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBROSPINAL-FLUID; BINDING-PROTEIN; ACID; 5-METHYLTETRAHYDROFOLATE; TRANSPORT	In infantile-onset cerebral folate deficiency, 5-methyltetrahydrofolate (5MTHF) levels in the cerebrospinal fluid are low, but folate levels in the serum and erythrocytes are normal. We examined serum specimens from 28 children with cerebral folate deficiency, 5 of their mothers, 28 age-matched control subjects, and 41 patients with an unrelated neurologic disorder. Serum from 25 of the 28 patients and 0 of 28 control subjects contained high-affinity blocking autoantibodies against membrane-bound folate receptors that are present on the choroid plexus. Oral folinic acid normalized 5MTHF levels in the cerebrospinal fluid and led to clinical improvement. Cerebral folate deficiency is a disorder in which autoantibodies can prevent the transfer of folate from the plasma to the cerebrospinal fluid.	Univ Klinikum Aachen, Dept Pediat, Div Pediat Neurol, D-52074 Aachen, Germany; SUNY Downstate Med Ctr, Dept Med, Brooklyn, NY USA; Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Vitamin Metab & Aging Lab, Boston, MA 02111 USA	RWTH Aachen University; RWTH Aachen University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University Children's Hospital Zurich; Tufts University; United States Department of Agriculture (USDA)	Ramaekers, VT (corresponding author), Univ Klinikum Aachen, Dept Pediat, Div Pediat Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	vramaekers@ukaachen.de		Blau, Nenad/0000-0003-4347-3230				ANTONY AC, 1992, BLOOD, V79, P2807; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; BLAU N, 2003, PHYSICIAN GUIDE LAB, P96; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; HOLM J, 1991, BIOCHEM J, V280, P267, DOI 10.1042/bj2800267; LEVITT M, 1971, J CLIN INVEST, V50, P1301, DOI 10.1172/JCI106609; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Ramaekers VT, 2002, NEUROPEDIATRICS, V33, P301, DOI 10.1055/s-2002-37082; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SVENDSEN IB, 1982, CARLSBERG RES COMMUN, V47, P371, DOI 10.1007/BF02907775; Wang YH, 2001, BBA-BIOMEMBRANES, V1513, P49, DOI 10.1016/S0005-2736(01)00340-6; Wright AJA, 2003, BRIT J NUTR, V90, P363, DOI 10.1079/BJN2003908; Wu DF, 1999, PHARMACEUT RES, V16, P415, DOI 10.1023/A:1018829920158	16	178	185	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1985	1991		10.1056/NEJMoa043160	http://dx.doi.org/10.1056/NEJMoa043160			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888699	Bronze			2022-12-01	WOS:000229017100009
J	Storm, C; Pastore, JJ; MacKintosh, FC; Lubensky, TC; Janmey, PA				Storm, C; Pastore, JJ; MacKintosh, FC; Lubensky, TC; Janmey, PA			Nonlinear elasticity in biological gels	NATURE			English	Article							ACTIN GELS; MODULUS	The mechanical properties of soft biological tissues are essential to their physiological function and cannot easily be duplicated by synthetic materials. Unlike simple polymer gels, many biological materials - including blood vessels(1), mesentery tissue(2), lung parenchyma(3), cornea(4) and blood clots(5) - stiffen as they are strained, thereby preventing large deformations that could threaten tissue integrity. The molecular structures and design principles responsible for this nonlinear elasticity are unknown. Here we report a molecular theory that accounts for strain-stiffening in a range of molecularly distinct gels formed from cytoskeletal and extracellular proteins and that reveals universal stress - strain relations at low to intermediate strains. The input to this theory is the force - extension curve for individual semi-flexible filaments and the assumptions that biological networks composed of these filaments are homogeneous, isotropic, and that they strain uniformly. This theory shows that systems of filamentous proteins arranged in an open crosslinked mesh invariably stiffen at low strains without requiring a specific architecture or multiple elements with different intrinsic stiffness.	Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; Vrije Univ Amsterdam, Div Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Vrije Universiteit Amsterdam; University of Pennsylvania	Storm, C (corresponding author), Leiden Univ, LION, Inst Lorentz Theoret Phys, POB 9506, NL-2300 RA Leiden, Netherlands.	cstorm@lorentz.leidenuniv.nl	MacKintosh, Frederick/AAB-9332-2021; Storm, Cornelis/K-1486-2013; MacKintosh, Fred C/A-9450-2008	MacKintosh, Frederick/0000-0002-2607-9541; Storm, Cornelis/0000-0002-4391-8984; MacKintosh, Fred C/0000-0002-2607-9541				FIXMAN M, 1973, J CHEM PHYS, V58, P1564, DOI 10.1063/1.1679396; Fung Y, 1994, APPL MECH; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; Grosberg A. Y. u., 1994, STAT PHYS MACROMOLEC; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P12; JANMEY PA, 1986, BIOPOLYMERS, V25, P1337, DOI 10.1002/bip.360250712; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KARAKAPLAN AD, 1980, ASME, V102, P124; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Landau L. D., 1980, STAT PHYS; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Morse DC, 1998, PHYS REV E, V58, pR1237, DOI 10.1103/PhysRevE.58.R1237; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; TELOAR LRG, 1975, PHYS RUBBER ELASTICI; Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200	29	1177	1189	11	453	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					191	194		10.1038/nature03521	http://dx.doi.org/10.1038/nature03521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889088	Green Submitted			2022-12-01	WOS:000229021100036
J	Xu, F; Zhang, KL; Grunstein, M				Xu, F; Zhang, KL; Grunstein, M			Acetylation in histone H3 globular domain regulates gene expression in yeast	CELL			English	Article							NUCLEOSOME CORE PARTICLE; SACCHAROMYCES-CEREVISIAE; SWI/SNF COMPLEX; ORDERED RECRUITMENT; LYSINE 9; PROMOTER; BINDING; TRANSCRIPTION; HETEROCHROMATIN; PROTEINS	In Saccharomyces cerevisiae, known histone acetylation sites regulating gene activity are located in the N-terminal tails protruding from the nucleosome core. We report lysine 56 in histone H3 as a novel acetylation site that is located in the globular domain, where it extends toward the DNA major groove at the entry-exit points of the DNA superhelix as it wraps around the nucleosome. We show that K56 acetylation is enriched preferentially at certain active genes, such as those coding for histones. SPT10, a putative acetyltransferase, is required for cell cycle-specific K56 acetylation at histone genes. This allows recruitment of the nucleosome remodeling factor Snf5 and subsequent transcription. These findings indicate that histone H3 K56 acetylation at the entry-exit gate enables recruitment of the SWI/SNF nucleosome remodeling complex and so regulates gene activity.	Univ Calif Los Angeles, Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Riverside, Dept Chem, Mass Spectrometry Facil, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Riverside	Grunstein, M (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	mg@mbi.ucla.edu		Xu, Feng/0000-0003-2016-7521	NIGMS NIH HHS [GM 23674, GM 42421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023674, R01GM042421, R37GM023674] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Geng FQ, 2001, MOL CELL BIOL, V21, P4311, DOI 10.1128/MCB.21.13.4311-4320.2001; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hess D, 2004, MOL CELL BIOL, V24, P135, DOI 10.1128/MCB.24.1.135-143.2004; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	52	314	318	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					375	385		10.1016/j.cell.2005.03.011	http://dx.doi.org/10.1016/j.cell.2005.03.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882620	Bronze			2022-12-01	WOS:000229031600008
J	Hua, JY; Smear, MC; Baier, H; Smith, SJ				Hua, JY; Smear, MC; Baier, H; Smith, SJ			Regulation of axon growth in vivo by activity-based competition	NATURE			English	Article							VISUAL-CORTEX; SYNAPTIC COMPETITION; OCULAR DOMINANCE; BRANCH DYNAMICS; NEURAL ACTIVITY; ZEBRAFISH; SYSTEM; REVEALS; ARBORS; BRAIN	The formation of functional neural networks requires precise regulation of the growth and branching of the terminal arbors of axons, processes known to be influenced by early network electrical activity(1-3). Here we show that a rule of activity-based competition between neighbouring axons appears to govern the growth and branching of retinal ganglion cell (RGC) axon arbors in the developing optic tectum of zebrafish. Mosaic expression of an exogenous potassium channel or a dominant-negative SNARE protein was used to suppress electrical or neurosecretory activity in subsets of RGC axons. Imaging in vivo showed that these forms of activity suppression strongly inhibit both net growth and the formation of new branches by individually transfected RGC axon arbors. The inhibition is relieved when the activity of nearby 'competing' RGC axons is also suppressed. These results therefore identify a new form of activity-based competition rule that might be a key regulator of axon growth and branch initiation.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco	Hua, JY (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	huayy@stanford.edu		Smith, Stephen/0000-0002-2290-8701				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cogen J, 2000, J NEUROBIOL, V45, P120, DOI 10.1002/1097-4695(20001105)45:2<120::AID-NEU6>3.0.CO;2-6; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Drapeau P, 2002, PROG NEUROBIOL, V68, P85, DOI 10.1016/S0301-0082(02)00075-8; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Johnson FA, 1999, J COMP NEUROL, V406, P548, DOI 10.1002/(SICI)1096-9861(19990419)406:4<548::AID-CNE8>3.0.CO;2-3; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Li WY, 2003, J NEUROSCI, V23, P10467; LICHTMAN JW, 1990, J NEUROBIOL, V21, P99, DOI 10.1002/neu.480210107; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schmidt JT, 2004, J NEUROBIOL, V58, P328, DOI 10.1002/neu.10286; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	25	172	173	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 21	2005	434	7036					1022	1026		10.1038/nature03409	http://dx.doi.org/10.1038/nature03409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846347				2022-12-01	WOS:000228524600039
J	Palleroni, A; Miller, CT; Hauser, M; Marler, P				Palleroni, A; Miller, CT; Hauser, M; Marler, P			Predation - Prey plumage adaptation against falcon attack	NATURE			English	Editorial Material							BIRDS		Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, Cambridge, MA 02138 USA; Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA; Univ Calif Davis, Anim Commun Lab, Davis, CA 95616 USA	Harvard University; Johns Hopkins University; University of California System; University of California Davis	Palleroni, A (corresponding author), Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.	aliparti@wjh.harvard.edu						[Anonymous], 1982, FALCONS WORLD; Bond AB, 1999, ANIM LEARN BEHAV, V27, P461, DOI 10.3758/BF03209981; Brooke MD, 1998, FUNCT ECOL, V12, P339; Cade TJ, 1988, PEREGRINE FALCON POP; Goodwin D., 1970, PIGEONS DOVES WORLD; Helfman GS, 2009, DIVERSITY FISHES BIO; Johnston R.F., 1995, FERAL PIGEONS; LIMA SL, 1993, WILSON BULL, V105, P1; Tinbergen N., 1951, STUDY INSTINCT; Tucker VA, 1998, J EXP BIOL, V201, P403	10	29	30	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					973	974		10.1038/434973b	http://dx.doi.org/10.1038/434973b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846334				2022-12-01	WOS:000228524600027
J	Krosnar, K				Krosnar, K			Cross-border trade in medicines causes concern in the EU	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1297	1298		10.1016/S0140-6736(05)61011-2	http://dx.doi.org/10.1016/S0140-6736(05)61011-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15828082				2022-12-01	WOS:000228219600012
J	Liu, YF; Chen, WM; Lin, YF; Yang, RC; Lin, MW; Li, LH; Chang, YH; Jou, YS; Lin, PY; Su, JS; Huang, SF; Hsiao, KJ; Fann, CSJ; Hwang, HW; Chen, YT; Tsai, SF				Liu, YF; Chen, WM; Lin, YF; Yang, RC; Lin, MW; Li, LH; Chang, YH; Jou, YS; Lin, PY; Su, JS; Huang, SF; Hsiao, KJ; Fann, CSJ; Hwang, HW; Chen, YT; Tsai, SF			Type II collagen gene variants and inherited osteonecrosis of the femoral head	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA; AVASCULAR NECROSIS; COL2A1 MUTATION; SERINE SUBSTITUTION; CARTILAGE; GLYCINE; HYPOCHONDROGENESIS; LINKAGE; FAMILY; BONE	BACKGROUND: Avascular necrosis of the femoral head (ANFH) causes disability that often requires surgical intervention. Most cases of ANFH are sporadic, but we identified three families in which there was autosomal dominant inheritance of the disease and mapped the chromosomal position of the gene to 12q13. METHODS: We carried out haplotype analysis in the families, selected candidate genes from the critical interval for ANFH on 12q13, and sequenced the promoter and exonic regions of the type II collagen gene (COL2A1) from persons with inherited and sporadic forms of ANFH. RESULTS: We identified a G(rightarrow)A transition in exon 50 of COL2A1 in affected members of a four-generation family with ANFH. This transition predicts the replacement of glycine with serine at codon 1170 in a GXY repeat of type II collagen. Another pedigree was shown to harbor the same transition, but the mutant allele occurred on a different haplotype background. In a third family, a G(rightarrow)A transition in exon 33 of the gene, causing a glycine-to-serine change at codon 717, was detected. No mutation was found in the COL2A1 coding region in sporadic cases of ANFH. CONCLUSIONS: All the patients with familial ANFH whom we studied carried COL2A1 mutations. In families with ANFH, haplotype and sequence analysis of the COL2A1 gene can be used to identify carriers of the mutant allele before the onset of clinical symptoms, allowing the initiation of measures that may delay progression of the disease.	Natl Yang Ming Univ, Sch Med, Inst Genet, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Med, Genome Res Ctr, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan; Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei, Taiwan; Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; Natl Hlth Res Inst, Div Mol & Genom Med, Taipei, Taiwan; Taipei Municipal Chung Hsing Hosp, Div Orthoped & Traumatol, Taipei, Taiwan; Chang Gung Mem Hosp, Dept Pathol, Taipei 10591, Taiwan; Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Academia Sinica - Taiwan	Tsai, SF (corresponding author), Natl Hlth Res Inst, Div Mol & Genom Med, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan.	petsai@nhri.org.tw	Jou, Yuh-Shan/O-5921-2018; Tsai, Shih-Feng/E-3997-2010; Fann, Cathy SJ/F-9410-2010; Huang, Shiu-Feng Kathy/E-3977-2010	Jou, Yuh-Shan/0000-0001-5090-3732; Fann, Cathy SJ/0000-0001-9025-2276; Hwang, Hun-Way/0000-0003-0522-1577				Agarwala S, 2002, RHEUMATOLOGY, V41, P346, DOI 10.1093/rheumatology/41.3.346-a; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; BONAVENTURE J, 1995, BIOCHEM J, V307, P823, DOI 10.1042/bj3070823; CHAN D, 1995, J BIOL CHEM, V270, P1747, DOI 10.1074/jbc.270.4.1747; CHAN D, 1991, J BIOL CHEM, V266, P12487; Chen WM, 2004, AM J HUM GENET, V75, P310, DOI 10.1086/422702; Christgau S, 2001, BONE, V29, P209, DOI 10.1016/S8756-3282(01)00504-X; COLE WG, 1993, J MED GENET, V30, P27, DOI 10.1136/jmg.30.1.27; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; Gardeniers JW, 1993, ARCO NEWS LETT, V5, P79; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; Korkko J, 2000, AM J MED GENET, V92, P95, DOI 10.1002/(SICI)1096-8628(20000515)92:2<95::AID-AJMG3>3.0.CO;2-9; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lieberman Jay R, 2003, Instr Course Lect, V52, P337; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P29; Mont M.A., 1998, CLIN ORTHOPAEDICS RE, V355, pS314, DOI [10.1097/00003086-199810001-00032, DOI 10.1097/00003086-199810001-00032]; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Mortier GR, 2000, J MED GENET, V37, P263, DOI 10.1136/jmg.37.4.263; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; RITVANIEMI P, 1994, HUM MUTAT, V3, P261, DOI 10.1002/humu.1380030314; Rozen S, 2000, Methods Mol Biol, V132, P365; URBANIAK JR, 1995, J BONE JOINT SURG AM, V77A, P681, DOI 10.2106/00004623-199505000-00004; VISSING H, 1989, J BIOL CHEM, V264, P18265; WILLIAMS CJ, 1995, HUM MOL GENET, V4, P309, DOI 10.1093/hmg/4.2.309; WINTERPACHT A, 1995, HUM GENET, V95, P437; WINTERPACHT A, 1994, HUM MUTAT, V4, P257, DOI 10.1002/humu.1380040405	30	116	134	3	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2005	352	22					2294	2301		10.1056/NEJMoa042480	http://dx.doi.org/10.1056/NEJMoa042480			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930VY	15930420				2022-12-01	WOS:000229446400006
J	Cochella, L; Green, R				Cochella, L; Green, R			An active role for tRNA in decoding beyond codon : anticodon pairing	SCIENCE			English	Article							AMINOACYL-TRANSFER-RNA; ELONGATION-FACTOR TU; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; GTP HYDROLYSIS; RIBOSOME; SPECIFICITY; DISCRIMINATION; RECOGNITION; SELECTION	During transfer RNA (tRNA) selection, a cognate codon:anticodon interaction triggers a series of events that ultimately results in the acceptance of that tRNA into the ribosome for peptide-bond formation. High-fidelity discrimination between the cognate tRNA and near- and noncognate ones depends both on their differential dissociation rates from the ribosome and on specific acceleration of forward rate constants by cognate species. Here we show that a mutant tRNA(Trp) carrying a single substitution in its D-arm achieves elevated levels of miscoding by accelerating these forward rate constants independent of codon:anticodon pairing in the decoding center. These data provide evidence for a direct role for tRNA in signaling its own acceptance during decoding and support its fundamental role during the evolution of protein synthesis.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu	Cochella, Luisa/B-6536-2016; Cochella, Luisa/AHD-8261-2022	Cochella, Luisa/0000-0003-4018-7722; Cochella, Luisa/0000-0003-4018-7722	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059425, R01GM059425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUCKINGHAM RH, 1977, P NATL ACAD SCI USA, V74, P5496, DOI 10.1073/pnas.74.12.5496; COCHELLA L, UNPUB; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; FAVRE A, 1975, NUCLEIC ACIDS RES, V2, P1421, DOI 10.1093/nar/2.8.1421; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HIRSH, 1971, J MOL BIOL, V58, P439, DOI 10.1016/0022-2836(71)90362-7; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; SMITH D, 1989, J MOL BIOL, V206, P489, DOI 10.1016/0022-2836(89)90496-8; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; VACHER J, 1979, J MOL BIOL, V129, P287; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Woese CR, 2001, RNA, V7, P1055, DOI 10.1017/S1355838201010615; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	23	182	188	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1178	1180		10.1126/science.1111408	http://dx.doi.org/10.1126/science.1111408			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905403	Green Accepted			2022-12-01	WOS:000229293400046
J	Jones, T; Ehardt, CL; Butynski, TM; Davenport, TRB; Mpunga, NE; Machaga, SJ; De Luca, DW				Jones, T; Ehardt, CL; Butynski, TM; Davenport, TRB; Mpunga, NE; Machaga, SJ; De Luca, DW			The highland mangabey Lophocebus kipunji: A new species of African monkey	SCIENCE			English	Article							UDZUNGWA MOUNTAINS; CONSERVATION; HOTSPOTS; PRIMATES	A distinct species of mangabey was independently found at two sites 370 kilometers apart in southern Tanzania (Mount Rungwe and Livingstone in the Southern Highlands and Ndundulu in the Udzungwa Mountains). This new species is described here and given the name "highland mangabey" Lophocebus kipunji sp. nov. We place this monkey in Lophocebus, because it possesses noncontrasting black eyelids and is arboreal. L. kipunji is distinguished from other mangabeys by the color of its pelage; long, upright crest; off-white tail and ventrum; and loud call. This find has implications for primate evolution, African biogeography, and forest conservation.	Udzungwa Mt Natl Pk, Mangula, Tanzania; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; Conservat Int, Nairobi, Kenya; Wildlife Conservat Soc, So Highlands Conservat Programme, Mbeya, Tanzania	University System of Georgia; University of Georgia	Jones, T (corresponding author), Udzungwa Mt Natl Pk, Box 99, Mangula, Tanzania.	tembomkubwa@gmail.com						Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burgess N.D., 2000, Journal of East African Natural History, V87, P37, DOI 10.2982/0012-8317(1998)87[37:FIOTEA]2.0.CO;2; Davenport TRB, 2002, ORYX, V36, P224; DAVENPORT TRB, 2004, SOC CONS BIOL ABST, V48, P20; Dinesen L, 2001, BIOL CONSERV, V99, P223, DOI 10.1016/S0006-3207(00)00218-4; Doody K., 2001, W KILOMBERO SCARP FO; DOWSETT RJ, 1990, SURVEY FAUNA FLORA N, P111; Ehardt C. L., 2001, AFRICAN PRIMATES, V4, P15; Ehardt CL, 2005, INT J PRIMATOL, V26, P557, DOI 10.1007/s10764-005-4366-y; EHARDT CL, 1999, CONSERVATION ENDANGE; Fleagle JG, 1999, P NATL ACAD SCI USA, V96, P1157, DOI 10.1073/pnas.96.3.1157; GROVES C P, 1978, Primates, V19, P1, DOI 10.1007/BF02373224; Groves CP., 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Harris EE, 1998, MOL BIOL EVOL, V15, P892, DOI 10.1093/oxfordjournals.molbev.a025993; HARRISON MJS, 1988, J ZOOL, V215, P561, DOI 10.1111/j.1469-7998.1988.tb02860.x; Homewood K.M., 1981, International Journal of Primatology, V2, P47, DOI 10.1007/BF02692299; IUCN, 2012, IUCN RED LIST CAT CR; Kingdon J., 2003, KINGDON FIELD GUIDE; Marshall AR, 2005, INT J PRIMATOL, V26, P127, DOI 10.1007/s10764-005-0011-z; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PERKIN A, COMMUNICATION; Range F, 2004, ETHOLOGY, V110, P301, DOI 10.1111/j.1439-0310.2004.00973.x; WAKEHAMDAWSON A, 2002, B ZOOL NOMENCLATURE, V59, P18; Waser P.M., 1982, P117	25	93	101	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1161	1164		10.1126/science.1109191	http://dx.doi.org/10.1126/science.1109191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905399				2022-12-01	WOS:000229293400041
J	Berkley, JA; Maitland, K; Mwangi, I; Ngetsa, C; Mwarumba, S; Lowe, BS; Newton, CRJC; Marsh, K; Scott, JAG; English, M				Berkley, JA; Maitland, K; Mwangi, I; Ngetsa, C; Mwarumba, S; Lowe, BS; Newton, CRJC; Marsh, K; Scott, JAG; English, M			Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE BACTERIAL-MENINGITIS; CEREBRAL MALARIA; PROGNOSTIC INDICATORS; GAMBIAN CHILDREN; MANAGEMENT; PNEUMONIA; OVERLAP; DIAGNOSIS; TANZANIA; FEATURES	Objectives To determine how well antibiotic treatment is targeted by simple clinical syndromes and to what extent drug resistance threatens affordable antibiotics. Design Observational study involving a priori definition of a hierarchy of syndromic indications for antibiotic therapy derived from World Health Organization integrated management of childhood illness and inpatient guidelines and application of these rules to a prospectively collected dataset. Setting Kilifi District Hospital, Kenya. Participants 11 847 acute paediatric admissions. Main outcome measures Presence of invasive bacterial infection (bacteraemia or meningitis) or Plasmodium falciparum parasitaemia; antimicrobial sensitivities of isolated bacteria. Results 6254 (53%) admissions met criteria for syndromes requiring antibiotics (sick young infants; meningitis/encephalopathy; severe malnutrition; very severe, severe, or mild pneumonia; skin or soft tissue infection): 672 (11%) had an invasive bacterial infection (80% of all invasive bacterial infections identified), and 753 (12%) (lied (93%) of all inpatient deaths). Among P falciparum infected children with a syndromic indication for parenteral antibiotics, an invasive bacterial infection was detected in 4.0-8.8%. For the syndrome of meningitis/encephalopathy, 96/123 (76%) isolates were fully sensitive in vitro to penicillin or chloramphenicol. Conclusions Simple clinical syndromes effectively target children admitted with invasive bacterial infection and those at risk of death. Malaria parasitaemia does not justify withholding empirical parenteral antibiotics. Lumbar puncture is critical to the rational use of antibiotics.	Ctr Geog Med Res Coast, Kilifi, Kenya		Berkley, JA (corresponding author), Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	jberkley@kilifi.mimcom.net	Newton, Charles/V-7872-2019; Newton, Charles RJC/B-7578-2014	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Berkley, James/0000-0002-1236-849X; English, Michael/0000-0002-7427-0826; Maitland, Kathryn/0000-0002-0007-0645	Wellcome Trust [061089, 081835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2004, PEDIATRICS, V114, pE713, DOI 10.1542/peds.2004-0007; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; BERKLEY JA, 2002, NEW ENGL J MED, V352, P39; Duke T, 2003, ARCH DIS CHILD, V88, P536, DOI 10.1136/adc.88.6.536; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; English M, 2003, B WORLD HEALTH ORGAN, V81, P166; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; Falade AG, 2001, ANN TROP PAEDIATR, V21, P293, DOI 10.1080/07430170120093472; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MOLYNEUX ME, 1989, Q J MED, V71, P441; *NAT COMM CLIN LAB, 1997, M100S7 NCCLS; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; PRADA J, 1993, LANCET, V342, P1114, DOI 10.1016/0140-6736(93)92096-C; *REP KEN MIN HLTH, 2001, AIDS KEN; *REP KENY MINST HL, 2001, AIDS KEN; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Robertson MA, 2001, ARCH DIS CHILD, V85, P214, DOI 10.1136/adc.85.3.214; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; *WHO, 2000, T ROYAL SOC TROP S1, V94; World Health Organization, 2000, MAN CHILD SER INF SE; 1993, ADV PAED LIFE SUPPOR	30	112	114	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					995	999		10.1136/bmj.38408.471991.8F	http://dx.doi.org/10.1136/bmj.38408.471991.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15797893	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000228935100019
J	Royle, SJ; Bright, NA; Lagnado, L				Royle, SJ; Bright, NA; Lagnado, L			Clathrin is required for the function of the mitotic spindle	NATURE			English	Article							RECEPTOR TRAFFICKING; PROTEINS; KINETOCHORES; IDENTIFICATION; SEGREGATION; DYNAMICS; LINK	Clathrin has an established function in the generation of vesicles that transfer membrane and proteins around the cell(1-4). The formation of clathrin-coated vesicles occurs continuously in nondividing cells(5), but is shut down during mitosis(6), when clathrin concentrates at the spindle apparatus(7,8). Here, we show that clathrin stabilizes fibres of the mitotic spindle to aid congression of chromosomes. Clathrin bound to the spindle directly by the amino-terminal domain of clathrin heavy chain. Depletion of clathrin heavy chain using RNA interference prolonged mitosis; kinetochore fibres were destabilized, leading to defective congression of chromosomes to the metaphase plate and persistent activation of the spindle checkpoint. Normal mitosis was rescued by clathrin triskelia but not the N-terminal domain of clathrin heavy chain, indicating that stabilization of kinetochore fibres was dependent on the unique structure of clathrin. The importance of clathrin for normal mitosis may be relevant to understanding human cancers that involve gene fusions of clathrin heavy chain.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Royle, SJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sjr51@mrc-lmb.cam.ac.uk	Gimenez, Luis E Diaz/D-9291-2011	Royle, Stephen/0000-0001-8927-6967	Medical Research Council [U.1051.02.006(78794), MC_U105178794] Funding Source: Medline; MRC [MC_U105178794] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Bright NA, 1997, J CELL SCI, V110, P2027; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; HEPLER PK, 1970, J CELL BIOL, V45, P438, DOI 10.1083/jcb.45.2.438; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; KIRCHHAUSEN T, 1986, J ULTRA MOL STRUCT R, V94, P199, DOI 10.1016/0889-1605(86)90067-4; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; MARO B, 1985, J EMBRYOL EXP MORPH, V90, P287; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Waters JC, 1996, J CELL SCI, V109, P2823; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	30	194	198	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1152	1157		10.1038/nature03502	http://dx.doi.org/10.1038/nature03502			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858577	Green Accepted			2022-12-01	WOS:000228693300048
J	Kim, JH; Kim, B; Cai, L; Choi, HJ; Ohgi, KA; Tran, C; Chen, C; Chung, CH; Huber, O; Rose, DW; Sawyers, CL; Rosenfeld, MG; Baek, SH				Kim, JH; Kim, B; Cai, L; Choi, HJ; Ohgi, KA; Tran, C; Chen, C; Chung, CH; Huber, O; Rose, DW; Sawyers, CL; Rosenfeld, MG; Baek, SH			Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes	NATURE			English	Article							NF-KAPPA-B; PROSTATE-CANCER; RNA INTERFERENCE; TARGET; CELLS; TRANSFORMATION; PONTIN52; PROTEIN; GROWTH; COLON	Defining the molecular strategies that integrate diverse signalling pathways in the expression of specific gene programmes that are critical in homeostasis and disease remains a central issue in biology. This is particularly pertinent in cancer biology because downregulation of tumour metastasis suppressor genes is a common occurrence(1,2), and the underlying molecular mechanisms are not well established. Here we report that the downregulation of a metastasis suppressor gene, KAI1, in prostate cancer cells involves the inhibitory actions of beta-catenin, along with a reptin chromatin remodelling complex. This inhibitory function of beta-catenin - reptin requires both increased beta-catenin expression and recruitment of histone deacetylase activity. The coordinated actions of beta- catenin - reptin components that mediate the repressive state serve to antagonize a Tip60 coactivator complex(3-8) that is required for activation; the balance of these opposing complexes controls the expression of KAI1 and metastatic potential. The molecular mechanisms underlying the antagonistic regulation of b- catenin - reptin and the Tip60 coactivator complexes for the metastasis suppressor gene, KAI1, are likely to be prototypic of a selective downregulation strategy for many genes, including a subset of NF-kappa B target genes.	Seoul Natl Univ, Coll Nat Sci, Dept Sci Biol, Seoul 151742, South Korea; Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Med, Los Angeles, CA 90095 USA; Charite, Inst Clin Chem & Pathobiochem, D-12200 Berlin, Germany; Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Seoul National University (SNU); Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego	Baek, SH (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Sci Biol, Seoul 151742, South Korea.	mrosenfeld@ucsd.edu; sbaek@snu.ac.kr	Tran, Canh-Dung/D-4442-2011; Huber, Otmar/AAA-4548-2021; Sawyers, Charles/G-5327-2016	Tran, Canh-Dung/0000-0002-1011-4226; Huber, Otmar/0000-0003-4359-1747; 				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ALBINI A, 1987, CANCER RES, V47, P3239; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Dong JT, 1996, CANCER RES, V56, P4387; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feng Y, 2003, CANCER RES, V63, P8726; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; KOBAYASHI H, 1992, CANCER RES, V52, P3610; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Madrid Lee V, 2003, Methods Mol Biol, V223, P523; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; PETRYLAK DP, 1995, NAT MED, V1, P739, DOI 10.1038/nm0895-739; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Shevde LA, 2003, CANCER LETT, V198, P1, DOI 10.1016/S0304-3835(03)00304-5; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X	25	255	268	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					921	926		10.1038/nature03452	http://dx.doi.org/10.1038/nature03452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829968				2022-12-01	WOS:000228327600046
J	Sekijima, Y; Wiseman, RL; Matteson, J; Hammarstrom, P; Miller, SR; Sawkar, AR; Balch, WE; Kelly, JW				Sekijima, Y; Wiseman, RL; Matteson, J; Hammarstrom, P; Miller, SR; Sawkar, AR; Balch, WE; Kelly, JW			The biological and chemical basis for tissue-selective amyloid disease	CELL			English	Article							ENDOPLASMIC-RETICULUM; SECRETION EFFICIENCY; FIBRIL FORMATION; QUALITY-CONTROL; HUMAN LYSOZYME; HUNGARIAN-TYPE; TRANSTHYRETIN; PROTEIN; POLYNEUROPATHY; PLASMA	Factors controlling the onset and progression of extracellular amyloid diseases remain largely unknown. Central to disease etiology is the efficiency of the endoplasmic reticulum (ER) machinery that targets destabilized mutant proteins for degradation and the enhanced tendency of these variants to aggregate if secreted. We demonstrate that mammalian cells secrete numerous transthyretin (TTR) disease-assock ated variants with wild-type efficiency in spite of compromised folding energetics. Only the most highly destabilized TTR variants are subjected to ER-associated degradation (ERAD) and then only in certain tissues, providing insight into tissue selective amyloidosis. Rather than a "quality control" standard based on wild-type stability, we find that ER-assisted folding (ERAF), based on global protein energetics, determines the extent of export. We propose that ERAF (influenced by the energetics of the protein fold, chaperone enzyme distributions, and metabolite chaperones) in competition with ERAD defines the unique secretory aptitude of each tissue.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Balch, WE (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd,BCC506, La Jolla, CA 92037 USA.	webalch@scripps.edu; jkelly@scripps.edu		Hammarstrom, Per/0000-0001-5827-3587; Wiseman, Luke/0000-0001-9287-6840	NCRR NIH HHS [M01 RR00833] Funding Source: Medline; NIGMS NIH HHS [GM 43226] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDO Y, 1995, BIOCHEM BIOPH RES CO, V211, P354, DOI 10.1006/bbrc.1995.1820; Benson MD, 1996, AM J PATHOL, V148, P351; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; DICKSON PW, 1987, J BIOL CHEM, V262, P13907; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DWULET FE, 1983, BIOCHEM BIOPH RES CO, V114, P657, DOI 10.1016/0006-291X(83)90831-8; DWULET FE, 1984, P NATL ACAD SCI-BIOL, V81, P694, DOI 10.1073/pnas.81.3.694; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Garzuly F, 1996, NEUROLOGY, V47, P1562, DOI 10.1212/WNL.47.6.1562; Garzuly Ferenc, 1996, Orvosi Hetilap, V137, P2393; Gelman Marina S, 2003, Methods Mol Biol, V232, P27; Green NS, 2003, J AM CHEM SOC, V125, P13404, DOI 10.1021/ja030294z; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Harkany T, 2002, BRIT J DERMATOL, V146, P674, DOI 10.1046/j.1365-2133.2002.04594.x; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ikeda S, 2002, CLIN CHEM LAB MED, V40, P1257, DOI 10.1515/CCLM.2002.217; JACOBSON DR, 1992, HUM GENET, V89, P353; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; LaPointe P, 2004, MOL CELL, V14, P413, DOI 10.1016/S1097-2765(04)00267-9; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; OMURA F, 1991, EUR J BIOCHEM, V198, P477, DOI 10.1111/j.1432-1033.1991.tb16038.x; Plante-Bordeneuve V, 1998, NEUROLOGY, V51, P708, DOI 10.1212/WNL.51.3.708; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Spagnoli FM, 1998, J CELL BIOL, V143, P1101, DOI 10.1083/jcb.143.4.1101; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suhr OB, 2002, LIVER TRANSPLANT, V8, P787, DOI 10.1053/jlts.2002.34386; TANIYAMA Y, 1992, J BIOL CHEM, V267, P4619; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; WALLACE MR, 1986, J CLIN INVEST, V78, P6, DOI 10.1172/JCI112573; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	54	347	353	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					73	85		10.1016/j.cell.2005.01.018	http://dx.doi.org/10.1016/j.cell.2005.01.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820680	Bronze			2022-12-01	WOS:000228348500011
J	Koster, DA; Croquette, V; Dekker, C; Shuman, S; Dekker, NH				Koster, DA; Croquette, V; Dekker, C; Shuman, S; Dekker, NH			Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB	NATURE			English	Article							VACCINIA TOPOISOMERASE; DUPLEX DNA; ESCHERICHIA-COLI; MECHANISM; MOLECULE; PROTEIN; ELASTICITY; COVALENT; ROTATION; GYRASE	Topoisomerases relieve the torsional strain in DNA that is built up during replication and transcription. They are vital for cell proliferation(1-3) and are a target for poisoning by anti-cancer drugs(4,5). Type IB topoisomerase (TopIB) forms a protein clamp around the DNA duplex(6-8) and creates a transient nick that permits removal of supercoils. Using real-time single-molecule observation, we show that TopIB releases supercoils by a swivel mechanism that involves friction between the rotating DNA and the enzyme cavity: that is, the DNA does not freely rotate. Unlike a nicking enzyme, TopIB does not release all the supercoils at once, but it typically does so in multiple steps. The number of supercoils removed per step follows an exponential distribution. The enzyme is found to be torque-sensitive, as the mean number of supercoils per step increases with the torque stored in the DNA. We propose a model for topoisomerization in which the torque drives the DNA rotation over a rugged periodic energy landscape in which the topoisomerase has a small but quantifiable probability to religate the DNA once per turn.	Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; Ecole Normale Super, Lab Phys Stat, F-75005 Paris, France; Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Delft University of Technology; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Memorial Sloan Kettering Cancer Center	Dekker, NH (corresponding author), Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	nynke.dekker@mb.tn.tudelft.nl		Dekker, Nynke/0000-0003-4029-0973; Croquette, Vincent/0000-0003-1400-0039; Dekker, Cees/0000-0001-6273-071X				BROWN PO, 1981, P NATL ACAD SCI-BIOL, V78, P843, DOI 10.1073/pnas.78.2.843; BROWN PO, 1979, P NATL ACAD SCI USA, V76, P6110, DOI 10.1073/pnas.76.12.6110; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Carey JF, 2003, P NATL ACAD SCI USA, V100, P5640, DOI 10.1073/pnas.1031537100; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Dekker NH, 2002, P NATL ACAD SCI USA, V99, P12126, DOI 10.1073/pnas.132378799; KIM RA, 1989, J MOL BIOL, V208, P257, DOI 10.1016/0022-2836(89)90387-2; Krogh BO, 2000, BIOCHEMISTRY-US, V39, P6422, DOI 10.1021/bi000184u; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; Moroz JD, 1997, P NATL ACAD SCI USA, V94, P14418, DOI 10.1073/pnas.94.26.14418; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; RICE JA, 1988, MATH STAT DATA ANAL, P31; SEKIGUCHI J, 1994, NUCLEIC ACIDS RES, V22, P5360, DOI 10.1093/nar/22.24.5360; Sekiguchi J, 1996, EMBO J, V15, P3448, DOI 10.1002/j.1460-2075.1996.tb00711.x; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P31731; Shuman S, 1997, EMBO J, V16, P6584, DOI 10.1093/emboj/16.21.6584; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stivers JT, 1997, BIOCHEMISTRY-US, V36, P5212, DOI 10.1021/bi962880t; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100	29	244	252	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					671	674		10.1038/nature03395	http://dx.doi.org/10.1038/nature03395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800630				2022-12-01	WOS:000228011000051
J	Muratani, M; Kung, C; Shokat, KM; Tansey, WR				Muratani, M; Kung, C; Shokat, KM; Tansey, WR			The F box protein Dsg1/Mdm30 is a transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing	CELL			English	Article							UBIQUITIN-DEPENDENT PROTEOLYSIS; POLYMERASE-II TRANSCRIPTION; CARBOXY-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; ACTIVATE TRANSCRIPTION; PHOSPHORYLATED FORMS; CAPPING ENZYME; ELONGATION; KINASE; YEAST	We report here that the prototypical yeast transcription factor Gal4 undergoes two distinct modes of ubiquitin-mediated proteolysis: one that occurs independent of transcription and restricts Gal4 function, and another that is transcription coupled and essential for productive activation of Gal4 target genes. Destruction of transcriptionally active Gal4 depends on an F box protein called Dsgl/Mdm30. In the absence of Dsg1, Gal4 is stable, nonubiquitylated, and unable to productively stimulate transcription. Analysis of the phenotype of dsgl-nuil yeast reveals a striking disconnect between GAL gene RNA and protein levels; in the absence of Dsgl, Gal4 target genes are transcribed, but the resulting RNAs are not translated. The translational defects of these RNAs are related to defects in phosphorylation of the RNA polymerase 11 carboxy-terminal domain, which in turn affects recruitment of RNA processing machinery. We propose that Gal4 ubiquitylation and destruction are required for initiation-competent transcription complexes to transition to fully mature elongating complexes capable of appropriate mRNA processing.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Cold Spring Harbor Laboratory; University of California System; University of California San Francisco	Tansey, WR (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	tansey@cshl.edu	Muratani, Masafumi/A-6379-2011		NCI NIH HHS [CA13106] Funding Source: Medline; NIAID NIH HHS [AI044009] Funding Source: Medline; NIGMS NIH HHS [GM067728] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067728] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; BAILEY RB, 1984, MOL GEN GENET, V193, P507, DOI 10.1007/BF00382091; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Fritz S, 2003, MOL BIOL CELL, V14, P2303, DOI 10.1091/mbc.E02-12-0831; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Lutfiyya LL, 1998, GENETICS, V150, P1377; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; MYLIN LM, 1990, MOL CELL BIOL, V10, P4623, DOI 10.1128/MCB.10.9.4623; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; SADOWSKI I, 1991, P NATL ACAD SCI USA, V88, P10510, DOI 10.1073/pnas.88.23.10510; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; YAGLOM J, 1995, MOL CELL BIOL, V15, P731	45	139	142	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					887	899		10.1016/j.cell.2004.12.025	http://dx.doi.org/10.1016/j.cell.2004.12.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797387	Bronze			2022-12-01	WOS:000228067500016
J	Chandran, K; Sullivan, NJ; Felbor, U; Whelan, SP; Cunningham, JM				Chandran, K; Sullivan, NJ; Felbor, U; Whelan, SP; Cunningham, JM			Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection	SCIENCE			English	Article							ENVELOPE GLYCOPROTEIN; CATHEPSIN-B; INFLUENZA HEMAGGLUTININ; MEMBRANE-FUSION; INHIBITORS; CYSTEINE; ENTRY; PROTEINASES; CELLS; MICE	Ebola virus (EboV) causes rapidly fatal hemorrhagic fever in humans and there is currently no effective treatment. We found that the infection of African green monkey kidney (Vero) cells by vesicular stornatitis viruses bearing the EboV gtycoprotein (GP) requires the activity of endosomal cysteine proteases. Using selective protease inhibitors and protease-deficient cell lines, we identified an essential role for cathepsin B (CatB) and an accessory role for cathepsin L (CatL) in EboV GP-dependent entry. Biochemical studies demonstrate that CatB and CatL mediate entry by carrying out proteolysis of the EboV GP subunit GP1 and support a multistep mechanism that explains the relative contributions of these enzymes to infection. CatB and CatB/CatL inhibitors diminish the multiplication of infectious EboV-Zaire in cultured cells and may merit investigation as anti-EboV drugs.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Biozentrum, Inst Human Genet, D-97074 Wurzburg, Germany; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wurzburg; Harvard University; Harvard Medical School	Cunningham, JM (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jcunningham@rics.bwh.harvard.edu		Whelan, Sean/0000-0003-1564-8590	NIAID NIH HHS [R01 AI059371, R01 AI059371-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059371, Z01AI005082, Z01AI005081, Z01AI005079] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOULAY F, 1987, EMBO J, V6, P2643, DOI 10.1002/j.1460-2075.1987.tb02555.x; Chandran K, 2003, TRENDS MICROBIOL, V11, P374, DOI 10.1016/S0966-842X(03)00178-1; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; NIBERT ML, 1993, THESIS HARVARD U; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; SHAW E, 1994, METHOD ENZYMOL, V244, P649; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Turk B, 1997, BIOL CHEM, V378, P141; Volchkov VE, 1999, CURR TOP MICROBIOL, V235, P35; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Zhang T, 2000, IMMUNOLOGY, V100, P13, DOI 10.1046/j.1365-2567.2000.00000.x	25	629	670	0	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1643	1645		10.1126/science.1110656	http://dx.doi.org/10.1126/science.1110656			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15831716	Green Accepted			2022-12-01	WOS:000229827000062
J	Wright, SI; Bi, IV; Schroeder, SG; Yamasaki, M; Doebley, JF; McMullen, MD; Gaut, BS				Wright, SI; Bi, IV; Schroeder, SG; Yamasaki, M; Doebley, JF; McMullen, MD; Gaut, BS			The effects of artificial selection of the maize genome	SCIENCE			English	Article							MORPHOLOGICAL DIFFERENCES; DOMESTICATION; DIVERSITY; PATTERN; DEMOGRAPHY; GENETICS; TEOSINTE; MODELS	Domestication promotes rapid phenotypic evolution through artificial selection. We investigated the genetic history by which the wild grass teosinte (Zea mays ssp. parviglumis) was domesticated into modem maize (Z. mays ssp. mays). Analysis of single-nucleotide polymorphisms in 774 genes indicates that 2 to 4% of these genes experienced artificial selection. The remaining genes retain evidence of a population bottleneck associated with domestication. Candidate selected genes with putative function in plant growth are clustered near quantitative trait loci that contribute to phenotypic differences between maize and teosinte. If we assume that our sample of genes is representative, 1200 genes throughout the maize genome have been affected by artificial selection.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; York Univ, Dept Biol, N York, ON M3J 1P3, Canada; Univ Missouri, Dept Agron, Plant Sci Unit, Columbia, MO 65211 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; ARS, Plant Genet Res Unit, USDA, Columbia, MO 65211 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; York University - Canada; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Gaut, BS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	bgaut@uci.edu	Wright, Stephen I/C-3113-2008; Yamasaki, Masanori/C-5193-2018	Wright, Stephen I/0000-0001-9973-9697; Yamasaki, Masanori/0000-0001-7759-3965; Schroeder, Steven/0000-0001-9103-5150				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; BRESSANI R, 1958, CEREAL CHEM, V35, P227; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; DOEBLEY J, 1993, GENETICS, V134, P559; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Galtier N, 2000, GENETICS, V155, P981; Hilton H, 1998, GENETICS, V150, P863; Hudson RR, 2001, GENETICS, V159, P1805; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TAJIMA F, 1989, GENETICS, V123, P597; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Wall JD, 2002, GENETICS, V162, P203; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Zhang LQ, 2002, GENETICS, V162, P851	25	590	628	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1310	1314		10.1126/science.1107891	http://dx.doi.org/10.1126/science.1107891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919994				2022-12-01	WOS:000229482300048
J	Kaur, R				Kaur, R			Breast cancer	LANCET			English	Editorial Material									Int Union Canc UICC, Reach Recovery Int Global Breast Canc Support Net, Geneva, Switzerland		Kaur, R (corresponding author), Int Union Canc UICC, Reach Recovery Int Global Breast Canc Support Net, Geneva, Switzerland.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1742	1742		10.1016/S0140-6736(05)66547-6	http://dx.doi.org/10.1016/S0140-6736(05)66547-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894100				2022-12-01	WOS:000229082300025
J	Beral, V; Bull, D; Reeves, G				Beral, V; Bull, D; Reeves, G		Million Women Study Collaborators	Endometrial cancer and hormone-replacement therapy in the Million Women Study	LANCET			English	Article							ESTROGEN REPLACEMENT; RISK; PROGESTIN	Background Postmenopausal women who use hormone-replacement therapy (HRT) containing oestrogen alone are at increased risk of endometrial cancer. To minimise this risk, many HRT users who have not had a hysterectomy use combined oestrogen-progestagen preparations or tibolone. Limited information is available on the incidence of endometrial cancer in users of these therapies. Methods 716 738 postmenopausal women in the UK without previous cancer or previous hysterectomy were recruited into the Million Women Study in 1996-2001, provided information about their use of HRT and other personal details, and were followed up for an average of 3.4 years, during which time 1320 incident endometrial cancers were diagnosed. Findings 320 953 women (45%) reported at recruitment that they had used HRT, among whom 69 577 (22%) last used continuous combined therapy (progestagen added daily to oestrogen), 145 486 (45%) last used cyclic combined therapy (progestagen added to oestrogen, usually for 10-14 days per month), 28 028 (9%) last used tibolone, and 14 204 (4%) last used oestrogen-only HRT. These HRT types had sharply contrasting effects on the overall risk of endometrial cancer (p<0.0001 for heterogeneity). Compared with never users of HRT, risk was: reduced with last use of continuous combined preparations (relative risk 0.71 [95% Cl 0.56-0.90]; p=0.005); increased with last use of tibolone (1.79 [1.43-2.25]; p<0.0001) and oestrogen only (1.45 [1.02-2.06]; p=0.04); and not significantly altered with last use of cyclic combined preparations (1.05 [0.91-1.22]; p=0.5). A woman's body-mass index significantly affected these associations, such that the adverse effects of tibolone and oestrogen-only HRT were greatest in non-obese women, and the beneficial effects of combined HRT were greatest in obese women. Interpretation Oestrogens and tibolone increase the risk of endometrial cancer. Progestagens counteract the adverse effect of oestrogens on the endometrium, the effect being greater the more days every month that they are added to oestrogen and the more obese that women are. However, combined oestrogen-progestagen HRT causes a greater increase in breast cancer than the other therapies do. Thus, when endometrial and breast cancers are added together, there is a greater increase in total cancer incidence with use of combined HRT, both continuous and cyclic, than with use of the other therapies.	Radcliffe Infirm, Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Oxford OX2 6HE, England	Cancer Research UK; Radcliffe Infirmary; University of Oxford	Beral, V (corresponding author), Radcliffe Infirm, Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Gibson Bldg,Woodstock Rd, Oxford OX2 6HE, England.	secretariat@millionwomenstudy.org						Abbott S, 2002, BJOG-INT J OBSTET GY, V109, P1319; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; ARMITAGE M, 2004, MENOPAUSE HORMONE RE, P325; BAKKEN K, 2002, INT J CANCER, V112, P130; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2005, BJOG-INT J OBSTET GY, V112, P692, DOI 10.1111/j.1471-0528.2005.00541.x; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; BRINTON LA, 1993, OBSTET GYNECOL, V81, P265; de Vries CS, 2005, DRUG SAFETY, V28, P241, DOI 10.2165/00002018-200528030-00005; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Hill DA, 2000, AM J OBSTET GYNECOL, V183, P1456, DOI 10.1067/mob.2000.108081; *IARC, 1999, IARC MON EV CARC RIS, V72; JICK SS, 1993, EPIDEMIOLOGY, V4, P20, DOI 10.1097/00001648-199301000-00005; *JOINT FORM COMM, 1999, BRIT NAT FORM; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Lukanova A, 2004, INT J CANCER, V108, P425, DOI 10.1002/ijc.11529; *NAT STAT, 2003, CANC STAT REG CA MB1, V31; Newcomb PA, 2003, CANCER CAUSE CONTROL, V14, P195, DOI 10.1023/A:1023066304473; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; SIITERI PK, 1987, AM J CLIN NUTR, V45, P277, DOI 10.1093/ajcn/45.1.277; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Townsend P, 1988, HLTH DEPRIVATION INE; VOIGT LF, 1991, LANCET, V338, P274, DOI 10.1016/0140-6736(91)90417-N; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; World Health Organization, 1998, INT CLASS DIS; Yazigi R, 2004, GYNECOL ONCOL, V93, P568, DOI 10.1016/j.ygyno.2004.02.003; Zeleniuch-Jacquotte A, 2001, BRIT J CANCER, V84, P975, DOI 10.1054/bjoc.2001.1704	29	441	465	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1543	1551						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866308				2022-12-01	WOS:000228754800026
J	Dimmeler, S				Dimmeler, S			Platelet-derived growth factor CC - A clinically useful angiogenic factor at last?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PDGF		Univ Frankfurt, Dept Mol Cardiol, D-6000 Frankfurt, Germany	Goethe University Frankfurt	Dimmeler, S (corresponding author), Univ Frankfurt, Dept Mol Cardiol, D-6000 Frankfurt, Germany.			Dimmeler, Stefanie/0000-0002-1045-2436				Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Vincent L, 2004, CANCER CELL, V6, P307, DOI 10.1016/j.ccr.2004.09.024	5	22	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1815	1816		10.1056/NEJMcibr050670	http://dx.doi.org/10.1056/NEJMcibr050670			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858193				2022-12-01	WOS:000228689000015
J	McQueen, A				McQueen, A			"I think she's just crazy"	LANCET			English	Editorial Material									Childrens Hosp Boston, Emergency Dept, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	McQueen, A (corresponding author), Childrens Hosp Boston, Emergency Dept, Boston, MA 02115 USA.	Alisa.mcqueen@childrens.harvard.edu							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1513	1513		10.1016/S0140-6736(05)66424-0	http://dx.doi.org/10.1016/S0140-6736(05)66424-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850638				2022-12-01	WOS:000228651600032
J	Huey, RB; Ward, PD				Huey, RB; Ward, PD			Hypoxia, global warming, and terrestrial Late Permian extinctions	SCIENCE			English	Article							TRIASSIC BOUNDARY; KAROO BASIN; OXYGEN; VERTEBRATES; DIVERSITY; CYCLE; MODEL	A catastrophic extinction occurred at the end of the Permian Period. However, baseline extinction rates appear to have been elevated even before the final catastrophe, suggesting sustained environmental degradation. For terrestrial vertebrates during the Late Permian, the combination of a drop in atmospheric oxygen plus climate warming would have induced hypoxic stress and consequently compressed altitudinal ranges to near sea level. Our simulations suggest that the magnitude of altitudinal compression would have forced extinctions by reducing habitat diversity, fragmenting and isolating populations, and inducing a species-area effect. It also might have delayed ecosystem recovery after the mass extinction.	Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Huey, RB (corresponding author), Univ Washington, Dept Biol, Box 351800, Seattle, WA 98195 USA.	hueyrb@u.washington.edu	Huey, Raymond/F-1597-2010	Huey, Raymond/0000-0002-4962-8670				ANGIELCZYK K, COMMUNICATION; BATTISTI D, COMMUNICATION; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berner R., 2004, PHANEROZOIC CARBON C; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2002, P NATL ACAD SCI USA, V99, P4172, DOI 10.1073/pnas.032095199; Berner RA, 2001, GEOCHIM COSMOCHIM AC, V65, P685, DOI 10.1016/S0016-7037(00)00572-X; BERNER RA, IN PRESS GEOCHIM COS; Bouverot P., 1985, ADAPTATION ALTITUDE; Bowring SA, 1999, P NATL ACAD SCI USA, V96, P8827, DOI 10.1073/pnas.96.16.8827; Erwin D. H., 1993, GREAT PALEOZOIC CRIS; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; GASTON KJ, 2003, STRUCTURE DYNAMICS; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Greenlee KJ, 2004, J EXP BIOL, V207, P497, DOI 10.1242/jeb.00767; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; Hanski I. A., 1999, METAPOPULATION ECOLO; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kidder DL, 2004, PALAEOGEOGR PALAEOCL, V203, P207, DOI 10.1016/S0031-0182(03)00667-9; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Lasaga AC, 2002, GEOCHIM COSMOCHIM AC, V66, P361, DOI 10.1016/S0016-7037(01)00685-8; Rees PM, 2002, GEOLOGY, V30, P827; Retallack GJ, 2003, GEOL SOC AM BULL, V115, P1133, DOI 10.1130/B25215.1; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Sheldon ND, 2002, GEOLOGY, V30, P919, DOI 10.1130/0091-7613(2002)030<0919:LOLIET>2.0.CO;2; SIDOR CA, IN PRESS NATURE; Ward PD, 2005, SCIENCE, V307, P709, DOI 10.1126/science.1107068; Wignall PB, 1999, J GEOL SOC LONDON, V156, P453, DOI 10.1144/gsjgs.156.3.0453	34	166	190	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					398	401		10.1126/science.1108019	http://dx.doi.org/10.1126/science.1108019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831755				2022-12-01	WOS:000228492000048
J	Guber, C				Guber, C			Type 2 diabetes	LANCET			English	Editorial Material																		American Diabetes Association, 2003, AM DIAB ASS COMPL GU; [No title captured]	2	0	0	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1347	1347		10.1016/S0140-6736(05)61033-1	http://dx.doi.org/10.1016/S0140-6736(05)61033-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823386				2022-12-01	WOS:000228219600031
J	Kloer, DP; Ruch, S; Al-Babili, S; Beyer, P; Schulz, GE				Kloer, DP; Ruch, S; Al-Babili, S; Beyer, P; Schulz, GE			The structure of a retinal-forming carotenoid oxygenase	SCIENCE			English	Article							BETA-CAROTENE; OXIDATIVE CLEAVAGE; SUBSTRATE-SPECIFICITY; DIOXYGENASE; ENZYME; IDENTIFICATION; BIOSYNTHESIS; ARABIDOPSIS; PROTEIN; 15,15'-DIOXYGENASE	Enzymes that produce retinal and related apocarotenoids constitute a sequence- and thus structure-related family, a member of which was analyzed by x-ray diffraction. This member is an oxygenase and contains an Fe2+-4-His arrangement at the axis of a seven-bladed beta-propeller chain fold covered by a dome formed by six large loops. The Fe2+ is accessible through a long nonpolar tunnel that holds a carotenoid derivative in one of the crystals. on binding, three consecutive double bonds of this carotenoid changed from a straight all-trans to a cranked cis-trans-cis conformation. The remaining trans bond is located at the dioxygen-ligated Fe2+ and cleaved by oxygen.	Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Schulz, GE (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	georg.schulz@ocbc.uni-freiburg.de		Al-Babili, Salim/0000-0003-4823-2882	NATIONAL EYE INSTITUTE [R01EY020551] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barua AB, 2000, J NUTR, V130, P1996, DOI 10.1093/jn/130.8.1996; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouvier F, 2003, SCIENCE, V300, P2089, DOI 10.1126/science.1085162; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Camara B, 2004, ARCH BIOCHEM BIOPHYS, V430, P16, DOI 10.1016/j.abb.2004.06.028; DellaPenna D, 1999, SCIENCE, V285, P375, DOI 10.1126/science.285.5426.375; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kajander T, 2002, STRUCTURE, V10, P483, DOI 10.1016/S0969-2126(02)00744-X; Kato T, 2003, J SURFACTANTS DETERG, V6, P331, DOI 10.1007/s11743-003-0278-x; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Lancaster CRD, 1999, J MOL BIOL, V286, P883, DOI 10.1006/jmbi.1998.2532; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; MOLNAR P, 1997, J CHEM RES, V5, P120; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Woggon WD, 2002, PURE APPL CHEM, V74, P1397, DOI 10.1351/pac200274081397; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	32	207	216	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					267	269		10.1126/science.1108965	http://dx.doi.org/10.1126/science.1108965			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821095				2022-12-01	WOS:000228273700058
J	Chapman, T				Chapman, T			Small-scale separation	NATURE			English	Article																			0	23	25	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					795	795		10.1038/434795b	http://dx.doi.org/10.1038/434795b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815637	Bronze			2022-12-01	WOS:000228160700050
J	Kimball, AM; Thant, M				Kimball, AM; Thant, M			"What, me worry?" Businesses and AIDS at Davos	LANCET			English	Editorial Material									Univ Washington, Sch Publ Hlth, Hlth Serv, Seattle, WA 98195 USA; Asian Dev Bank, Manila, Philippines	University of Washington; University of Washington Seattle; Asian Development Bank	Kimball, AM (corresponding author), Univ Washington, Sch Publ Hlth, Hlth Serv, Seattle, WA 98195 USA.	akimball@u.washington.edu		Thant, Myo/0000-0002-3696-5977				Arora P, 2004, CAN MED ASSOC J, V171, P1337, DOI 10.1503/cmaj.045032; BLOOM D, 2005, WORLD EC FOR DAV; Brooks RA, 2004, AIDS CARE, V16, P756, DOI 10.1080/09540120412331269594; *GLOB BUS COAL HIV, 2005, MIN HLTH GLOB BUS CO; Kimball AM, 1996, LANCET, V347, P1670, DOI 10.1016/S0140-6736(96)91493-2; NAGELKERKE JD, 2002, B WORLD HEALTH ORGAN, V8, P89; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; *UNAIDS, 2004, FACT SHEET AS; 2004, LANCET, V364, P909	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 2	2005	365	9466					1213	1215		10.1016/S0140-6736(05)74792-9	http://dx.doi.org/10.1016/S0140-6736(05)74792-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811442	Green Published, Bronze			2022-12-01	WOS:000228107600009
J	Stanton, H; Rogerson, FM; East, CJ; Golub, SB; Lawlor, KE; Meeker, CT; Little, CB; Last, K; Farmer, PJ; Campbell, IK; Fourie, AM; Fosang, AJ				Stanton, H; Rogerson, FM; East, CJ; Golub, SB; Lawlor, KE; Meeker, CT; Little, CB; Last, K; Farmer, PJ; Campbell, IK; Fourie, AM; Fosang, AJ			ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro	NATURE			English	Article							ANTIGEN-INDUCED ARTHRITIS; EXPRESSION; GENE; METALLOPROTEINASE; INTERLEUKIN-1; CHONDROCYTES; PROTEIN; CLONING; FAMILY; MICE	Aggrecan is the major proteoglycan in cartilage, endowing this tissue with the unique capacity to bear load and resist compression. In arthritic cartilage, aggrecan is degraded by one or more 'aggrecanases' from the ADAMTS ( a disintegrin and metalloproteinase with thrombospondin motifs(1)) family of proteinases. ADAMTS1, 8 and 9 have weak aggrecan-degrading activity(2-5). However, they are not thought to be the primary aggrecanases because ADAMTS1 null mice are not protected from experimental arthritis(6), and cleavage by ADAMTS8 and 9 is highly inefficient. Although ADAMTS4 and 5 are expressed in joint tissues(7-13), and are known to be efficient aggrecanases in vitro, the exact contribution of these two enzymes to cartilage pathology is unknown. Here we show that ADAMTS5 is the major aggrecanase in mouse cartilage, both in vitro and in a mouse model of inflammatory arthritis. Our data suggest that ADAMTS5 may be a suitable target for the development of new drugs designed to inhibit cartilage destruction in arthritis, although further work will be required to determine whether ADAMTS5 is also the major aggrecanase in human arthritis.	Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Surg, Parkville, Vic 3052, Australia; Univ Sydney, Royal N Shore Hosp, Raymond Purves Bone & Joint Res Labs, St Leonards, NSW 2065, Australia; Walter & Eliza Hall Inst Med Res, Reid Rheumatol Lab, Parkville, Vic 3052, Australia; Johnson & Johnson Pharmaceut Res & Dev, San Diego, CA 92121 USA	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal North Shore Hospital; University of Sydney; Walter & Eliza Hall Institute; Johnson & Johnson; Johnson & Johnson USA	Fosang, AJ (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	amanda.fosang@mcri.edu.au	Little, Christopher B/A-9280-2015	Little, Christopher B/0000-0002-0353-7634; Last, Karena/0000-0002-4396-8404; STANTON, HEATHER/0000-0002-3427-5614; Fosang, Amanda/0000-0002-5523-5427; Lawlor, Kate/0000-0003-0471-6842				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Ilic MZ, 2000, MATRIX BIOL, V19, P257, DOI 10.1016/S0945-053X(00)00069-X; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; LITTLE CB, IN PRESS ARTHRITIS R; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mould AW, 2003, ARTHRITIS RHEUM-US, V48, P2660, DOI 10.1002/art.11232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RODRIGUEZMANZANEQU, 2002, BIOCHEM BIOPH RES CO, V293, P501; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; van Meurs JBJ, 1998, ARTHRITIS RHEUM, V41, P647, DOI 10.1002/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T; van Meurs JBJ, 1999, ANN RHEUM DIS, V58, P350, DOI 10.1136/ard.58.6.350; van Meurs JBJ, 1999, ARTHRITIS RHEUM, V42, P1128, DOI 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405	24	701	739	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2005	434	7033					648	652		10.1038/nature03417	http://dx.doi.org/10.1038/nature03417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800625				2022-12-01	WOS:000228011000046
J	Huffard, CL; Boneka, F; Full, RJ				Huffard, CL; Boneka, F; Full, RJ			Underwater bipedal locomotion by octopuses in disguise	SCIENCE			English	Article							PATTERNS		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Sam Ratulangi, Dept Fisheries & Marine Sci, Manado, North Sulawesi, Indonesia	University of California System; University of California Berkeley; Universitas Sam Ratulangi	Huffard, CL (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	chuffard@berkeley.edu						Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Mather JA, 1998, J COMP PSYCHOL, V112, P306, DOI 10.1037/0735-7036.112.3.306; PACKARD A, 1971, ANIM BEHAV, V19, P780, DOI 10.1016/S0003-3472(71)80181-1; Steinbeck J, 2000, CANNERY ROW; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Vaughan CL, 2003, J BIOMECH, V36, P513, DOI 10.1016/S0021-9290(02)00419-0	8	62	64	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2005	307	5717					1927	1927		10.1126/science.1109616	http://dx.doi.org/10.1126/science.1109616			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790846				2022-12-01	WOS:000227957300047
J	Lange, S; Xiang, FQ; Yakovenko, A; Vihola, A; Hackman, P; Rostkova, E; Kristensen, J; Brandmeier, B; Franzen, G; Hedberg, B; Gunnarsson, LG; Hughes, SM; Marchand, S; Sejersen, T; Richard, I; Edstrom, L; Ehler, E; Udd, B; Gautel, M				Lange, S; Xiang, FQ; Yakovenko, A; Vihola, A; Hackman, P; Rostkova, E; Kristensen, J; Brandmeier, B; Franzen, G; Hedberg, B; Gunnarsson, LG; Hughes, SM; Marchand, S; Sejersen, T; Richard, I; Edstrom, L; Ehler, E; Udd, B; Gautel, M			The kinase domain of titin controls muscle gene expression and protein turnover	SCIENCE			English	Article							SERUM RESPONSE FACTOR; M-BAND; IDENTIFICATION; INACTIVATION; ACTIVATION; MYOMESIN; DYNAMICS; MYOPATHY; DELETION; FAMILY	The giant sarcomeric protein titin contains a protein kinase domain (TK) ideally positioned to sense mechanical load. We identified a signaling complex where TK interacts with the zinc-finger protein nbr1 through a mechanically inducible conformation. Nbr1 targets the ubiquitin-associated p62/SQSTM1 to sarcomeres, and p62 in turn interacts with MuRF2, a muscle-specific RING-B-box E3 ligase and ligand of the transactivation domain of the serum response transcription factor (SRF). Nuclear translocation of MuRF2 was induced by mechanical inactivity and caused reduction of nuclear SRF and repression of transcription. A human mutation in the titin,protein kinase domain causes hereditary muscle disease by disrupting this pathway.	Univ Helsinki, Folkhalsen Inst Genet, Biomedicum, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, Biomedicum, FIN-00290 Helsinki, Finland; Kings Coll London, Randall Div, London SE1 1UL, England; Kings Coll London, Div Cardiovasc, London SE1 1UL, England; ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland; Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, S-17176 Stockholm, Sweden; Orebro Univ Hosp, Dept Environm Med, S-70185 Orebro, Sweden; Genethon, CNRS, UMR 8115, F-91000 Evry, France; Astrid Lindgren Childrens Hosp, Dept Woman & Child Hlth, Neuropediat Unit, S-17176 Stockholm, Sweden; Vasa Cent Hosp, Dept Neurol, Vaasa 65130, Finland; Tampere Univ Hosp, Dept Neurol, Tampere 33520, Finland	University of Helsinki; University of Helsinki; University of London; King's College London; University of London; King's College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet; Karolinska University Hospital; Orebro University; Centre National de la Recherche Scientifique (CNRS); Vaasa Central Hospital; Tampere University; Tampere University Hospital	Gautel, M (corresponding author), Univ Helsinki, Folkhalsen Inst Genet, Biomedicum, FIN-00290 Helsinki, Finland.	Bjarne.Udd@vshp.fi; mathias.gautel@kcl.ac.uk	Richard, isabelle/J-8298-2013; Lange, Stephan/A-1422-2010; Gautel, Mathias/AAB-9860-2019; Hughes, Simon M/S-1073-2016	Lange, Stephan/0000-0001-9361-6602; Hughes, Simon M/0000-0001-8227-9225; Gautel, Mathias/0000-0003-4027-9803; Ehler, Elisabeth/0000-0001-5646-5964; Xiang, Fengqing/0000-0003-0892-1536; Sejersen, Thomas/0000-0001-5961-7097	British Heart Foundation [PG/03/049/15364] Funding Source: Medline; Medical Research Council [G0300213, G0200496(63216)] Funding Source: Medline; MRC [G0300213] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarkova I, 2003, J MUSCLE RES CELL M, V24, P191, DOI 10.1023/A:1026094924677; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Dai KS, 2001, J BIOL CHEM, V276, P23992, DOI 10.1074/jbc.M011208200; EDSTROM L, 1990, J NEUROL SCI, V96, P211, DOI 10.1016/0022-510X(90)90134-9; Fuller SJ, 1998, J BIOL CHEM, V273, P18146, DOI 10.1074/jbc.273.29.18146; Gautel M, 1999, REV PHYSIOL BIOCH P, V138, P97, DOI 10.1007/BF02346661; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; GOTTHARDT M, 2002, J BIOL CHEM, V2, P2; Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liang PQ, 1997, J BIOL CHEM, V272, P28050, DOI 10.1074/jbc.272.44.28050; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; MCETHINNY MS, 2002, J CELL BIOL, V157, P125; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miller G, 2003, J CELL SCI, V116, P4811, DOI 10.1242/jcs.00768; Nicolao P, 1999, AM J HUM GENET, V64, P788, DOI 10.1086/302281; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Pridgeon Julia W., 2003, Biol Proced Online, V5, P228, DOI 10.1251/bpo66; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Steiner F, 1999, GENOMICS, V56, P78, DOI 10.1006/geno.1998.5682; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; van der Ven PFM, 2000, J CELL SCI, V113, P1405	32	420	440	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1599	1603		10.1126/science.1110463	http://dx.doi.org/10.1126/science.1110463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15802564				2022-12-01	WOS:000229827000048
J	Yudkin, JS; Eringa, E; Stehouwer, CDA				Yudkin, JS; Eringa, E; Stehouwer, CDA			"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease	LANCET			English	Article							EPICARDIAL ADIPOSE-TISSUE; HUMAN SKELETAL-MUSCLE; CAPILLARY RECRUITMENT; NITRIC-OXIDE; PHYSIOLOGICAL HYPERINSULINEMIA; PROTEIN; SENSITIVITY; SYNTHASE; OBESITY; ALPHA	Adipose tissue expresses cytokines that inhibit insulin signalling pathways in liver and muscle. Obesity also results in impairment of endothelium-dependent vasodilatation in response to insulin. We propose a vasoregulatory role for local deposits of fat around the origin of arterioles supplying skeletal muscle. Isolated first-order arterioles from rat cremaster muscle are under dual regulation by insulin, which activates both endothelin-1 mediated vasoconstriction and nitric-oxide-mediated vasodilatation. In obese rat arterioles, insulin-stimulated NO synthesis is impaired, resulting in unopposed vasoconstriction. We propose that this vasoconstriction is the consequence of production of the adipocytokine tumour necrosis factor alpha from the cuff of fat seen surrounding the origin of the arteriole in obese rats-a depot to which we ascribe a specialist vasoregulatory role. We suggest that this cytokine accesses the nutritive vascular tree to inhibit insulin-mediated capillary recruitment-a mechanism we term "vasocrine" signalling. We also suggest a homology between this vasoactive periarteriolar fat and both periarterial and visceral fat, which may explain relations between visceral fat, insulin resistance, and vascular disease.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Diabet & Cardiovasc Dis Acad Unit, London N19 5LW, England; Vrije Univ Amsterdam, Inst Cardiovasc Res, Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Amsterdam, Netherlands; Univ Limburg, Acad Hosp Maastricht, Maastricht, Netherlands; Univ Maastricht, Maastricht, Netherlands	University of London; University College London; UCL Medical School; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Yudkin, JS (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Diabet & Cardiovasc Dis Acad Unit, Archway Campus,Holborn Union Bldg,2-10 Highgate H, London N19 5LW, England.	j.yudkin@ucl.ac.uk	Stehouwer, Coen/AAB-3435-2021; Eringa, Ed/ABA-3194-2021; Yudkin, John S/C-1988-2008	Eringa, Etto/0000-0002-9814-5149; Stehouwer, Coen/0000-0001-8752-3223				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Arner P, 2001, BIOCHEM SOC T, V29, P72, DOI 10.1042/bst0290072; BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; Coggins M, 2001, DIABETES, V50, P2682, DOI 10.2337/diabetes.50.12.2682; DAVDA RK, 1995, HYPERTENSION, V26, P764, DOI 10.1161/01.HYP.26.5.764; Eringa EC, 2004, AM J PHYSIOL-HEART C, V287, pH2043, DOI 10.1152/ajpheart.00067.2004; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GREENE AS, 1989, AM J PHYSIOL, V256, P126; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; MOHAMED F, 1995, ARTERIOSCL THROM VAS, V15, P52, DOI 10.1161/01.ATV.15.1.52; Newman JMB, 1997, MICROVASC RES, V54, P49, DOI 10.1006/mvre.1997.2021; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rattigan S, 1997, DIABETES, V46, P1381, DOI 10.2337/diabetes.46.9.1381; Schechter AN, 2003, NEW ENGL J MED, V348, P1483, DOI 10.1056/NEJMcibr023045; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Serne EH, 2002, DIABETES, V51, P1515, DOI 10.2337/diabetes.51.5.1515; Wallis MG, 2002, DIABETES, V51, P3492, DOI 10.2337/diabetes.51.12.3492; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zhang L, 2004, DIABETES, V53, P447, DOI 10.2337/diabetes.53.2.447; Zhang L, 2003, AM J PHYSIOL-ENDOC M, V285, pE654, DOI 10.1152/ajpendo.00119.2003	22	409	429	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 21	2005	365	9473					1817	1820		10.1016/S0140-6736(05)66585-3	http://dx.doi.org/10.1016/S0140-6736(05)66585-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	928SI	15910955				2022-12-01	WOS:000229291600027
J	Okada, Y; Takeda, S; Tanaka, Y; Belmonte, JCI; Hirokawa, N				Okada, Y; Takeda, S; Tanaka, Y; Belmonte, JCI; Hirokawa, N			Mechanism of nodal flow: A conserved symmetry breaking event in left-right axis determination	CELL			English	Article							LEFT-RIGHT ASYMMETRY; ZEBRAFISH; MICE; MICROTUBULE; EXPRESSION; MONOCILIA; FLUID	The leftward flow in extraembryonic fluid is critical for the initial determination of the left-right axis of mouse embryos. It is unclear if this is a conserved mechanism among other vertebrates and how the directionality of the flow arises from the motion of cilia. In this paper, we show that rabbit and medakafish embryos also exhibit a leftward fluid flow in their ventral nodes. In all cases, primary monocilia present a clockwise rotational-like motion. Observations of defective ciliary dynamics in mutant mouse embryos support the idea that the posterior tilt of the cilia during rotational-like beating can explain the leftward fluid flow. Moreover, we show that this leftward flow may produce asymmetric distribution of exogenously introduced proteins, suggesting morphogen gradients as a subsequent mechanism of left-right axis determination. Finally, we experimentally and theoretically characterize under which conditions a morphogen gradient can arise from the flow.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of Tokyo; Salk Institute	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Takeda, Sen/I-8462-2012; Okada, Yasushi/N-5067-2015	Takeda, Sen/0000-0001-7090-2139; Okada, Yasushi/0000-0003-2601-3689; Tanaka, Yosuke/0000-0001-5376-5726				Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Bellomo D, 1996, DEV DYNAM, V205, P471, DOI 10.1002/(SICI)1097-0177(199604)205:4<471::AID-AJA10>3.0.CO;2-4; Bisgrove BW, 2001, AM J MED GENET, V101, P315, DOI 10.1002/ajmg.1180; BLAKE JR, 1974, BIOL REV, V49, P85, DOI 10.1111/j.1469-185X.1974.tb01299.x; BROWN NA, 1990, DEVELOPMENT, V109, P1; Cartwright JHE, 2004, P NATL ACAD SCI USA, V101, P7234, DOI 10.1073/pnas.0402001101; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fanto M, 2004, J CELL SCI, V117, P527, DOI 10.1242/jcs.00973; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; NAKATA T, 1993, BIOPHYS J, V65, P2504, DOI 10.1016/S0006-3495(93)81304-3; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Supp DM, 1999, DEVELOPMENT, V126, P5495; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TAKEDA S, 1995, NEURON, V14, P1257, DOI 10.1016/0896-6273(95)90272-4; Vogan KJ, 1999, NATURE, V397, P295, DOI 10.1038/16796; Wargo MJ, 2003, P NATL ACAD SCI USA, V100, P137, DOI 10.1073/pnas.0135800100; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; YASUMASU S, 1992, DEV BIOL, V153, P250, DOI 10.1016/0012-1606(92)90110-3	25	333	344	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					633	644		10.1016/j.cell.2005.04.008	http://dx.doi.org/10.1016/j.cell.2005.04.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907475	Bronze			2022-12-01	WOS:000229331200018
J	Wang, XQ; Lu, T; Snider, RK; Liang, L				Wang, XQ; Lu, T; Snider, RK; Liang, L			Sustained firing in auditory cortex evoked by preferred stimuli	NATURE			English	Article							COMMUNICATION SOUNDS; CORTICAL-NEURONS; RESPONSES; REPRESENTATION; CAT; NOISE; ANESTHESIA; AMPLITUDE; PRIMATES; MONKEYS	It has been well documented that neurons in the auditory cortex of anaesthetized animals generally display transient responses to acoustic stimulation, and typically respond to a brief stimulus with one or fewer action potentials(1-5). The number of action potentials evoked by each stimulus usually does not increase with increasing stimulus duration(1,5-7). Such observations have long puzzled researchers across disciplines and raised serious questions regarding the role of the auditory cortex in encoding ongoing acoustic signals. Contrary to these long-held views, here we show that single neurons in both primary ( area A1) and lateral belt areas of the auditory cortex of awake marmoset monkeys ( Callithrix jacchus) are capable of firing in a sustained manner over a prolonged period of time, especially when they are driven by their preferred stimuli. In contrast, responses become more transient or phasic when auditory cortex neurons respond to non-preferred stimuli. These findings suggest that when the auditory cortex is stimulated by a sound, a particular population of neurons fire maximally throughout the duration of the sound. Responses of other, less optimally driven neurons fade away quickly after stimulus onset. This results in a selective representation of the sound across both neuronal population and time.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA	Johns Hopkins University	Wang, XQ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA.	xwang@bme.jhu.edu						AITKIN LM, 1986, J COMP NEUROL, V252, P175, DOI 10.1002/cne.902520204; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bieser A, 1996, EXP BRAIN RES, V108, P273; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Eggermont JJ, 1997, NEUROREPORT, V8, P2709, DOI 10.1097/00001756-199708180-00014; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Heil P, 1997, J NEUROPHYSIOL, V77, P2642, DOI 10.1152/jn.1997.77.5.2642; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lu T, 2004, J NEUROPHYSIOL, V91, P301, DOI 10.1152/jn.00022.2003; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; Mickey BJ, 2003, J NEUROSCI, V23, P8649; PFINGST BE, 1981, J NEUROPHYSIOL, V45, P16, DOI 10.1152/jn.1981.45.1.16; PHILLIPS DP, 1985, HEARING RES, V19, P253, DOI 10.1016/0378-5955(85)90145-5; PHILLIPS DP, 1993, ANN NY ACAD SCI, V682, P104, DOI 10.1111/j.1749-6632.1993.tb22963.x; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; RHODE WS, 1986, J NEUROPHYSIOL, V56, P261, DOI 10.1152/jn.1986.56.2.261; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SUGA N, 1989, J EXP BIOL, V146, P277; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	30	274	278	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					341	346		10.1038/nature03565	http://dx.doi.org/10.1038/nature03565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902257				2022-12-01	WOS:000229185000045
J	Hallenbeck, J				Hallenbeck, J			Palliative care in the final days of life - "They were expecting it at any time"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ILL CANCER-PATIENTS; LAST 48 HOURS; END-OF-LIFE; TERMINALLY-ILL; CULTURAL CONSIDERATIONS; HOSPITALIZED-PATIENTS; CONTROLLED-TRIAL; UNITED-STATES; DEATH RATTLE; BAD-NEWS	Providing care to actively dying patients presents unique challenges for the clinician. Patients, in their final days require careful symptom management. Families need support and coaching as death approaches. Care does not end with the death of the patient but continues through death pronouncement, family notification of the death, discussion of autopsy, and immediate bereavement support. Skills in these and related areas are discussed in the context of one man's death, as illuminated by comments made after death by his daughter and his physician. This case also highlights the often differing perspectives of families and clinicians as they work to deal with a patient's death. A goal of mastering the palliative skills necessary to competently care for an actively dying patient is to enable a patient to die peacefully and relatively free of discomfort. Achieving such competency should also help to relieve clinician stress attendant to caring for dying patients.	Stanford Univ, Sch Med, VA Palto Alto HCS, Palo Alto, CA 94304 USA	Stanford University	Hallenbeck, J (corresponding author), Stanford Univ, Sch Med, VA Palto Alto HCS, 1002C,3801 Miranda Ave, Palo Alto, CA 94304 USA.	james.hallenbeck@med.va.gov						Back IN, 2001, PALLIATIVE MED, V15, P329, DOI 10.1191/026921601678320313; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Breitbart W, 2002, PSYCHOSOMATICS, V43, P183, DOI 10.1176/appi.psy.43.3.183; Breitbart W, 2000, CLIN GERIATR MED, V16, P357, DOI 10.1016/S0749-0690(05)70061-6; Bruera E, 1990, J Pain Symptom Manage, V5, P341, DOI 10.1016/0885-3924(90)90027-H; Byock I., 1997, DYING WELL; BYOCK IR, 2004, 4 THINS MATTER MOST; Campbell ML, 2004, CRIT CARE CLIN, V20, P403, DOI 10.1016/j.ccc.2004.03.015; Chandler S, 1999, Am J Hosp Palliat Care, V16, P418, DOI 10.1177/104990919901600113; CHERNY NJ, 1995, CANCER-AM CANCER SOC, V76, P1283, DOI 10.1002/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0; Christakis Nicholas A., 1999, DEATH FORETOLD PROPH; Conill C, 1997, J PAIN SYMPTOM MANAG, V14, P328, DOI 10.1016/S0885-3924(97)00263-7; COYLE N, 1990, J PAIN SYMPTOM MANAG, V5, P83; Dalal Shalini, 2004, J Support Oncol, V2, P467; Ellershaw J, 2001, J PAIN SYMPTOM MANAG, V21, P12, DOI 10.1016/S0885-3924(00)00240-2; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; FAINSINGER R, 1991, J PALLIATIVE CARE, V7, P5; FAINSINGER RL, 1998, TOPICS PALLIATIVE CA, V4, P261; Hall P, 2002, J AM GERIATR SOC, V50, P501, DOI 10.1046/j.1532-5415.2002.50117.x; Hallenbeck J, 1996, CLIN GERIATR MED, V12, P393; Hallenbeck J, 1999, GENERATIONS, V23, P24; HALLENBECK J, 2002, PRINCIPLES PRACTICE, P661; HALLENBECK J, END OF LIFE CARE CUR; Hallenbeck J. L., 2003, PALLIATIVE CARE PERS; Herndon CM, 2001, J PAIN SYMPTOM MANAG, V22, P1027, DOI 10.1016/S0885-3924(01)00365-7; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KOENIG BA, 1997, APPROACHING DEATH IM; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Lichter I, 1990, J Palliat Care, V6, P7; Lo RSK, 2002, J PAIN SYMPTOM MANAG, V24, P388, DOI 10.1016/S0885-3924(02)00504-3; LYNN J, 1999, HDB MORTALS GUIDANCE; Marchand Lucille, 2004, J Palliat Med, V7, P80, DOI 10.1089/109662104322737322; Mazzocato C, 1999, ANN ONCOL, V10, P1511, DOI 10.1023/A:1008337624200; McPhee SJ, 1996, ARCH PATHOL LAB MED, V120, P743; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; MENKIN E, 2000, WRITING CONDOLENCE L; Morita T, 2004, ANN ONCOL, V15, P1551, DOI 10.1093/annonc/mdh386; Morita T, 2004, PSYCHOSOMATICS, V45, P107, DOI 10.1176/appi.psy.45.2.107; Morita T, 2002, J PAIN SYMPTOM MANAG, V24, P447, DOI 10.1016/S0885-3924(02)00499-2; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Morita T, 1998, Am J Hosp Palliat Care, V15, P217, DOI 10.1177/104990919801500407; ONeill B, 1997, BRIT MED J, V315, P801, DOI 10.1136/bmj.315.7111.801; Penson R T, 2000, Oncologist, V5, P425; PICKETT M, 1993, CANCER NURS, V16, P102; Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369; Puchalski Christina M, 2002, J Palliat Med, V5, P289, DOI 10.1089/109662102753641287; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; Rando T. A., 1993, TREATMENT COMPLICATE; ROUSSEAU P, 2003, J PALLIAT MED, V4, P255; SCHNEIDERMAN H, 1985, POSTGRAD MED, V77, P153, DOI 10.1080/00325481.1985.11698924; Sinard JH, 2001, EXP MOL PATHOL, V70, P333, DOI 10.1006/exmp.2001.2371; STEINHAUSER KE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI DOI 10.1001/JAMA.284.19.2476; STOREY P, 1998, PRINCIPLES PRACTICE, P741; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Vandekieft GK, 2001, AM FAM PHYSICIAN, V64, P1975; Ventafridda V, 1990, J Palliat Care, V6, P7; Wildiers H, 2002, J PAIN SYMPTOM MANAG, V23, P310, DOI 10.1016/S0885-3924(01)00421-3; Zeitlin SV, 2001, PRIMARY CARE, V28, P415, DOI 10.1016/S0095-4543(05)70031-2	60	28	29	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2265	2271		10.1001/jama.293.18.2265	http://dx.doi.org/10.1001/jama.293.18.2265			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	924LU	15886382				2022-12-01	WOS:000228981100028
J	Ye, XQ; Hama, K; Contos, JJA; Anliker, B; Inoue, A; Skinner, MK; Suzuki, H; Amano, T; Kennedy, G; Arai, H; Aoki, J; Chun, J				Ye, XQ; Hama, K; Contos, JJA; Anliker, B; Inoue, A; Skinner, MK; Suzuki, H; Amano, T; Kennedy, G; Arai, H; Aoki, J; Chun, J			LPA(3)-mediated lysophosphatidic acid signalling in embryo implantation and spacing	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; OBVIOUS PHENOTYPIC ABNORMALITY; MOUSE UTERUS; MICE LACKING; EXPRESSION; INITIATION; PREGNANCY; DEFICITS; CELLS; GENE	Every successful pregnancy requires proper embryo implantation. Low implantation rate is a major problem during infertility treatments using assisted reproductive technologies(1). Here we report a newly discovered molecular influence on implantation through the lysophosphatidic acid (LPA) receptor LPA(3) (refs 2 - 4). Targeted deletion of LPA(3) in mice resulted in significantly reduced litter size, which could be attributed to delayed implantation and altered embryo spacing. These two events led to delayed embryonic development, hypertrophic placentas shared by multiple embryos and embryonic death. An enzyme demonstrated to influence implantation, cyclooxygenase 2 (COX2) (ref. 5), was downregulated in LPA(3)-deficient uteri during preimplantation. Downregulation of COX2 led to reduced levels of prostaglandins E-2 and I-2 (PGE(2) and PGI(2)), which are critical for implantation(1). Exogenous administration of PGE(2) or carbaprostacyclin ( a stable analogue of PGI(2)) into LPA(3)-deficient female mice rescued delayed implantation but did not rescue defects in embryo spacing. These data identify LPA(3) receptor-mediated signalling as having an influence on implantation, and further indicate linkage between LPA signalling and prostaglandin biosynthesis.	Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child & Adolescent Neuropsychiat D, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Dev Med Technol Sankyo, Bunkyo Ku, Tokyo 1130033, Japan; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	Scripps Research Institute; University of Tokyo; University of Tokyo; Fred Hutchinson Cancer Center; Washington State University; Obihiro University of Agriculture & Veterinary Medicine	Chun, J (corresponding author), Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child & Adolescent Neuropsychiat D, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@scripps.edu	Chun, Jerold/Y-4670-2019; Kennedy, Grace/GRS-1071-2022	Aoki, Junken/0000-0001-9435-1896	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001723] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH001723] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Cleary-Goldman J, 2004, OBSTET GYNECOL SURV, V59, P285, DOI 10.1097/01.OGX.0000120165.52159.04; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Daniel Y, 2000, FERTIL STERIL, V74, P683, DOI 10.1016/S0015-0282(00)01491-6; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Frenkian M, 2001, PROSTAG OTH LIPID M, V65, P11, DOI 10.1016/S0090-6980(01)00116-2; Gabardi Steven, 2004, Prog Transplant, V14, P148; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; KENNEDY TG, 1977, BIOL REPROD, V16, P286, DOI 10.1095/biolreprod16.3.286; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kinoshita K, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P605; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Paria BC, 2001, INT J DEV BIOL, V45, P597; Reese J, 1999, MOL CELL ENDOCRINOL, V150, P23, DOI 10.1016/S0303-7207(99)00033-7; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Song H, 2002, DEVELOPMENT, V129, P2879; TOKUMURA A, 1980, ARCH INT PHARMACOD T, V245, P74; Umstad MP, 2003, MED J AUSTRALIA, V178, P613, DOI 10.5694/j.1326-5377.2003.tb05384.x; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Yang ZM, 1997, BIOL REPROD, V56, P368, DOI 10.1095/biolreprod56.2.368	30	400	428	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					104	108		10.1038/nature03505	http://dx.doi.org/10.1038/nature03505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875025	Green Accepted			2022-12-01	WOS:000228864600047
J	de Letona, JM				de Letona, JM			Aortic aneurysm: the physician as patient	LANCET			English	Editorial Material									Univ Autonoma Madrid, Hosp Puerta de Hierro, Madrid, Spain	Autonomous University of Madrid; Hospital Puerta de Hierro-Majadahonda	de Letona, JM (corresponding author), Univ Autonoma Madrid, Hosp Puerta de Hierro, Madrid, Spain.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1590	1590		10.1016/S0140-6736(05)66460-4	http://dx.doi.org/10.1016/S0140-6736(05)66460-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866313				2022-12-01	WOS:000228754800031
J	Bernhardt, ES; Palmer, MA; Allan, JD; Alexander, G; Barnas, K; Brooks, S; Carr, J; Clayton, S; Dahm, C; Follstad-Shah, J; Galat, D; Gloss, S; Goodwin, P; Hart, D; Hassett, B; Jenkinson, R; Katz, S; Kondolf, GM; Lake, PS; Lave, R; Meyer, JL; O'Donnell, TK; Pagano, L; Powell, B; Sudduth, E				Bernhardt, ES; Palmer, MA; Allan, JD; Alexander, G; Barnas, K; Brooks, S; Carr, J; Clayton, S; Dahm, C; Follstad-Shah, J; Galat, D; Gloss, S; Goodwin, P; Hart, D; Hassett, B; Jenkinson, R; Katz, S; Kondolf, GM; Lake, PS; Lave, R; Meyer, JL; O'Donnell, TK; Pagano, L; Powell, B; Sudduth, E			Ecology - Synthesizing US river restoration efforts	SCIENCE			English	Editorial Material							FRESH-WATER		Univ Maryland, College Pk, MD 20742 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; NOAA, Natl Fisheries Sci Ctr, Seattle, WA USA; Monash Univ, Clayton, Vic 3168, Australia; Natl Acad Sci, Philadelphia, PA USA; Univ Idaho, Boise, ID USA; Univ New Mexico, Albuquerque, NM 87131 USA; US Geol Survey, Cooperat Res Unit, Columbia, MO USA; Univ Missouri, Columbia, MO USA; USGS, SW Biol Sci Ctr, Tucson, AZ USA; Univ Idaho, Moscow, ID 83843 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Georgia, Athens, GA 30602 USA; USGS, Ctr Biol Informat, Denver, CO USA	University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; National Oceanic Atmospheric Admin (NOAA) - USA; Monash University; National Academies of Sciences, Engineering & Medicine; Idaho; University of Idaho; University of New Mexico; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho; University of California System; University of California Berkeley; University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey	Bernhardt, ES (corresponding author), Duke Univ, Durham, NC 27706 USA.	emily.bernhardt@duke.edu	Goodwin, Peter/AAP-1649-2021; Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010	Bernhardt, Emily S/0000-0003-3031-621X; Lave, Rebecca/0000-0001-5335-9058; Sudduth, Elizabeth/0000-0001-8274-8159; Brooks, Shane/0000-0002-5636-1783				Baron JS, 2002, ECOL APPL, V12, P1247; Buijse AD, 2002, FRESHWATER BIOL, V47, P889, DOI 10.1046/j.1365-2427.2002.00915.x; Cohn JP, 2001, BIOSCIENCE, V51, P998, DOI 10.1641/0006-3568(2001)051[0998:RTDALA]2.0.CO;2; G.A.O, 2002, GAO02612; GAO (United States General Accounting Office), 2003, GAO03515; GILLILAN S, IN PRESS J APPL ECOL; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; KOEBEL JW, 1995, RESTOR ECOL, V3, P149, DOI 10.1111/j.1526-100X.1995.tb00167.x; Lavendel B., 2002, ECOL RESTOR, V20, P173, DOI [10.3368/er.20.3.173, DOI 10.3368/ER.20.3.173]; Malakoff D, 2004, SCIENCE, V305, P937, DOI 10.1126/science.305.5686.937; *NRC, 1999, DOWNSTR AD MAN GLEN; NRC, 1999, OUR COMM JOURN TRANS; NRC (National Research Council), 1996, UPSTR SALM SOC PAC N; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; PALMER MA, IN PRESS J APPL ECOL; Postel Sandra, 2003, RIVERS LIFE MANAGING; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sand-Jensen Kaj, 2001, P89; *US EPA, 2000, EPA PUBL; Whalen PJ, 2002, WATER SCI TECHNOL, V45, P55, DOI 10.2166/wst.2002.0379	20	1298	1335	17	610	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					636	637		10.1126/science.1109769	http://dx.doi.org/10.1126/science.1109769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860611				2022-12-01	WOS:000228810900030
J	Cirelli, C; Bushey, D; Hill, S; Huber, R; Kreber, R; Ganetzky, B; Tononi, G				Cirelli, C; Bushey, D; Hill, S; Huber, R; Kreber, R; Ganetzky, B; Tononi, G			Reduced sleep in Drosophila shaker mutants	NATURE			English	Article							POTASSIUM CHANNELS; HEALTHY INSOMNIA; NERVOUS-SYSTEM; K+ CHANNEL; MELANOGASTER; GENE; MICE; HOMEOSTASIS; REST; DEPRIVATION	Most of us sleep 7-8 h per night, and if we are deprived of sleep our performance suffers greatly; however, a few do well with just 3-4 h of sleep-a trait that seems to run in families. Determining which genes underlie this phenotype could shed light on the mechanisms and functions of sleep. To do so, we performed mutagenesis in Drosophila melanogaster, because flies also sleep for many hours and, when sleep deprived, show sleep rebound and performance impairments. By screening 9,000 mutant lines, we found minisleep (mns), a line that sleeps for one-third of the wild-type amount. We show that mns flies perform normally in a number of tasks, have preserved sleep homeostasis, but are not impaired by sleep deprivation. We then show that mns flies carry a point mutation in a conserved domain of the Shaker gene. Moreover, after crossing out genetic modifiers accumulated over many generations, other Shaker alleles also become short sleepers and fail to complement the mns phenotype. Finally, we show that short-sleeping Shaker flies have a reduced lifespan. Shaker, which encodes a voltage-dependent potassium channel controlling membrane repolarization and transmitter release, may thus regulate sleep need or efficiency.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu	Tononi, Giulio/B-8387-2009	Hill, Sean/0000-0001-8055-860X				BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BENINGTON JH, 1995, BRAIN RES, V692, P86, DOI 10.1016/0006-8993(95)00591-D; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; Espinosa F, 2004, GENES BRAIN BEHAV, V3, P90, DOI 10.1046/j.1601-183x.2003.00054.x; HEATH AC, 1990, SLEEP, V13, P318, DOI 10.1093/sleep/13.4.318; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Horne J., 1989, WHY WE SLEEP; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; JONES HS, 1968, ELECTROEN CLIN NEURO, V24, P378, DOI 10.1016/0013-4694(68)90199-5; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kopp C, 2002, EUR J NEUROSCI, V16, P1099, DOI 10.1046/j.1460-9568.2002.02156.x; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093/brain/124.12.2417; Linkowski P, 1999, J SLEEP RES, V8, P11; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MEDDIS R, 1973, ELECTROEN CLIN NEURO, V35, P213, DOI 10.1016/0013-4694(73)90180-6; Naylor E, 2000, J NEUROSCI, V20, P8138; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rogero O, 1997, J NEUROSCI, V17, P5108; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schenck CH, 2001, SLEEP MED, V2, P531, DOI 10.1016/S1389-9457(01)00114-9; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Spradling AC, 1999, GENETICS, V153, P135; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; STUSS D, 1978, WAKING SLEEPING, V2, P101; SUTCLIFFE JG, 1988, TRENDS GENET, V4, P297, DOI 10.1016/0168-9525(88)90105-9; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Taheri S, 2002, LANCET NEUROL, V1, P242, DOI 10.1016/S1474-4422(02)00103-5; TIMPE LC, 1987, J NEUROSCI, V7, P1307; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6; Walcourt A, 2001, ANESTH ANALG, V92, P535, DOI 10.1213/00000539-200102000-00047; Webb W B, 1970, Int Psychiatry Clin, V7, P44; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	50	317	330	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1087	1092		10.1038/nature03486	http://dx.doi.org/10.1038/nature03486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858564				2022-12-01	WOS:000228693300032
J	Blower, MD; Nachury, M; Heald, R; Weis, K				Blower, MD; Nachury, M; Heald, R; Weis, K			A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly	CELL			English	Article							NUCLEAR-PORE COMPLEX; MESSENGER-RNA EXPORT; IMPORTIN-BETA; CELL-CYCLE; RAE1; PROTEIN; RAN; MICROTUBULES; NUP98; LOCALIZATION	Centrosome-independent microtubule polymerization around chromosomes has been shown to require a local gradient of RanGTP, which discharges mitotic cargoes from the nuclear import receptor importin beta. Here, we have used an activity-based assay in Xenopus egg extracts to purify the mRNA export protein Rae1 as a spindle assembly factor regulated by this pathway. Rae1 is a microtubule-associated protein that binds directly to importin beta. Depletion of Rae1 from extracts or cells severely inhibits mitotic spindle assembly. A purified Rae1 complex stabilizes microtubules in egg extracts in a RanGTP/importin beta-regulated manner. Interestingly, Rae1 exists in a large ribonucleoprotein complex, which requires RNA for its activity to control microtubule dynamics in vitro. Furthermore, we provide evidence that RNA associates with the mitotic spindle and that it plays a direct, translation-independent role in spindle assembly. Our studies reveal an unexpected function for RNA in spindle morphogenesis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	heald@socrates.berkeley.edu; kweis@berkeley.edu	Nachury, Maxence/H-3695-2019; Nachury, Maxence/A-8759-2008; Weis, Karsten/F-5719-2011	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; Weis, Karsten/0000-0001-7224-925X; Blower, Michael/0000-0002-5037-1972; Heald, Rebecca/0000-0001-6671-6528	NIGMS NIH HHS [GM65232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Budde PP, 2003, CURR TOP DEV BIOL, V56, P85, DOI 10.1016/S0070-2153(03)01008-1; Deshler JO, 1997, SCIENCE, V276, P1128, DOI 10.1126/science.276.5315.1128; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAMILL D, 1994, J CELL BIOL, V127, P973, DOI 10.1083/jcb.127.4.973; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kahana JA, 1999, J CELL BIOL, V146, P1205, DOI 10.1083/jcb.146.6.1205; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kraemer D, 1997, P NATL ACAD SCI USA, V94, P9119, DOI 10.1073/pnas.94.17.9119; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Lieb B, 1998, EXP CELL RES, V245, P272, DOI 10.1006/excr.1998.4249; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sitterlin D, 2004, GENE, V326, P107, DOI 10.1016/j.gene.2003.10.024; Tekotte H, 2002, TRENDS GENET, V18, P636, DOI 10.1016/S0168-9525(02)02819-6; Whalen WA, 1997, YEAST, V13, P1167, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1167::AID-YEA154>3.3.CO;2-F; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000	27	218	225	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					223	234		10.1016/j.cell.2005.02.016	http://dx.doi.org/10.1016/j.cell.2005.02.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851029	Bronze			2022-12-01	WOS:000228705000010
J	Al-Khatib, SM; Anstrom, KJ; Eisenstein, EL; Peterson, ED; Jollis, JG; Mark, DB; Li, Y; O'Connor, CM; Shaw, LK; Califf, RM				Al-Khatib, SM; Anstrom, KJ; Eisenstein, EL; Peterson, ED; Jollis, JG; Mark, DB; Li, Y; O'Connor, CM; Shaw, LK; Califf, RM			Clinical and economic implications of the multicenter automatic defibrillator implantation trial-II	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	52nd Annual Scientific Session of the American-College-of-Cardiology	MAR 30-APR 02, 2003	CHICAGO, IL	Amer Coll Cardiol			CORONARY-ARTERY-DISEASE; SUDDEN CARDIAC DEATH; COST-EFFECTIVENESS; CARDIOVERTER-DEFIBRILLATOR; MYOCARDIAL-INFARCTION; DRUG-THERAPY; HIGH-RISK; AMIODARONE; SURVIVAL; RECOMMENDATIONS	Background: The Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II demonstrated that implantable cardioverter defibrillators (ICDs) save lives when used in patients with a history of myocardial infarction (MI) and an ejection fraction of 0.3 or less. Objective: To investigate the cost-effectiveness of implanting ICDs in patients who met MADIT-II eligibility criteria and were enrolled in the Duke Cardiovascular Database between 1 January 1986 and 31 December 2001. Design: Cost-effectiveness analysis. Data Sources: Published literature, databases owned by Duke University Medical Center, and Medicare data. Target Population: Adults with a history of MI and an ejection fraction of 0.3 or less. Time Horizon: Lifetime. Perspective: societal. Interventions: ICD therapy versus conventional medical therapy. Outcomes Measures: Cost per life-year gained and incremental cost-effectiveness. Results: compared with conventional medical therapy, ICDs are projected to result in an increase of 1.80 discounted years in life expectancy and an incremental cost-effectiveness ratio of $50 500 per life-year gained. Cost-effectiveness varied dramatically with changes in time horizon: The cost-effectiveness ratio increased to $67 800 per life-year gained, $79 900 per life-year gained, $100 000 per life-year gained, $167 900 per life-year gained, and $367 200 per life-year gained for 15-year, 12-year, 9-year, 6-year, and 3-year time horizons, respectively. Changing the frequency of follow-up visits, complication rates, and battery replacements had less of an effect on the cost-effectiveness ratios than reducing the cost of ICD placement and leads. Limitations: The study was limited by the completeness of the data, referral bias, difference in medical therapy between the Duke cohort and the MADIT-II cohort, and not addressing potential upgrades to biventricular devices. Conclusions: The economic expense of defibrillator implantation in all patients who meet MADIT-II eligibility criteria is substantial. However, in the range of survival benefit observed in MADIT-II, ICD therapy for these patients is economically attractive by conventional standards.	Duke Univ, Clin Res Inst, Durham, NC 27715 USA	Duke University	Al-Khatib, SM (corresponding author), Duke Univ, Clin Res Inst, 2400 Pratt St, Durham, NC 27715 USA.		Peterson, Eric David/ABF-5033-2021	Mark, Daniel/0000-0001-6340-8087				American Heart Association, 2002, HEART DIS STROKE STA; Anderson R N, 2000, Vital Health Stat 2, P1; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077; COX DR, 1972, J R STAT SOC B, V34, P187; Eisenstein EL, 2001, MED CARE, V39, P824, DOI 10.1097/00005650-200108000-00008; EISENSTEIN EL, ACUTE CORONARY SYSND, P723; FORTIN DF, 1995, AM J CARDIOL, V76, P1177, DOI 10.1016/S0002-9149(99)80331-2; HARRIS PJ, 1979, CIRCULATION, V60, P1259, DOI 10.1161/01.CIR.60.6.1259; Kennergren C, 1996, AM J CARDIOL, V78, P15, DOI 10.1016/S0002-9149(96)00497-3; KUPPERMANN M, 1990, CIRCULATION, V81, P91, DOI 10.1161/01.CIR.81.1.91; Larsen G, 2002, CIRCULATION, V105, P2049, DOI 10.1161/01.CIR.0000015504.57641.D0; LARSEN GC, 1992, J AM COLL CARDIOL, V19, P1323, DOI 10.1016/0735-1097(92)90341-J; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; MARK DB, 1996, CIRCULATION, V94, P168; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mushlin AI, 1998, CIRCULATION, V97, P2129, DOI 10.1161/01.CIR.97.21.2129; O'Brien BJ, 2001, CIRCULATION, V103, P1416, DOI 10.1161/01.CIR.103.10.1416; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; ROSATI RA, 1975, ARCH INTERN MED, V135, P1017, DOI 10.1001/archinte.135.8.1017; Sanders GD, 2001, ANN INTERN MED, V135, P870, DOI 10.7326/0003-4819-135-10-200111200-00007; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Spath MA, 2002, PHARMACOECONOMICS, V20, P727, DOI 10.2165/00019053-200220110-00002; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; 2003, MEDTRONIC PRODUCT PE, V13	31	90	89	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2005	142	8					593	600		10.7326/0003-4819-142-8-200504190-00007	http://dx.doi.org/10.7326/0003-4819-142-8-200504190-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	916TZ	15838065				2022-12-01	WOS:000228410400001
J	Gorgoulis, VG; Vassiliou, LVF; Karakaidos, P; Zacharatos, P; Kotsinas, A; Liloglou, T; Venere, M; DiTullio, RA; Kastrinakis, NG; Levy, B; Kletsas, D; Yoneta, A; Herlyn, M; Kittas, C; Halazonetis, TD				Gorgoulis, VG; Vassiliou, LVF; Karakaidos, P; Zacharatos, P; Kotsinas, A; Liloglou, T; Venere, M; DiTullio, RA; Kastrinakis, NG; Levy, B; Kletsas, D; Yoneta, A; Herlyn, M; Kittas, C; Halazonetis, TD			Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions	NATURE			English	Article							CELL LUNG CARCINOMAS; DOUBLE-STRAND BREAKS; P53 MUTATIONS; HISTONE H2AX; HUMAN CANCER; ALLELE LOSS; CYCLIN-E; 53BP1; EXPRESSION; PATHWAY	DNA damage checkpoint genes, such as p53, are frequently mutated in human cancer, but the selective pressure for their inactivation remains elusive(1-3). We analysed a panel of human lung hyperplasias, all of which retained wild-type p53 genes and had no signs of gross chromosomal instability, and found signs of a DNA damage response, including histone H2AX and Chk2 phosphorylation, p53 accumulation, focal staining of p53 binding protein 1 (53BP1) and apoptosis. Progression to carcinoma was associated with p53 or 53BP1 inactivation and decreased apoptosis. A DNA damage response was also observed in dysplastic nevi and in human skin xenografts, in which hyperplasia was induced by overexpression of growth factors. Both lung and experimentally-induced skin hyperplasias showed allelic imbalance at loci that are prone to DNA double-strand break formation when DNA replication is compromised ( common fragile sites). We propose that, from its earliest stages, cancer development is associated with DNA replication stress, which leads to DNA double-strand breaks, genomic instability and selective pressure for p53 mutations.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; Univ Liverpool, Ctr Canc Res, Roy Castle Lung Canc Res Programme, Liverpool, Merseyside, England; Univ Penn, Grad Grp Biomed Sci, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Demokritos Natl Ctr Sci Res, Inst Biol, GR-15310 Athens, Greece	The Wistar Institute; Athens Medical School; National & Kapodistrian University of Athens; University of Liverpool; University of Pennsylvania; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; National Centre of Scientific Research "Demokritos"	Halazonetis, TD (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	halazonetis@wistar.upenn.edu	Halazonetis, Thanos/D-7923-2011; ZACHARATOS, PANAGIOTIS V/G-9954-2014; Karakaidos, Panagiotis/AAR-5858-2020; Kletsas, Dimitris/F-6953-2010; Gorgoulis, Vassilis/AAD-3630-2019	ZACHARATOS, PANAGIOTIS V/0000-0001-8324-5481; Karakaidos, Panagiotis/0000-0002-1156-4755; Gorgoulis, Vassilis/0000-0001-9001-4112; Kletsas, Dimitris/0000-0002-9828-3963				Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Gorgoulis VG, 1998, AM J PATHOL, V153, P1749, DOI 10.1016/S0002-9440(10)65690-8; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Halazonetis TD, 2004, DNA REPAIR, V3, P1057, DOI 10.1016/j.dnarep.2004.03.036; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Maitra A, 2001, AM J PATHOL, V159, P119, DOI 10.1016/S0002-9440(10)61679-3; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; Mochan TA, 2003, CANCER RES, V63, P8586; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wistuba II, 2000, CANCER RES, V60, P1949	29	1613	1668	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					907	913		10.1038/nature03485	http://dx.doi.org/10.1038/nature03485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829965				2022-12-01	WOS:000228327600043
J	Lo, B; Dornbrand, L; Dubler, NN				Lo, B; Dornbrand, L; Dubler, NN			HIPAA and patient care - The role for professional judgment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Federal health privacy regulations, commonly known as the Health Insurance Portability and Accountability Act (HIPAA) regulations, came into effect in April 2003. Many clinicians and institutions have relied on consultants and risk managers to tell them how to implement these regulations. Much of the controversy and confusion over the HIPAA regulations concern so-called incidental disclosures. Some interpretations of the privacy regulations would limit essential communication and compromise good patient care. This article analyzes misconceptions regarding what the regulations say about incidental disclosures and discusses the reasons for such misunderstandings. Many misconceptions arise from gaps in the regulations. These gaps are appropriately filled by professional judgment informed by ethical guidelines. The communication should be necessary and effective for good patient care, and the risks of a breach of confidentiality should be proportional to the likely benefit for the patient's care. The alternative for communication should be impractical. We offer specific recommendations to help physicians think through what incidental disclosures in patient care are ethically permissible and what safeguards ought to be taken. Physicians should work with risk managers and practice administrators to develop policies that promote good communication in patient care, while taking appropriate steps to protect patient privacy.	Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA; Montefiore Med Ctr, Dept Epidemiol & Social Med, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Montefiore Medical Center	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, Room C 126,521 Parnassus Ave, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu						Annas GJ, 2003, NEW ENGL J MED, V348, P1486, DOI 10.1056/NEJMlim035027; BEAUCHAMP TL, 1989, PRINCIPLES BIOMEDICA, P329; BEAUCHAMP TL, 2001, PRINCIPLES BIOMEDICA, P303; Beauchamp Tom L, 2001, PRINCIPLES BIOMEDICA, P165; Beauchamp Tom L., 2001, PRINCIPLES BIOMEDICA, P63; CALFEE JE, 1984, VA LAW REV, V70, P965, DOI 10.2307/1072946; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; CLARK C, 2003, SAN DIEGO UNION 0609, pA1; *CTR MED MED SERV, 2003, IS MAND ENCR HIPAA S; *DEP HLTH HUM SERV, 2003, MAY DOCT FAX EMAIL D; *DEP HLTH HUM SERV, 2004, US OCR RES FIGHT MYT; *DEP HLTH HUM SERV, 2003, CAN HLTH CAR PROV CO; *DEP HLTH HUM SERV, 2001, HHS ISS 1 GUID NEW P; *DEP HLTH HUM SERV, 2003, CAN PAT HAV FRIEND F; *DEP HLTH HUM SERV, 2003, MUST FAC PRIV SOUNDP; *DEP HLTH HUM SERV, 2003, HLTH CAR PROV CONF C; *DEP HLTH HUM SERV, 2003, WHAT SAF NEED CONT C; *DEP HLTH HUM SERV, 2003, GEN WHAT DOES HIPAA; GOSTIN LO, 2000, PUBLIC HLTH LAW, P85; *HLTH PRIV PROJ, 2003, MYTHS FACTS HLPAA PR; *HLTH PRIV WORK GR, 1999, BEST PRINC HLTH PRIV; JONSEN AR, 1978, ANN INTERN MED, V88, P827, DOI 10.7326/0003-4819-88-6-827; KISSINGER M, 2003, MILWAUKEE J SEN 1109, pA1; Lo B, 2000, JAMA-J AM MED ASSOC, V283, P801, DOI 10.1001/jama.283.6.801; LO B, 2000, RESOLVING ETHICAL DI, P43; *LTH PRIV PROJ, 2003, MED PRIV STOR; *MARKL FDN, 2004, CONN HLTH PRIV SEC W; *OFF CIV RIGHTS HI, 2002, STAND PRIV IND ID HL; *OFF CIV RIGHTS HI, 2003, MED PRIV NAT STAND P; OSTROM CM, 2004, SEATTLE TIMES   0330, pA1; SORKIN MD, 2003, ST LOUIS POST D 0629, pA12; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; STEIN R, 2003, WASH POST       0330, pA1; SUNNSTEIN CR, 1996, LEGAL REASONING POLI; TARKAN L, 2003, NY TIMES        0603, pA1; UBEL PA, 1995, AM J MED, V99, P190, DOI 10.1016/S0002-9343(99)80139-9; *US ATT OFF W DIST, 2004, SEATTL AR MAN GETS P; WEISS BD, 1982, JAMA-J AM MED ASSOC, V247, P2695, DOI 10.1001/jama.247.19.2695; 2002, FED REG, V67, P14793; 2002, FED REG, V67, P55918	40	20	20	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2005	293	14					1766	1771		10.1001/jama.293.14.1766	http://dx.doi.org/10.1001/jama.293.14.1766			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915JS	15827316				2022-12-01	WOS:000228301100031
J	Vrakking, AM; van der Heide, A; Onwuteaka-Philipsen, BD; Keij-Deerenberg, IM; van der Maas, PJ; van der Wal, G				Vrakking, AM; van der Heide, A; Onwuteaka-Philipsen, BD; Keij-Deerenberg, IM; van der Maas, PJ; van der Wal, G			Medical end-of-life decisions made for neonates and infants in the Netherlands, 1995-2001	LANCET			English	Article							INTENSIVE-CARE	End-of-life decision-making for severely affected infants might be influenced by technical advances and societal debates. In 2001, we assessed the proportion of deaths of infants younger than 1 year that were preceded by end-of-life decisions, by replicating a questionnaire study from 1995. This proportion increased from 62% to 68% (weighted percentages), but the difference was not significant. Most of these decisions were to forgo life-sustaining treatment. Decisions to actively end the lives of infants not dependent on life-sustaining treatment remained stable at 1%. The practice of end-of-life decision-making in neonatology of 2001 has changed little since 1995.	Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, NL-3000 DR Rotterdam, Netherlands; VU Univ Med Ctr Amsterdam, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; VU Univ Med Ctr Amsterdam, Inst Res Extramural Med, Amsterdam, Netherlands; Stat Netherlands, Div Social & Spatial Stat, Voorburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Vrakking, AM (corresponding author), Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, POB 1738, NL-3000 DR Rotterdam, Netherlands.	a.vrakking@erasmusmc.nl						Buitendijk S, 2003, EUR J OBSTET GYN R B, V111, pS66, DOI 10.1016/j.ejogrb.2003.09.007; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; Lemons JA, 2000, PEDIATRICS, V105, P454; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5; Wall SN, 1997, PEDIATRICS, V99, P64, DOI 10.1542/peds.99.1.64	5	43	43	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1329	1331		10.1016/S0140-6736(05)61030-6	http://dx.doi.org/10.1016/S0140-6736(05)61030-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823383	Green Submitted			2022-12-01	WOS:000228219600028
J	Adams, EJ; Chien, YH; Garcia, KC				Adams, EJ; Chien, YH; Garcia, KC			Structure of a gamma delta T cell receptor in complex with the nonclassical MHC T22	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ANTIGEN-RECOGNITION; LIGAND; PEPTIDE; LYMPHOCYTES; SPECIFICITY	gamma delta T cell receptors (TCRs), alpha beta TCRs, and antibodies are the three lineages of somatically recombined antigen receptors. The structural basis for ligand recognition is well. defined for alpha beta TCR and antibodies but is lacking for gamma delta TCRs. We present the 3.4 angstrom structure of the murine gamma delta TCR G8 bound to its major histocompatibillity complex (MHC) class Ib ligand, T22. G8 predominantly uses germ line-en coded residues of its 8 chain complementarity-determining region 3 (CDR3) loop to bind T22 in an orientation substantially different from that seen in alpha beta TCR/peptide-MHC. That junctionaily encoded G8 residues play an ancillary role in binding suggests a fusion of innate and adaptive recognition strategies.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94035 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94035 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94035 USA	Stanford University; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 94035 USA.	kcgarcia@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540, R56AI048540] Funding Source: NIH RePORTER; NIAID NIH HHS [AI048540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; CARDING SR, 1990, J EXP MED, V172, P1225, DOI 10.1084/jem.172.4.1225; Chien YH, 2000, SPRINGER SEMIN IMMUN, V22, P239, DOI 10.1007/PL00006752; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.iy.11.040193.003225; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Kabelitz D, 2003, CRIT REV IMMUNOL, V23, P339, DOI 10.1615/CritRevImmunol.v23.i56.10; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Matis L A, 1991, Semin Immunol, V3, P75; MATIS LA, 1987, NATURE, V330, P262, DOI 10.1038/330262a0; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Rudolph MG, 2004, ACTA CRYSTALLOGR D, V60, P656, DOI 10.1107/S0907444904002239; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310	31	192	196	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					227	231		10.1126/science.1106885	http://dx.doi.org/10.1126/science.1106885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821084				2022-12-01	WOS:000228273700045
J	Geffeney, SL; Fujimoto, E; Brodie, ED; Brodie, ED; Ruben, PC				Geffeney, SL; Fujimoto, E; Brodie, ED; Brodie, ED; Ruben, PC			Evolutionary diversification of TTX-resistant sodium channels in a predator-prey interaction	NATURE			English	Article							NA+ CHANNEL; SKELETAL-MUSCLE; OUTER VESTIBULE; GARTER SNAKES; GENES; TETRODOTOXIN; EXPRESSION; SAXITOXIN; PATTERNS; PORE	Understanding the molecular genetic basis of adaptations provides incomparable insight into the genetic mechanisms by which evolutionary diversification takes place. Whether the evolution of common traits in different lineages proceeds by similar or unique mutations, and the degree to which phenotypic evolution is controlled by changes in gene regulation as opposed to gene function, are fundamental questions in evolutionary biology that require such an understanding of genetic mechanisms(1-3). Here we identify novel changes in the molecular structure of a sodium channel expressed in snake skeletal muscle, tsNa(V)1.4, that are responsible for differences in tetrodotoxin (TTX) resistance among garter snake populations coevolving with toxic newts(4). By the functional expression of tsNa(V)1.4, we show how differences in the amino-acid sequence of the channel affect TTX binding and impart different levels of resistance in four snake populations. These results indicate that the evolution of a physiological trait has occurred through a series of unique functional changes in a gene that is otherwise highly conserved among vertebrates.	Utah State Univ, Dept Biol, Logan, UT 84322 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Utah System of Higher Education; Utah State University; Indiana University System; Indiana University Bloomington	Geffeney, SL (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	geffeney@biology.usu.edu	Brodie, Edmund D/B-2335-2013	Geffeney, Shana/0000-0003-0504-2077				Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Brodie ED, 2002, EVOLUTION, V56, P2067; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; Choudhary G, 2003, BIOPHYS J, V84, P287, DOI 10.1016/S0006-3495(03)74849-8; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hille B., 2001, ION CHANNELS EXCITAB, V3; Hoekstra HE, 2003, MOL ECOL, V12, P1185, DOI 10.1046/j.1365-294X.2003.01788.x; Huey RB, 2002, SCIENCE, V297, P1289, DOI 10.1126/science.1075987; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; Kaneko Y, 1997, BIOCHEM BIOPH RES CO, V240, P651, DOI 10.1006/bbrc.1997.7696; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; Penzotti JL, 1998, BIOPHYS J, V75, P2647, DOI 10.1016/S0006-3495(98)77710-0; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Yamagishi T, 2001, J GEN PHYSIOL, V118, P171, DOI 10.1085/jgp.118.2.171; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yotsu-Yamashita M, 2000, BIOCHEM BIOPH RES CO, V267, P403, DOI 10.1006/bbrc.1999.1974; Zakon HH, 2002, BRAIN BEHAV EVOLUT, V59, P250, DOI 10.1159/000063562	30	162	172	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2005	434	7034					759	763		10.1038/nature03444	http://dx.doi.org/10.1038/nature03444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815629				2022-12-01	WOS:000228160700040
J	Steffens, S; Veillard, NR; Arnaud, C; Pelli, G; Burger, F; Staub, C; Zimmer, A; Frossard, JL; Mach, F				Steffens, S; Veillard, NR; Arnaud, C; Pelli, G; Burger, F; Staub, C; Zimmer, A; Frossard, JL; Mach, F			Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice	NATURE			English	Article							E-DEFICIENT MICE; LESION FORMATION; RECEPTOR-DEFICIENT; CB2 RECEPTOR; LYMPHOCYTES; DELTA-9-TETRAHYDROCANNABINOL; INFLAMMATION; EXPRESSION; CELLS; DELTA(9)-TETRAHYDROCANNABINOL	Atherosclerosis is a chronic inflammatory disease, and is the primary cause of heart disease and stroke in Western countries(1). Derivatives of cannabinoids such as delta-9-tetrahydrocannabinol (THC) modulate immune functions(2) and therefore have potential for the treatment of inflammatory diseases. We investigated the effects of THC in a murine model of established atherosclerosis. Oral administration of THC (1 mg kg(-1) per day) resulted in significant inhibition of disease progression. This effective dose is lower than the dose usually associated with psychotropic effects of THC. Furthermore, we detected the CB2 receptor ( the main cannabinoid receptor expressed on immune cells(2,3)) in both human and mouse atherosclerotic plaques. Lymphoid cells isolated from THC-treated mice showed diminished proliferation capacity and decreased interferon-gamma secretion. Macrophage chemotaxis, which is a crucial step for the development of atherosclerosis(1), was also inhibited in vitro by THC. All these effects were completely blocked by a specific CB2 receptor antagonist(4). Our data demonstrate that oral treatment with a low dose of THC inhibits atherosclerosis progression in the apolipoprotein E knockout mouse model, through pleiotropic immunomodulatory effects on lymphoid and myeloid cells. Thus, THC or cannabinoids with activity at the CB2 receptor may be valuable targets for treating atherosclerosis.	Fdn Med Res, Dept Med, Div Cardiol, CH-1211 Geneva, Switzerland; Univ Hosp, Fac Med, Div Gastroenterol, CH-1211 Geneva, Switzerland; Univ Hosp, Fac Med, Inst Legal Med, CH-1211 Geneva, Switzerland; Univ Bonn, Dept Psychiat, Mol Neurobiol Lab, D-53105 Bonn, Germany	University of Geneva; University of Geneva; University of Geneva; University of Bonn	Mach, F (corresponding author), Fdn Med Res, Dept Med, Div Cardiol, CH-1211 Geneva, Switzerland.	Francois.Mach@medecine.unige.ch	Arnaud, Claire/D-4698-2014; Steffens, Sabine/AAV-4551-2020	Arnaud, Claire/0000-0003-0964-9423; Steffens, Sabine/0000-0002-6892-9751				Benagiano M, 2003, P NATL ACAD SCI USA, V100, P6658, DOI 10.1073/pnas.1135726100; Brenneisen R, 1996, INT J CLIN PHARM TH, V34, P446; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; CHESHER GB, 1990, PHARMACOL BIOCHEM BE, V35, P861, DOI 10.1016/0091-3057(90)90371-N; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Giroud C, 2001, FORENSIC SCI INT, V123, P159, DOI 10.1016/S0379-0738(01)00538-2; Hickey MJ, 2002, J IMMUNOL, V168, P4728, DOI 10.4049/jimmunol.168.9.4728; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kwak BR, 2003, CIRCULATION, V107, P1033, DOI 10.1161/01.CIR.0000051364.70064.D1; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]; Lichtman AH, 2001, DRUG ALCOHOL DEPEN, V63, P107, DOI 10.1016/S0376-8716(00)00205-2; LYMAN WD, 1989, J NEUROIMMUNOL, V23, P73, DOI 10.1016/0165-5728(89)90075-1; Mach F, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000129502.10459.fe; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Moeller F, 2003, ATHEROSCLEROSIS, V168, P49, DOI 10.1016/S0021-9150(03)00026-1; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380; Srivastava MD, 1998, IMMUNOPHARMACOLOGY, V40, P179, DOI 10.1016/S0162-3109(98)00041-1; Sulcova E, 1998, PHARMACOL BIOCHEM BE, V59, P347, DOI 10.1016/S0091-3057(97)00422-X; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Varvel SA, 2001, PSYCHOPHARMACOLOGY, V157, P142; Veillard NR, 2004, ARTERIOSCL THROM VAS, V24, P2339, DOI 10.1161/01.ATV.0000146532.98235.e6; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373	30	348	391	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					782	786		10.1038/nature03389	http://dx.doi.org/10.1038/nature03389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815632				2022-12-01	WOS:000228160700045
J	Yamaguchi, H; Calado, RT; Ly, H; Kajigaya, S; Baerlocher, GM; Chanock, SJ; Lansdorp, PM; Young, NS				Yamaguchi, H; Calado, RT; Ly, H; Kajigaya, S; Baerlocher, GM; Chanock, SJ; Lansdorp, PM; Young, NS			Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LINKED DYSKERATOSIS-CONGENITA; CATALYTIC SUBUNIT; IN-VIVO; FUNCTIONAL MULTIMERIZATION; MYELODYSPLASTIC SYNDROME; ENZYME-ACTIVITY; RNA INTERACTION; DISEASE; HAPLOINSUFFICIENCY; DEFICIENT	BACKGROUND: Mutations in TERC, the gene for the RNA component of telomerase, cause short telomeres in congenital aplastic anemia and in some cases of apparently acquired hematopoietic failure. We investigated whether mutations in genes for other components of telomerase also occur in aplastic anemia. METHODS: We screened blood or marrow cells from 124 patients with apparently acquired aplastic anemia and 282 control subjects for sequence variations in the TERT, DKC1, NHP2, and NOP10 genes; an additional 81 patients and 246 controls were examined for genetic variations in TERT. Telomere lengths and the telomerase activity of peripheral-blood leukocytes were evaluated in patients carrying genetic variants. Identified mutations were transfected into telomerase-deficient cell lines to examine their effects and their mechanism of action on telomerase function. RESULTS: Five heterozygous, nonsynonymous mutations (which cause an amino acid change in the corresponding protein) were identified in TERT, the gene for the telomerase reverse transcriptase catalytic enzyme, among seven unrelated patients. Leukocytes from these patients had short telomeres and low telomerase enzymatic activity. In three of these patients, the mutation was also detected in buccal mucosa cells. Family members carrying the mutations also had short telomeres and reduced telomerase activity but no evident hematologic abnormality. The results of coexpression of wild-type TERT and TERT with aplastic anemia-associated mutations in a telomerase-deficient cell line suggested that haploinsufficiency was the mechanism of telomere shortening due to TERT mutations. CONCLUSIONS: Heterozygous mutations in the TERT gene impair telomerase activity by haploinsufficiency and may be risk factors for marrow failure.	NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; Emory Univ, Dept Pathol & Lab Med, Div Expt Pathol, Atlanta, GA 30322 USA; Univ British Columbia, Terry Fox Lab, BC Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Young, NS (corresponding author), NHLBI, Hematol Branch, NIH, 10 Ctr Dr,Bldg 10,CRC,Rm 3E-5140, Bethesda, MD 20892 USA.	youngns@mail.nih.gov	Calado, Rodrigo T./G-2619-2011	Calado, Rodrigo T./0000-0002-7966-6029; Lansdorp, Peter/0000-0001-7435-1071	NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002315, Z01HL002315] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alter B.P., 1994, APLASTIC ANEMIA ACQU, P271; Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Baerlocher GM, 2003, CYTOM PART A, V55A, P1, DOI 10.1002/cyto.a.10064; Ball SE, 1998, BLOOD, V91, P3582; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Calado RT, 2002, LANCET, V360, P1608, DOI 10.1016/S0140-6736(02)11551-0; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Dufour C, 2004, BRIT J HAEMATOL, V126, P682, DOI 10.1111/j.1365-2141.2004.05102.x; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Kaufman DW, 1991, DRUG ETIOLOGY AGRANU; Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu Y, 2001, CURR BIOL, V11, P907; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Ly H, 2003, GENE DEV, V17, P1078, DOI 10.1101/gad.1060803; Maciejewski JP, 2001, BLOOD, V98, P3513, DOI 10.1182/blood.V98.13.3513; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Peng J, 2003, HUM IMMUNOL, V64, P896, DOI 10.1016/S0198-8859(03)00141-1; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Risitano AM, 2004, LANCET, V364, P355, DOI 10.1016/S0140-6736(04)16724-X; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Saunthararajah Y, 2002, BLOOD, V100, P1570, DOI 10.1182/blood.V100.5.1570.h81702001570_1570_1574; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Theimer CA, 2003, P NATL ACAD SCI USA, V100, P449, DOI 10.1073/pnas.242720799; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Young NS, 2002, ANN INTERN MED, V136, P534, DOI 10.7326/0003-4819-136-7-200204020-00011; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI200112687; Zhang AJ, 2003, AM J HUM GENET, V72, P940, DOI 10.1086/374565	53	514	556	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1413	1424		10.1056/NEJMoa042980	http://dx.doi.org/10.1056/NEJMoa042980			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814878				2022-12-01	WOS:000228145200005
J	Eisenberg, RS				Eisenberg, RS			Learning the value of drugs - Is rofecoxib a regulatory success story?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eisenberg, RS (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Eisenberg RS, 2001, HEALTH AFFAIR, V20, P119, DOI 10.1377/hlthaff.20.5.119; Mathews Anna Wilde, 2004, Wall St J (East Ed), pA7; Merrill RA, 1996, VA LAW REV, V82, P1753, DOI 10.2307/1073689; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286	5	14	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2005	352	13					1285	1287		10.1056/NEJMp048358	http://dx.doi.org/10.1056/NEJMp048358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JL	15800222	Green Submitted			2022-12-01	WOS:000227998300002
J	Reynolds, E				Reynolds, E			There is more to treatment of epilepsy than control of seizures	LANCET			English	Editorial Material									Kings Coll London, Inst Epileptol, Weston Educ Ctr, London SE5 9PJ, England	University of London; King's College London	Reynolds, E (corresponding author), Kings Coll London, Inst Epileptol, Weston Educ Ctr, London SE5 9PJ, England.	Reynolds@buckles.u-net.com							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1981	1981		10.1016/S0140-6736(05)66669-X	http://dx.doi.org/10.1016/S0140-6736(05)66669-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936429				2022-12-01	WOS:000229587800037
J	von Plessen, C; Aslaksen, A				von Plessen, C; Aslaksen, A			Improving the quality of palliative care for ambulatory patients with lung cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Most patients with advanced lung cancer currently receive much of their health care, including chemotherapy, as outpatients. Patients have to deal with the complex and time consuming logistics of ambulatory cancer care. At the same time, members of staff often waste considerable time and energy in organisational aspects of care that could be better used in direct interaction with patients. Design Quality improvement study using direct observation and run and flow charts, and focus group meetings with patients and families regarding perceptions of the clinic and with staff regarding satisfaction with working conditions. Setting Thoracic oncology outpatient clinic at a Norwegian university hospital where patients receive chemotherapy and complementary palliative care. Key measures for improvement Waiting time and time wasted during consultations; calmer working situation at the clinic; satisfaction among patients. Strategies for change Rescheduled patients' appointments, automated retrieval of blood test results, systematic reporting in patients' files, design of an information leaflet, and refurnishing of the waiting area at the clinic. Effects of change Interventions resulted in increased satisfaction for patients and staff, reduced waiting time, and reduced variability of waiting time. Lessons learnt Direct observation, focus groups, questionnaires on patients' satisfaction, and measurement of process time were useful in systematically improving care in this outpatient clinic. The description of this experience can serve as an example for the improvement of a microsystem, particularly in other settings with similar problems.	Haukeland Univ Hosp, Dept Thorac Med, N-5021 Bergen, Norway; Haukeland Univ Hosp, Dept Radiol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	von Plessen, C (corresponding author), Haukeland Univ Hosp, Dept Thorac Med, N-5021 Bergen, Norway.	christian.von.plessen@helse-bergen.no	von Plessen, Christian/AFZ-7617-2022	von Plessen, Christian/0000-0002-6134-6780				Batalden P B, 1997, Qual Manag Health Care, V5, P1; Benson RJ, 2001, CLIN ONCOL-UK, V13, P138; Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5; KLEINER A, 1994, 5 DISCIPLINE FIELDBO, P479; Lock Karen K, 2002, Can J Nurs Res, V34, P83; Mitchell Geoff, 2002, Aust Fam Physician, V31, P129; Nelson EC, 1998, ANN INTERN MED, V128, P460, DOI 10.7326/0003-4819-128-6-199803150-00007; Nelson EC, 1996, JOINT COMM J QUAL IM, V22, P243, DOI 10.1016/S1070-3241(16)30228-0; Nelson Eugene C, 2002, Jt Comm J Qual Improv, V28, P472; Newell S, 1999, EUR J CANCER CARE, V8, P73; Zimber J, 2001, MMW Fortschr Med, V143, P22	11	17	17	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1309	1313		10.1136/bmj.330.7503.1309	http://dx.doi.org/10.1136/bmj.330.7503.1309			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15933354	Green Published			2022-12-01	WOS:000229655700025
J	Young, AER; Chambers, TL				Young, AER; Chambers, TL			Standards for care of critically ill children with burns	LANCET			English	Editorial Material									N Bristol NHS Trust, S W Paediat Burn Serv, Bristol BS16 1LE, Avon, England; N Bristol NHS Trust, Dept Paediat, Bristol BS16 1LE, Avon, England	North Bristol NHS Trust; North Bristol NHS Trust	Young, AER (corresponding author), N Bristol NHS Trust, S W Paediat Burn Serv, Bristol BS16 1LE, Avon, England.	Amber.Young@north-bristol.swest.nhs.uk	Young, Amber/H-2988-2018	Young, Amber/0000-0001-7205-492X				*DEP HLTH NHS EX H, 1997, PAED INT CAR FRAM FU; Frame JD, 2003, LANCET, V361, P980, DOI 10.1016/S0140-6736(03)12840-1; Kennedy I., 2001, CM5207; National Service framework for Children, 2004, YOUNG PEOPL MAT SERV; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Radcliffe J, 1998, BRIT MED J, V316, P1547	6	1	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2005	365	9475					1911	1913		10.1016/S0140-6736(05)66639-1	http://dx.doi.org/10.1016/S0140-6736(05)66639-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936407				2022-12-01	WOS:000229587800008
J	Huber, GW; Chheda, JN; Barrett, CJ; Dumesic, JA				Huber, GW; Chheda, JN; Barrett, CJ; Dumesic, JA			Production of liquid alkanes by aqueous-phase processing of biomass-derived carbohydrates	SCIENCE			English	Article							ALDOL CONDENSATION; CATALYSTS; GLUCOSE; WATER; FUEL	Liquid alkanes with the number of carbon atoms ranging from C-7 to C-15 were selectively produced from biomass-derived carbohydrates by acid-catalyzed dehydration, which was followed by aldol condensation over solid base catalysts to form large organic compounds. These molecules were then converted into alkanes by dehydration/hydrogenation over bifunctional catalysts that contained acid and metal sites in a four-phase reactor, in which the aqueous organic reactant becomes more hydrophobic and a hexadecane alkane stream removes hydrophobic species from the catalyst before they go on further to form coke. These liquid alkanes are of the appropriate molecular weight to be used as transportation fuel components, and they contain 90% of the energy of the carbohydrate and H-2 feeds.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Huber, George/D-2569-2018; Barrett, Christopher J/B-7474-2008; Huber, George/Y-2473-2019	Barrett, Christopher J/0000-0001-6194-9066; Huber, George/0000-0002-7838-6893				CHEN NY, 1986, CHEMTECH, V16, P506; Choudary BM, 1999, J MOL CATAL A-CHEM, V142, P361, DOI 10.1016/S1381-1169(98)00301-X; Climent MJ, 2004, J CATAL, V225, P316, DOI 10.1016/j.jcat.2004.04.027; COLLINS P, 1995, MONOSACCHARIDES; ELLIOTT DC, 1991, ENERG FUEL, V5, P399, DOI 10.1021/ef00027a008; GUTSCHE CD, 1967, J AM CHEM SOC, V89, P1235, DOI 10.1021/ja00981a033; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Huber GW, 2003, SCIENCE, V300, P2075, DOI 10.1126/science.1085597; Katzen R, 2000, ADV BIOCHEM ENG BIOT, V70, P77; KATZEN R, 1981, FUELS BIOMASS WASTES, P393; Klass D. L., 1998, BIOMASS RENEWABLE EN, DOI DOI 10.1016/B978-0-12-410950-6.X5000-4; Lewkowski J, 2001, ARKIVOC, P17, DOI 10.3998/ark.5550190.0002.102; LOURVANIJ K, 1993, IND ENG CHEM RES, V32, P11, DOI 10.1021/ie00013a002; Ma FR, 1999, BIORESOURCE TECHNOL, V70, P1, DOI 10.1016/S0960-8524(99)00025-5; Moreau C, 1998, IND CROP PROD, V7, P95, DOI 10.1016/S0926-6690(97)00037-X; Moreau C, 1996, APPL CATAL A-GEN, V145, P211, DOI 10.1016/0926-860X(96)00136-6; OWEN K, 1990, AUTOMOTIVE FUELS HDB; Rao KK, 1998, J CATAL, V173, P115, DOI 10.1006/jcat.1997.1878; Sasaki M, 2002, GREEN CHEM, V4, P285, DOI 10.1039/b203968k; Serra-Holm V, 2000, APPL CATAL A-GEN, V198, P207, DOI 10.1016/S0926-860X(99)00510-4; Shabaker JW, 2003, J CATAL, V215, P344, DOI 10.1016/S0021-9517(03)00032-0; Shapouri H., 2002, 814 USDA OFF CHIEF E; WEISS MA, 2003, PUBLICATION MIT LAB; WEISZ PB, 1979, SCIENCE, V206, P57, DOI 10.1126/science.206.4414.57; Zhang WC, 1998, J CHEM SOC PERK T 1, P3131, DOI 10.1039/a806553e	25	1317	1439	23	795	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1446	1450		10.1126/science.1111166	http://dx.doi.org/10.1126/science.1111166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15933197	Green Published			2022-12-01	WOS:000229619300047
J	Sutherland, WJ				Sutherland, WJ			The best solution	NATURE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Sutherland, WJ (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.		Sutherland, William/B-1291-2013	Sutherland, William/0000-0002-6498-0437				Alexander R.M., 1996, OPTIMA ANIMALS; Lucas P.W., 2004, DENT FUNCTIONAL MORP; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP	3	39	39	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2005	435	7042					569	569		10.1038/435569a	http://dx.doi.org/10.1038/435569a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931199				2022-12-01	WOS:000229476200025
J	Aldaz, H; Rice, LM; Stearns, T; Agard, DA				Aldaz, H; Rice, LM; Stearns, T; Agard, DA			Insights into microtubule nucleation from the crystal structure of human gamma-tubulin	NATURE			English	Article							ALPHA-BETA-TUBULIN	Microtubules are hollow polymers of alpha beta-tubulin that show GTP-dependent assembly dynamics and comprise a critical part of the eukaryotic cytoskeleton. Initiation of new microtubules in vivo requires gamma-tubulin, organized as an oligomer within the 2.2-MDa gamma-tubulin ring complex (gamma-TuRC) of higher eukaryotes(1-3). Structural insight is lacking regarding gamma-tubulin, its oligomerization and how it promotes microtubule assembly. Here we report the 2.7-angstrom crystal structure of human gamma-tubulin bound to GTP-gamma S ( a non-hydrolysable GTP analogue). We observe a 'curved' conformation for gamma-tubulin -GTP gamma S, similar to that seen for GDP-bound, unpolymerized alpha beta-tubulin(4). Tubulins are thought to represent a distinct class of GTP-binding proteins, and conformational switching in gamma-tubulin might differ from the nucleotide-dependent switching of signalling GTPases. A crystal packing interaction replicates the lateral contacts between alpha- and beta-tubulins in the microtubule(5), and this association probably forms the basis for gamma-tubulin oligomerization within the gamma-TuRC. Laterally associated gamma-tubulins in the gamma-TuRC might promote microtubule nucleation by providing a template that enhances the intrinsically weak lateral interaction between alpha beta-tubulin heterodimers. Because they are dimeric, alpha beta-tubulins cannot form microtubule-like lateral associations in the curved conformation(5). The lateral array of gamma-tubulins we observe in the crystal reveals a unique functional property of a monomeric tubulin.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94143 USA.	agard@msg.ucsf.edu		Stearns, Tim/0000-0002-0671-6582				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	15	139	140	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					523	527		10.1038/nature03586	http://dx.doi.org/10.1038/nature03586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917813				2022-12-01	WOS:000229337800060
J	Fauci, AS				Fauci, AS			Race against time	NATURE			English	Editorial Material							VACCINE; VIRUS		NIAID, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, US Dept HHS, 9000 Rockville Pike, Bethesda, MD 20892 USA.							Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; CLEMENTS ML, 1984, LANCET, V1, P705; Gensheimer KF, 2003, EMERG INFECT DIS, V9, P1645, DOI 10.3201/eid0912.030289; Kilbourne ED, 1999, NAT MED, V5, P1119, DOI 10.1038/13436; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3	6	38	39	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					423	424		10.1038/435423a	http://dx.doi.org/10.1038/435423a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917781	Green Published			2022-12-01	WOS:000229337800027
J	Ho, D				Ho, D			Is China prepared for microbial threats?	NATURE			English	Editorial Material									Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University	Ho, D (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.								0	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					421	422		10.1038/435421a	http://dx.doi.org/10.1038/435421a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917780	Green Published, Bronze			2022-12-01	WOS:000229337800026
J	Wolfe, JM; Horowitz, TS; Kenner, NM				Wolfe, JM; Horowitz, TS; Kenner, NM			Rare items often missed in visual searches	NATURE			English	Editorial Material									Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, JM (corresponding author), Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA 02139 USA.	wolfe@search.bwh.harvard.edu	Wolfe, Jeremy M/C-1621-2012; Horowitz, Todd S/J-3376-2013; Wolfe, Jeremy M/A-9248-2016	Wolfe, Jeremy M/0000-0002-6475-1984; Wolfe, Jeremy M/0000-0002-6475-1984; Horowitz, Todd/0000-0001-5571-6266	NEI NIH HHS [R01 EY017001] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017001] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chun MM, 1996, COGNITIVE PSYCHOL, V30, P39, DOI 10.1006/cogp.1996.0002; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Gur D, 2003, ACAD RADIOL, V10, P1324, DOI 10.1016/S1076-6332(03)00466-5; Kundel HL, 2000, PROC SPIE, V3981, P135, DOI 10.1117/12.383100; Mackworth J, 1970, VIGILANCE ATTENTION; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Wickens C. D., 1993, WORKLOAD TRANSITION, P139; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016	8	328	332	4	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					439	440		10.1038/435439a	http://dx.doi.org/10.1038/435439a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917795	Green Accepted			2022-12-01	WOS:000229337800039
J	Okie, S				Okie, S			Traumatic brain injury in the war zone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189	2	549	578	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2005	352	20					2043	2047		10.1056/NEJMp058102	http://dx.doi.org/10.1056/NEJMp058102			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927GJ	15901856				2022-12-01	WOS:000229180100001
J	Stano, NM; Jeong, YJ; Donmez, I; Tummalapalli, P; Levin, MK; Patel, SS				Stano, NM; Jeong, YJ; Donmez, I; Tummalapalli, P; Levin, MK; Patel, SS			DNA synthesis provides the driving force to accelerate DNA unwinding by a helicase	NATURE			English	Article							SINGLE-STRANDED-DNA; REPLICATION FORK; BACTERIOPHAGE T7; BINDING PROTEIN; GENE-4 PROTEIN; POLYMERASE; PURIFICATION; MECHANISMS; DEFICIENT	Helicases are molecular motors that use the energy of nucleoside 5'-triphosphate (NTP) hydrolysis to translocate along a nucleic acid strand and catalyse reactions such as DNA unwinding. The ring-shaped helicase(1) of bacteriophage T7 translocates along single-stranded ( ss) DNA at a speed of 130 bases per second(2); however, T7 helicase slows down nearly tenfold when unwinding the strands of duplex DNA(3). Here, we report that T7 DNA polymerase, which is unable to catalyse strand displacement DNA synthesis by itself, can increase the unwinding rate to 114 base pairs per second, bringing the helicase up to similar speeds compared to its translocation along ssDNA. The helicase rate of stimulation depends upon the DNA synthesis rate and does not rely on specific interactions between T7 DNA polymerase and the carboxy-terminal residues of T7 helicase. Efficient duplex DNA synthesis is achieved only by the combined action of the helicase and polymerase. The strand displacement DNA synthesis by the DNA polymerase depends on the unwinding activity of the helicase, which provides ssDNA template. The rapid trapping of the ssDNA bases by the DNA synthesis activity of the polymerase in turn drives the helicase to move forward through duplex DNA at speeds similar to those observed along ssDNA.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea; Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Kookmin University; University of Connecticut	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			NIGMS NIH HHS [R01 GM055310] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; CHA TA, 1989, J BIOL CHEM, V264, P12220; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KIM YT, 1992, J BIOL CHEM, V267, P15022; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Levin M.K., 2003, MOL MOTORS, P179; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.bi.63.070194.002523; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MOK M, 1987, J BIOL CHEM, V262, P16644; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wang H, 2002, APPL PHYS A-MATER, V75, P315, DOI 10.1007/s003390201340	25	127	129	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					370	373		10.1038/nature03615	http://dx.doi.org/10.1038/nature03615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902262	Green Accepted			2022-12-01	WOS:000229185000050
J	Christiansen, SC; Cannegieter, SC; Koster, T; Vandenbroucke, JP; Rosendaal, FR				Christiansen, SC; Cannegieter, SC; Koster, T; Vandenbroucke, JP; Rosendaal, FR			Thrombophilia, clinical factors, and recurrent venous thrombotic events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-VEIN THROMBOSIS; FACTOR-V-LEIDEN; ACTIVATED PROTEIN-C; PROTHROMBIN GENE; RISK-FACTOR; HETEROZYGOUS CARRIERS; PLASMA-LEVELS; 1ST EPISODE; FACTOR-VIII; THROMBOEMBOLISM	Context Data on the recurrence rate of venous thrombotic events and the effect of several risk factors, including thrombophilia, remain controversial. The potential benefit of screening for thrombophilia with respect to prophylactic strategies and duration of anticoagulant treatment is not yet known. Objectives To estimate the recurrence rate of thrombotic events in patients after a first thrombotic event and its determinants, including thrombophilic abnormalities. Design, Setting, and Patients Prospective follow-up study of 474 consecutive patients aged 18 to 70 years without a known malignancy treated for a first objectively confirmed thrombotic event at anticoagulation clinics in the Netherlands. The Leiden Thrombophilia Study (LETS) was conducted from 1988 through 1992 and patients were followed up through 2000. Main Outcome Measures Recurrent thrombotic event based on thrombophilic risk factors, sex, type of initial thrombotic event (idiopathic or provoked), oral contraceptive use, elevated levels of factors VIII, IX, XI, fibrinogen, homocysteine, and anticoagulant deficiencies. Results A total of 474 patients were followed up for mean (SD) of 7.3 (2.7) years and complete follow-up was achieved in 447 (94%). Recurrence of thrombotic events occurred in 90 patients during a total of 3477 patient-years. The rate of thrombotic event recurrence was 25.9 per 1000 patient-years (95% confidence interval [CI], 20.8-31.8 per 1000 patient-years). The incidence rate of recurrence was highest during the first 2 years (31.9 per 1000 patient-years; 95% Cl, 20.3-43.5 per 1000 patient-years). The risk of thrombotic event recurrence was 2.7 times (95% Cl, 1.8-4.2 times) higher in men than in women. Patients whose initial thrombotic event was idiopathic had a higher risk of a thrombotic event recurrence than patients whose initial event was provoked (hazard ratio [HR], 1.9; 95% Cl, 1.2-2.9). Women who used oral contraceptives during follow-up had a higher thrombotic event recurrence rate (28.0 per,1000 patient-years; 95% Cl, 15.9-49.4 per 1000 patient-years) than those who did not (12.9 per 1000 patient-years; 95% Cl, 7.9-21.2 per 1000 patient-years). Recurrence risks of a thrombotic event by laboratory abnormality ranged from an HR of 0.6 (95% Cl, 0.3-1.1) in patients with elevated levels of factor XI to an HR of 1.8 (95% Cl, 0.9-3.7) for patients with anticoagulant deficiencies. Conclusions Prothrombotic abnormalities do not appear to play an important role in the risk of a recurrent thrombotic event. Testing for prothrombotic defects has little consequence with respect to prophylactic strategies. Clinical factors are probably more important than laboratory abnormalities in determining the duration of anticoagulation therapy.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, POB 9600, NL-2300 RC Leiden, Netherlands.	F.R.Rosendaal@lumc.nl	Vandenbroucke, Jan/AAM-3928-2020; Cannegieter, Suzanne/W-3696-2019; Rosendaal, Frits/Q-3842-2017; Christiansen, Sverre/AAD-5214-2020	Vandenbroucke, Jan/0000-0001-5668-6716; Cannegieter, Suzanne/0000-0003-4707-2303; Rosendaal, Frits/0000-0003-2558-7496; Christiansen, Sverre Christian/0000-0002-0378-0474				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Baglin T, 2004, J THROMB HAEMOST, V2, P2152, DOI 10.1111/j.1538-7836.2004.01050.x; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; De Stefano V, 2001, BRIT J HAEMATOL, V113, P630, DOI 10.1046/j.1365-2141.2001.02827.x; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Eichinger S, 2002, ARCH INTERN MED, V162, P2357, DOI 10.1001/archinte.162.20.2357; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; HULL RD, 1983, CIRCULATION, V67, P901, DOI 10.1161/01.CIR.67.4.901; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Lensing AWA, 1999, THROMB HAEMOSTASIS, V82, P1564; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Miles JS, 2001, J AM COLL CARDIOL, V37, P215, DOI 10.1016/S0735-1097(00)01080-9; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; RIDKER PM, 1995, CIRCULATION, V92, P2800, DOI 10.1161/01.CIR.92.10.2800; Rintelen C, 1996, THROMB HAEMOSTASIS, V75, P229; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Simioni P, 2003, J THROMB HAEMOST, V1, P16, DOI 10.1046/j.1538-7836.2003.00094.x; Simioni P, 2000, BLOOD, V96, P3329; vanderMeer FJM, 1997, THROMB HAEMOSTASIS, V78, P631; Vlieg AV, 2000, BLOOD, V95, P3678; Weltermann A, 2003, J THROMB HAEMOST, V1, P28, DOI 10.1046/j.1538-7836.2003.00038.x; DOCUMENT CLIN VALIDI	41	417	438	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2352	2361		10.1001/jama.293.19.2352	http://dx.doi.org/10.1001/jama.293.19.2352			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15900005	Bronze			2022-12-01	WOS:000229120600022
J	Matsumoto, S; Okitsu, T; Wanaga, Y; Noguchi, H; Nagata, H; Yonekawa, Y; Yamada, Y; Fukuda, K; Tsukiyama, K; Suzuki, H; Kawasaki, Y; Shimodaira, M; Matsuoka, K; Shibata, T; Kasai, Y; Maekawa, T; Shapiro, AMJ; Tanaka, K				Matsumoto, S; Okitsu, T; Wanaga, Y; Noguchi, H; Nagata, H; Yonekawa, Y; Yamada, Y; Fukuda, K; Tsukiyama, K; Suzuki, H; Kawasaki, Y; Shimodaira, M; Matsuoka, K; Shibata, T; Kasai, Y; Maekawa, T; Shapiro, AMJ; Tanaka, K			Insulin independence after living-donor distal pancreatectomy and islet allotransplantation	LANCET			English	Article							TRANSPLANTATION; PRESERVATION; PANCREAS	Rising demand for islet transplantation will lead to severe donor shortage in the near future, especially in countries where cadaveric organ donation is scarce. We undertook a successful transplantation of living-donor islets for unstable diabetes. The recipient was a 27-year-old woman who had had brittle, insulin-dependent diabetes mellitus for 12 years. The donor, who was a healthy 56-year-old woman and mother of the recipient, underwent a distal pancreatectomy. After isolation, 408 114 islet equivalents were transplanted immediately. The transplants functioned immediately and the recipient became insulin-independent 22 days after the operation. The donor had no complications and both women showed healthy glucose tolerance. Transplantation of living-donor islets from the distal pancreas can be sufficient to reverse brittle diabetes.	Kyoto Univ Hosp, Transplantat Unit, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Transplantat & Immunol, Kyoto, Japan; Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan; Kyoto Univ Hosp, Radiol & Nucl Med Serv, Kyoto 6068507, Japan; Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 6068507, Japan; Univ Alberta, Clin Islet TRansplant Programme, Edmonton, AB, Canada	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; University of Alberta	Matsumoto, S (corresponding author), Kyoto Univ Hosp, Transplantat Unit, Sakyo Ku, Kyoto 6068507, Japan.	shinichi@kuhp.kyoto-u.ac.jp	Yamada, Yuichiro/G-4766-2011	Noguchi, Hirofumi/0000-0002-0880-6805				GRUESSNER RWG, 2002, TRANSPLANT REV, V16, P108; Hathout E, 2003, ARCH DIS CHILD, V88, P591, DOI 10.1136/adc.88.7.591; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Matsumoto S, 2004, TRANSPLANTATION, V78, P839, DOI 10.1097/01.TP.0000130177.03326.D5; Matsumoto S, 2003, AM J TRANSPLANT, V3, P53, DOI 10.1034/j.1600-6143.2003.30110.x; Ryan EA, 2005, DIABETES CARE, V28, P343, DOI 10.2337/diacare.28.2.343; Sawada T, 2003, TRANSPLANTATION, V75, P1965, DOI 10.1097/01.TP.0000068871.09469.E0; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SUTHERLAND D E R, 1980, Diabetes, V29, P31	9	167	178	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1642	1644		10.1016/S0140-6736(05)66383-0	http://dx.doi.org/10.1016/S0140-6736(05)66383-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15889479				2022-12-01	WOS:000228933700029
J	Eichinger, L; Pachebat, JA; Glockner, G; Rajandream, MA; Sucgang, R; Berriman, M; Song, J; Olsen, R; Szafranski, K; Xu, Q; Tunggal, B; Kummerfeld, S; Madera, M; Konfortov, BA; Rivero, F; Bankier, AT; Lehmann, R; Hamlin, N; Davies, R; Gaudet, P; Fey, P; Pilcher, K; Chen, G; Saunders, D; Sodergren, E; Davis, P; Kerhornou, A; Nie, X; Hall, N; Anjard, C; Hemphill, L; Bason, N; Farbrother, P; Desany, B; Just, E; Morio, T; Rost, R; Churcher, C; Cooper, J; Haydock, S; van Driessche, N; Cronin, A; Goodhead, I; Muzny, D; Mourier, T; Pain, A; Lu, M; Harper, D; Lindsay, R; Hauser, H; James, K; Quiles, M; Babu, MM; Saito, T; Buchrieser, C; Wardroper, A; Felder, M; Thangavelu, M; Johnson, D; Knights, A; Loulseged, H; Mungall, K; Oliver, K; Price, C; Quail, MA; Urushihara, H; Hernandez, J; Rabbinowitsch, E; Steffen, D; Sanders, M; Ma, J; Kohara, Y; Sharp, S; Simmonds, M; Spiegler, S; Tivey, A; Sugano, S; White, B; Walker, D; Woodward, J; Winckler, T; Tanaka, Y; Shaulsky, G; Schleicher, M; Weinstock, G; Rosenthal, A; Cox, EC; Chisholm, RL; Gibbs, R; Loomis, WF; Platzer, M; Kay, RR; Williams, J; Dear, PH; Noegel, AA; Barrell, B; Kuspa, A				Eichinger, L; Pachebat, JA; Glockner, G; Rajandream, MA; Sucgang, R; Berriman, M; Song, J; Olsen, R; Szafranski, K; Xu, Q; Tunggal, B; Kummerfeld, S; Madera, M; Konfortov, BA; Rivero, F; Bankier, AT; Lehmann, R; Hamlin, N; Davies, R; Gaudet, P; Fey, P; Pilcher, K; Chen, G; Saunders, D; Sodergren, E; Davis, P; Kerhornou, A; Nie, X; Hall, N; Anjard, C; Hemphill, L; Bason, N; Farbrother, P; Desany, B; Just, E; Morio, T; Rost, R; Churcher, C; Cooper, J; Haydock, S; van Driessche, N; Cronin, A; Goodhead, I; Muzny, D; Mourier, T; Pain, A; Lu, M; Harper, D; Lindsay, R; Hauser, H; James, K; Quiles, M; Babu, MM; Saito, T; Buchrieser, C; Wardroper, A; Felder, M; Thangavelu, M; Johnson, D; Knights, A; Loulseged, H; Mungall, K; Oliver, K; Price, C; Quail, MA; Urushihara, H; Hernandez, J; Rabbinowitsch, E; Steffen, D; Sanders, M; Ma, J; Kohara, Y; Sharp, S; Simmonds, M; Spiegler, S; Tivey, A; Sugano, S; White, B; Walker, D; Woodward, J; Winckler, T; Tanaka, Y; Shaulsky, G; Schleicher, M; Weinstock, G; Rosenthal, A; Cox, EC; Chisholm, RL; Gibbs, R; Loomis, WF; Platzer, M; Kay, RR; Williams, J; Dear, PH; Noegel, AA; Barrell, B; Kuspa, A			The genome of the social amoeba Dictyostelium discoideum	NATURE			English	Article							HORIZONTAL GENE-TRANSFER; SIGNAL-TRANSDUCTION; ABC TRANSPORTERS; CELL-ADHESION; PROTEIN; DIFFERENTIATION; EVOLUTION; SEQUENCE; EXPRESSION; CELLULOSE	The social amoebae are exceptional in their ability to alternate between unicellular and multicellular forms. Here we describe the genome of the best-studied member of this group, Dictyostelium discoideum. The gene-dense chromosomes of this organism encode approximately 12,500 predicted proteins, a high proportion of which have long, repetitive amino acid tracts. There are many genes for polyketide synthases and ABC transporters, suggesting an extensive secondary metabolism for producing and exporting small molecules. The genome is rich in complex repeats, one class of which is clustered and may serve as centromeres. Partial copies of the extrachromosomal ribosomal DNA ( rDNA) element are found at the ends of each chromosome, suggesting a novel telomere structure and the use of a common mechanism to maintain both the rDNA and chromosomal termini. A proteome-based phylogeny shows that the amoebozoa diverged from the animal - fungal lineage after the plant - animal split, but Dictyostelium seems to have retained more of the diversity of the ancestral genome than have plants, animals or fungi.	MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Northwestern Univ, Ctr Med Genet, DictyBase, Chicago, IL 60611 USA; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Munich, Adolf Butenandt Inst Cell Biol, D-80336 Munich, Germany; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Inst Pasteur, Unite Genom Microorganismes Pathogenes, F-75724 Paris, France; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 2XZ, England; Natl Inst Genet, Ctr Genet Resource Informat, Shizuoka 4118540, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan; Goethe Univ Frankfurt, Biozentrum, Inst Pharmazeut Biol, D-60439 Frankfurt, Germany; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	MRC Laboratory Molecular Biology; University of Cologne; University of Cologne; Wellcome Trust Sanger Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; Northwestern University; University of Tsukuba; University of Munich; University of Cambridge; Hokkaido University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of York - UK; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Goethe University Frankfurt; Princeton University; University of Dundee	Dear, PH (corresponding author), MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England.	phd@mrc-lmb.cam.ac.uk	Goodhead, Ian/ABC-9200-2020; Puigbò, Pere/A-2214-2008; Hall, Neil/A-8717-2013; Mourier, Tobias/C-1164-2015; Pain, Arnab/L-5766-2015; Chisholm, Rex L/B-3418-2009; Eichinger, Ludwig/AAJ-8895-2021; Mohan, Babu P./I-7362-2019; Driemeier, David/H-3461-2012; Weinstock, George M/C-6314-2013; Dear, Paul H/A-1162-2012; Glöckner, Gernot/A-7800-2010; Fey, Petra/O-5977-2015; Quail, michael/ABE-6131-2020; Rivero, Francisco/N-2969-2013; Lu, Mingyang/F-6865-2013; Anjard, Christophe/H-5012-2017	Hall, Neil/0000-0002-7995-3810; Mourier, Tobias/0000-0003-2727-1903; Pain, Arnab/0000-0002-1755-2819; Chisholm, Rex L/0000-0002-5638-3990; Eichinger, Ludwig/0000-0003-1594-6117; Driemeier, David/0000-0003-3766-0654; Weinstock, George M/0000-0002-2997-4592; Glöckner, Gernot/0000-0002-9061-1061; Fey, Petra/0000-0002-4532-2703; Rivero, Francisco/0000-0001-5435-6991; MORIO, Takahiro/0000-0002-4007-881X; Hall, Neil/0000-0003-2808-0009; Anjard, Christophe/0000-0002-6905-1493; Kerr, Alan/0000-0001-9093-0348; Pachebat, Justin/0000-0003-3369-3205; Goodhead, Ian/0000-0002-3110-9442; Kuspa, Adam/0000-0002-9156-149X; Kerhornou, Arnaud/0000-0002-2890-295X; Kummerfeld, Sarah/0000-0002-0089-2358; Buchrieser, Carmen/0000-0003-3477-9190; Harper, David/0000-0002-8313-3516; Shaulsky, Gad/0000-0002-0532-0551; Davis, Paul/0000-0001-5545-0824; Kay, Robert R/0000-0001-9836-7967	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035925] Funding Source: NIH RePORTER; Medical Research Council [MC_U105115237] Funding Source: Medline; NICHD NIH HHS [R01 HD035925] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade AC, 2000, MOL GEN GENET, V263, P966, DOI 10.1007/PL00008697; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; Blumberg DD, 2002, J MUSCLE RES CELL M, V23, P817, DOI 10.1023/A:1024440014857; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; BURGER G, 1995, J MOL BIOL, V245, P522, DOI 10.1006/jmbi.1994.0043; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CAPPELLO J, 1984, MOL CELL BIOL, V4, P2207, DOI 10.1128/MCB.4.10.2207; CAPPELLO J, 1985, CELL, V43, P105, DOI 10.1016/0092-8674(85)90016-9; Chibalina Margarita V., 2004, BMC Developmental Biology, V4, P1; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COX EC, 1990, P NATL ACAD SCI USA, V87, P8247, DOI 10.1073/pnas.87.21.8247; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; DYNES JL, 1994, GENE DEV, V8, P948, DOI 10.1101/gad.8.8.948; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; FREEZE H, 1978, BIOCHIM BIOPHYS ACTA, V539, P529, DOI 10.1016/0304-4165(78)90086-7; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GINSBURG GT, 1995, J EUKARYOT MICROBIOL, V42, P200, DOI 10.1111/j.1550-7408.1995.tb01565.x; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Glockner G, 2001, GENOME RES, V11, P585, DOI 10.1101/gr.GR-1622RR; Good JR, 2003, DEVELOPMENT, V130, P2953, DOI 10.1242/dev.00523; Good JR, 2000, DEV BIOL, V220, P53, DOI 10.1006/dbio.2000.9611; Goodwin TJD, 2000, GENOME RES, V10, P174, DOI 10.1101/gr.10.2.174; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Katoh M, 2004, P NATL ACAD SCI USA, V101, P7005, DOI 10.1073/pnas.0306983101; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kessin RH, 1996, P NATL ACAD SCI USA, V93, P4857, DOI 10.1073/pnas.93.10.4857; KESSIN RH, 2001, DICTYOSTELIUM EVOLUT, V14, P294; Kibler K, 2003, DEV BIOL, V264, P506, DOI 10.1016/j.ydbio.2003.08.025; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; Konfortov BA, 2000, GENOME RES, V10, P1737, DOI 10.1101/gr.141700; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; KUSPA A, 1992, GENOMICS, V13, P49, DOI 10.1016/0888-7543(92)90201-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loomis WF, 1995, EXPERIENTIA, V51, P1110, DOI 10.1007/BF01944728; LOOMIS WF, 1995, GENETICS, V141, P147; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Maeda M, 2003, EUKARYOT CELL, V2, P627, DOI 10.1128/EC.2.3.627-637.2003; McClintock B, 1938, GENETICS, V23, P315; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; MORRISON A, 1994, DEV BIOL, V163, P457, DOI 10.1006/dbio.1994.1162; MULLER K, 1978, NATURE, V274, P445, DOI 10.1038/274445a0; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X; Noegel AA, 2000, J CELL SCI, V113, P759; Ogawa S, 2000, MOL GEN GENET, V263, P514, DOI 10.1007/PL00008685; OLSEN R, IN PRESS J MOL EVOL; Raisley B, 2004, DEV BIOL, V265, P433, DOI 10.1016/j.ydbio.2003.09.035; Raper K. B., 1984, DICTYOSTELIDS; Raper KB, 1935, J AGRIC RES, V50, P0135; RAPER KENNETH B., 1940, JOUR ELISHA MITCHELL SCI SOC, V56, P241; Richards TA, 2003, PROTIST, V154, P17, DOI 10.1078/143446103764928468; Rivero F, 2002, J MUSCLE RES CELL M, V23, P737, DOI 10.1023/A:1024423611223; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schoonbeek HJ, 2002, MOL PLANT MICROBE IN, V15, P1165, DOI 10.1094/MPMI.2002.15.11.1165; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; Skriwan C, 2002, INT J MED MICROBIOL, V291, P615, DOI 10.1078/1438-4221-00177; SMITH SS, 1991, BIOCHEM J, V277, P273, DOI 10.1042/bj2770273; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Su┬ll D., 1995, TRNA STRUCTURE BIOSY; Szafranski K, 2004, MOL GENET GENOMICS, V271, P98, DOI 10.1007/s00438-003-0961-9; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thomason P, 2000, J CELL SCI, V113, P3141; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Trusov YA, 1996, NUCLEIC ACIDS RES, V24, P995, DOI 10.1093/nar/24.6.995; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881; Wang YZ, 2001, EUR J BIOCHEM, V268, P4334, DOI 10.1046/j.1432-1327.2001.02354.x; West CM, 2002, EUKARYOT CELL, V1, P281, DOI 10.1128/EC.1.2.281-292.2002; Xu QK, 2004, EUKARYOT CELL, V3, P1101, DOI 10.1128/EC.3.5.1101-1110.2004; Zhang HY, 2003, BIOINFORMATICS, V19, P1391, DOI 10.1093/bioinformatics/btg168; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zhang P, 2001, DIFFERENTIATION, V67, P72, DOI 10.1046/j.1432-0436.2001.067003072.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	98	966	5105	9	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					43	57		10.1038/nature03481	http://dx.doi.org/10.1038/nature03481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875012	Green Accepted, Bronze			2022-12-01	WOS:000228864600034
J	Adams, PC; Reboussin, DM; Barton, JC; McLaren, CE; Eckfeldt, JH; McLaren, GD; Dawkins, FW; Acton, RT; Harris, EL; Gordeuk, VR; Leiendecker-Foster, C; Speechley, M; Snively, BM; Holup, JL; Thomson, E; Sholinsky, P; Acton, RT; Barton, JC; Dixon, D; Rivers, CA; Tucker, D; Ware, JC; McLaren, CE; McLaren, GD; Anton-Culver, H; Baca, JA; Bent, TC; Brunner, LC; Dao, MM; Jorgensen, KS; Kuniyoshi, J; Le, HD; Masatsugu, MK; Meyskens, FL; Morohashi, D; Nguyen, HP; Panagon, SN; Phung, C; Raymundo, V; Ton, T; Walker, AP; Wenzel, LB; Ziogas, A; Adams, PC; Bloch, E; Chakrabarti, S; Fleischhauer, A; Harrison, H; Jia, K; Larson, S; Lin, E; Lopez, M; Nguyen, L; Pepper, C; Power, T; Speechley, M; Sun, D; Woelfle, D; Jordan, J; Hogan, B; Moses, G; Harris, EL; Aickin, M; Baker, E; Erwin, M; Holup, J; Lloyd, C; Press, N; Press, RD; Reiss, J; Ritenbaugh, C; Uchida, A; Vogt, T; Yim, D; Gordeuk, VR; Dawkins, FW; Fadojutimi-Akinsiku, M; Castro, O; White-Coleman, D; Gerald, M; Harrison, BW; Lewis-Jack, O; Murray, RF; McDonald-Pinkett, S; Romagoza, J; Williams, R; Eckfeldt, JH; Leiendecker-Foster, C; McGlennen, RC; Rynders, G; Tsai, MY; Reboussin, DM; Snively, BM; Anderson, R; Bostic, E; Craven, BL; Ellis, S; Furberg, C; Griffin, J; Hall, M; Harris, D; Henkin, L; Jackson, S; Jewett, T; King, MD; Lohman, K; Lovato, L; Michaleckyj, J; Palla, S; Parks, T; Passmore, L; Phatak, PD; Rich, S; Ruggiero, A; Vitolins, M; Wolgast, G; Zaccaro, D; Sholinsky, P; Bookman, E; Chang, H; Fabsitz, R; Jaquish, C; Manolio, T; O'Neill, L; Thomson, E				Adams, PC; Reboussin, DM; Barton, JC; McLaren, CE; Eckfeldt, JH; McLaren, GD; Dawkins, FW; Acton, RT; Harris, EL; Gordeuk, VR; Leiendecker-Foster, C; Speechley, M; Snively, BM; Holup, JL; Thomson, E; Sholinsky, P; Acton, RT; Barton, JC; Dixon, D; Rivers, CA; Tucker, D; Ware, JC; McLaren, CE; McLaren, GD; Anton-Culver, H; Baca, JA; Bent, TC; Brunner, LC; Dao, MM; Jorgensen, KS; Kuniyoshi, J; Le, HD; Masatsugu, MK; Meyskens, FL; Morohashi, D; Nguyen, HP; Panagon, SN; Phung, C; Raymundo, V; Ton, T; Walker, AP; Wenzel, LB; Ziogas, A; Adams, PC; Bloch, E; Chakrabarti, S; Fleischhauer, A; Harrison, H; Jia, K; Larson, S; Lin, E; Lopez, M; Nguyen, L; Pepper, C; Power, T; Speechley, M; Sun, D; Woelfle, D; Jordan, J; Hogan, B; Moses, G; Harris, EL; Aickin, M; Baker, E; Erwin, M; Holup, J; Lloyd, C; Press, N; Press, RD; Reiss, J; Ritenbaugh, C; Uchida, A; Vogt, T; Yim, D; Gordeuk, VR; Dawkins, FW; Fadojutimi-Akinsiku, M; Castro, O; White-Coleman, D; Gerald, M; Harrison, BW; Lewis-Jack, O; Murray, RF; McDonald-Pinkett, S; Romagoza, J; Williams, R; Eckfeldt, JH; Leiendecker-Foster, C; McGlennen, RC; Rynders, G; Tsai, MY; Reboussin, DM; Snively, BM; Anderson, R; Bostic, E; Craven, BL; Ellis, S; Furberg, C; Griffin, J; Hall, M; Harris, D; Henkin, L; Jackson, S; Jewett, T; King, MD; Lohman, K; Lovato, L; Michaleckyj, J; Palla, S; Parks, T; Passmore, L; Phatak, PD; Rich, S; Ruggiero, A; Vitolins, M; Wolgast, G; Zaccaro, D; Sholinsky, P; Bookman, E; Chang, H; Fabsitz, R; Jaquish, C; Manolio, T; O'Neill, L; Thomson, E		HEIRS Study Res Investigators	Hemochromatosis and iron-overload screening in a racially diverse population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMOCHROMATOSIS; AFRICAN-AMERICANS; GENE HFE; PREVALENCE; MUTATION; HEPATITIS; FIBROSIS; ORIGIN	BACKGROUND: Iron overload and hemochromatosis are common, treatable conditions. HFE genotypes, levels of serum ferritin, transferrin saturation values, and self-reported medical history were studied in a multiethnic primary care population. METHODS: Participants were recruited from primary care practices and blood-drawing laboratories. Blood samples were tested for transferrin saturation, serum ferritin, and C282Y and H63D mutations of the HFE gene. Before genetic screening, participants were asked whether they had a history of medical conditions related to iron overload. RESULTS: Of the 99,711 participants, 299 were homozygous for the C282Y mutation. The estimated prevalence of C282Y homozygotes was higher in non-Hispanic whites (0.44 percent) than in Native Americans (0.11 percent), Hispanics (0.027 percent), blacks (0.014 percent), Pacific Islanders (0.012 percent), or Asians (0.000039 percent). Among participants who were homozygous for the C282Y mutation but in whom iron overload had not been diagnosed (227 participants), serum ferritin levels were greater than 300 microg per liter in 78 of 89 men (88 percent) and greater than 200 microg per liter in 79 of 138 women (57 percent). Pacific Islanders and Asians had the highest geometric mean levels of serum ferritin and mean transferrin saturation despite having the lowest prevalence of C282Y homozygotes. There were 364 participants in whom iron overload had not been diagnosed (29 C282Y homozygotes) who had a serum ferritin level greater than 1000 microg per liter. Among men, C282Y homozygotes and compound heterozygotes were more likely to report a history of liver disease than were participants without HFE mutations. CONCLUSIONS: The C282Y mutation is most common in whites, and most C282Y homozygotes have elevations in serum ferritin levels and transferrin saturation. The C282Y mutation does not account for high mean serum ferritin levels and transferrin saturation values in nonwhites.	London Hlth Sci Ctr, Dept Med, London, ON N6A 5A5, Canada; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA; So Iron Disorders Ctr, Birmingham, AL USA; Univ Calif Irvine, Dept Med, Div Hematol & Oncol, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA; Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; Howard Univ, Dept Med, Washington, DC 20059 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Kaiser Permanente Ctr Hlth Res, Honolulu, HI USA; NHGRI, Bethesda, MD 20892 USA; NHLBI, Epidemiol & Biometry Program, Bethesda, MD 20892 USA	London Health Sciences Centre; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Howard University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; Western University (University of Western Ontario); Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adams, PC (corresponding author), London Hlth Sci Ctr, Dept Med, 339 Windermere Rd, London, ON N6A 5A5, Canada.	padams@uwo.ca	Ellis, Shellie/GXG-6869-2022; Ellis, Shellie/I-4811-2015; Gordeuk, Victor/AAG-6577-2019; Adams, Paul/G-2868-2011	Ellis, Shellie/0000-0002-3599-0804; Adams, Paul/0000-0002-9921-2956; Barton, James/0000-0003-2876-8276	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005189, N01HC005188, N01HC005185, N01HC005186, N01HC005192, N01HC005191, N01HC005190] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827, M01RR010284, M01RR000032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL003679] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR10284, M01-RR00827, M01-RR00032] Funding Source: Medline; NHLBI NIH HHS [N01-HC-05189, UH1-HL03679-05, N01-HC-05185, N01-HC-05186, N01-HC-05188, N01-HC-05190, N01-HC-05191, N01-HC-05192] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams PC, 1996, HEPATOLOGY, V23, P724, DOI 10.1002/hep.510230411; Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002; Bacon BR, 2001, GASTROENTEROLOGY, V120, P718, DOI 10.1053/gast.2001.21913; Barton JC, 2003, BLOOD CELL MOL DIS, V31, P310, DOI 10.1016/S1079-9796(03)00166-9; Beaton M, 2002, HEPATOLOGY, V36, P673, DOI 10.1053/jhep.2002.35343; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Cox DR, 1979, THEORETICAL STAT; DIBISCEGLIE AM, 1992, GASTROENTEROLOGY, V102, P2108, DOI 10.1016/0016-5085(92)90339-Z; EASON RJ, 1990, AUST NZ J MED, V20, P226, DOI 10.1111/j.1445-5994.1990.tb01024.x; GORDEUK VR, 1986, LANCET, V1, P1310; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016/S1079-9796(03)00164-5; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Kng C, 2001, J CLIN GASTROENTEROL, V33, P69, DOI 10.1097/00004836-200107000-00017; Lucotte G, 2003, BLOOD CELL MOL DIS, V31, P262, DOI 10.1016/S1079-9796(03)00133-5; McLaren CE, 2003, AM J MED SCI, V325, P53, DOI 10.1097/00000441-200302000-00001; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Morrison ED, 2003, ANN INTERN MED, V139, P235, DOI 10.7326/0003-4819-139-3-200308050-00022; Morrison ED, 2003, ANN INTERN MED, V138, P627, DOI 10.7326/0003-4819-138-8-200304150-00008; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; OLIVER M, 1995, DIGEST DIS SCI, V40, P1589, DOI 10.1007/BF02285215; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Olynyk JK, 2004, MAYO CLIN PROC, V79, P309, DOI 10.4065/79.3.309; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Riggio O, 1997, AM J GASTROENTEROL, V92, P1298; Rochette J, 1999, AM J HUM GENET, V64, P1056, DOI 10.1086/302318; Steinberg KK, 2001, JAMA-J AM MED ASSOC, V285, P2216, DOI 10.1001/jama.285.17.2216; Tung BY, 2003, GASTROENTEROLOGY, V124, P318, DOI 10.1053/gast.2003.50046; Weir B.S., 1996, GENETIC DATA ANAL; Yamashita C, 2003, CLIN GASTROENTEROL H, V1, P388, DOI 10.1053/S1542-3565(03)00187-3	33	518	537	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1769	1778		10.1056/NEJMoa041534	http://dx.doi.org/10.1056/NEJMoa041534			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858186	Green Published			2022-12-01	WOS:000228689000007
J	Chamberlain, P				Chamberlain, P			Death after withdrawal of nutrition and hydration	LANCET			English	Editorial Material							RIGHT-TO-DIE		John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Chamberlain, P (corresponding author), John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	paul.chamberlain@obs-gyn.ox.ac.uk						GOVE M, 2005, TIMES LONDON    0329, P18; *IR MED COUNC, 1995, IR MED COUNC STAT; JENNETT B, 2002, VEGETATIVE STATE MED; MURDOCH A, 1995, BRIT MED J, V311, P405; SHERWELL P, 2005, SUNDAY TELEGRAP 0327, P17; WALL M, 1995, LANCET, V346, P368, DOI 10.1016/S0140-6736(95)92243-1	6	9	9	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1446	1447		10.1016/S0140-6736(05)66397-0	http://dx.doi.org/10.1016/S0140-6736(05)66397-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850616				2022-12-01	WOS:000228651600007
J	Macleod, J; Salisbury, C; Low, N; McCarthy, A; Sterne, JAC; Holloway, A; Patel, R; Sanford, E; Morcom, A; Horner, P; Smith, GD; Skidmore, S; Herring, A; Caul, O; Hobbs, FDR; Egger, M				Macleod, J; Salisbury, C; Low, N; McCarthy, A; Sterne, JAC; Holloway, A; Patel, R; Sanford, E; Morcom, A; Horner, P; Smith, GD; Skidmore, S; Herring, A; Caul, O; Hobbs, FDR; Egger, M			Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article								Objective To measure the coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and the prevalence of infection in the general population in the United Kingdom. To investigate factors associated with these measures. Design Cross sectional survey of people randomly selected from general practice registers. Invitation to provide a specimen collected at home. Setting England. Participants 19 773 men and women aged 16-39 years invited to participate in screening. Main outcome measures Coverage and uptake of screening; prevalence of chlamydia. Results Coverage of chlamydia screening was 73% and was lower in areas with a higher proportion of non-white residents. Uptake in 16-24 year olds was 31.5% and was lower in men, younger adults, and practices in disadvantaged areas. Overall prevalence of chlamydia was 2.8% (95% confidence interval 2.2% to 3.4%) in men and 3.6% (3. 1 % to 4.9%) in women, but it was higher in people younger than 25 years (men 5. 1 %; 4.0% to 6.3%; women 6.2%; 5.2% to 7.8%). Prevalence was higher in the subgroup of younger women who were harder to engage in screening. The strongest determinant of chlamydial infection was having one or more new sexual partners in the past year. Conclusions Postal chlamydia screening was feasible, but coverage was incomplete and uptake was modest. Lower coverage of postal screening in areas with more non-white residents along with poorer uptake in more deprived areas and among women at higher risk of infection could mean that screening leads to wider inequalities in sexual health.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Bristol, Dept Community Based Med, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; United Bristol Healthcare Trust, Milne Ctr, Bristol BS21 7LR, Avon, England; Publ Hlth Lab Serv, Birmingham B9 5SS, W Midlands, England; Publ Hlth Lab Serv, Genitourinary Infect Reference Lab, Bristol BS2 8EL, Avon, England	University of Birmingham; University of Bristol; University of Bristol; University of Bern	Macleod, J (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	j.a.macleod@bham.ac.uk	Fazli, Ghazal/AAE-8320-2022; Davey Smith, George/A-7407-2013; Low, Nicola/H-4718-2019; Sterne, Jonathan/Z-3106-2019; Salisbury, Chris/C-6724-2008	Davey Smith, George/0000-0002-1407-8314; Low, Nicola/0000-0003-4817-8986; Sterne, Jonathan/0000-0001-8496-6053; Salisbury, Chris/0000-0002-4378-3960; Macleod, John/0000-0001-8202-1144; hobbs, richard/0000-0001-7976-7172; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Egger, Matthias/0000-0001-7462-5132; Horner, Paddy/0000-0003-0411-8332; s, hema/0000-0002-3440-9475; Holloway, Aisha/0000-0003-3070-3703				Andersen B, 2002, J INFECT DIS, V185, P252, DOI 10.1086/338268; *DEP HLTH, 2001, CHOOS HLTH MAK HLTH; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Low N, 2003, LANCET, V362, P1157, DOI 10.1016/S0140-6736(03)14480-7; Low N, 2002, INT J EPIDEMIOL, V31, P891, DOI 10.1093/ije/31.5.891; Low N, 2001, SEX TRANSM INFECT, V77, P15, DOI 10.1136/sti.77.1.15; Low N, 2004, SEX TRANSM INFECT, V80, P342, DOI 10.1136/sti.2003.006197; Macleod J, 1999, BRIT J GEN PRACT, V49, P455; OSTERGAARD L, 2002, SCREENING KLAMYDIA M; SALISBURY C, 2005, IN PRESS BRIT J GEN	10	97	98	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					940	942		10.1136/bmj.38413.663137.8F	http://dx.doi.org/10.1136/bmj.38413.663137.8F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15809231	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000228715900021
J	Singh, DK; Kumar, D; Siddiqui, Z; Basu, SK; Kumar, V; Rao, KVS				Singh, DK; Kumar, D; Siddiqui, Z; Basu, SK; Kumar, V; Rao, KVS			The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CELL ANTIGEN RECEPTOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; B-LYMPHOCYTES; NADPH OXIDASE; IN-VIVO; ACTIVATION; KINASE; IDENTIFICATION	Activation of cell-surface receptors stimulates generation of intracellular signals that, in turn, direct the cellular response. However, mechanisms that ensure combinatorial control of these signaling events are not well understood. We show here that the Ca2+ and reactive oxygen intermediates generated upon BCR activation rapidly engage in a cooperative interaction that acts in a feedback manner to amplify the early signal generated. This cooperativity acts by regulating the concentration of the oxidant produced. The latter exerts its influence through a pulsed inactivation of receptor-coupled phosphatases, where the amplitude of this pulse is determined by oxidant concentration. The extent of phosphatase inhibition, in turn, dictates what proportion of receptor-proximal kinases are activated and, as a result, the net strength of the initial signal. It is the strength of this initial signal that finally determines the eventual duration of BCR signaling and the rate of its transmission through downstream pathways.	Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	Singh, Dinesh/S-3636-2019; Kumar, Vikas/D-3406-2009; Singh, Dinesh/A-1045-2009	Singh, Dinesh/0000-0002-3594-2431; Singh, Dinesh/0000-0002-3594-2431				Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fuentes-Panana EM, 2004, IMMUNOL REV, V197, P26, DOI 10.1111/j.0105-2896.2004.0105.x; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hua CT, 1998, J BIOL CHEM, V273, P28332, DOI 10.1074/jbc.273.43.28332; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kubohara Y, 1999, BIOCHEM BIOPH RES CO, V263, P790, DOI 10.1006/bbrc.1999.1468; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; NAKAMURA Y, 1991, BIOCHEMISTRY-US, V30, P4880, DOI 10.1021/bi00234a007; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; Qin SF, 2000, P NATL ACAD SCI USA, V97, P7118, DOI 10.1073/pnas.130198197; Reth M, 2004, NAT REV IMMUNOL, V4, P269, DOI 10.1038/nri1335; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X; Yoshida K, 2001, MOL PHARMACOL, V60, P1431, DOI 10.1124/mol.60.6.1431; Zhang S, 1998, ACM SIGPLAN NOTICES, V33, P11, DOI 10.1145/277633.277635	38	166	171	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					281	293		10.1016/j.cell.2005.02.036	http://dx.doi.org/10.1016/j.cell.2005.02.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851034	Bronze			2022-12-01	WOS:000228705000015
J	Dean, RA; Talbot, NJ; Ebbole, DJ; Farman, ML; Mitchell, TK; Orbach, MJ; Thon, M; Kulkarni, R; Xu, JR; Pan, HQ; Read, ND; Lee, YH; Carbone, I; Brown, D; Oh, YY; Donofrio, N; Jeong, JS; Soanes, DM; Djonovic, S; Kolomiets, E; Rehmeyer, C; Li, WX; Harding, M; Kim, S; Lebrun, MH; Bohnert, H; Coughlan, S; Butler, J; Calvo, S; Ma, LJ; Nicol, R; Purcell, S; Nusbaum, C; Galagan, JE; Birren, BW				Dean, RA; Talbot, NJ; Ebbole, DJ; Farman, ML; Mitchell, TK; Orbach, MJ; Thon, M; Kulkarni, R; Xu, JR; Pan, HQ; Read, ND; Lee, YH; Carbone, I; Brown, D; Oh, YY; Donofrio, N; Jeong, JS; Soanes, DM; Djonovic, S; Kolomiets, E; Rehmeyer, C; Li, WX; Harding, M; Kim, S; Lebrun, MH; Bohnert, H; Coughlan, S; Butler, J; Calvo, S; Ma, LJ; Nicol, R; Purcell, S; Nusbaum, C; Galagan, JE; Birren, BW			The genome sequence of the rice blast fungus Magnaporthe grisea	NATURE			English	Article							INDUCED POINT MUTATION; GENE-EXPRESSION; DRAFT SEQUENCE; PHYSICAL MAP; RESISTANCE; INFECTION; KINASE; ORGANIZATION; SPECIFICITY; CONTAINS	Magnaporthe grisea is the most destructive pathogen of rice worldwide and the principal model organism for elucidating the molecular basis of fungal disease of plants. Here, we report the draft sequence of the M. grisea genome. Analysis of the gene set provides an insight into the adaptations required by a fungus to cause disease. The genome encodes a large and diverse set of secreted proteins, including those defined by unusual carbohydrate-binding domains. This fungus also possesses an expanded family of G-protein-coupled receptors, several new virulence-associated genes and large suites of enzymes involved in secondary metabolism. Consistent with a role in fungal pathogenesis, the expression of several of these genes is upregulated during the early stages of infection-related development. The M. grisea genome has been subject to invasion and proliferation of active transposable elements, reflecting the clonal nature of this fungus imposed by widespread rice cultivation.	N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; Univ Exeter, Sch Biol & Chem Sci, Washington Singer Labs, Exeter EX4 4QG, Devon, England; Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Univ Arizona, Dept Plant Pathol, Tucson, AZ 85721 USA; Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland; Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151742, South Korea; Bayer Cropsci, CNRS Bayer, FRE2579, F-69263 Lyon, France; Agilent Technol, Wilmington, DE 19808 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA	University of North Carolina; North Carolina State University; University of Exeter; Texas A&M University System; Texas A&M University College Station; University of Kentucky; University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Edinburgh; Seoul National University (SNU); Bayer AG; Bayer CropScience; Agilent Technologies; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Dean, RA (corresponding author), N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA.	Ralph_Dean@ncsu.edu	Thon, Michael R/M-9463-2014; Talbot, Nicholas J/I-9584-2014; Talbot, Nicholas J/I-5618-2019; Ma, Li-Jun/AAG-2359-2020; Harding, Michael/R-4098-2019	Thon, Michael R/0000-0002-7225-7003; Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757; Harding, Michael/0000-0002-9322-1894; Nicol, Robert/0000-0003-1932-1392; Galagan, James/0000-0003-0542-3291; LEBRUN, marc-henri/0000-0003-1562-1902; Oh, Yeonyee/0000-0002-5571-3687; Pan, Huaqin/0000-0002-7166-108X; Read, Nick/0000-0002-2286-2862; Ma, Li-Jun/0000-0002-2733-3708; Rehmeyer Caudill, Cathryn/0000-0001-8267-8795; Bohnert, Heidi/0000-0002-0887-5026				Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bolker M, 1998, FUNGAL GENET BIOL, V25, P143, DOI 10.1006/fgbi.1998.1102; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; CHAO CCT, 1991, CAN J BOT, V69, P2130, DOI 10.1139/b91-267; Dean RA, 1997, ANNU REV PHYTOPATHOL, V35, P211, DOI 10.1146/annurev.phyto.35.1.211; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Ebbole DJ, 2004, MOL PLANT MICROBE IN, V17, P1337, DOI 10.1094/MPMI.2004.17.12.1337; Farman ML, 2002, GENETICS, V160, P137; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; MOSS J, 1993, J BIOL CHEM, V268, P6383; Nakayashiki H, 2001, NUCLEIC ACIDS RES, V29, P4106, DOI 10.1093/nar/29.20.4106; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nitta N, 1997, THEOR APPL GENET, V95, P20, DOI 10.1007/s001220050528; Ptashne M, 2003, SCIENCE, V299, P1025, DOI 10.1126/science.1081519; Schmidt R, 2000, CURR OPIN PLANT BIOL, V3, P97, DOI 10.1016/S1369-5266(99)00048-5; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Steiner-Lange S, 2003, MOL PLANT MICROBE IN, V16, P893, DOI 10.1094/MPMI.2003.16.10.893; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; SWEIGARD JA, 1993, GENETIC MAPS; Takano Y, 2003, MOL PLANT PATHOL, V4, P337, DOI [10.1046/j.1364-3703.2003.00182.x, 10.1046/J.1364-3703.2003.00182.X]; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; THIERINGER R, 1991, J BIOL CHEM, V266, P13110; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Thon MR, 2004, FUNGAL GENET BIOL, V41, P657, DOI 10.1016/j.fgb.2004.02.003; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; Weiland J., 1997, FUNGAL GENET NEWSL, V44, P60, DOI DOI 10.4148/1941-4765.1290; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZEIGELR RS, 1994, RICE BLAST DIS; Zhu H, 1999, GENOME RES, V9, P739	50	1115	1645	12	242	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					980	986		10.1038/nature03449	http://dx.doi.org/10.1038/nature03449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846337	hybrid			2022-12-01	WOS:000228524600029
J	Tanaka, K; Mukae, N; Dewar, H; van Breugel, M; James, EK; Prescott, AR; Antony, C; Tanaka, TU				Tanaka, K; Mukae, N; Dewar, H; van Breugel, M; James, EK; Prescott, AR; Antony, C; Tanaka, TU			Molecular mechanisms of kinetochore capture by spindle microtubules	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; NEWT LUNG-CELLS; BUDDING YEAST; MITOTIC-SPINDLE; CHROMOSOME ATTACHMENT; PRECOCIOUS SEPARATION; SISTER CHROMATIDS; BI-ORIENTATION; DASH COMPLEX; DYNAMICS	For high-fidelity chromosome segregation, kinetochores must be properly captured by spindle microtubules, but the mechanisms underlying initial kinetochore capture have remained elusive. Here we visualized individual kinetochore-microtubule interactions in Saccharomyces cerevisiae by regulating the activity of a centromere. Kinetochores are captured by the side of microtubules extending from spindle poles, and are subsequently transported poleward along them. The microtubule extension from spindle poles requires microtubule plus-end-tracking proteins and the Ran GDP/GTP exchange factor. Distinct kinetochore components are used for kinetochore capture by microtubules and for ensuring subsequent sister kinetochore bi-orientation on the spindle. Kar3, a kinesin-14 family member, is one of the regulators that promote transport of captured kinetochores along microtubules. During such transport, kinetochores ensure that they do not slide off their associated microtubules by facilitating the conversion of microtubule dynamics from shrinkage to growth at the plus ends. This conversion is promoted by the transport of Stu2 from the captured kinetochores to the plus ends of microtubules.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Dundee; Max Planck Society; European Molecular Biology Laboratory (EMBL)	Tanaka, K (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	t.tanaka@dundee.ac.uk	antony, claude/K-5342-2013; Tanaka, Tomoyuki U/A-4775-2008; Prescott, Alan/Y-5956-2018; James, Euan K/K-1135-2012; Tanaka, Kozo/Y-6566-2018	Prescott, Alan/0000-0002-0747-7317; James, Euan K/0000-0001-7969-6570; Tanaka, Kozo/0000-0001-6086-2858; Tanaka, Tomoyuki/0000-0002-9886-5947				Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; King JM, 2000, J CELL BIOL, V151, P739, DOI 10.1083/jcb.151.4.739; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MERDES A, 1990, EUR J CELL BIOL, V53, P313; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Muller-Reichert T, 2003, CHROMOSOMA, V111, P417, DOI 10.1007/s00412-002-0220-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; PICKETTHEAPS J, 1991, INT REV CYTOL, V128, P63; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, PHILOS T R SOC B, V360, P581, DOI 10.1098/rstb.2004.1612; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663	50	216	219	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					987	994		10.1038/nature03483	http://dx.doi.org/10.1038/nature03483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846338				2022-12-01	WOS:000228524600030
J	Fridkin, SK; Hageman, JC; Morrison, M; Sanza, LT; Como-Sabetti, K; Jernigan, JA; Harriman, K; Harrison, LH; Lynfield, R; Farley, MM				Fridkin, SK; Hageman, JC; Morrison, M; Sanza, LT; Como-Sabetti, K; Jernigan, JA; Harriman, K; Harrison, LH; Lynfield, R; Farley, MM		Active Bacterial Core Surveillance	Methicillin-resistant staphylococcus aureus disease in three communities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CLINDAMYCIN TREATMENT; UNITED-STATES; INFECTIONS; CHILDREN; SKIN; EPIDEMIOLOGY; BACTEREMIA; ADULTS	BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear. METHODS: We evaluated MRSA infections in patients identified from population-based surveillance in Baltimore and Atlanta and from hospital-laboratory-based sentinel surveillance of 12 hospitals in Minnesota. Information was obtained by interviewing patients and by reviewing their medical records. Infections were classified as community-acquired MRSA disease if no established risk factors were identified. RESULTS: From 2001 through 2002, 1647 cases of community-acquired MRSA infection were reported, representing between 8 and 20 percent of all MRSA isolates. The annual disease incidence varied according to site (25.7 cases per 100,000 population in Atlanta vs. 18.0 per 100,000 in Baltimore) and was significantly higher among persons less than two years old than among those who were two years of age or older (relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) and among blacks than among whites in Atlanta (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07). Six percent of cases were invasive, and 77 percent involved skin and soft tissue. The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. Among patients with skin or soft-tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. Overall, 23 percent of patients were hospitalized for the MRSA infection. CONCLUSIONS: Community-associated MRSA infections are now a common and serious problem. These infections usually involve the skin, especially among children, and hospitalization is common.	Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Minneapolis, MN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Minnesota Department of Health (MHD)	Fridkin, SK (corresponding author), CDC, NCID, DBMD, MDB, MS C-09,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	skf0@cdc.gov		Jernigan, John/0000-0001-8163-925X				Albanese BA, 2002, CLIN INFECT DIS, V34, P15, DOI 10.1086/323674; [Anonymous], 1999, JAMA, V282, P1123; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baggett HC, 2003, INFECT CONT HOSP EP, V24, P397, DOI 10.1086/502221; BRUMFITT W, 1989, NEW ENGL J MED, V320, P1188, DOI 10.1056/NEJM198905043201806; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P919; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Culpepper R, 2002, JAMA-J AM MED ASSOC, V287, P181; Daum RS, 2001, CRIT CARE MED, V29, pN92, DOI 10.1097/00003246-200104001-00007; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Frank AL, 2002, PEDIATR INFECT DIS J, V21, P530, DOI 10.1097/00006454-200206000-00010; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Iyer S, 2004, J AM ACAD DERMATOL, V50, P854, DOI 10.1016/j.jaad.2003.12.043; JORGENSEN JH, 1986, EUR J CLIN MICROBIOL, V5, P693, DOI 10.1007/BF02013307; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marcinak JF, 2003, CURR OPIN INFECT DIS, V16, P265, DOI 10.1097/00001432-200306000-00014; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NNIS System, 2002, AM J INFECT CONTROL, V30, P458, DOI 10.1067/mic.2002.130032; Raney PM, 2002, DIAGN MICR INFEC DIS, V43, P135, DOI 10.1016/S0732-8893(02)00378-4; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Taylor G, 1990, Can J Infect Dis, V1, P121; Watt JP, 2004, CLIN INFECT DIS, V38, P496, DOI 10.1086/381198; 2003, MMWR MORB MORTAL WKL, V52, P793; 2003, MMWR MORB MORTAL WKL, V52, P992; 2003, JAMA, V289, P1377; 2004, MMWR MORB MORTAL WKL, V53, P767	38	1114	1183	0	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2005	352	14					1436	1444		10.1056/NEJMoa043252	http://dx.doi.org/10.1056/NEJMoa043252			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913IP	15814879				2022-12-01	WOS:000228145200007
J	DeRiemer, K; Garcia-Garcia, L; Bobadilla-del-Valle, M; Palacios-Martinez, M; Martinez-Gamboa, A; Small, PM; Sifuentes-Osornio, J; Ponce-de-Leon, A				DeRiemer, K; Garcia-Garcia, L; Bobadilla-del-Valle, M; Palacios-Martinez, M; Martinez-Gamboa, A; Small, PM; Sifuentes-Osornio, J; Ponce-de-Leon, A			Does DOTS work in populations with drug-resistant tuberculosis?	LANCET			English	Article							EPIDEMIOLOGY; STANDARD	Background Directly observed therapy (DOTS) is the main strategy for prevention and control of tuberculosis worldwide. However, its effect on tuberculosis transmission in populations with moderate rates of drug-resistant disease is not known. Methods This population-based prospective study in southern Mexico between March, 1995, and February, 2000, was based on passive case finding and detection of acid-fast bacilli in sputum samples to diagnose pulmonary tuberculosis. We also used cultures, drug-susceptibility testing, bacterial genotyping, and monitoring of treatment outcomes. Findings We enrolled 436 patients; the HIV seroprevalence rate was 2%. We used three indicators to monitor continuing tuberculosis transmission: the incidence rate of pulmonary tuberculosis, which decreased by 54.4% between 1995 and 2000, from 42.1 to 19.2 per 10(5) population (p=0.00048); the percentage of clustered pulmonary tuberculosis cases, which decreased by 62.6% from 22% to 8% (p=0.02); and the rate of primary drug resistance, which decreased by 84.0% from 9.4 to 1.5 per 10(5) population (p=0.004). Rates of multidrug-resistant (MDR) tuberculosis also decreased (p<0.0001). The case-fatality ratio was 12% for MDR tuberculosis (five of 41), 7% for strains resistant to at least one drug after exclusion of MDR (four of 55), and 3% for pansusceptible strains (nine of 272). There were 13 treatment failures (11%) in 1995 and one (2%) in 2000 (p=0.012). Interpretation Even in settings with moderate rates of MDR tuberculosis, DOTS can rapidly reduce the transmission and incidence of both drug-susceptible and drug-resistant tuberculosis. However, further interventions, such as drug-susceptibility testing and standardised or individualised treatment regimens, are needed to reduce mortality rates for MDR tuberculosis.	Inst Nacl Salud Publ, TB Unit, Cuernavaca 62508, Morelos, Mexico; Stanford Univ, Med Ctr, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; Bill & Melinda Gates Fdn, Seattle, WA USA; Univ Panamericana, Sch Med, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Stanford University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Bill & Melinda Gates Foundation; Universidad Panamericana - Ciudad de Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, TB Unit, Ave Univ 655,Colonia Sta Maria Ahuacatitlan, Cuernavaca 62508, Morelos, Mexico.	garcigar@correo.insp.mx	Bobadilla-del-Valle, Miriam/AAD-6418-2020; García, Maria de Lourdes/I-2724-2019	García, Maria de Lourdes/0000-0001-5262-1157; Sifuentes-Osornio, Jose/0000-0001-9584-1360; BOBADILLA-DEL VALLE, MIRIAM/0000-0003-1184-827X; DeRiemer, Kathryn/0000-0002-8375-7505; Ponce-de-Leon, Alfredo/0000-0003-2640-2916	FIC NIH HHS [K01 TW000001, K01 TW000001-06] Funding Source: Medline; NIAID NIH HHS [AI 35969] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [K01TW000001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035969] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Garcia-Garcia MD, 1999, INT J EPIDEMIOL, V28, P135, DOI 10.1093/ije/28.1.135; Garcia-Garcia MD, 2000, INT J TUBERC LUNG D, V4, P12; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; *I NAC EST GEOGR I, 1995, AN EST EST VER MEX T; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Kim JY, 2003, TUBERCULOSIS, V83, P59, DOI 10.1016/S1472-9792(02)00078-1; Lie RK, 2004, J MED ETHICS, V30, P190, DOI 10.1136/jme.2003.006031; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Pan AmericanHealthOrganization, 1998, B EPIDEMIOL, P1; Park SK, 2002, INT J TUBERC LUNG D, V6, P143; Pio A, 1997, B WORLD HEALTH ORGAN, V75, P569; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P707; *SECR SAL, 2000, NOM006SSA2 NORM OF M; Secretaria de Salud, 1995, NOM006SSA2 SECR SAL, P20; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; *WHO IUATLD, 2000, WHOCDCTB2000278; World Health Organization, 2002, WHOCDSTB2002297; YANEZVELASCO LB, 1997, INT J TUBERC LUNG D, V1, pS68; Yang ZH, 2000, J CLIN MICROBIOL, V38, P3572, DOI 10.1128/JCM.38.10.3572-3576.2000	30	64	67	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2005	365	9466					1239	1245		10.1016/S0140-6736(05)74812-1	http://dx.doi.org/10.1016/S0140-6736(05)74812-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811457				2022-12-01	WOS:000228107600027
J	Schoffelen, JM; Oostenveld, R; Fries, P				Schoffelen, JM; Oostenveld, R; Fries, P			Neuronal coherence as a mechanism of effective corticospinal interaction	SCIENCE			English	Article							CAT VISUAL-CORTEX; CORTICAL-NEURONS; COINCIDENCE DETECTION; MOTOR CORTEX; HUMAN BRAIN; IN-VIVO; SYNCHRONIZATION; OSCILLATIONS; MODULATION; MUSCLE	Neuronal groups can interact with each other even if they are widely separated. One group might modulate its firing rate or its internal oscillatory synchronization to influence another group. We propose that coherence between two neuronal groups is a mechanism of efficient interaction, because it renders mutual input optimally timed and thereby maximally effective. Modulations of subjects' readiness to respond in a simple reaction-time task were closely correlated with the strength of gamma-band (40 to 70 hertz) coherence between motor cortex and spinal cord neurons. This coherence may contribute to an effective corticospinal interaction and shortened reaction times.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands; Aalborg Univ, Ctr Sensory Motor Interact, DK-9220 Aalborg, Denmark	Radboud University Nijmegen; Radboud University Nijmegen; Aalborg University	Schoffelen, JM (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands.	jan.schoffelen@fcdonders.ru.nl	Schoffelen, Jan-Mathijs/D-3716-2009; Fries, Pascal/E-3196-2010; Oostenveld, Robert/D-3259-2009	Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Fries, Pascal/0000-0002-4270-1468; Oostenveld, Robert/0000-0002-1974-1293				Andino SLG, 2005, HUM BRAIN MAPP, V24, P50, DOI 10.1002/hbm.20056; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kilner JM, 2000, J NEUROSCI, V20, P8838; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Livingstone MS, 1996, J NEUROPHYSIOL, V75, P2467, DOI 10.1152/jn.1996.75.6.2467; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Pinto DJ, 2003, J COMPUT NEUROSCI, V15, P283, DOI 10.1023/A:1025825102620; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Tiesinga PHE, 2004, NEURAL COMPUT, V16, P251, DOI 10.1162/089976604322742029; Trillenberg P, 2000, CLIN NEUROPHYSIOL, V111, P1216, DOI 10.1016/S1388-2457(00)00274-1; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1	26	371	377	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					111	113		10.1126/science.1107027	http://dx.doi.org/10.1126/science.1107027			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802603	Green Published			2022-12-01	WOS:000228221500044
J	Croll, DA; Maron, JL; Estes, JA; Danner, EM; Byrd, GV				Croll, DA; Maron, JL; Estes, JA; Danner, EM; Byrd, GV			Introduced predators transform subarctic islands from grassland to tundra	SCIENCE			English	Article							TROPHIC CASCADES; FOOD WEBS; COMMUNITIES; ECOLOGY; MARINE	Top predators often have powerful direct effects on prey populations, but whether these direct effects propagate to the base of terrestrial food webs is debated. There are few examples of trophic cascades strong enough to alter the abundance and composition of entire plant communities. We show that the introduction of arctic foxes (Alopex lagopus) to the Aleutian archipelago induced strong shifts in plant productivity and community structure via a previously unknown pathway. By preying on seabirds, foxes reduced nutrient transport from ocean to land, affecting soil fertility and transforming grasslands to dwarf shrub/forb-dominated ecosystems.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; US Geol Survey, Western Ecol Res Ctr, Santa Cruz, CA 95060 USA; US Fish & Wildlife Serv, Homer, AK 99603 USA	University of California System; University of California Santa Cruz; University of Montana System; University of Montana; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Croll, DA (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.	croll@biology.ucsc.edu	Bond, Alexander L/A-3786-2010	Byrd, George Vernon/0000-0003-1108-541X; Danner, Eric/0000-0003-0860-2869				[Anonymous], 2004, FOOD WEBS LANDSCAPE; BYRD GV, 1994, T N AM WILDL NAT RES, P317; Carpenter S. R., 1993, Bulletin of the Ecological Society of America, V74, P186; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; COUNCIL NR, 1996, BERING SEA ECOSYSTEM; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Halaj J, 2002, ECOLOGY, V83, P3141, DOI 10.2307/3071849; Kitchell JF, 1999, LIMNOL OCEANOGR, V44, P828, DOI 10.4319/lo.1999.44.3_part_2.0828; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1980, J ANIM ECOL, V49, P667; Paine RT, 2000, J MAMMAL, V81, P637, DOI 10.1644/1545-1542(2000)081<0637:PFTMMR>2.3.CO;2; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; SCHNEIDER DE, 2004, FOOD WEBS LANDSCAPE, P12; SHAVER GR, 1986, ARCTIC ALPINE RES, V18, P261, DOI 10.2307/1550883; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; *US FISH WILDL SER, 2004, BER SEAB COL CAT COM; Williamson M. H., 1981, ISLAND POPULATIONS; [No title captured]	23	350	366	4	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2005	307	5717					1959	1961		10.1126/science.1108485	http://dx.doi.org/10.1126/science.1108485			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790855				2022-12-01	WOS:000227957300056
J	Stainier, DYR				Stainier, DYR			No organ left behind: Tales of gut development and evolution	SCIENCE			English	Editorial Material							SONIC HEDGEHOG; GENES; REGIONALIZATION; ORGANOGENESIS; MORPHOGENESIS; EXPRESSION	The function of an organ is dependent on its cellular constituents as well as on their assembly into a cohesive unit. The developing gut faces unique challenges as one of the longest and largest organs in the body and also because it is constantly interfacing with external factors through the diet. Its location deep within the body has until recently hampered investigation into its formation. The patterning of the gut along its longitudinal, dorsoventral, left-right, and radial axes is one of the fascinating issues that pertain to the development, function, and homeostasis of this understudied organ.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA.	didier_stainier@biochem.ucsf.edu		Stainier, Didier/0000-0002-0382-0026				Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barbara PD, 2002, AM J MED GENET, V115, P221, DOI 10.1002/ajmg.10978; Beck F, 2000, BIOESSAYS, V22, P431, DOI 10.1002/(SICI)1521-1878(200005)22:5<431::AID-BIES5>3.0.CO;2-X; BIENZ M, 1994, TRENDS GENET, V10, P22, DOI 10.1016/0168-9525(94)90015-9; Brittan M, 2004, CELL PROLIFERAT, V37, P35, DOI 10.1111/j.1365-2184.2004.00299.x; Clements D, 2001, INT REV CYTOL, V203, P383; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Fukuda K, 2002, J GASTROENTEROL, V37, P239, DOI 10.1007/s005350200030; Grapin-Botton A, 2000, TRENDS GENET, V16, P124, DOI 10.1016/S0168-9525(99)01957-5; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Huang D, 1998, DEVELOPMENT, V125, P3235; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kiefer JC, 2003, DEV DYNAM, V228, P287, DOI 10.1002/dvdy.10382; Kondo T, 1996, DEVELOPMENT, V122, P2651; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Matsumoto A, 2002, ANAT EMBRYOL, V205, P53, DOI 10.1007/s00429-001-0226-5; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Parisi MA, 2000, CURR OPIN PEDIATR, V12, P610, DOI 10.1097/00008480-200012000-00017; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Yelon D, 2002, CURR BIOL, V12, pR707, DOI 10.1016/S0960-9822(02)01213-7; YOKOUCHI Y, 1995, DEV BIOL, V169, P76, DOI 10.1006/dbio.1995.1128	31	75	76	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1902	1904		10.1126/science.1108709	http://dx.doi.org/10.1126/science.1108709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790841				2022-12-01	WOS:000227957300042
J	Izawa, D; Goto, M; Yamashita, A; Yamano, H; Yamamoto, M				Izawa, D; Goto, M; Yamashita, A; Yamano, H; Yamamoto, M			Fission yeast Mes1p ensures the onset of meiosis II by blocking degradation of cyclin Cdc13p	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; CYTOSTATIC FACTOR ARREST; SCHIZOSACCHAROMYCES-POMBE; GENETICALLY INTERACTS; SPINDLE CHECKPOINT; PROTEIN-KINASE; DIRECT BINDING; CELL-CYCLE; MITOSIS; APC	Meiosis is a special form of nuclear division to generate eggs, spermand spores in eukaryotes. Meiosis consists of the first (MI) and the second (MII) meiotic divisions, which occur consecutively. MI is reductional, in which homologous chromosomes derived from parents segregate. MI is supported by an elaborate mechanism involving meiosis-specific cohesin and its protector(1). MII is equational, in which replicated sister-chromatids separate as in mitosis. MII is generally considered to mimic mitosis in mechanism. However, fission yeastMes1p is essential for MII but dispensable for mitosis. The mes1-B44 mutant arrests before MII2. Transcription of mes1 is low in vegetative cells and boosted in a narrow window between late MI and late MII3. The mes1 mRNA undergoes meiosis-specific splicing(4). Here we show that Mes1p is a factor that suppresses the degradation of cyclin Cdc13p at anaphase I. Mes1p binds to Slp1p, an activator of APC/C ( anaphase promoting complex/cyclosome), and counteracts its function to engage Cdc13p in proteolysis. Inhibition of APC/C-dependent degradation of Cdc13p by Mes1p was reproduced in a Xenopus egg extract. We therefore propose that Mes1p has a key function in saving a sufficient level of MPF ( M-phase-promoting factor) activity required for the execution of MII.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan; Natl Inst Basic Biol, Dept Cell Proliferat, Okazaki, Aichi 4440867, Japan; Marie Curie Res Inst, Cell Cycle Control Grp, Surrey RH8 0TL, England	University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Yamamoto, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	myamamot@ims.u-tokyo.ac.jp	Yamashita, Akira/A-5278-2015	Yamashita, Akira/0000-0002-1805-1434				Blanco MA, 2001, J CELL SCI, V114, P2135; Borgne A, 2002, MOL BIOL CELL, V13, P2080, DOI 10.1091/mbc.01-10-0507; BUENO A, 1993, MOL CELL BIOL, V13, P2286, DOI 10.1128/MCB.13.4.2286; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Decottignies A, 2001, J CELL SCI, V114, P2627; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KISHIDA M, 1994, CURR GENET, V25, P497, DOI 10.1007/BF00351668; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsumoto T, 1997, MOL CELL BIOL, V17, P742, DOI 10.1128/MCB.17.2.742; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nakajo N, 2000, GENE DEV, V14, P328; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; SHIMODA C, 1985, MOL GEN GENET, V200, P252, DOI 10.1007/BF00425432; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watanabe Y, 2004, J CELL SCI, V117, P4017, DOI 10.1242/jcs.01352; Yamada HY, 2000, J CELL SCI, V113, P3989; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0	30	61	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					529	533		10.1038/nature03406	http://dx.doi.org/10.1038/nature03406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791259				2022-12-01	WOS:000227836000047
J	Pelkmans, L; Fava, E; Grabner, H; Hannus, M; Habermann, B; Krausz, E; Zerial, M				Pelkmans, L; Fava, E; Grabner, H; Hannus, M; Habermann, B; Krausz, E; Zerial, M			Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis	NATURE			English	Article							MEMBRANE DOMAINS; SIGNAL-TRANSDUCTION; CELL; TRANSPORT; ENTRY; SIMIAN-VIRUS-40; CAVEOLIN-1; RECEPTOR; COMPLEX; FUSION	Endocytosis is a key cellular process, encompassing different entry routes and endocytic compartments. To what extent endocytosis is subjected to high-order regulation by the cellular signalling machinery remains unclear. Using high-throughput RNA interference and automated image analysis, we explored the function of human kinases in two principal types of endocytosis: clathrin- and caveolae/raft-mediated endocytosis. We monitored this through infection of vesicular stomatitis virus, simian virus 40 and transferrin trafficking, and also through cell proliferation and apoptosis assays. Here we show that a high number of kinases are involved in endocytosis, and that each endocytic route is regulated by a specific kinase subset. Notably, one group of kinases exerted opposite effects on the two endocytic routes, suggesting coordinate regulation. Our analysis demonstrates that signalling functions such as those controlling cell adhesion, growth and proliferation, are built into the machinery of endocytosis to a much higher degree than previously recognized.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; MPI CBG High Throughput Technol Dev Studio, D-01307 Dresden, Germany; Scionics Comp Innovat GmbH, D-01307 Dresden, Germany; Ceniix Biosci GmbH, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Habermann, Bianca/N-4886-2016	Habermann, Bianca/0000-0002-2457-7504; Fava, Eugenio/0000-0002-3737-0334; Pelkmans, Lucas/0000-0002-6754-9730				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; LUCOCQ J, 1991, J CELL SCI, V100, P753; MACE G, UNPUB EMBO J; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; PELKMANS L, UNPUB NATURE; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331; Xue LZ, 1998, CELL SIGNAL, V10, P339, DOI 10.1016/S0898-6568(98)00011-4; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	51	494	516	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					78	86		10.1038/nature03571	http://dx.doi.org/10.1038/nature03571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	15889048				2022-12-01	WOS:000230296600042
J	Depaepe, V; Suarez-Gonzalez, N; Dufour, A; Passante, L; Gorski, JA; Jones, KR; Ledent, C; Vanderhaeghen, P				Depaepe, V; Suarez-Gonzalez, N; Dufour, A; Passante, L; Gorski, JA; Jones, KR; Ledent, C; Vanderhaeghen, P			Ephrin signalling controls brain size by regulating apoptosis of neural progenitors	NATURE			English	Article							CELL-DEATH; MOUSE NEOCORTEX; RECEPTORS; MIGRATION; SURVIVAL; PROLIFERATION; NEUROGENESIS; INHIBITION; NEURONS; CORTEX	Mechanisms controlling brain size include the regulation of neural progenitor cell proliferation, differentiation, survival and migration(1,2). Here we show that ephrin-A/EphA receptor signalling plays a key role in controlling the size of the mouse cerebral cortex by regulating cortical progenitor cell apoptosis. In vivo gain of EphA receptor function, achieved through ectopic expression of ephrin-A5 in early cortical progenitors expressing EphA7, caused a transient wave of neural progenitor cell apoptosis, resulting in premature depletion of progenitors and a subsequent dramatic decrease in cortical size. In vitro treatment with soluble ephrin-A ligands similarly induced the rapid death of cultured dissociated cortical progenitors in a caspase-3-dependent manner, thereby confirming a direct effect of ephrin/Eph signalling on apoptotic cascades. Conversely, in vivo loss of EphA function, achieved through EphA7 gene disruption, caused a reduction in apoptosis occurring normally in forebrain neural progenitors, resulting in an increase in cortical size and, in extreme cases, exencephalic forebrain overgrowth. Together, these results identify ephrin/Eph signalling as a physiological trigger for apoptosis that can alter brain size and shape by regulating the number of neural progenitors.	Univ Brussels, IRIBHM, B-1070 Brussels, Belgium; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Universite Libre de Bruxelles; University of Colorado System; University of Colorado Boulder	Vanderhaeghen, P (corresponding author), Univ Brussels, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	pvdhaegh@ulb.ac.be		JONES, KEVIN/0000-0002-3802-7562; Vanderhaeghen, Pierre/0000-0001-7899-5720				Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Gorski JA, 2002, J NEUROSCI, V22, P6309; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Wilkie AL, 2004, DEV BIOL, V267, P109, DOI 10.1016/j.ydbio.2003.11.006; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Yue Y, 1999, J NEUROSCI, V19, P10026; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	30	222	230	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1244	1250		10.1038/nature03651	http://dx.doi.org/10.1038/nature03651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15902206				2022-12-01	WOS:000230140500046
J	Rooney, HCE; van 't Klooster, JW; van der Hoorn, RAL; Joosten, MHAJ; Jones, JDG; de Wit, PJGM				Rooney, HCE; van 't Klooster, JW; van der Hoorn, RAL; Joosten, MHAJ; Jones, JDG; de Wit, PJGM			Cladosporium Avr2 inhibits tomato Rcr3 protease required for Cf-2-dependent disease resistance	SCIENCE			English	Article							FOR-GENE CONCEPT; III EFFECTOR; CYSTEINE PROTEASE; AVIRULENCE GENE; PROTEINS; FULVUM; ARABIDOPSIS; PLANTS; RIN4; AVRRPT2	How plants recognize pathogens and activate defense is still mysterious. Direct interaction between pathogen avirulence (Avr) proteins and plant disease resistance proteins is the exception rather than the rule. During infection, Cladosporium fulvum secretes Avr2 protein into the apoplast of tomato leaves and, in the presence of the extracellular leucine-rich repeat receptor-like Cf-2 protein, triggers a hypersensitive response (HR) that also requires the extracellular tomato cysteine protease Rcr3. We show here that Avr2 binds and inhibits Rcr3 and propose that the Rcr3-Avr2 complex enables the Cf-2 protein to activate an HR.	Univ Wageningen & Res Ctr, Phytopathol Lab, NL-6709 PD Wageningen, Netherlands; John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	de Wit, PJGM (corresponding author), Univ Wageningen & Res Ctr, Phytopathol Lab, Binnenhaven 5, NL-6709 PD Wageningen, Netherlands.	pierre.dewit@wur.nl	van der Hoorn, Renier/E-5346-2011; de Wit, Pierre J. G.M./CAI-9966-2022; van der Hoorn, Renier/AAU-1005-2020; de Wit, Pierre/A-1998-2013; Joosten, Matthieu/AAB-5150-2022; Jones, Jonathan DG/J-5129-2012; Joosten, Matthieu/AAB-5131-2022	van der Hoorn, Renier/0000-0002-3692-7487; de Wit, Pierre/0000-0002-4208-288X; Jones, Jonathan DG/0000-0002-4953-261X; Joosten, Matthieu/0000-0002-6243-4547				Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DEWIT P, UNPUB; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; Kocks C, 2003, MOL CELL PROTEOMICS, V2, P1188, DOI 10.1074/mcp.M300067-MCP200; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lauge R, 2000, PLANT J, V23, P735, DOI 10.1046/j.1365-313x.2000.00843.x; LAZAROVITS G, 1976, CAN J BOT, V54, P224, DOI 10.1139/b76-022; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; Luderer R, 2001, MOL PLANT MICROBE IN, V14, P867, DOI 10.1094/MPMI.2001.14.7.867; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; Wit P. J. G. M. de, 1977, Netherlands Journal of Plant Pathology, V83, P109, DOI 10.1007/BF01981556	28	328	345	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2005	308	5729					1783	1786		10.1126/science.1111404	http://dx.doi.org/10.1126/science.1111404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15845874				2022-12-01	WOS:000229926800053
J	McClellan, AJ; Scott, MD; Frydman, J				McClellan, AJ; Scott, MD; Frydman, J			Folding and quality control of the VHL tumor suppressor proceed through distinct chaperone pathways	CELL			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INTERACTING PROTEINS; ABNORMAL PROTEINS; ELONGIN C; YEAST	The mechanisms by which molecular chaperones assist quality control of cytosolic proteins are poorly understood. Analysis of the chaperone requirements for degradation of misfolded variants of a cytosolic protein, the VHL tumor suppressor, reveals that distinct chaperone pathways mediate its folding and quality control. While both folding and degradation of VHL require Hsp70, the chaperonin TRiC is essential for folding but is dispensable for degradation. Conversely, the chaperone Hsp90 neither participates in VHL folding nor is required to maintain misfolded VHL solubility but is essential for its degradation. The cochaperone HOP/Sti1 p also participates in VHL quality control and may direct the triage decision by bridging the Hsp70-Hsp90 interaction. Our finding that a distinct chaperone complex is uniquely required for quality control provides evidence for active and specific chaperone participation in triage decisions and suggests that a hierarchy of chaperone interactions can control the alternate fates of a cytosolic protein.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Stanford Univ, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.	jfrydman@stanford.edu	McClellan, Amie/V-8950-2019	, judith/0000-0003-2302-6943; McClellan, Amie/0000-0002-8033-6748	NIGMS NIH HHS [GM56433, GM64992] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064992, R37GM056433, R01GM056433] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams A, 1997, METHODS YEAST GENETI; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Bohen SP, 1998, MOL CELL BIOL, V18, P3330, DOI 10.1128/MCB.18.6.3330; Botuyan MV, 1999, P NATL ACAD SCI USA, V96, P9033, DOI 10.1073/pnas.96.16.9033; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Goasduff T, 2000, ARCH BIOCHEM BIOPHYS, V379, P321, DOI 10.1006/abbi.2000.1870; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Jackson T, 2000, BBA-GENE STRUCT EXPR, V1491, P161, DOI 10.1016/S0167-4781(00)00052-X; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; KANDROR O, 1994, J BIOL CHEM, V269, P23575; Kaser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Mitsui K, 2002, J NEUROSCI, V22, P9267; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	58	201	205	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					739	748		10.1016/j.cell.2005.03.024	http://dx.doi.org/10.1016/j.cell.2005.03.024			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935760	Bronze			2022-12-01	WOS:000229658000012
J	Anderson, JD; Johnson, TV; Schubert, G; Asmar, S; Jacobson, RA; Johnston, D; Lau, EL; Lewis, G; Moore, WB; Taylor, A; Thomas, PC; Weinwurm, G				Anderson, JD; Johnson, TV; Schubert, G; Asmar, S; Jacobson, RA; Johnston, D; Lau, EL; Lewis, G; Moore, WB; Taylor, A; Thomas, PC; Weinwurm, G			Amalthea's density is less than that of water	SCIENCE			English	Article							SMALL INNER SATELLITES; JUPITER; DISCOVERY; ORBITS	Radio Doppler data from the Galileo spacecraft's encounter with Amalthea, one of Jupiter's small inner moons, on 5 November 2002 yield a mass of (2.08 +/- 0.15) x 10(18) kilograms. Images of Amalthea from two Voyager spacecraft in 1979 and Galileo imaging between November 1996 and June 1997 yield a volume of (2.43 +/- 0.22) x 10(6) cubic kilometers. The satellite thus has a density of 857 +/- 99 kilograms per cubic meter. We suggest that Amalthea is porous and composed of water ice, as well as rocky material, and thus formed in a cold region of the solar system, possibly not at its present location near Jupiter.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Cornell Univ, Ctr Radio Phys & Space Res, Ithaca, NY 14853 USA; Vienna Univ Technol, Inst Geodesy & Geophys, A-1040 Vienna, Austria	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; Cornell University; Technische Universitat Wien	Anderson, JD (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	john.d.anderson@jpl.nasa.gov						Anderson JD, 1999, ICARUS, V138, P309, DOI 10.1006/icar.1998.6075; Barnard E. E., 1892, AJ, V12, P81; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; DEIMAND D, 2001, TR0112 ERDCCRREL US; Drummond J.D., 1989, ASTEROIDS, VII, P171; Gundlach JH, 2000, PHYS REV LETT, V85, P2869, DOI 10.1103/PhysRevLett.85.2869; JEWITT DC, 1979, SCIENCE, V206, P951, DOI 10.1126/science.206.4421.951; JOHNSON TV, 1973, ICARUS, V18, P612, DOI 10.1016/0019-1035(73)90064-X; Lagerkvist C.-I., 1989, ASTEROIDS, P1162; LOCKNER DA, 1995, HDB PHYSICAL CONSTAN, V3, P127; Millis R. L., 1989, ASTEROIDS, V148; Simonelli DP, 2000, ICARUS, V147, P353, DOI 10.1006/icar.2000.6474; SYNNOTT SP, 1980, SCIENCE, V210, P786, DOI 10.1126/science.210.4471.786; SYNNOTT SP, 1984, ICARUS, V58, P178, DOI 10.1016/0019-1035(84)90036-8; SYNNOTT SP, 1981, SCIENCE, V212, P191, DOI 10.1126/science.212.4491.191; SYNNOTT SP, 1980, SCIENCE, V210, P1392; THOLEN DJ, 2000, ALLENS ASTROPHYSICAL, P302; Thomas P., 1986, IAU C 77 SOME BACKGR, P802; Thomas PC, 1998, ICARUS, V135, P360, DOI 10.1006/icar.1998.5976; *USA CORPS ENG, 1951, 4 SIPRE US ARM CORPS; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; [No title captured]	22	53	53	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2005	308	5726					1291	1293		10.1126/science.1110422	http://dx.doi.org/10.1126/science.1110422			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919987				2022-12-01	WOS:000229482300041
J	Mihaylova, B; Briggs, A; Armitage, J; Parish, S; Gray, A; Collins, R				Mihaylova, B; Briggs, A; Armitage, J; Parish, S; Gray, A; Collins, R		Heart Protection Study Collaborati	Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20536 individuals	LANCET			English	Article								Background Statin therapy reduces the rates of heart attack, stroke, and revascularisation among a wide range of individuals. Reliable assessment of its cost-effectiveness in different circumstances is needed. Methods 20 536 adults (aged 40-80 years) with vascular disease or diabetes were randomly allocated 40 mg sinnivastatin daily (10 269) or placebo (10 267) for an average of 5 years. Comparisons were made of hospitalisation and statin costs (2001 UK prices) during the scheduled treatment period between all simvastatin-allocated versus all placebo-allocated participants. Cost-effectiveness was estimated among different categories of participant. Findings Allocation to simvastatin was associated with a highly significant 22% (95% Cl 16-27; p<0.0001) proportional reduction in hospitalisation costs for all vascular events, with similar proportional reductions in every subcategory of participant studied. During an average of 5 years, estimated absolute reductions in vascular event costs per person allocated 40 mg simvastatin daily ranged from UK 847 pound (SE 137) in the highest risk quintile studied to,[264 (48) in the lowest. Mean excess cost of statin therapy among participants allocated simvastatin was 1497 pound (8), with similar absolute increases in every subcategory. Costs of preventing a major vascular event with 40 mg simvastatin daily ranged from,C4500 (95% CI 2300-7400) among participants with a 42% 5-year major vascular event rate to 31 pound 100 (22 900-42 500) among those with a 12% rate (corresponding to 5-year major coronary event rates of 22% and 4%, respectively). Interpretation Statin therapy is cost effective for a wider range of individuals with vascular disease or diabetes than previously recognised (particularly with lower-priced generics). It would be appropriate to consider reducing the estimated level of vascular event risk at which statin therapy is recommended.	Radcliffe Infirm, Clin Trial Serv Unit, Heart Protect Study, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Mihaylova, B (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Heart Protect Study, Harkness Bldg, Oxford OX2 6HE, England.	hps@ctsu.ox.ac.uk		Mihaylova, Borislava/0000-0002-0951-1304; Briggs, Andrew/0000-0002-0777-1997				Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2004, LANCET, V363, P757; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; *DEP HLTH, 2003, GOV EXP PLANS DEP RE; Department of Health, 2004, PRESCR COST AN ENGL; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Glasziou PP, 2002, MED J AUSTRALIA, V177, P428; *JOINT FORM COMM, 2001, BRIT NAT FORM, V41; Jonsson B, 1999, DIABETOLOGIA, V42, P1293, DOI 10.1007/s001250051441; Jonsson B, 1996, EUR HEART J, V17, P1001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Meade T, 1999, EUR HEART J, V20, P725; *NHS EX, 2001, TRUST FIN RET; *NHS EX, 2002, TRUST FIN RET; *PRESCR PRIC AUTH, NHS EL DRUG TAR; Sniderman AD, 2004, AM J CARDIOL, V94, p30F, DOI 10.1016/j.amjcard.2004.07.052; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; *TAMR, 2003, INT REP JAN JUN; Wood D, 2000, BRIT MED J, V320, P705, DOI 10.1136/bmj.320.7236.705; ZOCOR DATASHEET	23	88	90	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2005	365	9473					1779	1785		10.1016/S0140-6736(05)63014-0	http://dx.doi.org/10.1016/S0140-6736(05)63014-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	928SI	15910950				2022-12-01	WOS:000229291600022
J	Hiesinger, PR; Fayyazuddin, A; Mehta, SQ; Rosenmund, T; Schulze, KL; Zhai, RG; Verstreken, P; Cao, Y; Zhou, Y; Kunz, J; Bellen, HJ				Hiesinger, PR; Fayyazuddin, A; Mehta, SQ; Rosenmund, T; Schulze, KL; Zhai, RG; Verstreken, P; Cao, Y; Zhou, Y; Kunz, J; Bellen, HJ			The v-ATPase V-0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila	CELL			English	Article							READILY RELEASABLE POOL; VACUOLAR H+-ATPASE; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; SYNAPTOBREVIN; CELLS; YEAST; TRANSMISSION; MUTATIONS; SECRETION	The V-0 complex forms the proteolipid pore of an ATPase that acidifies vesicles. In addition, an independent function in membrane fusion has been proposed largely based on yeast vacuolar fusion experiments. We have isolated mutations in the largest V-0 component vha100-1 in flies in an unbiased genetic screen for synaptic malfunction. The protein is only required in neurons, colocalizes with markers for synaptic vesicles as well as active zones, and interacts with t-SNAREs. Loss of vha100-1 leads to vesicle accumulation in synaptic terminals, suggesting a deficit in release. The amplitude of spontaneous release events and release with hypertonic stimulation indicate normal levels of neurotransmitter loading, yet mutant embryos display severe defects in evoked synaptic transmission and FM1-43 uptake. Our data suggest that Vha100-1 functions downstream of SNAREs in synaptic vesicle fusion.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Zhai, R. Grace/AGZ-3936-2022; Verstreken, Patrik/AAC-7591-2022	Verstreken, Patrik/0000-0002-5073-5393; Zhai, Rong/0000-0002-7599-1430; Mehta, Sunil/0000-0003-3020-4939; Bellen, Hugo/0000-0001-5992-5989	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068098] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 068098, R01 GM068098-03, R01 GM068098] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHOU TB, 1992, GENETICS, V131, P643; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Drose S, 1997, J EXP BIOL, V200, P1; FalkVairant J, 1996, P NATL ACAD SCI USA, V93, P5203, DOI 10.1073/pnas.93.11.5203; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Hiesinger PR, 1999, J NEUROSCI, V19, P7548, DOI 10.1523/JNEUROSCI.19-17-07548.1999; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; ISRAEL M, 1986, P NATL ACAD SCI USA, V83, P9226, DOI 10.1073/pnas.83.23.9226; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jena BP, 2004, J CELL MOL MED, V8, P1, DOI 10.1111/j.1582-4934.2004.tb00255.x; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Meinertzhagen Ian A., 1993, P1363; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Morel N, 2003, BIOL CELL, V95, P453, DOI 10.1016/S0248-4900(03)00075-3; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; Perzov N, 2002, J EXP BIOL, V205, P1209; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sorensen JB, 2004, PFLUG ARCH EUR J PHY, V448, P347, DOI 10.1007/s00424-004-1247-8; Stowers RS, 1999, GENETICS, V152, P1631; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	239	249	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					607	620		10.1016/j.cell.2005.03.012	http://dx.doi.org/10.1016/j.cell.2005.03.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907473	Green Accepted, Bronze			2022-12-01	WOS:000229331200016
J	Hundley, HA; Walter, W; Bairstow, S; Craig, EA				Hundley, HA; Walter, W; Bairstow, S; Craig, EA			Human Mpp11 J protein: Ribosome-tethered molecular chaperones are ubiquitous	SCIENCE			English	Article							NEWLY SYNTHESIZED PROTEINS; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; NASCENT CHAIN; HSP70; COMPLEX; DNAJ; SSB; TRANSLOCATION; BINDING	The existence of specialized molecular chaperones that interact directly with ribosomes is well established in microorganisms. Such proteins bind polypeptides exiting the ribosomal tunnel and provide a physical link between translation and protein folding. We report that ribosome-associated molecular chaperones have been maintained throughout eukaryotic evolution, as illustrated by Mpp11, the human ortholog of the yeast ribosome-associated J protein Zuo. When expressed in yeast, Mpp11 partially substituted for Zuo by partnering with the multipurpose Hsp70 Ssa, the homolog of mammalian Hsc70. We propose that in metazoans, ribosome-associated Mpp11 recruits the multifunctional soluble Hsc70 to nascent polypeptide chains as they exit the ribosome.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Grad Program Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu	Hundley, Heather/AAV-2808-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031107] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM031107] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albanese V, 2002, NAT STRUCT BIOL, V9, P716, DOI 10.1038/nsb1002-716; Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horwich A, 2004, NATURE, V431, P520, DOI 10.1038/431520a; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Kim SY, 2005, EUKARYOT CELL, V4, P82, DOI 10.1128/EC.4.1.82-89.2005; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; WALL D, 1994, J BIOL CHEM, V269, P5446; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	24	85	89	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1032	1034		10.1126/science.1109247	http://dx.doi.org/10.1126/science.1109247			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15802566				2022-12-01	WOS:000229190700049
J	Wang, D; Weaver, ND; Kesarwani, M; Dong, XN				Wang, D; Weaver, ND; Kesarwani, M; Dong, XN			Induction of protein secretory pathway is required for systemic acquired resistance	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; GENOMIC ANALYSIS; EXPRESSION; GENE; HOMOLOG; NPR1	In plants, systemic acquired resistance (SAR) is established as a result of NPR1-regulated expression of pathogenesis-related (PR) genes. Using gene expression profiling in Arabidopsis, we found that in addition to controlling the expression of PR genes, NPR1 also directly controls the expression of the protein secretory pathway genes. Up-regulation of these genes is essential for SAR, because mutations in some of them diminished the secretion of PR proteins (for example, PR1), resulting in reduced resistance. We provide evidence that NPR1 coordinately,regulates these secretion-related genes through a previously undescribed cis-element. Activation of this cis-element is controlled by a transcription factor that is translocated into the nucleus upon SAR induction.	Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA	Duke University	Dong, XN (corresponding author), Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, POB 91000, Durham, NC 27708 USA.	xdong@duke.edu						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fu J, 2000, J BIOL CHEM, V275, P3984, DOI 10.1074/jbc.275.6.3984; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Lin BL, 2001, CELL STRESS CHAPERON, V6, P201, DOI 10.1379/1466-1268(2001)006<0201:GAOTHS>2.0.CO;2; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; WALTHERLARSEN H, 1993, PLANT MOL BIOL, V21, P1097, DOI 10.1007/BF00023606; Wick P, 2003, PLANT PHYSIOL, V132, P343, DOI 10.1104/pp.102.012633; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894	25	398	422	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1036	1040		10.1126/science.1108791	http://dx.doi.org/10.1126/science.1108791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890886				2022-12-01	WOS:000229190700051
J	Chinn, S; Jarvis, D; Melotti, R; Luczynska, C; Ackermann-Liebrich, U; Anto, JM; Cerveri, I; de Marco, R; Gislason, T; Heinrich, J; Janson, C; Kunzli, N; Leynaert, B; Neukirch, F; Schouten, J; Sunyer, J; Svanes, C; Vermeire, P; Wjst, M; Burney, P				Chinn, S; Jarvis, D; Melotti, R; Luczynska, C; Ackermann-Liebrich, U; Anto, JM; Cerveri, I; de Marco, R; Gislason, T; Heinrich, J; Janson, C; Kunzli, N; Leynaert, B; Neukirch, F; Schouten, J; Sunyer, J; Svanes, C; Vermeire, P; Wjst, M; Burney, P			Smoking cessation, lung function, and weight gain: a follow-up study	LANCET			English	Article							FORCED EXPIRATORY VOLUME; LONGITUDINAL CHANGES; PULMONARY-FUNCTION; ONE 2ND; DECLINE; ADULTS; SYMPTOMS; HABITS; FEV(1); GENDER	Background Only one population-based study in one country has reported effects of smoking cessation and weight change on lung function, and none has reported the net effect. We estimated the net benefit of smoking cessation, and the independent effects of smoking and weight change on change in ventilatory lung function in the international European Community Respiratory Health Survey. Methods 6654 participants in 27 centres had lung function measured in 1991-93, when aged 20-44 years, and in 1998-2002. Smoking information was obtained from detailed questionnaires. Changes in lung function were analysed by change in smoking and weight, adjusted for age and height, in men and women separately and together with interaction terms. Findings Compared with those who had never smoked, decline in FEV1 was lower in male sustained quitters (mean difference 5.4 mL per year, 95% CI 1.7 to 9.1) and those who quit between surveys (2.5 mL, -1.9 to 7.0), and greater in smokers (-4.8 mL, -7.9 to -1.6). In women, estimates were 1.3 mL per year (-1.5 to 4.1), 2.8 mL (-0.8 to 6.3) and -5.1 mL (-7.5 to -2.8), respectively.. These sex differences were not significant. FEV1 changed by -11.5 mL (-13.3 to -9.6) per kg weight gained in men, and by -3.7 mL per kg (-5.0 to -2.5) in women, which diminished the benefit of quitting by 38% in men, and by 17% in women. Interpretation Smoking cessation is beneficial for lung function, but maximum benefit needs control of weight gain, especially in men.	Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England; Univ Verona, Dept Med & Publ Hlth, Div Epidemiol & Stat, I-37100 Verona, Italy; Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland; Univ Pompeu Fabra, Inst Med Res, Barcelona, Spain; Univ Pavia, IRCCS San Matteo Hosp, Div Resp Dis, I-27100 Pavia, Italy; Univ Hosp E7, Dept Allergy Resp Med & Sleep, Reykjavik, Iceland; GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany; Uppsala Univ, Uppsala, Sweden; Univ So Calif, Keck Sch Med, Los Angeles, CA USA; Univ Paris 07, INSERM, French Inst Hlth & Med Res, Unit 408, Paris, France; Univ Groningen Hosp, Dept Epidemiol, Groningen, Netherlands; Haukeland Hosp, Dept Thorac Med, Bergen, Norway; Univ Antwerp, B-2020 Antwerp, Belgium	University of London; King's College London; University of Verona; University of Basel; Pompeu Fabra University; IRCCS Fondazione San Matteo; University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; University of Southern California; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Groningen; University of Bergen; Haukeland University Hospital; University of Antwerp	Chinn, S (corresponding author), Kings Coll London, Dept Publ Hlth Sci, 5th Floor Capital House,42 Weston St, London SE1 3QD, England.	sue.chinn@kcl.ac.uk	Kuenzli, Nino/F-7195-2014; Jarvis, Deborah/E-6494-2011; Svanes, Cecilie/N-7556-2017; SESM, SESM/C-1440-2008; Anto, J M/H-2676-2014; Sunyer, Jordi/G-6909-2014; Heinrich, Joachim/N-1720-2013; de Marco, Roberto/A-5470-2008; Leynaert, Benedicte/N-5251-2018	Kuenzli, Nino/0000-0001-8360-080X; Svanes, Cecilie/0000-0001-8512-5192; Anto, J M/0000-0002-4736-8529; Sunyer, Jordi/0000-0002-2602-4110; Heinrich, Joachim/0000-0002-9620-1629; Burney, Peter/0000-0001-8635-5678; Jarvis, Deborah/0000-0002-1753-3896; Leynaert, Benedicte/0000-0001-5045-2492; Cerveri, Isa/0000-0003-0337-043X; MELOTTI, Roberto/0000-0003-4115-317X	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005521] Funding Source: NIH RePORTER; NCRR NIH HHS [2 S07 RR05521-28] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*AM THOR SOC, 1995, AM J RESP CRIT CARE, V152, P1122; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Bottai M, 2002, EUR RESPIR J, V20, P665, DOI 10.1183/09031936.02.01282001; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; CAMILLI AE, 1987, AM REV RESPIR DIS, V135, P794, DOI 10.1164/arrd.1987.135.4.794; Carey IM, 1999, INT J OBESITY, V23, P979, DOI 10.1038/sj.ijo.0801029; CHEN Y, 1993, THORAX, V48, P375, DOI 10.1136/thx.48.4.375; Chinn S, 2004, THORAX, V59, P646, DOI 10.1136/thx.2004.021642; Connett JE, 2003, AM J EPIDEMIOL, V157, P973, DOI 10.1093/aje/kwg083; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOCKERY DW, 1988, AM REV RESPIR DIS, V137, P286, DOI 10.1164/ajrccm/137.2.286; Harik-Khan RI, 2001, J CLIN EPIDEMIOL, V54, P399, DOI 10.1016/S0895-4356(00)00318-8; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; LANGE P, 1989, EUR RESPIR J, V2, P811; LANGE P, 1989, INT J EPIDEMIOL, V18, P882, DOI 10.1093/ije/18.4.882; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Thun MJ, 1998, AM J EPIDEMIOL, V148, P831; TOWNSEND MC, 1991, PREV MED, V20, P621, DOI 10.1016/0091-7435(91)90059-D; Varner LM, 1999, J AM DIET ASSOC, V99, P1272, DOI 10.1016/S0002-8223(99)00312-0; Wang ML, 1996, AM J RESP CRIT CARE, V153, P1907, DOI 10.1164/ajrccm.153.6.8665054; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Wise RA, 1998, AM J RESP CRIT CARE, V157, P866, DOI 10.1164/ajrccm.157.3.9706076; XU X, 1994, EUR RESPIR J, V7, P1056	25	137	140	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1629	1635		10.1016/S0140-6736(05)66511-7	http://dx.doi.org/10.1016/S0140-6736(05)66511-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885295				2022-12-01	WOS:000228933700027
J	Dworkin, J; Losick, R				Dworkin, J; Losick, R			Developmental commitment in a bacterium	CELL			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; CELL-TYPE; SPORULATION; GENE; ENGULFMENT; COMPARTMENTALIZATION; ACTIVATION; INHIBITOR; SEPTATION	We investigated developmental commitment during sporulation in Bacillus subtilis. Sporulation is initiated by nutrient limitation and involves division of the developing cell into two progeny, the forespore and the mother cell, with different fates. Differentiation becomes irreversible following division when neither the forespore nor the mother cell can resume growth when provided with nutrients. We show that commitment is governed by the transcription factors sigma(F) and sigma(E), which are activated in the forespore and the mother cell, respectively. We further show that commitment involves spollQ, which is under the control of sigma(F), and spollP, which is under the control of both sigma(F) and sigma(E). In the presence of nutrients, the forespore can exhibit rodlike, longitudinal growth when SpollQ and SpollP are absent, whereas the mother cell can do so when SpollP alone is absent. Thus, developmental commitment of this single-celled organism, like that of the cells of complex, multicellular organisms, ensures that differentiation is maintained despite changes in the extracellular milieu.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Harvard University; Columbia University	Dworkin, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dworkin@microbiology.columbia.edu; losick@mcb.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 18568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Bernhardt TG, 2001, J BIOL CHEM, V276, P6093, DOI 10.1074/jbc.M007638200; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FRANDSEN N, 1995, J BACTERIOL, V177, P716, DOI 10.1128/jb.177.3.716-722.1995; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 2002, MOL MICROBIOL, V43, P27, DOI 10.1046/j.1365-2958.2002.02732.x; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Gilbert S.F., 2000, DEV BIOL; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Harwood C.R., 1990, MOL BIOL METHODS BAC; HO RK, 1993, SCIENCE, V261, P109, DOI 10.1126/science.8316841; Li ZS, 2004, J BACTERIOL, V186, P2221, DOI 10.1128/JB.186.7.2221-2223.2003; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; LondonoVallejo JA, 1997, MOL MICROBIOL, V24, P29, DOI 10.1046/j.1365-2958.1997.3181680.x; LONDONOVALLEJO JA, 1995, GENE DEV, V9, P503, DOI 10.1101/gad.9.4.503; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; Parker GF, 1996, MICROBIOL-UK, V142, P3445, DOI 10.1099/13500872-142-12-3445; Piggot P, 2002, BACILLUS SUBTILIS IT, P483; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Spemann H, 1918, ARCH ENTWICKLUNG ORG, V43, P448, DOI 10.1007/BF02267308; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Stragier P., 2002, BACILLUS SUBTILIS IT, P519; STRAUCH M, 1990, P NATL ACAD SCI USA, V87, P1801, DOI 10.1073/pnas.87.5.1801; SUSSMAN MD, 1991, J BACTERIOL, V173, P291, DOI 10.1128/jb.173.1.291-300.1991; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	34	80	82	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					401	409		10.1016/j.cell.2005.02.032	http://dx.doi.org/10.1016/j.cell.2005.02.032			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882622	Bronze			2022-12-01	WOS:000229031600010
J	Tzou, WS; Douglas, PS; Srinivasan, SR; Chen, W; Berenson, G; Stein, JH				Tzou, WS; Douglas, PS; Srinivasan, SR; Chen, W; Berenson, G; Stein, JH			Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: The bogalusa heart study	ANNALS OF INTERNAL MEDICINE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; CORONARY-ARTERY-DISEASE; MAGNETIC-RESONANCE-SPECTROSCOPY; CAROTID-ARTERY; MYOCARDIAL-INFARCTION; PARTICLE DIAMETER; ROC CURVE; DENSITY; MEN	Background: The clinical value of advanced lipoprotein testing relative to traditional lipid testing remains controversial. To date, no studies have evaluated associations between advanced lipoprotein testing and subclinical atherosclerosis in healthy young adults. Objective: To determine whether advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation better predicts carotid intima-media thickness, a validated measure of subclinical atherosclerosis, than does traditional lipoprotein testing in asymptornatic young adults. Design: Cross-sectional community-based study. Setting: Bogalusa, Louisiana. Participants: 311 randomly selected adults from the Bogalusa Heart Study who were 20 to 38 years of age. Measurements: The authors performed advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation, traditional testing using enzymatic methods, and Friedewald formula estimation of low-density lipoprotein cholesterol levels. A certified reader blinded to lipoprotein results determined carotid intimamedia thickness by B-mode ultrasonography. C-statistics from area under the receiver-operating characteristic curves (ALICs) derived from multivariable regression models were compared. Results: Lipid values obtained with advanced lipoprotein testing did not predict carotid intima-media thickness better than traditionally measured lipid values in 236 participants for whom all data were available. A model using traditional lipoprotein measures (AUC, 0.754 [95% Cl, 0.690 to 0.812]) did not differ significantly from a model using advanced lipoprotein measures (AUC, 0.779 [Cl, 0.662 to 0.871]) for prediction of carotid intimamedia thickness (P > 0.2). Subclass pattern of LDL, lipoprotein(a) cholesterol, intermediate-density lipoprotein cholesterol, high-density lipoprotein cholesterol subclasses, and very- low-density lipoprotein subclasses did not improve the performance of models for prediction of carotid intima-media thickness. Limitations: The study was cross-sectional, cardiac events were not determined, and only 1 method of advanced lipoprotein testing was used. Conclusions: Advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation did not improve prediction of carotid intima-media thickness in young adults and may not be useful for assessing cardiovascular risk in this population.	Univ Wisconsin, Sch Med, Dept Med, Sect Cardiovasc Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Stein, JH (corresponding author), Univ Wisconsin, Sch Med, Dept Med, Sect Cardiovasc Med, 600 Highland Ave,G7-341 CSC,MC 3248, Madison, WI 53792 USA.		Tzou, Wen-Shyong/H-4517-2014	Tzou, Wen-Shyong/0000-0002-6726-1390; Douglas, Pamela/0000-0001-9876-4049; Stein, James/0000-0002-2770-8223	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043820] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038844, U01HL038844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-1617601] Funding Source: Medline; NHLBI NIH HHS [HL-38844, HL-07936] Funding Source: Medline; NIA NIH HHS [AG-16592] Funding Source: Medline; NICHD NIH HHS [HD-043820] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*ARIC STUD GROUP, 1991, J NEUROIMAGING, V1, P68; Belsley D. A., 2005, REGRESSION DIAGNOSTI; BERESON GS, 1980, CARDIOVASCULAR RISK; Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; Colhoun HM, 2002, DIABETES, V51, P1949, DOI 10.2337/diabetes.51.6.1949; CORESH J, 1993, J LIPID RES, V34, P1687; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Freedman DS, 2004, INT J OBESITY, V28, P159, DOI 10.1038/sj.ijo.0802515; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; GENEST J, 1992, J AM COLL CARDIOL, V19, P792, DOI 10.1016/0735-1097(92)90520-W; Greenland P, 2000, CIRCULATION, V101, P723; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Karpe F, 2001, J LIPID RES, V42, P17; Kieltyka L, 2003, ATHEROSCLEROSIS, V170, P125, DOI 10.1016/S0021-9150(03)00244-2; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Krishnan Priya, 2003, J La State Med Soc, V155, P165; KULKARNI KR, 1995, J LIPID RES, V36, P2291; Kulkarni KR, 1999, ARTERIOSCL THROM VAS, V19, P2749, DOI 10.1161/01.ATV.19.11.2749; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; *NCEP, 1995, 953044 NIH; *NCEP, 2002, 025215 NIH; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Soedamah-Muthu SS, 2003, DIABETOLOGIA, V46, P674, DOI 10.1007/s00125-003-1094-8; Srinivasan SR, 2001, ATHEROSCLEROSIS, V159, P391, DOI 10.1016/S0021-9150(01)00514-7; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Stein JH, 1997, ARCH INTERN MED, V157, P1170, DOI 10.1001/archinte.157.11.1170; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7	37	13	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					742	750		10.7326/0003-4819-142-9-200505030-00009	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867406				2022-12-01	WOS:000228825800003
J	Burris, S; Csete, J; Goumei, X; Dan, Z; Loff, B				Burris, S; Csete, J; Goumei, X; Dan, Z; Loff, B			Shanghai plans responses to AIDS	LANCET			English	Editorial Material									Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; Johns Hopkins Sch Hyg & Publ Hlth, Ctr Law & Publ Hlth, Baltimore, MD USA; Canadian HIV AIDS Legal Network, Montreal, PQ, Canada; Shanghai Acad Social Sci, Ctr Publ Policy Study HIV AIDS, Shanghai, Peoples R China; Richard Wang & Co, Shanghai, Peoples R China; Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; Shanghai Academy of Social Sciences; Monash University	Burris, S (corresponding author), Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA.	scott.burris@temple.edu	Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503; Burris, Scott/0000-0002-6013-5842				*STAT COUNC CHIN, 1998, 250 STAT COUNC CHIN; *STAT COUNC CHIN, 1998, GF199838 STAT COUNC; WHO, 2004, UNAIDS WHO POL STAT	3	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1524	1525		10.1016/S0140-6736(05)66435-5	http://dx.doi.org/10.1016/S0140-6736(05)66435-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866293				2022-12-01	WOS:000228754800008
J	Zink, MC; Uhrlaub, J; DeWitt, J; Voelker, T; Bullock, B; Mankowski, J; Tarwater, P; Clements, J; Barber, S				Zink, MC; Uhrlaub, J; DeWitt, J; Voelker, T; Bullock, B; Mankowski, J; Tarwater, P; Clements, J; Barber, S			Neuroprotective and anti-human immunodeficiency virus, activity of minocycline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL-NERVOUS-SYSTEM; ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; ANTIRETROVIRAL THERAPY; CEREBROSPINAL-FLUID; COGNITIVE IMPAIRMENT; HIV-INFECTION; AIDS DEMENTIA; GROWTH-FACTOR; MOUSE MODEL	Context The prevalence of human immunodeficiency virus (HIV) central nervous system (CNS) disease has not decreased despite highly active antiretroviral therapy. Current antiretroviral drugs are expensive, have significant adverse effects including neurotoxicity, and few cross the blood-brain barrier. Objective To examine the ability of minocycline, an antibiotic with potent anti-inflammatory and neuroprotective properties, to protect against encephalitis and neurodegeneration using a rapid, high viral load simian immunodeficiency virus (SIV) model of HIV-associated CNS disease that constitutes a rigorous in vivo test for potential therapeutics. Design and Subjects Five SIV-infected pigtailed macaques were treated with 4 mg/kg per day of minocycline beginning at early asymptomatic infection (21 days after inoculation). Another 6 macaques were inoculated with SIV but remained untreated. Blood and cerebrospinal fluid (CSF) samples were taken on days 7,10,14, 21, 28, 35, 43, 56, 70, 77, and 84, and all macaques were humanely killed at 84 days after inoculation, a time that corresponds to late-stage infection in HIV-infected individuals. Main Outcome Measures Blood and CSF samples were tested for viral load by real-time reverse transcription-polymerase chain reaction and levels of monocyte chemoattractant protein 1 were quantitated by enzyme-linked immunosorbent assay. The presence and severity of encephalitis was determined by microscopic examination of tissues. Central nervous system inflammation was further assessed by measuring infiltration and activation of macrophages, activation of p38 mitogen-activated protein kinase and expression of amyloid precursor protein by quantitative immunohistochemistry.. Results Minocycline-treated macaques had less severe encephalitis (P=.02), reduced CNS expression of neuroinflammatory markers (major histocompatibility complex class II, P=.03; macrophage marker CD68, P=.07; T-cell intracytoplasmic antigen 1, P=.03; CSF monocyte chemoattractant protein 1., P=.001), reduced activation of p38 mitogen-activated protein kinase (P<.001), less axonal degeneration (beta-amyloid precursor protein, P=.03), and lower CNS virus replication (viral RNA, P=.04; Viral antigen, P=.04). In in vitro analysis, minocycline suppression of HIV and SIV replication in cultured primary macrophages did not correlate with suppression of activation of p38-mitogen-activated protein kinase pathways, whereas suppression in primary lymphocytes correlated with suppression of p38 activation. Conclusions In this experimental SIV model of HIV CNS disease, minocycline reduced the severity of encephalitis, suppressed viral load in the brain, and decreased the expression of CNS inflammatory markers. In vitro, minocycline inhibited SIV and, HIV replication. These findings suggest that minocycline, a safe, inexpensive, and readily available antibiotic should be investigated as an anti-HIV therapeutic.	Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Univ Texas, Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Epidemiol, El Paso, TX 79968 USA	Johns Hopkins University; University of Texas System; University of Texas El Paso; University of Texas Health Science Center Houston	Zink, MC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Comparat Med, 733 N Broadway,Room 839, Baltimore, MD 21205 USA.	mczink@jhmi.edu	Aljarah, Ali/Q-7105-2016	Aljarah, Ali/0000-0003-0535-090X; Uhrlaub, Jennifer/0000-0002-7745-0179	NIMH NIH HHS [MH069116] Funding Source: Medline; NINDS NIH HHS [NS44815] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044815] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P1377, DOI 10.1093/jac/dkg244; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Clifford DB, 2002, NEUROLOGY, V59, P1568, DOI 10.1212/01.WNL.0000034177.47015.DA; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Darcissac ECA, 2000, J VIROL, V74, P7794, DOI 10.1128/JVI.74.17.7794-7802.2000; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; EVERALL I, 1993, J NEUROPATH EXP NEUR, V52, P561, DOI 10.1097/00005072-199311000-00002; Flaherty MT, 1997, J VIROL, V71, P5790, DOI 10.1128/JVI.71.8.5790-5798.1997; GELBARD HA, 1995, NEUROPATH APPL NEURO, V21, P208, DOI 10.1111/j.1365-2990.1995.tb01052.x; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gordon PH, 2004, NEUROLOGY, V62, P1845, DOI 10.1212/01.WNL.0000125321.92112.7E; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kinlaw WB, 2004, ENDOCRINOLOGY, V145, P484, DOI 10.1210/en.2003-1513; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Mankowski JL, 2002, J NEUROPATH EXP NEUR, V61, P85, DOI 10.1093/jnen/61.1.85; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Metz LM, 2004, ANN NEUROL, V55, P756, DOI 10.1002/ana.20111; Montessori V, 2004, CAN MED ASSOC J, V170, P229; MURRAY EA, 1992, SCIENCE, V255, P1246, DOI 10.1126/science.1546323; Neuenburg JK, 2002, JAIDS-J ACQ IMM DEF, V31, P171, DOI 10.1097/00126334-200210010-00007; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Sacktor N, 2000, NEUROLOGY, V54, P233, DOI 10.1212/WNL.54.1.233; Schifitto G, 2001, NEUROLOGY, V57, P1313, DOI 10.1212/WNL.57.7.1313; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; SHARER LR, 1988, ANN NEUROL, V23, pS108, DOI 10.1002/ana.410230727; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Suk K, 2001, BRAIN RES, V900, P342, DOI 10.1016/S0006-8993(01)02326-5; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; YEN PKJ, 1975, J DENT RES, V54, P423; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	43	168	177	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					2003	2011		10.1001/jama.293.16.2003	http://dx.doi.org/10.1001/jama.293.16.2003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855434	Bronze			2022-12-01	WOS:000228651500026
J	Wang, YX; Botvinick, EL; Zhao, YH; Berns, MW; Usami, S; Tsien, RY; Chien, S				Wang, YX; Botvinick, EL; Zhao, YH; Berns, MW; Usami, S; Tsien, RY; Chien, S			Visualizing the mechanical activation of Src	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; FOCAL ADHESIONS; FAMILY KINASES; LIVING CELLS; V-SRC; CYTOSKELETON; DOMAIN; SPECIFICITY; P130(CAS); MEMBRANE	The mechanical environment crucially influences many cell functions(1). However, it remains largely mysterious how mechanical stimuli are transmitted into biochemical signals. Src is known to regulate the integrin-cytoskeleton interaction(2), which is essential for the transduction of mechanical stimuli(3-5). Using fluorescent resonance energy transfer (FRET), here we develop a genetically encoded Src reporter that enables the imaging and quantification of spatio-temporal activation of Src in live cells. We introduced a local mechanical stimulation to human umbilical vein endothelial cells (HUVECs) by applying laser-tweezer traction on fibronectin-coated beads adhering to the cells. Using the Src reporter, we observed a rapid distal Src activation and a slower directional wave propagation of Src activation along the plasma membrane. This wave propagated away from the stimulation site with a speed (mean +/- s.e.m.) of 18.1 +/- 1.7 nm s(-1). This force-induced directional and long-range activation of Src was abolished by the disruption of actin filaments or microtubules. Our reporter has thus made it possible to monitor mechanotransduction in live cells with spatio-temporal characterization. We find that the transmission of mechanically induced Src activation is a dynamic process that directs signals via the cytoskeleton to spatial destinations.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Whitaker Inst Biomed Engn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92697 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine	Chien, S (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	schien@bioeng.ucsd.edu		Berns, Michael/0000-0002-9640-2885				ALENGHAT FJ, 2002, SCI STKE, pE6; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bradshaw JM, 1999, BIOCHEMISTRY-US, V38, P5147, DOI 10.1021/bi982974y; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Mack PJ, 2004, AM J PHYSIOL-CELL PH, V287, pC954, DOI 10.1152/ajpcell.00567.2003; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Yang F, 1999, ANAL BIOCHEM, V266, P167, DOI 10.1006/abio.1998.2885; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	30	525	557	5	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1040	1045		10.1038/nature03469	http://dx.doi.org/10.1038/nature03469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846350	Green Published			2022-12-01	WOS:000228524600043
J	Syvitski, JPM; Vorosmarty, CJ; Kettner, AJ; Green, P				Syvitski, JPM; Vorosmarty, CJ; Kettner, AJ; Green, P			Impact of humans on the flux of terrestrial sediment to the global coastal ocean	SCIENCE			English	Article							CLIMATE-CHANGE; RIVERS; VARIABILITY; CALIFORNIA; DISCHARGE	Here we provide global estimates of the seasonal flux of sediment, on a river-by-river basis, under modern and prehuman conditions. Humans have simultaneously increased the sediment transport by global rivers through soil erosion (by 2.3 +/- 0.6 billion metric tons per year), yet reduced the flux of sediment reaching the world's coasts (by 1.4 +/- 0.3 billion metric tons per year) because of retention within reservoirs. Over 100 billion metric tons of sediment and 1 to 3 billion metric tons of carbon are now sequestered in reservoirs constructed largely within the past So years. African and Asian rivers carry a greatly reduced sediment load; Indonesian rivers deliver much more sediment to coastal areas.	Univ Colorado, Inst Arctic & Alpine Res, Environm Computat & Imaging Facil, Boulder, CO 80309 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Water Syst Anal Grp, Durham, NH 03824 USA; Delft Univ Technol, Delft, Netherlands	University of Colorado System; University of Colorado Boulder; University System Of New Hampshire; University of New Hampshire; Delft University of Technology	Syvitski, JPM (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Environm Computat & Imaging Facil, Boulder, CO 80309 USA.	james.syvitski@colorado.edu	Syvitski, James P M/L-2008-2013; Kettner, Albert/ABI-7635-2020	Kettner, Albert/0000-0002-7191-6521; Syvitski, Jaia/0000-0003-3116-6997				Dearing JA, 2003, GLOBAL PLANET CHANGE, V39, P147, DOI 10.1016/S0921-8181(03)00022-5; Douglas I., 1993, EARTH TRANSFORMED HU, P215; Fekete B.M., 1999, 22 GRDC; Hagemann S, 1998, CLIM DYNAM, V14, P17, DOI 10.1007/s003820050205; Hu D, 2001, IGBP PUBLICATION SER, V3, P245; Inman DL, 1999, J GEOL, V107, P251, DOI 10.1086/314346; Liquete C, 2004, OCEANOGRAPHY, V17, P70; Marmulla G., 2001, 419 FAO; McLaughlin CJ, 2003, GLOBAL PLANET CHANGE, V39, P191, DOI 10.1016/S0921-8181(03)00024-9; Milliman J.D., 1992, J GEOL, V100, P25; Morehead MD, 2003, GLOBAL PLANET CHANGE, V39, P95, DOI 10.1016/S0921-8181(03)00019-5; Morehead MK, 2001, GLOBAL PLANET CHANGE, V28, P107, DOI 10.1016/S0921-8181(00)00068-0; Pasternack GB, 2001, EARTH SURF PROC LAND, V26, P409, DOI 10.1002/esp.189; RESTROPO JD, IN PRESS GLOBAL PLAN; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Syvitski J.P.M., 1987, FJORDS PROCESSES PRO; Syvitski JP, 1999, MAR GEOL, V154, P13, DOI 10.1016/S0025-3227(98)00100-5; Syvitski JPM, 2004, SEDIMENT GEOL, V164, P345, DOI 10.1016/j.sedgeo.2003.11.001; Syvitski JPM, 2003, SEDIMENT GEOL, V162, P5, DOI 10.1016/S0037-0738(03)00232-X; Syvitski JPM, 2003, GLOBAL PLANET CHANGE, V39, P1, DOI 10.1016/S0921-8181(03)00008-0; Syvitski JPM, 2002, POLAR RES, V21, P323, DOI 10.1111/j.1751-8369.2002.tb00087.x; SYVITSKI JPM, IN PRESS J COASTAL R; SYVITSKI JPM, IN PRESS MAR GEOL; SYVITSKI JPM, IN PRESS LOICZ COAST; Vorosmarty CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P599, DOI 10.1029/1999GB900092; Vorosmarty CJ, 2003, GLOBAL PLANET CHANGE, V39, P169, DOI 10.1016/S0921-8181(03)00023-7; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wolanski E, 2000, REG ENVIRON CHANGE, V1, P152, DOI 10.1007/s101130000014; [No title captured], DOI DOI 10.1126/SCIENCE.278.5341.1209C	30	1754	1875	35	680	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					376	380		10.1126/science.1109454	http://dx.doi.org/10.1126/science.1109454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831750				2022-12-01	WOS:000228492000042
J	Banerjee, A; Yang, W; Karplus, M; Verdine, GL				Banerjee, A; Yang, W; Karplus, M; Verdine, GL			Structure of a repair enzyme interrogating undamaged DNA elucidates recognition of damaged DNA	NATURE			English	Article							FREE-ENERGY SIMULATIONS; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; REVERSE-TRANSCRIPTASE; PROTEIN; GLYCOSYLASE; 8-OXOGUANINE; CATALYSIS; COMPLEX; BASES	How DNA repair proteins distinguish between the rare sites of damage and the vast expanse of normal DNA is poorly understood. Recognizing the mutagenic lesion 8-oxoguanine (oxoG) represents an especially formidable challenge, because this oxidized nucleobase differs by only two atoms from its normal counterpart, guanine (G). Here we report the use of a covalent trapping strategy to capture a human oxoG repair protein, 8-oxogunanine DNA glycosylase I (hOGG1), in the act of interrogating normal DNA. The X-ray structure of the trapped complex features a target G nucleobase extruded from the DNA helix but denied insertion into the lesion recognition pocket of the enzyme. Free energy difference calculations show that both attractive and repulsive interactions have an important role in the preferential binding of oxoG compared with G to the active site. The structure reveals a remarkably effective gate-keeping strategy for lesion discrimination and suggests a mechanism for oxoG insertion into the hOGG1 active site.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Strasbourg 1, ISIS, F-67000 Strasbourg, France	Harvard University; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	marci@tammy.harvard.edu; verdine@chemistry.harvard.edu	Yang, Wei/H-5428-2011; Banerjee, Anirban/AAC-4286-2020	Banerjee, Anirban/0000-0002-9314-2862; banerjee, anirban/0000-0003-1494-6801	NCI NIH HHS [R01 CA100742] Funding Source: Medline; NIGMS NIH HHS [R01 GM044853] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASH PA, 1991, BIOCHEMISTRY-US, V30, P5826, DOI 10.1021/bi00238a003; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; BROOKS CL, 1988, ADV CHEM PHYS, V71; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cappelli E, 2001, CARCINOGENESIS, V22, P387, DOI 10.1093/carcin/22.3.387; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P379; CERVI AR, 1993, NUCLEIC ACIDS RES, V21, P5623, DOI 10.1093/nar/21.24.5623; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACMILLAN AM, 1991, TETRAHEDRON, V47, P2603, DOI 10.1016/S0040-4020(01)81793-2; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Norman DPG, 2001, J AM CHEM SOC, V123, P359, DOI 10.1021/ja003144m; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Schaefer M, 1997, J PHYS CHEM B, V101, P1663, DOI 10.1021/jp962972s; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; SIMONSON T, 1997, J PHYS CHEM-US, V41, P8347; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Verdine GL, 1997, CHEM BIOL, V4, P329, DOI 10.1016/S1074-5521(97)90123-X; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; Yang W, 2004, J CHEM PHYS, V120, P9450, DOI 10.1063/1.1738106	31	289	318	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					612	618		10.1038/nature03458	http://dx.doi.org/10.1038/nature03458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800616				2022-12-01	WOS:000228011000037
J	Penkner, AM; Prinz, S; Ferscha, S; Klein, F				Penkner, AM; Prinz, S; Ferscha, S; Klein, F			Mnd2, an essential antagonist of the anaphase-promoting complex during meiotic prophase	CELL			English	Article							MEIOSIS-I DEPENDS; CHROMOSOME SEGREGATION; MITOTIC EXIT; SACCHAROMYCES-CEREVISIAE; SPORE FORMATION; PROTEIN; SEPARASE; SUBUNITS; CDC20; DEGRADATION	Melotic cohesin serves in sister chromatid linkage and DNA repair until its subunit Rec8 is cleaved by separase. Separase is activated when its inhibitor, securin, is polyubiquitinated by the Cdc20 regulated anaphase-promoting complex (ApC(Cdc20)) and consequently degraded. Differently regulated APCs (ApC(Cdh1), ApC(Ama1)) have not been implicated in securin degradation at meiosis 1. We show that Mnd2, a factor known to associate with APC components, prevents premature securin degradation in meiosis by ApC(Ama1). mnd2 Delta cells lack linear chromosome axes and exhibit precocious sister chromatid separation, but deletion of AMA1 suppresses these defects. Besides securin, Sgo1, a protein essential for protection of centromeric cohesion during anaphase 1, is also destabilized in mnd2 Delta cells. Mnd2 ' s disappearance prior to anaphase 11 may activate ApC(Ama1). Human oocytes may spend many years in meiotic prophase before maturation. Inhibitors of meiotic APC variants could prevent loss of chiasmata also in these cells, thereby guarding against aberrant chromosome segregation.	Vienna Bioctr 2, Max Perutz Labs, Dept Chromosome Biol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Klein, F (corresponding author), Vienna Bioctr 2, Max Perutz Labs, Dept Chromosome Biol, Dr Bohr Gasse 1, A-1030 Vienna, Austria.	franz.klein@univie.ac.at		Klein, Franz/0000-0001-7204-1432				Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; Blanco MA, 2001, J CELL SCI, V114, P2135; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Davis ES, 2002, GENETICS, V160, P805; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; GOLDWAY M, 1993, GENETICS, V133, P159; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kamieniecki RJ, 2000, CURR BIOL, V10, P1182, DOI 10.1016/S0960-9822(00)00723-5; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; PRIELER S, 2005, GENE DEV, V19, P1516; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1995, J CELL BIOL, V128, P455, DOI 10.1083/jcb.128.4.455; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	55	51	56	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					789	801		10.1016/j.cell.2005.01.017	http://dx.doi.org/10.1016/j.cell.2005.01.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797380	Bronze			2022-12-01	WOS:000228067500009
J	Sonnichsen, B; Koski, LB; Walsh, A; Marschall, P; Neumann, B; Brehm, M; Alleaume, AM; Artelt, J; Bettencourt, P; Cassin, E; Hewitson, M; Holz, C; Khan, M; Lazik, S; Martin, C; Nitzsche, B; Ruer, M; Stamford, J; Winzi, M; Heinkel, R; Roder, M; Finell, J; Hantsch, H; Jones, SJM; Jones, M; Piano, F; Gunsalus, KC; Oegema, K; Gonczy, P; Coulson, A; Hyman, AA; Echeverri, CJ				Sonnichsen, B; Koski, LB; Walsh, A; Marschall, P; Neumann, B; Brehm, M; Alleaume, AM; Artelt, J; Bettencourt, P; Cassin, E; Hewitson, M; Holz, C; Khan, M; Lazik, S; Martin, C; Nitzsche, B; Ruer, M; Stamford, J; Winzi, M; Heinkel, R; Roder, M; Finell, J; Hantsch, H; Jones, SJM; Jones, M; Piano, F; Gunsalus, KC; Oegema, K; Gonczy, P; Coulson, A; Hyman, AA; Echeverri, CJ			Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans	NATURE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; CELL-DIVISION; INTERFERENCE; GENES; GENERATION; EMBRYOS	A key challenge of functional genomics today is to generate well-annotated data sets that can be interpreted across different platforms and technologies. Large-scale functional genomics data often fail to connect to standard experimental approaches of gene characterization in individual laboratories. Furthermore, a lack of universal annotation standards for phenotypic data sets makes it difficult to compare different screening approaches. Here we address this problem in a screen designed to identify all genes required for the first two rounds of cell division in the Caenorhabditis elegans embryo. We used RNA-mediated interference to target 98% of all genes predicted in the C. elegans genome in combination with differential interference contrast time-lapse microscopy. Through systematic annotation of the resulting movies, we developed a phenotypic profiling system, which shows high correlation with cellular processes and biochemical pathways, thus enabling us to predict new functions for previously uncharacterized genes.	Cenix Biosci GmbH, D-01307 Dresden, Germany; Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; British Columbia Canc Res Ctr, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA	Max Planck Society; British Columbia Cancer Agency; Wellcome Trust Sanger Institute; New York University	Sonnichsen, B (corresponding author), Cenix Biosci GmbH, Tatzberg 47-51, D-01307 Dresden, Germany.	soennichsen@cenix.bioscience.com	Bettencourt, Paulo/V-5793-2017; Hyman, Tony/F-1923-2011; Jones, Steven J/C-3621-2009; Hyman, Anthony A/B-3917-2017	Bettencourt, Paulo/0000-0002-4884-5470; Jones, Steven J/0000-0003-3394-2208; Hyman, Anthony A/0000-0003-3664-154X; Gonczy, Pierre/0000-0002-6305-6883; Neumann, Beate/0000-0002-6899-502X; Alleaume, Anne-Marie/0000-0001-7881-1880; Nitzsche, Bjorn/0000-0002-4759-0760				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KIGER A, 2003, J BIOL, V2; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	21	683	704	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					462	469		10.1038/nature03353	http://dx.doi.org/10.1038/nature03353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791247				2022-12-01	WOS:000227836000032
J	Winn, MP; Conlon, PJ; Lynn, KL; Farrington, MK; Creazzo, T; Hawkins, AF; Daskalakis, N; Kwan, SY; Ebersviller, S; Burchette, JL; Pericak-Vance, MA; Howel, DN; Vance, JM; Rosenberg, PB				Winn, MP; Conlon, PJ; Lynn, KL; Farrington, MK; Creazzo, T; Hawkins, AF; Daskalakis, N; Kwan, SY; Ebersviller, S; Burchette, JL; Pericak-Vance, MA; Howel, DN; Vance, JM; Rosenberg, PB			A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis	SCIENCE			English	Article							NEPHROTIC SYNDROME; SLIT DIAPHRAGM; GENETIC-HETEROGENEITY; GLOMERULAR-DISEASE; PODOCIN; ALPHA-ACTININ-4; EXPRESSION; INSERTION; NEPHRIN; PROTEIN	Focal and segmental glomerulosclerosis (FSGS) is a kidney disorder of unknown etiology, and up to 20% of patients on dialysis have been diagnosed with it. Here we show that a large family with hereditary FSGS carries a missense mutation in the TRPC6 gene on chromosome 11q, encoding the ion-channel protein transient receptor potential cation channel 6 (TRPC6). The proline-to-glutamine substitution at position 112, which occurs in a highly conserved region of the protein, enhances TRPC6-mediated calcium signals in response to agonists such as angiotensin II and appears to alter the intracellular distribution of TRPC6 protein. Previous work has emphasized the importance of cytosketetal and structural proteins in proteinuric kidney diseases. Our findings suggest an alternative mechanism for the pathogenesis of glomerular disease.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Beaumont Hosp, Dept Nephrol, Dublin, Ireland; Christchurch Hosp, Dept Nephrol, Christchurch, New Zealand; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Durham VA Med Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Christchurch Hospital New Zealand; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Winn, MP (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	michelle.winn@duke.edu; jeff@chg.duhs.duke.edu; rosen029@mc.duke.edu	Ebersviller, Seth/ABA-7279-2021	Ebersviller, Seth/0000-0002-3035-5000; Rosenberg, Paul/0000-0002-5659-160X; Vance, Jeffery/0000-0003-3815-8199	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074748] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK074748] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balla T, 1998, ENDOCR RES, V24, P335, DOI 10.3109/07435809809032613; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Conlon PJ, 1999, KIDNEY INT, V56, P1863, DOI 10.1046/j.1523-1755.1999.00727.x; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurtado A, 2000, CLIN NEPHROL, V53, P325; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Korbet SM, 1996, AM J KIDNEY DIS, V27, P647, DOI 10.1016/S0272-6386(96)90098-0; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Srivastava T, 1999, PEDIATR NEPHROL, V13, P13, DOI 10.1007/s004670050555; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; Winn MP, 1999, GENOMICS, V58, P113, DOI 10.1006/geno.1999.5828; Winn MP, 1999, KIDNEY INT, V55, P1241, DOI 10.1046/j.1523-1755.1999.00384.x	23	776	849	5	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1801	1804		10.1126/science.1106215	http://dx.doi.org/10.1126/science.1106215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15879175				2022-12-01	WOS:000229926800059
J	Levin, LI; Munger, KL; Rubertone, MV; Peck, CA; Lennette, ET; Spiegelman, D; Ascherio, A				Levin, LI; Munger, KL; Rubertone, MV; Peck, CA; Lennette, ET; Spiegelman, D; Ascherio, A			Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUCLEAR ANTIGEN; INFECTION; DISEASE; MONONUCLEOSIS; EXPOSURE; EBNA-2; LEVEL; RISK	Context Infection with Epstein-Barr virus (EBV) has been associated with an increased risk of multiple sclerosis (MS), but the temporal relationship remains unclear. Objective To determine whether antibodies to EBV are elevated before the onset of MS. Design, Setting, and Participants Nested case-control study conducted among more than 3 million US military personnel with blood samples collected between 1988 and 2000 and stored in the Department of Defense Serum Repository. Cases were identified as individuals granted temporary or permanent disability because of MS. For each case (n = 83), 2 controls matched by age, sex, race/ethnicity, and dates of blood sample collection were selected. Serial samples collected before the onset of symptoms were available for 69 matched case-control sets. Main Outcome Measures Antibodies including IgA against EBV viral capsid antigen (VCA), and IgG against VCA, nuclear antigens (EBNA complex, EBNA-1, and EBNA-2), diffuse and restricted early antigens, and cytomegalovirus. Results The average time between blood collection and MS onset was 4 years (range, <1-11 years). The strongest predictors of MS were serum levels of IgG antibodies to EBNA complex or EBNA-1. Among individuals who developed MS, serum antibody titers to EBNA complex were similar to those of controls before the age of 20 years (geometric mean titers: cases=245, controls=265), but 2- to 3-fold higher at age 25 years and older (cases=684, controls=282; P<.001). The risk of MS increased with these antibody titers; the relative risk (RR) in persons with EBNA complex titers of at least 1280 compared with those with titers less than 80 was 9.4 (95% confidence interval [CI], 2.5-35.4; P for trend <.001). In longitudinal analyses, a 4-fold increase in anti-EBNA complex or anti-EBNA-1 titers during the follow-up was associated with a 3-fold increase in MS risk (EBNA complex: RR,3.0; 95% Cl, 1.3-6.5; EBNA-1: RR, 3.0; 95% Cl, 1.2-7.3). No association was found between cytomegalovirus antibodies and MS. Conclusion These results suggest an age-dependent relationship between EBV infection and development of MS.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Walter Reed Army Inst Res, Div Prevent Med, Silver Spring, MD USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; USA, Army Med Surveillance Act, Ctr Hlth Promot & Prevent Med, Washington, DC 20310 USA; USA, Phys Disabil Agcy, Washington, DC 20310 USA; Virolab Inc, Berkeley, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	Alberto.Ascherio@channing.harvard.edu			NINDS NIH HHS [NS42194] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042194] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Brex PA, 1999, NEUROLOGY, V53, P1184, DOI 10.1212/WNL.53.6.1184; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; DETHE G, 1982, HERPESVIRUSES, V1, P25; DIGGLE PJ, 1994, ANAL LONGITUDINAL DA, P253; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; HENLE W, 1971, J INFECT DIS, V124, P58, DOI 10.1093/infdis/124.1.58; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; HORWITZ CA, 1985, J INFECT DIS, V151, P1150, DOI 10.1093/infdis/151.6.1150; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Kaslow, 1997, VIRAL INFECT HUMANS, P253; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; KUSUNOKI Y, 1993, MICROBIOL IMMUNOL, V37, P461, DOI 10.1111/j.1348-0421.1993.tb03237.x; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; LENNETTE ET, 1993, EUR J CANCER, V29A, P1584, DOI 10.1016/0959-8049(93)90299-U; LENNETTE ET, 2000, CLIN VIROLOGY MANUAL, P140; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SHIRODARIA PV, 1987, ARCH NEUROL-CHICAGO, V44, P1237, DOI 10.1001/archneur.1987.00520240019006; Sitki-Green D, 2003, J VIROL, V77, P1840, DOI 10.1128/JVI.77.3.1840-1847.2003; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820	30	291	299	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2005	293	20					2496	2500		10.1001/jama.293.20.2496	http://dx.doi.org/10.1001/jama.293.20.2496			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929BX	15914750				2022-12-01	WOS:000229318200024
J	Liu, Y; Schiff, M; Czymmek, K; Talloczy, Z; Levine, B; Dinesh-Kumar, SP				Liu, Y; Schiff, M; Czymmek, K; Talloczy, Z; Levine, B; Dinesh-Kumar, SP			Autophagy regulates programmed cell death during the plant innate immune response	CELL			English	Article							MEDIATED RESISTANCE; PROTEINS; GENE; INHIBITION; DISEASE; MACROAUTOPHAGY; TUMORIGENESIS; DISRUPTION; SENESCENCE; SURVIVAL	The plant innate immune response includes the hypersensitive response (HR), a form of programmed cell death (PCD). PCD must be restricted to infection sites to prevent the HR from playing a pathologic rather than protective role. Here we show that plant BECLIN 1, an ortholog of the yeast and mammalian autophagy gene ATG6/VPS30/beclin 1, functions to restrict HR PCD to infection sites. Initiation of HR PCD is normal in BECLIN 1-deficient plants, but remarkably, healthy uninfected tissue adjacent to HR lesions and leaves distal to the inoculated leaf undergo unrestricted PCD. In the HR PCD response, autophagy is induced in both pathogen-infected cells and distal uninfected cells; this is reduced in BECLIN 1-deficient plants. The restriction of HR PCD also requires orthologs of other autophagy-related genes including P13K/VPS34, ATG3, and ATG7. Thus, the evolutionarily conserved autophagy pathway plays an essential role in plant innate immunity and negatively regulates PCD.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Delaware, Delaware Biotechnol Inst, Dept Biol Sci, Newark, DE 19711 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75390 USA	Yale University; University of Delaware; Columbia University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Dinesh-Kumar, SP (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	savithramma.dinesh-kumar@yale.edu	Liu, Yule/E-5700-2010; Dinesh-Kumar, Savithramma/E-1153-2011	Liu, Yule/0000-0002-4423-6045; Czymmek, Kirk/0000-0002-5471-7395	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI051367, R01AI051367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062625] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 51367] Funding Source: Medline; NIGMS NIH HHS [GM 62625] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.pp.46.060195.001201; Bourett TM, 1999, PLANTA, V208, P472, DOI 10.1007/s004250050584; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Erickson FL, 1999, PLANT J, V18, P67, DOI 10.1046/j.1365-313X.1999.00426.x; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lee CY, 2001, DEVELOPMENT, V128, P1443; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Marathe R, 2002, MOL PLANT PATHOL, V3, P167, DOI 10.1046/j.1364-3703.2002.00110.x; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moriyasu Y, 2003, PLANT CELL PHYSIOL, V44, P795, DOI 10.1093/pcp/pcg100; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Surpin M, 2003, PLANT CELL, V15, P2885, DOI 10.1105/tpc.016121; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	48	642	700	9	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					567	577		10.1016/j.cell.2005.03.007	http://dx.doi.org/10.1016/j.cell.2005.03.007			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907470	Bronze			2022-12-01	WOS:000229331200013
J	English, SK				English, SK			Saying good-bye	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												shamrock25@iname.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2321	2322						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15899986				2022-12-01	WOS:000229120600001
J	Piercy, J				Piercy, J			10-minute consultation - Hyperhidrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England	University of Warwick	Piercy, J (corresponding author), Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England.	ann.mcpherson@dphpc.ox.ac.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1127	1127		10.1136/bmj.330.7500.1127	http://dx.doi.org/10.1136/bmj.330.7500.1127			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891228	Bronze, Green Published			2022-12-01	WOS:000229166900021
J	Yuan, XL; Xiao, SH; Taylor, TN				Yuan, XL; Xiao, SH; Taylor, TN			Lichen-like symbiosis 600 million years ago	SCIENCE			English	Article							NEOPROTEROZOIC DOUSHANTUO FORMATION; FUNGI; EVOLUTION	The fossil record of fungi and lichens is scarce. Here we report the discovery of lichen-like fossils, involving filamentous hyphae closely associated with coccoidal cyanobacteria or algae, preserved in marine phosphorite of the Doushantuo Formation (between 551 and 635 million years old) at Weng'an, South China. These fossils indicate that fungi developed symbiotic partnerships with photoautotrophs before the evolution of vascular plants.	Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Kansas	Xiao, SH (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	xiao@vt.edu	Xiao, Shuhai/A-2190-2009	Xiao, Shuhai/0000-0003-4655-2663				Alexopoulos C. J., 1996; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Berbee ML, 2001, MYCOTA, V7, P229; Butterfield NJ, 2005, PALEOBIOLOGY, V31, P165, DOI 10.1666/0094-8373(2005)031<0165:PPF>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DePriest PT, 2004, ANNU REV MICROBIOL, V58, P273, DOI 10.1146/annurev.micro.58.030603.123730; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; KNOLL AH, 1979, PRECAMBRIAN RES, V10, P115, DOI 10.1016/0301-9268(79)90022-6; Kohlmeyer J., 1979, Marine mycology. The higher fungi.; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; TAYLOR TN, 1995, MYCOLOGIA, V87, P560, DOI 10.2307/3760776; Taylor TN, 2004, T ROY SOC EDIN-EARTH, V94, P457, DOI 10.1017/S026359330000081X; Taylor TN, 1997, AM J BOT, V84, P992, DOI 10.2307/2446290; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Tehler A, 2003, MYCOL RES, V107, P901, DOI 10.1017/S0953756203008128; Wedin M, 2004, NEW PHYTOL, V164, P459, DOI 10.1111/j.1469-8137.2004.01198.x; Xiao SH, 2004, AM J BOT, V91, P214, DOI 10.3732/ajb.91.2.214; ZHANG XG, 1989, LETHAIA, V22, P13, DOI 10.1111/j.1502-3931.1989.tb01164.x; ZHANG Y, 1998, PALEONTOL SOC MEM, V50, P1	26	195	240	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1017	1020		10.1126/science.1111347	http://dx.doi.org/10.1126/science.1111347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890881				2022-12-01	WOS:000229190700045
J	Kent, SC; Chen, YH; Bregoli, L; Clemmings, SM; Kenyon, NS; Ricordi, C; Hering, BJ; Hafler, DA				Kent, SC; Chen, YH; Bregoli, L; Clemmings, SM; Kenyon, NS; Ricordi, C; Hering, BJ; Hafler, DA			Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope	NATURE			English	Article							CLASS-II MOLECULES; GENE USAGE; MICE; MELLITUS; RESPONSES; ANTIGENS; DISEASE; CLONES; IDENTIFICATION; AUTOANTIGENS	In autoimmune type 1 diabetes, pathogenic T lymphocytes are associated with the specific destruction of insulin-producing beta-islet cells(1,2). Identification of the autoantigens involved in triggering this process is a central question. Here we examined T cells from pancreatic draining lymph nodes, the site of islet-cell-specific self-antigen presentation(3). We cloned single T cells in a non-biased manner from pancreatic draining lymph nodes of subjects with type 1 diabetes and from non-diabetic controls. A high degree of T-cell clonal expansion was observed in pancreatic lymph nodes from long-term diabetic patients but not from control subjects. The oligoclonally expanded T cells from diabetic subjects with DR4, a susceptibility allele for type 1 diabetes(4), recognized the insulin A 1 - 15 epitope restricted by DR4. These results identify insulin-reactive, clonally expanded T cells from the site of autoinflammatory drainage in long-term type 1 diabetics, indicating that insulin may indeed be the target antigen causing autoimmune diabetes.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Minnesota, Dept Surg, Diabet Inst Immunol & Transplantat, Minneapolis, MN 55455 USA; Univ Miami, Diabet Res Inst, Cell Transplant Ctr, Miami, FL 33136 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Miami	Hafler, DA (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dhafler@rics.bwh.harvard.edu	RICORDI, CAMILLO/AAA-4740-2019	Ricordi, Camillo/0000-0001-8092-7153; Bregoli, Lisa/0000-0001-9376-1914				ACHAORBEA H, 1990, CURR TOP MICROBIOL, V156, P103; Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Astill TP, 2003, DIABETOLOGIA, V46, P496, DOI 10.1007/s00125-003-1070-3; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; DAYAN CM, 1991, P NATL ACAD SCI USA, V88, P7415, DOI 10.1073/pnas.88.16.7415; Eisenbarth George S., 2002, Autoimmunity Reviews, V1, P139, DOI 10.1016/S1568-9972(02)00035-6; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Endl J, 1997, J CLIN INVEST, V99, P2405, DOI 10.1172/JCI119423; HAFLER DA, 1988, J EXP MED, V167, P1313, DOI 10.1084/jem.167.4.1313; Han M, 1999, J IMMUNOL, V163, P301; HARRISON LC, 1992, J CLIN INVEST, V89, P1161, DOI 10.1172/JCI115698; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622; Mycko MP, 2004, J IMMUNOL, V173, P1689, DOI 10.4049/jimmunol.173.3.1689; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Peakman M, 2001, DIABETES, V50, P1749, DOI 10.2337/diabetes.50.8.1749; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Schloot NC, 2003, J AUTOIMMUN, V21, P365, DOI 10.1016/S0896-8411(03)00111-2; SIBLEY RK, 1985, LAB INVEST, V53, P132; THOMSON G, 1988, AM J HUM GENET, V43, P799; Tian J, 1997, J EXP MED, V186, P2039, DOI 10.1084/jem.186.12.2039; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183	32	315	335	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					224	228		10.1038/nature03625	http://dx.doi.org/10.1038/nature03625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889096				2022-12-01	WOS:000229021100045
J	Sugasawa, K; Okuda, Y; Saijo, M; Nishi, R; Matsuda, N; Chu, G; Mori, T; Iwai, S; Tanaka, K; Tanaka, K; Hanaoka, F				Sugasawa, K; Okuda, Y; Saijo, M; Nishi, R; Matsuda, N; Chu, G; Mori, T; Iwai, S; Tanaka, K; Tanaka, K; Hanaoka, F			UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-C; DNA-BINDING PROTEIN; GLOBAL GENOMIC REPAIR; GROUP-E CELLS; CYCLOBUTANE PYRIMIDINE DIMERS; DAMAGED-DNA; ULTRAVIOLET-LIGHT; GENE-PRODUCT; IN-VIVO	The xeroderma pigmentosum group C (XPC) protein complex plays a key role in recognizing DNA damage throughout the genome for mammalian nucleotide excision repair (NER). Ultraviolet light (UV)-damaged DNA binding protein (UV-DDB) is another complex that appears to be involved in the recognition of NER-inducing damage, although the precise role it plays and its relationship to XPC remain to be elucidated. Here we show that XPC undergoes reversible ubiquitylation upon UV irradiation of cells and that this depends on the presence of functional UV-DDB activity. XPC and UV-DDB were demonstrated to interact physically, and both are polyubiquitylated by the recombinant UV-DDB-ubiquitin ligase complex. The polyubiquitylation altered the DNA binding properties of XPC and UV-DDB and appeared to be required for cell-free NER of UV-induced (6-4) photoproducts specifically when UV-DDB was bound to the lesion. Our results strongly suggest that ubiquitylation plays a critical role in the transfer of the UV-induced lesion from UVDDB to XPC.	RIKEN, Discovery Drug Res, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Wako, Saitama 3510198, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; Stanford Univ, Dept Med & Biochem, Stanford, CA 94305 USA; Nara Med Univ, Radioisotope Ctr, Kashihara, Nara 6348521, Japan; Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	RIKEN; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science; Stanford University; Nara Medical University; Osaka University	Sugasawa, K (corresponding author), RIKEN, Discovery Drug Res, Cellular Physiol Lab, Wako, Saitama 3510198, Japan.	sugasawa@riken.jp	Matsuda, Noriyuki/AAI-3156-2020; Nishi, Ryotaro/AAA-3372-2019	Matsuda, Noriyuki/0000-0001-8199-952X; Nishi, Ryotaro/0000-0001-8179-5818; Mori, Toshio/0000-0002-8321-0710				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Araujo SJ, 2000, GENE DEV, V14, P349; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; BOOTSMA D, 1997, METABOLIC BASIS INHE, P245; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fitch ME, 2003, DNA REPAIR, V2, P819, DOI 10.1016/S1568-7864(03)00066-1; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Itoh T, 2004, P NATL ACAD SCI USA, V101, P2052, DOI 10.1073/pnas.0306551101; Itoh T, 2000, J INVEST DERMATOL, V114, P1022, DOI 10.1046/j.1523-1747.2000.00952.x; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; MATSUMOTO Y, 1983, FEBS LETT, V151, P139, DOI 10.1016/0014-5793(83)80359-7; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nichols AF, 1996, J BIOL CHEM, V271, P24317, DOI 10.1074/jbc.271.40.24317; Okuda Y, 2004, DNA REPAIR, V3, P1285, DOI 10.1016/j.dnarep.2004.06.010; Otrin VR, 1997, J CELL SCI, V110, P1159; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; SHIVJI MKK, 1994, J BIOL CHEM, V269, P22749; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200	39	441	459	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					387	400		10.1016/j.cell.2005.02.035	http://dx.doi.org/10.1016/j.cell.2005.02.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882621	Bronze			2022-12-01	WOS:000229031600009
J	Osterholm, MT				Osterholm, MT			Preparing for the next pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLUENZA		Ctr Infect Dis Res & Policy, Minneapolis, MN USA; Natl Ctr Food Protect & Def, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Ctr Infect Dis Res & Policy, Minneapolis, MN USA.							Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; SANDMAN PM, 2005, PANDEMIC INFLUENZA R; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344	5	364	407	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1839	1842		10.1056/NEJMp058068	http://dx.doi.org/10.1056/NEJMp058068			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872196	Bronze, Green Submitted			2022-12-01	WOS:000228858600001
J	Murata, T; Yamato, I; Kakinuma, Y; Leslie, AGW; Walker, JE				Murata, T; Yamato, I; Kakinuma, Y; Leslie, AGW; Walker, JE			Structure of the rotor of the V-type Na+-ATPase from Enterococcus hirae	SCIENCE			English	Article							SUBUNIT-C; MOLECULAR ARCHITECTURE; ROTARY MOTOR; F1F0; SYNTHASE; BINDING; RING; SYMMETRY; SINGLE	The membrane rotor ring from the vacuolar-type (V-type) sodium ion-pumping adenosine triphosphatase (Na+-ATPase) from Enterococcus hirae consists of 10 NtpK subunits, which are homologs of the 16-kilodalton and 8-kilodalton proteotipids found in other V-ATPases and in F1F0- or F-ATPases, respectively. Each NtpK subunit has four transmembrane a helices, with a sodium ion bound between helices 2 and 4 at a site buried deeply in the membrane that includes the essential residue glutamate-139. This site is probably connected to the membrane surface by two half-channels in subunit Ntpl, against which the ring rotates. Symmetry mismatch between the rotor and catalytic domains appears to be an intrinsic feature of both V- and F-ATPases.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Tokyo University of Science; Ehime University	Leslie, AGW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	andrew@mrc-tmb.cam.ac.uk; watker@mrc-dunn.cam.ac.uk	Murata, Takeshi/J-6181-2017; Murata, Takeshi/F-6114-2011	Murata, Takeshi/0000-0002-5748-4670; Walker, John/0000-0001-7929-2162				ARAI H, 1988, J BIOL CHEM, V263, P8796; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HOLZENBURG A, 1993, EUR J BIOCHEM, V213, P21, DOI 10.1111/j.1432-1033.1993.tb17730.x; IBBOTT FA, 1964, BIOCHEMISTRY-US, V3, P2008, DOI 10.1021/bi00900a039; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kaim G, 1998, EMBO J, V17, P5887, DOI 10.1093/emboj/17.20.5887; Kaim G, 1998, EMBO J, V17, P688, DOI 10.1093/emboj/17.3.688; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Kawano M, 2002, J BIOL CHEM, V277, P24405, DOI 10.1074/jbc.M200973200; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishi T, 2003, J BIOL CHEM, V278, P5821, DOI 10.1074/jbc.M209875200; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; von Ballmoos C, 2002, J BIOL CHEM, V277, P3504, DOI 10.1074/jbc.M110301200; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W	31	308	316	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					654	659		10.1126/science.1110064	http://dx.doi.org/10.1126/science.1110064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15802565				2022-12-01	WOS:000228810900038
J	Rajan, S; Plant, LD; Rabin, ML; Butler, MH; Goldstein, SAN				Rajan, S; Plant, LD; Rabin, ML; Butler, MH; Goldstein, SAN			Sumoylation silences the plasma membrane leak K+ channel K2P1	CELL			English	Article							CEREBELLAR GRANULE NEURONS; DOMAIN POTASSIUM CHANNELS; CONJUGATING ENZYME MUBC9; 2 PORE DOMAINS; SUMO CONJUGATION; UBIQUITIN; EXPRESSION; TASK-1; LOCALIZATION; PROTEINS	Reversible, covalent modification with small ubiquitin-related modifier proteins (SUMOs) is known to mediate nuclear import/export and activity of transcription factors. Here, the SUMO pathway is shown to operate at the plasma membrane to control ion channel function. SUMO-conjugating enzyme is seen to be resident in plasma membrane, to assemble with K2P1, and to modify K2P1 lysine 274. K2P1 had not previously shown function despite mRNA expression in heart, brain, and kidney and sequence features like other two-P loop K+ leak (K2P) pores that control activity of excitable cells. Removal of the peptide adduct by SUMO protease reveals K2P1 to be a K+-selective, pH-sensitive, openly rectifying channel regulated by reversible peptide linkage.	Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA	University of Chicago	Goldstein, SAN (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat, 5721 S Maryland Ave, Chicago, IL 60637 USA.	sangoldstein@uchicago.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Bockenhauer D, 2000, GENE, V261, P365, DOI 10.1016/S0378-1119(00)00492-3; Colquhoun David, 1995, P483; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; GOLDSTEIN SAN, 2002, IUPHAR COMPENDIUM VO, P173; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Ilan N, 2001, BIOPHYS J, V80, P241, DOI 10.1016/S0006-3495(01)76010-9; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Kuryshev YA, 2000, AM J PHYSIOL-CELL PH, V278, pC931, DOI 10.1152/ajpcell.2000.278.5.C931; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Levy DI, 2004, KIDNEY INT, V65, P918, DOI 10.1111/j.1523-1755.2004.00458.x; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Machon O, 2000, MECH DEVELOP, V97, P3, DOI 10.1016/S0925-4773(00)00402-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Malbert-Colas L, 2003, CR BIOL, V326, P615, DOI 10.1016/S1631-0691(03)00154-9; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Orias M, 1997, AM J PHYSIOL-RENAL, V273, pF663, DOI 10.1152/ajprenal.1997.273.4.F663; Plant LD, 2002, STROKE, V33, P2324, DOI 10.1161/01.STR.0000027440.68031.B0; Rajan S, 2001, J BIOL CHEM, V276, P7302, DOI 10.1074/jbc.M008985200; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Salinas M, 1999, J BIOL CHEM, V274, P11751, DOI 10.1074/jbc.274.17.11751; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Ubbels GA, 1997, CELL MOL LIFE SCI, V53, P382, DOI 10.1007/PL00000613; Wang ZG, 1998, CIRCULATION, V98, P2422, DOI 10.1161/01.CIR.98.22.2422; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	51	205	211	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					37	47		10.1016/j.cell.2005.01.019	http://dx.doi.org/10.1016/j.cell.2005.01.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820677	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000228348500008
J	Shin, S; El-Diwany, R; Schaffert, S; Adams, EJ; Garcia, KC; Pereira, P; Chien, YH				Shin, S; El-Diwany, R; Schaffert, S; Adams, EJ; Garcia, KC; Pereira, P; Chien, YH			Antigen recognition determinants of gamma delta T cell receptors	SCIENCE			English	Article							REPERTOIRE; SELECTION; SPECIFICITY; LYMPHOCYTES; POPULATION; REGION; MICE	The molecular basis of gamma delta T cell receptor (TCR) recognition is poorly understood. Here, we analyze the TCR sequences of a natural gamma delta T cell population specific for the major histocompatibility complex class Ib molecule T22. We find that T22 recognition correlates strongly with a somatically recombined TCR delta complementarity-determining region 3 (CDR3) motif derived from germ line-encoded residues. Sequence diversity around these residues modulates TCR ligand-binding affinities, whereas V gene usage correlates mainly with tissue origin. These results show how an antigen-specific gamma delta TCR repertoire can be generated at a high frequency and suggest that gamma delta T cells recognize a limited number of antigens.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Inst Pasteur, Unite Dev Lymphocytes, CNRS, URA 1961, F-75724 Paris, France	Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chien, YH (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	chien@stanford.edu	Pereira, Pablo/M-7224-2014	Pereira, Pablo/0000-0003-1784-2776; El-Diwany, Ramy/0000-0002-3224-6414; Schaffert, Steven/0000-0001-8842-0218	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033431] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33431] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Azuara V, 1998, EUR J IMMUNOL, V28, P3456, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3456::AID-IMMU3456&gt;3.0.CO;2-F; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; CANDEIAS S, 1991, J EXP MED, V174, P989, DOI 10.1084/jem.174.5.989; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DAVIS MM, 2003, FUNDAMENTAL IMMUNOLO; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; PEREIRA P, 1995, J EXP MED, V182, P1921, DOI 10.1084/jem.182.6.1921; Pereira P, 2004, J IMMUNOL, V173, P3261, DOI 10.4049/jimmunol.173.5.3261; Pereira P, 2000, EUR J IMMUNOL, V30, P1988, DOI 10.1002/1521-4141(200007)30:7<1988::AID-IMMU1988>3.0.CO;2-W; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; SHIN S, UNPUB; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; SPERLING AI, 1992, J IMMUNOL, V149, P3200; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	25	138	141	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2005	308	5719					252	255		10.1126/science.1106480	http://dx.doi.org/10.1126/science.1106480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821090				2022-12-01	WOS:000228273700053
J	Simpson, SD; Meekan, M; Montgomery, J; McCauley, R; Jeffs, A				Simpson, SD; Meekan, M; Montgomery, J; McCauley, R; Jeffs, A			Homeward sound	SCIENCE			English	Article							CORAL-REEF FISHES; RECRUITMENT; POPULATION		Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; Australian Inst Marine Sci, Darwin, NT, Australia; Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand; Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia; Natl Inst Water & Atmospher Res Ltd, Auckland, New Zealand	University of Edinburgh; Australian Institute of Marine Science; University of Auckland; Curtin University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Simpson, SD (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	s.simpson@ed.ac.uk	Jeffs, Andrew G/D-9474-2012; Montgomery, John C/D-4310-2009	Montgomery, John C/0000-0002-7451-3541; Simpson, Stephen/0000-0002-4856-6164; Meekan, Mark/0000-0002-3067-9427; Jeffs, Andrew/0000-0002-8504-1949	Natural Environment Research Council [NE/B501720/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; McCauley RD, 2000, PHILOS T ROY SOC B, V355, P1289, DOI 10.1098/rstb.2000.0686; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533	6	245	249	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					221	221		10.1126/science.1107406	http://dx.doi.org/10.1126/science.1107406			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821083				2022-12-01	WOS:000228273700043
J	Wang, MC; Bohmann, D; Jasper, H				Wang, MC; Bohmann, D; Jasper, H			JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling	CELL			English	Article							TRANSCRIPTION FACTOR FOXO3A; N-TERMINAL KINASE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; FAT-BODY; DROSOPHILA; RECEPTOR; DAF-16; PATHWAY	Aging of a eukaryotic organism is affected by its nutrition state and by its ability to prevent or repair oxidative damage. Consequently, signal transduction systems that control metabolism and oxidative stress responses influence life span. When nutrients are abundant, the insulin/IGF signaling (IIS) pathway promotes growth and energy storage but shortens life span. The transcription factor Foxo, which is inhibited by IIS, extends life span in conditions of low IIS activity. Life span can also be increased by activating the stress-responsive Jun-N-terminal kinase (JNK) pathway. Here we show that JNK requires Foxo to extend life span in Drosophila. JNK antagonizes IIS, causing nuclear localization of Foxo and inducing its targets, including growth control and stress defense genes. JNK and Foxo also restrict IIS activity systemically by repressing IIS ligand expression in neuroendocrine cells. The convergence of JNK signaling and IIS on Foxo provides a model to explain the effects of stress and nutrition on longevity.	Univ Rochester, Med Ctr, Dept Biomed Genet, Aab Inst Biomed Sci, Rochester, NY 14642 USA	University of Rochester	Bohmann, D (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Aab Inst Biomed Sci, 601 Elmwood Ave,Box 633, Rochester, NY 14642 USA.	dirk_bohmann@urmc.rochester.edu; henri_jasper@urmc.rochester.edu	Wang, Meng/F-2951-2019; Gimenez, Luis E Diaz/D-9291-2011	Wang, Meng/0000-0002-5898-6007; 				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Arrigo AP, 1998, BIOL CHEM, V379, P19; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oldham S, 2002, DEVELOPMENT, V129, P4103; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weber U, 2000, DEVELOPMENT, V127, P3619; Welsh MJ, 1998, ANN NY ACAD SCI, V851, P28, DOI 10.1111/j.1749-6632.1998.tb08973.x; WESSELL RJ, 2004, GENET, V36, P1275; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; Zhang B, 2003, DIABETES, V52, P2720, DOI 10.2337/diabetes.52.11.2720	59	418	437	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					115	125		10.1016/j.cell.2005.02.030	http://dx.doi.org/10.1016/j.cell.2005.02.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820683	Bronze			2022-12-01	WOS:000228348500014
J	Yamashita, M; Ying, SX; Zhang, GM; Li, CL; Cheng, SY; Deng, CX; Zhang, YE				Yamashita, M; Ying, SX; Zhang, GM; Li, CL; Cheng, SY; Deng, CX; Zhang, YE			Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation	CELL			English	Article							ACTIVATED PROTEIN-KINASE; TGF-BETA RECEPTOR; C-JUN; TRANSCRIPTIONAL ACTIVATION; I RECEPTOR; SMAD; DIFFERENTIATION; EXPRESSION; PROMOTER; ELEMENTS	Bone is constantly resorbed and formed throughout life by coordinated actions of osteoclasts and osteoblasts. Here we show that Smurf1, a HECT domain ubiquitin ligase, has a specific physiological role in suppressing the osteogenic activity of osteoblasts. Smurf1-deficient mice are born normal but exhibit an age-dependent increase of bone mass. The cause of this increase can be traced to enhanced activities of osteoblasts, which become sensitized to bone morphogenesis protein (BMP) in the absence of Smurf1. However, loss of Smurf1 does not affect the canonical Smad-mediated intracellular TGF beta or BMP signaling; instead, it leads to accumulation of phosphorylated MEKK2 and activation of the downstream JNK signaling cascade. We demonstrate that Smurf1 physically interacts with MEKK2 and promotes the ubiquitination and turnover of MEKK2. These results indicate that Smurf1 negatively regulates osteoblast activity and response to BMP through controlling MEKK2 degradation.	NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; NCI, Lab Anim Sci Program, Frederick, MD 21702 USA; NIDDKD, Mammalian Genet Sect, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zhang, YE (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bldg 37, Bethesda, MD 20892 USA.	yingz@helix.nih.gov	deng, chuxia/N-6713-2016; Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601	Intramural NIH HHS [Z01 BC010419-08, ZIA BC011168-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bakin AV, 2002, J CELL SCI, V115, P3193; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; FRACESCHI RT, 2003, J CELL BIOCHEM, V88, P446; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; HOGAN B, 1994, MANUPULATING MOUSE E; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wong C, 1999, MOL CELL BIOL, V19, P1821; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	51	269	286	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					101	113		10.1016/j.cell.2005.01.035	http://dx.doi.org/10.1016/j.cell.2005.01.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820682	Bronze, Green Accepted			2022-12-01	WOS:000228348500013
J	Wright, JT; Dunn, JK; Cutler, JA; Davis, BR; Cushman, WC; Ford, CE; Haywood, LJ; Leenen, FHH; Margolis, KL; Papademetriou, V; Probstfield, JL; Whelton, PK; Habib, GB				Wright, JT; Dunn, JK; Cutler, JA; Davis, BR; Cushman, WC; Ford, CE; Haywood, LJ; Leenen, FHH; Margolis, KL; Papademetriou, V; Probstfield, JL; Whelton, PK; Habib, GB		ALLHAT Collaborative Res Grp	Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING-ENZYME-INHIBITOR; LIPID-LOWERING TREATMENT; CALCIUM-CHANNEL BLOCKER; HEART-FAILURE EVENTS; ATTACK TRIAL ALLHAT; BLOOD-PRESSURE; COMBINATION THERAPY; CARDIOVASCULAR MORBIDITY; RANDOMIZED-TRIAL; MORTALITY	Context Few cardiovascular outcome data are available for blacks with hypertension treated with angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs). Objective To determine whether an ACE inhibitor or CCB is superior to a thiazide-type diuretic in reducing cardiovascular disease (CVD) incidence in racial subgroups. Design, Setting, and Participants Prespecified subgroup analysis of ALLHAT, a randomized, double-blind, active-controlled, clinical outcome trial conducted between February 1994 and March 2002 in 33 357 hypertensive US and Canadian patients aged 55 years or older (35% black) with at least 1 other cardiovascular risk factor. Interventions Anti hypertensive regimens initiated with a CCB (amlodipine) or an ACE inhibitor (lisinopril) vs a thiazide-type diuretic (chlorthalidone). Other medications were added to achieve goal blood pressures (BPs) less than 140/90 mm Hg. Main Outcome Measures The primary outcome was combined fatal coronary heart disease (CHD) or nonfatal myocardial infarction (MI), analyzed by intention-to-treat. Secondary outcomes included all-cause mortality, stroke, combined CVD (CND death, nonfatal MI, stroke, angina, coronary revascularization, heart failure [HF], or peripheral vascular disease), and end-stage renal disease. Results No significant difference was found between treatment groups for the primary CHD outcome in either racial subgroup. For amlodipine vs chlorthalidone only, HF was the only prespecified clinical outcome that differed significantly (overall: relative risk [RR], 1.37; 95% confidence interval [Cl], 1.24-1.51; blacks: RR, 1.46; 95% CI, 1.24-1.73; nonblacks: RR, 1.32; 95% CI, 1.17-1.49; P<.001 for each comparison) with no difference in treatment effects by race (P=.38 for interaction). For lisinopril vs chlorthalidone, results differed by race for systolic BP (greater decrease in blacks with chlorthalidone), stroke, and combined CVD outcomes (P<.001, P=.01, and P=.04, respectively, for interactions). In blacks and nonblacks, respectively, the RRs for stroke were 1.40 (95% CI, 1.17-1.68) and 1.00 (95% CI, 0.85-1.17) and for combined CVD were 1.19 (95% CI, 1.09-1.30) and 1.06(95% CI, 1.00-1.13). For HF, the RRs were 1.30 (95% CI, 1.10-1.54) and 1.13 (95% CI, 1.00-1.28), with no significant interaction by race. Time-dependent BP adjustment did not significantly alter differences in outcome for lisinopril vs chlorthalidone in blacks. Conclusions In blacks and nonblack subgroups, rates were not lower in the amlodipine or lisinopril groups than in the chlorthalidone group for either the primary CHD or any other prespecified clinical outcome, and diuretic-based treatment resulted in the lowest risk of heart failure. While the improved outcomes with chlorthalidone were more pronounced for some outcomes in blacks than in nonblacks, thiazide-type diuretics remain the drugs of choice for initial therapy of hypertension in both black and nonblack hypertensive patients.	Case Western Reserve Univ, Gen Clin Res Ctr, Cleveland, OH 44106 USA; Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA; NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Memphis Vet Affairs Med Ctr, Memphis, TN USA; Univ So Calif, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; Berman Ctr Outcomes & Clin Res, Minneapolis, MN USA; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Univ Washington, Seattle, WA 98195 USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA; Houston Vet Affairs Med Ctr, Houston, TX USA	Case Western Reserve University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Southern California; University of Ottawa; University of Ottawa Heart Institute; Hennepin County Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; Tulane University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	Wright, JT (corresponding author), Case Western Reserve Univ, Gen Clin Res Ctr, 11000 Euclid Ave,Bowell Bldg,5th Floor, Cleveland, OH 44106 USA.	jackson.wright@case.edu		Margolis, Karen/0000-0003-1862-7402; Papademetriou, Vasilios/0000-0002-2882-2757	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; [Anonymous], WORLD HLTH REP 2002; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; BOLZANO K, 1987, J CARDIOVASC PHARM, V9, pS43, DOI 10.1097/00005344-198700003-00011; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2000, ARCH INTERN MED, V160, P825, DOI 10.1001/archinte.160.6.825; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Davis BR, 2002, ANN INTERN MED, V137, P313, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00006; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Einhorn P, 2003, CIRCULATION, V108, P399; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; GILLUM RF, 1991, CARDIOVASCULAR DIS B, P3; Grimm RH, 2001, HYPERTENSION, V37, P19, DOI 10.1161/01.HYP.37.1.19; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; JOHNSON E, 2005, HYPERTENSION, P587; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Khan NA, 2004, CAN J CARDIOL, V20, P41; Klein JP., 2003, SURVIVAL ANAL TECHNI, DOI 10.1007/b97377; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LUTHER RR, 1986, AM J MED, V80, P73, DOI 10.1016/0002-9343(86)90856-9; MACGREGOR GA, 1985, J CARDIOVASC PHARM, V7, pS82, DOI 10.1097/00005344-198507001-00016; MANDER A, 2000, HOTDECK IMPUTATION, P196; Materson BJ, 1996, AM J HYPERTENS, V9, pS187, DOI 10.1016/S0895-7061(96)90100-4; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; Messerli FH, 2000, AM J CARDIOL, V86, P1182, DOI 10.1016/S0002-9149(00)01199-1; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Piller LB, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-10; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rahman M, 1997, ENDOCRIN METAB CLIN, V26, P125, DOI 10.1016/S0889-8529(05)70237-1; RAHMAN M, IN PRESS ARCH INTERN; Roca-Cusachs A, 2001, J CARDIOVASC PHARM, V38, P840, DOI 10.1097/00005344-200112000-00005; SAUNDERS E, 1990, ARCH INTERN MED, V150, P1707, DOI 10.1001/archinte.150.8.1707; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turnbull F, 2003, LANCET, V362, P1527; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; WILLIAMS GH, 1988, NEW ENGL J MED, V319, P1517; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yusuf S, 2000, NEW ENGL J MED, V342, P145	51	304	311	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2005	293	13					1595	1607		10.1001/jama.293.13.1595	http://dx.doi.org/10.1001/jama.293.13.1595			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913EV	15811979				2022-12-01	WOS:000228135300022
J	Pedraza, JM; van Oudenaarden, A				Pedraza, JM; van Oudenaarden, A			Noise propagation in gene networks	SCIENCE			English	Article							STOCHASTICITY; EXPRESSION	Accurately predicting noise propagation in gene networks is crucial for understanding signal fidelity in natural networks and designing noise-tolerant gene circuits. To quantify how noise propagates through gene networks, we measured expression correlations between genes in single cells. We found that noise in a gene was determined by its intrinsic fluctuations, transmitted noise from upstream genes, and global noise affecting all genes. A model was developed that explains the complex behavior exhibited by the correlations and reveals the dominant noise sources. The model successfully predicts the correlations as the network is systematically perturbed. This approach provides a step toward understanding and manipulating noise propagation in more complex gene networks.	MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Pedraza, Juan/0000-0002-1802-3337	NIGMS NIH HHS [R01-GM068957] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; SAVAGEAU MA, 1976, BIOCH SYSTEMS ANAL; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; van Kampen NG., 1981, STOCHASTIC PROCESSES	18	588	601	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1965	1969		10.1126/science.1109090	http://dx.doi.org/10.1126/science.1109090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790857				2022-12-01	WOS:000227957300058
J	Mattner, J; DeBord, KL; Ismail, N; Goff, RD; Cantu, C; Zhou, DP; Saint-Mezard, P; Wang, V; Gao, Y; Yin, N; Hoebe, K; Schneewind, O; Walker, D; Beutler, B; Teyton, L; Savage, PB; Bendelac, A				Mattner, J; DeBord, KL; Ismail, N; Goff, RD; Cantu, C; Zhou, DP; Saint-Mezard, P; Wang, V; Gao, Y; Yin, N; Hoebe, K; Schneewind, O; Walker, D; Beutler, B; Teyton, L; Savage, PB; Bendelac, A			Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections	NATURE			English	Article							KILLER T-CELLS; ANAPLASMA-PHAGOCYTOPHILUM; GLYCOSPHINGOLIPIDS; IDENTIFICATION; BACTERIUM; SYNTHASE; INNATE	CD1d-restricted natural killer T ( NKT) cells are innate-like lymphocytes that express a conserved T-cell receptor and contribute to host defence against various microbial pathogens(1,2). However, their target lipid antigens have remained elusive. Here we report evidence for microbial, antigen-specific activation of NKT cells against Gram-negative, lipopolysaccharide (LPS)negative alpha-Proteobacteria such as Ehrlichia muris and Sphingomonas capsulata. We have identified glycosylceramides from the cell wall of Sphingomonas that serve as direct targets for mouse and human NKT cells, controlling both septic shock reaction and bacterial clearance in infected mice. In contrast, Gram-negative, LPS-positive Salmonella typhimurium activates NKT cells through the recognition of an endogenous lysosomal glycosphingolipid, iGb3, presented by LPS-activated dendritic cells. These findings identify two novel antigenic targets of NKT cells in antimicrobial defence, and show that glycosylceramides are an alternative to LPS for innate recognition of the Gram-negative, LPS-negative bacterial cell wall.	Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of Chicago; University of Chicago; University of Texas System; University of Texas Medical Branch Galveston; Brigham Young University; Scripps Research Institute	Savage, PB (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	paul_savage@byu.edu; abendela@bsd.uchicago.edu	Savage, Paul B/E-1448-2011; Yin, NIng/C-8991-2011; Mattner, Jochen/AAT-7866-2021; Zhou, Dapeng/A-6446-2019; Savage, Paul B/HGB-3414-2022; zhou, dapeng/GXG-9715-2022	Savage, Paul B/0000-0002-4642-6109; Zhou, Dapeng/0000-0003-1347-3811; Savage, Paul B/0000-0002-4642-6109; Hoebe, Kasper/0000-0002-3626-8098				AMANO K, 1987, INFECT IMMUN, V55, P2290, DOI 10.1128/IAI.55.9.2290-2292.1987; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hsueh PR, 1998, CLIN INFECT DIS, V26, P676, DOI 10.1086/514595; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Olano JP, 2002, MED CLIN N AM, V86, P375, DOI 10.1016/S0025-7125(03)00093-2; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; von Loewenich FD, 2004, EUR J IMMUNOL, V34, P1789, DOI 10.1002/eji.200425250; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	24	889	932	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2005	434	7032					525	529		10.1038/nature03408	http://dx.doi.org/10.1038/nature03408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909CH	15791258				2022-12-01	WOS:000227836000046
J	Perry, AL; Low, PJ; Ellis, JR; Reynolds, JD				Perry, AL; Low, PJ; Ellis, JR; Reynolds, JD			Climate change and distribution shifts in marine fishes	SCIENCE			English	Article								We show that the distributions of both exploited and nonexploited North Sea fishes have responded markedly to recent increases in sea temperature, with nearly two-thirds of species shifting in mean latitude or depth or both over 25 years. For species with northerly or southerly range margins in the North Sea, half have shown boundary shifts with warming, and all but one shifted northward. Species with shifting distributions have faster life cycles and smaller body sizes than nonshifting species. Further temperature rises are likely to have profound impacts on commercial fisheries through continued shifts in distribution and alterations in community interactions.	Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England	University of East Anglia; Centre for Environment Fisheries & Aquaculture Science	Perry, AL (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	a.perry@uea.ac.uk; reynolds@uea.ac.uk	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074				Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Brander KM, 2003, ICES MARINE SCI S, V219, P261; DAAN N, 2003, N10 ICES; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; *ICES ADV COMM FIS, 2004, 2004ACFM24; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jennings S, 1999, FISH RES, V40, P125, DOI 10.1016/S0165-7836(98)00208-2; Knijn RJ, 1993, ICES COOPERATIVE RES, P194; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; REYNOLDS JD, 2001, CONSERVATION EXPLOIT, P145; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Strahler A., 1997, PHYS GEOGRAPHY SCI S; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas M, 1998, REHABILITATED ESTUARINE ECOSYSTEMS, P115; *UK CLIM IMP PROGR, UKCIPO2 SCEN GAT MAP; Wood C.M., 1997, GLOBAL WARMING IMPLI	19	2011	2087	24	969	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1912	1915		10.1126/science.1111322	http://dx.doi.org/10.1126/science.1111322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15890845	Green Submitted			2022-12-01	WOS:000230120000041
J	Kidd, AR; Miskowski, JA; Siegfried, KR; Sawa, H; Kimble, J				Kidd, AR; Miskowski, JA; Siegfried, KR; Sawa, H; Kimble, J			A beta-catenin identified by functional rather than sequence criteria and its role in Wnt/MAPK signaling	CELL			English	Article							C-ELEGANS EMBRYOS; CANONICAL WNT PATHWAY; NEMO-LIKE-KINASE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; VULVAL DEVELOPMENT; POLARITY SIGNALS; PROTEIN-KINASE; AXIS FORMATION; CELL POLARITY	Wnt/MAPK signaling is a common variant of Wnt signaling, in C. elegans and has been implicated in vertebrates. The sys-1 gene works with Wnt/MAPK signaling to control cell fates during C. elegans development. We report that the SYS-1 amino acid sequence is novel but that SYS-1 functions as P-catenin: SYS-1 rescues a bar-1/beta-catenin null mutant, binds the POP-1/TCF beta-catenin binding domain, and coactivates POP-1-dependent transcription. Moreover, we provide genetic and molecular evidence that SYS-1 levels are crucial to POP-1 activity. Our results suggest that Wnt/MAPK signaling promotes POP-1 export from the nucleus to accommodate the limiting availability of its SYS-1/beta-catenin transcriptional coactivator. Discovery of SYS-1/beta-catenin extends our definition of beta-catenins and brings together aspects of the canonical mechanism for Wnt signaling with the noncanonical Wnt/ MAPK mechanism. We discuss the idea that a similar pathway may be employed broadly in animal development.	Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; RIKEN, Ctr Dev Biol, Lab Cell Fate Decis, Kobe, Hyogo 6500047, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; RIKEN	Kimble, J (corresponding author), Univ Wisconsin, Mol & Cellular Biol Program, 433 Babcock Dr, Madison, WI 53706 USA.	jekimble@wisc.edu		Siegfried, Kellee/0000-0002-7951-392X; Sawa, Hitoshi/0000-0001-9774-7976	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, T32GM007133] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM07133, T32 GM07215] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behrens J, 2000, J CELL SCI, V113, P911; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 1998, CURR OPIN CELL BIOL, V10, P366, DOI 10.1016/S0955-0674(98)80013-6; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Deshpande R, 2005, DEV BIOL, V278, P118, DOI 10.1016/j.ydbio.2004.10.020; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Herman MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1530, DOI 10.2741/1306; Herman MA, 2001, DEVELOPMENT, V128, P581; Huber F, 2000, AMA WINTER EDUC CONF, V11, P3; Inoue Takao, 2002, Gene Expression Patterns, V2, P235, DOI 10.1016/S1567-133X(02)00055-8; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Maloof JN, 1999, DEVELOPMENT, V126, P37; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Miskowski J, 2001, DEV BIOL, V230, P61, DOI 10.1006/dbio.2000.9998; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Natarajan L, 2001, GENETICS, V159, P159; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park FD, 2003, DEVELOPMENT, V130, P3547, DOI 10.1242/dev.00563; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Siegfried KR, 2004, GENETICS, V166, P171, DOI 10.1534/genetics.166.1.171; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Usami N, 2003, ONCOGENE, V22, P7922, DOI 10.1038/sj.onc.1206533; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Waltzer L, 1999, CANCER METAST REV, V18, P231, DOI 10.1023/A:1006321324190; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	63	109	118	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					761	772		10.1016/j.cell.2005.03.029	http://dx.doi.org/10.1016/j.cell.2005.03.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935762	Bronze			2022-12-01	WOS:000229658000014
J	Boyd, J				Boyd, J			Mouse models of gynecologic pathology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OVARIAN-CANCER		Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Boyd, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.							Connolly DC, 2003, CANCER RES, V63, P1389; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002	5	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2005	352	21					2240	2242		10.1056/NEJMcibr051024	http://dx.doi.org/10.1056/NEJMcibr051024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929HS	15917391				2022-12-01	WOS:000229333300016
J	Lou, XL; Scheuss, V; Schneggenburger, R				Lou, XL; Scheuss, V; Schneggenburger, R			Allosteric modulation of the presynaptic Ca2+ sensor for vesicle fusion	NATURE			English	Article							PROTEIN-KINASE-C; TRANSMITTER RELEASE; CALCIUM SENSITIVITY; CHROMAFFIN CELLS; MEMBRANE-FUSION; PHORBOL ESTERS; POTENTIATION; POOL; NEUROTRANSMITTER; AUGMENTATION	Neurotransmitter release is triggered by an increase in the cytosolic Ca2+ concentration ([Ca2+](i)), but it is unknown whether the Ca2+-sensitivity of vesicle fusion is modulated during synaptic plasticity. We investigated whether the potentiation of neurotransmitter release by phorbol esters(1-3), which target presynaptic protein kinase C (PKC)/munc-13 signalling cascades(4-6), exerts a direct effect on the Ca2+-sensitivity of vesicle fusion. Using direct presynaptic Ca2+-manipulation and Ca2+ uncaging at a giant presynaptic terminal, the calyx of Held, we show that phorbol esters potentiate transmitter release by increasing the apparent Ca2+-sensitivity of vesicle fusion. Phorbol esters potentiate Ca2+-evoked release as well as the spontaneous release rate. We explain both effects by an increased fusion 'willingness' in a new allosteric model of Ca2+-activation of vesicle fusion. In agreement with an allosteric mechanism, we observe that the classically high Ca2+ cooperativity in triggering vesicle fusion (similar to 4) is gradually reduced below 3 mu M [Ca2+](i), reaching a value of < 1 at basal [Ca2+](i). Our data indicate that spontaneous transmitter release close to resting [Ca2+](i) is a consequence of an intrinsic property of the molecular machinery(7,8) that mediates synaptic vesicle fusion.	Max Planck Inst Biophys Chem, AG Synapt Dynam & Modulat, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Schneggenburger, R (corresponding author), Max Planck Inst Biophys Chem, AG Synapt Dynam & Modulat, Fassberg 11, D-37077 Gottingen, Germany.	rschneg@gwdg.de	Volker, Scheuss/G-7846-2015	Scheuss, Volker/0000-0002-0659-3228; Lou, Xuelin/0000-0002-0576-8575				Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899	28	204	220	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					497	501		10.1038/nature03568	http://dx.doi.org/10.1038/nature03568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917809	Green Published			2022-12-01	WOS:000229337800055
J	Carter, NJ; Cross, RA				Carter, NJ; Cross, RA			Mechanics of the kinesin step	NATURE			English	Article							HAND-OVER-HAND; 8-NM STEP; ATP HYDROLYSIS; MYOSIN MOTOR; FORCE CLAMP; MOLECULES; CYCLE; PROCESSIVITY; MICROSCOPY; DEPENDENCE	Kinesin is a molecular walking machine that organizes cells by hauling packets of components directionally along microtubules. The physical mechanism that impels directional stepping is uncertain. We show here that, under very high backward loads, the intrinsic directional bias in kinesin stepping can be reversed such that the motor walks sustainedly backwards in a previously undescribed mode of ATP-dependent backward processivity. We find that both forward and backward 8-nm steps occur on the microsecond timescale and that both occur without mechanical substeps on this timescale. The data suggest an underlying mechanism in which, once ATP has bound to the microtubule-attached head, the other head undergoes a diffusional search for its next site, the outcome of which can be biased by an applied load.	Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England		Cross, RA (corresponding author), Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.	r.cross@mcri.ac.uk	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832				Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Howard J., 2001, MECH MOTOR PROTEINS; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY AF, 1957, PROGR BIOPHYS BIOPHY, V7, P257; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Nishiyama M, 2003, BIOSYSTEMS, V71, P145, DOI 10.1016/S0303-2647(03)00122-9; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thomas N, 2002, P ROY SOC B-BIOL SCI, V269, P2363, DOI 10.1098/rspb.2002.2117; Tsiavaliaris G, 2004, NATURE, V427, P558, DOI 10.1038/nature02303; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	35	555	569	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					308	312		10.1038/nature03528	http://dx.doi.org/10.1038/nature03528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902249				2022-12-01	WOS:000229185000037
J	Norris, JM; Barriga, K; Hoffenberg, EJ; Taki, I; Miao, DM; Haas, JE; Emery, LM; Sokol, RJ; Erlich, HA; Eisenbarth, GS; Rewers, M				Norris, JM; Barriga, K; Hoffenberg, EJ; Taki, I; Miao, DM; Haas, JE; Emery, LM; Sokol, RJ; Erlich, HA; Eisenbarth, GS; Rewers, M			Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE TRANSGLUTAMINASE; CHILDREN; OATS; AUTOANTIBODIES; ANTIBODIES; GLIADIN; MARKERS	Context While gluten ingestion is responsible for the signs and symptoms of celiac disease, it is not known what factors are associated with initial appearance of the disease. Objective To examine whether the timing of gluten exposure in the infant diet was associated with the development of celiac disease autoimmunity (CDA). Design, Setting, and Patients Prospective observational study conducted in Denver, Colo, from 1994-2004 of 1560 children at increased risk for celiac disease or type 1 diabetes, as defined by possession of either HLA-DR3 or DR4 alleles, or having a first-degree relative with type 1 diabetes. The mean follow-up was 4.8 years. Main Outcome Measure Risk of CDA defined as being positive for tissue transglutaminase (tTG) autoantibody on 2 or more consecutive visits or being positive for tTG once and having a positive small bowel biopsy for celiac disease, by timing of introduction of gluten-containing foods into the diet Results Fifty-one children developed CDA. Findings adjusted for HLA-DR3 status indicated that children exposed to foods containing wheat, barley, or rye (gluten-containing foods) in the first 3 months of life Q [6%] CDA positive vs 40 [3%] CDA negative) had a 5-fold increased risk of CDA compared with children exposed to gluten-containing foods at 4 to 6 months (12 [23%] CDA positive vs 574 [38%) CDA negative) (hazard ratio [HR], 5.17; 95% confidence interval [CI], 1.44-18.57). Children not exposed to gluten until the seventh month or later (36 [71%] CDA positive vs 895 [59%] CDA negative) had a marginally increased risk of CDA compared with those exposed at 4 to 6 months (HR, 1.87; 95% Cl, 0.97-3.60). After restricting our case group to only the 25 CDA-positive children who had biopsy-diagnosed celiac disease, initial exposure to wheat, barley, or rye in the first 3 months Q [12%] CDA positive vs 40 [3%] CDA negative) or in the seventh month or later (19 [76%] CDA positive vs 912 [59%] CDA negative) significantly increased risk of CDA compared with exposure at 4 to 6 months (3 [12%] CDA positive vs 583 [38%] CDA negative) (HR, 22.97; 95% Cl, 4,55-115.93; P=.001; and HR, 3.98; 95% Cl, 1.18-13.46; P=.04, respectively). Conclusion Timing of introduction of gluten into the infant diet is associated with the appearance of CDA in children at increased risk for the disease.	Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Univ Colorado, Dept Pathol, Denver, CO 80262 USA; Hlth Sci Ctr, Denver, CO 80262 USA; Univ Colorado, Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, Denver, CO 80262 USA; Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Roche Mol Syst Inc, Dept Human Genet, Alameda, CA USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Roche Holding	Norris, JM (corresponding author), Univ Colorado, Dept Prevent Med & Biometr, 4200 E 9th Ave,Box B119, Denver, CO 80262 USA.	jill.norris@uchsc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032493, R01DK049654, P30DK057516, R01DK050979, R01DK032083, R37DK032083] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00069] Funding Source: Medline; NIAID NIH HHS [AI 50864] Funding Source: Medline; NIDDK NIH HHS [DK49654, DK50979, DK32083, R01-DK32493, P30 DK 57516] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison P., 1995, SURVIVAL ANAL USING; Ascher H, 1997, ARCH DIS CHILD, V76, P113, DOI 10.1136/adc.76.2.113; AURICCHIO S, 1983, J PEDIATR GASTR NUTR, V2, P428, DOI 10.1097/00005176-198302030-00006; Baldas V, 2000, GUT, V47, P628, DOI 10.1136/gut.47.5.628; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Bonamico M, 2001, AM J GASTROENTEROL, V96, P1536; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Collin P, 2002, ENDOCR REV, V23, P464, DOI 10.1210/er.2001-0035; Dieterich W, 1999, J INVEST DERMATOL, V113, P133, DOI 10.1046/j.1523-1747.1999.00627.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; FalthMagnusson K, 1996, PEDIAT ALLERG IMM-UK, V7, P1, DOI 10.1111/j.1399-3038.1996.tb00098.x; Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852; GRECO L, 1988, J PEDIATR GASTR NUTR, V7, P395, DOI 10.1097/00005176-198805000-00013; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P356, DOI 10.1067/mpd.2000.107582; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P361, DOI 10.1067/mpd.2000.109003; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Hogberg L, 2004, GUT, V53, P649, DOI 10.1136/gut.2003.026948; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; JANATUINEN EK, 1995, NEW ENGL J MED, V333, P1033, DOI 10.1056/NEJM199510193331602; KLEINMAN RE, 1998, PEDIAT NUTR HDB, P43; Li RW, 2003, PEDIATRICS, V111, P1198; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Peters U, 2001, ANN NUTR METAB, V45, P135, DOI 10.1159/000046720; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Schapira M, 2003, ACTA GASTRO-ENT BELG, V66, P234; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Srinivasan U, 1996, BRIT MED J, V313, P1300, DOI 10.1136/bmj.313.7068.1300; Stern M, 2000, J PEDIATR GASTR NUTR, V31, P513, DOI 10.1097/00005176-200011000-00012; Storsrud S, 2003, EUR J CLIN NUTR, V57, P163, DOI 10.1038/sj.ejcn.1601525; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160; Wieser H, 1998, CHANGING FEATURES OF COELIAC DISEASE, P25; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	38	304	319	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2005	293	19					2343	2351		10.1001/jama.293.19.2343	http://dx.doi.org/10.1001/jama.293.19.2343			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926JX	15900004	Bronze			2022-12-01	WOS:000229120600021
J	Savage, E; Ramsay, M; White, J; Beard, S; Lawson, H; Hunjan, R; Brown, D				Savage, E; Ramsay, M; White, J; Beard, S; Lawson, H; Hunjan, R; Brown, D			Mumps outbreaks across England and Wales in 2004: observational, study	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy, Ctr Infect, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Infect, Enter Resp & Neurol Virus Lab, London NW9 5EQ, England	Health Protection Agency; Health Protection Agency	Savage, E (corresponding author), Hlth Protect Agcy, Ctr Infect, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England.	Emma.Savage@HPA.org.uk	; Ramsay, Mary Elizabeth/S-8281-2016	White, Joanne/0000-0001-7786-4462; Ramsay, Mary Elizabeth/0000-0002-7156-7640				*COMM DIS SURV CTR, 2002, COMMUN DIS REP CDR W, V12; *COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P227; *COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P230; GAY N, 1997, COMMUNICAB DIS REP, V7, P21; Gay N J, 1994, Commun Dis Rep CDR Rev, V4, pR77; HARLING R, 2005, IN PRESS VACCINE	6	64	64	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1119	1120		10.1136/bmj.330.7500.1119	http://dx.doi.org/10.1136/bmj.330.7500.1119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891227	Green Published, Bronze			2022-12-01	WOS:000229166900018
J	Shemansky, DE; Stewart, AIF; West, RA; Esposito, LW; Hallett, JT; Liu, XM				Shemansky, DE; Stewart, AIF; West, RA; Esposito, LW; Hallett, JT; Liu, XM			The Cassini UVIS stellar probe of the Titan atmosphere	SCIENCE			English	Article							PHOTOABSORPTION CROSS-SECTIONS; VACUUM ULTRAVIOLET; ABSORPTION; METHANE; TEMPERATURE; PHOTOCHEMISTRY; THERMOSPHERE; SPECTROSCOPY; ACETYLENE; SPECTRA	The Cassini Ultraviolet Imaging Spectrometer (UVIS) observed the extinction of photons from two stars by the atmosphere of Titan during the Titan flyby. Six species were identified and measured: methane, acetylene, ethylene, ethane, diacetylene, and hydrogen cyanide. The observations cover altitudes from 450 to 1600 kilometers above the surface. A mesopause is inferred from extraction of the temperature structure of methane, located at 615 km with a temperature minimum of 114 kelvin. The asymptotic kinetic temperature at the top of the atmosphere determined from this experiment is 151 kelvin. The higher order hydrocarbons and hydrogen cyanide peak sharply in abundance and are undetectable below altitudes ranging from 750 to 600 km, leaving methane as the only identifiable carbonaceous molecule in this experiment below 600 km.	Univ So Calif, Dept Aerosp Engn, Los Angeles, CA 90089 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Southern California; University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Shemansky, DE (corresponding author), Univ So Calif, Dept Aerosp Engn, Univ Pk, Los Angeles, CA 90089 USA.	dons@hippolyta.usc.edu	ESPOSITO, LARRY W/AAB-3673-2021	ESPOSITO, LARRY W/0000-0003-3381-2016				AU JW, 1993, CHEM PHYS, V173, P209, DOI 10.1016/0301-0104(93)80142-V; Chen FZ, 2004, J QUANT SPECTROSC RA, V85, P195, DOI 10.1016/S0022-4073(03)00225-5; COOPER G, 1995, J ELECTRON SPECTROSC, V73, P139, DOI 10.1016/0368-2048(94)02271-2; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Flasar FM, 1998, PLANET SPACE SCI, V46, P1109, DOI 10.1016/S0032-0633(97)00182-7; Flasar FM, 1998, PLANET SPACE SCI, V46, P1125, DOI 10.1016/S0032-0633(97)00223-7; FRIEDSON AJ, 1984, J GEOPHYS RES-SPACE, V89, P85, DOI 10.1029/JA089iA01p00085; LELLOUCH E, 1990, ICARUS, V83, P308, DOI 10.1016/0019-1035(90)90070-P; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; MOUNT GH, 1977, ASTROPHYS J, V214, pL47, DOI 10.1086/182440; MOUNT GH, 1978, ASTROPHYS J, V224, pL35, DOI 10.1086/182753; Muller-Wodarg ICF, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016100; NAGATA T, 1981, CHEM PHYS, V57, P45, DOI 10.1016/0301-0104(81)80019-5; NUTH JA, 1982, J QUANT SPECTROSC RA, V28, P223, DOI 10.1016/0022-4073(82)90025-5; OKABE H, 1981, J CHEM PHYS, V75, P2772, DOI 10.1063/1.442348; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; SAMSON JAR, 1989, J CHEM PHYS, V90, P6925, DOI 10.1063/1.456267; SAMSON JAR, 1974, J OPT SOC AM, V64, P47, DOI 10.1364/JOSA.64.000047; SICARDY B, 2004, 362206S AASDPS; SMITH GR, 1982, J GEOPHYS RES-SPACE, V87, P1351, DOI 10.1029/JA087iA03p01351; STROBEL DF, 1992, ICARUS, V100, P512, DOI 10.1016/0019-1035(92)90114-M; STROBEL DF, COMMUNICATION; SUN H, 1955, J CHEM PHYS, V23, P1160, DOI 10.1063/1.1742205; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; Wu CYR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002180; Wu CYR, 2001, J GEOPHYS RES-PLANET, V106, P7629, DOI 10.1029/2000JE001292; YELLE R, COMMUNICATION; YELLE RV, 1997, ESA SP PUBL, V1177, P243; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	31	113	113	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					978	982		10.1126/science.1111790	http://dx.doi.org/10.1126/science.1111790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890872				2022-12-01	WOS:000229190700033
J	Schousboe, JT; Nyman, JA; Kane, RL; Ensrud, KE				Schousboe, JT; Nyman, JA; Kane, RL; Ensrud, KE			Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; VERTEBRAL FRACTURES; HIP FRACTURE; POPULATION HEALTH; ECONOMIC-EVALUATION; CLINICAL-PRACTICE; BONE-DENSITY; BACK-PAIN; OSTEOPOROSIS; RISK	Background: Treatment guidelines recommend drug treatment to prevent fractures for some postmenopausal women who have low bone mass (osteopenia) but do not have osteoporosis or a history of clinical fractures. Objective: To estimate the societal costs and health benefits of alendronate drug treatment to prevent fractures in postmenopausal women with osteopenia. Design: Markov model with 8 health states: no fracture, post-distal forearm fracture, post-clinical vertebral fracture, post-radiographic (but clinically inapparent) vertebral fracture, post-hip fracture, post-hip and vertebral fractures, post-other fracture, and death. Data Sources: Population -based studies of age-specific fracture rates and costs, prospectively measured estimates of disutility after fractures, and the Fracture Intervention Trial of alendronate versus placebo to prevent fracture. Target Population: Postmenopausal women 55 to 75 years of age with femoral neck T-scores between -1.5 and -2.4. Time Horizon: Lifetime. Perspective: Societal. Interventions: Five years of alendronate therapy or no drug treatment. Outcome Measures: Costs, quality-adjusted life-years, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: For women with no additional fracture risk factors, the cost per quality-adjusted life-year gained ranged from $70 000 to $332 000, depending on age and femoral neck bone density. Limitations: Results apply only to postmenopausal white women residing in the United States. Conclusion: Alendronate therapy for postmenopausal women with femoral neck T-scores better than -2.5 and no history of clinical fractures or other bone mineral density-independent risk factors for fracture is not cost-effective, assuming U.S. costs of alendronate and currently available estimates of alendronate efficacy in osteopenic women.	Univ Minnesota, Pk Nicollet Hlth Serv, Minneapolis, MN USA; Vet Adm Med Ctr, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Schousboe, JT (corresponding author), Pk Nicollet Clin, 3800 Pk Nocollet Blvd, Minneapolis, MN 55416 USA.	schouj@parknicollet.com		Ensrud, Kristine/0000-0002-9069-3036				American Association of Clinical Endocrinologists Osteoporosis Task Force, 2001, Endocr Pract, V7, P293; American College of Obstetricians and Gynecologists Women's Health Care Physicians, 2004, Obstet Gynecol, V103, P203; Anderson Robert N, 2002, Natl Vital Stat Rep, V50, P1; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Brecht JG, 2003, INT J CLIN PHARM RES, V23, P93; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; *CTR MED MED SERV, 2005, NAT PHYS FEE SCH REL; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; De Laet CEDH, 1998, J BONE MINER RES, V13, P1587, DOI 10.1359/jbmr.1998.13.10.1587; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ensrud K, 2003, J BONE MINER RES, V18, pS90; Ettinger M, 2004, ARTHRITIS RHEUM, V50, pS513; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Halpern EF, 2000, MED DECIS MAKING, V20, P314, DOI 10.1177/0272989X0002000308; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Huopio J, 2000, OSTEOPOROSIS INT, V11, P219, DOI 10.1007/s001980050284; Iglesias CP, 2002, QJM-INT J MED, V95, P305, DOI 10.1093/qjmed/95.5.305; Johannesson M, 1998, HEALTH ECON, V7, P1, DOI 10.1002/(SICI)1099-1050(199802)7:1<1::AID-HEC327>3.0.CO;2-U; Johannesson M, 1996, J INTERN MED, V240, P23, DOI 10.1046/j.1365-2796.1996.491830000.x; Johnell O, 2003, PHARMACOECONOMICS, V21, P305, DOI 10.2165/00019053-200321050-00002; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P15, DOI 10.1007/s00198-004-1688-0; Kanis JA, 2002, BONE, V31, P26, DOI 10.1016/S8756-3282(02)00813-X; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Kanis JA, 2002, J BONE MINER RES, V17, pS146; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P765, DOI 10.1007/s001980200106; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Macran S, 2003, MED CARE, V41, P218; *MED EC, 2001, 2001 DRUG TOPICS RED; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Melton LJ, 2000, J AM GERIATR SOC, V48, P338, DOI 10.1111/j.1532-5415.2000.tb02658.x; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Meunier PJ, 1999, CLIN THER, V21, P1025, DOI 10.1016/S0149-2918(99)80022-8; Miller PD, 2004, ARCH INTERN MED, V164, P1113, DOI 10.1001/archinte.164.10.1113; National Osteoporosis Foundation, 2003, PHYS GUID PREV TREAT; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; O'Neill TW, 2004, OSTEOPOROSIS INT, V15, P760, DOI 10.1007/s00198-004-1615-4; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; Rosner AJ, 1998, PHARMACOECONOMICS, V14, P559, DOI 10.2165/00019053-199814050-00007; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P1042, DOI 10.1007/s001980170015; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P849, DOI 10.1007/s001980170036; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Wainwright SA, 2001, J BONE MINER RES, V16, pS155; Wehren LE, 2004, CURR MED RES OPIN, V20, P525, DOI 10.1185/030079904125003269; 1998, OSTEOPOROS INT S, V4, pS7	57	88	89	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					734	741		10.7326/0003-4819-142-9-200505030-00008	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922GW	15867405				2022-12-01	WOS:000228825800002
J	Wormser, GP; McKenna, D; Carlin, J; Nadelman, RB; Cavaliere, LF; Holmgren, D; Byrne, DW; Nowakowski, J				Wormser, GP; McKenna, D; Carlin, J; Nadelman, RB; Cavaliere, LF; Holmgren, D; Byrne, DW; Nowakowski, J			Brief communication: Hematogenous dissemination in early Lyme disease	ANNALS OF INTERNAL MEDICINE			English	Article							BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; GENETIC DIVERSITY; BLOOD CULTURES; ASSOCIATION; EVOLUTION; YIELD; PCR	Background: Bloodstream invasion in Lyme disease has been difficult to study because until recently blood culture methods were too insensitive to detect spirochetemia. Objective: To evaluate the clinical and laboratory features of spirochetemic patients. Design: Cross-sectional study. Setting: Lyme Disease Diagnostic Center in Valhalla, New York, 1997 to 2002. Patients: 213 untreated adults with erythema migrans. Intervention: Blood culture for Borrelia burgdorferi. Measurements: Symptom scores and selected laboratory measures. Results: Spirocheternia was found in 93 (43.7%) patients. Spirochetemic patients were more often symptomatic (89.2% vs. 74.2%; P = 0.006) and more often had multiple erythema migrans lesions (41.9% vs. 15.0%; P < 0.001) than patients without spirochetemia. However, 8 (22.9%) of the 35 asymptomatic patients with a single skin lesion nevertheless had a positive blood culture. Risk for spirochetemia was present the day the patient noticed the lesion and continued for more than 2 weeks. Limitations: Long-term outcome data were not available. Conclusions: The high rate, early onset, and prolonged duration of risk for spirochetemia explain why untreated patients with erythema migrans are at risk for dissemination of B. burgdorferi to anatomic sites beyond the lesion site. Differences in the strain of the infecting spirochete, as well as host factors, may be important determinants of hematogenous dissemination.	New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA; Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA	New York Medical College; Vanderbilt University	Wormser, GP (corresponding author), New York Med Coll, Div Infect Dis, Munger Pavil,Room 245, Valhalla, NY 10595 USA.	gary_wormser@nymc.edu			ODCDC CDC HHS [U50/CCU219613, U50/CCU219612] Funding Source: Medline	ODCDC CDC HHS		AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Bakken JS, 2001, CLIN INFECT DIS, V32, P862, DOI 10.1086/319350; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P20; Harrel F.E., 2001, REGRESSION MODELING; Kim N, 1998, CLIN INFECT DIS, V26, P1218, DOI 10.1086/520302; Lagal V, 2003, J CLIN MICROBIOL, V41, P5059, DOI 10.1128/JCM.41.11.5059-5065.2003; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; NADELMAN RB, 1990, AM J MED, V88, P21, DOI 10.1016/0002-9343(90)90122-T; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Wormser GP, 1998, J CLIN MICROBIOL, V36, P296, DOI 10.1128/JCM.36.1.296-298.1998; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Wormser GP, 2001, J INFECT DIS, V184, P1070, DOI 10.1086/323424	18	80	83	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					751	755		10.7326/0003-4819-142-9-200505030-00011	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867407				2022-12-01	WOS:000228825800004
J	Li, QS; Duan, LJ; Estes, JD; Ma, ZM; Rourke, T; Wang, YC; Reilly, C; Carlis, J; Miller, CJ; Haase, AT				Li, QS; Duan, LJ; Estes, JD; Ma, ZM; Rourke, T; Wang, YC; Reilly, C; Carlis, J; Miller, CJ; Haase, AT			Peak SIV replication in resting memory CD4(+) T cells depletes gut lamina propria CD4(+) T cells	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GASTROINTESTINAL-TRACT; HIV-1 INFECTION; RHESUS MACAQUES; LYMPHOCYTES; TRANSMISSION; FAS; EXPRESSION; APOPTOSIS; LEU-23	In early simian immunodeficiency virus (SIV) and human immunodeficiency virus-1 (HIV-1) infections, gut-associated lymphatic tissue (GALT), the largest component of the lymphoid organ system(1), is a principal site of both virus production and depletion of primarily lamina propria memory CD4(+) T cells; that is, CD4-expressing T cells that previously encountered antigens and microbes and homed to the lamina propria of GALT(2-9). Here, we show that peak virus production in gut tissues of SIV-infected rhesus macaques coincides with peak numbers of infected memory CD4(+) T cells. Surprisingly, most of the initially infected memory cells were not, as expected(10,11), activated but were instead immunophenotypically 'resting' cells that, unlike truly resting cells, but like the first cells mainly infected at other mucosal sites and peripheral lymph nodes(12,13), are capable of supporting virus production. In addition to inducing immune activation and thereby providing activated CD4(+) T-cell targets to sustain infection, virus production also triggered(14) an immunopathologically limiting Fas-Fas-ligand-mediated apoptotic pathway(15,16) in lamina propria CD4(+) T cells, resulting in their preferential ablation. Thus, SIV exploits a large, resident population of resting memory CD4(+) T cells in GALT to produce peak levels of virus that directly (through lytic infection) and indirectly ( through apoptosis of infected and uninfected cells) deplete CD4(+) T cells in the effector arm of GALT. The scale of this CD4(+) T-cell depletion has adverse effects on the immune system of the host, underscoring the importance of developing countermeasures to SIV that are effective before infection of GALT.	Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Div Infect Dis, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haase, AT (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, MMC 196,420 Delaware St SE, Minneapolis, MN 55455 USA.	haase001@umn.edu						Boirivant M, 1996, J CLIN INVEST, V98, P2616, DOI 10.1172/JCI119082; Boirivant M, 1998, J CLIN IMMUNOL, V18, P39, DOI 10.1023/A:1023235803948; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Clayton F, 1997, CLIN EXP IMMUNOL, V107, P288, DOI 10.1111/j.1365-2249.1997.236-ce1111.x; DeMaria R, 1996, J CLIN INVEST, V97, P316, DOI 10.1172/JCI118418; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; MILLER CJ, UNPUB J VIROL; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; POPPEMA S, 1991, AM J PATHOL, V139, P725; Reilly C, 2002, J AM STAT ASSOC, V97, P943, DOI 10.1198/016214502388618735; REYNOLDS MR, IN PRESS J VIROL; SCHNEIDER T, 1995, GUT, V37, P524, DOI 10.1136/gut.37.4.524; TESTI R, 1989, J IMMUNOL, V142, P1854; TESTI R, 1988, J IMMUNOL, V141, P2557; Veazey Ronald, 2003, AIDS Rev, V5, P245; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	26	755	788	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1148	1152		10.1038/nature03513	http://dx.doi.org/10.1038/nature03513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15793562				2022-12-01	WOS:000228693300047
J	Goes, JI; Thoppil, PG; Gomes, HD; Fasullo, JT				Goes, JI; Thoppil, PG; Gomes, HD; Fasullo, JT			Warming of the Eurasian landmass is making the Arabian Sea more productive	SCIENCE			English	Article							INDIAN-SUMMER MONSOON; DIPOLE MODE; SNOW COVER; OCEAN; OCEANOGRAPHY; VARIABILITY; CIRCULATION; MECHANISMS; DYNAMICS; SURFACE	The recent trend of declining winter and spring snow cover over Eurasia is causing a land-ocean thermal gradient that is particularly favorable to stronger southwest (summer) monsoon winds. Since 1997, sea surface winds have been strengthening over the western Arabian Sea. This escalation in the intensity of summer monsoon winds, accompanied by enhanced upwelling and an increase of more than 350% in average summertime phytoplankton biomass along the coast and over 300% offshore, raises the possibility that the current warming trend of the Eurasian landmass is making the Arabian Sea more productive.	Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; USN, Dept Oceanog, Postgrad Sch, Monterey, CA 93943 USA; Univ Colorado, Program Atmospher & Ocean Sci, Boulder, CO 80309 USA	Bigelow Laboratory for Ocean Sciences; United States Department of Defense; United States Navy; Naval Postgraduate School; University of Colorado System; University of Colorado Boulder	Goes, JI (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA.	jgoes@bigelow.org	Fasullo, John/H-4552-2019	Fasullo, John/0000-0003-1216-892X; Thoppil, Prasad/0000-0003-2240-9782; DO ROSARIO GOMES, MARIA HELGA/0000-0002-6287-354X; Goes, Joaquim/0000-0002-9785-6985				Bamzai AS, 1999, J CLIMATE, V12, P3117, DOI 10.1175/1520-0442(1999)012<3117:RBESCS>2.0.CO;2; Banse K, 2000, DEEP-SEA RES PT II, V47, P1623, DOI 10.1016/S0967-0645(99)00157-5; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; Blanford HF., 1884, P ROY SOC LOND, V37, P3, DOI [10.1098/rspl.1884.0003, DOI 10.1098/RSPL.1884.0003]; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Fasham MJR, 2001, AMBIO, P4; FINDLATER J, 1969, Q J ROY METEOR SOC, V95, P362, DOI 10.1002/qj.49709540409; Hitchcock GL, 2000, DEEP-SEA RES PT II, V47, P1605, DOI 10.1016/S0967-0645(99)00156-3; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Lee CM, 2000, DEEP-SEA RES PT II, V47, P1177, DOI 10.1016/S0967-0645(99)00141-1; MEEHL GA, 1994, J CLIMATE, V7, P1033, DOI 10.1175/1520-0442(1994)007<1033:IOTLSI>2.0.CO;2; MEEHL GA, 1994, SCIENCE, V266, P263, DOI 10.1126/science.266.5183.263; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Murtugudde R, 2000, J GEOPHYS RES-OCEANS, V105, P3295, DOI 10.1029/1999JC900294; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Overland JE, 2001, FISH OCEANOGR, V10, P69, DOI 10.1046/j.1365-2419.2001.00154.x; Parthasarathy B, 1995, Advances in Atmospheric Sciences, V12, P143, DOI 10.1007/BF02656828; Prasad TG, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001872; Prasad TG, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002000; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; SCHOTT F, 1983, PROG OCEANOGR, V12, P357, DOI 10.1016/0079-6611(83)90014-9; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2002, PROG OCEANOGR, V53, P57, DOI 10.1016/S0079-6611(02)00039-3; SENGUPTA R, 1984, DEEP-SEA RES, V31, P671; SHINODA TM, 2004, J CLIMATOL, V7, P929; Slingo JM, 2000, MON WEATHER REV, V128, P1778, DOI 10.1175/1520-0493(2000)128<1778:TENOOT>2.0.CO;2; Smith SL, 1998, DEEP-SEA RES PT II, V45, P1905, DOI 10.1016/S0967-0645(98)00058-7; SWALLOW JC, 1984, DEEP-SEA RES, V31, P639, DOI 10.1016/0198-0149(84)90032-3; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; WHITE WB, 1988, EOS, V69, P122; Wiggert JD, 2002, DEEP-SEA RES PT II, V49, P2319, DOI 10.1016/S0967-0645(02)00039-5	34	168	174	5	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					545	547		10.1126/science.1106610	http://dx.doi.org/10.1126/science.1106610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845852				2022-12-01	WOS:000228810500050
J	Okada, Y; Feng, Q; Lin, YH; Jiang, Q; Li, YQ; Coffield, VM; Su, LS; Xu, GL; Zhang, Y				Okada, Y; Feng, Q; Lin, YH; Jiang, Q; Li, YQ; Coffield, VM; Su, LS; Xu, GL; Zhang, Y			hDOT1L links histone methylation to leukemogenesis	CELL			English	Article							PROTO-ONCOPROTEIN MLL; HOX GENE-EXPRESSION; BONE-MARROW-CELLS; HOMEOBOX GENES; SET DOMAIN; METHYLTRANSFERASE COMPLEX; MYELOID PROGENITORS; LYSINE METHYLATION; LEUCINE-ZIPPER; FAMILY	Epigenetic modifications play an important role in human cancer. One such modification, histone methylation, contributes to human cancer through deregulation of cancer-relevant genes. The yeast Dot1 and its human counterpart, hDOT1L, methylate lysine 79 located within the globular domain of histone H3. Here we report that hDOT1L interacts with AF10, an MLL (mixed lineage leukemia) fusion partner involved in acute myeloid leukemia, through the OM-LZ region of AF10 required for MLL-AF10-mediated leukemogenesis. We demonstrate that direct fusion of hDOT1L to MLL results in leukemic transformation in an hDOT1L methyltransferase activity-dependent manner. Transformation by MLL-hDOT1L and MLL-AF10 results in upregulation of a number of leukemia-relevant genes, such as Hoxa9, concomitant with hypermethylation of H3-K79. Our studies thus establish that mistargeting of hDOT1L to Hoxa9 plays an important role in MLLAF10-mediated leukemogenesis and suggests that the enzymatic activity of hDOT1L may provide a potential target for therapeutic intervention.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	NATIONAL CANCER INSTITUTE [R01CA119133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA119133-01A1] Funding Source: Medline; NIAID NIH HHS [AI5380402, AI04840704] Funding Source: Medline; NIGMS NIH HHS [GM68804, GM63076] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Buske C, 2000, INT J HEMATOL, V71, P301; Caslini C, 2000, LEUKEMIA, V14, P1898, DOI 10.1038/sj.leu.2401933; CHAPLIN T, 1995, BLOOD, V86, P2073, DOI 10.1182/blood.V86.6.2073.bloodjournal8662073; Coffield VM, 2003, NAT BIOTECHNOL, V21, P1321, DOI 10.1038/nbt889; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakamura T, 1996, ONCOGENE, V13, P2235; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	35	610	632	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					167	178		10.1016/j.cell.2005.02.020	http://dx.doi.org/10.1016/j.cell.2005.02.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851025	Bronze, Green Published			2022-12-01	WOS:000228705000006
J	Sachs, K; Perez, O; Pe'er, D; Lauffenburger, DA; Nolan, GP				Sachs, K; Perez, O; Pe'er, D; Lauffenburger, DA; Nolan, GP			Causal protein-signaling networks derived from multiparameter single-cell data	SCIENCE			English	Article							FLOW-CYTOMETRY; RAF-1; ACTIVATION; EXPRESSION	Machine learning was applied for the automated derivation of causal influences in cellular signaling networks. This derivation relied on the simultaneous measurement of multiple phosphorylated protein and phospholipid components in thousands of individual primary human immune system cells. Perturbing these cells with molecular interventions drove the ordering of connections between pathway components, wherein Bayesian network computational methods automatically elucidated most of the traditionally reported signaling relationships and predicted novel interpathway network causalities, which we verified experimentally. Reconstruction of network models from physiologically relevant primary single cells might be applied to understanding native-state tissue signaling biology, complex drug actions, and dysfunctional signaling in diseased cells.	MIT, Biol Engn Div, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Stanford University; Harvard University; Harvard Medical School	Lauffenburger, DA (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lauffen@mit.edu; gnotan@stanford.edu	Califano, Andrea/F-7239-2012; Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035304, P01AI039646] Funding Source: NIH RePORTER; NIAID NIH HHS [AI35304, P01-AI39646] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CARROLL MP, 1994, J BIOL CHEM, V269, P1249; FRIEDMAN KMN, 1998, P 14 ANN C UNC ART I; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fukuda R, 2003, CANCER RES, V63, P2330; Hartemink A J, 2001, Pac Symp Biocomput, P422; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; IRENE JDG, 2002, BIOINFORMATICS, V18, pS241; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pearl, 2000, CAUSALITY; Pearl J., 1988, PROBABILISTIC REASON, DOI [10.1016/C2009-0-27609-4, DOI 10.1016/C2009-0-27609-4, 10.1016/B978-0-08-051489-5.50008-4]; PEER D, 2005, SCI STKE 2005; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Roederer M, 2004, CLIN IMMUNOL, V110, P199, DOI 10.1016/j.clim.2003.11.015; Sachs Karen, 2002, Sci STKE, V2002, ppe38, DOI 10.1126/stke.2002.148.pe38; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; Zhang WM, 1998, AM J PHYSIOL-CELL PH, V274, pC82, DOI 10.1152/ajpcell.1998.274.1.C82	26	962	1007	7	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					523	529		10.1126/science.1105809	http://dx.doi.org/10.1126/science.1105809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845847				2022-12-01	WOS:000228810500045
J	Honda, K; Ohba, Y; Yanai, H; Negishi, H; Mizutani, T; Takaoka, A; Taya, C; Taniguchi, T				Honda, K; Ohba, Y; Yanai, H; Negishi, H; Mizutani, T; Takaoka, A; Taya, C; Taniguchi, T			Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction	NATURE			English	Article							CPG-DNA; BACTERIAL-DNA; CELLS; ACTIVATION; RECOGNITION; ENDOCYTOSIS; ALPHA/BETA; EXPRESSION; MOTIFS; MYD88	Robust type-I interferon (IFN-alpha/beta) induction in plasmacytoid dendritic cells, through the activation of Toll-like receptor 9 (TLR9), constitutes a critical aspect of immunity(1-6). It is absolutely dependent on the transcription factor IRF-7, which interacts with and is activated by the adaptor MyD88 (ref. 7). How plasmacytoid dendritic cells, but not other cell types (such as conventional dendritic cells), are able to activate the MyD88 IRF-7-dependent IFN induction pathway remains unknown. Here we show that the spatiotemporal regulation of MyD88 IRF-7 signalling is critical for a high-level IFN induction in response to TLR9 activation. The IFN-inducing TLR9 ligand, A/D-type CpG oligodeoxynucleotide (CpG-A)(3,4,8-11), is retained for long periods in the endosomal vesicles of plasmacytoid dendritic cells, together with the MyD88-IRF-7 complex. However, in conventional dendritic cells, CpG-A is rapidly transferred to lysosomal vesicles. We further show that conventional dendritic cells can also mount a robust IFN induction if CpG-A is manipulated for endosomal retention using a cationic lipid. This strategy also allows us to demonstrate endosomal activation of the IFN pathway by the otherwise inactive TLR9 ligand B/K-type oligodeoxynucleotide (CpG-B)(3,4,8-12). Thus, our study offers insights into the regulation of TLR9 signalling in space, potentially suggesting a new avenue for therapeutic intervention.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; JST, PRESTO, Informat & Cell Funct, Kawaguchi, Saitama 3320012, Japan; Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Bunkyo Ku, Tokyo 1138613, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Yanai, Hideyuki/AGK-5933-2022; Honda, Kenya/N-5297-2015; Ohba, Yusuke/E-7944-2011; Serei, Virian D/B-4616-2015; Mizutani, Tatsuaki/AAA-5044-2021	Yanai, Hideyuki/0000-0002-0115-9000; Mizutani, Tatsuaki/0000-0002-4323-4347; Honda, Kenya/0000-0001-8937-9835				Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Brunetti CR, 1998, J VIROL, V72, P3330, DOI 10.1128/JVI.72.4.3330-3339.1998; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; HONDA K, 2005, NATURE          0330, DOI DOI 10.1038/NATURE03464; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Ronnblom L, 2003, ARTHRITIS RES THER, V5, P68, DOI 10.1186/ar625; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997	30	694	730	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1035	1040		10.1038/nature03547	http://dx.doi.org/10.1038/nature03547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15815647				2022-12-01	WOS:000228524600042
J	Frevert, U; Nardin, E				Frevert, U; Nardin, E			Arrest in the liver - A genetically defined malaria vaccine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10003 USA	New York University	Frevert, U (corresponding author), NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10003 USA.			Frevert, Ute/0000-0001-9556-7330				CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Frevert U, 2004, TRENDS PARASITOL, V20, P417, DOI 10.1016/j.pt.2004.07.007; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188	5	7	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1600	1602		10.1056/NEJMcibr050521	http://dx.doi.org/10.1056/NEJMcibr050521			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915SH	15829544				2022-12-01	WOS:000228324200017
J	Leliveld, J; Lechtenbolumer, S; Assonov, SS; Brenninkmeijer, CAM; Dienst, C; Fischedick, M; Hanke, T				Leliveld, J; Lechtenbolumer, S; Assonov, SS; Brenninkmeijer, CAM; Dienst, C; Fischedick, M; Hanke, T			Greenhouse gases: Low methane leakage from gas pipelines	NATURE			English	Editorial Material									Max Planck Inst Chem, D-55128 Mainz, Germany; Wuppertal Inst Climate Environm & Energy, D-42103 Wuppertal, Germany	Max Planck Society	Leliveld, J (corresponding author), Max Planck Inst Chem, D-55128 Mainz, Germany.	leliveld@mpch-mainz.mpg.de	Lechtenböhmer, Stefan/H-4940-2019; Brenninkmeijer, Carl/B-6860-2013; Lelieveld, Jos/A-1986-2013	Lechtenböhmer, Stefan/0000-0001-5987-5416; Lelieveld, Jos/0000-0001-6307-3846; Assonov, Sergey/0000-0001-9096-4150; Fischedick, Manfred/0000-0003-2893-5003				*BRIT PETR, 2004, STAT REV WORLD EN 20; Dedikov JV, 1999, ATMOS ENVIRON, V33, P3291, DOI 10.1016/S1352-2310(98)00388-4; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Fiore AM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015601; International Energy Agency, 2004, NAT GAS INF 2004; LELIEVELD J, 1992, NATURE, V355, P339, DOI 10.1038/355339a0; Ramaswamy V., CLIMATE CHANGE 2001, P349; Reshetnikov AI, 2000, J GEOPHYS RES-ATMOS, V105, P3517, DOI 10.1029/1999JD900761; *US EPA, 2004, INV US GREENH GAS SO; *US EPA, 1996, EPA600R96080 US; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180	11	70	71	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					841	842		10.1038/434841a	http://dx.doi.org/10.1038/434841a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829951				2022-12-01	WOS:000228327600027
J	Malausa, T; Bethenod, MT; Bontemps, A; Bourguet, D; Cornuet, JM; Ponsard, S				Malausa, T; Bethenod, MT; Bontemps, A; Bourguet, D; Cornuet, JM; Ponsard, S			Assortative mating in sympatric host races of the European corn borer	SCIENCE			English	Article							OSTRINIA-NUBILALIS HUBNER; REPRODUCTIVE ISOLATION; GENETIC ISOLATION; LARCH BUDMOTH; PLANT RACES; SPECIATION; POPULATIONS; SPECIALIZATION; LEPIDOPTERA; PYRALIDAE	Although a growing body of work supports the plausibility of sympatric speciation in animals, the practical difficulties of directly quantifying reproductive isolation between diverging taxa remain an obstacle to analyzing this process. We used a combination of genetic and biogeochemical markers to produce a direct field estimate of assortative mating in phytophagous insect populations. We show that individuals of the same insect species, the European corn borer Ostrinia nubilalis, that develop on different host plants can display almost absolute reproductive isolation-the proportion of assortative mating was >95%-even in the absence of temporal or spatial isolation.	Univ Toulouse 3, Lab Dynam Biodivers, CNRS, UMR 5172, F-31062 Toulouse, France; Inst Natl Rech Agron, CBGP, F-34988 Montferrier Sur Lez, France; Inst Natl Rech Agron, Unite Genet Microbienne & Environm, F-78285 Guyancourt, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Institut de Recherche pour le Developpement (IRD); INRAE	Malausa, T (corresponding author), Univ Toulouse 3, Lab Dynam Biodivers, CNRS, UMR 5172, F-31062 Toulouse, France.	malausa@cict.fr	Malausa, Thibaut/X-1614-2018	Malausa, Thibaut/0000-0003-1681-7958; Bourguet, Denis/0000-0002-2109-5323				Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Bethenod MT, 2005, HEREDITY, V94, P264, DOI 10.1038/sj.hdy.6800611; Bontemps A, 2004, P ROY SOC B-BIOL SCI, V271, P2179, DOI 10.1098/rspb.2004.2851; Craig TP, 1997, EVOLUTION, V51, P1552, DOI 10.1111/j.1558-5646.1997.tb01478.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Emelianov I, 2003, J EVOLUTION BIOL, V16, P208, DOI 10.1046/j.1420-9101.2003.00524.x; Emelianov I, 2001, EVOLUTION, V55, P2002, DOI 10.1111/j.0014-3820.2001.tb01317.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1993, ENTOMOL EXP APPL, V69, P117, DOI 10.1007/BF02380639; KLUN JA, 1975, ENVIRON ENTOMOL, V4, P891, DOI 10.1093/ee/4.6.891; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; Martel C, 2003, HEREDITY, V90, P141, DOI 10.1038/sj.hdy.6800186; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Parker PG, 1998, ECOLOGY, V79, P361, DOI 10.1890/0012-9658(1998)079[0361:WMCTUA]2.0.CO;2; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; SHOWERS WB, 1976, ENVIRON ENTOMOL, V5, P1099, DOI 10.1093/ee/5.6.1099; Thomas Y, 2003, EVOLUTION, V57, P261; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 1999, EVOLUTION, V53, P1446, DOI [10.1111/j.1558-5646.1999.tb05409.x, 10.2307/2640891]	22	123	130	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2005	308	5719					258	260		10.1126/science.1107577	http://dx.doi.org/10.1126/science.1107577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915BX	15821092				2022-12-01	WOS:000228273700055
J	Mooney, H; Cropper, A; Reid, W				Mooney, H; Cropper, A; Reid, W			Confronting the human dilemma	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Millennium Ecosyst Assessment, Oakland, CA 94611 USA; Cropper Fdn, Port Of Spain, Trinidad Tobago	Stanford University	Mooney, H (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							2002, NATURE, V417, P112	1	93	102	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					561	562		10.1038/434561a	http://dx.doi.org/10.1038/434561a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800597				2022-12-01	WOS:000228011000019
J	Coulibaly, F; Chevalier, C; Gutsche, I; Pous, J; Navaza, J; Bressanelli, S; Delmas, B; Rey, FA				Coulibaly, F; Chevalier, C; Gutsche, I; Pous, J; Navaza, J; Bressanelli, S; Delmas, B; Rey, FA			The birnavirus crystal structure reveals structural relationships among icosahedral viruses	CELL			English	Article							INFECTIOUS BURSAL DISEASE; DOUBLE-STRANDED-RNA; PANCREATIC NECROSIS VIRUS; MAJOR CAPSID PROTEIN; L-A VIRUS; ATOMIC-STRUCTURE; ANGSTROM RESOLUTION; POLYMERASE-ACTIVITY; MATURATION PROCESS; AMINO-ACIDS	Double-stranded RNA virions are transcriptionally competent icosahedral particles that must translocate across a lipid bilayer to function within the cytoplasm of the target cell. Birnaviruses are unique among dsRNA viruses as they have a single T = 13 icosahedral shell, lacking the characteristic inner capsid observed in the others. We determined the crystal structures of the T = 1 subviral particle (260 A in diameter) and of the T = 13 intact virus particle (700 A in diameter) of an avian birnavirus to 3 A and 7 A resolution, respectively. Our results show that VP2, the only component of the virus icosahedral capsid, is homologous both to the capsid protein of positive-strand RNA viruses, like the T = 3 nodaviruses, and to the T = 13 capsid protein of members of the Reoviridae family of dsRNA viruses. Together, these results provide important insights into the multiple functions of the birnavirus capsid and reveal unexpected structural relationships among icosahedral viruses.	INRA, Unite Virol & Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France; CNRS, INRA, UMR 2472 1157, Lab Virol Mol & Struct, F-91198 Gif Sur Yvette, France; IFR 115, F-91198 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Universite Paris Saclay	Delmas, B (corresponding author), INRA, Unite Virol & Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France.	delmas@jouy.inra.fr	Chevalier, Christophe/C-2575-2009; Chevalier, Christophe/AAK-4461-2020; Rey, Felix/B-6497-2012; Chevalier, Christophe/AAW-5560-2020	Chevalier, Christophe/0000-0003-3231-9027; Rey, Felix/0000-0002-9953-7988; Bressanelli, Stephane/0000-0002-0921-6727; Coulibaly, Fasseli/0000-0003-3380-2117				Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Bourgeois D, 1999, ACTA CRYSTALLOGR D, V55, P1733, DOI 10.1107/S0907444999008355; Brandt M, 2001, J VIROL, V75, P11974, DOI 10.1128/JVI.75.24.11974-11982.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Chevalier C, 2002, J VIROL, V76, P2384, DOI 10.1128/JVI.76.5.2384-2392.2002; COHEN J, 1975, BIOCHEM BIOPH RES CO, V62, P689, DOI 10.1016/0006-291X(75)90454-4; Da Costa B, 2002, J VIROL, V76, P2393, DOI [10.1128/jvi.76.5.2393-2402.2002, 10.1128/JVI.76.5.2393-2402.2002]; DeFilippis VR, 2001, FIELDS VIROLOGY, P353; Delmas B, 2004, VIRUS TAXONOMY, P561; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; FLORES TP, 1994, PROTEIN ENG, V7, P31, DOI 10.1093/protein/7.1.31; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hanzlik TN, 1997, ADV VIRUS RES, V48, P101, DOI 10.1016/S0065-3527(08)60287-0; Harrison SC, 2001, CURR OPIN STRUC BIOL, V11, P195, DOI 10.1016/S0959-440X(00)00189-5; Helgstrand C, 2004, VIROLOGY, V318, P192, DOI 10.1016/j.virol.2003.08.045; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JONES TA, 1992, MOL REPLACEMENT, P91; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Lim BL, 1999, J VIROL, V73, P2854, DOI 10.1128/JVI.73.4.2854-2862.1999; Mathieu M, 2001, EMBO J, V20, P1485, DOI 10.1093/emboj/20.7.1485; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Mundt E, 1999, J GEN VIROL, V80, P2067, DOI 10.1099/0022-1317-80-8-2067; Munshi S, 1996, J MOL BIOL, V261, P1, DOI 10.1006/jmbi.1996.0437; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Nakagawa A, 2003, STRUCTURE, V11, P1227, DOI 10.1016/j.str.2003.08.012; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Nibert ML., 2001, FIELDS VIROLOGY, P1679; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OZEL M, 1985, ARCH VIROL, V84, P149, DOI 10.1007/BF01378968; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; SCHNITZLER D, 1993, J GEN VIROL, V74, P1563, DOI 10.1099/0022-1317-74-8-1563; SPIES U, 1987, VIRUS RES, V8, P127, DOI 10.1016/0168-1702(87)90024-4; Tan BH, 2001, J VIROL, V75, P3937, DOI 10.1128/JVI.75.8.3937-3947.2001; Tang L, 2002, J VIROL, V76, P6370, DOI 10.1128/JVI.76.12.6370-6375.2002; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Loon AAWM, 2002, J GEN VIROL, V83, P121, DOI 10.1099/0022-1317-83-1-121; [No title captured]	64	243	262	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					761	772		10.1016/j.cell.2005.01.009	http://dx.doi.org/10.1016/j.cell.2005.01.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797378	Bronze			2022-12-01	WOS:000228067500007
J	Ihrie, RA; Marques, MR; Nguyen, BT; Horner, JS; Papazoglu, C; Bronson, RT; Mills, AA; Attardi, LD				Ihrie, RA; Marques, MR; Nguyen, BT; Horner, JS; Papazoglu, C; Bronson, RT; Mills, AA; Attardi, LD			Perp is a p63-regulated gene essential for epithelial integrity	CELL			English	Article							P53-DEPENDENT APOPTOSIS; EPIDERMAL MORPHOGENESIS; P53 HOMOLOG; P63; CELL; PLAKOPHILIN-1; TARGET; DESMOPLAKIN; DESMOSOMES; COMPLEX	p63 is a master regulator of stratified epithelial development that is both necessary and sufficient for specitying this multifaceted program. We show here that Perp, a tetraspan membrane protein originally identified as an apoptosis-associated target of the p53 tumor suppressor, is the first direct target of p63 clearly involved in mediating this developmental program in vivo. During embryogenesis, Perp is expressed in an epithelial pattern, and its expression depends on p63. Perp(-/-) mice die postnatally, with dramatic blistering in stratified epithelia symptomatic of compromised adhesion. Perp localizes specifically to desmosomes, adhesion junctions important for tissue integrity, and numerous structural defects in desmosomes are observed in Perp-deficient skin, suggesting a role for Perp in promoting the stable assembly of desmosomal adhesive complexes. These findings demonstrate that Perp is a key effector in the p63 developmental program, playing an essential role in an adhesion subprogram central to epithelial integrity and homeostasis.	Stanford Univ, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Harvard University; Harvard Medical School	Attardi, LD (corresponding author), Stanford Univ, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	attardi@stanford.edu		Ihrie, Rebecca/0000-0003-0439-0141	NCI NIH HHS [CA93665-01, CA09302] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093665] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attardi LD, 2000, GENE DEV, V14, P704; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Bornslaeger EA, 2001, J CELL SCI, V114, P727; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jetten AM, 2000, PROG NUCLEIC ACID RE, V64, P97, DOI 10.1016/S0079-6603(00)64003-5; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kurata S, 2004, J BIOL CHEM, V279, P50069, DOI 10.1074/jbc.M406322200; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Reczek EE, 2003, MOL CANCER RES, V1, P1048; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wong P, 2000, J CELL BIOL, V150, P921, DOI 10.1083/jcb.150.4.921; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	31	247	255	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					843	856		10.1016/j.cell.2005.01.008	http://dx.doi.org/10.1016/j.cell.2005.01.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797384	Bronze			2022-12-01	WOS:000228067500013
J	Tao, QH; Yokota, C; Puck, H; Kofron, M; Birsoy, B; Yan, D; Asashima, M; Wylie, CC; Lin, XH; Heasman, J				Tao, QH; Yokota, C; Puck, H; Kofron, M; Birsoy, B; Yan, D; Asashima, M; Wylie, CC; Lin, XH; Heasman, J			Maternal Wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos	CELL			English	Article							CONVERGENT EXTENSION MOVEMENTS; HEPARAN-SULFATE PROTEOGLYCANS; DORSAL-VENTRAL AXIS; BETA-CATENIN; CORTICAL ROTATION; ZEBRAFISH GASTRULATION; MIDBLASTULA TRANSITION; VERTEBRATE DEVELOPMENT; MESODERM INDUCTION; KIDNEY DEVELOPMENT	Wnt signaling pathways play essential roles in patterning and proliferation of embryonic and adult tissues. In many organisms, this signaling pathway directs axis formation. Although the importance of intracellular components of the pathway, including P-catenin and Tcf3, has been established, the mechanism of their activation is uncertain. In Xenopus, the initiating signal that localizes p-catenin to dorsal nuclei has been suggested to be intracellular and Wnt independent. Here, we provide three lines of evidence that the pathway specifying the dorsal axis is activated extracellularly in Xenopus embryos. First, we identify Wnt11 as the initiating signal. Second, we show that activation requires the glycosyl transferase X.EXT1. Third, we find that the EGF-CFC protein, FRL1, is also essential and interacts with Wnt11 to activate canonical Wnt signaling.	Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Tokyo	Heasman, J (corresponding author), Cincinnati Childrens Res Fdn, Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	heabq9@chmcc.org		Birsoy, Bilge/0000-0003-4337-4582; Kofron, Matthew/0000-0001-6427-4148	NICHD NIH HHS [HD33002] Funding Source: Medline; NIGMS NIH HHS [GM-63891] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063891] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072; AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; BRANDT R, 1994, J BIOL CHEM, V269, P17320; Branford WW, 2002, CURR BIOL, V12, P2136, DOI 10.1016/S0960-9822(02)01360-X; Chang CB, 2000, MECH DEVELOP, V90, P227, DOI 10.1016/S0925-4773(99)00257-9; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Christiansen JH, 1996, ONCOGENE, V12, P2705; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Ding XY, 1998, MECH DEVELOP, V70, P15, DOI 10.1016/S0925-4773(97)00163-9; Djiane A, 2000, DEVELOPMENT, V127, P3091; Dominguez I, 2000, DEVELOPMENT, V127, P861; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.3.CO;2-C; ELINSON RP, 1988, DEV BIOL, V128, P185, DOI 10.1016/0012-1606(88)90281-3; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hacker U, 1997, DEVELOPMENT, V124, P3565; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HOULISTON E, 1991, J CELL BIOL, V114, P1017, DOI 10.1083/jcb.114.5.1017; Houston DW, 2002, DEVELOPMENT, V129, P4015; Katada T, 2002, DEV GENES EVOL, V212, P248, DOI 10.1007/s00427-002-0237-0; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Kirikoshi H, 2001, INT J MOL MED, V8, P651; Kofron M, 2004, DEVELOPMENT, V131, P5065, DOI 10.1242/dev.01396; Kofron M, 2001, DEV BIOL, V237, P183, DOI 10.1006/dbio.2001.0371; KU M, 1993, DEVELOPMENT, V119, P1161; Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Larabell CA, 1996, DEVELOPMENT, V122, P1281; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lopez SL, 2003, DEVELOPMENT, V130, P2225, DOI 10.1242/dev.00443; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; MOON RT, 1993, DEVELOPMENT, V119, P97; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nasevicius A, 1998, DEVELOPMENT, V125, P4283; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Ohkawara B, 2003, DEVELOPMENT, V130, P2129, DOI 10.1242/dev.00435; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Perrimon N, 2004, DEVELOPMENT, V131, P2509, DOI 10.1242/dev.01225; Quaas J, 2002, DEV BIOL, V243, P272, DOI 10.1006/dbio.2001.0564; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Rowning BA, 1997, P NATL ACAD SCI USA, V94, P1224, DOI 10.1073/pnas.94.4.1224; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schohl A, 2002, DEVELOPMENT, V129, P37; Schroeder KE, 1999, DEV BIOL, V214, P288, DOI 10.1006/dbio.1999.9426; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Sun BI, 1999, DEVELOPMENT, V126, P1467; Tanegashima K, 2004, INT J DEV BIOL, V48, P275, DOI 10.1387/ijdb.041805kt; Teel AL, 1996, MECH DEVELOP, V59, P115, DOI 10.1016/0925-4773(96)00584-9; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; VINCENT JP, 1986, DEV BIOL, V113, P484, DOI 10.1016/0012-1606(86)90184-3; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Xanthos JB, 2002, DEVELOPMENT, V129, P4027; Xanthos JB, 2001, DEVELOPMENT, V128, P167; Yabe SI, 2003, DEVELOPMENT, V130, P2071, DOI 10.1242/dev.00430; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yang J, 2002, DEVELOPMENT, V129, P5743, DOI 10.1242/dev.00150; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Yokota C, 2003, DEVELOPMENT, V130, P2199, DOI 10.1242/dev.00434; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zuck M. V., 1998, COMP METHODS APPROAC, P341	85	383	403	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					857	871		10.1016/j.cell.2005.01.013	http://dx.doi.org/10.1016/j.cell.2005.01.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797385	Bronze			2022-12-01	WOS:000228067500014
J	Zaidi, AKM; Huskins, WC; Thaver, D; Bhutta, ZA; Abbas, Z; Goldmann, DA				Zaidi, AKM; Huskins, WC; Thaver, D; Bhutta, ZA; Abbas, Z; Goldmann, DA			Hospital-acquired neonatal infections in developing countries	LANCET			English	Review							INTENSIVE-CARE-UNIT; SPECTRUM BETA-LACTAMASE; LOW-BIRTH-WEIGHT; LATE-ONSET INFECTION; KLEBSIELLA-PNEUMONIAE; NOSOCOMIAL INFECTIONS; MOLECULAR EPIDEMIOLOGY; BACTERIAL-MENINGITIS; PEDIATRIC CARE; RISK-FACTORS	Hospital-born babies in developing countries are at increased risk of neonatal infections because of poor intraparturn and postnatal infection-control practices. We reviewed data from developing countries on rates of neonatal infections among hospital-born babies, range of pathogens, antimicrobial resistance, and infection-control interventions. Reported rates of neonatal infections were 3-20 times higher than those reported for hospital-born babies in industrialised countries. Klebsiella pneumoniae, other gram-negative rods (Escherichia coli, Pseudomonas spp, Acinetobacter spp), and Staphylococcus aureus were the major pathogens among 11471 bloodstream isolates reported. These infections can often present soon after birth. About 70% would not be covered by an empiric regimen of ampicillin and gentamicin, and many might be untreatable in resource-constrained environments. The associated morbidity, mortality, costs, and adverse effect on future health-seeking behaviour by communities pose barriers to improvement of neonatal outcomes in developing countries. Low-cost, "bundled" interventions using systems quality improvement approaches for improved infection control are possible, but should be supported by evidence in developing country settings.	Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan; Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Infect Dis, Rochester, MN USA; Mayo Clin, Coll Med, Rochester, MN USA; Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; Inst Healthcare Improvement, Cambridge, MA USA	Aga Khan University; Mayo Clinic; Mayo Clinic; Harvard University; Boston Children's Hospital; Harvard Medical School; Institute for Healthcare Improvement	Zaidi, AKM (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Stadium Rd,POB 3500, Karachi 74800, Pakistan.	anita.zaidi@aku.edu		Huskins, W. Charles/0000-0002-9989-175X				Adejuyigbe E A, 2001, East Afr Med J, V78, P540; ADHIKARI M, 1995, J TROP PEDIATRICS, V41, P81, DOI 10.1093/tropej/41.2.81; ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x; Ahmed A S M Nawshad Uddin, 2002, Indian Pediatr, V39, P1034; AIREDE AI, 1993, DEV MED CHILD NEUROL, V35, P424; AIREDE AI, 1992, J TROP PEDIATRICS, V38, P189, DOI 10.1093/tropej/38.4.189; Aktas E, 2002, J INT MED RES, V30, P445, DOI 10.1177/147323000203000414; Al-Harthi AA, 2000, SAUDI MED J, V21, P550; Ali Z, 2004, ANN TROP PAEDIATR, V24, P41, DOI 10.1179/027249304225013367; [Anonymous], HAZ AN CRIT CONTR PO; [Anonymous], 1980, EXPLORATIONS QUALITY; ANTIAOBONG OE, 1992, CENT AFR J MED, V38, P161; Anwer S K, 2000, J Pak Med Assoc, V50, P91; Anyebuno M, 1995, E AFR MED J, V72, P805; Arif MA, 1999, J TROP PEDIATRICS, V45, P278, DOI 10.1093/tropej/45.5.278; Aurangzeb Brekhna, 2003, J Coll Physicians Surg Pak, V13, P629; Ayan M, 2003, INFECT CONT HOSP EP, V24, P495, DOI 10.1086/502245; AYENGAR V, 1991, Indian Journal of Pediatrics, V58, P661, DOI 10.1007/BF02820186; Bakr AF, 2003, J TROP PEDIATRICS, V49, P295, DOI 10.1093/tropej/49.5.295; Baltimore Robert S, 2003, Paediatr Drugs, V5, P723, DOI 10.2165/00148581-200305110-00002; Baltimore RS, 1998, SEMIN PERINATOL, V22, P25, DOI 10.1016/S0146-0005(98)80005-0; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Barroso-Aguirre J, 1992, Bol Med Hosp Infant Mex, V49, P666; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Ben-Hamouda T, 2003, J MED MICROBIOL, V52, P427, DOI 10.1099/jmm.0.04981-0; BERG DE, 1995, CLIN INFECT DIS, V21, P588, DOI 10.1093/clinids/21.3.588; Bhutta ZA, 2004, BRIT MED J, V329, P1151, DOI 10.1136/bmj.329.7475.1151; Bhutta ZA, 1997, AM J PERINAT, V14, P577, DOI 10.1055/s-2007-994338; Bhutta ZA, 2000, IMPROVING NEWBORN INFANT HEALTH IN DEVELOPING COUNTRIES, P289, DOI 10.1142/9781848160705_0016; BHUTTA ZA, 1991, ACTA PAEDIATR SCAND, V80, P596, DOI 10.1111/j.1651-2227.1991.tb11916.x; BOO NY, 1994, J PAEDIATR CHILD H, V30, P23, DOI 10.1111/j.1440-1754.1994.tb00560.x; Boukadida J, 2002, ARCH PEDIATRIE, V9, P463, DOI 10.1016/S0929-693X(01)00827-2; Brown SM, 2003, INFECT CONT HOSP EP, V24, P172, DOI 10.1086/502186; BUETOW KC, 1965, AM J DIS CHILD, V110, P29, DOI 10.1001/archpedi.1965.02090030035005; Chandrashekar M R, 1997, J Indian Med Assoc, V95, P72; Cisse C T, 2001, Gynecol Obstet Fertil, V29, P433, DOI 10.1016/S1297-9589(01)00157-6; CISSE MF, 1992, PRESSE MED, V21, P413; Clark Reese, 2004, J Perinatol, V24, P382, DOI 10.1038/sj.jp.7211120; CONDEAGUDELO A, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002771.PUB2]; CONNER JM, 2003, COCHRANE DB SYST REV, V4; Cotton MF, 2000, J HOSP INFECT, V44, P13, DOI 10.1053/jhin.1999.0650; CRAIG WS, 1962, CARE NEWLY BORN INFA; Daoud AS, 1996, J TROP PEDIATRICS, V42, P267, DOI 10.1093/tropej/42.5.267; DAOUD AS, 1995, ANN TROP PAEDIATR, V15, P93, DOI 10.1080/02724936.1995.11747755; Darmstadt GL, 2004, PEDIATR INFECT DIS J, V23, P719, DOI 10.1097/01.inf.0000133047.50836.6f; Darmstadt GL, 2003, B WORLD HEALTH ORGAN, V81, P224; Dawodu A, 1997, J TROP PEDIATRICS, V43, P84, DOI 10.1093/tropej/43.2.84; DEALMEIDA SH, 2003, BRAZ J INFECT DIS, V7, P381; Desinor OY, 2004, J TROP PEDIATRICS, V50, P48, DOI 10.1093/tropej/50.1.48; DREWS MB, 1995, J HOSP INFECT, V30, P65, DOI 10.1016/0195-6701(95)90250-3; Edwards MS., 2015, INFECT DIS FETUS NEW, V8th ed., P1091; EICKHOFF TC, 1964, NEW ENGL J MED, V271, P1221, DOI 10.1056/NEJM196412102712401; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Ferguson JK, 1996, J PAEDIATR CHILD H, V32, P525, DOI 10.1111/j.1440-1754.1996.tb00967.x; Fernandez A, 1993, J Postgrad Med, V39, P57; Fernandez Armida, 2003, Indian Pediatr, V40, P1161; FIKREE FF, 2001, STATE WORLDS NEWBORN; Gebremariam A, 1998, ANN TROP PAEDIATR, V18, P279, DOI 10.1080/02724936.1998.11747960; Ghiorghis B, 1997, ETHIOPIAN MED J, V35, P169; GHIORGIS B, 1991, ETHIOPIAN MED J, V29, P167; GLUCK L, 1966, PEDIATR CLIN N AM, V13, P1131; Goldmann DA, 1997, CLIN INFECT DIS, V24, pS139, DOI 10.1093/clinids/24.Supplement_1.S139; Gonzalez-Vertiz A, 2001, INFECT CONT HOSP EP, V22, P723, DOI 10.1086/501854; GUPTA AK, 1993, J TROP PEDIATRICS, V39, P32, DOI 10.1093/tropej/39.1.32; Gupta P, 1997, Indian Pediatr, V34, P144; Gupta Piyush, 1993, Indian Journal of Pediatrics, V60, P565, DOI 10.1007/BF02751435; Halder D, 1999, Med J Malaysia, V54, P52; HALEY RW, 1995, J INFECT DIS, V171, P614, DOI 10.1093/infdis/171.3.614; HAQUE KN, 1990, J TROP PEDIATRICS, V36, P20, DOI 10.1093/tropej/36.1.20; Harris JS, 2001, INFECT DIS FETUS NEW, P1371; Ho JJ, 2001, PEDIATR INFECT DIS J, V20, P557, DOI 10.1097/00006454-200106000-00002; Hyder AA, 2003, BJOG-INT J OBSTET GY, V110, P894, DOI 10.1111/j.1471-0528.2003.02446.x; Isturiz RE, 2000, INFECT CONT HOSP EP, V21, P394, DOI 10.1086/501780; Jain A, 2003, J MED MICROBIOL, V52, P421, DOI 10.1099/jmm.0.04966-0; Jain S, 2004, J TROP PEDIATRICS, V50, P170, DOI 10.1093/tropej/50.3.170; Joshi S. G., 2000, Indian Journal of Pediatrics, V67, P27; KARPUCH J, 1983, ISRAEL J MED SCI, V19, P963; Karthikeyan G., 2001, Indian Journal of Pediatrics, V68, P715, DOI 10.1007/BF02752407; Karunasekera K. A. W., 1999, Ceylon Medical Journal, V44, P81; Kaushik Shayam L., 1998, Journal of Communicable Diseases, V30, P147; Kilani R A, 2000, J Med Liban, V48, P77; Klein O.J., 2001, INFECT DIS FETUS NEW, P943; Klingenberg C, 2003, ANN TROP PAEDIATR, V23, P293, DOI 10.1179/027249303225007806; Koksal Nilgun, 2001, Indian Journal of Pediatrics, V68, P15, DOI 10.1007/BF02728850; KONAI AK, 1999, J TROP PEDIATRICS, V45, P146; Kumar M, 2002, J TROP PEDIATRICS, V48, P43, DOI 10.1093/tropej/48.1.43; Kumhar GD, 2002, J HEALTH POPUL NUTR, V20, P343; Kurlat I, 1998, J HOSP INFECT, V40, P149, DOI 10.1016/S0195-6701(98)90094-9; Kuruvilla K A, 1998, Indian Pediatr, V35, P851; Langley N., 1996, IMPROVEMENT GUIDE PR; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Lim N L, 1995, Med J Malaysia, V50, P59; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; LUMBIGANON P, 2004, COCHRANE DB SYST REV, V4; Mahmood A, 2002, J Pak Med Assoc, V52, P348; Malik A S, 1994, Med J Malaysia, V49, P17; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; MANTARING JB, 2004, REDUCTION NEONATAL B, P80; Martinez-Aguilar G, 2001, INFECT CONT HOSP EP, V22, P725, DOI 10.1086/501855; Mas-Munoz R L, 1992, Bol Med Hosp Infant Mex, V49, P839; MASSOUD R, MODERN PARADIGM IMPR; MATHUR N B, 1991, Indian Pediatrics, V28, P1259; MCCRACKEN GH, 1966, AM J DIS CHILD, V112, P33, DOI 10.1001/archpedi.1966.02090100069006; Misallati A, 2000, East Mediterr Health J, V6, P483; Mishra A, 1998, Indian Pediatr, V35, P27; MOFFET HL, 1967, AM J DIS CHILD, V114, P13, DOI 10.1001/archpedi.1967.02090220019003; Mokuolu A O, 2002, Afr J Med Med Sci, V31, P127; MONDAL G P, 1991, Indian Journal of Pediatrics, V58, P529, DOI 10.1007/BF02750936; MORENO MT, 1994, PEDIATR INFECT DIS J, V13, P516, DOI 10.1097/00006454-199406000-00010; Moss William, 2002, J Perinatol, V22, P484; Mullany LC, 2003, PEDIATR INFECT DIS J, V22, P996, DOI 10.1097/01.inf.0000095429.97172.48; Musoke RN, 2000, J TROP PEDIATRICS, V46, P86, DOI 10.1093/tropej/46.2.86; Mussi-Pinhata MM, 2004, J TROP PEDIATRICS, V50, P6, DOI 10.1093/tropej/50.1.6; Nagata E, 2002, AM J INFECT CONTROL, V30, P26, DOI 10.1067/mic.2002.119823; *NAT NEON FOR, 2000, NAT NEON PER DAT REP; NATHOO KJ, 1990, CENT AFR J MED, V36, P150; NATHOO KJ, 1993, PEDIATR INFECT DIS J, V12, P840, DOI 10.1097/00006454-199310000-00009; NATHOO KJ, 1991, ANN TROP PAEDIATR, V11, P11, DOI 10.1080/02724936.1991.11747472; Nejjari Noureddine, 2003, Tunis Med, V81, P121; Nel E, 2000, J TROP PEDIATRICS, V46, P237, DOI 10.1093/tropej/46.4.237; Newman Mercy J, 2002, West Afr J Med, V21, P310; Ng PC, 2004, ARCH DIS CHILD-FETAL, V89, pF336, DOI 10.1136/adc.2003.031104; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; NTIAOBONG OE, 1991, TROP DOCT, V21, P169; Nuland SB, 2003, DOCTORS PLAGUE GERMS; Orrett FA, 1998, INFECT CONT HOSP EP, V19, P136; Orrett FA, 2001, ANN TROP PAEDIATR, V21, P20, DOI 10.1080/02724930020028867; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; PANNUTI CS, 1995, INFECT CONT HOSP EP, V16, P170; Pearse J, 1997, Afr Health, V19, P10; PEGUES DA, 1994, AM J INFECT CONTROL, V22, P163, DOI 10.1016/0196-6553(94)90005-1; Pengsaa Krisana, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P102; Pessoa-Silva CL, 2004, INFECT CONT HOSP EP, V25, P772, DOI 10.1086/502475; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; Petdachai Witaya, 2000, Journal of the Medical Association of Thailand, V83, P392; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; Pillay T, 1998, AM J PERINAT, V15, P47, DOI 10.1055/s-2007-993898; Pittet D, 2004, J HOSP INFECT, V58, P1, DOI 10.1016/j.jhin.2004.06.002; PONCEDELEON S, 1991, J HOSP INFECT, V18, P376, DOI 10.1016/0195-6701(91)90044-9; PRASERTSOM W, 1990, Journal of the Medical Association of Thailand, V73, P106; RAGHAVAN M, 1992, Indian Journal of Pediatrics, V59, P335, DOI 10.1007/BF02821801; Rahman S, 2002, ARCH DIS CHILD-FETAL, V87, pF52, DOI 10.1136/fn.87.1.F52; RAJAB A, 1990, ANN TROP PAEDIATR, V10, P39, DOI 10.1080/02724936.1990.11747407; RAO PS, 1993, J TROP PEDIATRICS, V39, P230, DOI 10.1093/tropej/39.4.230; Raza MW, 2004, J HOSP INFECT, V57, P294, DOI 10.1016/j.jhin.2004.03.019; RHINEHART E, 1991, AM J MED, V91, pS213, DOI 10.1016/0002-9343(91)90371-4; Richards C, 2004, INFECT CONT HOSP EP, V25, P221, DOI 10.1086/502382; Saez-Llorens X, 2000, PEDIATR INFECT DIS J, V19, P200, DOI 10.1097/00006454-200003000-00005; Sanghvi KP, 1996, J PAEDIATR CHILD H, V32, P333, DOI 10.1111/j.1440-1754.1996.tb02565.x; SENSES D A, 1991, Mikrobiyoloji Bulteni, V25, P238; SHINEFIELD HR, 2001, INFECT DIS FETUS NEW, P1217; Silva J, 2001, J CLIN MICROBIOL, V39, P3193, DOI 10.1128/JCM.39.9.3193-3196.2001; Singh D, 2000, IMPROVING NEWBORN INFANT HEALTH IN DEVELOPING COUNTRIES, P503, DOI 10.1142/9781848160705_0030; Sjahrodji A M, 1990, Paediatr Indones, V30, P191; SOBAYO EI, 1991, J HOSP INFECT, V18, P388, DOI 10.1016/0195-6701(91)90046-B; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Stoll BJ, 2001, J PEDIATR-US, V139, P729, DOI 10.1067/mpd.2001.118881; Stoll BJ, 2001, INFECT DIS FETUS NEW, P139; Szabo D, 1999, J CLIN MICROBIOL, V37, P4167; Tallur Shashikala S., 2000, Indian Journal of Pediatrics, V67, P169, DOI 10.1007/BF02723654; Taskin E, 2004, J TROP PEDIATRICS, V50, P124, DOI 10.1093/tropej/50.2.124; Tietjen L, 2003, INFECT PREVENTION GU; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Ursprung R, 2004, PEDIATR RES, V55, p435A; VAIDYA U, 1991, Indian Pediatrics, V28, P1265; Vargas P E, 1990, Rev Med Panama, V15, P127; Velazco E, 2002, ENFERM INFEC MICR CL, V20, P321, DOI 10.1016/S0213-005X(02)72808-5; Waheed Maryam, 2003, J Coll Physicians Surg Pak, V13, P449; Webster J, 2003, Cochrane Database Syst Rev, pCD003670; Weinberg M, 2001, ARCH INTERN MED, V161, P2357, DOI 10.1001/archinte.161.19.2357; WHEELER WE, 1967, AM J DIS CHILD, V101, P273; *WHO, 1993, MOTH BAB PACK ROAD M; *WHO, APPR RAP SCAL UP US; *WHO DEP REPR HLTH, 2001, INT MAN PREGN CHILD; *WHO UNICEF, 2000, WHOFCHCAH0012000; Yalcin Ata Nevzat, 2003, Indian J Med Sci, V57, P450; Yu J. L., 2001, SMJ Singapore Medical Journal, V42, P107; ZAIDI AK, 2002, EXPLORE SIMPLIFIED A; ZAIDI M, 1995, J HOSP INFECT, V31, P25, DOI 10.1016/0195-6701(95)90080-2; ZAIDI-JACOBSON M, 1991, Boletin Medico del Hospital Infantil de Mexico, V48, P538; Zupan J, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/1465-1858.CD001057; 1999, MARTINDALE COMPLETE, P1108; 2001, SAVING NEWBORN LIVES	184	431	446	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2005	365	9465					1175	1188		10.1016/S0140-6736(05)71881-X	http://dx.doi.org/10.1016/S0140-6736(05)71881-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	910DD	15794973				2022-12-01	WOS:000227909500031
J	Allen, GS; Zavialov, A; Gursky, R; Ehrenberg, M; Frank, J				Allen, GS; Zavialov, A; Gursky, R; Ehrenberg, M; Frank, J			The cryo-EM structure of a translation initiation complex from Escherichia coli	CELL			English	Article							30S RIBOSOMAL-SUBUNITS; AMINOACYL-TRANSFER-RNA; FACTOR IF2; FACTOR-II; GUANOSINE TRIPHOSPHATE; CRYSTAL-STRUCTURE; GTPASE ACTIVITY; PROTEIN L7/L12; DENSITY MAPS; IN-VITRO	The 70S ribosome and its complement of factors required for initiation of translation in E. coli were purified separately and reassembled in vitro with GDPNP, producing a stable initiation complex (IC) stalled after 70S assembly. We have obtained a cryo-EM reconstruction of the IC showing IF2 center dot GDPNP at the intersubunit cleft of the 70S ribosome. IF2 center dot GDPNP contacts the 30S and 50S subunits as well as fMet-tRNA(fMet). IF2 here adopts a conformation radically different from that seen in the recent crystal structure of IF2. The C-terminal domain of IF2 binds to the singlestranded portion of fMet-tRNA(fmet), thereby forcing the tRNA into a novel orientation at the P site. The GTP binding domain of IF2 binds to the GTPase-associated center of the 50S subunit in a manner similar to EF-G and EF-Tu. Additionally, we present evidence for the localization of IF1, IF3, one C-terminal domain of L7/L12, and the N-terminal domain of IF2 in the initiation complex.	Hlth Res Inc, Wadsworth Ctr, Howard Hughes Med Inst, Albany, NY 12201 USA; Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), Hlth Res Inc, Wadsworth Ctr, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	joachim@wadsworth.org		Zavialov, Andrey/0000-0001-6420-0368	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055440, R37GM029169] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055440-08, R01 GM55440, R37 GM029169-24, R37 GM29169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antoun A, 2003, EMBO J, V22, P5593, DOI 10.1093/emboj/cdg525; Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; BEAUDRY P, 1979, BIOCHEMISTRY-US, V18, P202, DOI 10.1021/bi00568a031; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; Brooijmans N, 2002, PROTEINS, V48, P645, DOI 10.1002/prot.10139; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANONACO MA, 1986, FEBS LETT, V207, P198, DOI 10.1016/0014-5793(86)81488-0; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Chen JZ, 2003, J STRUCT BIOL, V144, P144, DOI 10.1016/j.jsb.2003.09.008; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Dey D, 1998, J BIOL CHEM, V273, P1670, DOI 10.1074/jbc.273.3.1670; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gao HX, 2004, J STRUCT BIOL, V147, P283, DOI 10.1016/j.jsb.2004.02.008; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; GOSS DJ, 1982, J BIOL CHEM, V257, P119; GRIGORIADOU C, 2004, TRANSLATIONAL CONT A, P407; GRONER Y, 1973, J MOL BIOL, V74, P407, DOI 10.1016/0022-2836(73)90381-1; Grunberg-Manago M, 1975, J Mol Biol, V94, P461; GRUNBERGMANAGO M, 1972, FEBS LETT, V22, P217, DOI 10.1016/0014-5793(72)80049-8; GUALERZI C, 1971, BIOCHEM BIOPH RES CO, V45, P1312, DOI 10.1016/0006-291X(71)90162-8; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Guenneugues M, 2000, EMBO J, V19, P5233, DOI 10.1093/emboj/19.19.5233; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; HARTZ D, 1990, GENE DEV, V4, P1790, DOI 10.1101/gad.4.10.1790; HEIMARK RL, 1976, J BIOL CHEM, V251, P7779; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; KAY AC, 1972, BIOCHIM BIOPHYS ACTA, V277, P225, DOI 10.1016/0005-2787(72)90369-3; Lee JH, 1999, P NATL ACAD SCI USA, V96, P4342, DOI 10.1073/pnas.96.8.4342; LOCKWOOD AH, 1971, P NATL ACAD SCI USA, V68, P3122, DOI 10.1073/pnas.68.12.3122; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Marzi S, 2003, RNA, V9, P958, DOI 10.1261/rna.2116303; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Montesano-Roditis L, 2001, J BIOL CHEM, V276, P14117, DOI 10.1074/jbc.M008430200; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; NYENGAARD NR, 1991, BIOCHEM BIOPH RES CO, V181, P1572, DOI 10.1016/0006-291X(91)92118-4; PETERSEN HU, 1979, BIOCHEM BIOPH RES CO, V91, P1068, DOI 10.1016/0006-291X(79)91989-2; PETERSEN HU, 1981, FEBS LETT, V128, P161, DOI 10.1016/0014-5793(81)81105-2; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; PON CL, 1986, FEBS LETT, V195, P215, DOI 10.1016/0014-5793(86)80163-6; PON CL, 1984, FEBS LETT, V175, P203, DOI 10.1016/0014-5793(84)80737-1; Rath BK, 2003, J STRUCT BIOL, V144, P95, DOI 10.1016/j.jsb.2003.09.029; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WAKAO H, 1989, J BIOL CHEM, V264, P20363; WAKAO H, 1990, BIOCHEMISTRY-US, V29, P8144, DOI 10.1021/bi00487a023; WEIEL J, 1982, J BIOL CHEM, V257, P1215; WINTERMEYER W, 1983, BIOCHEMISTRY-US, V22, P690, DOI 10.1021/bi00272a025; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; ZUCKER FH, 1986, BIOCHEMISTRY-US, V25, P3682, DOI 10.1021/bi00360a031	64	221	227	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	2005	121	5					703	712		10.1016/j.cell.2005.03.023	http://dx.doi.org/10.1016/j.cell.2005.03.023			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	933UI	15935757	Bronze			2022-12-01	WOS:000229658000009
J	Kural, C; Kim, H; Syed, S; Goshima, G; Gelfand, VI; Selvin, PR				Kural, C; Kim, H; Syed, S; Goshima, G; Gelfand, VI; Selvin, PR			Kinesin and dynein move a peroxisome in vivo: A tug-of-war or coordinated movement?	SCIENCE			English	Article							HAND-OVER-HAND; CYTOPLASMIC DYNEIN; ORGANELLE TRANSPORT; MOLECULAR MOTORS; PROTEINS; NEURONS; LOAD	We used fluorescence imaging with one nanometer accuracy (FIONA) to analyze organelle movement by conventional kinesin and cytoplasmic dynein in a cell. We located a green fluorescence protein (GFP)-tagged peroxisome in cultured Drosophila S2 cells to within 1.5 nanometers in 1.1 milliseconds, a 400-fold improvement in temporal resolution, sufficient to, determine the average step size to be similar to 8 nanometers for both dynein and kinesin. Furthermore, we found that dynein and kinesin do not work against each other in vivo during peroxisome transport. Rather, multiple kinesins or multiple dyneins work together, producing up to 10 times the in vitro speed.	Univ Illinois, Loomis Lab Phys, Ctr Biophys, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Francisco	Selvin, PR (corresponding author), Univ Illinois, Loomis Lab Phys, Ctr Biophys, 1110 W Green St, Urbana, IL 61801 USA.	selvin@uiuc.edu	Gelfand, Vladimir I/D-2545-2013; Gelfand, Vladimir/M-1974-2019	Gelfand, Vladimir I/0000-0002-6361-2798; Gelfand, Vladimir/0000-0002-6361-2798; Kural, Comert/0000-0002-9065-6542	NIAMS NIH HHS [AR44420] Funding Source: Medline; NIGMS NIH HHS [GM52111, GM 068625] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044420, R29AR044420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052111, R01GM068625, R55GM052111] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Ma YT, 2004, CURR BIOL, V14, P725, DOI 10.1016/j.cub.2004.03.061; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	23	464	480	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1469	1472		10.1126/science.1108408	http://dx.doi.org/10.1126/science.1108408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15817813				2022-12-01	WOS:000229619300054
J	Urnov, FD; Miller, JC; Lee, YL; Beausejour, CM; Rock, JM; Augustus, S; Jamieson, AC; Porteus, MH; Gregory, PD; Holmes, MC				Urnov, FD; Miller, JC; Lee, YL; Beausejour, CM; Rock, JM; Augustus, S; Jamieson, AC; Porteus, MH; Gregory, PD; Holmes, MC			Highly efficient endogenous human gene correction using designed zinc-finger nucleases	NATURE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA RECOGNITION; SITE; CLEAVAGE; SPECIFICITY; ACTIVATION; PROTEINS; THERAPY; REPAIR	Permanent modification of the human genome in vivo is impractical owing to the low frequency of homologous recombination in human cells, a fact that hampers biomedical research and progress towards safe and effective gene therapy. Here we report a general solution using two fundamental biological processes: DNA recognition by C2H2 zinc-finger proteins and homology-directed repair of DNA double-strand breaks. Zinc-finger proteins engineered to recognize a unique chromosomal site can be fused to a nuclease domain, and a double-strand break induced by the resulting zinc-finger nuclease can create specific sequence alterations by stimulating homologous recombination between the chromosome and an extrachromosomal DNA donor. We show that zinc-finger nucleases designed against an X-linked severe combined immune deficiency ( SCID) mutation in the IL2R gamma gene yielded more than 18% gene-modified human cells without selection. Remarkably, about 7% of the cells acquired the desired genetic modification on both X chromosomes, with cell genotype accurately reflected at the messenger RNA and protein levels. We observe comparably high frequencies in human T cells, raising the possibility of strategies based on zinc-finger nucleases for the treatment of disease.	Sangamo BioSci Inc, Richmond, CA 94804 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Sangamo Therapeutics, Inc.; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Holmes, MC (corresponding author), Sangamo BioSci Inc, Pt Richmond Tech Ctr 501,Canal Blvd,Suite A100, Richmond, CA 94804 USA.	matthew.porteus@UTSouthwestern.edu; mholmes@sangamo.com	Wilson, Matthew H/K-3193-2013	Rock, Jeremy/0000-0002-9310-951X; Urnov, Fyodor/0000-0001-7542-4084; Gregory, Philip/0000-0001-9249-2468				Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Buckley RH, 2000, NEW ENGL J MED, V343, P1313, DOI 10.1056/NEJM200011023431806; Bunz F, 2002, CANCER RES, V62, P1129; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KLUG A, 1993, GENE, V135, P83, DOI 10.1016/0378-1119(93)90052-5; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Persons Derek A, 2003, Curr Hematol Rep, V2, P348; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Schell T, 2002, GENOME BIOL, V3; SEDIVY JM, 1992, GENE TARGETING; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wilson JH, 2003, NAT BIOTECHNOL, V21, P759, DOI 10.1038/nbt0703-759; Yanez RJ, 1998, GENE THER, V5, P149, DOI 10.1038/sj.gt.3300601; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200	39	1174	1514	6	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					646	651		10.1038/nature03556	http://dx.doi.org/10.1038/nature03556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15806097				2022-12-01	WOS:000229476200043
J	Boucrot, E; Henry, T; Borg, JP; Gorvel, JP; Meresse, S				Boucrot, E; Henry, T; Borg, JP; Gorvel, JP; Meresse, S			The intracellular fate of Salmonella depends on the recruitment of kinesin	SCIENCE			English	Article							TYPHIMURIUM; PROTEIN; SIFA; IDENTIFICATION; EFFECTOR; DOMAINS; COMPLEX	Salmonella enterica causes a variety of diseases, including gastroenteritis and typhoid fever. The success of this pathogen depends on its capacity to proliferate within host cells in a membrane-bound compartment. We found that the Salmonella-containing vacuole recruited the plus-end-directed motor kinesin. Bacterial effector proteins translocated into the host cell by a type III secretion system antagonistically regulated this event. Among these effectors, SifA targeted SKIP, a host protein that down-regulated the recruitment of kinesin on the bacterial. vacuole and, in turn, controlled vacuolar membrane dynamics.	Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; Inst J Paoli I Calmettes, F-13009 Marseille, France; INSERM, UMR 599, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm)	Meresse, S (corresponding author), Univ Mediterranee, CNRS, INSERM, Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille, France.	meresse@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; Meresse, Stephane/E-2192-2012; Borg, Jean-Paul/AAX-8096-2020; Henry, Thomas/G-3160-2013	Gorvel, Jean-Pierre/0000-0002-2829-9804; Meresse, Stephane/0000-0001-6578-5177; Borg, Jean-Paul/0000-0001-8418-3382; Henry, Thomas/0000-0002-0687-8565				Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Clarke EJ, 2002, CURR BIOL, V12, pR596, DOI 10.1016/S0960-9822(02)01102-8; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Marsman M, 2004, MOL BIOL CELL, V15, P2954, DOI 10.1091/mbc.E03-08-0614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x	22	190	198	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1174	1178		10.1126/science.1110225	http://dx.doi.org/10.1126/science.1110225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905402				2022-12-01	WOS:000229293400045
J	Kustikova, O; Fehse, B; Modlich, U; Yang, M; Dullmann, J; Kamino, K; von Neuhoff, N; Schlegelberger, B; Li, ZX; Baum, C				Kustikova, O; Fehse, B; Modlich, U; Yang, M; Dullmann, J; Kamino, K; von Neuhoff, N; Schlegelberger, B; Li, ZX; Baum, C			Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking	SCIENCE			English	Article							CANCER; PROLIFERATION; THERAPY; MOUSE	Gene marking with replication-defective retroviral vectors has been used for more than 20 years to track the in vivo fate of cell clones. We demonstrate that retroviral integrations themselves may trigger nonmalignant clonal expansion in murine long-term hematopoiesis. All 29 insertions recovered from clones dominating in serially transplanted recipients affected loci with an established or potential role in the self-renewal or survival of hematopoietic stem cells. Transcriptional dysregulation occurred in all 12 insertion sites analyzed. These findings have major implications for diagnostic gene marking and the discovery of genes regulating stem cell turnover.	Hannover Med Sch, Dept Hematol Hemostaseol & Oncol, D-30625 Hannover, Germany; Hannover Med Sch, Inst Cellular & Mol Pathol, D-30625 Hannover, Germany; Univ Hosp Eppendorf, Inst Anat Expt Morphol 2, D-20251 Hamburg, Germany; Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA	Hannover Medical School; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Li, ZX (corresponding author), Hannover Med Sch, Dept Hematol Hemostaseol & Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	li.zhixiong@mh-hannover.de; baum.christopher@mh-hannover.de	Fehse, Boris/A-8721-2012	Fehse, Boris/0000-0001-9780-7211; Modlich, Ute/0000-0001-8018-4118				Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Brenner MK, 2003, CYTOTHERAPY, V5, P190, DOI 10.1080/14653240310001307; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Fehse B, 2000, MOL THER, V1, P448, DOI 10.1006/mthe.2000.0068; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kohn DB, 2003, MOL THER, V8, P180, DOI 10.1016/S1525-0016(03)00212-0; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lemischka IR, 2001, NAT IMMUNOL, V2, P11, DOI 10.1038/83115; Li Z, 2002, LEUKEMIA, V16, P1655, DOI 10.1038/sj.leu.2402619; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101	27	276	296	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1171	1174		10.1126/science.1105063	http://dx.doi.org/10.1126/science.1105063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905401				2022-12-01	WOS:000229293400044
J	Aluwihare, LI; Repeta, DJ; Pantoja, S; Johnson, CG				Aluwihare, LI; Repeta, DJ; Pantoja, S; Johnson, CG			Two chemically distinct pools of organic nitrogen accumulate in the ocean	SCIENCE			English	Article							PACIFIC SUBTROPICAL GYRE; MARINE-BACTERIA; AMINO-ACIDS; SEA-WATER; MATTER; PROTEIN; SAMPLES; PROTEOBACTERIA; CHROMATOGRAPHY; PARTICULATE	The chemical dynamics of marine dissolved organic nitrogen (DON), a reservoir featuring surface accumulations even in areas where nitrogen limits productivity, have yet to be resolved. We exploited differences in the acid lability of amide bonds within high-molecular-weight (HMW) DON to show that vertical DON profiles result in part from the presence of two chemically distinct pools of amide. Half of HMWDON in surface waters is present as N-acetyl amino polysaccharides. In contrast, nearly all deep-sea HMWDON, and therefore, most HMWDON, is present in amides that resist both chemical hydrolysis and biological degradation.	Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Concepcion, Dept Oceanog, Concepcion, Chile; Univ Concepcion, FONDAP, Ctr Invest Oceanog Pacifico SurOriental, Concepcion, Chile	University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution; Universidad de Concepcion; Universidad de Concepcion	Aluwihare, LI (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA.	laluwihare@ucsd.edu						Abell J, 2000, J MAR RES, V58, P203, DOI 10.1357/002224000321511142; Albert DB, 1997, MAR CHEM, V56, P27, DOI 10.1016/S0304-4203(96)00083-7; Aluwihare LI, 2002, DEEP-SEA RES PT II, V49, P4421, DOI 10.1016/S0967-0645(02)00124-8; Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Boon JJ, 1998, ORG GEOCHEM, V29, P1051, DOI 10.1016/S0146-6380(98)00121-1; BRONK DA, 2002, BIOGEOCHEMISTRY MARI, P163; Church MJ, 2002, LIMNOL OCEANOGR, V47, P1, DOI 10.4319/lo.2002.47.1.0001; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P1195, DOI 10.1128/AEM.66.3.1195-1201.2000; HADJA O, 1974, ANAL BIOCHEM, V60, P512; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HENRICHS SM, 1985, MAR CHEM, V17, P141, DOI 10.1016/0304-4203(85)90070-2; Kaiser K, 2000, ANAL CHEM, V72, P2566, DOI 10.1021/ac991407t; KEIL RG, 1994, MAR CHEM, V45, P187, DOI 10.1016/0304-4203(94)90002-7; Knicker H, 1997, NATURWISSENSCHAFTEN, V84, P231, DOI 10.1007/s001140050384; Leenheer JA, 2004, BIOGEOCHEMISTRY, V69, P125, DOI 10.1023/B:BIOG.0000031044.16410.27; Libby PS, 1997, DEEP-SEA RES PT I, V44, P345; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Nagata Y, 1998, BBA-GEN SUBJECTS, V1379, P76, DOI 10.1016/S0304-4165(97)00084-6; Palenik B, 1997, LIMNOL OCEANOGR, V42, P1544, DOI 10.4319/lo.1997.42.7.1544; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Svitil AL, 1998, MICROBIOL-SGM, V144, P1299, DOI 10.1099/00221287-144-5-1299; TANOUE E, 1995, GEOCHIM COSMOCHIM AC, V59, P2643, DOI 10.1016/0016-7037(95)00134-4; ZHAO MX, 1995, J CHROMATOGR A, V690, P55, DOI 10.1016/0021-9673(94)00927-2	28	136	137	6	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1007	1010		10.1126/science.1108925	http://dx.doi.org/10.1126/science.1108925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890880				2022-12-01	WOS:000229190700042
J	Sobel, RK				Sobel, RK			MSL - Medicine as a second language	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sobel, RK (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Harber RJ, 2001, J GEN INTERN MED, V16, P308, DOI 10.1046/j.1525-1497.2001.00233.x	1	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1945	1946		10.1056/NEJMp048342	http://dx.doi.org/10.1056/NEJMp048342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888692				2022-12-01	WOS:000229017100002
J	Durr, H; Korner, C; Muller, M; Hickmann, V; Hopfner, KP				Durr, H; Korner, C; Muller, M; Hickmann, V; Hopfner, KP			X-ray structures of the Sulfolobus solfataricus SWI2/SNF2 ATPase core and its complex with DNA	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; CRYSTAL-STRUCTURE; SUPERHELICAL TORSION; FUNCTIONAL-ANALYSIS; NUCLEOSOME; HELICASE; REPAIR; RAD54; RECOMBINATION; TRANSCRIPTION	SWI2/SNF2 ATPases remodel chromatin or other DNA:protein complexes by a poorly understood mechanism that involves ATP-dependent DNA translocation and generation of superhelical torsion. Crystal structures of a dsDNA-translocating SWI2/SNF2 ATPase core from Sulfolobus solfataricus reveal two helical SWI2/SNF2 specific subdomains, fused to a DExx box helicase-related ATPase core. Fully base paired duplex DNA binds along a central cleft via both minor groove strands, indicating that SWI2/SNF2 ATPases travel along the dsDNA minor groove without strand separation. A structural switch, linking DNA binding and the active site DExx motif, may account for the stimulation of ATPase activity by dsDNA. Our results suggest that torque in remodeling processes is generated by an ATP-driven screw motion of DNA along the active site cleft. The structures also redefine SWI2/SNF2 functional motifs and uncover unexpected structural correlation of mutations in Cockayne and X-linked mental retardation syndromes.	Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357; Hickmann, Volker/0000-0003-2625-0414				Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Asturias FJ, 2004, METHOD ENZYMOL, V376, P48; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Manzan A, 2004, EMBO REP, V5, P54, DOI 10.1038/sj.embor.7400037; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Owen-Hughes T, 2003, BIOCHEM SOC T, V31, P893; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TURCK D, 1992, THESIS TECHNICAL U M; van den Boom V, 2002, BIOESSAYS, V24, P780, DOI 10.1002/bies.10150; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yu SR, 2004, DNA REPAIR, V3, P277, DOI 10.1016/j.dnarep.2003.11.004; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	56	209	213	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					363	373		10.1016/j.cell.2005.03.026	http://dx.doi.org/10.1016/j.cell.2005.03.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882619	Bronze, Green Submitted			2022-12-01	WOS:000229031600007
J	Cauley, JA; Lui, LY; Ensrud, KE; Zmuda, JM; Stone, KL; Hochberg, MC; Cummings, SR				Cauley, JA; Lui, LY; Ensrud, KE; Zmuda, JM; Stone, KL; Hochberg, MC; Cummings, SR			Bone mineral density and the risk of incident nonspinal fractures in black and white women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OSTEOPOROTIC FRACTURES; AFRICAN-AMERICAN; VOLUMETRIC DENSITY; RACIAL-DIFFERENCES; OLDER WOMEN; MASS; AGE; PREDICTION; CURVES	Context Black women have a lower rate of fracture than white women, but whether bone mineral density (BMD) predicts fracture risk as well in black women as it does in white women is not established. Objective To examine the association between BMD and incident nonspinal fractures in older black and white women. Design, Setting, and Participants Prospective cohort study of baseline data collected from 1986 through 1990 (7334 white women aged 67-99 years) and from 1996 through 1998 (636 black women aged 65-94 years) at 4 US clinical centers in the Study of Osteoporotic Fractures; mean (SD) follow-up of 6.1 (1.5) years until October 1, 2004. Main Outcome Measures Incident nonspinal fractures were confirmed by radiograpic report. Total hip and femoral neck BMD and bone mineral content were measured by dual energy x-ray absorptiometry. Results A total of 58 black women had a combined total of 61 fractures and 1606 white women had a combined total of 1712 fractures. In age-adjusted proportional hazard models, a 1-SD decrease in femoral neck BMD was associated with a 37% increased risk of fracture in black women (relative risk [RR], 1.37; 95% confidence interval [CI], 1.08-1.74) and a 49% increase in fracture in white women (RR, 1.49; 95% Cl, 1.40-1.58). Adjustment for body weight and other risk factors for fracture weakened the association between BMD and fracture, especially among black women (multivariable adjusted RR per 1-SD decrease in femoral neck BMD for black vs white women: RR, 1.20 [95% Cl, 0.93-1.55) vs RR, 1.42 [95% Cl, 1.32-1.52]). The absolute incidence of fracture across the pooled BMD distribution was 30% to 40% lower among black women at every BMD tertile. The lower risk of fracture among black compared with white women was independent of BMD and other risk factors (RR, 0.48; 95% Cl, 0.36-0.64). Conclusions Decreased total hip and femoral neck BMD is associated with an increased risk of fracture in both older black and white women, but this relationship was largely explained by other risk factors in black women. Black women have a lower fracture risk than white women at every level of BMD. Race-specific normative data-bases may be appropriate for the densitometric definition of osteoporosis.	Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Minnesota, Vet Affairs Med Ctr, Minneapolis, MN USA; Univ Minnesota, Dept Med & Epidemiol, Minneapolis, MN USA; Univ Maryland, Dept Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA; Univ Maryland, Dept Prevent Med, Baltimore, MD 21201 USA; Calif Pacific Med Ctr, San Francisco, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; California Pacific Medical Center	Cauley, JA (corresponding author), Univ Pittsburgh, Dept Epidemiol, 130 DeSoto St,Crabtree Hall A543, Pittsburgh, PA 15261 USA.	jcauley@pitt.edu	YAMAMOTO, MASAHIRO/F-9094-2011; Cauley, Jane A/N-4836-2015	YAMAMOTO, MASAHIRO/0000-0003-3859-0125; Cauley, Jane A/0000-0003-0752-4408; Ensrud, Kristine/0000-0002-9069-3036	NIAMS NIH HHS [AR35584, AR35583, AR35582, AR44811] Funding Source: Medline; NIA NIH HHS [AG05407] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035583, R01AR035582, R01AR035584, P60AR044811] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; BARON JA, 1994, EPIDEMIOLOGY, V5, P42, DOI 10.1097/00001648-199401000-00008; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Binkley Neil C, 2002, J Clin Densitom, V5 Suppl, pS19, DOI 10.1385/JCD:5:3S:S19; BLACK DM, 1992, J BONE MINER RES, V7, P633; BLOCK G, 1992, J AM DIET ASSOC, V92, P969; Bohannon AD, 1999, AM J EPIDEMIOL, V149, P1002; Cauley JA, 1997, OSTEOPOROSIS INT, V7, P100, DOI 10.1007/BF01623683; Cauley JA, 2005, J AM GERIATR SOC, V53, P183, DOI 10.1111/j.1532-5415.2005.53101.x; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; CUMMINGS SR, 1994, OSTEOPOROSIS INT, V4, P226, DOI 10.1007/BF01623243; CUMMINGS SR, 1994, J BONE MINER RES, V9, P1429; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3051, DOI 10.1210/jc.87.7.3051; GRISSO JA, 1994, NEW ENGL J MED, V330, P1555, DOI 10.1056/NEJM199406023302202; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; KLEEREKOPER M, 1994, J BONE MINER RES, V9, P1267; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Robbins J, 2004, J NATL MED ASSOC, V96, P1609; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; STEIGER P, 1992, J BONE MINER RES, V7, P625; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; *US DEP HHS, 2004, BONE HLTH OST REP SU; Zmuda JM, 1999, GENET EPIDEMIOL, V16, P356, DOI 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I	35	194	204	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2102	2108		10.1001/jama.293.17.2102	http://dx.doi.org/10.1001/jama.293.17.2102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870413	Bronze, Green Published			2022-12-01	WOS:000228808200019
J	Ma, L; Chen, ZB; Erdjument-Bromage, H; Tempst, P; Pandolfi, PP				Ma, L; Chen, ZB; Erdjument-Bromage, H; Tempst, P; Pandolfi, PP			Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis	CELL			English	Article							INITIATION-FACTOR 4E; P70 S6 KINASE; TUMOR-SUPPRESSOR PROTEINS; CELL-GROWTH; MAP KINASE; GENE-PRODUCTS; IN-VIVO; TRANSLATIONAL CONTROL; 3-KINASE/AKT PATHWAY; SIGNALING PATHWAY	Tuberous sclerosis (TSC) is a tumor syndrome caused by mutation in TSC1 or TSC2genes. TSC tumorigenesis is not always accompanied by loss of heterozygosity (LOH). Recently, extracellular signal-regulated kinase (Erk) has been found activated in TSC lesions lacking TSC1 or TSC2 LOH. Here, we show that Erk may play a critical role in TSC progression through posttranslational inactivation of TSC2. Erk-dependent phosphorylation leads to TSC1-TSC2 dissociation and markedly impairs TSC2 ability to inhibit mTOR signaling, cell proliferation, and oncogenic transformation. Importantly, expression of an Erk nonphosphorylatable TSC2 mutant in TSC2(+/-) tumor cells where Erk is constitutively activated blocks tumori-genecity in vivo, while wild-type TSC2 is ineffective. Our findings position the Ras/MAPK pathway upstream of the TSC complex and suggest that Erk may modulate mTOR signaling and contribute to disease progression through phosphorylation and inactivation of TSC2.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Physiol Biophys & Syst Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Ma, Li/GQR-1313-2022	Ma, Li/0000-0001-9965-989X; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	NATIONAL CANCER INSTITUTE [P30CA008748, U01CA084292] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA08748, U01 CA-84292] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gomez M., 1999, TUBEROUS SCLEROSIS C; Gomez MR, 1988, TUBEROUS SCLEROSIS; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Govindarajan B, 2003, CLIN CANCER RES, V9, P3469; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Henske EP, 1996, AM J HUM GENET, V59, P400; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kobayashi T, 1999, CANCER RES, V59, P1206; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plank TL, 1998, CANCER RES, V58, P4766; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shah OJ, 2002, BIOCHEM J, V366, P57, DOI 10.1042/bj20020198; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	60	974	1009	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					179	193		10.1016/j.cell.2005.02.031	http://dx.doi.org/10.1016/j.cell.2005.02.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851026	Bronze			2022-12-01	WOS:000228705000007
J	Okie, S				Okie, S			Physician-assisted suicide - Oregon and beyond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		COLBURN D, 2005, OREGONIAN       0304, pA1; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Tolle SW, 2004, J CLIN ETHIC, V15, P111	3	23	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1627	1630		10.1056/NEJMp058004	http://dx.doi.org/10.1056/NEJMp058004			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843663				2022-12-01	WOS:000228515200001
J	Weil, M; Bressler, J; Parsons, P; Bolla, K; Glass, T; Schwartz, B				Weil, M; Bressler, J; Parsons, P; Bolla, K; Glass, T; Schwartz, B			Blood mercury levels and neurobehavioral function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; FATTY-ACIDS; METHYLMERCURY; POPULATION; PERFORMANCE; PRESSURE; EXPOSURE; HEALTH	Context Due to its cardiovascular benefits, fish consumption is widely encouraged among older Americans. However, this fast-growing population is at increased risk of cognitive impairment and may be particularly sensitive to methylmercury, a neurotoxicant found in fish. Objective To describe associations of blood mercury levels with neurobehavioral test scores in an urban adult population. Design, Setting, and Participants Cross-sectional analysis to determine the effect of mercury levels on neurobehavior in 474 randomly selected participants in the Baltimore Memory Study, a longitudinal study of cognitive decline involving 1140 Baltimore residents aged 50 to 70 years. We measured total mercury in whole blood samples and used multiple linear regression to examine its associations with neurobehavioral test scores. First-visit data were obtained in 2001-2002. Main Outcome Measures Twenty scores from 12 neurobehavioral tests. Results The median blood mercury level was 2.1 mu g/L (range, 0-16 mu g/L). After adjustment for covariates, increasing blood mercury was associated with worse performance on Rey complex figure delayed recall, a test of visual memory (beta, -0.224; 95% confidence interval, -0.402 to -0.047). However, increasing blood mercury levels were associated with better performance on finger tapping, a test of manual dexterity (beta for dominant hand, 0.351; 95% confidence interval, 0.017-0.686). Conclusion Overall, the data do not provide strong evidence that blood mercury levels are associated with worse neurobehavioral performance in this population of older urban adults.	Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Kennedy Krieger Inst, Baltimore, MD USA; New York State Dept Hlth, Wadsworth Ctr, Trace Met Lab, Albany, NY USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kennedy Krieger Institute; State University of New York (SUNY) System; Wadsworth Center	Weil, M (corresponding author), Assoc State & Terr Hlth Officials, 1275 K St NW,Suite 800, Washington, DC 20005 USA.	mweil@jhsph.edu	Parsons, Patrick/ABE-2655-2020; Parsons, Patrick J/I-2985-2015	Parsons, Patrick/0000-0001-9133-875X; Parsons, Patrick J/0000-0001-9133-875X; Glass, Thomas/0000-0003-4399-612X	NATIONAL INSTITUTE ON AGING [R01AG019604] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG19604] Funding Source: Medline; NIEHS NIH HHS [ES-07141] Funding Source: Medline; ODCDC CDC HHS [T42/CCT310419] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ODCDC CDC HHS		Agency for Toxic Substances and Disease Registry, 1999, TOX PROF MERC UPD; Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168; *AM DIAB ASS, SPEC TYP FAT; Bannon DI, 2001, CLIN CHEM, V47, P1703; Barbosa F, 2004, J ANAL ATOM SPECTROM, V19, P1000, DOI 10.1039/b400315b; Beuter A, 1998, NEUROTOXICOL TERATOL, V20, P581, DOI 10.1016/S0892-0362(98)00021-X; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Block G., 1998, REVISION BLOCK DIETA; *BMDP STAT SOFTW I, 1991, POW AN SOLO; Breteler MMB, 1998, HAEMOSTASIS, V28, P167; CALNE DB, 1986, LANCET, V2, P1067, DOI 10.1016/S0140-6736(86)90469-1; *CDCP, 2003, 2 NAT CTR ENV HLTH; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dolbec J, 2000, INT ARCH OCC ENV HEA, V73, P195, DOI 10.1007/s004200050027; Eto K, 2000, NEUROPATHOLOGY, V20, pS14; Ferraro FR, 2002, BRAIN COGNITION, V50, P139; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; GORMAN J, 2003, NY TIMES F      0729, P5; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Halstead WC, 1985, HALSTEADREITAN NEURO; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hightower JM, 2003, ENVIRON HEALTH PERSP, V111, P604, DOI 10.1289/ehp.5837; Johansson N, 2002, BIOMETALS, V15, P189, DOI 10.1023/A:1015202301127; JONES DP, 1992, NUTR CANCER, V17, P57, DOI 10.1080/01635589209514173; Kales SN, 2002, J OCCUP ENVIRON MED, V44, P143, DOI 10.1097/00043764-200202000-00009; Kaplan EF., 2001, BOSTON NAMING TEST; KAPUR N, 1977, J STUD ALCOHOL, V38, P2025, DOI 10.15288/jsa.1977.38.2025; KERSHAW TG, 1980, ARCH ENVIRON HEALTH, V35, P28; Kleinbaum D.G., 1988, APPL REGRESSION ANAL; *LAF INSTR CO, 1999, 32020 LAF INSTR CO; Lebel J, 1996, NEUROTOXICOLOGY, V17, P157; Lebel J, 1998, ENVIRON RES, V79, P20, DOI 10.1006/enrs.1998.3846; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; MacKay AJ, 2002, J INT NEUROPSYCH SOC, V8, P764, DOI 10.1017/S1355617702860040; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; National Academy of Sciences, 2000, TOX EFF METH; PHELPS RW, 1980, ARCH ENVIRON HEALTH, V35, P161, DOI 10.1080/00039896.1980.10667486; PLAISIER MK, 2005, COMMUNICATION   0131; RAINES B, 2003, HEALTH, P120; Raven J. C., 1965, COLOURED PROGR MATRI; RAVEN JC, 1965, MANUAL RAVENS COLOUR; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Rice DC, 1996, NEUROTOXICOLOGY, V17, P583; Sadowski M, 2004, NEUROCHEM RES, V29, P1257, DOI 10.1023/B:NERE.0000023612.66691.e6; Schafer JH, 2005, J AM GERIATR SOC, V53, P381, DOI 10.1111/j.1532-5415.2005.53153.x; Schmidt M., 1996, REY AUDITORY VERBAL; Schober SE, 2003, JAMA-J AM MED ASSOC, V289, P1667, DOI 10.1001/jama.289.13.1667; Schwartz BS, 2004, ENVIRON HEALTH PERSP, V112, P314, DOI 10.1289/ehp.6727; SIMON JA, 1995, AM J EPIDEMIOL, V142, P469, DOI 10.1093/oxfordjournals.aje.a117662; Skoog I, 1997, BIOMED PHARMACOTHER, V51, P367, DOI 10.1016/S0753-3322(97)89428-0; Starr JM, 1999, CURR OPIN NEPHROL HY, V8, P347, DOI 10.1097/00041552-199905000-00012; UCHINO M, 1995, J ENVIRON SCI HEAL B, V30, P699, DOI 10.1080/03601239509372961; *US EPA, 2003, MERC FREQ ASK QUEST; *US EPA, NAT LIST FISH ADV FA; US FDA, 2001, RAT ISS REV ADV METH; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; VALCIUKAS JA, 1980, ENVIRON RES, V21, P275, DOI 10.1016/0013-9351(80)90029-8; WEAVER V, 2003, J HOPK BLOOMB SCH PU; Weiss B, 2002, ENVIRON HEALTH PERSP, V110, P851, DOI 10.1289/ehp.02110s5851; Weiss B, 1996, NEUROTOXICOLOGY, V17, P257; WHO, 1990, METH; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409; Yokoo Edna M, 2003, Environ Health, V2, P8, DOI 10.1186/1476-069X-2-8	64	69	76	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1875	1882		10.1001/jama.293.15.1875	http://dx.doi.org/10.1001/jama.293.15.1875			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916QW	15840862	Bronze			2022-12-01	WOS:000228401700026
J	Mistry, AR; Felix, CA; Whitmarsh, RJ; Mason, A; Reiter, A; Cassinat, B; Parry, A; Walz, C; Wiemels, JL; Segal, MR; Ades, L; Blair, IA; Osheroff, N; Peniket, AJ; Lafage-Pochitaloff, M; Cross, NCP; Chomienne, C; Solomon, E; Fenaux, P; Grimwade, D				Mistry, AR; Felix, CA; Whitmarsh, RJ; Mason, A; Reiter, A; Cassinat, B; Parry, A; Walz, C; Wiemels, JL; Segal, MR; Ades, L; Blair, IA; Osheroff, N; Peniket, AJ; Lafage-Pochitaloff, M; Cross, NCP; Chomienne, C; Solomon, E; Fenaux, P; Grimwade, D			DNA topoisomerase II in therapy-related acute promyelocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAKPOINT CLUSTER REGION; BALANCED CHROMOSOME-ABERRATIONS; ACUTE MYELOID-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; INTERNATIONAL WORKSHOP; TRANSLOCATION BREAKPOINTS; SECONDARY LEUKEMIA; CLEAVAGE; MLL; INHIBITORS	Background Chromosomal translocations leading to chimeric oncoproteins are important in leukemogenesis, but how they form is unclear. We studied acute promyelocytic leukemia (APL) with the t(15;17) translocation that developed after treatment of breast or laryngeal cancer with chemotherapeutic agents that poison topoisomerase II. Methods We used long-range polymerase chain reaction and sequence analysis to characterize t(15;17) genomic breakpoints in therapy-related APL. To determine whether topoisomerase II was directly involved in mediating breaks of double-stranded DNA at the observed translocation breakpoints, we used a functional in vitro assay to examine topoisomerase II-mediated cleavage in the normal homologues of the PML and RARA breakpoints. Results Translocation breakpoints in APL that developed after exposure to mitoxantrone, a topoisomerase II poison, were tightly clustered in an 8-bp region within PML intron 6. In functional assays, this ``hot spot'' and the corresponding RARA breakpoints were common sites of mitoxantrone-induced cleavage by topoisomerase II. Etoposide and doxorubicin also induced cleavage by topoisomerase II at the translocation breakpoints in APL arising after exposure to these agents. Short, homologous sequences in PML and RARA suggested the occurrence of DNA repair by means of the nonhomologous end-joining pathway. Conclusions Drug-induced cleavage of DNA by topoisomerase II mediates the formation of chromosomal translocation breakpoints in mitoxantrone-related APL and in APL that occurs after therapy with other topoisomerase II poisons.	Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England; Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Heidelberg, Fak Klin Med Mannheim, D-6800 Mannheim, Germany; Hop St Louis, Nucl Med Serv, Unite Biol Cellulaire, Paris, France; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Paris 13, Hop Avicenne, Bobigny, France; Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England; Inst J Paoli I Calmettes, INSERM, UMR 599, F-13009 Marseille, France; Univ Aix Marseille 2, Marseille, France; Wessex Reg Genet Lab, Salisbury, Wilts, England; UCL Hosp, Dept Haematol, London, England	University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; Vanderbilt University; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; University College London Hospitals NHS Foundation Trust; University of London; University College London	Mistry, AR (corresponding author), Guys Hosp, Dept Med & Mol Genet, Canc Genet Lab, 8th Fl,Guys Tower, London SE1 9RT, England.	david.grimwade@genetics.kcl.ac.uk	Cross, Nicholas/B-4817-2009; Ades, lionel/T-6882-2019; Blair, Ian A/B-3320-2010; CASSINAT, BRUNO/N-2752-2017	Cross, Nicholas/0000-0001-5481-2555; CASSINAT, BRUNO/0000-0002-6514-3905; CHOMIENNE, Christine/0000-0001-5513-5752	NCI NIH HHS [R01 CA80175, CA89032, R01 CA77683] Funding Source: Medline; NIGMS NIH HHS [GM33944] Funding Source: Medline; PHS HHS [R0185469] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089032, R01CA077683, R01CA080175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahuja HG, 2000, GENE CHROMOSOME CANC, V29, P96, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1013>3.0.CO;2-T; Andersen MK, 2002, GENE CHROMOSOME CANC, V33, P395, DOI 10.1002/gcc.10043; Aplan PD, 1996, BLOOD, V87, P2649, DOI 10.1182/blood.V87.7.2649.bloodjournal8772649; Beaumont M, 2003, J CLIN ONCOL, V21, P2123, DOI 10.1200/JCO.2003.09.072; Betti CJ, 2003, CANCER RES, V63, P1377; Betti CJ, 2001, CANCER RES, V61, P4550; Bloomfield CD, 2002, GENE CHROMOSOME CANC, V33, P362, DOI 10.1002/gcc.10046; Carli PM, 2000, LEUKEMIA, V14, P1014, DOI 10.1038/sj.leu.2401787; DOMER PH, 1995, LEUKEMIA, V9, P1305; DONG S, 1993, GENE CHROMOSOME CANC, V6, P133, DOI 10.1002/gcc.2870060302; Eguchi-Ishimae M, 2001, BLOOD, V97, P737, DOI 10.1182/blood.V97.3.737; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; GLAZ J, 1991, ADV APPL PROBAB, V23, P751; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2001, BEST PRACT RES CL HA, V14, P497, DOI 10.1053/beha.2001.0152; Grimwade D, 1996, BRIT J HAEMATOL, V94, P557; Kudo K, 1998, LEUKEMIA, V12, P1171, DOI 10.1038/sj.leu.2401089; Lovett BD, 2001, BIOCHEMISTRY-US, V40, P1159, DOI 10.1021/bi002361x; Lovett BD, 2001, P NATL ACAD SCI USA, V98, P9802, DOI 10.1073/pnas.171309898; Megonigal MD, 2000, P NATL ACAD SCI USA, V97, P2814, DOI 10.1073/pnas.050397097; Mistry AR, 2003, BLOOD REV, V17, P71, DOI 10.1016/S0268-960X(02)00075-9; NEGRINI M, 1993, CANCER RES, V53, P4489; PEDERSENBJERGAARD, 2002, BLOOD, V99, P1909; PEDERSENBJERGAARD, 1994, BLOOD, V83, P2780; Piazza F, 2001, ONCOGENE, V20, P7216, DOI 10.1038/sj.onc.1204855; Pulsoni A, 2002, BLOOD, V100, P1972, DOI 10.1182/blood-2001-12-0312; Reiter A, 2003, GENE CHROMOSOME CANC, V36, P175, DOI 10.1002/gcc.10154; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rowley JD, 2002, GENE CHROMOSOME CANC, V33, P331, DOI 10.1002/gcc.10040; Segal MR, 2002, J AM STAT ASSOC, V97, P66, DOI 10.1198/016214502753479239; Smith MA, 1999, J CLIN ONCOL, V17, P569, DOI 10.1200/JCO.1999.17.2.569; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Strissel PL, 1998, BLOOD, V92, P3793, DOI 10.1182/blood.V92.10.3793.422a24_3793_3803; Whitmarsh RJ, 2003, ONCOGENE, V22, P8448, DOI 10.1038/sj.onc.1207052; Zhang YM, 2002, P NATL ACAD SCI USA, V99, P3070, DOI 10.1073/pnas.042702899	38	213	218	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2005	352	15					1529	1538		10.1056/NEJMoa042715	http://dx.doi.org/10.1056/NEJMoa042715			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915SH	15829534				2022-12-01	WOS:000228324200005
J	Lima, SQ; Miesenbock, G				Lima, SQ; Miesenbock, G			Remote control of behavior through genetically targeted photostimulation of neurons	CELL			English	Article							DROSOPHILA NERVOUS-SYSTEM; ION CHANNELS; GIANT-FIBER; CAPSAICIN RECEPTOR; IDENTIFIED NEURONS; MAMMALIAN NEURONS; EXPRESSION; MELANOGASTER; DOPAMINE; MUTATIONS	Optically gated ion channels were expressed in circumscribed groups of neurons in the Drosophila CNS so that broad illumination of flies evoked action potentials only in genetically designated target cells. Flies harboring the "phototriggers" in different sets of neurons responded to laser light with behaviors specific to the sites of phototrigger expression. Photostimulation of neurons in the giant fiber system elicited the characteristic escape behaviors of jumping, wing beating, and flight; photostimulation of dopaminergic neurons caused changes in locomotor activity and locomotor patterns. These responses reflected the direct optical activation of central neuronal targets rather than confounding visual input, as they persisted unabated in carriers of a mutation that eliminates phototransduction. Encodable phototriggers provide noninvasive control interfaces for studying the connectivity and dynamics of neural circuits, for assigning behavioral content to neurons and their activity patterns, and, potentially, for restoring information corrupted by injury or disease.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Miesenbock, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	gero.miesenboeck@yale.edu		Lima, Susana/0000-0003-2446-9869; Miesenboeck, Gero/0000-0003-2940-3228				Allen MJ, 1999, J NEUROSCI, V19, P9374; ARBUTHNOTT GW, 1975, EXP NEUROL, V47, P162, DOI 10.1016/0014-4886(75)90244-7; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BROADIE KS, 2000, DROSOPHILA PROTOCOLS, P273; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Burrows M, 1996, NEUROBIOLOGY INSECT; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; FARBER IC, 1983, SCIENCE, V222, P1025, DOI 10.1126/science.6648515; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FORK RL, 1971, SCIENCE, V171, P907, DOI 10.1126/science.171.3974.907; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; GALVANI L, 1791, DEVIRIBUS ELECT MOTU; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Jacobs K, 2000, DEVELOPMENT, V127, P5203; Johns DC, 1999, J NEUROSCI, V19, P1691; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOTO M, 1981, BRAIN RES, V221, P213, DOI 10.1016/0006-8993(81)90772-1; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Kupfermann I, 2001, CURR OPIN NEUROBIOL, V11, P673, DOI 10.1016/S0959-4388(01)00267-7; Lechner HAE, 2002, J NEUROSCI, V22, P5287; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.bb.18.060189.001323; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Nakayama S, 1997, MOL GEN GENET, V254, P449, DOI 10.1007/s004380050438; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; QUINN WG, 1984, ANNU REV NEUROSCI, V7, P67, DOI 10.1146/annurev.ne.07.030184.000435; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SELVERSTON AI, 1985, ANNU REV PHYSIOL, V47, P29; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Slimko EM, 2002, J NEUROSCI, V22, P7373; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THOMAS JB, 1982, NATURE, V298, P650, DOI 10.1038/298650a0; THOMAS JB, 1984, J NEUROSCI, V4, P530; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trimarchi JR, 1999, INT REV NEUROBIOL, V43, P241, DOI 10.1016/S0074-7742(08)60548-6; TRIMARCHI JR, 1995, J COMP PHYSIOL A, V176, P355, DOI 10.1007/BF00219061; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; Wyman R.J., 1984, P133; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zemelman BV, 2001, CURR OPIN NEUROBIOL, V11, P409, DOI 10.1016/S0959-4388(00)00227-0	69	382	425	1	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					141	152		10.1016/j.cell.2005.02.004	http://dx.doi.org/10.1016/j.cell.2005.02.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820685	Bronze			2022-12-01	WOS:000228348500016
J	Pan, H; Yan, BS; Rojas, M; Shebzukhov, YV; Zhou, HW; Kobzik, L; Higgins, DE; Daly, MJ; Bloom, BR; Kramnik, I				Pan, H; Yan, BS; Rojas, M; Shebzukhov, YV; Zhou, HW; Kobzik, L; Higgins, DE; Daly, MJ; Bloom, BR; Kramnik, I			Ipr1 gene mediates innate immunity to tuberculosis	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RECEPTOR; MICE; INFECTION; PROTEIN; SUSCEPTIBILITY; SUBSTRAINS; EXPRESSION; RESISTANCE; EVOLUTION	An estimated eight million people are infected each year with the pathogen Mycobacterium tuberculosis, and more than two million die annually(1). Yet only about 10% of those infected develop tuberculosis. Genetic variation within host populations is known to be significant in humans and animals(2,3), but the nature of genetic control of host resistance to tuberculosis remains poorly understood. Previously we mapped a new genetic locus on mouse chromosome 1, designated sst1 (for supersusceptibility to tuberculosis 1)(4). Here we show that this locus mediates innate immunity in sst1 congenic mouse strains and identify a candidate gene, Intracellular pathogen resistance 1 (Ipr1), within the sst1 locus. The Ipr1 gene is upregulated in the sst1 resistant macrophages after activation and infection, but it is not expressed in the sst1 susceptible macrophages. Expression of the Ipr1 transgene in the sst1 susceptible macrophages limits the multiplication not only of M. tuberculosis but also of Listeria monocytogenes and switches a cell death pathway of the infected macrophages from necrosis to apoptosis. Our data indicate that the Ipr1 gene product might have a previously undocumented function in integrating signals generated by intracellular pathogens with mechanisms controlling innate immunity, cell death and pathogenesis.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Physiol Program, Boston, MA 02115 USA; Univ Antioquia, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Universidad de Antioquia; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Kramnik, I (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 667 Huntington Ave, Boston, MA 02115 USA.	ikramnik@hsph.harvard.edu	Daly, Mark J/B-2453-2017; Rojas Lopez, Mauricio/P-4924-2018	Daly, Mark J/0000-0002-0949-8752; Yan, Bo-Shiun/0000-0002-9613-4788; Kramnik, Igor/0000-0001-6511-9246; Rojas Lopez, Mauricio/0000-0002-7791-9328	NIAID NIH HHS [R01 AI049421] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049421] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGULNIK S, 1993, MAMM GENOME, V4, P704, DOI 10.1007/BF00357793; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Bleed D, 2000, Curr Opin Pulm Med, V6, P174, DOI 10.1097/00063198-200005000-00002; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Bloom BR, 2002, NEW ENGL J MED, V346, P1434, DOI 10.1056/NEJM200205093461902; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Boyartchuk V, 2004, J IMMUNOL, V173, P5112, DOI 10.4049/jimmunol.173.8.5112; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; KADEREIT S, 1993, J BIOL CHEM, V268, P24432; Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003; Kramnik I, 1998, NOVART FDN SYMP, V217, P120, DOI 10.1002/0470846526.ch9; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; KROG HH, 1978, J HERED, V69, P66, DOI 10.1093/oxfordjournals.jhered.a108905; Lo Surdo P, 2003, MOL ENDOCRINOL, V17, P1283, DOI 10.1210/me.2002-0409; Nicewonger J, 2004, J VIROL, V78, P9412, DOI 10.1128/JVI.78.17.9412-9422.2004; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Taylor JL, 2003, INFECT IMMUN, V71, P2192, DOI 10.1128/IAI.71.4.2192-2198.2003; Traut W, 2001, CHROMOSOMA, V110, P247, DOI 10.1007/s004120100152; Wasylyk C, 2002, MOL CELL BIOL, V22, P2687, DOI 10.1128/MCB.22.8.2687-2702.2002; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Weichenhan D, 2001, MAMM GENOME, V12, P590, DOI 10.1007/s00335-001-3015-9	30	323	350	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2005	434	7034					767	772		10.1038/nature03419	http://dx.doi.org/10.1038/nature03419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	913NU	15815631	Green Accepted			2022-12-01	WOS:000228160700042
J	Luo, ZX; Wible, JR				Luo, ZX; Wible, JR			A Late Jurassic digging mammal and early mammalian diversification	SCIENCE			English	Article							EVOLUTION; CHINA	A fossil mammal from the Late Jurassic Morrison Formation, Colorado, has highly specialized teeth similar to those of xenarthran and tubulidentate placental mammals and different from the generalized insectivorous or omnivorous dentitions of other Jurassic mammals. It has many forelimb features specialized for digging, and its lumbar vertebrae show xenarthrous articulations. Parsimony analysis suggests that this fossil represents a separate basal mammalian lineage with some dental and vertebral convergences to those of modern xenarthran placentals, and reveals a previously unknown ecomorph of early mammals.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA		Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemnh.org	Luo, Zhe-XI/AAU-2263-2021					Gaudin Timothy J., 1999, Fieldiana Geology, V41, P1; GAUDIN TJ, 1992, J MORPHOL, V214, P63, DOI 10.1002/jmor.1052140105; Gow C. E., 2001, Palaeontologia Africana, V37, P93; Hildebrand M., 1985, P89; Hu Yaoming, 1998, Vertebrata Palasiatica, V36, P102; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z., 2004, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; LUO ZX, IN PRESS J MAMM EVOL; Martin T, 2000, GUIMAROTA JURASSIC E; McKenna MC, 1997, CLASSIFICATION MAMMA; MCLEOD N, 1993, AM J SCI, V293, P300; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Nowak R.M., 1983, WALKERS MAMMALS WORL; Prothero DR, 1981, B AM MUS NAT HIST, V167, P277; ROSE KD, 1993, MAMMAL PHYLOGENY : PLACENTALS, P81; ROSE KD, 1999, ENCY PALEONTOLOGY, V1, P220; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SIMPSON GEORGE GAYLORD, 1929, MEM PEABODY MUS YALE UNIV, V3, P1; SUES HD, 1983, THESIS HARVARD U; Swofford D, 2000, PAUP PHYLOGENETIC AN; Szalay F.S., 1994, EVOLUTIONARY HIST MA; Weil A, 2002, NATURE, V416, P798, DOI 10.1038/416798a	35	146	161	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					103	107		10.1126/science.1108875	http://dx.doi.org/10.1126/science.1108875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802602				2022-12-01	WOS:000228221500042
J	Zatz, M				Zatz, M			When science is not enough: Fighting genetic disease in Brazil	SCIENCE			English	Editorial Material									Univ Sao Paulo, Biosci Inst, BR-05508090 Sao Paulo, Brazil	Universidade de Sao Paulo	Zatz, M (corresponding author), Univ Sao Paulo, Biosci Inst, Rua Matao 277,Sala 211, BR-05508090 Sao Paulo, Brazil.		Zatz, Mayana/M-5338-2015	Zatz, Mayana/0000-0003-3970-8025					0	5	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2005	308	5718					55	57		10.1126/science.1111730	http://dx.doi.org/10.1126/science.1111730			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802588				2022-12-01	WOS:000228221500026
J	Parker, JS; Roe, SM; Barford, D				Parker, JS; Roe, SM; Barford, D			Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex	NATURE			English	Article							CRYSTAL-STRUCTURE; MICRORNA; ARGONAUTE2; INTERFERENCE; MECHANISMS; CLEAVAGE	RNA interference and related RNA silencing phenomena use short antisense guide RNA molecules to repress the expression of target genes(1,2). Argonaute proteins(3), containing amino-terminal PAZ (for PIWI/Argonaute/Zwille) domains and carboxy-terminal PIWI domains, are core components of these mechanisms. Here we show the crystal structure of a Piwi protein from Archaeoglobus fulgidus (AfPiwi) in complex with a small interfering RNA (siRNA)-like duplex, which mimics the 5 ' end of a guide RNA strand bound to an overhanging target messenger RNA. The structure contains a highly conserved metal-binding site that anchors the 5 ' nucleotide of the guide RNA. The first base pair of the duplex is unwound, separating the 5 ' nucleotide of the guide from the complementary nucleotide on the target strand, which exits with the 3 ' overhang through a short channel. The remaining base-paired nucleotides assume an A-form helix, accommodated within a channel in the PIWI domain, which can be extended to place the scissile phosphate of the target strand adjacent to the putative slicer catalytic site. This study provides insights into mechanisms of target mRNA recognition and cleavage by an Argonaute-siRNA guide complex.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Roe, Mark/0000-0002-7371-9855	Wellcome Trust [074543] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129	30	371	408	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					663	666		10.1038/nature03462	http://dx.doi.org/10.1038/nature03462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800628	Green Accepted			2022-12-01	WOS:000228011000049
J	Beuvink, I; Boulay, A; Fumagalli, S; Zilbermann, F; Ruetz, S; O'Reilly, T; Natt, F; Hall, J; Lane, HA; Thomas, G				Beuvink, I; Boulay, A; Fumagalli, S; Zilbermann, F; Ruetz, S; O'Reilly, T; Natt, F; Hall, J; Lane, HA; Thomas, G			The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation	CELL			English	Article							INDUCED G(1) ARREST; P53 GENE-MUTATIONS; CDK INHIBITOR; GROWTH ARREST; CANCER; ACTIVATION; CISPLATIN; KINASE; TARGET; MYC	Although DNA damaging agents have revolutionized chemotherapy against solid tumors, a narrow therapeutic window combined with severe side effects has limited their broader use. Here we show that RAD001 (everolimus), a rapamycin derivative, dramatically enhances cisplatin-induced apoptosis in wild-type p53, but not mutant p53 tumor cells. The use of isogenic tumor cell lines expressing either wild-type mTOR cDNA or a mutant that does not bind RAD001 demonstrates that the effects of RAD001 are through inhibition of mTOR function. We further show that RAD001 sensitizes cells to cisplatin by inhibiting p53-induced p21 expression. Unexpectedly, this effect is attributed to a small but significant inhibition of p2l translation combined with its short half-life. These findings provide the molecular rationale for combining DNA damaging agents with RAD001, showing that a general effect on a major anabolic process may dramatically enhance the efficacy of an established drug protocol in the treatment of cancer patients with solid tumors.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis	Lane, HA (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66,POB 2543, CH-4058 Basel, Switzerland.	heidi.lane@pharma.novartis.com; gthomas@fmi.ch	FUMAGALLI, Stefano/C-2914-2019; Thomas, George/K-9235-2014	Thomas, George/0000-0003-3518-8149; Hall, Jonathan/0000-0003-4160-7135; , Stefano/0000-0001-5832-8680				Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dutcher Janice P, 2004, Curr Oncol Rep, V6, P111, DOI 10.1007/s11912-004-0022-5; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan SJ, 1997, ONCOGENE, V14, P2127, DOI 10.1038/sj.onc.1201052; FAN SJ, 1994, CANCER RES, V54, P5824; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gaben AM, 2004, INT J CANCER, V108, P200, DOI 10.1002/ijc.11521; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Huang SL, 2001, CANCER RES, V61, P3373; Jaeschke A, 2003, CURR TOP MICROBIOL, V279, P283; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kralj M, 2003, CANCER GENE THER, V10, P457, DOI 10.1038/sj.cgt.7700588; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Luan FL, 2002, TRANSPLANTATION, V73, P1565, DOI 10.1097/00007890-200205270-00008; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Marygold SJ, 2002, CURR BIOL, V12, pR785, DOI 10.1016/S0960-9822(02)01294-0; McCormick F, 2004, NATURE, V428, P267, DOI 10.1038/428267a; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Panwalkar A, 2004, CANCER-AM CANCER SOC, V100, P657, DOI 10.1002/cncr.20026; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Prendergast GC, 2003, CANCER CELL, V4, P244, DOI 10.1016/S1535-6108(03)00247-2; Proud CG, 2003, CURR TOP MICROBIOL, V279, P215; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Segal-Bendirdjian E, 1998, CELL DEATH DIFFER, V5, P390, DOI 10.1038/sj.cdd.4400357; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; SHI YF, 1995, CANCER RES, V55, P1982; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tian H, 2000, CANCER RES, V60, P679; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vousden KH, 2002, CANCER CELL, V2, P351, DOI 10.1016/S1535-6108(02)00186-1; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Weiss RH, 2003, CANCER LETT, V189, P39, DOI 10.1016/S0304-3835(02)00495-0; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	57	423	437	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					747	759		10.1016/j.cell.2004.12.040	http://dx.doi.org/10.1016/j.cell.2004.12.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797377	Bronze			2022-12-01	WOS:000228067500006
J	Beaglehole, R; Horton, R				Beaglehole, R; Horton, R			Chronic diseases of adults - a call for papers	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland; The Lancet, London NW1 7BY, England	World Health Organization	Beaglehole, R (corresponding author), WHO, CH-1211 Geneva, Switzerland.	beaglehole@WHO.int						LEEDER S, 2004, RACE TIME; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743	2	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1913	1914		10.1016/S0140-6736(05)66640-8	http://dx.doi.org/10.1016/S0140-6736(05)66640-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936408				2022-12-01	WOS:000229587800009
J	Cohen, MS; Zhang, C; Shokat, KM; Taunton, J				Cohen, MS; Zhang, C; Shokat, KM; Taunton, J			Structural bioinformatics-based design of selective, irreversible kinase inhibitors	SCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; IDENTIFICATION; COMPLEX; SITE; LCK	The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.	Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Taunton, J (corresponding author), Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94143 USA.	taunton@cmp.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071434-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barker AJ, 2001, BIOORG MED CHEM LETT, V11, P1911, DOI 10.1016/S0960-894X(01)00344-4; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Burchat AF, 2000, BIOORG MED CHEM LETT, V10, P2171, DOI 10.1016/S0960-894X(00)00442-X; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; COHEN M, UNPUB; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Tsigelny I, 1999, BIOPOLYMERS, V50, P513, DOI 10.1002/(SICI)1097-0282(19991015)50:5<513::AID-BIP5>3.0.CO;2-I; Vik TA, 1997, BIOCHEM BIOPH RES CO, V235, P398, DOI 10.1006/bbrc.1997.6794; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	21	401	494	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1318	1321		10.1126/science1108367	http://dx.doi.org/10.1126/science1108367			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919995	Green Accepted			2022-12-01	WOS:000229482300050
J	Bernal-Mizrachi, C; Gates, AC; Weng, S; Imamura, T; Knutsen, RH; DeSantis, P; Coleman, T; Townsend, RR; Muglia, LJ; Semenkovich, CF				Bernal-Mizrachi, C; Gates, AC; Weng, S; Imamura, T; Knutsen, RH; DeSantis, P; Coleman, T; Townsend, RR; Muglia, LJ; Semenkovich, CF			Vascular respiratory uncoupling increases blood pressure and atherosclerosis	NATURE			English	Article							BROWN ADIPOSE-TISSUE; IDENTIFICATION; METABOLISM; DEFICIENT; PROTEINS; RADICALS; LIPIDS; CELLS; MICE	The observations that atherosclerosis often occurs in nonsmokers without elevated levels of low-density lipoprotein cholesterol, and that most atherosclerosis loci so far identified in mice do not affect systemic risk factors associated with atherosclerosis(1), suggest that as-yet-unidentified mechanisms must contribute to vascular disease. Arterial walls undergo regional disturbances of metabolism(2) that include the uncoupling of respiration and oxidative phosphorylation, a process that occurs to some extent in all cells and may be characteristic of blood vessels being predisposed to the development of atherosclerosis(3). To test the hypothesis that inefficient metabolism in blood vessels promotes vascular disease, we generated mice with doxycycline-inducible expression of uncoupling protein-1 (UCP1) in the artery wall. Here we show that UCP1 expression in aortic smooth muscle cells causes hypertension and increases dietary atherosclerosis without affecting cholesterol levels. UCP1 expression also increases superoxide production and decreases the availability of nitric oxide, evidence of oxidative stress. These results provide proof of principle that inefficient metabolism in blood vessels can cause vascular disease.	Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA.	csemenko@im.wustl.edu		Bernal-Mizrachi, Carlos/0000-0002-8991-7522; Semenkovich, Clay/0000-0003-1163-1871	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088083] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK088083] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allayee H, 2003, ARTERIOSCL THROM VAS, V23, P1501, DOI 10.1161/01.ATV.0000090886.40027.DC; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; CORNWELL D G, 1981, Progress in Lipid Research, V20, P365, DOI 10.1016/0163-7827(81)90069-2; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; HAYASHIDA T, 1960, P SOC EXP BIOL MED, V103, P656, DOI 10.3181/00379727-103-25625; HEATON JM, 1972, J ANAT, V112, P35; HEUPER WC, 1944, ARCH PATHOL, V38, P162; JENNINGS RB, 1967, ARCH PATHOL, V84, P15; Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003; KLEIN PD, 1954, J BIOL CHEM, V211, P103; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Levin M, 2003, ARTERIOSCL THROM VAS, V23, P1801, DOI 10.1161/01.ATV.0000092872.54026.8D; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Moessler H, 1996, DEVELOPMENT, V122, P2415; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NOHL H, 1994, ANN BIOL CLIN-PARIS, V52, P199; PETTERSSON G, 1985, ACTA PHARMACOL TOX, V57, P184, DOI 10.1111/bcpt.1985.57.3.184; SANTERRE RF, 1974, EXP MOL PATHOL, V20, P397, DOI 10.1016/0014-4800(74)90069-0; SJODIN B, 1990, SPORTS MED, V10, P236; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; SMITH EB, 1962, BIOCHEM J, V84, pP49; SMITH EB, 1962, LANCET, V2, P530; Su B, 2001, CIRC RES, V89, P39, DOI 10.1161/hh1301.093615; SZEKELY M, 1970, EXPERIENTIA, V26, P1314, DOI 10.1007/BF02112999; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; WATTS HF, 1963, EVOLUTION ATHEROSCLE, P117; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	30	141	150	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					502	506		10.1038/nature03527	http://dx.doi.org/10.1038/nature03527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917810				2022-12-01	WOS:000229337800056
J	Ballas, N; Grunseich, C; Lu, DD; Speh, JC; Mandel, G				Ballas, N; Grunseich, C; Lu, DD; Speh, JC; Mandel, G			REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis	CELL			English	Article							RESTRICTIVE SILENCER FACTOR; EMBRYONIC STEM-CELLS; RETT-SYNDROME; TARGET GENES; METHYLATION PATTERNS; HISTONE METHYLATION; REPRESSOR COMPLEX; ACTIVE REPRESSION; NEURAL INDUCTION; IN-VIVO	Regulation of neuronal gene expression is critical to central nervous system development. Here, we show that REST regulates the transitions from pluripotent to neural stem/progenitor cell and from progenitor to mature neuron. In the transition to progenitor cell, REST is degraded to levels just sufficient to maintain neuronal gene chromatin in an inactive state that is nonetheless poised for expression. As progenitors differentiate into neurons, REST and its corepressors dissociate from the RE1 site, triggering activation of neuronal genes. In some genes, the level of expression is adjusted further in neurons by CoREST/MeCP2 repressor complexes that remain bound to a site of methylated DNA distinct from the RE1 site. Expression profiling based on this mechanism indicates that REST defines a gene set subject to plasticity in mature neurons. Thus, a multistage repressor mechanism controls the orderly expression of genes during development while still permitting fine tuning in response to specific stimuli.	SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Ballas, N (corresponding author), SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	nballas@notes.cc.sunysb.edu						Anderson D, 1997, MOL CELLULAR APPROAC, P26; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Casarosa S, 1999, DEVELOPMENT, V126, P525; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nan XH, 2001, BRAIN DEV-JPN, V23, pS32, DOI 10.1016/S0387-7604(01)00333-3; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sasai Y, 1998, NEURON, V21, P455, DOI 10.1016/S0896-6273(00)80554-1; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; SUCOV HM, 1995, MOL NEUROBIOL, V10, P169, DOI 10.1007/BF02740674; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van den Veyver IB, 2001, BRAIN DEV-JPN, V23, pS147, DOI 10.1016/S0387-7604(01)00376-X; Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	48	683	707	1	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 20	2005	121	4					645	657		10.1016/j.cell.2005.03.013	http://dx.doi.org/10.1016/j.cell.2005.03.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907476	Bronze			2022-12-01	WOS:000229331200019
J	Tews, I; Findeisen, F; Sinning, I; Schultz, A; Schultz, JE; Linder, JU				Tews, I; Findeisen, F; Sinning, I; Schultz, A; Schultz, JE; Linder, JU			The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme	SCIENCE			English	Article							TUBERCULOSIS; CAMP	Class III adenylyl cyclases contain catalytic and regulatory domains, yet structural insight into their interactions is missing. We show that the mycobacterial adenylyl cyclase Rv1264 is rendered a pH sensor by its N-terminal domain. In the structure of the inhibited state, catalytic and regulatory domains share a large interface involving catalytic residues. In the structure of the active state, the two catalytic domains rotate by 55 degrees to form two catalytic sites at their interface. Two alpha helices serve as molecular switches. Mutagenesis is consistent with a regulatory role of the structural transition, and we suggest that the transition is regulated by pH.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Inst Pharmazeut, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Tews, I (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ivo.tews@bzh.uni-heidelberg.de; juergen.linder@uni-tuebingen.de	Tews, Ivo/A-2750-2010	Tews, Ivo/0000-0002-4704-1139				Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; FINDEISEN F, UNPUB; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tews I., UNPUB; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	19	96	101	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1020	1023		10.1126/science.1107642	http://dx.doi.org/10.1126/science.1107642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890882				2022-12-01	WOS:000229190700046
J	Turek, FW; Joshu, C; Kohsaka, A; Lin, E; Ivanova, G; McDearmon, E; Laposky, A; Losee-Olson, S; Easton, A; Jensen, DR; Eckel, RH; Takahashi, JS; Bass, J				Turek, FW; Joshu, C; Kohsaka, A; Lin, E; Ivanova, G; McDearmon, E; Laposky, A; Losee-Olson, S; Easton, A; Jensen, DR; Eckel, RH; Takahashi, JS; Bass, J			Obesity and metabolic syndrome in circadian Clock mutant mice	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; ENERGY HOMEOSTASIS; GENE-EXPRESSION; MOUSE; GHRELIN; SLEEP; LIVER; IDENTIFICATION; REPRODUCTION; PATHWAYS	The CLOCK transcription factor is a key component of the molecular circadian clock within pacemaker neurons of the hypothalamic suprachiasmatic nucleus. We found that homozygous Clock mutant mice have a greatly attenuated diurnal feeding rhythm, are hyperphagic and obese, and develop a metabolic syndrome of hyperleptinemia, hyperlipidemia, hepatic steatosis, hyperglycemia, and hypoinsulinemia. Expression of transcripts encoding selected hypothalamic peptides associated with energy balance was attenuated in the Clock mutant mice. These results suggest that the circadian clock gene network plays an important rote in mammalian energy balance.	Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Evanston NW Healthcare Res Inst, Evanston, IL 60208 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Howard Hughes Medical Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA.	j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Jansen, Heiko T./A-5770-2008	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Jansen, Heiko T./0000-0003-0178-396X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059598, R01HL075029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002675, R01DK026356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412, R01AG018200] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL59598, R01 HL059598, R01 HL075029, HL75029] Funding Source: Medline; NIA NIH HHS [AG11412, AG18200, R01 AG018200, P01 AG011412] Funding Source: Medline; NIDDK NIH HHS [DK26356, K08 DK002675, R01 DK026356, DK02675] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Kanamoto N, 2004, ENDOCRINOLOGY, V145, P4144, DOI 10.1210/en.2003-1718; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; TAKAHASHI JS, 2001, HDB BEHAV NEUROBIOLO, V12, P770; VANCAUTER E, 2000, HDB PHYSL 7, P313; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamada K, 2002, INT J OBESITY, V26, P132, DOI 10.1038/sj.ijo.0801848; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	27	1731	1802	14	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1043	1045		10.1126/science.1108750	http://dx.doi.org/10.1126/science.1108750			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15845877	Green Accepted			2022-12-01	WOS:000229190700053
J	Lucchetta, EM; Lee, JH; Fu, LA; Patel, NH; Ismagilov, RF				Lucchetta, EM; Lee, JH; Fu, LA; Patel, NH; Ismagilov, RF			Dynamics of Drosophila embryonic patterning network perturbed in space and time using microfluidics	NATURE			English	Article							EXPRESSION PATTERNS; POLY(DIMETHYLSILOXANE); PROTEIN; DEVICES	Biochemical networks are perturbed both by fluctuations in environmental conditions and genetic variation. These perturbations must be compensated for, especially when they occur during embryonic pattern formation. Complex chemical reaction networks displaying spatiotemporal dynamics have been controlled and understood by perturbing their environment in space and time(1-3). Here, we apply this approach using microfluidics to investigate the robust network in Drosophila melanogaster that compensates for variation in the Bicoid morphogen gradient. We show that the compensation system can counteract the effects of extremely unnatural environmental conditions-a temperature step-in which the anterior and posterior halves of the embryo are developing at different temperatures and thus at different rates. Embryonic patterning was normal under this condition, suggesting that a simple reciprocal gradient system is not the mechanism of compensation. Time-specific reversals of the temperature step narrowed down the critical period for compensation to between 65 and 100 min after onset of embryonic development. The microfluidic technology used here may prove useful to future studies, as it allows spatial and temporal regulation of embryonic development.	Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol Mol & Cell Biol, Berkeley, CA 94720 USA	University of Chicago; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ismagilov, RF (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	nipam@uclink.berkeley.edu; r-ismagilov@uchicago.edu		Fu, Lydia/0000-0003-2800-3388; Patel, Nipam/0000-0003-4328-654X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077331] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077331, R01 GM077331-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JR, 2000, ANAL CHEM, V72, P3158, DOI 10.1021/ac9912294; DiGregorio PJ, 2001, J BIOL CHEM, V276, P1930, DOI 10.1074/jbc.M003911200; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FOE VE, 1993, DEV DROSOPHILA MELAN; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Hatch A, 2001, NAT BIOTECHNOL, V19, P461, DOI 10.1038/88135; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; NIEMUTH J, 1995, ROUX ARCH DEV BIOL, V204, P444, DOI 10.1007/BF00360852; PATEL NH, 1994, NATURE, V367, P429, DOI 10.1038/367429a0; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Stasiek JA, 2002, OPTO-ELECTRON REV, V10, P1; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Vanag VK, 2000, NATURE, V406, P389, DOI 10.1038/35019038; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Wolff J, 2001, SCIENCE, V294, P134, DOI 10.1126/science.1063597	21	345	358	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1134	1138		10.1038/nature03509	http://dx.doi.org/10.1038/nature03509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858575	Green Accepted, Bronze			2022-12-01	WOS:000228693300044
J	Indovina, I; Maffei, V; Bosco, G; Zago, M; Macaluso, E; Lacquaniti, F				Indovina, I; Maffei, V; Bosco, G; Zago, M; Macaluso, E; Lacquaniti, F			Representation of visual gravitational motion in the human vestibular cortex	SCIENCE			English	Article							INTERNAL-MODELS; EYE-MOVEMENTS; PERCEPTION; GRAVITY; ACCELERATION; INTERCEPTION; RESPONSES; BRAIN; LAWS; STIMULATION	How do we perceive the visual motion of objects that. are accelerated by gravity? We propose that, because vision is poorly sensitive to accelerations, an internal model that calculates the effects of gravity is derived from graviceptive information, is stored in the vestibular cortex, and is activated by visual motion that appears to be coherent with natural gravity. The acceleration of visual targets was manipulated while brain activity was measured using functional magnetic resonance imaging. In agreement with the internal model hypothesis, we found that the vestibular network was selectively engaged when acceleration was consistent with natural gravity. These findings demonstrate that predictive mechanisms of physical laws of motion are represented in the human brain.	Sci Inst Fdn Santa Lucia, Dept Neuromotor Physiol, I-00179 Rome, Italy; Sci Inst Fdn Santa Lucia, Dept Neuroimaging, I-00179 Rome, Italy; Univ Roma Tor Vergata, Dept Neurosci, I-00133 Rome, Italy; Univ Roma Tor Vergata, Ctr Space Biomed, I-00173 Rome, Italy	IRCCS Santa Lucia; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Lacquaniti, F (corresponding author), Sci Inst Fdn Santa Lucia, Dept Neuromotor Physiol, Via Ardeatina 306, I-00179 Rome, Italy.	lacquaniti@caspur.it	Lacquaniti, Francesco/J-9842-2016; Zago, Myrka/B-3669-2012; Indovina, Iole/Z-2978-2019; Macaluso, Emiliano/AAE-9185-2019; Bosco, Gianfranco/AAA-1548-2019; Macaluso, Emiliano/H-3139-2017	Lacquaniti, Francesco/0000-0003-0896-7315; Zago, Myrka/0000-0001-7100-7582; Indovina, Iole/0000-0002-1183-0013; Macaluso, Emiliano/0000-0002-1919-5288; Bosco, Gianfranco/0000-0002-7080-0674; Macaluso, Emiliano/0000-0002-1919-5288; maffei, vincenzo/0000-0003-0957-6615				Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; BOTTINI G, 1994, EXP BRAIN RES, V99, P164; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Jokisch D, 2003, J VISION, V3, P252, DOI 10.1167/3.4.1; KIM IK, 1992, J EXP PSYCHOL HUMAN, V18, P385, DOI 10.1037/0096-1523.18.2.385; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Lacquaniti F., 1993, MULTISENSORY CONTROL, P379, DOI [10.1093/acprof:oso/9780198547853.003.0190, DOI 10.1093/ACPROF:OSO/9780198547853.003.0190]; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; Lisberger SG, 1999, J NEUROSCI, V19, P2224; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Merchant H, 2004, CEREB CORTEX, V14, P314, DOI 10.1093/cercor/bhg130; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Peterka RJ, 2004, J NEUROPHYSIOL, V92, P2333, DOI 10.1152/jn.00174.2004; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Smetacek V, 2002, NATURE, V415, P481, DOI 10.1038/415481a; Todd J T, 1981, J Exp Psychol Hum Percept Perform, V7, P975; Twardy CR, 2002, PERCEPT PSYCHOPHYS, V64, P956, DOI 10.3758/BF03196799; WATSON JS, 1992, PERCEPTION, V21, P69, DOI 10.1068/p210069; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	31	233	235	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					416	419		10.1126/science.1107961	http://dx.doi.org/10.1126/science.1107961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831760	Green Published			2022-12-01	WOS:000228492000054
J	Wootton, SK; Halbert, CL; Miller, AD				Wootton, SK; Halbert, CL; Miller, AD			Sheep retrovirus structural protein induces lung tumours	NATURE			English	Article							RODENT FIBROBLASTS; JAAGSIEKTE; TRANSFORMATION; RECEPTOR; VECTORS; TRANSDUCTION; CELLS; HYAL2; GENE; BRONCHIOLOALVEOLAR	Jaagsiekte sheep retrovirus ( JSRV) causes a contagious lung cancer in sheep and goats, with significant animal health and economic consequences(1). The host range of JSRV is in part limited by species-specific differences in the virus entry receptor, hyaluronidase 2 (Hyal2), which is not functional as a receptor in mice but is functional in humans(2). Sheep are immunotolerant of JSRV because of the expression of closely related endogenous retroviruses(3,4), which are not present in humans and most other species, and this may facilitate oncogenesis. Here we show that expression of the JSRV envelope (Env) protein alone in lungs of mice, by using a replication-incompetent adeno-associated virus vector, results in tumours with a bronchiolo-alveolar localization like those seen in sheep. Whereas lethal disease was observed in immunodeficient mice, tumour development was almost entirely blocked in immunocompetent mice. Our results provide a rare example of an oncogenic viral structural protein, show that interaction of the viral Env protein with the virus entry receptor Hyal2 is not required for tumorigenesis, and indicate that immune recognition of Env can protect against JSRV tumorigenesis.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Miller, AD (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	dmiller@fhcrc.org		Miller, Dusty/0000-0002-3736-3660	NIDDK NIH HHS [P30 DK047754] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047754] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen JM, 2000, MOL THER, V1, P88, DOI 10.1006/mthe.1999.0010; Allen TE, 2002, J GEN VIROL, V83, P2733, DOI 10.1099/0022-1317-83-11-2733; Danilkovitch-Miagkova A, 2003, P NATL ACAD SCI USA, V100, P4580, DOI 10.1073/pnas.0837136100; De las Heras M, 2000, EUR RESPIR J, V16, P330, DOI 10.1034/j.1399-3003.2000.16b23.x; FAN H, 2003, JAAGSIEKTE SHEEP RET; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hiatt KM, 2002, HUM PATHOL, V33, P680, DOI 10.1053/hupa.2002.125776; Liu SL, 2005, J VIROL, V79, P927, DOI 10.1128/JVI.79.2.927-933.2005; Liu SL, 2003, J VIROL, V77, P7924, DOI 10.1128/JVI.77.14.7924-7935.2003; Liu SL, 2003, J VIROL, V77, P2850, DOI 10.1128/JVI.77.5.2850-2858.2003; Maeda N, 2001, P NATL ACAD SCI USA, V98, P4449, DOI 10.1073/pnas.071547598; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; Miller AD, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-64; Palmarini M, 2001, J VIROL, V75, P11002, DOI 10.1128/JVI.75.22.11002-11009.2001; Platt JA, 2002, VET PATHOL, V39, P341, DOI 10.1354/vp.39-3-341; Rai SK, 2000, J VIROL, V74, P4698, DOI 10.1128/JVI.74.10.4698-4704.2000; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; SHARP JM, 1983, ARCH VIROL, V78, P89, DOI 10.1007/BF01310861; Spencer TE, 2003, J VIROL, V77, P749, DOI 10.1128/JVI.77.1.749-753.2003; Summers C, 2002, J GEN VIROL, V83, P1753, DOI 10.1099/0022-1317-83-7-1753; Yousem SA, 2001, HUM PATHOL, V32, P1039, DOI 10.1053/hupa.2001.28249	24	115	126	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					904	907		10.1038/nature03492	http://dx.doi.org/10.1038/nature03492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829964	Green Accepted			2022-12-01	WOS:000228327600042
J	Hughes, AL; Todd, BL; Espenshade, PJ				Hughes, AL; Todd, BL; Espenshade, PJ			SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast	CELL			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; REGULATORY ELEMENT; SCHIZOSACCHAROMYCES-POMBE; CHOLESTEROL HOMEOSTASIS; SITE-1 PROTEASE; LIPID-SYNTHESIS; SCAP; GENES	Cholesterol and fatty acid synthesis in mammals are controlled by SREBPs, a family of membrane bound transcription factors. Our studies identified homologs of SREBP, its binding partner SCAP, and the ER retention protein Insig in Schizosaccharomyces pombe, named sre1(+), scp1(+), and ins1(+). Like SREBP, Sre1 is cleaved and activated in response to sterol depletion in a Scp1-dependent manner. Microarray analysis revealed that Sre1 activates sterol biosynthetic enzymes as in mammals, and, surprisingly, Sre1 also stimulates transcription of genes required for adaptation to hypoxia. Furthermore, Sre1 rapidly activates these target genes in response to low oxygen and is itself required for anaerobic growth. Based on these findings, we propose and test a model in which Sre1 and Scp1 monitor oxygen-dependent sterol synthesis as an indirect measure of oxygen supply and mediate a hypoxic response in fission yeast.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu		Hughes, Adam/0000-0002-7095-3793	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL077588-01, HL-077588, R01 HL077588] Funding Source: Medline; NIGMS NIH HHS [GM007445] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Kwast KE, 1998, J EXP BIOL, V201, P1177; Loewen CJR, 2002, CURR BIOL, V12, pR779, DOI 10.1016/S0960-9822(02)01292-7; LORENZ RT, 1991, LIPIDS, V26, P598, DOI 10.1007/BF02536423; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Sambrook JF., 2001, MOL CLONING LAB MANU; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Wang H, 2001, J NEUROCHEM, V77, P53; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123	36	254	256	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					831	842		10.1016/j.cell.2005.01.012	http://dx.doi.org/10.1016/j.cell.2005.01.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797383	Bronze			2022-12-01	WOS:000228067500012
J	Rosenfeld, N; Young, JW; Alon, U; Swain, PS; Elowitz, MB				Rosenfeld, N; Young, JW; Alon, U; Swain, PS; Elowitz, MB			Gene regulation at the single-cell level	SCIENCE			English	Article							BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; EXPRESSION; NETWORKS; STOCHASTICITY; REPRESSOR; NOISE; TRANSCRIPTION; FEEDBACK; OPERATOR	The quantitative relation between transcription factor concentrations and the rate of protein production from downstream genes is central to the function of genetic networks. Here we show that this relation, which we call the gene regulation function (GRF), fluctuates dynamically in individual living cells, thereby limiting the accuracy with which transcriptional genetic circuits can transfer signals. Using fluorescent reporter genes and fusion proteins, we characterized the bacteriophage lambda promoter P-R in Escherichia coli. A novel technique based on binomial errors in protein partitioning enabled calibration of in vivo biochemical parameters in molecular units. We found that protein production rates fluctuate over a time scale of about one cell cycle, while intrinsic noise decays rapidly. Thus, biochemical parameters, noise, and slowly varying cellular states together determine the effective single-cell GRF. These results can form a basis for quantitative modeling of natural gene circuits and for design of synthetic ones.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; Weizmann Inst Sci, Dept Mol Cell Biol & Phys Complex Syst, IL-76100 Rehovot, Israel; McGill Univ, Dept Physiol, Ctr Nonlinear Dynam, Montreal, PQ H3G 1Y6, Canada	California Institute of Technology; California Institute of Technology; Weizmann Institute of Science; McGill University	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Swain, Peter S/AAW-3265-2020	Swain, Peter/0000-0001-7489-8587				Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Darling PJ, 2000, J MOL BIOL, V302, P625, DOI 10.1006/jmbi.2000.4050; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; KOBLAN KS, 1992, BIOCHEMISTRY-US, V31, P57, DOI 10.1021/bi00116a010; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Mirasoli M, 2002, ANAL CHEM, V74, P5948, DOI 10.1021/ac0259008; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Ptashne M, 1992, GENETIC SWITCH PHAGE; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; SAVAGEAU MA, 1976, BIOCH SYSTEMS ANAL; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073	29	786	807	4	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2005	307	5717					1962	1965		10.1126/science.1106914	http://dx.doi.org/10.1126/science.1106914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910UI	15790856				2022-12-01	WOS:000227957300057
J	Magnus, D; Cho, MK				Magnus, D; Cho, MK			Issues in oocyte donation for stem cell research	SCIENCE			English	Editorial Material							INFORMED-CONSENT; GUIDELINES; DONORS; EMBRYO		Stanford Univ, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA; Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Cho, MK (corresponding author), Stanford Univ, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	micho@stanford.edu						Abecassis M, 2000, JAMA-J AM MED ASSOC, V284, P2919; Adams PL, 2002, TRANSPLANTATION, V74, P582, DOI 10.1097/00007890-200208270-00030; *AM SOC TRANSPL SU, 2005, STAT SOL DON ORG; APPELBAUM PS, 1982, INT J LAW PSYCHIAT, V5, P319, DOI 10.1016/0160-2527(82)90026-7; Biller-Andorno N, 2001, THEOR MED BIOETH, V22, P351, DOI 10.1023/A:1011842211016; Committee on Guidelines for Human Embryonic Stem Cell Research, 2005, GUID HUM EMBR STEM C; Delmonico FL, 2003, TRANSPLANTATION, V76, P1257, DOI 10.1097/01.TP.0000089674.07433.DA; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004; Henderson GE, 2004, MOL THER, V10, P225, DOI 10.1016/j.ymthe.2004.05.013; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; King NMP, 1999, HUM GENE THER, V10, P133, DOI 10.1089/10430349950019264; Lo B, 2004, FERTIL STERIL, V82, P559, DOI 10.1016/j.fertnstert.2004.01.040; Lo B, 2003, SCIENCE, V301, P921, DOI 10.1126/science.1087038; Macklin R, 2001, KENNEDY INST ETHIC J, V11, P17, DOI 10.1353/ken.2001.0005; Rimington M R, 2003, Reprod Biomed Online, V6, P277; SCHENKER JG, 1978, FERTIL STERIL, V30, P255; White MT, 1999, J LAW MED ETHICS, V27, P87, DOI 10.1111/j.1748-720X.1999.tb01440.x; Zink S, 2005, AM J BIOETHICS, V5, P6, DOI 10.1080/15265160590953085	19	78	78	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1747	1748		10.1126/science.1114454	http://dx.doi.org/10.1126/science.1114454			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15905363				2022-12-01	WOS:000229926800039
J	Spilianakis, CG; Lalioti, MD; Town, T; Lee, GR; Flavell, RA				Spilianakis, CG; Lalioti, MD; Town, T; Lee, GR; Flavell, RA			Interchromosomal associations between alternatively expressed loci	NATURE			English	Article							TH2 CYTOKINE LOCUS; HYPERSENSITIVE SITES; NUCLEAR-LOCALIZATION; HISTONE ACETYLATION; GENE; ENHANCER; HETEROCHROMATIN; TRANSCRIPTION; ORGANIZATION; MOBILITY	The T-helper- cell 1 and 2 (T(H)1 and T(H)2) pathways, defined by cytokines interferon-gamma (IFN-gamma) and interleukin-4 ( IL-4), respectively, comprise two alternative CD4(+) T-cell fates, with functional consequences for the host immune system. These cytokine genes are encoded on different chromosomes. The recently described T(H)2 locus control region (LCR) coordinately regulates the T(H)2 cytokine genes by participating in a complex between the LCR and promoters of the cytokine genes Il4, Il5 and Il13. Although they are spread over 120 kilobases, these elements are closely juxtaposed in the nucleus in a poised chromatin conformation. In addition to these intrachromosomal interactions, we now describe interchromosomal interactions between the promoter region of the IFN-gamma gene on chromosome 10 and the regulatory regions of the T(H)2 cytokine locus on chromosome 11. DNase I hypersensitive sites that comprise the T(H)2 LCR developmentally regulate these interchromosomal interactions. Furthermore, there seems to be a cell-type-specific dynamic interaction between interacting chromatin partners whereby interchromosomal interactions are apparently lost in favour of intrachromosomal ones upon gene activation. Thus, we provide an example of eukaryotic genes located on separate chromosomes associating physically in the nucleus via interactions that may have a function in coordinating gene expression.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schubeler D, 2000, GENE DEV, V14, P940; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5	37	532	556	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					637	645		10.1038/nature03574	http://dx.doi.org/10.1038/nature03574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15880101				2022-12-01	WOS:000229476200042
J	Smirnakis, SM; Brewer, AA; Schmid, MC; Tolias, AS; Schuz, A; Augath, M; Inhoffen, W; Wandell, BA; Logothetis, NK				Smirnakis, SM; Brewer, AA; Schmid, MC; Tolias, AS; Schuz, A; Augath, M; Inhoffen, W; Wandell, BA; Logothetis, NK			Lack of long-term cortical reorganization after macaque retinal lesions	NATURE			English	Article							PRIMARY VISUAL-CORTEX; PRIMATE STRIATE CORTEX; CROSS-MODAL PLASTICITY; RECEPTIVE-FIELD; ADULT CAT; SENSORY DEAFFERENTATION; TOPOGRAPHIC PLASTICITY; MACULAR DEGENERATION; FUNCTIONAL MRI; BLIND HUMANS	Several aspects of cortical organization are thought to remain plastic into adulthood, allowing cortical sensorimotor maps to be modified continuously by experience. This dynamic nature of cortical circuitry is important for learning, as well as for repair after injury to the nervous system. Electrophysiology studies suggest that adult macaque primary visual cortex (V1) undergoes large-scale reorganization within a few months after retinal lesioning, but this issue has not been conclusively settled. Here we applied the technique of functional magnetic resonance imaging ( fMRI) to detect changes in the cortical topography of macaque area V1 after binocular retinal lesions. fMRI allows non-invasive, in vivo, long-term monitoring of cortical activity with a wide field of view, sampling signals from multiple neurons per unit cortical area. We show that, in contrast with previous studies, adult macaque V1 does not approach normal responsivity during 7.5 months of follow-up after retinal lesions, and its topography does not change. Electrophysiology experiments corroborated the fMRI results. This indicates that adult macaque V1 has limited potential for reorganization in the months following retinal injury.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Tubingen, Dept Ophthalmol 1, D-72076 Tubingen, Germany	Max Planck Society; Harvard University; Massachusetts General Hospital; Stanford University; Stanford University; Eberhard Karls University of Tubingen	Smirnakis, SM (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	smsmirnakis@partners.org	Schmid, Michael C./G-1867-2010; Logothetis, Nikos/U-9282-2019; Schmid, Michael Christoph/AAH-4835-2020	Schmid, Michael C./0000-0003-1424-130X; Schmid, Michael Christoph/0000-0003-1424-130X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS044759] Funding Source: NIH RePORTER; NINDS NIH HHS [F30 NS044759] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelucci A, 2002, PROG BRAIN RES, V136, P373; Angelucci A, 2002, J NEUROSCI, V22, P8633; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer AA, 2002, J NEUROSCI, V22, P10416; Calford MB, 1999, P ROY SOC B-BIOL SCI, V266, P499, DOI 10.1098/rspb.1999.0665; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DEANGELIS GC, 1995, P NATL ACAD SCI USA, V92, P9682, DOI 10.1073/pnas.92.21.9682; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fenrich K, 2004, CAN J NEUROL SCI, V31, P142, DOI 10.1017/S0317167100053798; FIORANI M, 1992, P NATL ACAD SCI USA, V89, P8547, DOI 10.1073/pnas.89.18.8547; GILBERT CD, 1990, COLD SH Q B, V55, P663; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Li W, 2001, EXP BRAIN RES, V139, P359, DOI 10.1007/s002210100757; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Murakami I, 1997, VISUAL NEUROSCI, V14, P89, DOI 10.1017/S0952523800008798; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; ROSA MGP, 1995, J PHYSIOL-LONDON, V482, P589, DOI 10.1113/jphysiol.1995.sp020543; ROSIER AM, 1995, J COMP NEUROL, V359, P476, DOI 10.1002/cne.903590309; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; SCHMID LM, 1995, NEUROREPORT, V6, P1349, DOI 10.1097/00001756-199506090-00030; Schmid LM, 1996, CEREB CORTEX, V6, P388, DOI 10.1093/cercor/6.3.388; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; VOLCHAN E, 1995, VISION RES, V35, P1, DOI 10.1016/0042-6989(94)E0083-W; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561	47	150	157	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2005	435	7040					300	307		10.1038/nature03495	http://dx.doi.org/10.1038/nature03495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902248				2022-12-01	WOS:000229185000036
J	Sinclair, J; Green, J				Sinclair, J; Green, J			Understanding resolution of deliberate self harm: qualitative interview study of patients' experiences	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE; DISORDERS; ADOLESCENTS; TRIAL	Objective To explore the accounts of those with a history of deliberate self harm but who no longer do so, to understand how they perceive this resolution and to identify potential implications for provision of health services. Design Qualitative in-depth interview study. Setting Interviews in a community setting. Participants 20 participants selected from a representative cohort identified in 1997 after an episode of deliberate self poisoning that resulted hospital treatment. Participants were included if they had no further episodes for at least two years before interview Results We identified three recurrent themes: the resolution of adolescent distress; the recognition of the role of alcohol as a precipitating and maintaining factor in self harm; and the understanding of deliberate self harm as a symptom of untreated or unrecognised illness. Conclusion Patients with a history of deliberate self harm who no longer harm themselves talk about their experiences in terms of lack of control over their lives, either through alcohol dependence, untreated depression, or, in adolescents, uncertainty within their family relationships. Hospital management of deliberate self harm has a role in the identification and treatment of depression and alcohol misuse, although in adolescents such interventions may be less appropriate.	Univ Oxford, Warneford Hosp, Ctr Suicide Res, Dept Psychiat, Oxford OX3 7JX, England; Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Sinclair, J (corresponding author), Univ Oxford, Warneford Hosp, Ctr Suicide Res, Dept Psychiat, Oxford OX3 7JX, England.	julia.sinclair@psych.ox.ac.uk	Sinclair, Julia/AAD-8049-2019	Sinclair, Julia/0000-0002-1905-2025; Green, Judith/0000-0002-2315-5326; Houston, Mary/0000-0002-8837-4503				Beck AT, 1974, PREDICTION SUICIDE; Bennett S, 2003, SOC SCI MED, V57, P289, DOI 10.1016/S0277-9536(02)00347-7; Channaz K., 1999, QUAL HEALTH RES, V9, P362, DOI DOI 10.1177/104973239900900306; Coggan C, 1997, SOC SCI MED, V45, P1563, DOI 10.1016/S0277-9536(97)00098-1; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Everall RD., 2000, CAN J COUNS, V34, P111; Frank A, 1997, WOUNDED STORY TELLER; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Green J., 2018, QUALITATIVE METHODS; Hammersley M, 1992, WHATS WRONG ETHNOGRA, P85; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hawton K, 2003, J CHILD PSYCHOL PSYC, V44, P1191, DOI 10.1111/1469-7610.00200; Hawton K, 2003, AM J PSYCHIAT, V160, P1494, DOI 10.1176/appi.ajp.160.8.1494; Hawton K, 1998, BRIT MED J, V317, P441; National Institute of Clinical Excellence, 2004, SHORT TERM PHYS PSYC; Pirkola SP, 2004, CNS DRUGS, V18, P423, DOI 10.2165/00023210-200418070-00002; PLATT S, 1992, ACTA PSYCHIAT SCAND, V85, P97, DOI 10.1111/j.1600-0447.1992.tb01451.x; Redley M, 2003, SOCIOL HEALTH ILL, V25, P348, DOI 10.1111/1467-9566.00350; Strauss A., 1987, QUALITATIVE ANAL SOC; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171	22	83	84	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1112	1115		10.1136/bmj.38441.503333.8F	http://dx.doi.org/10.1136/bmj.38441.503333.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927BH	15843425	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000229166900016
J	Ito, K; Ito, M; Elliott, WM; Cosio, B; Caramori, G; Kon, OM; Barczyk, A; Hayashi, S; Adcock, IM; Hogg, JC; Barnes, PJ				Ito, K; Ito, M; Elliott, WM; Cosio, B; Caramori, G; Kon, OM; Barczyk, A; Hayashi, S; Adcock, IM; Hogg, JC; Barnes, PJ			Decreased histone deacetylase activity in chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THEOPHYLLINE; MACROPHAGES; EXPRESSION; ASTHMA	BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation that is greater in patients with advanced disease. We asked whether there is a link between the severity of disease and the reduction in histone deacetylase (HDAC) activity in the peripheral lung tissue of patients with COPD of varying severity. HDAC is a key molecule in the repression of production of proinflammatory cytokines in alveolar macrophages. METHODS: HDAC activity and histone acetyltransferase (HAT) activity were determined in nuclear extracts of specimens of surgically resected lung tissue from nonsmokers without COPD, patients with COPD of varying severity, and patients with pneumonia or cystic fibrosis. Alveolar macrophages from nonsmokers, smokers, and patients with COPD and bronchial-biopsy specimens from nonsmokers, healthy smokers, patients with COPD, and those with mild asthma were also examined. Total RNA extracted from lung tissue and macrophages was used for quantitative reverse-transcriptase-polymerase-chain-reaction assay of HDAC1 through HDAC8 and interleukin-8. Expression of HDAC2 protein was quantified with the use of Western blotting. Histone-4 acetylation at the interleukin-8 promoter was evaluated with the use of a chromatin immunoprecipitation assay. RESULTS: Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter. The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease. HDAC activity was decreased in patients with COPD, as compared with normal subjects, in both the macrophages and biopsy specimens, with no changes in HAT activity, whereas HAT activity was increased in biopsy specimens obtained from patients with asthma. Neither HAT activity nor HDAC activity was changed in lung tissue from patients with cystic fibrosis or pneumonia. CONCLUSIONS: Patients with COPD have a progressive reduction in total HDAC activity that reflects the severity of the disease.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London SW3 6LY, England; St Marys Hosp, Chest & Allergy Clin, London, England; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; St Pauls Hosp, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC V6Z 1Y6, Canada; Univ Ferrara, Dept Clin & Expt Med, Ctr Ric Asma & Broncopneumopatia Cron Ostrutt, I-44100 Ferrara, Italy; L Warynski Silesian Med Acad, Dept Pneumol, Katowice, Poland	Imperial College London; Imperial College London; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of Ferrara; Medical University Silesia	Barnes, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, Dovehouse St, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk	Caramori, Gaetano/AAS-8611-2020; G.Cosio, Borja/P-4963-2017; Barczyk, Adam/GYV-4487-2022; Adcock, Ian/L-3217-2019; Ito, Kazuhiro/AAF-5994-2019	Caramori, Gaetano/0000-0002-9807-327X; G.Cosio, Borja/0000-0002-6388-8209; Barczyk, Adam/0000-0002-6567-9208; Barnes, Peter/0000-0002-5122-4018; Adcock, Ian/0000-0003-2101-8843				Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DING L, 2004, J COPD, V1, P191; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; *GOLD, 2001, NIH PUBL; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Ito K, 2001, FASEB J, V15, pA473; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323	18	704	744	2	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1967	1976		10.1056/NEJMoa041892	http://dx.doi.org/10.1056/NEJMoa041892			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888697				2022-12-01	WOS:000229017100007
J	Moore, P				Moore, P			Amplifying the signal	NATURE			English	Article																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					236	236		10.1038/435236a	http://dx.doi.org/10.1038/435236a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889101	Bronze			2022-12-01	WOS:000229021100050
J	Rowe, SM; Miller, S; Sorscher, EJ				Rowe, SM; Miller, S; Sorscher, EJ			Mechanisms of disease: Cystic fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSMEMBRANE CONDUCTANCE REGULATOR; VASOACTIVE-INTESTINAL-PEPTIDE; PREMATURE STOP MUTATIONS; AIRWAY EPITHELIAL-CELLS; LUNG-DISEASE; CHLORIDE CHANNEL; SUBMUCOSAL GLANDS; DRUG DISCOVERY; CFTR; GENE		Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sorscher, EJ (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, 1530 3rd Ave S,MCLM 796, Birmingham, AL 35294 USA.	sorscher@uab.edu		Sorscher, Eric J./0000-0001-9341-3354				BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; *CYST FIBR FDN, 2004, CYST FIBR FDN NAT PA; DETERDING RR, 2004, PEDIATR PULM, V38, P249; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Frangolias DD, 2003, AM J RESP CELL MOL, V29, P390, DOI 10.1165/rcmb.2002-0271OC; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; GAN KH, 1995, NEW ENGL J MED, V333, P95, DOI 10.1056/NEJM199507133330204; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gill S, 2003, ASSAY DRUG DEV TECHN, V1, P709, DOI 10.1089/154065803770381066; Grubb BR, 1999, AM J PHYSIOL-GASTR L, V277, pG167, DOI 10.1152/ajpgi.1999.277.1.G167; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Hilliard Jay B, 2002, Methods Mol Med, V70, P409; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Keeling KM, 2002, J MOL MED-JMM, V80, P367, DOI 10.1007/s00109-001-0317-z; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; Konstan MW, 2002, ADV DRUG DELIVER REV, V54, P1409, DOI 10.1016/S0169-409X(02)00146-1; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240051039; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LOWE CU, 1949, AM J DIS CHILD, V78, P349, DOI 10.1001/archpedi.1949.02030050362008; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Olivier KN, 1996, AM J RESP CRIT CARE, V154, P217, DOI 10.1164/ajrccm.154.1.8680683; Puchelle E, 2001, PEDIATR PULM, P143; QUINTON PM, 1986, AM J PHYSIOL, V251, pC649, DOI 10.1152/ajpcell.1986.251.4.C649; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1437; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sagel SD, 2002, CLIN REV ALLERG IMMU, V23, P41, DOI 10.1385/CRIAI:23:1:041; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Verkman AS, 2004, AM J PHYSIOL-CELL PH, V286, pC465, DOI 10.1152/ajpcell.00397.2003; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; VERKMAN AS, 2003, PEDIATR PULM, V36, P290; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; WELSH MJ, 1986, SCIENCE, V232, P1648, DOI 10.1126/science.2424085; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Wyckoff TJO, 2002, MICROBIOL-SGM, V148, P3423, DOI 10.1099/00221287-148-11-3423; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S; Zeitlin P, 2004, NEW ENGL J MED, V351, P606, DOI 10.1056/NEJMcibr041584; Zeitlin PL, 2000, KIDNEY INT, V57, P832, DOI 10.1046/j.1523-1755.2000.00922.x; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	65	1108	1164	11	254	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1992	2001		10.1056/NEJMra043184	http://dx.doi.org/10.1056/NEJMra043184			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888700				2022-12-01	WOS:000229017100010
J	Conigliaro, RL				Conigliaro, RL			Satisfaction?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												conigliarorl@upmc.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2193	2193		10.1001/jama.293.18.2193	http://dx.doi.org/10.1001/jama.293.18.2193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886362				2022-12-01	WOS:000228981100001
J	Nel, A				Nel, A			Air pollution-related illness: Effects of particles	SCIENCE			English	Editorial Material							DIESEL EXHAUST PARTICLES; OXIDATIVE STRESS; INFLAMMATION; MORTALITY; HEART		Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Nel, A (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	anel@mednet.ucla.edu	Nel, Andre E/J-2808-2012					Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2002, INHAL TOXICOL, V14, P5, DOI 10.1080/089583701753338613; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Lim HB, 1998, FREE RADICAL BIO MED, V25, P635, DOI 10.1016/S0891-5849(98)00073-2; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; *NAT AC SCI NAT RE, 1998, RES PRIOR AIRB PART, V1; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Silbajoris R, 2000, INHAL TOXICOL, V12, P453; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; 1994, ENVIRONMENT, V36, P4; 2002, HLTH EFFECTS I PERSP	19	1110	1178	11	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					804	806		10.1126/science.1108752	http://dx.doi.org/10.1126/science.1108752			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879201				2022-12-01	WOS:000228986500030
J	Tanaka, KD; Ueda, K				Tanaka, KD; Ueda, K			Horsfield's hawk-cuckoo nestlings simulate multiple gapes for begging	SCIENCE			English	Article							SIGNALS		Rikkyo Univ, Dept Life Sci, Tokyo 1718501, Japan	Rikkyo University	Tanaka, KD (corresponding author), Rikkyo Univ, Dept Life Sci, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	keita@zaf.att.ne.jp	Tanaka, Keita/A-5543-2008	Tanaka, Keita/0000-0001-9749-5094				Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kilner RM, 2004, SCIENCE, V305, P877, DOI 10.1126/science.1098487; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Tanaka K., UNPUB; TANAKA KD, IN PRESS J AVIAN BIO	7	56	58	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					653	653		10.1126/science.1109957	http://dx.doi.org/10.1126/science.1109957			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860618				2022-12-01	WOS:000228810900037
J	Kralovics, R; Passamonti, F; Buser, AS; Teo, S; Tiedt, R; Passweg, JR; Tichelli, A; Cazzola, M; Skoda, RC				Kralovics, R; Passamonti, F; Buser, AS; Teo, S; Tiedt, R; Passweg, JR; Tichelli, A; Cazzola, M; Skoda, RC			A gain-of-function mutation of JAK2 in myeloproliferative disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; ERYTHROID PROGENITORS; DIAGNOSTIC-CRITERIA; UNIPARENTAL DISOMY; IMATINIB MESYLATE; STEM-CELL; IN-VITRO; EXPRESSION; CLONALITY	BACKGROUND: Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases. METHODS: We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis). RESULTS: Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene. In patients with 9pLOH, JAK2 had a homozygous G(rightarrow)T transversion, causing phenylalanine to be substituted for valine at position 617 of JAK2 (V617F). All 51 patients with 9pLOH had the V617F mutation. Of 193 patients without 9pLOH, 66 were heterozygous for V617F and 127 did not have the mutation. The frequency of V617F was 65 percent among patients with polycythemia vera (83 of 128), 57 percent among patients with idiopathic myelofibrosis (13 of 23), and 23 percent among patients with essential thrombocythemia (21 of 93). V617F is a somatic mutation present in hematopoietic cells. Mitotic recombination probably causes both 9pLOH and the transition from heterozygosity to homozygosity for V617F. Genetic evidence and in vitro functional studies indicate that V617F gives hematopoietic precursors proliferative and survival advantages. Patients with the V617F mutation had a significantly longer duration of disease and a higher rate of complications (fibrosis, hemorrhage, and thrombosis) and treatment with cytoreductive therapy than patients with wild-type JAK2. CONCLUSIONS: A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.	Univ Basel Hosp, Dept Res Expt Hematol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Lab Med, CH-4031 Basel, Switzerland; Univ Pavia, Sch Med, Div Hematol, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ric & Cura Carattere Sci, I-27100 Pavia, Italy	University of Basel; University of Basel; University of Basel; University of Pavia; IRCCS Fondazione San Matteo	Skoda, RC (corresponding author), Univ Basel Hosp, Dept Res, Hebelstr 20, CH-4031 Basel, Switzerland.	radek.skoda@unibas.ch	Buser, Andreas S/A-2660-2008; Cazzola, Mario/AAQ-8854-2021; Passamonti, Francesco/AAB-2262-2022; passweg, jakob/AAG-3911-2020; Buser, Andreas/AAL-8676-2020	Buser, Andreas S/0000-0002-7942-6746; Cazzola, Mario/0000-0001-6984-8817; Passamonti, Francesco/0000-0001-8068-5289; Buser, Andreas/0000-0002-7942-6746; Kralovics, Robert/0000-0002-6997-8539; Passweg, Jakob R/0000-0001-7092-3351				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Axelrad AA, 2000, BLOOD, V96, P3310; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Brodmann S, 2000, ANN HEMATOL, V79, P312, DOI 10.1007/s002779900136; Chen Z, 1998, GENE CHROMOSOME CANC, V22, P321, DOI 10.1002/(SICI)1098-2264(199808)22:4<321::AID-GCC8>3.0.CO;2-X; CORREA PN, 1994, BLOOD, V83, P99; DAI CH, 1991, J CLIN INVEST, V87, P391, DOI 10.1172/JCI115009; DAI CH, 1992, BLOOD, V80, P891; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; DIEZMARTIN JL, 1991, MAYO CLIN PROC, V66, P287, DOI 10.1016/S0025-6196(12)61011-8; ElKassar N, 1997, BLOOD, V89, P128, DOI 10.1182/blood.V89.1.128.128_128_134; Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Harrison CN, 1999, BLOOD, V93, P417, DOI 10.1182/blood.V93.2.417.402a33_417_424; Horikawa Y, 1997, BLOOD, V90, P4031, DOI 10.1182/blood.V90.10.4031; Kralovics R, 2003, BLOOD, V102, P3793, DOI 10.1182/blood-2003-03-0885; Kralovics R, 2003, BLOOD, V102, P1869, DOI 10.1182/blood-2003-03-0744; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Liu E, 2003, BLOOD, V101, P3294, DOI 10.1182/blood-2002-07-2287; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; MERTENS F, 1991, LEUKEMIA, V5, P214; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murphy S, 1999, SEMIN HEMATOL, V36, P9; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; PAL N, 1990, ONCOGENE, V5, P1665; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Passamonti F, 2004, BRIT J HAEMATOL, V126, P650, DOI 10.1111/j.1365-2141.2004.05098.x; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Raghavan M, 2005, CANCER RES, V65, P375; REGECAMBRIN G, 1987, CANCER GENET CYTOGEN, V25, P233, DOI 10.1016/0165-4608(87)90183-X; Roder S, 2001, EXP HEMATOL, V29, P694, DOI 10.1016/S0301-472X(01)00637-3; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Silver RT, 2003, LEUKEMIA, V17, P1186, DOI 10.1038/sj.leu.2402938; Spivak JL, 2004, BLOOD, V103, P3241, DOI 10.1182/blood-2003-12-4248; Spivak JL, 2004, SEMIN HEMATOL, V41, P1, DOI 10.1053/j.seminhematol.2004.02.011; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; WADEY RB, 1990, ONCOGENE, V5, P901; Weinberg RS, 1997, SEMIN HEMATOL, V34, P64; Westwood NB, 2000, BRIT J HAEMATOL, V110, P839, DOI 10.1046/j.1365-2141.2000.02242.x; Westwood NB, 2001, HAEMATOLOGICA, V86, P464	47	2682	2871	2	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1779	1790		10.1056/NEJMoa051113	http://dx.doi.org/10.1056/NEJMoa051113			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858187	Bronze			2022-12-01	WOS:000228689000008
J	Malescio, G				Malescio, G			Predicting with unpredictability	NATURE			English	Editorial Material							RANDOMNESS		Univ Messina, Dept Phys, I-98166 Messina, Italy	University of Messina	Malescio, G (corresponding author), Univ Messina, Dept Phys, I-98166 Messina, Italy.							Calude CS, 1999, NATURE, V400, P319, DOI 10.1038/22435; CHAITIN GJ, 1975, SCI AM, V232, P47, DOI 10.1038/scientificamerican0575-47; Metropolis N., 1987, LOS ALAMOS SCI, P125	3	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1073	1073		10.1038/4341073a	http://dx.doi.org/10.1038/4341073a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858553	Bronze			2022-12-01	WOS:000228693300021
J	Nilsson, C; Reidy, CA; Dynesius, M; Revenga, C				Nilsson, C; Reidy, CA; Dynesius, M; Revenga, C			Fragmentation and flow regulation of the world's large river systems	SCIENCE			English	Article							CONSERVATION; DAM; RESERVOIR; ZONE; FISH	A global overview of dam-based impacts on large river systems shows that over half (172 out of 292) are affected by dams, including the eight most biogeographicalty diverse. Dam-impacted catchments experience higher irrigation pressure and about 25 times more economic activity per unit of water than do unaffected catchments. In view of projected changes in climate and water resource use, these findings can be used to identify ecological risks associated with further impacts on large river systems.	Umea Univ, Dept Ecol & Environm Sci, Landscape Ecol Grp, SE-90187 Umea, Sweden; Nature Conservancy, Global Prior Grp, Arlington, VA 22203 USA	Umea University; Nature Conservancy	Nilsson, C (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Landscape Ecol Grp, SE-90187 Umea, Sweden.	christer.nilsson@emg.umu.se	Nilsson, Christer/AAI-1354-2019; Dynesius, Mats/A-6219-2009	Dynesius, Mats/0000-0003-0628-4203				ARTHINGTON AH, 1995, CONDITION WORLDS AQU; Avakyan A. B., 1998, Lakes Reservoirs Research and Management, V3, P45, DOI 10.1111/j.1440-1770.1998.tb00031.x; Bubb DH, 2004, FRESHWATER BIOL, V49, P357, DOI 10.1111/j.1365-2426.2003.01178.x; Chang SP, 1998, WATER SCI TECHNOL, V37, P325, DOI 10.1016/S0273-1223(98)00040-7; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; FEKETE B, 1999, 22 WORLD MET ORG GLO; Gehrke PC, 2002, RIVER RES APPL, V18, P265, DOI 10.1002/rra.669; Gillett RM, 2002, AM J HUM BIOL, V14, P50, DOI 10.1002/ajhb.10019; GORMITZ V, 2000, SEA LEVEL RISE HIST, P97; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Indrabudi H, 1998, LAND DEGRAD DEV, V9, P311, DOI 10.1002/(SICI)1099-145X(199807/08)9:4<311::AID-LDR294>3.0.CO;2-X; *INT COMM LARG DAM, 2003, WORLD REG DAMS 2003; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Lemly AD, 2000, ENVIRON MANAGE, V25, P485, DOI 10.1007/s002679910039; Levine JM, 2003, ECOLOGY, V84, P1215, DOI 10.1890/0012-9658(2003)084[1215:APMATT]2.0.CO;2; McCully P., 1996, SILENCED RIVERS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Penczak T, 2000, ECOL FRESHW FISH, V9, P109, DOI 10.1034/j.1600-0633.2000.90113.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Prowse TD, 2002, WATER INT, V27, P58, DOI 10.1080/02508060208686978; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; QING D, 1998, RIVER DRAGON COM 3 G; Rosa LP, 2004, CLIMATIC CHANGE, V66, P9, DOI 10.1023/B:CLIM.0000043158.52222.ee; SHIKLOMANOV A, 1997, COMPREHENSIVE ASSESS; SIEBERT S, 2001, GLOBAL MAP IRRIGATED; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; STGEORGES M, 1995, CAN J ZOOL, V73, P755, DOI 10.1139/z95-089; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; World Commission on Dams, 2000, REP WORLD COMM DAMS	31	2230	2373	45	1117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					405	408		10.1126/science.1107887	http://dx.doi.org/10.1126/science.1107887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831757				2022-12-01	WOS:000228492000050
J	Westall, F				Westall, F			Life on the early earth: A sedimentary view	SCIENCE			English	Editorial Material							GREENSTONE-BELT; SOUTH-AFRICA; MICROFOSSILS; FOSSILS; ROCKS		CNRS, Ctr Biophys Mol, F-45071 Orleans, France	Centre National de la Recherche Scientifique (CNRS)	Westall, F (corresponding author), CNRS, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans, France.	westall@cnrs-orleans.fr						Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Furnes H, 2004, SCIENCE, V304, P578, DOI 10.1126/science.1095858; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Rasmussen B, 2000, NATURE, V405, P676, DOI 10.1038/35015063; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; TYLER SA, 1954, SCIENCE, V119, P606, DOI 10.1126/science.119.3096.606; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; Walsh MM, 2004, ASTROBIOLOGY, V4, P429, DOI 10.1089/ast.2004.4.429; Westall F, 2003, CR PALEVOL, V2, P485, DOI 10.1016/j.crpv.2003.09.009; Westall F, 2003, PRECAMBRIAN RES, V126, P313, DOI 10.1016/S0301-9268(03)00102-5; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3; WESTALL F, ASTROBIOLOGY FUTURE, P287	16	54	56	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 15	2005	308	5720					366	367		10.1126/science.1107227	http://dx.doi.org/10.1126/science.1107227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831746				2022-12-01	WOS:000228492000038
J	Armstrong, K; Micco, E; Carney, A; Stopfer, J; Putt, M				Armstrong, K; Micco, E; Carney, A; Stopfer, J; Putt, M			Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AFRICAN-AMERICAN FAMILIES; GENERAL-POPULATION; ETHNIC-DIFFERENCES; HEREDITARY BREAST; INCREASED RISK; HEALTH-CARE; MUTATIONS; DECISIONS; ATTITUDES; RACE	Context Given the current context of racial disparities in health and health care and the historical context of eugenics, racial disparities in the use of genetic susceptibility testing have been widely anticipated. However, to our knowledge there are no published studies examining the magnitude and determinants of racial differences in the use of genetic susceptibility testing. Objectives To investigate the relationship between race and the use of BRCA1/2 counseling among women with a family history of breast or ovarian cancer and to determine the contribution of socioeconomic characteristics, cancer risk perception and worry, attitudes about genetic testing, and interactions with primary care physicians to racial differences in utilization. Design, Setting, and Participants Case-control study (December 1999-August 2003) of 408 women with a family history of breast or ovarian cancer, of whom 217 underwent genetic counseling for BRCA1/2 testing (cases) and 191 women did not (controls). Participants received primary care within a large health system in greater Philadelphia, Pa. Main Outcome Measures Probability of carrying a BRCA1/2 mutation, socioeconomic characteristics, perception of breast and ovarian cancer risk, worry about breast and ovarian cancer, attitudes about BRCA1/2 testing, and primary care physician discussion of BRCA1/2 testing were measured prior to undergoing BRCA1/2 counseling for cases and at the time of enrollment for controls. Results African American women with a family history of breast or ovarian cancer were significantly less likely to undergo genetic counseling for BRCA1/2 testing than were white women with a family history of breast or ovarian cancer (odds ratio, 0.22; 95% confidence interval, 0.12-0.40). This association persisted after adjustment for probability of BRCA1/2 mutation, socioeconomic characteristics, breast and ovarian cancer risk perception and worry, attitudes about the risks and benefits of BRCA1/2 testing, and primary care physician discussion of BRCA1/2 testing (adjusted odds ratio for African American vs white, 0.28; 95% confidence interval, 0.09-0.89). Conclusions Racial disparities in the use of BRCA1/2 counseling are large and do not appear to be explained by differences in risk factors for carrying a BRCA1/2 mutation, socioeconomic factors, risk perception, attitudes, or primary care physician recommendations. The benefit of predictive genetic testing will not be fully realized unless these disparities can be addressed.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Armstrong, K (corresponding author), 1204 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	karmstro@mail.med.upenn.edu						*AM CANC SOC, 2002, CANC FACTS FIG 2002; Andrykowski MA, 1997, J CLIN ONCOL, V15, P2139, DOI 10.1200/JCO.1997.15.5.2139; Armstrong K, 2002, PREV MED, V34, P590, DOI 10.1006/pmed.2002.1022; Armstrong K, 2000, MED DECIS MAKING, V20, P308, DOI 10.1177/0272989X0002000307; Armstrong K, 2003, AM J MED GENET A, V117A, P154, DOI 10.1002/ajmg.a.10928; Armstrong K, 2000, CANCER EPIDEM BIOMAR, V9, P1251; Ashton CM, 2003, J GEN INTERN MED, V18, P146, DOI 10.1046/j.1525-1497.2003.20532.x; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Bluman LG, 1999, J CLIN ONCOL, V17, P1040, DOI 10.1200/JCO.1999.17.3.1040; Bosompra K, 2000, PREV MED, V30, P155, DOI 10.1006/pmed.1999.0610; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chen WY, 2002, J CLIN ONCOL, V20, P4485, DOI 10.1200/JCO.2002.08.147; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gao Q, 2000, HUM GENET, V107, P186, DOI 10.1007/s004390000290; Gao Q, 1997, AM J HUM GENET, V60, P1233; Gao Q, 2001, HUM GENET, V109, P239, DOI 10.1007/s004390100533; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; Grieco EM, 2001, OVERVIEW RACE HISPAN; HOLTZMAN NA, 1992, AM J HUM GENET, V50, P457; Hughes C, 1997, PATIENT EDUC COUNS, V32, P51, DOI 10.1016/S0738-3991(97)00064-5; Hughes C, 1996, BREAST CANCER RES TR, V40, P25, DOI 10.1007/BF01806000; *I MED, 2002, UN TREATM CONFR RAC; Lee SC, 2002, CANCER-AM CANCER SOC, V94, P1876, DOI 10.1002/cncr.10420; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lerman C, 1999, CANCER EPIDEM BIOMAR, V8, P361; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; Mefford HC, 1999, AM J HUM GENET, V65, P575, DOI 10.1086/302511; Meijers-Heijboer H, 2003, J CLIN ONCOL, V21, P1675, DOI 10.1200/JCO.2003.09.052; Olopade Olufunmilayo I., 2003, Cancer, V97, P236, DOI 10.1002/cncr.11019; Panguluri RCK, 1999, HUM GENET, V105, P28, DOI 10.1007/s004390051059; Peters N, 2004, CANCER EPIDEM BIOMAR, V13, P361; Rose A, 2004, J GEN INTERN MED, V19, P57, DOI 10.1111/j.1525-1497.2004.21146.x; STRUEWING JP, 1995, CANCER EPIDEM BIOMAR, V4, P169; Tambor ES, 1997, AM J MED GENET, V68, P43, DOI 10.1002/(SICI)1096-8628(19970110)68:1<43::AID-AJMG8>3.3.CO;2-X; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thompson HS, 2002, CANCER EPIDEM BIOMAR, V11, P1579; MUTATION PREVALENCE	42	324	323	1	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2005	293	14					1729	1736		10.1001/jama.293.14.1729	http://dx.doi.org/10.1001/jama.293.14.1729			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915JS	15827311	Bronze			2022-12-01	WOS:000228301100026
J	Foster, GR				Foster, GR			Apoptotic cell death: the caspase-cleavage "gold rush"	LANCET			English	Editorial Material									Barts & London NHS Trust, Queen Marys Sch Med & Dent, London E1 2AT, England	Barts Health NHS Trust; University of London; Queen Mary University London	Foster, GR (corresponding author), Barts & London NHS Trust, Queen Marys Sch Med & Dent, London E1 2AT, England.	g.r.foster@qmul.ac.uk		Foster, Graham/0000-0002-3704-386X				Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Matteucci C, 1999, CYTOMETRY, V35, P145, DOI 10.1002/(SICI)1097-0320(19990201)35:2<145::AID-CYTO6>3.0.CO;2-2; Que FG, 1996, GASTROENTEROLOGY, V110, P1238, DOI 10.1053/gast.1996.v110.pm8613014; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050	5	3	3	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1293	1294		10.1016/S0140-6736(05)61009-4	http://dx.doi.org/10.1016/S0140-6736(05)61009-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15823368				2022-12-01	WOS:000228219600010
J	Jones, EM; Surewicz, WK				Jones, EM; Surewicz, WK			Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids	CELL			English	Article							MOLECULAR-BASIS; HAMSTER PRP; PROTEIN; CONVERSION; SCRAPIE; TRANSMISSION; VARIANT; YEAST; PROPAGATION; OXIDATION	Spongiform encephalopathies are believed to be transmitted by self-perpetuating conformational conversion of the prion protein. It was shown recently that fundamental aspects of mammalian prion propagation can be reproduced in vitro in a seeded fibrillization of the recombinant prion protein variant Y145Stop (PrP23-144). Here we demonstrate that PrP23-144 amyloids from different species adopt distinct secondary structures and morphologies, and that these structural differences are controlled by one or two residues in a critical region. These sequence-specific structural characteristics correlate strictly with the seeding specificity of amyloid fibrils. However, cross-seeding of PrP23-144 from one species with preformed fibrils from another species may overcome natural sequence-based structural preferences, resulting in a new amyloid strain that inherits the secondary structure and morphology of the template. These data provide direct biophysical evidence that protein conformations are transmitted in PrP amyloid strains, establishing a foundation for a structural basis of mammalian prion transmission barriers.	Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu			NHLBI NIH HHS [HL007653] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Caughey B, 2001, TRENDS BIOCHEM SCI, V26, P235, DOI 10.1016/S0968-0004(01)01792-3; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Derkatch IL, 1996, GENETICS, V144, P1375; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott Michael, 2004, VVolume 41, P435; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	50	213	218	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 8	2005	121	1					63	72		10.1016/j.cell.2005.01.034	http://dx.doi.org/10.1016/j.cell.2005.01.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	915YU	15820679	Bronze			2022-12-01	WOS:000228348500010
J	Levesque, LE; Brophy, JM; Zhang, B				Levesque, LE; Brophy, JM; Zhang, B			The risk for myocardial infarction with cyclooxygenase-2 inhibitors: A population study of elderly adults	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CARDIOVASCULAR THROMBOTIC EVENTS; RANDOMIZED CONTROLLED-TRIAL; CORONARY HEART-DISEASE; GASTROINTESTINAL TOXICITY; RHEUMATOID-ARTHRITIS; NAPROXEN; COX-2; ROFECOXIB; HYPERTENSION	Background: Cyclooxygenase-2 (COX-2) selective inhibitors have been marketed since 1999 as safer alternatives to nonsterok dal anti-inflammatory drugs (NSAIDs). Debate about their cardiac safety has culminated in the recent withdrawal of rofecoxib. Additional studies are needed to better understand this risk and to determine whether this safety concern represents a class effect. Objective: To assess the influence of various NSAIDs on the risk for a first myocardial infarction (MI). Design: Population-based, retrospective cohort study analyzed using a time-matched, nested case-control approach. Setting: Quebec, Canada. Participants: 113 927 elderly persons without previous MI and newly treated with an NSAID between 1 January 1999 and 30 June 2002. Measurements: NSAID exposure and occurrence of MI assessed by using Quebec's administrative health databases. Results: Compared with no use of NSAIDs in the year preceding the event, current use of rofecoxib was associated with an increased risk for an acute MI (rate ratio [11111, 1.24 [95% Cl, 1.05 to 1.46]) that was more pronounced at higher doses (RR, 1.73 [Cl, 1.09 to 2.76]). The concomitant use of aspirin appears to decrease the risk associated with low-dose rofecoxib (1111, 1.00 [CI, 0.77 to 1.28]) but not with high-dose rofecoxib (1111, 2.36 [Cl, 1.27 to 4.391). No increased risks were observed with celecoxib (1111, 0.99 [Cl, 0.85 to 1.161) or the other NSAIDs. Limitations: The study could not completely account for all potential confounders, including over-the-counter use of aspirin and ibuprofen. Conclusions: These results provide evidence of an increased risk for acute MI in current users of rofecoxib among elderly persons with no history of MI. This risk appears greater at higher doses. Aspirin use mitigates the risk associated with low-dose but not high-dose rofecoxib. There was no evidence of an increased risk with the other NSAIDs.	McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Cardiol, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Brophy, JM (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Cardiol, Room M4-76,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	james.brophy@mcgill.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				ABRAHAM C, 2004, GLOBE MAIL      0901, pA1; [Anonymous], 2000, PHARMACOEPIDEM DR S; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Beaulieu MD, 2004, QJM-INT J MED, V97, P21, DOI 10.1093/qjmed/hch006; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Brassard P, 2003, AM HEART J, V145, DOI 10.1016/S0002-8703(03)00087-5; Brassard P, 2003, STROKE, V34, DOI 10.1161/01.STR.0000085831.91042.BF; Breslow NL, 1987, STAT METHODS CANC RE, VII, P178; Brophy JM, 2003, CAN MED ASSOC J, V169, P1153; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Collet D, 1999, MODELLING BINARY DAT, P223; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; *FDA ADV COMM, 2001, CARD SAF REV ROF; FitzGerald GA, 2001, CLIN EXP RHEUMATOL, V19, pS31; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Jick SS, 2000, PHARMACOTHERAPY, V20, P741, DOI 10.1592/phco.20.9.741.35209; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; LEVESQUE L, 2004, PHARMACOEPIDEMIOL S1, V13, pS49; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; MORROW JD, 2001, GOODMAN GILMANS PHAR; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; NEILAN T, 2004, NY TIMES        0930; Patrono Carlo, 2001, American Journal of Medicine, V110, p62S, DOI 10.1016/S0002-9343(00)00645-8; Rahme E, 2002, ARCH INTERN MED, V162, P1111, DOI 10.1001/archinte.162.10.1111; Rahme E, 2000, ARTHRITIS RHEUM-US, V43, P917, DOI 10.1002/1529-0131(200004)43:4<917::AID-ANR25>3.0.CO;2-F; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Reicin AS, 2002, AM J CARDIOL, V89, P204, DOI 10.1016/S0002-9149(01)02201-9; Roberts LJMJ, 2001, GOODMAN GILMANS PHAR; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Singh G, 1998, AM J MED, V105, p31S, DOI DOI 10.1016/S0002-9343(98)00072-2; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Solomon DH, 2002, ARCH INTERN MED, V162, P1099, DOI 10.1001/archinte.162.10.1099; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; *US FOOD DRUG ADM, FDA PUBL HLTH ADV SA; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; VELENTGAS P, 2001, PHARMACOEPIDEM DR S, V10, pS103; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; White WB, 2003, AM J CARDIOL, V92, P411, DOI 10.1016/S0002-9149(03)00659-3; Wright JM, 2002, CAN MED ASSOC J, V167, P1131	50	178	184	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2005	142	7					481	489		10.7326/0003-4819-142-7-200504050-00113	http://dx.doi.org/10.7326/0003-4819-142-7-200504050-00113			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913QL	15809459	Green Published			2022-12-01	WOS:000228167800001
J	Venter, L				Venter, L			Firms fill antiretroviral gap in South Africa	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Venter, L (corresponding author), The Lancet, London NW1 7BY, England.	lester.venter@btopenworld.com						*AS BUS COAL AIDS, 2002, WELC THAIL BUS COAL; *AV, 2005, HIV THAIL; BLOOM D, 2005, BUSINESS HIV AIDS CO; UNAIDS, UNAIDS S AFR; *WHO UNAIDS, 2004, UNAIDS S AFR; 2004, WORLD EC FOR GLOB HL; 2004, WORLD EC FOR US DIR; 2004, WORLD EC FOR RAP ASS; 2004, WORLD EC FOR PROV CO; 2004, WORLD EC FOR CHANG B	10	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 2	2005	365	9466					1215	1216		10.1016/S0140-6736(05)74793-0	http://dx.doi.org/10.1016/S0140-6736(05)74793-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912VI	15811443				2022-12-01	WOS:000228107600010
J	Hashizume, K; Chaussidon, M				Hashizume, K; Chaussidon, M			A non-terrestrial O-16-rich isotopic composition for the protosolar nebula	NATURE			English	Article							EARLY SOLAR-SYSTEM; OXYGEN ISOTOPES; METEORITES; HETEROGENEITY; INCLUSIONS; RESERVOIR; NITROGEN; SAMPLES; GRAINS; ORIGIN	The discovery in primitive components of meteorites(1,2) of large oxygen isotopic variations that could not be attributed to mass-dependent fractionation effects has raised a fundamental question: what is the composition of the protosolar gas from which the host grains formed? This composition is probably preserved in the outer layers of the Sun, but the resolution of astronomical spectroscopic measurements is still too poor to be useful for comparison with planetary material(3,4). Here we report a precise determination of the oxygen isotopic composition of the solar wind from particles implanted in the outer hundreds of nanometres of metallic grains in the lunar regolith. These layers of the grains are enriched in O-16 by >20 +/- 4 parts per thousand relative to the Earth, Mars and bulk meteorites, which implies the existence in the solar accretion disk of reactions-as yet unknown-that were able to change the O-17/O-16 and O-18/O-16 ratios in a way that was not dependent strictly on the mass of the isotope. Photochemical self-shielding of the CO gas irradiated by ultraviolet light(5-7) may be one of these key processes, because it depends on the abundance of the isotopes, rather than their masses.	Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Osaka 5600043, Japan; CNRS, CRPG, F-54501 Vandoeuvre Les Nancy, France	Osaka University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Hashizume, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Osaka 5600043, Japan.	kohash@ess.sci.osaka-u.ac.jp	Chaussidon, Marc/E-7067-2017					Chaussidon M, 1999, NATURE, V402, P270, DOI 10.1038/46235; CLAYTON, 1974, P LUNAR PLANET SCI C, V2, P1801; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.ea.21.050193.000555; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; EPSTEIN S, 1973, P LUNAR PLANET SCI C, P1559; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Hashizume K, 2004, ASTROPHYS J, V600, P480, DOI 10.1086/379637; Hashizume K, 2002, EARTH PLANET SC LETT, V202, P201, DOI 10.1016/S0012-821X(02)00781-1; IRELAND TR, 1992, GEOCHIM COSMOCHIM AC, V56, P2503, DOI 10.1016/0016-7037(92)90205-W; IRELAND TR, 2004, LUNAR PLANET SCI, V35, P1448; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; LYONS JR, 2004, LUNAR PLANET SCI, V35, P1970; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Morris R.V., 1980, P 11 LUN PLAN SCI C, P1697; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; ROBERT F, 1992, EARTH PLANET SC LETT, V108, P1, DOI 10.1016/0012-821X(92)90055-Z; Taylor Jr. H. P., 1973, P 4 LUN SCI C, P1657; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wieler R, 1998, SPACE SCI REV, V85, P303, DOI 10.1023/A:1005166904225; Wiens RC, 1999, METEORIT PLANET SCI, V34, P99, DOI 10.1111/j.1945-5100.1999.tb01735.x; Wiens RC, 2004, EARTH PLANET SC LETT, V222, P697, DOI 10.1016/j.epsl.2004.03.025; Wimmer-Schweingruber RF, 2003, AIP CONF PROC, V679, P577, DOI 10.1063/1.1618662; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Ziegler J.F, 1985, STOPPING RANGE IONS	30	84	86	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2005	434	7033					619	622		10.1038/nature03432	http://dx.doi.org/10.1038/nature03432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911NN	15800617				2022-12-01	WOS:000228011000038
J	Brandes, M; Willimann, K; Moser, B				Brandes, M; Willimann, K; Moser, B			Professional antigen-presentation function by human gamma delta T cells	SCIENCE			English	Article							ADAPTIVE IMMUNE-RESPONSE; DENDRITIC CELLS; IN-VIVO; ACTIVATION; RECEPTOR; IMMUNOTHERAPY; RECOGNITION; COMPLEX; SYSTEM; CANCER	Human gamma delta T cells are considered to play a vital role in protective immunity through cytokine secretion and cytotoxic activity. We report that cells expressing the V delta 2V delta 2(+)-T cell receptor (V delta 2(+) T cells) also display principal characteristics of professional antigen-presenting cells such as dendritic cells. Thus, when activated, these cells efficiently processed and displayed antigens and provided co-stimulatory signals sufficient for strong induction of naive alpha beta T cell proliferation and differentiation. We suggest that, upon microbial activation, V delta 2(+) T cells participate in the induction of adaptive immune responses and that these cells may be a useful tool in vaccine development and immunotherapy.	Japan Sci & Technol Agcy, Int Cooperat Res Project, Quantum Spin Informat Project, Atsugi, Kanagawa 2430198, Japan; Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1130033, Japan	Japan Science & Technology Agency (JST); Harvard University; University of Tokyo	Moser, B (corresponding author), Japan Sci & Technol Agcy, Int Cooperat Res Project, Quantum Spin Informat Project, Morinosato Wakamiya 3-1, Atsugi, Kanagawa 2430198, Japan.	bernhard.moser@izb.unibe.ch		Moser, Bernhard/0000-0002-4354-4572				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Brandes M, 2003, BLOOD, V102, P3693, DOI 10.1182/blood-2003-04-1016; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen ZW, 2003, TRENDS IMMUNOL, V24, P213, DOI 10.1016/S1471-4906(03)00032-2; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; INABA K, 1989, J EXP MED, V170, P527, DOI 10.1084/jem.170.2.527; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Petersen TR, 2004, INT IMMUNOL, V16, P889, DOI 10.1093/intimm/dxh098; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; WYMANN MP, 1990, J BIOL CHEM, V265, P619	35	480	522	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					264	268		10.1126/science.1110267	http://dx.doi.org/10.1126/science.1110267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	15933162				2022-12-01	WOS:000230449800034
J	Evans, JMM; Donnelly, LA; Emslie-Smith, AM; Alessi, DR; Morris, AD				Evans, JMM; Donnelly, LA; Emslie-Smith, AM; Alessi, DR; Morris, AD			Metformin and reduced risk of cancer in diabetic patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECORD LINKAGE		Univ Dundee, Div Community Hlth Sci, Sect Publ Hlth, Dundee DD2 4BF, Scotland; Univ Dundee, Sch Life Sci, Dundee, Scotland; Univ Dundee, Div Med, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee	Evans, JMM (corresponding author), Univ Dundee, Div Community Hlth Sci, Sect Publ Hlth, Dundee DD2 4BF, Scotland.	j.m.mstansfield@dundee.ac.uk	Morris, Andrew D/C-2837-2009	Alessi, Dario/0000-0002-2140-9185	MRC [MC_U127070193] Funding Source: UKRI; Medical Research Council [MC_U127070193] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		EVANS JMM, 1995, BMJ-BRIT MED J, V311, P22, DOI 10.1136/bmj.311.6996.22; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524	5	1702	1815	3	168	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1304	1305		10.1136/bmj.38415.708634.F7	http://dx.doi.org/10.1136/bmj.38415.708634.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15849206	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000229655700023
J	Summerskill, W				Summerskill, W			Our children, our future	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Summerskill, W (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 4	2005	365	9475					1914	1914		10.1016/S0140-6736(05)66641-X	http://dx.doi.org/10.1016/S0140-6736(05)66641-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932XJ	15936409				2022-12-01	WOS:000229587800010
J	Lee, SJ; Matsuura, Y; Liu, SM; Stewart, M				Lee, SJ; Matsuura, Y; Liu, SM; Stewart, M			Structural basis for nuclear import complex dissociation by RanGTP	NATURE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; EXPORT; KARYOPHERINS; DOMAIN; BIND	Nuclear protein import is mediated mainly by the transport factor importin-beta that binds cytoplasmic cargo, most often via the importin-alpha adaptor, and then transports it through nuclear pore complexes. This active transport is driven by disassembly of the import complex by nuclear RanGTP(1-4). The switch I and II loops of Ran change conformation with nucleotide state(5-7), and regulate its interactions with nuclear trafficking components. Importin-beta consists of 19 HEAT repeats that are based on a pair of antiparallel alpha-helices ( referred to as the A- and B-helices). The HEAT repeats stack to yield two C-shaped arches, linked together to form a helicoidal molecule that has considerable conformational flexibility(1,8) (-12). Here we present the structure of full-length yeast importin-beta (Kap95p or karyopherin-beta) complexed with RanGTP, which provides a basis for understanding the crucial cargo-release step of nuclear import. We identify a key interaction site where the RanGTP switch I loop binds to the carboxy-terminal arch of Kap95p. This interaction produces a change in helicoidal pitch that locks Kap95p in a conformation that cannot bind importin-alpha or cargo. We suggest an allosteric mechanism for nuclear import complex disassembly by RanGTP.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	23	163	167	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					693	696		10.1038/nature03578	http://dx.doi.org/10.1038/nature03578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15864302				2022-12-01	WOS:000229476200054
J	Lawton, J; Ahmad, N; Hallowell, N; Hanna, L; Douglas, M				Lawton, J; Ahmad, N; Hallowell, N; Hanna, L; Douglas, M			Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION; ADHERENCE; KNOWLEDGE; HEALTH	Objective To explore British Pakistani and British. Indian patients' perceptions and experiences of taking oral hypoglycaemic agents (OHAs). Design Observational cross sectional study using in-depth interviews in English or Punjabi. Setting and participants 32 patients of Pakistani and Indian origin with type 2 diabetes, recruited from primary care and community sources in Edinburgh, Scotland. Results Respondents reported complex and ambivalent views about OHAs, which reflected their ambivalent attitudes towards Western drugs in general. Respondents considered OHAs to be an important part of the diabetic regimen because they perceived British healthcare professionals to be competent and trustworthy prescribers, and they considered the medicines available in Britain to be superior to those on the Indian subcontinent. Despite this, some respondents made deliberate efforts to reduce their tablet intake without being advised to do so. Reasons for this included perceptions that drugs worked by providing relief of symptoms and concerns that OHAs could be detrimental to health if taken for long periods, in conjunction with other drugs, or without traditional foods. Conclusions British Pakistani and Indian patients' perceptions of their ORAs may partly derive from popular ideas about drugs on the Indian subcontinent. Cultural factors need to be understood and taken into consideration to ensure that these patients are given appropriate advice and to avoid unnecessary changes to prescriptions.	Univ Edinburgh, Sch Clin Sci & Community Hlth, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland; Lothian NHS Board, Edinburgh EH8 9RS, Midlothian, Scotland	University of Edinburgh	Lawton, J (corresponding author), Univ Edinburgh, Sch Clin Sci & Community Hlth, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland.	J.Lawton@ed.ac.uk		Douglas, Margaret/0000-0003-1560-5451				Aadil N, 2004, BMJ-BRIT MED J, V329, P778, DOI 10.1136/bmj.329.7469.778; [Anonymous], [No title captured]; BENSON J, 2002, BRIT MED J, V325, P1314; BHOPAL RS, 1988, COMMUNITY MED, V10, P215; Cambridge Jan, 1999, TRANSLATOR, V5, P201, DOI DOI 10.1080/13556509.1999.10799041; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; DCOSTA FD, 2000, PRACTICAL DIABETES, V8, P64, DOI DOI 10.1002/PDI.1960080208; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Evans JMM, 2002, DIABETIC MED, V19, P685, DOI 10.1046/j.1464-5491.2002.00749.x; Gillam S, 1999, BRIT MED J, V319, P1215, DOI 10.1136/bmj.319.7219.1215; HUNTE PA, 1992, SOC SCI MED, V34, P1385, DOI 10.1016/0277-9536(92)90147-I; Lau DT, 2004, DIABETES CARE, V27, P2149, DOI 10.2337/diacare.27.9.2149; McLean CA, 2003, ETHNIC HEALTH, V8, P41, DOI 10.1080/13557850303558; Miller N H, 1997, Am J Med, V102, P43; NICHTER N, 1996, ANTHR INT HLTH ASIAN; Pardhan S, 2004, EYE, V18, P509, DOI 10.1038/sj.eye.6700680; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; QIDWAI W, 2002, JCPSP-J COLL PHYSICI, V12, P651; Saradamma RD, 2000, SOC SCI MED, V50, P891, DOI 10.1016/S0277-9536(99)00380-9; Sin CH, 2004, AGEING SOC, V24, P257, DOI 10.1017/S0144686X03001545; Strauss A., 1998, BASICS QUALITATIVE R; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; tain RPS of G, 1997, COMPLIANCE CONCORDAN	24	68	69	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2005	330	7502					1247	1249		10.1136/bmj.38460.642789.E0	http://dx.doi.org/10.1136/bmj.38460.642789.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15883139	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000229448900019
J	Gilbert, M; Mitchell, A; Bourn, D; Mawdsley, J; Cliton-Hadley, R; Wint, W				Gilbert, M; Mitchell, A; Bourn, D; Mawdsley, J; Cliton-Hadley, R; Wint, W			Cattle movements and bovine tuberculosis in Great Britain	NATURE			English	Article							DISEASE; PREDICTION; EPIDEMIC; DYNAMICS	For 20 years, bovine tuberculosis (BTB) has been spreading in Great Britain ( England, Wales and Scotland) and is now endemic in the southwest and parts of central England and in southwest Wales, and occurs sporadically elsewhere. Although its transmission pathways remain poorly understood, the disease's distribution was previously modelled statistically by using environmental variables and measures of their seasonality(1). Movements of infected animals have long been considered a critical factor in the spread of livestock diseases, as reflected in strict import/export regulations, the extensive movement restrictions imposed during the 2001 foot-and-mouth disease outbreak(2,3), the tracing procedures after a new case of BTB has been confirmed and the Government's recently published strategic framework for the sustainable control on BTB4. Since January 2001 it has been mandatory for stock-keepers in Great Britain to notify the British Cattle Movement Service of all cattle births, movements and deaths(5). Here we show that movements as recorded in the Cattle Tracing System data archive, and particularly those from areas where BTB is reported, consistently outperform environmental, topographic and other anthropogenic variables as the main predictor of disease occurrence. Simulation distribution models for 2002 and 2003, incorporating all predictor categories, are presented and used to project distributions for 2004 and 2005.	Environm Res Grp Oxford Ltd, Oxford OX1 3QE, England; Univ Libre Bruxelles, B-1050 Brussels, Belgium; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England	Universite Libre de Bruxelles; Veterinary Laboratories Agency	Wint, W (corresponding author), Environm Res Grp Oxford Ltd, POB 346, Oxford OX1 3QE, England.	william.wint@zoo.ox.ac.uk	Gilbert, Marius/C-6969-2009; Clifton-Hadley, Richard S/C-2503-2011; Mitchell, Andrew P/L-6141-2014	Wint, William/0000-0003-0916-0847; Gilbert, Marius/0000-0003-3708-3359				BOURNE FJ, 2001, EPIDEMIOLOGICAL INVE; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Defra, 2005, GOV STRAT FRAM SUST; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hay SI, 1999, TROP MED INT HEALTH, V4, P58, DOI 10.1046/j.1365-3156.1999.00355.x; HAY SI, 2000, ADV PARASITOLOGY, V47; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Hengeveld, 1989, DYNAMICS BIOL INVASI; Krebs J., 1997, PB3423 HMSO; Mitchell A, 2005, ANIM SCI, V80, P265, DOI 10.1079/ASC50020265; *NAO, 2003, ID TRACK LIV ENGL; Russell CA, 2004, P ROY SOC B-BIOL SCI, V271, P21, DOI 10.1098/rspb.2003.2559; Shigesada N., 1997, BIOL INVASIONS THEOR; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Wint GRW, 2002, TRENDS MICROBIOL, V10, P441, DOI 10.1016/S0966-842X(02)02444-7	17	270	272	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					491	496		10.1038/nature03548	http://dx.doi.org/10.1038/nature03548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917808	Green Published			2022-12-01	WOS:000229337800054
J	Kepinski, S; Leyser, O				Kepinski, S; Leyser, O			The Arabidopsis F-box protein TIR1 is an auxin receptor	NATURE			English	Article							AUX/IAA PROTEINS; SCF; DEGRADATION; GENETICS; GROWTH; GENES	Despite 100 years of evidence showing a pivotal role for indole-3-acetic acid (IAA or auxin) in plant development, the mechanism of auxin perception has remained elusive. Central to auxin response are changes in gene expression, brought about by auxin-induced interaction between the Aux/IAA transcriptional repressor proteins and the ubiquitin - ligase complex SCFTIR1, thus targeting for them proteolysis. Regulated SCF-mediated protein degradation is a widely occurring signal transduction mechanism. Target specificity is conferred by the F-box protein subunit of the SCF (TIR1 in the case of Aux/IAAs) and there are multiple F-box protein genes in all eukaryotic genomes examined so far. Although SCF - target interaction is usually regulated by signal-induced modification of the target, we have previously shown that auxin signalling involves the modification of SCFTIR1. Here we show that this modification involves the direct binding of auxin to TIR1 and thus that TIR1 is an auxin receptor mediating transcriptional responses to auxin.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; SLU, Umea Plant Sci Ctr, S-90183 Umea, Sweden	University of York - UK; Swedish University of Agricultural Sciences; Umea University	Kepinski, S (corresponding author), Univ York, Dept Biol, Box 373, York YO10 5YW, N Yorkshire, England.	ssk2@york.ac.uk; hmol1@york.ac.uk	Leyser, Ottoline/AAC-5577-2019	Leyser, Ottoline/0000-0003-2161-3829	Biotechnology and Biological Sciences Research Council [BBS/B/09392] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Berleth T, 2004, CURR OPIN PLANT BIOL, V7, P553, DOI 10.1016/j.pbi.2004.07.016; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Leyser O, 2002, ANNU REV PLANT BIOL, V53, P377, DOI 10.1146/annurev.arplant.53.100301.135227; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	30	1185	1326	8	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					446	451		10.1038/nature03542	http://dx.doi.org/10.1038/nature03542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15917798				2022-12-01	WOS:000229337800044
J	Latvala, J; von Hertzen, L; Lindholm, H; Haahtela, T				Latvala, J; von Hertzen, L; Lindholm, H; Haahtela, T			Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHINITIS		Finnish Inst Occupat Hlth, Res Inst Mil Med, Oulu 90220, Finland; Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki 00029, Finland; Finnish Inst Occupat Hlth, Helsinki 00250, Finland	Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health	Latvala, J (corresponding author), Finnish Inst Occupat Hlth, Res Inst Mil Med, Aapistie 1, Oulu 90220, Finland.	jari.latvala@ttl.fi						Braback L, 2004, CLIN EXP ALLERGY, V34, P38, DOI 10.1111/j.1365-2222.2004.01841.x; Braun-Fahrlander C, 2004, EUR RESPIR J, V23, P407, DOI 10.1183/09031936.04.00074004; HAAHTELA T, 1990, BRIT MED J, V301, P266, DOI 10.1136/bmj.301.6746.266; Haahtela T, 2001, THORAX, V56, P806, DOI 10.1136/thorax.56.10.806; Verlato G, 2003, J ALLERGY CLIN IMMUN, V111, P1232, DOI 10.1067/mai.2003.1484	5	82	86	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2005	330	7501					1186	1187		10.1136/bmj.38448.603924.AE	http://dx.doi.org/10.1136/bmj.38448.603924.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15849204	Green Published, Bronze			2022-12-01	WOS:000229320500019
J	Essers, MAG; de Vries-Smits, LMM; Barker, N; Polderman, PE; Burgering, BMT; Korswagen, HC				Essers, MAG; de Vries-Smits, LMM; Barker, N; Polderman, PE; Burgering, BMT; Korswagen, HC			Functional interaction between beta-catenin and FOXO in oxidative stress signaling	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; FORKHEAD TRANSCRIPTION FACTORS; CELL-CYCLE; C-ELEGANS; GENE-EXPRESSION; DAF-16; ACTIVATION; PATHWAY; RAS	beta-Catenin is a multifunctional protein that mediates Writ signaling by binding to members of the T cell factor (TCF) family of transcription factors. Here, we report an evolutionarily conserved interaction of beta-catenin with FOXO transcription factors, which are regulated by insulin and oxidative stress signaling. beta-Catenin binds directly to FOXO and enhances FOXO transcriptional activity in mammalian cells. In Caenorhabditis elegans, loss of the beta-catenin BAR-1 reduces the activity of the FOXO ortholog DAF-16 in dauer formation and life span. Association of beta-catenin with FOXO was enhanced in cells exposed to oxidative stress. Furthermore, BAR-1 was required for the oxidative stress-induced expression of the DAF-16 target gene sod-3 and for resistance to oxidative damage. These results demonstrate a role for beta-catenin in regulating FOXO function that is particularly important under conditions of oxidative stress.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Univ Med Ctr, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Burgering, BMT (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	b.m.t.burgering@med.uu.nl; rkors@niob.knaw.nl	Essers, Marieke A.G./B-7758-2017; Barker, Nick/A-5535-2011; Korswagen, Hendrik/I-8782-2012; Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021	Essers, Marieke A.G./0000-0003-3117-1809; Barker, Nick/0000-0003-3566-4475				Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; ESSERS MA, UNPUB; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	20	583	618	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2005	308	5725					1181	1184		10.1126/science.1109083	http://dx.doi.org/10.1126/science.1109083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928TA	15905404				2022-12-01	WOS:000229293400047
J	Hao, ZY; Duncan, GS; Chang, CC; Elia, A; Fang, M; Wakeham, A; Okada, H; Calzascia, T; Jang, YJ; Annick, YT; Yeh, WC; Ohashi, P; Wang, XD; Mak, TW				Hao, ZY; Duncan, GS; Chang, CC; Elia, A; Fang, M; Wakeham, A; Okada, H; Calzascia, T; Jang, YJ; Annick, YT; Yeh, WC; Ohashi, P; Wang, XD; Mak, TW			Specific ablation of the apoptotic functions of cytochrome c reveals a differential requirement for cytochrome c and apaf-1 in apoptosis	CELL			English	Article							FAMILY MEMBER BIM; CELL-DEATH; PARAVENTRICULAR NUCLEUS; CASPASE ACTIVATION; GROWTH-HORMONE; FACTOR BRN-2; FACTOR-I; MICE; DEFICIENCY; BAX	As components of the apoptosome, a caspase-activating complex, cytochrome c (Cyt c) and Apaf-1 are thought to play critical roles during apoptosis. Due to the obligate function of Cyt c in electron transport, its requirement for apoptosis in animals has been difficult to establish. We generated "knockin" mice expressing a mutant Cyt c (KA allele), which retains normal electron transfer function but fails to activate Apaf-1. Most KA/KA mice displayed embryonic or perinatal lethality caused by defects in the central nervous system, and surviving mice exhibited impaired lymphocyte homeostasis. Although fibroblasts from the KA/KA mice were resistant to apoptosis, their thymocytes were markedly more sensitive to death stimuli than Apaf-1(-/-) thymocytes. Upon treatment with gamma irradiation, procaspases were efficiently activated in apoptotic KA/KA thymocytes, but Apaf-1 oligomerization was not observed. These studies indicate the existence of a Cyt c- and apoptosome-independent but Apaf-1-dependent mechanism(s) for caspase activation.	Univ Toronto, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Dept Immunol, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hao, ZY (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada.	zyhao@uhnres.utoronto.ca; tmak@uhnres.utoronto.ca	Duncan, Gordon/AIE-7011-2022	Calzascia, Thomas/0000-0001-8225-6744; Wang, Xiaodong/0000-0001-9885-356X; Ohashi, Pamela S./0000-0003-2915-9317; Chang, Chia-Che/0000-0003-3509-3713	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM R01 57158] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Buller KM, 2003, NEUROSCIENCE, V118, P189, DOI 10.1016/S0306-4522(02)00808-4; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; Dorshkind K, 2003, CLIN IMMUNOL, V109, P197, DOI 10.1016/S1521-6616(03)00181-5; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hefco V, 2004, BRAIN BEHAV IMMUN, V18, P158, DOI 10.1016/S0889-1591(03)00114-4; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; RATHMELL JC, 2002, CELL S, V109, P97; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Wrona D, 2003, BRAIN BEHAV IMMUN, V17, P453, DOI 10.1016/S0889-1591(03)00065-5; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	46	208	225	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					579	591		10.1016/j.cell.2005.03.016	http://dx.doi.org/10.1016/j.cell.2005.03.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907471	Bronze			2022-12-01	WOS:000229331200014
J	Youngren, KK; Coveney, D; Peng, XN; Bhattacharya, C; Schmidt, LS; Nickerson, ML; Lamb, BT; Deng, JM; Behringer, RR; Capel, B; Rubin, EM; Nadeau, JH; Matin, A				Youngren, KK; Coveney, D; Peng, XN; Bhattacharya, C; Schmidt, LS; Nickerson, ML; Lamb, BT; Deng, JM; Behringer, RR; Capel, B; Rubin, EM; Nadeau, JH; Matin, A			The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours	NATURE			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; STEM-CELLS; MOUSE CHROMOSOME-18; MICE; TERATOMAS; DEFICIENCY; CYCLOOXYGENASE-2; TRANSCRIPTION; EXPRESSION	In mice, the Ter mutation causes primordial germ cell (PGC) loss in all genetic backgrounds(1). Ter is also a potent modifier of spontaneous testicular germ cell tumour (TGCT) susceptibility in the 129 family of inbred strains, and markedly increases TGCT incidence in 129-Ter/Termales(2-4). In 129-Ter/Ter mice, some of the remaining PGCs transform into undifferentiated pluripotent embryonal carcinoma cells(2-6), and after birth differentiate into various cells and tissues that compose TGCTs. Here, we report the positional cloning of Ter, revealing a point mutation that introduces a termination codon in the mouse orthologue (Dnd1) of the zebrafish dead end (dnd) gene. PGC deficiency is corrected both with bacterial artificial chromosomes that contain Dnd1 and with a Dnd1-encoding transgene. Dnd1 is expressed in fetal gonads during the critical period when TGCTs originate. DND1 has an RNA recognition motif and is most similar to the apobec complementation factor, a component of the cytidine to uridine RNA-editing complex. These results suggest that Ter may adversely affect essential aspects of RNA biology during PGC development. DND1 is the first protein known to have an RNA recognition motif directly implicated as a heritable cause of spontaneous tumorigenesis. TGCT development in the 129-Ter mouse strain models paediatric TGCT in humans. This work will have important implications for our understanding of the genetic control of TGCT pathogenesis and PGC biology.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; SAIC Frederick Inc, Basic Res Program, Frederick, MD 21702 USA; NCI, Immunobiol Lab, Frederick, MD 21702 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, Berkeley, CA 94720 USA	University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University; Case Western Reserve University; Duke University; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nadeau, JH (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.	jhn4@case.edu; amatin@mdanderson.org			NCI NIH HHS [P30 CA016672, R01 CA075056, R01 CA093754] Funding Source: Medline; NHLBI NIH HHS [R01 HL063054] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093754] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; Barbouti A, 2003, CANCER RES, V63, P1202; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Donovan PJ, 2003, CURR OPIN GENET DEV, V13, P463, DOI 10.1016/j.gde.2003.08.010; Drabkin HA, 1999, ONCOGENE, V18, P2589, DOI 10.1038/sj.onc.1202601; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Jinawath N, 2004, CANCER SCI, V95, P430, DOI 10.1111/j.1349-7006.2004.tb03227.x; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; SAKURAI T, 1994, MAMM GENOME, V5, P333, DOI 10.1007/BF00356550; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEVENS LC, 1961, J NATL CANCER I, V27, P443; Tsuei DJ, 2004, ONCOGENE, V23, P5815, DOI 10.1038/sj.onc.1207773; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836	30	269	289	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2005	435	7040					360	364		10.1038/nature03595	http://dx.doi.org/10.1038/nature03595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927HM	15902260	Green Accepted			2022-12-01	WOS:000229185000048
J	Kemper, AR; Cohn, LM; Fant, KE; Dombkowski, KJ; Hudson, SR				Kemper, AR; Cohn, LM; Fant, KE; Dombkowski, KJ; Hudson, SR			Follow-up testing among children with elevated screening blood lead levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION; GUIDELINES; HEALTH	Context Follow-up testing after an abnormal screening blood lead level is a key component of lead poisoning prevention. Objectives To measure the proportion of children with elevated screening lead levels who have follow-up testing and to determine factors associated with such care. Design, Setting, and Participants Retrospective, observational cohort study of 3682 Michigan Medicaid-enrolled children aged 6 years or younger who had a screening blood lead level of at least 10 mu g/dL (0.48 mu mol/L) between,January 1, 2002, and June 30, 2003. Main Outcome Measure Testing within 180 days of an elevated screening lead level. Results Follow-up testing was received by 53.9% (95% confidence interval [01, 52.2%-55.5%) of the children. In multivariate analysis adjusting for age, screening blood lead level results, and local health department catchment area, the relative risk of follow-up testing was lower for Hispanic or nonwhite children than for white children (0.91; 95% Cl, 0.87-0.94), for children living in urban compared with rural areas (0.92; 95% Cl, 0.89-0.96), and for children living in high- compared with low-risk lead areas (0.94; 95% Cl, 0.92-0.96). Among children who did not have follow-up testing, 58.6% (95% Cl, 56.3%-61.0%) had at least 1 medical encounter in the 6-month period after the elevated screening blood lead level, including encounters for evaluation and management (39.3 %; 95% Cl, 36.9%-41.6%) or preventive care (13.2 %; 95% Cl, 11.6%-14.8%). Conclusions The rate of follow-up testing after an abnormal screening blood lead level was low, and children with increased likelihood of lead poisoning were less likely to receive follow-up testing. At least half of the children had a missed opportunity for follow-up testing. The observed disparities of care may increase the burden of cognitive impairment among at-risk children.	Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; Michigan Dept Community Hlth, Childhood Lead Poisoning Prevent Program, Lansing, MI USA	University of Michigan System; University of Michigan; MDHHS - Michigan Department of Health & Human Services	Kemper, AR (corresponding author), 6E18 300 N Ingalls Bldg, Ann Arbor, MI 48109 USA.	kempera@med.umich.edu		Kemper, Alex/0000-0001-5491-3997				*AM MED ASS, 2003, CURR PROC TERM 2004; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; *CDCP, 2002, MAN EL BLOOD LEADS L; *CDCP, 1997, SCREEN YYOUNG CHILDR; Hoyle T, 2004, J PUBLIC HEALTH MAN, V10, pS66; Kaufmann RB, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e79; Meyer Pamela A, 2003, MMWR Surveill Summ, V52, P1; Papadouka Vikki, 2004, J Public Health Manag Pract, VSuppl, pS72; Piecoro LT, 2001, HEALTH SERV RES, V36, P357; ROPER WL, PREVENTING LEAD POIS; Sox CM, 2003, JAMA-J AM MED ASSOC, V290, P1057, DOI 10.1001/jama.290.8.1057; *US DEP COMM CENS, METR MICR STAT AR; US Department of Health and Human Services, 2000, HLTH PEOPL 2010; *US GAO, 1998, MED EL BLOOD LEAD LE; Wall TC, 2002, AMBUL PEDIATR, V2, P449, DOI 10.1367/1539-4409(2002)002<0449:CWVSGA>2.0.CO;2; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	17	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2232	2237		10.1001/jama.293.18.2232	http://dx.doi.org/10.1001/jama.293.18.2232			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886378	Bronze			2022-12-01	WOS:000228981100024
J	Hampton, T				Hampton, T			Breaking barriers in transdermal drug delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								The first successful method of transdermal drug administration was in the formof a skin patch. Since then the use of patches has constantly progressed as new, less irritating chemical permeation enhancers are developed. This form of drug delivery is now applied in areas such as contraception, hormone-replacement and smoking cessation.										Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102	1	13	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2083	2083		10.1001/jama.293.17.2083	http://dx.doi.org/10.1001/jama.293.17.2083			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870404				2022-12-01	WOS:000228808200005
J	Block, BA; Teo, SLH; Walli, A; Boustany, A; Stokesbury, MJW; Farwell, CJ; Weng, KC; Dewar, H; Williams, TD				Block, BA; Teo, SLH; Walli, A; Boustany, A; Stokesbury, MJW; Farwell, CJ; Weng, KC; Dewar, H; Williams, TD			Electronic tagging and population structure of Atlantic bluefin tuna	NATURE			English	Article							THUNNUS-THYNNUS; EAST ATLANTIC; TEMPERATURE; SATELLITE; GULF; MOVEMENTS; BIOLOGY; FISH	Electronic tags that archive or transmit stored data to satellites have advanced the mapping of habitats used by highly migratory fish in pelagic ecosystems(1-6). Here we report on the electronic tagging of 772 Atlantic bluefin tuna in the western Atlantic Ocean in an effort to identify population structure. Reporting electronic tags provided accurate location data(7-9) that show the extensive migrations of individual fish (n = 330). Geoposition data delineate two populations, one using spawning grounds in the Gulf of Mexico and another from the Mediterranean Sea. Transatlantic movements of western-tagged bluefin tuna reveal site fidelity to known spawning areas in the Mediterranean Sea. Bluefin tuna that occupy western spawning grounds move to central and eastern Atlantic foraging grounds. Our results are consistent with two populations of bluefin tuna with distinct spawning areas that overlap on North Atlantic foraging grounds. Electronic tagging locations, when combined with US pelagic longline observer and logbook catch data, identify hot spots for spawning bluefin tuna in the northern slope waters of the Gulf of Mexico. Restrictions on the time and area where longlining occurs would reduce incidental catch mortalities on western spawning grounds.	Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Monterey Bay Aquarium, Monterey, CA 93940 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Stanford University; Monterey Bay Aquarium Research Institute; Dalhousie University	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Weng, Kevin Chi-Ming/C-4709-2013	Weng, Kevin Chi-Ming/0000-0002-7069-7152				Apostolaki Panayiota, 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1121; Atwood TC, 2003, CAN J ZOOL, V81, P1589, DOI 10.1139/Z03-144; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1973, COMP BIOCHEM PHYSIOL, V44, P375, DOI 10.1016/0300-9629(73)90490-8; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Cort J.L., 1991, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V35, P213; EKSTROM PA, 2004, NATL I POLAR RES, V58, P210; Fromentin JM, 2003, SCI MAR, V67, P51, DOI 10.3989/scimar.2003.67s151; Hill R.D., 2001, ELECT TAGGING TRACKI, V1, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Landeira-Fernandez AM, 2004, AM J PHYSIOL-REG I, V286, pR398, DOI 10.1152/ajpregu.00392.2003; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mather F. J., 1995, 370 NOAA; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; National Research Council, 1994, ASS ATL BLUEF TUN; Nemerson D, 2000, FISH B-NOAA, V98, P118; Rivas L. R., 1954, Bulletin of Marine Science of the Gulf and Caribbean, V4, P302; Rooker JR, 2003, FISH OCEANOGR, V12, P75, DOI 10.1046/j.1365-2419.2003.00223.x; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; TURNER SC, 1994, ICCAT COLL VOL SCI P, V42, P170; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured]	30	571	591	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1121	1127		10.1038/nature03463	http://dx.doi.org/10.1038/nature03463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858572				2022-12-01	WOS:000228693300041
J	Ofri, D				Ofri, D			They sent me here	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY 10003 USA	New York University	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10003 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1746	1748		10.1056/NEJMp038252	http://dx.doi.org/10.1056/NEJMp038252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858183				2022-12-01	WOS:000228689000004
J	Kiernan, AE; Pelling, AL; Leung, KKH; Tang, ASP; Bell, DM; Tease, C; Lovell-Badge, R; Steel, KP; Cheah, KSE				Kiernan, AE; Pelling, AL; Leung, KKH; Tang, ASP; Bell, DM; Tease, C; Lovell-Badge, R; Steel, KP; Cheah, KSE			Sox2 is required for sensory organ development in the mammalian inner ear	NATURE			English	Article							HAIR-CELLS; STEM-CELLS; EXPRESSION; DROSOPHILA; MATH1; GENERATION; CHICKEN; GENES; DIFFERENTIATION; EPITHELIUM	Sensory hair cells and their associated non-sensory supporting cells in the inner ear are fundamental for hearing and balance. They arise from a common progenitor(1), but little is known about the molecular events specifying this cell lineage. We recently identified two allelic mouse mutants, light coat and circling (Lcc) and yellow submarine (Ysb), that show hearing and balance impairment(2). Lcc/Lcc mice are completely deaf, whereas Ysb/Ysb mice are severely hearing impaired(2). We report here that inner ears of Lcc/Lcc mice fail to establish a prosensory domain and neither hair cells nor supporting cells differentiate, resulting in a severe inner ear malformation, whereas the sensory epithelium of Ysb/Ysb mice shows abnormal development with disorganized and fewer hair cells. These phenotypes are due to the absence (in Lcc mutants) or reduced expression (in Ysb mutants) of the transcription factor SOX2, specifically within the developing inner ear. SOX2 continues to be expressed in the inner ears of mice lacking Math1 (also known as Atoh1 and HATH1), a gene essential for hair cell differentiation, whereas Math1 expression is absent in Lcc mutants, suggesting that Sox2 acts upstream of Math1.	Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England	University of Hong Kong; University of Nottingham; MRC National Institute for Medical Research; MRC Harwell	Cheah, KSE (corresponding author), Univ Hong Kong, Dept Biochem, Fac Med Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	hrmbdkc@hkusua.hku.hk	Cheah, Kathryn/C-4222-2009; Leung, Keith/C-4491-2009	Bell, Donald/0000-0002-3788-1580; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Buescher M, 2002, DEVELOPMENT, V129, P4193; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; CHEAH KSE, 1995, J CELL BIOL, V128, P223, DOI 10.1083/jcb.128.1.223; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Dong S, 2002, GENOMICS, V79, P777, DOI 10.1006/geno.2002.6783; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Fekete DM, 1998, J NEUROSCI, V18, P7811; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kishi M, 2000, DEVELOPMENT, V127, P791; KNOWLTON VY, 1967, J MORPHOL, V121, P179, DOI 10.1002/jmor.1051210302; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; LYON MF, 1979, MUTAT RES, V63, P161, DOI 10.1016/0027-5107(79)90113-1; Morsli H, 1998, J NEUROSCI, V18, P3327; Overton PM, 2002, DEVELOPMENT, V129, P4219; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	30	395	414	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1031	1035		10.1038/nature03487	http://dx.doi.org/10.1038/nature03487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846349				2022-12-01	WOS:000228524600041
J	Lin, XR; Hull, CM; Heitman, J				Lin, XR; Hull, CM; Heitman, J			Sexual reproduction between partners of the same mating type in Cryptococcus neoformans	NATURE			English	Article							PNEUMOCYSTIS-CARINII; FILOBASIDIELLA-NEOFORMANS; SACCHAROMYCES-CEREVISIAE; ALPHA; YEAST; GENE; ASSOCIATION; TOXOPLASMA; ACTIVATION; EVOLUTION	Cryptococcus neoformans is a globally distributed human fungal pathogen that causes life-threatening meningoencephalitis in immunocompromised patients(1). It has a defined sexual cycle involving haploid cells of a and a mating types(2), yet the vast majority of environmental and clinical isolates are a (ref. 3). Sexual recombination is normally expected to occur between isolates of opposite mating type in organisms with two mating types (or sexes). How sexual reproductive potential can be maintained in an organism with a largely unisexual, nearly clonal population genetic structure is unknown. One clue, however, is that a strains undergo fruiting, a process that resembles sexual mating(4) but is thought to be strictly mitotic and asexual. We report here that hallmarks of mating occur during fruiting, including diploidization and meiosis. Pheromone response pathway elements and the key meiotic regulator Dmc1 are required for efficient fruiting. Furthermore, fusion and meiosis can occur between non-isogenic a strains, enabling genetic exchange. These studies reveal how sexual reproduction can occur between partners of the same mating type. These findings have implications for the evolution of microbial pathogens, as well as for parthenogenesis, cell fusion events and transitions between self-fertilizing and outcrossing modes of reproduction observed in both fungi and other kingdoms.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Lin, XR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	xrlin@duke.edu; heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021; Lin, Xiaorong/ABC-4163-2021	Lin, Xiaorong/0000-0002-3390-8387				Anderson JB, 2004, GENETICS, V168, P1915, DOI 10.1534/genetics.104.033266; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hull CM, 2002, GENE DEV, V16, P3046, DOI 10.1101/gad.1041402; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Johnson A, 2003, NAT REV MICROBIOL, V1, P106, DOI 10.1038/nrmicro752; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; MATSUMOTO Y, 1984, J PROTOZOOL, V31, P420, DOI 10.1111/j.1550-7408.1984.tb02989.x; McClelland CM, 2004, TRENDS MICROBIOL, V12, P208, DOI 10.1016/j.tim.2004.03.003; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; ROSE MD, 1986, MOL CELL BIOL, V6, P3490, DOI 10.1128/MCB.6.10.3490; Sauvageau S, 2004, BIOESSAYS, V26, P1151, DOI 10.1002/bies.20150; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Sia RA, 2000, FUNGAL GENET BIOL, V29, P153, DOI 10.1006/fgbi.2000.1192; Smulian AG, 2001, GENETICS, V157, P991; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wyder MA, 1998, J EUKARYOT MICROBIOL, V45, P233, DOI 10.1111/j.1550-7408.1998.tb04531.x; Zeyl C, 2004, FEMS MICROBIOL LETT, V233, P187, DOI 10.1016/j.femsle.2004.02.007; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	30	293	307	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1017	1021		10.1038/nature03448	http://dx.doi.org/10.1038/nature03448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846346				2022-12-01	WOS:000228524600038
J	Thompson, WG; Goldstein, SL				Thompson, WG; Goldstein, SL			Open-system coral ages reveal persistent suborbital sea-level cycles	SCIENCE			English	Article							LAST INTERGLACIAL PERIOD; HUON PENINSULA; NORTH-ATLANTIC; REEF TERRACES; CLIMATE; TEMPERATURE; STALAGMITE; FLUCTUATIONS; OSCILLATIONS; CHRONOLOGY	Sea level is a sensitive index of global climate that has been linked to Earth's orbital variations, with a minimum periodicity of about 21,000 years. Although there is ample evidence for climate oscillations that are too frequent to be explained by orbital forcing, suborbital-frequency sea-level change has been difficult to resolve, primarily because of problems with uranium/thorium coral dating. Here we use a new approach that corrects coral ages for the frequently observed open-system behavior of uranium-series nuclides, substantially improving the resolution of sea-level reconstruction. This curve reveals persistent sea-level oscillations that are too frequent to be explained exclusively by orbital forcing.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Columbia University; Columbia University	Thompson, WG (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Clark Lab 118, Mail Stop 23, Woods Hole, MA 02543 USA.	wthompson@whoi.edu	Thompson, William/H-2407-2011					Abegg C, 2002, BIOL J LINN SOC, V75, P555, DOI 10.1046/j.1095-8312.2002.00045.x; [Anonymous], [No title captured]; Bard E, 2002, EARTH PLANET SC LETT, V196, P135, DOI 10.1016/S0012-821X(01)00600-8; BROECKER WS, 1963, J GEOPHYS RES, V68, P2817, DOI 10.1029/JZ068i009p02817; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; Fruijtier C, 2000, GEOL SOC AM BULL, V112, P267, DOI 10.1130/0016-7606(2000)112<0267:MSUTAF>2.3.CO;2; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; Genty D, 2003, NATURE, V421, P833, DOI 10.1038/nature01391; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Holgate SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019626; Lea DW, 2002, QUATERNARY SCI REV, V21, P283, DOI 10.1016/S0277-3791(01)00081-6; LI WX, 1989, NATURE, V339, P534, DOI 10.1038/339534a0; LUNDBERG J, 1994, QUATERNARY SCI REV, V13, P1, DOI 10.1016/0277-3791(94)90121-X; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; MESOLELL.KJ, 1969, J GEOL, V77, P250, DOI 10.1086/627434; Oppo DW, 2001, PALEOCEANOGRAPHY, V16, P280, DOI 10.1029/2000PA000527; Oppo DW, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000260; PLANGES V, 2002, EARTH PLANET SC LETT, V201, P87; Potter EK, 2004, EARTH PLANET SC LETT, V225, P191, DOI 10.1016/j.epsl.2004.05.034; Potter EK, 2004, EARTH PLANET SC LETT, V217, P171, DOI 10.1016/S0012-821X(03)00587-9; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; RICHARDS DA, 1994, NATURE, V367, P357, DOI 10.1038/367357a0; Sasaki K, 2004, QUATERN INT, V120, P51, DOI 10.1016/j.quaint.2004.01.006; Schellmann G, 2004, EARTH-SCI REV, V64, P157, DOI 10.1016/S0012-8252(03)00043-6; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Smart P. L., 1998, CAVE KARST SCI, V25, P67; Speed RC, 2004, GEOL SOC AM BULL, V116, P219, DOI 10.1130/B25167.1; Spotl C, 2002, GEOLOGY, V30, P815, DOI 10.1130/0091-7613(2002)030<0815:SOTLIP>2.0.CO;2; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; STIRLING CH, 1995, EARTH PLANET SC LETT, V135, P115, DOI 10.1016/0012-821X(95)00152-3; Stirling CH, 2001, SCIENCE, V291, P290, DOI 10.1126/science.291.5502.290; STIRLING CH, 1998, EARTH PLANET SC LETT, V160, P115; Thompson WG, 2003, EARTH PLANET SC LETT, V210, P365, DOI 10.1016/S0012-821X(03)00121-3; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Yokoyama Y, 2001, EARTH PLANET SC LETT, V193, P579, DOI 10.1016/S0012-821X(01)00515-5; Zhao JX, 2001, EARTH PLANET SC LETT, V184, P635, DOI 10.1016/S0012-821X(00)00353-8	45	198	204	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					401	404		10.1126/science.1104035	http://dx.doi.org/10.1126/science.1104035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917TL	15831756				2022-12-01	WOS:000228492000049
J	Bryant, HE; Schultz, N; Thomas, HD; Parker, KM; Flower, D; Lopez, E; Kyle, S; Meuth, M; Curtin, NJ; Helleday, T				Bryant, HE; Schultz, N; Thomas, HD; Parker, KM; Flower, D; Lopez, E; Kyle, S; Meuth, M; Curtin, NJ; Helleday, T			Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase	NATURE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; DNA-DAMAGE; REPLICATION FORKS; NUCLEAR FOCI; REPAIR; PARP-1; STABILITY; REQUIREMENT	Poly( ADP-ribose) polymerase (PARP1) facilitates DNA repair by binding to DNA breaks and attracting DNA repair proteins to the site of damage(1-3). Nevertheless, PARP1(-/-) mice are viable, fertile and do not develop early onset tumours(4). Here, we show that PARP inhibitors trigger gamma-H2AX and RAD51 foci formation. We propose that, in the absence of PARP1, spontaneous single-strand breaks collapse replication forks and trigger homologous recombination for repair. Furthermore, we show that BRCA2-deficient cells, as a result of their deficiency in homologous recombination, are acutely sensitive to PARP inhibitors, presumably because resultant collapsed replication forks are no longer repaired. Thus, PARP1 activity is essential in homologous recombination-deficient BRCA2 mutant cells. We exploit this requirement in order to kill BRCA2-deficient tumours by PARP inhibition alone. Treatment with PARP inhibitors is likely to be highly tumour specific, because only the tumours ( which are BRCA2(-/-)) in BRCA2(+/-) patients are defective in homologous recombination. The use of an inhibitor of a DNA repair enzyme alone to selectively kill a tumour, in the absence of an exogenous DNA-damaging agent, represents a new concept in cancer treatment.	Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Stockholm Univ, Arrhenius Lab, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Sheffield; Stockholm University; Newcastle University - UK	Helleday, T (corresponding author), Univ Sheffield, Sch Med, Inst Canc Studies, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	t.helleday@sheffield.ac.uk	bryant, helen/AHB-1139-2022; Helleday, Thomas/D-5224-2013; Schultz, Niklas/AFQ-8244-2022	bryant, helen/0000-0003-2720-7020; Lopez Knowles, Elena/0000-0002-0893-3361; Curtin, Nicola/0000-0003-1369-1843; Helleday, Thomas/0000-0002-7384-092X	NCI NIH HHS [F31 CA260794] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; CALDECOTT KW, 1992, NUCLEIC ACIDS RES, V20, P4575, DOI 10.1093/nar/20.17.4575; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; GRUBE K, 1991, ANAL BIOCHEM, V193, P236, DOI 10.1016/0003-2697(91)90015-L; HALLDORSSON H, 1978, FEBS LETT, V85, P349, DOI 10.1016/0014-5793(78)80489-X; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lundin C, 2003, J MOL BIOL, V328, P521, DOI 10.1016/S0022-2836(03)00313-9; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491	25	3371	3493	18	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2005	434	7035					913	917		10.1038/nature03443	http://dx.doi.org/10.1038/nature03443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829966				2022-12-01	WOS:000228327600044
J	Riedl, SJ; Li, WY; Chao, Y; Schwarzenbacher, R; Shi, YG				Riedl, SJ; Li, WY; Chao, Y; Schwarzenbacher, R; Shi, YG			Structure of the apoptotic protease-activating factor 1 bound to ADP	NATURE			English	Article							CYTOCHROME-C; CASPASE-9 ACTIVATION; PROCASPASE-9; APAF-1; OLIGOMERIZATION; ASSOCIATION; MECHANISMS; APOPTOSOME; BINDING; PROGRAM	Apoptosis is executed by caspases, which undergo proteolytic activation in response to cell death stimuli(1). The apoptotic protease-activating factor 1 (Apaf-1) controls caspase activation downstream of mitochondria(2). During apoptosis, Apaf-1 binds to cytochrome c and in the presence of ATP/dATP forms an apoptosome, leading to the recruitment and activation of the initiator caspase, caspase-9 ( ref. 2). The mechanisms underlying Apaf-1 function are largely unknown. Here we report the 2.2-angstrom crystal structure of an ADP-bound, WD40-deleted Apaf-1, which reveals the molecular mechanism by which Apaf-1 exists in an inactive state before ATP binding. The amino-terminal caspase recruitment domain packs against a three-layered alpha/beta fold, a short helical motif and a winged-helix domain, resulting in the burial of the caspase-9-binding interface. The deeply buried ADP molecule serves as an organizing centre to strengthen interactions between these four adjoining domains, thus locking Apaf-1 in an inactive conformation. Apaf-1 binds to and hydrolyses ATP/dATP and their analogues. The binding and hydrolysis of nucleotides seem to drive conformational changes that are essential for the formation of the apoptosome and the activation of caspase-9.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Calif San Diego, Joint Ctr Struct Genom, La Jolla, CA 92093 USA	Princeton University; University of California System; University of California San Diego	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu		Shi, Yigong/0000-0003-2030-168X				Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Genini D, 2000, J BIOL CHEM, V275, P29, DOI 10.1074/jbc.275.1.29; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Jaroszewski L, 2000, PROTEINS, V39, P197, DOI 10.1002/(SICI)1097-0134(20000515)39:3<197::AID-PROT10>3.0.CO;2-V; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang XD, 2001, GENE DEV, V15, P2922; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	30	261	274	6	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2005	434	7035					926	933		10.1038/nature03465	http://dx.doi.org/10.1038/nature03465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915SV	15829969				2022-12-01	WOS:000228327600047
J	Kistorp, C; Raymond, I; Pedersen, F; Gustafsson, F; Faber, J; Hildebrandt, P				Kistorp, C; Raymond, I; Pedersen, F; Gustafsson, F; Faber, J; Hildebrandt, P			N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; VENTRICULAR SYSTOLIC FUNCTION; ACUTE MYOCARDIAL-INFARCTION; GENERAL-POPULATION; RISK PREDICTION; LARGE-SAMPLE; PLASMA; DYSFUNCTION; FAILURE; MARKERS	Context B-type natriuretic peptides have been shown to predict cardiovascular disease in apparently healthy individuals but their predictive ability for mortality and future cardiovascular events compared with C-reactive protein (CRP) and urinary albumin/creatinine ratio is unknown. Objective To assess the prognostic value of the N-amino terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) vs CRP and urinary albumin/creatinine ratio in an older adult population. Design, Setting, and Participants A population-based prospective study of 764 participants aged 50 to 89 years from a community in Copenhagen, Denmark, in which 658 participants provided blood and urinary samples and were examined between September 1, 1998, and January 24, 2000. Of these participants, 626 without heart or renal failure were enrolled. A subgroup of 537 had no history of cardiovascular disease at baseline. During 5 years of follow-up (to December 31, 2003), 94 participants died and 65 developed a first major cardiovascular event. Main Outcome Measures Risk of mortality and first major cardiovascular event by baseline levels of NT-proBNP, CRP, and urinary albumin/creatinine ratio levels. Results After adjustment for the cardiovascular risk factors of age, sex, smoking, diabetes mellitus, hypertension or ischemic heart disease, total cholesterol, and serum creatinine, the hazard ratio (HR) of mortality for values above the 80th percentile of NT-proBNP was 1.96 (95% confidence interval [CI], 1.21-3.19); for CRP, 1.46 (95% CI, 0.89-2.24); and for urinary albumin/creatinine ratio, 1.88 (95% CI, 1.18-2.98). Additional adjustment for left ventricular systolic dysfunction did not markedly attenuate the predictive value of NT-proBNP (HR, 1.82; 95% CI, 1.11-2.98). The absolute unadjusted increase in mortality risk for participants with values above the 80th percentile vs equal to or below the 80th percentile was 24.5% for NT-proBNP, 7.8% for CRP, and 19.5% for urinary albumin/creatinine ratio. The NT-proBNP levels were associated with first major cardiovascular events (nonfatal myocardial infarction, fatal coronary heart disease, unstable angina, heart failure, stroke, and transient ischemic attack) with an adjusted HR of 3.24 (95% CI, 1.80-5.79) vs 1.02 (95% CI, 0.56-1.85) for CRP and 2.32 (95% CI, 1.33-4.05) for urinary albumin/creatinine ratio when comparing participants with values above the 80th percentile with those with values equal to or below the 80th percentile. Conclusions Measurements of NT-proBNP provide prognostic information of mortality and first major cardiovascular events beyond traditional risk factors. NT-proBNP was a stronger risk biomarker for cardiovascular disease and death than CRP was in nonhospitalized individuals aged 50 to 89 years.	Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Copenhagen, Denmark; Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Kistorp, C (corresponding author), Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, 57 Nordre Fasanvej, DK-2000 Copenhagen, Denmark.	cnkistorp@dadlnet.dk		Gustafsson, Finn/0000-0003-2144-341X; Kistorp, Caroline/0000-0002-3019-6775				Andersen TF, 1999, DAN MED BULL, V46, P263; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Borch-Johnsen K, 1999, ARTERIOSCL THROM VAS, V19, P1992, DOI 10.1161/01.ATV.19.8.1992; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Eda S, 1998, J CLIN LAB ANAL, V12, P137, DOI 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Goetze JP, 2004, EUR HEART J, V25, P759, DOI 10.1016/j.ehj.2004.02.009; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; Gustafsson Finn, 2003, HeartDrug, V3, P141, DOI 10.1159/000073839; HAMA N, 1995, CIRCULATION, V92, P1558, DOI 10.1161/01.CIR.92.6.1558; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; Karl J, 1999, SCAND J CLIN LAB INV, V59, P177; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; McClure SJ, 1998, BRIT MED J, V317, P516; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982; Mizuno Y, 2000, AM J CARDIOL, V86, P1036, DOI 10.1016/S0002-9149(00)01147-4; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 1996, HEART, V76, P232, DOI 10.1136/hrt.76.3.232; Pearson TA, 2003, CIRCULATION, V107, P645, DOI 10.1161/01.CIR.0000054482.38437.13; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Raymond I, 2003, HEART, V89, P745, DOI 10.1136/heart.89.7.745; Raymond Ilan, 2002, HeartDrug, V2, P167, DOI 10.1159/000065944; Richards AM, 2003, CIRCULATION, V107, P2786, DOI 10.1161/01.CIR.0000070953.76250.B9; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rossing P, 1996, BRIT MED J, V313, P779; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Tateishi J, 2000, CLIN CARDIOL, V23, P776, DOI 10.1002/clc.4960231016; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Troughton RW, 2004, J AM COLL CARDIOL, V43, P416, DOI 10.1016/j.jacc.2003.08.046; Tsutamoto T, 1997, CIRCULATION, V96, P509; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wiese S, 2000, CIRCULATION, V102, P3074	44	425	440	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2005	293	13					1609	1616		10.1001/jama.293.13.1609	http://dx.doi.org/10.1001/jama.293.13.1609			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913EV	15811980	Bronze			2022-12-01	WOS:000228135300023
J	Gardner, RG; Nelson, ZW; Gottschling, DE				Gardner, RG; Nelson, ZW; Gottschling, DE			Degradation-mediated protein quality control in the nucleus	CELL			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; UBIQUITIN-CONJUGATING ENZYMES; ER-ASSOCIATED DEGRADATION; YEAST SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; INTRACELLULAR-LOCALIZATION; MOLECULAR CHAPERONES; PROTEASOME PATHWAY; BINDING-PROTEIN; BUDDING YEAST	Protein quality control degradation systems rid the cell of aberrant proteins, preventing detrimental effects on normal cellular function. Although such systems have been identified in most subcellular compartments, none have been found in the nucleus. Here, we report the discovery of such a system in Saccharomyces cerevisiae. It is defined by San1p, a ubiquitin-protein ligase that, in conjunction with the ubiquitin-conjugating enzymes Cdc34p and Ubc1p, targets four distinct mutant nuclear proteins for ubiquitination and destruction by the proteasome. San1p has exquisite specificity for aberrant proteins and does not target the wild-type versions of its mutant substrates. San1p is nuclear localized and requires nuclear localization for function. Loss of SAN1 results in a chronic stress response, underscoring its role of protein quality control in the cell. We propose that San1p-mediated degradation acts as the last line of proteolytic defense against the deleterious accumulation of aberrant proteins in the nucleus and that analogous systems exist in other eukaryotes.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98109 USA.	dgottsch@fhcrc.org		Gardner, Richard/0000-0003-2162-6275	NIGMS NIH HHS [R01 GM043893-14, GM43893] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043893] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Baker A, 2003, HUM MOL GENET, V12, P2609, DOI 10.1093/hmg/ddg293; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; BANERJEE A, 1995, J BIOL CHEM, V270, P26209, DOI 10.1074/jbc.270.44.26209; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Betting J, 1996, J BIOL CHEM, V271, P25790, DOI 10.1074/jbc.271.42.25790; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brais B, 2003, CYTOGENET GENOME RES, V100, P252, DOI 10.1159/000072861; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Burchett SA, 2002, J BIOL CHEM, V277, P22156, DOI 10.1074/jbc.M202254200; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Cameroni E, 2004, CELL CYCLE, V3, P462; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chughtai ZS, 2001, J BIOL CHEM, V276, P20261, DOI 10.1074/jbc.M100364200; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Evans DRH, 1998, GENETICS, V150, P1393; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grandin N, 2001, MOL GENET GENOMICS, V265, P126, DOI 10.1007/s004380000398; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jana NR, 2003, J CHEM NEUROANAT, V26, P95, DOI 10.1016/S0891-0618(03)00029-2; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kahana A, 1999, MOL CELL BIOL, V19, P6608; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kawai R, 1999, CELL STRESS CHAPERON, V4, P46, DOI 10.1054/csac.1999.0076; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; LIU Y, 1995, MOL CELL BIOL, V15, P5635; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MADURA K, 1993, J BIOL CHEM, V268, P12046; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Ptak C, 2001, MOL CELL BIOL, V21, P6537, DOI 10.1128/MCB.21.19.6537-6548.2001; Qi HY, 2000, GENE DEV, V14, P1777; RINE J, 1987, GENETICS, V116, P9; ROSSI JM, 1989, J CELL BIOL, V108, P425, DOI 10.1083/jcb.108.2.425; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; SCHNELL R, 1989, GENETICS, V122, P29; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stirling PC, 2003, EMBO REP, V4, P565, DOI 10.1038/sj.embor.embor869; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; XU QL, 1995, MOL CELL BIOL, V15, P6025; XU QL, 1993, MOL CELL BIOL, V13, P7553, DOI 10.1128/MCB.13.12.7553	72	205	207	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 25	2005	120	6					803	815		10.1016/j.cell.2005.01.016	http://dx.doi.org/10.1016/j.cell.2005.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	912HF	15797381	Bronze			2022-12-01	WOS:000228067500010
J	Fitzpatrick, JW; Lammertink, M; Luneau, MD; Gallagher, TW; Harrison, BR; Sparling, GM; Rosenberg, KV; Rohrbaugh, RW; Swarthout, ECH; Wrege, PH; Swarthout, SB; Dantzker, MS; Charif, RA; Barksdale, TR; Remsen, JV; Simon, SD; Zollner, D				Fitzpatrick, JW; Lammertink, M; Luneau, MD; Gallagher, TW; Harrison, BR; Sparling, GM; Rosenberg, KV; Rohrbaugh, RW; Swarthout, ECH; Wrege, PH; Swarthout, SB; Dantzker, MS; Charif, RA; Barksdale, TR; Remsen, JV; Simon, SD; Zollner, D			Ivory-billed woodpecker (Campephilus principalis) persists in continental North America	SCIENCE			English	Article								The ivory-billed woodpecker (Campephilus principalis), long suspected to be extinct, has been rediscovered in the Big Woods region of eastern Arkansas. Visual encounters during 2004 and 2005, and analysis of a video clip from April 2004, confirm the existence of at least one mate. Acoustic signatures consistent with Campephilus display drums also have been heard from the region. Extensive efforts to find birds away from the primary encounter site remain unsuccessful, but potential habitat for a thinly distributed source population is vast (over 220,000 hectares).	Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1092 AD Amsterdam, Netherlands; Univ Arkansas, Dept Engn Technol, Little Rock, AR 72204 USA; Univ Arkansas, Dept Informat Technol, Little Rock, AR 72204 USA; Oakwood Coll, Dept Commun, Huntsville, AL 35896 USA; Birdman Prod, Choteau, MT 59422 USA; Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; Nature Conservancy, Little Rock, AR 72205 USA	Cornell University; University of Amsterdam; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Oakwood University; Louisiana State University System; Louisiana State University; Nature Conservancy	Fitzpatrick, JW (corresponding author), Cornell Univ, Cornell Lab Ornithol, 159 Sapsucker Woods Rd, Ithaca, NY 14850 USA.	jwf7@cornell.edu	Charif, Russell/AAA-8506-2021; Zöllner, Dana/AAP-2725-2020	Zöllner, Dana/0000-0002-0413-2700; Charif, Russell/0000-0002-2228-4740				ALLEN ARTHUR A., 1937, AUK, V54, P164; American Ornithologists' Union, 1998, CHECKL N AM BIRDS; BLUME D, 1996, SCHWARZSPECHT GRUSPE; Bull EL, 1995, BIRDS N AM; Christensen Hans, 2002, Dansk Ornitologisk Forenings Tidsskrift, V96, P187; Eckelberry D., 1961, DISCOVERY GREAT MOME, P195; Hoose Phillip M., 2004, RACE SAVE LORD GOD B; Jackson J.A, 2002, BIRDS N AM; Jackson JJ, 2004, SEARCH IVORY BILLED; LAMB GR, 1957, 1 INT COMM BIRD PRES; Lammertink Martjan, 1995, Bird Conservation International, V5, P53; Tanner JT., 1942, 1 NAT AUD SOC; The Nature Conservancy, 2002, CONS PLANN MISS RIV; TJERNBERG M, 1993, ORNIS FENNICA, V70, P155; 1991, BIRDS PREY NATURAL H, P111	15	107	116	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2005	308	5727					1460	1462		10.1126/science.1114103	http://dx.doi.org/10.1126/science.1114103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15860589				2022-12-01	WOS:000229619300051
J	Feng, L; Zhou, SP; Gu, LC; Gell, DA; Mackay, JP; Weiss, MJ; Gow, AJ; Shi, YG				Feng, L; Zhou, SP; Gu, LC; Gell, DA; Mackay, JP; Weiss, MJ; Gow, AJ; Shi, YG			Structure of oxidized alpha-haemoglobin bound to AHSP reveals a protective mechanism for haem	NATURE			English	Article							STABILIZING PROTEIN; SULFHEME PROTEINS; HYDROGEN-PEROXIDE; MYOGLOBIN; BINDING; SULFMYOGLOBIN; DEGRADATION; THALASSEMIA; INSIGHTS	The synthesis of haemoglobin A (HbA) is exquisitely coordinated during erythrocyte development to prevent damaging effects from individual alpha- and beta-subunits(1,2). The alpha-haemoglobin-stabilizing protein (AHSP) binds alpha-haemoglobin (alpha Hb), inhibits the ability of alpha Hb to generate reactive oxygen species and prevents its precipitation on exposure to oxidant stress(3-5). The structure of AHSP bound to ferrous alpha Hb is thought to represent a transitional complex through which alpha Hb is converted to a non-reactive, hexacoordinate ferric form(5). Here we report the crystal structure of this ferric alpha Hb - AHSP complex at 2.4 angstrom resolution. Our findings reveal a striking bis-histidyl configuration in which both the proximal and the distal histidines coordinate the haem iron atom. To attain this unusual conformation, segments of alpha Hb undergo drastic structural rearrangements, including the repositioning of several alpha-helices. Moreover, conversion to the ferric bis-histidine configuration strongly and specifically inhibits redox chemistry catalysis and haem loss from alpha Hb. The observed structural changes, which impair the chemical reactivity of haem iron, explain how AHSP stabilizes alpha Hb and prevents its damaging effects in cells.	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Princeton University; University of Pennsylvania; University of Sydney	Gow, AJ (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	gow@email.chop.edu; yshi@molbio.princeton.edu	Mackay, Joel P/D-6834-2011; Gow, Andrew/AAR-2309-2020; Gow, Andrew/N-8566-2013; Weiss, Mitchell J/A-1245-2013; Weiss, Mitchell J/W-9814-2018	Mackay, Joel P/0000-0001-7508-8033; Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Weiss, Mitchell J/0000-0003-2460-3036; Gell, David/0000-0003-0382-1181; Shi, Yigong/0000-0003-2030-168X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061692] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; BAGLIONI C, 1966, BIBL HAEMATOL, V29, P1056; BERZOFSKY JA, 1972, J BIOL CHEM, V247, P3783; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNN HF, 1987, BLOOD, V69, P1; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Dickerson RE, 1983, HEMOGLOBIN STRUCTURE; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; Herold S, 2001, J BIOL INORG CHEM, V6, P543, DOI 10.1007/s007750100231; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Nagababu E, 2000, BIOCHEMISTRY-US, V39, P12503, DOI 10.1021/bi992170y; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Rachmilewitz EA, 2001, DISORDERS HEMOGLOBIN, P233; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832	30	92	100	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					697	701		10.1038/nature03609	http://dx.doi.org/10.1038/nature03609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15931225				2022-12-01	WOS:000229476200055
J	Oremland, RS; Kulp, TR; Blum, JS; Hoeft, SE; Baesman, S; Miller, LG; Stolz, JF				Oremland, RS; Kulp, TR; Blum, JS; Hoeft, SE; Baesman, S; Miller, LG; Stolz, JF			A microbial arsenic cycle in a salt-saturated, extreme environment	SCIENCE			English	Article							MONO LAKE WATER; REDUCTION; CALIFORNIA; SEDIMENTS; SULFATE; ECOLOGY	Searles Lake is a salt-saturated, alkaline brine unusually rich in the toxic element arsenic. Arsenic speciation changed from arsenate [As(V)] to arsenite (As(III)) with sediment depth. Incubated anoxic sediment slurries displayed dissimilatory As(V)-reductase activity that was markedly stimulated by H-2 or sulfide, whereas aerobic slurries had rapid As(III)-oxidase activity. An anaerobic, extremely haloalkaliphilic bacterium was isolated from the sediment that grew via As(V) respiration, using either lactate or sulfide as its electron donor. Hence, a full biogeochemical cycle of arsenic occurs in Searles Lake, driven in part by inorganic electron donors.	US Geol Survey, Menlo Pk, CA 94025 USA; Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA	United States Department of the Interior; United States Geological Survey; Duquesne University	Oremland, RS (corresponding author), US Geol Survey, MS 480,345 Middlefield Rd, Menlo Pk, CA 94025 USA.	roremlan@usgs.gov		Baesman, Shaun/0000-0003-0741-8269; Miller, Laurence/0000-0002-7807-3475				Bard A.J., 1985, STANDARD POTENTIALS; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Blum JS, 2001, ARCH MICROBIOL, V175, P208; Brandt KK, 2001, MICROBIAL ECOL, V41, P1; DiPasquale MM, 1998, MICR EXTREM UNUSUAL, P149; FELMY AR, 1986, GEOCHIM COSMOCHIM AC, V50, P2771, DOI 10.1016/0016-7037(86)90226-7; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Hoeft SE, 2004, APPL ENVIRON MICROB, V70, P2741, DOI 10.1128/AEM.70.5.2741-2747.2004; Hoeft SE, 2002, GEOMICROBIOL J, V19, P23, DOI 10.1080/014904502317246147; Hollibaugh JT, 2005, GEOCHIM COSMOCHIM AC, V69, P1925, DOI 10.1016/j.gca.2004.10.011; JAVOR B, 1989, HYPERSALINE ENV; KULP TR, UNPUB; Liu A, 2004, FEMS MICROBIOL ECOL, V48, P323, DOI 10.1016/j.femsec.2004.02.008; Newman DK, 1998, GEOMICROBIOL J, V15, P255, DOI 10.1080/01490459809378082; OREMLAND RS, 1987, GEOCHIM COSMOCHIM AC, V51, P2915, DOI 10.1016/0016-7037(87)90367-X; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Oremland RS, 2004, FEMS MICROBIOL ECOL, V48, P15, DOI 10.1016/j.femsec.2003.12.016; Oremland RS, 2002, APPL ENVIRON MICROB, V68, P4795, DOI 10.1128/AEM.68.10.4795-4802.2002; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Oremland RS, 2000, GEOCHIM COSMOCHIM AC, V64, P3073, DOI 10.1016/S0016-7037(00)00422-1; OREN A, 1988, ADV MICROB ECOL, V10, P193; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren A, 1998, MICR EXTREM UNUSUAL, P1; SMITH GI, 1979, US GEOL SURV PROF PA, V1043, P143; Sorensen KB, 2004, APPL ENVIRON MICROB, V70, P1608, DOI 10.1128/AEM.70.3.1608-1616.2004; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569	27	130	139	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1305	1308		10.1126/science.1110832	http://dx.doi.org/10.1126/science.1110832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15919992				2022-12-01	WOS:000229482300046
J	Rose, R; Weyand, M; Lammers, M; Ishizaki, T; Ahmadian, MR; Wittinghofer, A				Rose, R; Weyand, M; Lammers, M; Ishizaki, T; Ahmadian, MR; Wittinghofer, A			Structural and mechanistic insights into the interaction between Rho and mammalian Dia	NATURE			English	Article							DIAPHANOUS-RELATED FORMIN; SMALL G-PROTEIN; CRYSTAL-STRUCTURE; ACTIN NUCLEATION; EFFECTOR RECOGNITION; SMALL GTPASE; MDIA1; DOMAIN; SWITCH; REORGANIZATION	Formins are involved in a variety of cellular processes that require the remodelling of the cytoskeleton. They contain formin homology domains FH1 and FH2, which initiate actin assembly(1,2). The Diaphanous-related formins form a subgroup that is characterized by an amino-terminal Rho GTPase-binding domain (GBD) and an FH3 domain, which bind somehow to the carboxy-terminal Diaphanous autoregulatory domain ( DAD) to keep the protein in an inactive conformation(3,4). Upon binding of activated Rho proteins, the DAD is released and the ability of the formin to nucleate and elongate unbranched actin filaments is induced. Here we present the crystal structure of RhoC in complex with the regulatory N terminus of mammalian Diaphanous 1 (mDia1) containing the GBD/FH3 region, an all-helical structure with armadillo repeats. Rho uses its 'switch' regions for interacting with two subdomains of GBD/FH3. We show that the FH3 domain of mDia1 forms a stable dimer and we also identify the DAD-binding site. Although binding of Rho and DAD on the N-terminal fragment of mDia1 are mutually exclusive, their binding sites are only partially overlapping. On the basis of our results, we propose a structural model for the regulation of mDia1 by Rho and DAD.	Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	Alfred.wittinghofer@mpi-dortmund.mpg.de	Lammers, Michael/AAX-1164-2020	Lammers, Michael/0000-0003-4168-4640				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; EHRESMAN.B, 1973, ANAL BIOCHEM, V54, P454, DOI 10.1016/0003-2697(73)90374-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kato T, 2001, J CELL SCI, V114, P775; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Krebs A, 2001, J CELL SCI, V114, P3663; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	30	197	206	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					513	518		10.1038/nature03604	http://dx.doi.org/10.1038/nature03604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15864301				2022-12-01	WOS:000229337800058
J	Stein, AJ; Fuchs, G; Fu, CM; Wolin, SL; Reinisch, KM				Stein, AJ; Fuchs, G; Fu, CM; Wolin, SL; Reinisch, KM			Structural insights into RNA quality control: The Ro autoantigen binds misfolded RNAs via its central cavity	CELL			English	Article							SMALL CYTOPLASMIC RIBONUCLEOPROTEINS; 5S RIBOSOMAL-RNA; PROTEIN; RECOGNITION; EVOLUTION; DOMAIN	The Ro 60 kDa autoantigen is a major target of the immune response in patients with systemic lupus erythematosus. In vertebrate cells, Ro binds misfolded small RNAs and likely functions in RNA quality control. In eukaryotes and bacteria, Ro also associates with small RNAs called Y RNAs. We present structures of unliganded Ro and Ro complexed with two RNAs at 1.95 and 2.2 angstrom resolution, respectively. Ro consists of a von Willebrand factor A domain and a doughnut-shaped domain composed of HEAT repeats. In the complex, a fragment of Y RNA binds on the outer surface of the HEAT-repeat ring, and single-stranded RNA binds in the toroid hole. Mutagenesis supports a binding site for misfolded RNAs that encompasses both sites, with a single-stranded end inserted into the toroid cavity. Our experiments suggest that one role of Y RNAs may be to regulate access of other RNAs to Ro.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Reinisch, KM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	karin.reinisch@yale.edu	Wolin, Sandra/H-2333-2016	Wolin, Sandra/0000-0001-6730-0399; Fuchs, Gabriele/0000-0002-6838-2100	NCRR NIH HHS [P41 RR012408] Funding Source: Medline; NIGMS NIH HHS [R01 GM073863, R01 GM070521, R01 GM 48410, R01 GM048410, R01 GM073863-04, R01 GM 70521, R01 GM073863-03, R01 GM073863-01, R01 GM073863-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070521, R01GM073863, R01GM048410] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; Bateman A, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-49; Batey RT, 2001, J MOL BIOL, V307, P229, DOI 10.1006/jmbi.2000.4454; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buyon JP, 2004, LUPUS, V13, P705, DOI 10.1191/0961203304lu2008oa; CARTER DM, 1971, J BIOL CHEM, V246, P2502; Chen XG, 2000, GENE DEV, V14, P777; Chen XG, 2004, J MOL MED, V82, P232, DOI 10.1007/s00109-004-0529-0; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; FARRIS AD, 1995, GENE, V154, P193, DOI 10.1016/0378-1119(94)00823-B; Green CD, 1998, RNA, V4, P750, DOI 10.1017/S1355838298971667; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HENDRICK JP, 1981, MOL CELL BIOL, V1, P1138, DOI 10.1128/MCB.1.12.1138; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; OBRIEN CA, 1993, P NATL ACAD SCI USA, V90, P7250, DOI 10.1073/pnas.90.15.7250; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Patel P, 2002, DERMATOL CLIN, V20, P373, DOI 10.1016/S0733-8635(02)00016-5; PRUIJN GJM, 1991, NUCLEIC ACIDS RES, V19, P5173, DOI 10.1093/nar/19.19.5173; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Shi H, 1996, RNA, V2, P769; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANHORN DJ, 1995, RNA, V1, P293; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WOLIN SL, 1984, P NATL ACAD SCI-BIOL, V81, P1996, DOI 10.1073/pnas.81.7.1996; Xue DH, 2003, P NATL ACAD SCI USA, V100, P7503, DOI 10.1073/pnas.0832411100	37	134	137	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	2005	121	4					529	539		10.1016/j.cell.2005.03.009	http://dx.doi.org/10.1016/j.cell.2005.03.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	929GX	15907467	Bronze, Green Accepted			2022-12-01	WOS:000229331200010
J	Wilson, JF				Wilson, JF			Is sleep the new vital sign?	ANNALS OF INTERNAL MEDICINE			English	News Item							INSULIN-RESISTANCE; APNEA; RISK; DEPRIVATION; DURATION; INTERNS; MEN					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Namen AM, 2001, SOUTHERN MED J, V94, P874; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Quan SF, 2004, GERIATRICS-US, V59, P37; Roehrs T, 2004, SLEEP, V27, P887, DOI 10.1093/sleep/27.5.887; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Tamakoshi A, 2004, SLEEP, V27, P51; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	17	26	26	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2005	142	10					877	880		10.7326/0003-4819-142-10-200505170-00026	http://dx.doi.org/10.7326/0003-4819-142-10-200505170-00026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	926CE	15897548				2022-12-01	WOS:000229099600022
J	Dale, VH; Crisafulli, CM; Swanson, FJ				Dale, VH; Crisafulli, CM; Swanson, FJ			Ecology - 25 years of ecological change at Mount St. Helens	SCIENCE			English	Editorial Material									Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Olympia, WA 98512 USA; US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Corvallis, OR 97331 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Dale, VH (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.	dalevh@ornl.gov	Dale, Virginia/GSO-3448-2022; Dale, Virginia H/B-6023-2009; Dale, Virginia H/ABI-6672-2020	Dale, Virginia H/0000-0002-4123-7202				Dale V, 2005, ECOLOGICAL RESPONSES; Dzurisin D, 2005, EOS T AGU, V86, P25, DOI DOI 10.1029/2005EO030001; Lipman P. W., 1981, GEOL SURV PROF PAPER, V1250, DOI DOI 10.3133/PP1250	3	21	25	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					961	962		10.1126/science.1109684	http://dx.doi.org/10.1126/science.1109684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890864				2022-12-01	WOS:000229190700024
J	Kawakami, Y; Raya, A; Raya, RM; Rodriguez-Esteban, C; Belmonte, JCI				Kawakami, Y; Raya, A; Raya, RM; Rodriguez-Esteban, C; Belmonte, JCI			Retinoic acid signalling links left-right asymmetric patterning and bilaterally symmetric somitogenesis in the zebrafish embryo	NATURE			English	Article							SEGMENTATION CLOCK; NODAL EXPRESSION; VERTEBRATE SEGMENTATION; PRESOMITIC MESODERM; SOMITE SEGMENTATION; AXIS FORMATION; MOTOR PROTEIN; EARLY STEP; GENES; OSCILLATOR	During embryogenesis, cells are spatially patterned as a result of highly coordinated and stereotyped morphogenetic events. In the vertebrate embryo, information on laterality is conveyed to the node, and subsequently to the lateral plate mesoderm, by a complex cascade of epigenetic and genetic events, eventually leading to a left - right asymmetric body plan. At the same time, the paraxial mesoderm is patterned along the anterior - posterior axis in metameric units, or somites, in a bilaterally symmetric fashion. Here we characterize a cascade of laterality information in the zebrafish embryo and show that blocking the early steps of this cascade ( before it reaches the lateral plate mesoderm) results in random left - right asymmetric somitogenesis. We also uncover a mechanism mediated by retinoic acid signalling that is crucial in buffering the influence of the flow of laterality information on the left - right progression of somite formation, and thus in ensuring bilaterally symmetric somitogenesis.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Raya, Angel/E-6205-2010	Raya, Angel/0000-0003-2189-9775; Kawakami, Yasuhiko/0000-0002-0043-9705				Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Campione M, 1999, DEVELOPMENT, V126, P1225; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KANE DA, 1993, DEVELOPMENT, V119, P447; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2003, BIOESSAYS, V25, P1002, DOI 10.1002/bies.10339; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Oates AC, 2002, DEVELOPMENT, V129, P2929; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sawada A, 2000, DEVELOPMENT, V127, P1691; Stickney HL, 2000, DEV DYNAM, V219, P287; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; VERMOT J, NATURE; Weinmaster G, 2003, ANNU REV CELL DEV BI, V19, P367, DOI 10.1146/annurev.cellbio.19.111301.115434; Westerfield M., 1993, GUIDE LAB USE ZEBRAF; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zile MH, 2000, DEV BIOL, V223, P323, DOI 10.1006/dbio.2000.9754	50	208	224	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					165	171		10.1038/nature03512	http://dx.doi.org/10.1038/nature03512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889082				2022-12-01	WOS:000229021100030
J	Moore, P				Moore, P			Simplifying the probe set	NATURE			English	Article																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					238	238		10.1038/435238a	http://dx.doi.org/10.1038/435238a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889103	Bronze			2022-12-01	WOS:000229021100052
J	Berk, DR; Falkovitz-Halpern, MS; Hill, DW; Albin, C; Arrieta, A; Bork, JM; Cohan, D; Nilson, B; Petru, A; Ruiz, J; Weintrub, PS; Wenman, W; Maldonado, YA				Berk, DR; Falkovitz-Halpern, MS; Hill, DW; Albin, C; Arrieta, A; Bork, JM; Cohan, D; Nilson, B; Petru, A; Ruiz, J; Weintrub, PS; Wenman, W; Maldonado, YA		California Pediat HIV Study Grp	Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PROTEASE INHIBITOR; 1-INFECTED INFANTS; COMBINATION THERAPY; DISEASE PROGRESSION; FOLLOW-UP; CHILDREN; ZIDOVUDINE	Context The effect of early antiretroviral therapy (ART) on the early progression of perinatal human immunodeficiency virus (HIV) infection is not well defined. Objective To examine early disease progression and survival in a population-based cohort with perinatal HIV infection in relation to year of birth and use of ART. Design, Setting, and Patients Retrospective study of temporal trends in early progression of perinatal HIV infection among 205 HIV-infected children in Northern California born between January 1, 1988, and December 31, 2001, and followed up through age 3 years. Main Outcome Measures Prevalence of and age at progression to a first US Centers for Disease Control and Prevention category C diagnosis relative to year of birth, type of ART, and age at initiation of therapy. Results Of 205 children, 134 (65%)received ART and/or Pneumocystis jiroveci pneumonia prophylaxis. By age 3 years, 81 (40%) progressed to a category C diagnosis, 41 (51%) of whom died. Untreated children were significantly more likely to progress to a category C diagnosis (62% [44/71] untreated vs 28% [37/134] treated children, P<.001); none of 23 infants who received triple ART progressed to category C. However, even without triple ART, very early mono/dual ART (by age 2 months vs 3-4 months) was associated with delayed and decreased progression to category C (P=.02). Of 33 children born between January 1, 1996, and December 31, 2001, only 7 (21%) progressed to category C (P=.02 compared with 1988-1995), 6 of 7 of whom received no therapy. More recent year of birth and more advanced therapy were associated with improved survival. Conclusions This population-based cohort demonstrated decreased early HIV progression and improved survival at age 3 years, associated with more advanced therapy. Although limited by small sample size, the findings suggest that very early treatment, even without triple ART, was associated with improved outcome.	Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA; Santa Clara Valley Med Ctr, Dept Pediat, San Jose, CA 95128 USA; Childrens Hosp Orange Cty, Orange, CA 92668 USA; Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Bay Area Perinatal AIDS Ctr, San Francisco, CA USA; Univ Med Ctr, Specialty Serv, Fresno, CA USA; Calif Dept Hlth Serv, Off AIDS, Sacramento, CA USA; Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; Univ Calif Davis, Sacramento, CA 95817 USA	Stanford University; Santa Clara Valley Medical Center; Childrens Hospital of Orange County; Children's Hospital Los Angeles; Loma Linda University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; California Department of Health Care Services; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Davis	Maldonado, YA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, G312B ID,MC 5208, Stanford, CA 94305 USA.	bonniem@stanford.edu						Aboulker JP, 2004, AIDS, V18, P237, DOI [10.1097/00002030-200401230-00013, 10.1097/01.aids.0000111388.02002.6b]; Aboulker JP, 2001, ARCH DIS CHILD, V84, P230, DOI 10.1136/adc.84.3.230; Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; Barnett AA, 1996, LANCET, V347, P678; Blanche S, 1997, J ACQ IMMUN DEF SYND, V14, P442, DOI 10.1097/00042560-199704150-00008; BLANCHE S, 1990, AM J DIS CHILD, V144, P1210, DOI 10.1001/archpedi.1990.02150350042021; Blazevic V, 2001, CLIN DIAGN LAB IMMUN, V8, P943, DOI 10.1128/CDLI.8.5.943-948.2001; *CAL DEP HLTH SERV, 2001, CAL CHILDB WOM COMP; Centers for Disease Control and Prevention, 2005, HIV AIDS SURV REP; Chougnet C, 2001, J INFECT DIS, V184, P201, DOI 10.1086/322006; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 1998, J PEDIATR-US, V132, P808, DOI 10.1016/S0022-3476(98)70308-7; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; DULIEGE AM, 1992, PEDIATR INFECT DIS J, V11, P630; Englund JA, 1997, NEW ENGL J MED, V336, P1704, DOI 10.1056/NEJM199706123362403; Faye A, 2004, CLIN INFECT DIS, V39, P1692, DOI 10.1086/425739; Faye A, 2002, PEDIATR INFECT DIS J, V21, P518, DOI 10.1097/00006454-200206000-00008; *FDA, 1990, ONCOLOGY HUNTINGT, V4, P96; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Hainaut M, 2000, EUR J PEDIATR, V159, P778, DOI 10.1007/PL00008346; Jankelevich S, 2001, J INFECT DIS, V183, P1116, DOI 10.1086/319274; *JOINT UN PROGR HI, 2003, AIDS EP UPD; Krogstad P, 1999, CLIN INFECT DIS, V28, P1109, DOI 10.1086/514759; LOBATO MN, 1995, J PEDIATR-US, V126, P710, DOI 10.1016/S0022-3476(95)70397-7; LOYAL JK, 2002, 14 INT AIDS C JUL 7; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; MALDONADO YA, 1995, J INFECT DIS, V171, P689, DOI 10.1093/infdis/171.3.689; Maldonado YA, 1998, PEDIATR INFECT DIS J, V17, P398, DOI 10.1097/00006454-199805000-00010; MAWHINNEY S, 1993, J ACQ IMMUN DEF SYND, V6, P1139; MCKINNEY RE, 1991, NEW ENGL J MED, V324, P1018, DOI 10.1056/NEJM199104113241503; Mueller BU, 1998, PEDIATRICS, V101, P335, DOI 10.1542/peds.101.3.335; Nachman SA, 2000, JAMA-J AM MED ASSOC, V283, P492, DOI 10.1001/jama.283.4.492; Palumbo P, 2002, CLIN LAB MED, V22, P759, DOI 10.1016/S0272-2712(02)00010-0; Rich KC, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e8; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; SANCHEZ JM, 2003, PEDIATR INFECT DIS J, V22, P863; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Stephenson J, 1997, JAMA-J AM MED ASSOC, V277, P614, DOI 10.1001/jama.277.8.614; Sullivan JL, 2001, NEW ENGL J MED, V345, P1568, DOI 10.1056/NEJM200111223452111; *US PUBL HLTH SERV, 1995, MMWR-MORBID MORTAL W, V44, P1; Wade NA, 2004, JAIDS-J ACQ IMM DEF, V36, P1075, DOI 10.1097/00126334-200408150-00011; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007; Wiznia A, 2000, AIDS RES HUM RETROV, V16, P1113, DOI 10.1089/088922200414956; *WORK GROUP ANT TH, 2004, GUID US ANT AG PED H; 1994, MMWR MORB MORTAL WKL, V43, P285	52	47	48	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2221	2231		10.1001/jama.293.18.2221	http://dx.doi.org/10.1001/jama.293.18.2221			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886377	Bronze			2022-12-01	WOS:000228981100023
J	Kroymann, J; Mitchell-Olds, T				Kroymann, J; Mitchell-Olds, T			Epistasis and balanced polymorphism influencing complex trait variation	NATURE			English	Article							ARABIDOPSIS-THALIANA; GENETIC-VARIATION; DNA POLYMORPHISM; KINASE; ARCHITECTURE; DROSOPHILA; EVOLUTION; ENCODES; LOCUS	Complex traits such as human disease, growth rate, or crop yield are polygenic, or determined by the contributions from numerous genes in a quantitative manner. Although progress has been made in identifying major quantitative trait loci (QTL), experimental constraints have limited our knowledge of small-effect QTL, which may be responsible for a large proportion of trait variation(1-3). Here, we identified and dissected a one-centimorgan chromosome interval in Arabidopsis thaliana without regard to its effect on growth rate, and examined the signature of historical sequence polymorphism among Arabidopsis accessions. We found that the interval contained two growth rate QTL within 210 kilobases. Both QTL showed epistasis; that is, their phenotypic effects depended on the genetic background. This amount of complexity in such a small area suggests a highly polygenic architecture of quantitative variation, much more than previously documented(4). One QTL was limited to a single gene. The gene in question displayed a nucleotide signature indicative of balancing selection, and its phenotypic effects are reversed depending on genetic background. If this region typifies many complex trait loci, then non-neutral epistatic polymorphism may be an important contributor to genetic variation in complex traits.	Max Planck Inst Chem Ecol, Dept Genet & Evolut, D-07745 Jena, Germany	Max Planck Society	Kroymann, J (corresponding author), Max Planck Inst Chem Ecol, Dept Genet & Evolut, Hans Knoell Str 8, D-07745 Jena, Germany.	kroymann@ice.mpg.de	Kroymann, Juergen/B-4317-2013; Kroymann, Juergen/AAY-8562-2021; Mitchell-Olds, Thomas/K-8121-2012	Kroymann, Juergen/0000-0002-4573-6498; Mitchell-Olds, Thomas/0000-0003-3439-9921				Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; Dilda CL, 2002, GENETICS, V162, P1655; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Haubold B, 2002, GENETICS, V161, P1269; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lauter N, 2002, GENETICS, V160, P333; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAJIMA F, 1989, GENETICS, V123, P585; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	22	214	221	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2005	435	7038					95	98		10.1038/nature03480	http://dx.doi.org/10.1038/nature03480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875023				2022-12-01	WOS:000228864600045
J	Panakova, D; Sprong, H; Marois, E; Thiele, C; Eaton, S				Panakova, D; Sprong, H; Marois, E; Thiele, C; Eaton, S			Lipoprotein particles are required for Hedgehog and Wingless signalling	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-ADHESION MOLECULE; INTERCELLULAR TRANSFER; SONIC HEDGEHOG; MULTIVESICULAR BODY; DROSOPHILA; PROTEIN; RECEPTOR; GRADIENT; DOMAIN	Wnt and Hedgehog family proteins are secreted signalling molecules (morphogens) that act at both long and short range to control growth and patterning during development. Both proteins are covalently modified by lipid, and the mechanism by which such hydrophobic molecules might spread over long distances is unknown. Here we show that Wingless, Hedgehog and glycophosphatidylinositol-linked proteins copurify with lipoprotein particles, and co-localize with them in the developing wing epithelium of Drosophila. In larvae with reduced lipoprotein levels, Hedgehog accumulates near its site of production, and fails to signal over its normal range. Similarly, the range of Wingless signalling is narrowed. We propose a novel function for lipoprotein particles, in which they act as vehicles for the movement of lipid-linked morphogens and glycophosphatidylinositol-linked proteins.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Thiele, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	thiele@mpi-cbg.de; eaton@mpi-cbg.de	Marois, Eric/H-9246-2016; Marois, Eric/AAZ-5549-2021; Eaton, Suzanne/D-7698-2017	Marois, Eric/0000-0003-4147-3747; Marois, Eric/0000-0003-4147-3747; Eaton, Suzanne/0000-0002-8319-284X; Sprong, Hein/0000-0002-0218-4320; Panakova, Daniela/0000-0002-8739-6225				Anderson SM, 1996, P NATL ACAD SCI USA, V93, P5894, DOI 10.1073/pnas.93.12.5894; Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Butler SJ, 1997, DEVELOPMENT, V124, P781; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Denzer K, 2000, J CELL SCI, V113, P3365; Dunn DE, 1996, P NATL ACAD SCI USA, V93, P7938, DOI 10.1073/pnas.93.15.7938; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; Incardona JP, 1996, MOL BIOL CELL, V7, P613, DOI 10.1091/mbc.7.4.613; Klueg KM, 1999, J CELL SCI, V112, P3289; Kutty RK, 1996, J BIOL CHEM, V271, P20641, DOI 10.1074/jbc.271.34.20641; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Mahley RW, 1999, J LIPID RES, V40, P1; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Micchelli CA, 2002, DEVELOPMENT, V129, P843; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; NEUMANN CJ, 1997, DEVELOPMENT, V124, P861; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1997, DEVELOPMENT, V124, P4697; Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TAYLOR AM, 1993, MECH DEVELOP, V42, P89, DOI 10.1016/0925-4773(93)90101-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams KP, 1999, J CELL SCI, V112, P4405; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	48	492	511	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					58	65		10.1038/nature03504	http://dx.doi.org/10.1038/nature03504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875013				2022-12-01	WOS:000228864600035
J	Jeffcoate, W; Bakker, K				Jeffcoate, W; Bakker, K			World Diabetes Day: footing the bill	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England; Int Diabet Federat, Consultat Sect Diabet Foot, Heemstede, Netherlands		Jeffcoate, W (corresponding author), The Lancet, 32 Jamestown Rd, London NW1 7BY, England.	william.jeffcoate@lancet.com						Apelqvist J, 2000, DIABETES-METAB RES, V16, pS84, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR113>3.0.CO;2-S; *INT WORK GROUP DI, 2003, INT CONS DIAB FOOT P; Meltzer DD, 2002, J AM PODIAT MED ASSN, V92, P425, DOI 10.7547/87507315-92-8-425; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Tennvall GR, 2004, CLIN INFECT DIS, V39, pS132, DOI 10.1086/383275; Tentolouris N, 2004, DIABETES CARE, V27, P1598, DOI 10.2337/diacare.27.7.1598; Tsalikian E, 2004, DIABETES CARE, V27, P722; Vileikyte L, 2004, DIABETES-METAB RES, V20, pS13, DOI 10.1002/dmrr.437	8	43	44	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1527	1527		10.1016/S0140-6736(05)66437-9	http://dx.doi.org/10.1016/S0140-6736(05)66437-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866295				2022-12-01	WOS:000228754800010
J	Allen, E; Xie, ZX; Gustafson, AM; Carrington, JC				Allen, E; Xie, ZX; Gustafson, AM; Carrington, JC			microRNA-directed phasing during trans-acting siRNA biogenesis in plants	CELL			English	Article							DEPENDENT RNA-POLYMERASE; DSRNA-BINDING-PROTEIN; ARABIDOPSIS-THALIANA; NUCLEAR EXPORT; CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; LEAF POLARITY; GENES; INITIATION; MIRNA	Plants and animals use small RNAs (microRNAs [miRNAs] and siRNAs) as guides for posttranscriptional and epigenetic regulation. In plants, miRNAs and trans-acting (ta) siRNAs form through distinct biogenesis pathways, although they both interact with target transcripts and guide cleavage. An integrated approach to identify targets of Arabidopsis thaliana miRNAs and ta-siRNAs revealed several new classes of small RNA-regulated genes, including conventional genes such as Argonaute2 and an E2-ubiquitin conjugating enzyme. Surprisingly, five tasiRNA-generating transcripts were identified as targets of miR173 or miR390. Rather than functioning as negative regulators, miR173- and miR390-guided cleavage was shown to set the 21-nucleotide phase for ta-siRNA precursor processing. These data support a model in which miRNA-guided formation of a 5' or 3' terminus within pre-ta-siRNA transcripts, followed by RDR6-dependent formation of dsRNA and Dicer-like processing, yields phased ta-siRNAs that negatively regulate other genes.	Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Carrington, JC (corresponding author), Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	Carrington, James/A-4656-2012	Carrington, James/0000-0003-3572-129X; Xie, Zhixin/0000-0002-6191-5170; Allen, Edwards/0000-0002-8318-6319	NIAID NIH HHS [AI43288] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043288, R21AI043288, R01AI043288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Guan HC, 2000, P NATL ACAD SCI USA, V97, P12451, DOI 10.1073/pnas.97.23.12451; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lappartient AG, 1999, PLANT J, V18, P89, DOI 10.1046/j.1365-313X.1999.00416.x; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; RAO ALN, 1989, P NATL ACAD SCI USA, V86, P5335, DOI 10.1073/pnas.86.14.5335; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sessions A, 1997, DEVELOPMENT, V124, P4481; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	66	1647	1826	7	251	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					207	221		10.1016/j.cell.2005.04.004	http://dx.doi.org/10.1016/j.cell.2005.04.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851028	Bronze			2022-12-01	WOS:000228705000009
J	Kwiterovich, PO; Cockrill, SL; Virgil, DG; Garrett, ES; Otvos, J; Knight-Gibson, C; Alaupovic, P; Forte, T; Zhang, L; Farwig, ZN; Macfarlane, RD				Kwiterovich, PO; Cockrill, SL; Virgil, DG; Garrett, ES; Otvos, J; Knight-Gibson, C; Alaupovic, P; Forte, T; Zhang, L; Farwig, ZN; Macfarlane, RD			A large high-density lipoprotein enriched in apolipoprotein C-I - A novel biochemical marker in infants of lower birth weight and younger gestational age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAUTERINE GROWTH RESTRICTION; ESTER TRANSFER PROTEIN; HUMAN CORD BLOOD; TRIGLYCERIDE-RICH LIPOPROTEINS; CHOLESTEROL ACYLTRANSFERASE; SUBCLASS DISTRIBUTION; PLACENTAL APOPTOSIS; MASS-SPECTROMETRY; HEPATIC LIPASE; HUMAN-PLASMA	Context Low birth weight is associated with increased cardiovascular disease in adulthood, and differences in the molecular weight, composition, and quantity of lipoprotein subclasses are associated with coronary artery disease. Objective To determine if there are novel patterns of lipoprotein heterogeneity in low-birth-weight infants. Design, Setting, and Participants Prospective study at a US medical center of a representative sample of infants (n = 163; 70 white and 93 black) born at 28 or more weeks of gestational age between January 3, 2000, and September 27, 2000. This sample constituted 20% of all infants born during the study period at this site. Main Outcome Measures Plasma levels and particle sizes of lipoprotein subclasses and plasma concentrations of lipids, lipoproteins (high-density lipoprotein [HDL] and low-density lipoprotein [LDL]), and apolipoproteins. Results An elevated lipoprotein peak of a particle with density between 1.062 and 1.072 g/mL was identified using physical-chemical methods. This subclass of large HDL was enriched in apolipoprotein C-I (apo C-I). Based on the amount of the apo C-I-enriched HDL peak, 156 infants were assigned to 1 of 4 groups: 0 (none detected), 17%; 1 (possibly present), 41%; 2 (probably present), 22%; 3 (elevated), 19%. Infants in group 3, compared with those in the other 3 groups, had significantly (P < .001) lower mean birth weight (2683.7 vs 3307.1 g) and younger mean gestational age (36.2 vs 39.3 wk). After correction for age, infants in group 3 had significantly higher levels of total and large HDL cholesterol and of total and large LDL cholesterol and LDL particle number. However, infants in group 3 had lower levels of small HDL, very low-density lipoproteins, and triglycerides than infants in the other 3 groups. This lipoprotein profile differed from that in infants born small for gestational age, who had significantly higher triglyceride (P < .001) and apo B (P = .04) levels, but lower levels of total and large HDL cholesterol (P < .001) and apo A-I (P < .001). Conclusions Because apo C-l-enriched HDL, and purified apo C-I alone, promotes apoptosis in vitro, increased amounts of this particle may have physiological significance and identify a novel group of low-birth-weight infants apparently distinct from traditionally classified small-for-gestational-age infants.	Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Texas A&M Univ, Lab Cardiovasc Chem, College Stn, TX USA; LipoSci Inc, Raleigh, NC USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Calif Berkeley, Donner Lab, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Medicine; Texas A&M University System; Texas A&M University College Station; LipoScience, Inc; Oklahoma Medical Research Foundation; University of California System; University of California Berkeley	Kwiterovich, PO (corresponding author), 550 N Broadway,Suite 308, Baltimore, MD 21205 USA.	pkwitero@jhmi.edu		Garrett-Mayer, Elizabeth/0000-0003-4709-0333	NCRR NIH HHS [M01-RR-00052] Funding Source: Medline; NHLBI NIH HHS [HL 68794, HL 18574, HL 54566] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068794, P01HL018574, R01HL054566] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aban M, 2004, TOHOKU J EXP MED, V204, P195, DOI 10.1620/tjem.204.195; ALBERS JJ, 1979, ARTERY, V5, P61; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Bjorkegren J, 2002, ARTERIOSCL THROM VAS, V22, P1470, DOI 10.1161/01.ATV.0000029972.42487.42; Bjorkegren J, 2000, CIRCULATION, V101, P227, DOI 10.1161/01.CIR.101.3.227; BLUM CB, 1985, J LIPID RES, V26, P755; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Conde-Knape K, 2002, J LIPID RES, V43, P2136, DOI 10.1194/jlr.M200210-JLR200; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; CURRY MD, 1981, CLIN CHEM, V27, P543; DAVIS PA, 1983, BIOCHIM BIOPHYS ACTA, V753, P186, DOI 10.1016/0005-2760(83)90006-1; DAVIS PA, 1983, ARTERIOSCLEROSIS, V3, P357, DOI 10.1161/01.ATV.3.4.357; DIAZ M, 1989, METABOLISM, V38, P435, DOI 10.1016/0026-0495(89)90194-7; Farwig ZN, 2003, ANAL CHEM, V75, P3823, DOI 10.1021/ac026273p; Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200; GENZELBOROVICZENY O, 1988, PEDIATR RES, V23, P543, DOI 10.1203/00006450-198806000-00001; GENZELBOROVICZENY O, 1986, PEDIATR RES, V20, P487, DOI 10.1203/00006450-198606000-00001; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Kaser S, 2001, METABOLISM, V50, P723, DOI 10.1053/meta.2001.23307; KHERKEULIDZE P, 1991, ACTA PAEDIATR SCAND, V80, P770, DOI 10.1111/j.1651-2227.1991.tb11947.x; KLIMOV AN, 1979, PEDIATR RES, V13, P208, DOI 10.1203/00006450-197903000-00018; Kolmakova A, 2004, ARTERIOSCL THROM VAS, V24, P264, DOI 10.1161/01.ATV.0000112036.72200.ac; Kwiterovich PO, 2004, ETHNIC DIS, V14, P351; Kwiterovich PO, 2002, AM J CARDIOL, V90, p1I, DOI 10.1016/S0002-9149(02)02796-0; LACKO AG, 1972, LIPIDS, V7, P426, DOI 10.1007/BF02531515; Macfarlane RD, 1997, ELECTROPHORESIS, V18, P1796, DOI 10.1002/elps.1150181014; Mayhew TM, 2004, PLACENTA, V25, P829, DOI 10.1016/j.placenta.2004.04.011; Merzouk H, 1997, ACTA PAEDIATR, V86, P528, DOI 10.1111/j.1651-2227.1997.tb08925.x; Nagasaka H, 2002, ATHEROSCLEROSIS, V161, P215, DOI 10.1016/S0021-9150(01)00663-3; Navab M, 2001, J LIPID RES, V42, P1308; NICHOLS AV, 1991, BIOCHIM BIOPHYS ACTA, V1085, P306, DOI 10.1016/0005-2760(91)90134-4; OTVOS JD, 2000, HDB LIPOPROTEIN TEST, P609; Radunovic N, 2000, J CLIN ENDOCR METAB, V85, P85, DOI 10.1210/jc.85.1.85; ROSSENEU M, 1983, PEDIATR RES, V17, P788, DOI 10.1203/00006450-198310000-00004; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shachter NS, 2001, CURR OPIN LIPIDOL, V12, P297, DOI 10.1097/00041433-200106000-00009; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; WINDLER E, 1985, J LIPID RES, V26, P556; WINDLER EET, 1980, J BIOL CHEM, V255, P464; Xu Y, 1999, J LIPID RES, V40, P50; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	43	18	21	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1891	1899		10.1001/jama.293.15.1891	http://dx.doi.org/10.1001/jama.293.15.1891			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840864	Bronze			2022-12-01	WOS:000228401700028
J	Charest, MG; Lerner, CD; Brubaker, JD; Siege, DR; Myers, AG				Charest, MG; Lerner, CD; Brubaker, JD; Siege, DR; Myers, AG			A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics	SCIENCE			English	Article							RIBOSOMAL-SUBUNIT; BENZOIC-ACID; TETRACYCLINES; DERIVATIVES; CHEMISTRY; ALCOHOLS	Complex antibiotics based on natural products are almost invariably prepared by semisynthesis, or chemical transformation of the isolated natural products. This approach greatly limits the range of accessible structures that might be studied as new antibiotic candidates. Here we report a short and enantioselective synthetic route to a diverse range of 6-deoxytetracycline antibiotics. The common feature of this class is a scaffold of four linearly fused rings, labeled A through D. We targeted not a single compound but a group of structures with the D ring as a site of structural variability. A late-stage, diastereoselective C-ring construction was used to couple structurally varied D-ring precursors with an AB precursor containing much of the essential functionality for binding to the bacterial ribosome. Five derivatives were synthesized from benzoic acid in yields ranging from 5 to 7% over 14 to 15 steps, and a sixth, (-)-doxycycline, was synthesized in 8.3% yield over 18 steps.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Myers, AG (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	myers@chemistry.harvard.edu			NIAID NIH HHS [AI48825] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048825] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMYYES SGB, 2001, MAGIC BULLETS LOST H; BERK SC, 1990, ORGANOMETALLICS, V9, P3053, DOI 10.1021/om00162a016; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Bush K, 2004, CURR OPIN MICROBIOL, V7, P466, DOI 10.1016/j.mib.2004.08.013; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; COREY EJ, 1981, TETRAHEDRON LETT, V22, P3455, DOI 10.1016/S0040-4039(01)81930-4; DAVIS FA, 1992, J ORG CHEM, V57, P7274, DOI 10.1021/jo00052a050; Dodd J.H., 1979, TETRAHEDRON LETT, V20, P3593; FRIGERIO M, 1994, TETRAHEDRON LETT, V35, P8019, DOI 10.1016/0040-4039(94)80038-3; GUREVICH AI, 1967, TETRAHEDRON LETT, V8, P131; HAUSER FM, 1980, SYNTHESIS-STUTTGART, P72; HAUSER FM, 1978, J ORG CHEM, V43, P178, DOI 10.1021/jo00395a048; Ho T.-L., 1992, TANDEM ORGANIC REACT; Katz L, 1997, CHEM REV, V97, P2557, DOI 10.1021/cr960025+; KORST JJ, 1968, J AM CHEM SOC, V90, P439, DOI 10.1021/ja01004a041; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; LEEPER FJ, 1978, J CHEM SOC CHEM COMM, P406, DOI 10.1039/c39780000406; MUXFELDT H, 1979, J AM CHEM SOC, V101, P689, DOI 10.1021/ja00497a035; Myers AG, 2001, ORG LETT, V3, P2923, DOI 10.1021/ol010151m; Myers AG, 1996, TETRAHEDRON LETT, V37, P4841, DOI 10.1016/0040-4039(96)00965-3; NELSON M, 2001, TETRACYCLINES BIOL C; PARHAM WE, 1976, J ORG CHEM, V41, P1184, DOI 10.1021/jo00869a022; PEVARELLO P, 1992, SYNTHETIC COMMUN, V22, P1939, DOI 10.1080/00397919208021324; Pine S.H., 1970, ORGANIC REACTIONS, P403; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Prilezhaeva E. N., 2001, RUSS CHEM REV, V70, P897; REINER AM, 1971, BIOCHEMISTRY-US, V10, P2530, DOI 10.1021/bi00789a017; ROGALSKI W, 1985, HDB EXPT PHARM, V78, pCH5; STEPHENS CR, 1963, J AM CHEM SOC, V85, P2643, DOI 10.1021/ja00900a027; Stork G, 1996, J AM CHEM SOC, V118, P5304, DOI 10.1021/ja960434n; STORK G, 1978, J AM CHEM SOC, V100, P3609, DOI 10.1021/ja00479a060; Strohl WR, 2001, METAB ENG, V3, P4, DOI 10.1006/mben.2000.0172; Sum PE, 1999, BIOORG MED CHEM LETT, V9, P1459, DOI 10.1016/S0960-894X(99)00216-4; Tatsuta K, 2000, CHEM LETT, P646, DOI 10.1246/cl.2000.646; VYAS DM, 1984, TETRAHEDRON LETT, V25, P487, DOI 10.1016/S0040-4039(00)99918-0; Walsh C., 2003, ANTIBIOTICS ACTIONS; WHITE JD, 1986, J ORG CHEM, V51, P1150, DOI 10.1021/jo00357a047	37	231	248	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2005	308	5720					395	398		10.1126/science.1109755	http://dx.doi.org/10.1126/science.1109755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	917TL	15831754				2022-12-01	WOS:000228492000047
J	Kohfeld, KE; Le Quere, C; Harrison, SP; Anderson, RF				Kohfeld, KE; Le Quere, C; Harrison, SP; Anderson, RF			Role of marine biology in glacial-interglacial CO2 cycles	SCIENCE			English	Article							SOUTHERN-OCEAN; ATMOSPHERIC CO2; PHYTOPLANKTON BLOOM; IRON ENRICHMENT; CARBON-CYCLE; BOX MODELS; RECORDS; PACIFIC; PUMP; REPRESENTATION	It has been hypothesized that changes in the marine biological pump caused a major portion of the glacial reduction of atmospheric carbon dioxide by 80 to 100 parts per million through increased iron fertilization of marine plankton, increased ocean nutrient content or utilization, or shifts in dominant plankton types. We analyze sedimentary records of marine productivity at the peak and the middle of the last glacial cycle and show that neither changes in nutrient utilization in the Southern Ocean nor shifts in plankton dominance explain the CO2 drawdown. Iron fertilization and associated mechanisms can be responsible for no more than half the observed drawdown.	Max Planck Inst Biogeochem, Jena, Germany; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA	Max Planck Society; Columbia University; Columbia University	Kohfeld, KE (corresponding author), CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA.	office@kohfeld.com	Le Quere, Corinne/C-2631-2017	Le Quere, Corinne/0000-0003-2319-0452; Harrison, Sandy/0000-0001-5687-1903; Kohfeld, Karen/0000-0001-7241-1624; Anderson, Robert/0000-0002-8472-2494				Anderson DM, 2002, NATURE, V416, P70, DOI 10.1038/416070a; Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Archer DE, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000760; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Bijma J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000388; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Bopp L, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000810; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Broecker W, 1999, GLOBAL BIOGEOCHEM CY, V13, P817, DOI 10.1029/1999GB900050; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Budziak D, 2000, PALEOCEANOGRAPHY, V15, P307, DOI 10.1029/1999PA000433; Calvo E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000992; Catubig NR, 1998, PALEOCEANOGRAPHY, V13, P298, DOI 10.1029/98PA00609; Clemens SC, 1990, PALEOCEANOGRAPHY, V5, P109, DOI 10.1029/PA005i002p00109; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; CONKRIGHT ME, 2002, 46 NOAA NESDIS, V5; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; Elderfield H, 2000, NATURE, V405, P305, DOI 10.1038/35012507; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; HESSE PP, 1994, QUATERNARY SCI REV, V13, P257, DOI 10.1016/0277-3791(94)90029-9; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Ikehara M, 2000, PALEOCEANOGRAPHY, V15, P170, DOI 10.1029/1999PA000425; Kaplan JO, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013366; Kawahata H, 2000, QUATERNARY SCI REV, V19, P1279, DOI 10.1016/S0277-3791(99)00096-7; Kawahata H., 1999, J OCEANOGR, V55, P747; Kohfeld KE, 2001, EARTH-SCI REV, V54, P81, DOI 10.1016/S0012-8252(01)00042-3; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez P, 1996, ORG GEOCHEM, V24, P411, DOI 10.1016/0146-6380(96)00044-7; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Muller PJ, 1997, PALAEOGEOGR PALAEOCL, V135, P71, DOI 10.1016/S0031-0182(97)00018-7; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Robinson RS, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000996; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P65, DOI 10.1029/1999PA000369; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; SCHNEIDER S, 2002, BER FACHBER GEOWISS, V187, P134; Sicre MA, 2000, ORG GEOCHEM, V31, P577, DOI 10.1016/S0146-6380(00)00021-8; Sigman DM, 1999, PALEOCEANOGRAPHY, V14, P118, DOI 10.1029/1998PA900018; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001841; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001401; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; XIE LS, 1995, FISH OCEANOGR, V4, P52, DOI 10.1111/j.1365-2419.1995.tb00060.x	53	288	296	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2005	308	5718					74	78		10.1126/science.1105375	http://dx.doi.org/10.1126/science.1105375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914IQ	15802597				2022-12-01	WOS:000228221500035
J	Okie, S				Okie, S			Perspective: Raising the safety bar - the FDA's coxib meeting.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; HARRIS G, 2005, NY TIMES        0827, pA1; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405	4	43	43	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2005	352	13					1283	1285		10.1056/NEJMp058055	http://dx.doi.org/10.1056/NEJMp058055			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JL	15800221				2022-12-01	WOS:000227998300001
J	Ali, Y				Ali, Y			Always trust your gut feeling	LANCET			English	Editorial Material									Brown Univ, Dept Med, Providence, RI 02906 USA	Brown University	Ali, Y (corresponding author), Brown Univ, Dept Med, 49 Seekonk St, Providence, RI 02906 USA.	yali@lifespan.org							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2005	365	9465					1201	1201		10.1016/S0140-6736(05)71884-5	http://dx.doi.org/10.1016/S0140-6736(05)71884-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	910DD	15794976				2022-12-01	WOS:000227909500034
